Citrus Sinensis ID: 010088
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 518 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FX99 | 663 | Probable receptor-like pr | yes | no | 0.965 | 0.754 | 0.610 | 0.0 | |
| C0LGD7 | 953 | Probable LRR receptor-lik | no | no | 0.629 | 0.342 | 0.428 | 3e-68 | |
| Q9SA72 | 849 | Probable receptor-like pr | no | no | 0.650 | 0.396 | 0.405 | 1e-65 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.733 | 0.746 | 0.358 | 1e-64 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.723 | 0.528 | 0.345 | 3e-64 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.536 | 0.408 | 0.429 | 7e-64 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.544 | 0.393 | 0.416 | 3e-63 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.750 | 0.758 | 0.344 | 5e-63 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.538 | 0.673 | 0.446 | 1e-62 | |
| Q9LFV3 | 436 | Probable leucine-rich rep | no | no | 0.525 | 0.623 | 0.409 | 2e-62 |
| >sp|Q9FX99|Y1497_ARATH Probable receptor-like protein kinase At1g49730 OS=Arabidopsis thaliana GN=At1g49730 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 635 bits (1638), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/524 (61%), Positives = 404/524 (77%), Gaps = 24/524 (4%)
Query: 1 MLYLHHVVGAE-DNMTLSTCRDATFAALASQLDNVSAIEIASCFFQVRRLNIPPVSEPSS 59
+ YL +++GAE +N+TL TCRDAT+A LAS++D+ SA+E+ SCFFQV LNIP SE S
Sbjct: 158 ITYLRNLIGAETNNITLCTCRDATYATLASRIDDTSALELLSCFFQVTELNIP--SESFS 215
Query: 60 SMLAPKASPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILI 119
+ +P+ SPS + +SPS + + + +PYHLT++P IGI VTAVA+ +L+VL+ILI
Sbjct: 216 PVASPEPSPSTVGGISPSNSDSQMTTSRSTNPYHLTMVPTIGIVVTAVALTMLVVLVILI 275
Query: 120 RRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEG-PSPMFQKFSYKETKKATDNFSTIIGQ 178
RRK+R L++ E+LD+ S K P + K E S F+KFSYKE AT++F+T+IGQ
Sbjct: 276 RRKNRELDESESLDRKSTKSVPSSLPVFKIHEDDSSSAFRKFSYKEMTNATNDFNTVIGQ 335
Query: 179 GGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE 238
GGFGTVYKA+F+DG + AVK+M+K+SEQ E DFCREI LLA+LHHR+LVAL+GFCI K+E
Sbjct: 336 GGFGTVYKAEFNDGLIAAVKKMNKVSEQAEQDFCREIGLLAKLHHRNLVALKGFCINKKE 395
Query: 239 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSS 298
RFL+Y+YM NGSLKDHLH+ G+ P SW TR++IAIDVANALEYLHFYCDPPLCHRDIKSS
Sbjct: 396 RFLVYDYMKNGSLKDHLHAIGKPPPSWGTRMKIAIDVANALEYLHFYCDPPLCHRDIKSS 455
Query: 299 NILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYS 358
NILLDENFVAKL+DFGLAH+S+DGS+CFEPVNTDIRGTPGY+DPEYVVTQELTEKSDVYS
Sbjct: 456 NILLDENFVAKLSDFGLAHSSRDGSVCFEPVNTDIRGTPGYVDPEYVVTQELTEKSDVYS 515
Query: 359 YGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD---MEQLRTIVT 415
YGVVLLE++T RRAV +G+NLVE +Q + ++S+ ELVDPRIKDS + +QL +VT
Sbjct: 516 YGVVLLELITGRRAVDEGRNLVEMSQRFLLAKSKHLELVDPRIKDSINDAGGKQLDAVVT 575
Query: 416 IVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRS 475
+VR CT++EG++RPSIKQVLR+L ES DP+HS F +AVE+E D R R++ R
Sbjct: 576 VVRLCTEKEGRSRPSIKQVLRLLCESCDPVHSAFAKAVEEE--IGWDSRKRSNLR----- 628
Query: 476 DPTFYSGDGRYLA-SSSSTSRSYCSRSFLLENGSPQSPPNLLSL 518
GD R SSS+TSRS+ SRS P SP N S
Sbjct: 629 ---IQRGDSRIFGPSSSTTSRSHYSRSL------PHSPINGFSF 663
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 259 bits (663), Expect = 3e-68, Method: Compositional matrix adjust.
Identities = 153/357 (42%), Positives = 218/357 (61%), Gaps = 31/357 (8%)
Query: 97 IPGIGIAVTAVAVILLMVL-IILIRRKSRG---LEDPENLDKTSLKPFPPPRSLRKFQEG 152
+ GI + A AV L ++ +I++R++ RG + + K SLK EG
Sbjct: 561 VAGIVLGSVAAAVTLTAIIALIIMRKRMRGYSAVARRKRSSKASLK-----------IEG 609
Query: 153 PSPMFQKFSYKETKKATDNF--STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGD 210
+ F+Y E ATDNF ST IGQGG+G VYK G+++A+KR + S Q E +
Sbjct: 610 ----VKSFTYAELALATDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKE 665
Query: 211 FCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ 270
F EIELL+RLHHR+LV+L GFC E+ E+ L+YEYM NG+L+D++ + PL + R++
Sbjct: 666 FLTEIELLSRLHHRNLVSLLGFCDEEGEQMLVYEYMENGTLRDNISVKLKEPLDFAMRLR 725
Query: 271 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS----KDGSICF 326
IA+ A + YLH +PP+ HRDIK+SNILLD F AK+ADFGL+ + +G I
Sbjct: 726 IALGSAKGILYLHTEANPPIFHRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEG-ISP 784
Query: 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC 386
+ V+T ++GTPGY+DPEY +T +LT+KSDVYS GVVLLE+ T + + GKN+V +
Sbjct: 785 QHVSTVVKGTPGYLDPEYFLTHQLTDKSDVYSLGVVLLELFTGMQPITHGKNIVREINIA 844
Query: 387 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR---ILYE 440
S S L+ VD R+ D E L T+ C + E ARPS+ +V+R I++E
Sbjct: 845 YESGSILST-VDKRMSSVPD-ECLEKFATLALRCCREETDARPSMAEVVRELEIIWE 899
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (640), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 145/358 (40%), Positives = 204/358 (56%), Gaps = 21/358 (5%)
Query: 99 GIGIAVTAVAVIL-LMVLIILIRRKSRGLEDPEN----------LDKTSLKPFPPPRSLR 147
G GIA+ V L ++V+ + +R+S+ E N ++ ++ SLR
Sbjct: 436 GAGIAIIIFFVFLGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVNNSTANAKATGGSLR 495
Query: 148 KFQEGPSPMFQKFSYKETKKATDNF--STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISE 205
S M +KF+ E + AT NF IG GGFG VY+ + DG+LIA+KR S+
Sbjct: 496 LNTLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQ 555
Query: 206 QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW 265
Q +F EI +L+RL HRHLV+L GFC E E L+YEYMANG+L+ HL PLSW
Sbjct: 556 QGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSW 615
Query: 266 QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325
+ R++ I A L YLH + + HRD+K++NILLDENFVAK++DFGL+ A S+
Sbjct: 616 KQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGP--SMD 673
Query: 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV-----QDGKNLV 380
V+T ++G+ GY+DPEY Q+LTEKSDVYS+GVVL E V AR + +D NL
Sbjct: 674 HTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLA 733
Query: 381 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
E A + + L ++D ++ ++ E L I C EG+ RP + +VL L
Sbjct: 734 EWA-LSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSL 790
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 247 bits (631), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 149/416 (35%), Positives = 236/416 (56%), Gaps = 36/416 (8%)
Query: 51 IPPVSEPSSSMLAPKASPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPG----------- 99
IP +S P + P +P + +PSQ + P + P T I G
Sbjct: 6 IPSLSSPPAPEF-PSTTPDTATSPAPSQPSIIGPSSLAPFPETTTNIDGGSRNVALTGLI 64
Query: 100 IGIAVTAVAVILLMVLIILI------RRKSRGLEDPE-NLDKTSLKPFPPPRSLRKFQEG 152
G+ + A V+L + + + + K + ED E ++++ SL P +L+++
Sbjct: 65 TGVVLGATFVLLGVCIFVCFYKRKKRKLKKKKKEDIEASINRDSLDPKDDSNNLQQWSS- 123
Query: 153 PSPMFQK-FSYKETKKATDNFST--IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEG 209
S + Q F+Y++ KAT NFS ++GQGGFG V++ DG+L+A+K++ S Q E
Sbjct: 124 -SEIGQNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGER 182
Query: 210 DFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI 269
+F EI+ ++R+HHRHLV+L G+CI +R L+YE++ N +L+ HLH R + W R+
Sbjct: 183 EFQAEIQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRM 242
Query: 270 QIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329
+IA+ A L YLH C+P HRD+K++NIL+D+++ AKLADFGLA +S D V
Sbjct: 243 KIALGAAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTH---V 299
Query: 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQ------DGKNLVESA 383
+T I GT GY+ PEY + +LTEKSDV+S GVVLLE++T RR V D ++V+ A
Sbjct: 300 STRIMGTFGYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWA 359
Query: 384 QVCMA---SESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
+ M ++ LVDPR+++ FD+ ++ +V + + RP + Q++R
Sbjct: 360 KPLMIQALNDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVR 415
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 246 bits (628), Expect = 3e-64, Method: Compositional matrix adjust.
Identities = 156/451 (34%), Positives = 226/451 (50%), Gaps = 76/451 (16%)
Query: 58 SSSMLAPKASPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPG------IGIAVTAVAVIL 111
SS L PK++ + SPS+ VP + N P G G A+ AVI
Sbjct: 192 SSHALPPKSTAAGGPLTSPSR---GVPSSGNSVPPPANSGGGYQGKTMAGFAIAGFAVIA 248
Query: 112 LMVLIILIRRKSRGLEDPENLDKTSLKPFPPPRSLR-------------KFQEGPSPMFQ 158
LM ++ L+RRK + N+D S + PP + K GP
Sbjct: 249 LMAVVFLVRRKKK-----RNIDAYSDSQYLPPSNFSIKSDGFLYGQNPTKGYSGPGGYNS 303
Query: 159 K------------------------------------FSYKETKKATDNFS--TIIGQGG 180
+ F+Y+E T+ FS I+G+GG
Sbjct: 304 QQQSNSGNSFGSQRGGGGYTRSGSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGG 363
Query: 181 FGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERF 240
FG VYK + +DG L+AVK++ S Q + +F E+E+++R+HHRHLV+L G+CI ER
Sbjct: 364 FGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERL 423
Query: 241 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 300
L+YEY+ N +L+ HLH GR L W R++IAI A L YLH C P + HRDIKS+NI
Sbjct: 424 LIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANI 483
Query: 301 LLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYG 360
LLD+ F A++ADFGLA + V+T + GT GY+ PEY + +LT++SDV+S+G
Sbjct: 484 LLDDEFEAQVADFGLAKLNDSTQTH---VSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFG 540
Query: 361 VVLLEIVTARRAVQDGKNLVESAQVCMA--------SESRLAELVDPRIKDSFDMEQLRT 412
VVLLE++T R+ V + L E + V A +ELVD R++ + ++
Sbjct: 541 VVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFR 600
Query: 413 IVTIVRWCTQREGQARPSIKQVLRILYESSD 443
++ C + G RP + QV+R L D
Sbjct: 601 MIETAAACVRHSGPKRPRMVQVVRALDSEGD 631
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 245 bits (625), Expect = 7e-64, Method: Compositional matrix adjust.
Identities = 124/289 (42%), Positives = 181/289 (62%), Gaps = 11/289 (3%)
Query: 160 FSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEL 217
FSY E + T FS ++G+GGFG VYK SDG +AVK++ Q E +F E+E+
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386
Query: 218 LARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN 277
++R+HHRHLV L G+CI ++ R L+Y+Y+ N +L HLH+PGR ++W+TR+++A A
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAAR 446
Query: 278 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 337
+ YLH C P + HRDIKSSNILLD +F A +ADFGLA +++ + V+T + GT
Sbjct: 447 GIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTH-VSTRVMGTF 505
Query: 338 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK-----NLVESAQVCMAS--- 389
GYM PEY + +L+EK+DVYSYGV+LLE++T R+ V + +LVE A+ +
Sbjct: 506 GYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIE 565
Query: 390 ESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
ELVDPR+ +F ++ +V C + RP + QV+R L
Sbjct: 566 NEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRAL 614
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 243 bits (620), Expect = 3e-63, Method: Compositional matrix adjust.
Identities = 123/295 (41%), Positives = 185/295 (62%), Gaps = 13/295 (4%)
Query: 160 FSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEL 217
F+Y+E +AT+ FS ++GQGGFG V+K +G +AVK++ + S Q E +F E+ +
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401
Query: 218 LARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN 277
++R+HHRHLVAL G+CI +R L+YE++ N +L+ HLH GR + W +R++IA+ A
Sbjct: 402 ISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIAVGSAK 461
Query: 278 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 337
L YLH C+P + HRDIK+SNIL+D F AK+ADFGLA + D + V+T + GT
Sbjct: 462 GLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTH---VSTRVMGTF 518
Query: 338 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARR-----AVQDGKNLVESAQVCMASESR 392
GY+ PEY + +LTEKSDV+S+GVVLLE++T RR V +LV+ A+ + S
Sbjct: 519 GYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVSE 578
Query: 393 LAE---LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 444
L +VD ++ + +D E++ +V C + RP + QV R+L + P
Sbjct: 579 LGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNISP 633
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 242 bits (617), Expect = 5e-63, Method: Compositional matrix adjust.
Identities = 159/462 (34%), Positives = 242/462 (52%), Gaps = 73/462 (15%)
Query: 52 PPVS----EPSSSMLAPKASPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAV 107
PP S EP++ + P S SP PS P L+ +GI++
Sbjct: 93 PPASPSGQEPTTPTMTPGFSLSP-----PS-------------PSRLSTGAVVGISIGGG 134
Query: 108 AVILLMVLIILIRRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKK 167
+L ++ + +++ R D +L P P L Q F+Y E +
Sbjct: 135 VFVLTLIFFLCKKKRPR--------DDKAL-PAPIGLVLGIHQS-------TFTYGELAR 178
Query: 168 ATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRH 225
AT+ FS ++G+GGFG VYK ++G+ +AVK++ S Q E +F E+ +++++HHR+
Sbjct: 179 ATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRN 238
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
LV+L G+CI +R L+YE++ N +L+ HLH GR + W R++IA+ + L YLH
Sbjct: 239 LVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSLRLKIAVSSSKGLSYLHEN 298
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 345
C+P + HRDIK++NIL+D F AK+ADFGLA + D + V+T + GT GY+ PEY
Sbjct: 299 CNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTH---VSTRVMGTFGYLAPEYA 355
Query: 346 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN------LVESAQ---VCMASESRLAEL 396
+ +LTEKSDVYS+GVVLLE++T RR V D N LV+ A+ V ES L
Sbjct: 356 ASGKLTEKSDVYSFGVVLLELITGRRPV-DANNVYADDSLVDWARPLLVQALEESNFEGL 414
Query: 397 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI---------LYESSDPMHS 447
D ++ + +D E++ +V C + + RP + QV+R+ L + P HS
Sbjct: 415 ADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEGNISPSDLNQGITPGHS 474
Query: 448 GFV------QAVEDEEYEETDGRPRTSQRKAHRSDPTFYSGD 483
V +AV + + E D R +R A R Y GD
Sbjct: 475 NTVSVRLDARAVRVKPHGEMDSRWGRFKRTAQR-----YGGD 511
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (614), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 130/291 (44%), Positives = 179/291 (61%), Gaps = 12/291 (4%)
Query: 158 QKFSYKETKKATDNF--STIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCRE 214
Q FS++E AT NF +IG+GGFG VYK + G ++AVK++D+ Q +F E
Sbjct: 65 QTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIVE 124
Query: 215 IELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLH--SPGRTPLSWQTRIQIA 272
+ +L+ LHH+HLV L G+C + +R L+YEYM+ GSL+DHL +P + PL W TRI+IA
Sbjct: 125 VLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIA 184
Query: 273 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 332
+ A LEYLH +PP+ +RD+K++NILLD F AKL+DFGLA G + V++
Sbjct: 185 LGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDK--QHVSSR 242
Query: 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV-----QDGKNLVESAQVCM 387
+ GT GY PEY T +LT KSDVYS+GVVLLE++T RR + +D +NLV AQ
Sbjct: 243 VMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVF 302
Query: 388 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
SR EL DP ++ F + L V + C Q E RP + V+ L
Sbjct: 303 KEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTAL 353
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFV3|Y5157_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730 OS=Arabidopsis thaliana GN=At5g15730 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 240 bits (613), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 115/281 (40%), Positives = 184/281 (65%), Gaps = 9/281 (3%)
Query: 159 KFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELL 218
+++YK+ +KAT NF+T++GQG FG VYKA +G L A K S Q + +F E+ LL
Sbjct: 103 RYNYKDIQKATQNFTTVLGQGSFGPVYKAVMPNGELAAAKVHGSNSSQGDREFQTEVSLL 162
Query: 219 ARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLH-SPGRTPLSWQTRIQIAIDVAN 277
RLHHR+LV L G+C++K R L+YE+M+NGSL++ L+ G L+W+ R+QIA+D+++
Sbjct: 163 GRLHHRNLVNLTGYCVDKSHRMLIYEFMSNGSLENLLYGGEGMQVLNWEERLQIALDISH 222
Query: 278 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 337
+EYLH PP+ HRD+KS+NILLD + AK+ADFGL+ + + + + ++GT
Sbjct: 223 GIEYLHEGAVPPVIHRDLKSANILLDHSMRAKVADFGLSK-----EMVLDRMTSGLKGTH 277
Query: 338 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 397
GYMDP Y+ T + T KSD+YS+GV++LE++T A+ +NL+E + S + E++
Sbjct: 278 GYMDPTYISTNKYTMKSDIYSFGVIILELIT---AIHPQQNLMEYINLASMSPDGIDEIL 334
Query: 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
D ++ + +E++R + I C + + RPSI +V + +
Sbjct: 335 DQKLVGNASIEEVRLLAKIANRCVHKTPRKRPSIGEVTQFI 375
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 518 | ||||||
| 147801125 | 673 | hypothetical protein VITISV_029977 [Viti | 0.992 | 0.763 | 0.798 | 0.0 | |
| 359475361 | 734 | PREDICTED: probable receptor-like protei | 0.992 | 0.700 | 0.798 | 0.0 | |
| 356519713 | 670 | PREDICTED: probable receptor-like protei | 0.990 | 0.765 | 0.732 | 0.0 | |
| 356499747 | 670 | PREDICTED: probable receptor-like protei | 0.990 | 0.765 | 0.730 | 0.0 | |
| 449445884 | 680 | PREDICTED: probable receptor-like protei | 0.990 | 0.754 | 0.720 | 0.0 | |
| 297741261 | 619 | unnamed protein product [Vitis vinifera] | 0.915 | 0.765 | 0.767 | 0.0 | |
| 357475327 | 671 | Senescence-induced receptor-like serine/ | 0.980 | 0.757 | 0.714 | 0.0 | |
| 297834848 | 663 | kinase family protein [Arabidopsis lyrat | 0.959 | 0.749 | 0.651 | 0.0 | |
| 75309871 | 663 | RecName: Full=Probable receptor-like pro | 0.965 | 0.754 | 0.610 | 1e-179 | |
| 186489859 | 693 | protein kinase domain-containing protein | 0.965 | 0.721 | 0.610 | 1e-179 |
| >gi|147801125|emb|CAN68826.1| hypothetical protein VITISV_029977 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 804 bits (2077), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/517 (79%), Positives = 463/517 (89%), Gaps = 3/517 (0%)
Query: 3 YLHHVVGAEDNMTLSTCRDATFAALASQLDNVSAIEIASCFFQVRRLNIPPVSEPSSSML 62
YLH ++GAE+NMTLSTCRDATFAALASQ+DN SA++IASCFF ++ L+I EP +
Sbjct: 159 YLHRLLGAENNMTLSTCRDATFAALASQVDNTSAVDIASCFFGIQGLSIS--PEPPPPVH 216
Query: 63 APKASPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRK 122
P+ SPSPLVA SPSQ + V ++ENHHPYHLTLIPG+GIAVTAVAVI+L+VLIILIR+K
Sbjct: 217 TPEVSPSPLVAASPSQVVSTVTRDENHHPYHLTLIPGVGIAVTAVAVIMLVVLIILIRKK 276
Query: 123 SRGLEDPENLDKTSLKPFPPP-RSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGF 181
+R LE+ EN KTS K FPPP R +RK QEG S MFQK+SYKETKKAT+NF+TI+GQGGF
Sbjct: 277 NRELENFENTGKTSSKDFPPPPRPIRKLQEGSSSMFQKYSYKETKKATNNFNTIVGQGGF 336
Query: 182 GTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241
GTVYKAQF DGS+ AVKRM+K+SEQ E +FC+EIELLARLHHRHLVALRGFCIEK RFL
Sbjct: 337 GTVYKAQFRDGSVAAVKRMNKVSEQGEDEFCQEIELLARLHHRHLVALRGFCIEKHNRFL 396
Query: 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 301
MYEYM NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL
Sbjct: 397 MYEYMENGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 456
Query: 302 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGV 361
LDENFVAK+ADFGLAHASKDGSICFEPVNTD+RGTPGYMDPEYV+T+ELTEKSDVYSYGV
Sbjct: 457 LDENFVAKVADFGLAHASKDGSICFEPVNTDVRGTPGYMDPEYVITRELTEKSDVYSYGV 516
Query: 362 VLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCT 421
VLLE+VTARRA+QD KNLVE +Q+ MASESRLAELVDP I DSFD +QL+T+VTIVRWCT
Sbjct: 517 VLLELVTARRAIQDNKNLVEWSQIFMASESRLAELVDPSIGDSFDFDQLQTVVTIVRWCT 576
Query: 422 QREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFYS 481
QRE +ARPSIKQVLR+LYESSDPMH+GFVQAVEDEEYEET+ R RTS+ K +R D F+S
Sbjct: 577 QREARARPSIKQVLRLLYESSDPMHNGFVQAVEDEEYEETEERGRTSKGKMNRGDGIFHS 636
Query: 482 GDGRYLASSSSTSRSYCSRSFLLENGSPQSPPNLLSL 518
GDGR LASSSSTSRSYCSRSFLLENGSPQSP +LS+
Sbjct: 637 GDGRCLASSSSTSRSYCSRSFLLENGSPQSPSGILSV 673
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475361|ref|XP_002282345.2| PREDICTED: probable receptor-like protein kinase At1g49730-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 803 bits (2073), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/517 (79%), Positives = 462/517 (89%), Gaps = 3/517 (0%)
Query: 3 YLHHVVGAEDNMTLSTCRDATFAALASQLDNVSAIEIASCFFQVRRLNIPPVSEPSSSML 62
YLH ++GAE+NMTLSTCRDATFAALASQ+DN SA++IASCFF ++ L+I EP +
Sbjct: 220 YLHRLLGAENNMTLSTCRDATFAALASQVDNTSAVDIASCFFGIQGLSIS--PEPPPPVH 277
Query: 63 APKASPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRK 122
P+ SPSPLVA SPSQ + V ++ENHHPYHLTLIPG+GIAVTAVAVI+L+VLIILIR+K
Sbjct: 278 TPEVSPSPLVAASPSQVVSTVTRDENHHPYHLTLIPGVGIAVTAVAVIMLVVLIILIRKK 337
Query: 123 SRGLEDPENLDKTSLKPFPPP-RSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGF 181
+R LE+ EN KTS K FPPP R +RK QEG S MFQK+SYKETKKAT+NF+TI+GQGGF
Sbjct: 338 NRELENFENTGKTSSKDFPPPPRPIRKLQEGSSSMFQKYSYKETKKATNNFNTIVGQGGF 397
Query: 182 GTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241
GTVYKAQF DGS+ AVKRM+K+SEQ E +FC+EIELLARLHHRHLVALRGFCIEK RFL
Sbjct: 398 GTVYKAQFRDGSVAAVKRMNKVSEQGEDEFCQEIELLARLHHRHLVALRGFCIEKHNRFL 457
Query: 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 301
MYEYM NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL
Sbjct: 458 MYEYMENGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 517
Query: 302 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGV 361
LDENFVAK+ADFGLAHASKDGSICFEPVNTD+RGTPGYMDPEYV+TQELTEKSDVYSYGV
Sbjct: 518 LDENFVAKVADFGLAHASKDGSICFEPVNTDVRGTPGYMDPEYVITQELTEKSDVYSYGV 577
Query: 362 VLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCT 421
VLLE+VTARRA+QD KNLVE +Q+ MASESRLAELVDP I DSFD +QL+T+VTIVRWCT
Sbjct: 578 VLLELVTARRAIQDNKNLVEWSQIFMASESRLAELVDPSIGDSFDFDQLQTVVTIVRWCT 637
Query: 422 QREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFYS 481
Q E +ARPSIKQVLR+LYESSDPMH+GFVQAVEDEEYEET+ R RTS+ K +R D F+S
Sbjct: 638 QGEARARPSIKQVLRLLYESSDPMHNGFVQAVEDEEYEETEERGRTSKGKMNRGDGIFHS 697
Query: 482 GDGRYLASSSSTSRSYCSRSFLLENGSPQSPPNLLSL 518
GDGR LASSSSTSRSYCSRSFLLENGSPQSP +LS+
Sbjct: 698 GDGRCLASSSSTSRSYCSRSFLLENGSPQSPSGILSV 734
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356519713|ref|XP_003528514.1| PREDICTED: probable receptor-like protein kinase At1g49730-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 757 bits (1955), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/516 (73%), Positives = 442/516 (85%), Gaps = 3/516 (0%)
Query: 3 YLHHVVGAEDNMTLSTCRDATFAALASQLDNVSAIEIASCFFQVRRLNIPPVSEPSSSML 62
YLHH+ G EDN++LSTCRDATFAALASQ+D +S I+IA CFF V+ L IPP S PS
Sbjct: 158 YLHHI-GIEDNISLSTCRDATFAALASQVDEISIIDIAICFFGVQGLLIPPESSPSFPAP 216
Query: 63 APKASPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRK 122
SP LVA PSQ +L+ P NHH YHLTL+PGI IAVTAVAVI L+VLI+LIR+K
Sbjct: 217 KASPSPP-LVADGPSQPLLSAPLKGNHHSYHLTLVPGIAIAVTAVAVITLIVLIVLIRQK 275
Query: 123 SRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFG 182
SR L++P+N K+ K PP + KFQEG S MF+KFSY+E KKAT++FST+IGQGGFG
Sbjct: 276 SRELDEPDNFGKSCSKTLPPCATW-KFQEGSSSMFRKFSYREIKKATEDFSTVIGQGGFG 334
Query: 183 TVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242
TVYKAQFSDG +IAVKRM++ISEQ E +FCREIELLARLHHRHLVAL+GFCI+KRERFL+
Sbjct: 335 TVYKAQFSDGLVIAVKRMNRISEQGEDEFCREIELLARLHHRHLVALKGFCIKKRERFLL 394
Query: 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL 302
YEYM NGSLKDHLHSPG+TPLSW+TRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN LL
Sbjct: 395 YEYMGNGSLKDHLHSPGKTPLSWRTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNTLL 454
Query: 303 DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVV 362
DENFVAK+ADFGLA ASKDGS+CFEPVNT+IRGTPGYMDPEYVVTQELTEKSD+YS+GV+
Sbjct: 455 DENFVAKIADFGLAQASKDGSVCFEPVNTEIRGTPGYMDPEYVVTQELTEKSDIYSFGVL 514
Query: 363 LLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQ 422
LLEIVT RRA+Q KNLVE AQ M S++RL ELVDP +++SFD++QL+T+++IV WCTQ
Sbjct: 515 LLEIVTGRRAIQGNKNLVEWAQPYMESDTRLLELVDPNVRESFDLDQLQTVISIVAWCTQ 574
Query: 423 REGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFYSG 482
REG+ARPSIKQVLR+LYE+S+PMHS F+QAVEDEE + + R R S+ K R++ +SG
Sbjct: 575 REGRARPSIKQVLRLLYETSEPMHSEFLQAVEDEECQGSQHRGRRSKGKMLRNEALSHSG 634
Query: 483 DGRYLASSSSTSRSYCSRSFLLENGSPQSPPNLLSL 518
DGRYLASSSSTSRSYCSR+FLLE+GSPQSPPN+ SL
Sbjct: 635 DGRYLASSSSTSRSYCSRTFLLESGSPQSPPNIFSL 670
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356499747|ref|XP_003518698.1| PREDICTED: probable receptor-like protein kinase At1g49730-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1946), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/516 (73%), Positives = 439/516 (85%), Gaps = 3/516 (0%)
Query: 3 YLHHVVGAEDNMTLSTCRDATFAALASQLDNVSAIEIASCFFQVRRLNIPPVSEPSSSML 62
YLHH+ G EDN+TLSTCRDATFAALASQ+D S I+IA CFF V+ L IPP S P
Sbjct: 158 YLHHI-GIEDNITLSTCRDATFAALASQVDETSIIDIAICFFGVQGLLIPPESSPPLPAP 216
Query: 63 APKASPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRK 122
SP VA PS +L+ P NHH YHLTL+PGI IAVTAVAVI L+VLI+LIR+K
Sbjct: 217 KASPSPPR-VADGPSHPLLSAPLKGNHHSYHLTLVPGIAIAVTAVAVITLIVLIVLIRQK 275
Query: 123 SRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFG 182
SR L++P+N K+ K PP + KFQEG S MF+KFSY+E KKAT++FST+IGQGGFG
Sbjct: 276 SRELDEPDNFGKSCSKTLPPCATW-KFQEGSSSMFRKFSYREIKKATNDFSTVIGQGGFG 334
Query: 183 TVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242
TVYKAQFSDG ++AVKRM++ISEQ E +FCREIELLARLHHRHLVALRGFCI+K ERFLM
Sbjct: 335 TVYKAQFSDGLIVAVKRMNRISEQGEDEFCREIELLARLHHRHLVALRGFCIKKCERFLM 394
Query: 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL 302
YEYM NGSLKDHLHSPG+TPLSW+TRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN LL
Sbjct: 395 YEYMGNGSLKDHLHSPGKTPLSWRTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNTLL 454
Query: 303 DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVV 362
DENFVAK+ADFGLA ASKDGS+CFEPVNT+IRGTPGYMDPEY+VTQELTEKSD+YS+GV+
Sbjct: 455 DENFVAKIADFGLAQASKDGSVCFEPVNTEIRGTPGYMDPEYIVTQELTEKSDIYSFGVL 514
Query: 363 LLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQ 422
LLEIVT RRA+QD KNLVE AQ M S++RL ELVDP +++SFD++QL+T+++IV WCTQ
Sbjct: 515 LLEIVTGRRAIQDNKNLVEWAQPYMESDTRLLELVDPNVRESFDLDQLQTVISIVVWCTQ 574
Query: 423 REGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFYSG 482
REG+ARPSIKQVLR+LYE+S+PMHS F+QAVEDEE + + R R S+ K R++ F+SG
Sbjct: 575 REGRARPSIKQVLRLLYETSEPMHSEFLQAVEDEEGQGSQHRGRRSKGKMLRNEALFHSG 634
Query: 483 DGRYLASSSSTSRSYCSRSFLLENGSPQSPPNLLSL 518
DGRYLASSSSTSRSYCSR+FLLE+GSPQSPPN+ SL
Sbjct: 635 DGRYLASSSSTSRSYCSRTFLLESGSPQSPPNMFSL 670
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449445884|ref|XP_004140702.1| PREDICTED: probable receptor-like protein kinase At1g49730-like [Cucumis sativus] gi|449486593|ref|XP_004157342.1| PREDICTED: probable receptor-like protein kinase At1g49730-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1932), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/519 (72%), Positives = 440/519 (84%), Gaps = 6/519 (1%)
Query: 1 MLYLHHVVGAEDNMTLSTCRDATFAALASQLDNVSAIEIASCFFQVRRLNIPPVSEPSSS 60
+LYL +++G EDN+TL+TCRDATF ALASQLD S I++A+CFF V+ + PP P S
Sbjct: 160 ILYLRNLIGREDNITLNTCRDATFVALASQLDPASVIDLATCFFGVQGFHKPPA--PPPS 217
Query: 61 MLAPKASPSPLVAVSPSQHMLAVP--QNENHHPYHLTLIPGIGIAVTAVAVILLMVLIIL 118
+ PK SPSP A SP L V ++ HH YHLTL+ GIGIAVT +V++L+VLI+L
Sbjct: 218 LTTPKISPSPSAAESPGSLTLDVAGDKSHQHHSYHLTLVAGIGIAVTVGSVMMLVVLIVL 277
Query: 119 IRRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQ 178
IRRKSR L+D + +D S K FP R ++K+QEGPS MF+KFSYKE KKATD+FST IGQ
Sbjct: 278 IRRKSRELKDSDKMDANSSKSFPS-RPIKKYQEGPS-MFKKFSYKEIKKATDSFSTTIGQ 335
Query: 179 GGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE 238
GG+GTVYKAQF+D ++AVKRM+K+SEQ E +F REIELLARLHHRHLVALRGFC+EK E
Sbjct: 336 GGYGTVYKAQFTDDVVVAVKRMNKVSEQGEDEFGREIELLARLHHRHLVALRGFCVEKHE 395
Query: 239 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSS 298
RFL+YE+MANGSLKDHLH+PGRTPLSW+TRIQIAIDVANALEYLH+YCDPPLCHRDIKSS
Sbjct: 396 RFLLYEFMANGSLKDHLHAPGRTPLSWRTRIQIAIDVANALEYLHYYCDPPLCHRDIKSS 455
Query: 299 NILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYS 358
NILLDENFVAK+ADFGLAHASK GS+ FEPVNTDIRGTPGYMDPEYV+TQELTEKSD+YS
Sbjct: 456 NILLDENFVAKVADFGLAHASKGGSVFFEPVNTDIRGTPGYMDPEYVITQELTEKSDIYS 515
Query: 359 YGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVR 418
YGV+LLEIVT RRA+QDGKNLVE + M S+SR++ELVDP IK F+++QL TIV+IVR
Sbjct: 516 YGVLLLEIVTGRRAIQDGKNLVEWSLGYMISDSRISELVDPSIKGCFNLDQLHTIVSIVR 575
Query: 419 WCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPT 478
WCT+ EG+ARPSIKQVLR+LYESSDPMH G ++AV+DEEY T+GR S+RK H+SD
Sbjct: 576 WCTEGEGRARPSIKQVLRLLYESSDPMHQGLMEAVDDEEYGGTEGRQSMSKRKMHKSDVI 635
Query: 479 FYSGDGRYLASSSSTSRSYCSRSFLLENGSPQSPPNLLS 517
F+SGDGRYLASSSSTSRSYCSRSFLLE GSPQSPPN+ S
Sbjct: 636 FHSGDGRYLASSSSTSRSYCSRSFLLETGSPQSPPNIYS 674
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741261|emb|CBI32392.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 743 bits (1918), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/494 (76%), Positives = 422/494 (85%), Gaps = 20/494 (4%)
Query: 23 TFAALASQLDNVSAIEIASCFFQVRRLNIPPVSEPSSSMLAPKASPSPLVAVSPSQHMLA 82
T + Q+DN SA++IASCFF ++ L+I EP + P+ SPSPLVA SPSQ +
Sbjct: 105 TVVQMLDQVDNTSAVDIASCFFGIQGLSIS--PEPPPPVHTPEVSPSPLVAASPSQVVST 162
Query: 83 VPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRKSRGLEDPENLDKTSLKPFPP 142
V ++ENHHPYHLTLIPG+GIAVTAVAVI+L+VLIILIR+K+R LE+ EN KTS K FPP
Sbjct: 163 VTRDENHHPYHLTLIPGVGIAVTAVAVIMLVVLIILIRKKNRELENFENTGKTSSKDFPP 222
Query: 143 P-RSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMD 201
P R +RK QEG S MFQK+SYKETKKAT+NF+TI+GQGGFGTVYKAQF DGS+ AVKRM+
Sbjct: 223 PPRPIRKLQEGSSSMFQKYSYKETKKATNNFNTIVGQGGFGTVYKAQFRDGSVAAVKRMN 282
Query: 202 KISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRT 261
K+SEQ E +FC+EIELLARLHHRHLVALRGFCIEK RFLMYEYM NGSLKDHLHSPGRT
Sbjct: 283 KVSEQGEDEFCQEIELLARLHHRHLVALRGFCIEKHNRFLMYEYMENGSLKDHLHSPGRT 342
Query: 262 PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321
PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAK+ADFGLAHASKD
Sbjct: 343 PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKVADFGLAHASKD 402
Query: 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 381
GSICFEPVNTD+RGTPGYMDPEYV+TQELTEKSDVYSYGVVLLE+VTARRA+QD KNLVE
Sbjct: 403 GSICFEPVNTDVRGTPGYMDPEYVITQELTEKSDVYSYGVVLLELVTARRAIQDNKNLVE 462
Query: 382 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441
+Q+ MASESRLAELVDP I DSFD +QL+T+VTIVRWCTQ E +ARPSIKQVLR+LYES
Sbjct: 463 WSQIFMASESRLAELVDPSIGDSFDFDQLQTVVTIVRWCTQGEARARPSIKQVLRLLYES 522
Query: 442 SDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFYSGDGRYLASSSSTSRSYCSRS 501
SDPMH+GFVQAVEDEE D F+SGDGR LASSSSTSRSYCSRS
Sbjct: 523 SDPMHNGFVQAVEDEE-----------------GDGIFHSGDGRCLASSSSTSRSYCSRS 565
Query: 502 FLLENGSPQSPPNL 515
FLLENGSPQSP +
Sbjct: 566 FLLENGSPQSPSGI 579
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357475327|ref|XP_003607949.1| Senescence-induced receptor-like serine/threonine-protein kinase [Medicago truncatula] gi|355509004|gb|AES90146.1| Senescence-induced receptor-like serine/threonine-protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 726 bits (1875), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/512 (71%), Positives = 428/512 (83%), Gaps = 4/512 (0%)
Query: 8 VGAEDNMTLSTCRDATFAALASQLDNVSAIEIASCFFQVRRLNIPPVSEPSSSMLAPKAS 67
+G EDN+TLSTCRDATFAALASQ+D + +IASCFF V+ L P S PS + AP+ S
Sbjct: 163 LGIEDNITLSTCRDATFAALASQVDEMYTTDIASCFFGVQGLLRTPESSPS--LPAPEVS 220
Query: 68 PSPLVAV-SPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRKSRGL 126
PSP VA SPSQ +L +P HH YHL L+P I IAVTAVA ++ +VL+ILIR+KSR L
Sbjct: 221 PSPPVAADSPSQLLLGLPTKGKHHSYHLALVPCIAIAVTAVAFVMFIVLMILIRQKSREL 280
Query: 127 EDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYK 186
+P N K S K P + KFQEG S MF+KF++KE KKAT+ FSTIIGQGGFGTVYK
Sbjct: 281 NEPHNFGKPSSKTVPS-MAKWKFQEGSSSMFRKFNFKEIKKATEGFSTIIGQGGFGTVYK 339
Query: 187 AQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246
A FSDG + AVKRMD++SEQ E DFCREIELLARLHHRHLV LRGFCI+K+ERFL+YEYM
Sbjct: 340 AHFSDGQVAAVKRMDRVSEQGEDDFCREIELLARLHHRHLVTLRGFCIKKQERFLLYEYM 399
Query: 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF 306
NGSLKDHLHSPG+TPLSW+TRIQIAIDVANALEYLHFYCDPPL HRDIK+SN LLDENF
Sbjct: 400 GNGSLKDHLHSPGKTPLSWRTRIQIAIDVANALEYLHFYCDPPLFHRDIKASNTLLDENF 459
Query: 307 VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEI 366
VAK+ADFGLA ASKDGSICFEPVNT+I GTPGYMDPEY+VTQELTEKSD+YSYGV+LLEI
Sbjct: 460 VAKIADFGLAQASKDGSICFEPVNTEIWGTPGYMDPEYIVTQELTEKSDIYSYGVLLLEI 519
Query: 367 VTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQ 426
VT RRA+QD KNLVE A+ M SE+RL ELVDP +++SFD++QL+T+++IV WCTQREG+
Sbjct: 520 VTGRRAIQDNKNLVEWAKPYMESETRLLELVDPNVRESFDLDQLQTVISIVGWCTQREGR 579
Query: 427 ARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFYSGDGRY 486
ARPSIKQVLR+LYE+S+PMH+ F+QAVEDEE + + R R S+ K R++ F+SGDGRY
Sbjct: 580 ARPSIKQVLRLLYETSEPMHTEFLQAVEDEESQGNEQRGRRSKGKMLRNEGNFHSGDGRY 639
Query: 487 LASSSSTSRSYCSRSFLLENGSPQSPPNLLSL 518
LASSSSTSRSYCSRSFLLENGS QS PN+ S+
Sbjct: 640 LASSSSTSRSYCSRSFLLENGSAQSSPNVFSV 671
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297834848|ref|XP_002885306.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297331146|gb|EFH61565.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 653 bits (1685), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/525 (65%), Positives = 412/525 (78%), Gaps = 28/525 (5%)
Query: 1 MLYLHHVVGAEDNMTLSTCRDATFAALASQLDNVSAIEIASCFFQVRRLNIPPVSEPSSS 60
+ YL +VGA++++ LSTCRDAT+A LAS++DN SA+E+ASCFF N+P +S S S
Sbjct: 160 ITYLRSLVGADNSIKLSTCRDATYAVLASRVDNSSALELASCFF-----NVPELSPASGS 214
Query: 61 MLAPKASPSP--LVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIIL 118
+ + + ++A SPS L + ++HH YHLT++P IGIAV+AVA+++L+ LI+L
Sbjct: 215 SPSSLSPEASPPVLADSPSSDNLVLSPLKSHHRYHLTMVPTIGIAVSAVALVMLVFLIVL 274
Query: 119 IRRKSRGLEDPE----NLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFST 174
I+RK R L+D + NL +TS P P PRS+ EG S F+KFSYKE +KAT++F+T
Sbjct: 275 IQRKKRELDDSKGMDCNLKRTS--PSPHPRSM--IHEGDSSGFRKFSYKEIRKATEDFNT 330
Query: 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
+IG+GGFGTVYKA+FS+G + AVKRM+K SEQ E +FCREIELLARLHHRHLVAL+GFC
Sbjct: 331 VIGRGGFGTVYKAEFSNGLVAAVKRMNKSSEQAEDEFCREIELLARLHHRHLVALKGFCN 390
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 294
+K ERFL+YEYM NGSLKDHLHS + PLSW+TR++IAIDVANALEYLHFYCDPPLCHRD
Sbjct: 391 KKNERFLVYEYMENGSLKDHLHSTEKPPLSWETRMKIAIDVANALEYLHFYCDPPLCHRD 450
Query: 295 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 354
IKS NILLDENFVAKLADFGLAHAS+DGSICFEPVNTDIRGTPGY+DPEYVVTQELTEKS
Sbjct: 451 IKSGNILLDENFVAKLADFGLAHASRDGSICFEPVNTDIRGTPGYVDPEYVVTQELTEKS 510
Query: 355 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIV 414
DVYSYGVVLLEI+T +RAV +G+NLVE Q + SESR +LVDPRIKD D EQL T+V
Sbjct: 511 DVYSYGVVLLEIITGKRAVDEGRNLVELCQPLLVSESRRIDLVDPRIKDCIDGEQLETLV 570
Query: 415 TIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHR 474
+VRWCT++EG ARPSIKQVLR+LYES DP+H G AV EE GR + R
Sbjct: 571 AVVRWCTEKEGVARPSIKQVLRLLYESCDPLHLGLAMAV-----EENKGR-------SLR 618
Query: 475 SDPTFYSGDGRYLA-SSSSTSRSYCSRSFLLENGSPQSPPNLLSL 518
D F SGD R LA SSS+TSRS+CSRSFLLE GSP SPPN LS
Sbjct: 619 GDSGFQSGDIRGLASSSSTTSRSHCSRSFLLETGSPHSPPNGLSF 663
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|75309871|sp|Q9FX99.1|Y1497_ARATH RecName: Full=Probable receptor-like protein kinase At1g49730; Flags: Precursor gi|10120430|gb|AAG13055.1|AC011807_14 Unknown protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1638), Expect = e-179, Method: Compositional matrix adjust.
Identities = 320/524 (61%), Positives = 404/524 (77%), Gaps = 24/524 (4%)
Query: 1 MLYLHHVVGAE-DNMTLSTCRDATFAALASQLDNVSAIEIASCFFQVRRLNIPPVSEPSS 59
+ YL +++GAE +N+TL TCRDAT+A LAS++D+ SA+E+ SCFFQV LNIP SE S
Sbjct: 158 ITYLRNLIGAETNNITLCTCRDATYATLASRIDDTSALELLSCFFQVTELNIP--SESFS 215
Query: 60 SMLAPKASPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILI 119
+ +P+ SPS + +SPS + + + +PYHLT++P IGI VTAVA+ +L+VL+ILI
Sbjct: 216 PVASPEPSPSTVGGISPSNSDSQMTTSRSTNPYHLTMVPTIGIVVTAVALTMLVVLVILI 275
Query: 120 RRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEG-PSPMFQKFSYKETKKATDNFSTIIGQ 178
RRK+R L++ E+LD+ S K P + K E S F+KFSYKE AT++F+T+IGQ
Sbjct: 276 RRKNRELDESESLDRKSTKSVPSSLPVFKIHEDDSSSAFRKFSYKEMTNATNDFNTVIGQ 335
Query: 179 GGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE 238
GGFGTVYKA+F+DG + AVK+M+K+SEQ E DFCREI LLA+LHHR+LVAL+GFCI K+E
Sbjct: 336 GGFGTVYKAEFNDGLIAAVKKMNKVSEQAEQDFCREIGLLAKLHHRNLVALKGFCINKKE 395
Query: 239 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSS 298
RFL+Y+YM NGSLKDHLH+ G+ P SW TR++IAIDVANALEYLHFYCDPPLCHRDIKSS
Sbjct: 396 RFLVYDYMKNGSLKDHLHAIGKPPPSWGTRMKIAIDVANALEYLHFYCDPPLCHRDIKSS 455
Query: 299 NILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYS 358
NILLDENFVAKL+DFGLAH+S+DGS+CFEPVNTDIRGTPGY+DPEYVVTQELTEKSDVYS
Sbjct: 456 NILLDENFVAKLSDFGLAHSSRDGSVCFEPVNTDIRGTPGYVDPEYVVTQELTEKSDVYS 515
Query: 359 YGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD---MEQLRTIVT 415
YGVVLLE++T RRAV +G+NLVE +Q + ++S+ ELVDPRIKDS + +QL +VT
Sbjct: 516 YGVVLLELITGRRAVDEGRNLVEMSQRFLLAKSKHLELVDPRIKDSINDAGGKQLDAVVT 575
Query: 416 IVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRS 475
+VR CT++EG++RPSIKQVLR+L ES DP+HS F +AVE+E D R R++ R
Sbjct: 576 VVRLCTEKEGRSRPSIKQVLRLLCESCDPVHSAFAKAVEEE--IGWDSRKRSNLR----- 628
Query: 476 DPTFYSGDGRYLA-SSSSTSRSYCSRSFLLENGSPQSPPNLLSL 518
GD R SSS+TSRS+ SRS P SP N S
Sbjct: 629 ---IQRGDSRIFGPSSSTTSRSHYSRSL------PHSPINGFSF 663
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|186489859|ref|NP_849788.2| protein kinase domain-containing protein [Arabidopsis thaliana] gi|332194345|gb|AEE32466.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1638), Expect = e-179, Method: Compositional matrix adjust.
Identities = 320/524 (61%), Positives = 404/524 (77%), Gaps = 24/524 (4%)
Query: 1 MLYLHHVVGAE-DNMTLSTCRDATFAALASQLDNVSAIEIASCFFQVRRLNIPPVSEPSS 59
+ YL +++GAE +N+TL TCRDAT+A LAS++D+ SA+E+ SCFFQV LNIP SE S
Sbjct: 188 ITYLRNLIGAETNNITLCTCRDATYATLASRIDDTSALELLSCFFQVTELNIP--SESFS 245
Query: 60 SMLAPKASPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILI 119
+ +P+ SPS + +SPS + + + +PYHLT++P IGI VTAVA+ +L+VL+ILI
Sbjct: 246 PVASPEPSPSTVGGISPSNSDSQMTTSRSTNPYHLTMVPTIGIVVTAVALTMLVVLVILI 305
Query: 120 RRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEG-PSPMFQKFSYKETKKATDNFSTIIGQ 178
RRK+R L++ E+LD+ S K P + K E S F+KFSYKE AT++F+T+IGQ
Sbjct: 306 RRKNRELDESESLDRKSTKSVPSSLPVFKIHEDDSSSAFRKFSYKEMTNATNDFNTVIGQ 365
Query: 179 GGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE 238
GGFGTVYKA+F+DG + AVK+M+K+SEQ E DFCREI LLA+LHHR+LVAL+GFCI K+E
Sbjct: 366 GGFGTVYKAEFNDGLIAAVKKMNKVSEQAEQDFCREIGLLAKLHHRNLVALKGFCINKKE 425
Query: 239 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSS 298
RFL+Y+YM NGSLKDHLH+ G+ P SW TR++IAIDVANALEYLHFYCDPPLCHRDIKSS
Sbjct: 426 RFLVYDYMKNGSLKDHLHAIGKPPPSWGTRMKIAIDVANALEYLHFYCDPPLCHRDIKSS 485
Query: 299 NILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYS 358
NILLDENFVAKL+DFGLAH+S+DGS+CFEPVNTDIRGTPGY+DPEYVVTQELTEKSDVYS
Sbjct: 486 NILLDENFVAKLSDFGLAHSSRDGSVCFEPVNTDIRGTPGYVDPEYVVTQELTEKSDVYS 545
Query: 359 YGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD---MEQLRTIVT 415
YGVVLLE++T RRAV +G+NLVE +Q + ++S+ ELVDPRIKDS + +QL +VT
Sbjct: 546 YGVVLLELITGRRAVDEGRNLVEMSQRFLLAKSKHLELVDPRIKDSINDAGGKQLDAVVT 605
Query: 416 IVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRS 475
+VR CT++EG++RPSIKQVLR+L ES DP+HS F +AVE+E D R R++ R
Sbjct: 606 VVRLCTEKEGRSRPSIKQVLRLLCESCDPVHSAFAKAVEEE--IGWDSRKRSNLR----- 658
Query: 476 DPTFYSGDGRYLA-SSSSTSRSYCSRSFLLENGSPQSPPNLLSL 518
GD R SSS+TSRS+ SRS P SP N S
Sbjct: 659 ---IQRGDSRIFGPSSSTTSRSHYSRSL------PHSPINGFSF 693
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 518 | ||||||
| TAIR|locus:2090634 | 663 | AT3G19300 [Arabidopsis thalian | 0.961 | 0.751 | 0.573 | 1e-148 | |
| TAIR|locus:2012191 | 693 | AT1G49730 [Arabidopsis thalian | 0.911 | 0.681 | 0.564 | 1.5e-138 | |
| TAIR|locus:2172149 | 440 | CRLK1 "calcium/calmodulin-regu | 0.527 | 0.620 | 0.421 | 1.1e-55 | |
| TAIR|locus:2181017 | 951 | AT5G01950 [Arabidopsis thalian | 0.534 | 0.291 | 0.411 | 9.4e-55 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.600 | 0.320 | 0.387 | 1.1e-54 | |
| TAIR|locus:2099009 | 400 | AT3G58690 [Arabidopsis thalian | 0.557 | 0.722 | 0.396 | 7e-54 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.569 | 0.309 | 0.415 | 2.5e-53 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.540 | 0.394 | 0.420 | 4.2e-53 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.571 | 0.453 | 0.391 | 5.4e-53 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.592 | 0.420 | 0.384 | 6.3e-53 |
| TAIR|locus:2090634 AT3G19300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1452 (516.2 bits), Expect = 1.0e-148, P = 1.0e-148
Identities = 297/518 (57%), Positives = 360/518 (69%)
Query: 3 YLHHVVGAEDNMTLSTCRDATFAALASQLDNVSAIEIASCFFQVRRLNIPPVSEPSSSMX 62
YL +VGA++++ LSTCRDAT+A LAS++DN SA+E+ASCFF V L+ P S PSS
Sbjct: 162 YLRSLVGADNSIKLSTCRDATYAVLASRVDNSSALELASCFFNVPELSPTPGSSPSS--L 219
Query: 63 XXXXXXXXXXXXXXXQHMLAVPQNENHHPYHLTLIPGXXXXXXXXXXXXXXXXXXXXRRK 122
+++ P ++HHPYHLT++P +RK
Sbjct: 220 SPEASPPVLADSPSSDNLVLSPL-KSHHPYHLTMVPTIGIAVTVFALVMVVVLIVLIQRK 278
Query: 123 SRGLEDPENL--DKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGG 180
R L+D +++ + T P P PRS+ EG S F+KFSYKE +KAT++F+ +IG+GG
Sbjct: 279 KRELDDSKSIACNLTRTSPSPRPRSM--IHEGNSFGFRKFSYKEIRKATEDFNAVIGRGG 336
Query: 181 FGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERF 240
FGTVYKA+FS+G + AVK+M+K SEQ E +FCREIE GFC +K ERF
Sbjct: 337 FGTVYKAEFSNGLVAAVKKMNKSSEQAEDEFCREIELLARLHHRHLVALKGFCNKKNERF 396
Query: 241 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 300
L+YEYM NGSLKDHLHS ++PLSW++R++IAIDVANALEYLHFYCDPPLCHRDIKSSNI
Sbjct: 397 LVYEYMENGSLKDHLHSTEKSPLSWESRMKIAIDVANALEYLHFYCDPPLCHRDIKSSNI 456
Query: 301 LLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYG 360
LLDE+FVAKLADFGLAHAS+DGSICFEPVNTDIRGTPGY+DPEYVVT ELTEKSDVYSYG
Sbjct: 457 LLDEHFVAKLADFGLAHASRDGSICFEPVNTDIRGTPGYVDPEYVVTHELTEKSDVYSYG 516
Query: 361 VVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWC 420
VVLLEI+T +RAV +G+NLVE +Q + SESR +LVDPRIKD D EQL T+V +VRWC
Sbjct: 517 VVLLEIITGKRAVDEGRNLVELSQPLLVSESRRIDLVDPRIKDCIDGEQLETVVAVVRWC 576
Query: 421 TQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFY 480
T++EG ARPSIKQVLR+LYES DP+H G AVE E GR + R D F
Sbjct: 577 TEKEGVARPSIKQVLRLLYESCDPLHLGLAMAVE-----ENKGR-------SLRGDSGFQ 624
Query: 481 SGDGRYLAXXXXXXXXXX-XXXFLLENGSPQSPPNLLS 517
SGD R LA FLLE GSP SPPN LS
Sbjct: 625 SGDIRGLASSSSTTSRSHCSRSFLLETGSPHSPPNGLS 662
|
|
| TAIR|locus:2012191 AT1G49730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1356 (482.4 bits), Expect = 1.5e-138, P = 1.5e-138
Identities = 273/484 (56%), Positives = 343/484 (70%)
Query: 3 YLHHVVGAE-DNMTLSTCRDATFAALASQLDNVSAIEIASCFFQVRRLNIPPVS-EPSSS 60
YL +++GAE +N+TL TCRDAT+A LAS++D+ SA+E+ SCFFQV LNIP S P +S
Sbjct: 190 YLRNLIGAETNNITLCTCRDATYATLASRIDDTSALELLSCFFQVTELNIPSESFSPVAS 249
Query: 61 MXXXXXXXXXXXXXXXXQHMLAVPQNENHHPYHLTLIPGXXXXXXXXXXXXXXXXXXXXR 120
M + + +PYHLT++P R
Sbjct: 250 PEPSPSTVGGISPSNSDSQMTT---SRSTNPYHLTMVPTIGIVVTAVALTMLVVLVILIR 306
Query: 121 RKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPM-FQKFSYKETKKATDNFSTIIGQG 179
RK+R L++ E+LD+ S K P + K E S F+KFSYKE AT++F+T+IGQG
Sbjct: 307 RKNRELDESESLDRKSTKSVPSSLPVFKIHEDDSSSAFRKFSYKEMTNATNDFNTVIGQG 366
Query: 180 GFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRER 239
GFGTVYKA+F+DG + AVK+M+K+SEQ E DFCREI GFCI K+ER
Sbjct: 367 GFGTVYKAEFNDGLIAAVKKMNKVSEQAEQDFCREIGLLAKLHHRNLVALKGFCINKKER 426
Query: 240 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 299
FL+Y+YM NGSLKDHLH+ G+ P SW TR++IAIDVANALEYLHFYCDPPLCHRDIKSSN
Sbjct: 427 FLVYDYMKNGSLKDHLHAIGKPPPSWGTRMKIAIDVANALEYLHFYCDPPLCHRDIKSSN 486
Query: 300 ILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSY 359
ILLDENFVAKL+DFGLAH+S+DGS+CFEPVNTDIRGTPGY+DPEYVVTQELTEKSDVYSY
Sbjct: 487 ILLDENFVAKLSDFGLAHSSRDGSVCFEPVNTDIRGTPGYVDPEYVVTQELTEKSDVYSY 546
Query: 360 GVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM---EQLRTIVTI 416
GVVLLE++T RRAV +G+NLVE +Q + ++S+ ELVDPRIKDS + +QL +VT+
Sbjct: 547 GVVLLELITGRRAVDEGRNLVEMSQRFLLAKSKHLELVDPRIKDSINDAGGKQLDAVVTV 606
Query: 417 VRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSD 476
VR CT++EG++RPSIKQVLR+L ES DP+HS F +AVE+E D R R++ R R D
Sbjct: 607 VRLCTEKEGRSRPSIKQVLRLLCESCDPVHSAFAKAVEEEI--GWDSRKRSNLR-IQRGD 663
Query: 477 PTFY 480
+
Sbjct: 664 SRIF 667
|
|
| TAIR|locus:2172149 CRLK1 "calcium/calmodulin-regulated receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 574 (207.1 bits), Expect = 1.1e-55, P = 1.1e-55
Identities = 119/282 (42%), Positives = 174/282 (61%)
Query: 159 KFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXX 218
++SY++ +KAT NF+T+IGQG FG VYKAQ S G ++AVK + S+Q E +F E+
Sbjct: 102 EYSYRDLQKATCNFTTLIGQGAFGPVYKAQMSTGEIVAVKVLATDSKQGEKEFQTEVMLL 161
Query: 219 XXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 278
G+C EK + L+Y YM+ GSL HL+S PLSW R+ IA+DVA
Sbjct: 162 GRLHHRNLVNLIGYCAEKGQHMLIYVYMSKGSLASHLYSEKHEPLSWDLRVYIALDVARG 221
Query: 279 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 338
LEYLH PP+ HRDIKSSNILLD++ A++ADFGL S++ + N IRGT G
Sbjct: 222 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL---SREEMVDKHAAN--IRGTFG 276
Query: 339 YMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA--EL 396
Y+DPEY+ T+ T+KSDVY +GV+L E++ R Q LVE A M +E ++ E+
Sbjct: 277 YLDPEYISTRTFTKKSDVYGFGVLLFELIAGRNPQQGLMELVELA--AMNAEEKVGWEEI 334
Query: 397 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
VD R+ +D++++ + C R + RP+++ ++++L
Sbjct: 335 VDSRLDGRYDLQEVNEVAAFAYKCISRAPRKRPNMRDIVQVL 376
|
|
| TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 572 (206.4 bits), Expect = 9.4e-55, P = 9.4e-55
Identities = 117/284 (41%), Positives = 177/284 (62%)
Query: 160 FSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEX 217
FS+KE +ATD+FS T++G+GG+G VY+ SD ++ A+KR D+ S Q E +F EIE
Sbjct: 614 FSFKELAEATDDFSSSTLVGRGGYGKVYRGVLSDNTVAAIKRADEGSLQGEKEFLNEIEL 673
Query: 218 XXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN 277
G+C E+ E+ L+YE+M+NG+L+D L + G+ LS+ RI++A+ A
Sbjct: 674 LSRLHHRNLVSLIGYCDEESEQMLVYEFMSNGTLRDWLSAKGKESLSFGMRIRVALGAAK 733
Query: 278 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS---KDGSICFEPVNTDIR 334
+ YLH +PP+ HRDIK+SNILLD NF AK+ADFGL+ + +D + V+T +R
Sbjct: 734 GILYLHTEANPPVFHRDIKASNILLDPNFNAKVADFGLSRLAPVLEDEEDVPKHVSTVVR 793
Query: 335 GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 394
GTPGY+DPEY +T +LT+KSDVYS GVV LE++T A+ GKN+V + +
Sbjct: 794 GTPGYLDPEYFLTHKLTDKSDVYSIGVVFLELLTGMHAISHGKNIVREVKTA-EQRDMMV 852
Query: 395 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
L+D R+ + + ME + + C+ + RP + +V++ L
Sbjct: 853 SLIDKRM-EPWSMESVEKFAALALRCSHDSPEMRPGMAEVVKEL 895
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 572 (206.4 bits), Expect = 1.1e-54, P = 1.1e-54
Identities = 127/328 (38%), Positives = 187/328 (57%)
Query: 138 KPFPPPRSLRKFQEGPSPMFQK---FSYKETKKATDNFSTI--IGQGGFGTVYKAQFSDG 192
+PF S K G +P + FSY+E KK T+NFS +G GG+G VYK DG
Sbjct: 602 RPFVSWASSGK-DSGGAPQLKGARWFSYEELKKITNNFSVSSELGYGGYGKVYKGMLQDG 660
Query: 193 SLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLK 252
++A+KR + S Q +F EIE GFC E+ E+ L+YEYM+NGSLK
Sbjct: 661 HMVAIKRAQQGSTQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNGSLK 720
Query: 253 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLAD 312
D L L W+ R+++A+ A L YLH DPP+ HRD+KS+NILLDEN AK+AD
Sbjct: 721 DSLTGRSGITLDWKRRLRVALGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAKVAD 780
Query: 313 FGLAHASKDGSICFEP-VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARR 371
FGL+ D C + V+T ++GT GY+DPEY TQ+LTEKSDVYS+GVV++E++TA++
Sbjct: 781 FGLSKLVSD---CTKGHVSTQVKGTLGYLDPEYYTTQKLTEKSDVYSFGVVMMELITAKQ 837
Query: 372 AVQDGKNLVESAQVCMASESR----LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQA 427
++ GK +V ++ M L + +D ++D + +L + + C
Sbjct: 838 PIEKGKYIVREIKLVMNKSDDDFYGLRDKMDRSLRDVGTLPELGRYMELALKCVDETADE 897
Query: 428 RPSIKQVLR---ILYESSDPMHSGFVQA 452
RP++ +V++ I+ ++S S A
Sbjct: 898 RPTMSEVVKEIEIIIQNSGASSSSSASA 925
|
|
| TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 557 (201.1 bits), Expect = 7.0e-54, P = 7.0e-54
Identities = 121/305 (39%), Positives = 176/305 (57%)
Query: 147 RKFQEGPSPMFQKFSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS 204
+K Q+ Q F++K+ AT FS ++G GGFG VY+ +DG +A+K MD
Sbjct: 62 QKVQDVTENGLQIFTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKVAIKLMDHAG 121
Query: 205 EQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRT--- 261
+Q E +F E+E G+C + + L+YE+MANG L++HL+ P R+
Sbjct: 122 KQGEEEFKMEVELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLYLPNRSGSV 181
Query: 262 P--LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 319
P L W+TR++IA++ A LEYLH PP+ HRD KSSNILLD NF AK++DFGLA
Sbjct: 182 PPRLDWETRMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGLAKVG 241
Query: 320 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTAR------RAV 373
D + V+T + GT GY+ PEY +T LT KSDVYSYGVVLLE++T R RA
Sbjct: 242 SDKA--GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKRAT 299
Query: 374 QDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQ 433
+G LV A +A ++ +++DP ++ + +++ + I C Q E RP +
Sbjct: 300 GEGV-LVSWALPQLADRDKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPLMAD 358
Query: 434 VLRIL 438
V++ L
Sbjct: 359 VVQSL 363
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 559 (201.8 bits), Expect = 2.5e-53, P = 2.5e-53
Identities = 127/306 (41%), Positives = 177/306 (57%)
Query: 139 PFPPPRSLRKFQEGPSPMFQK-FSYKETKKATDNFSTI--IGQGGFGTVYKAQFSDGSLI 195
PF + + + P M K F+++E KK TDNFS +G GG+G VY+ +G LI
Sbjct: 597 PFAKWDTSKSSIDAPQLMGAKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLI 656
Query: 196 AVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHL 255
A+KR + S Q +F EIE GFC ++ E+ L+YEY++NGSLKD L
Sbjct: 657 AIKRAQQGSLQGGLEFKTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSL 716
Query: 256 HSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL 315
L W R++IA+ L YLH DPP+ HRDIKS+NILLDEN AK+ADFGL
Sbjct: 717 SGKSGIRLDWTRRLKIALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGL 776
Query: 316 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQD 375
+ D V T ++GT GY+DPEY +T +LTEKSDVY +GVVLLE++T R ++
Sbjct: 777 SKLVGDPEKTH--VTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVLLELLTGRSPIER 834
Query: 376 GKNLVESAQVCMASESR----LAELVDPRI-KDSFDMEQLRTIVTIVRWCTQREGQARPS 430
GK +V + M ++SR L EL+D I S +++ V + C + EG RPS
Sbjct: 835 GKYVVREVKTKM-NKSRSLYDLQELLDTTIIASSGNLKGFEKYVDLALRCVEEEGVNRPS 893
Query: 431 IKQVLR 436
+ +V++
Sbjct: 894 MGEVVK 899
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 530 (191.6 bits), Expect = 4.2e-53, Sum P(2) = 4.2e-53
Identities = 124/295 (42%), Positives = 176/295 (59%)
Query: 160 FSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEX 217
F+Y+E T+ FS I+G+GGFG VYK + +DG L+AVK++ S Q + +F E+E
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400
Query: 218 XXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN 277
G+CI ER L+YEY+ N +L+ HLH GR L W R++IAI A
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAK 460
Query: 278 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 337
L YLH C P + HRDIKS+NILLD+ F A++ADFGLA + D + V+T + GT
Sbjct: 461 GLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLN-DSTQTH--VSTRVMGTF 517
Query: 338 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQD----GK-NLVESAQVCM--ASE 390
GY+ PEY + +LT++SDV+S+GVVLLE++T R+ V G+ +LVE A+ + A E
Sbjct: 518 GYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIE 577
Query: 391 SR-LAELVDPRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443
+ +ELVD R++ + + E R I T C + G RP + QV+R L D
Sbjct: 578 TGDFSELVDRRLEKHYVENEVFRMIETAAA-CVRHSGPKRPRMVQVVRALDSEGD 631
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 528 (190.9 bits), Expect = 5.4e-53, Sum P(2) = 5.4e-53
Identities = 125/319 (39%), Positives = 181/319 (56%)
Query: 133 DKTSLKPFPPPRSLRKFQEGPSPMFQK--FSYKETKKATDNFS--TIIGQGGFGTVYKAQ 188
D + L PPP G F K F+Y+E +AT+ FS ++GQGGFG V+K
Sbjct: 245 DYSDLPVLPPP------SPGLVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGI 298
Query: 189 FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMAN 248
G +AVK++ S Q E +F E+E G+C+ +R L+YE++ N
Sbjct: 299 LPSGKEVAVKQLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPN 358
Query: 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVA 308
+L+ HLH GR + W TR++IA+ A L YLH C+P + HRDIK+SNIL+D F A
Sbjct: 359 NNLEFHLHGKGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEA 418
Query: 309 KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
K+ADFGLA + D + V+T + GT GY+ PEY + +LTEKSDV+S+GVVLLE++T
Sbjct: 419 KVADFGLAKIASDTNT---HVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELIT 475
Query: 369 ARRAVQDGKN------LVESAQVCM--ASESRLAE-LVDPRIKDSFDMEQLRTIVTIVRW 419
RR V D N LV+ A+ + ASE E L D ++ + +D E++ +V
Sbjct: 476 GRRPV-DANNVYVDDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAA 534
Query: 420 CTQREGQARPSIKQVLRIL 438
C + + RP + Q++R L
Sbjct: 535 CVRHSARRRPRMSQIVRAL 553
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 548 (198.0 bits), Expect = 6.3e-53, P = 6.3e-53
Identities = 123/320 (38%), Positives = 183/320 (57%)
Query: 150 QEGPSPMFQKFSYKETKKATDNFST--IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQV 207
++G M + FS KE +KATDNFS ++GQGG GTVYK DGS++AVKR + E
Sbjct: 407 KDGNVEMSKIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDK 466
Query: 208 EGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRT-PLSWQ 266
+F EI G C+E L+YEY+ NG L LH ++W+
Sbjct: 467 MEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWE 526
Query: 267 TRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326
R++IAI++A AL Y+H P+ HRDIK++NILLDE + AK++DFG S+ ++
Sbjct: 527 VRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFG---TSRSVTLDQ 583
Query: 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV-----QDGKNLVE 381
+ T + GT GYMDPEY ++ + T KSDVYS+GVVL+E++T + + ++G+ L
Sbjct: 584 THLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLAT 643
Query: 382 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE- 440
M E+R+ +++D RIKD +EQ+ + + R C R+G+ RP++K+V L
Sbjct: 644 HFLEAM-KENRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERI 702
Query: 441 SSDPMHSGFVQAVEDEEYEE 460
S P EDEE ++
Sbjct: 703 RSSPEDLDVRTENEDEEEDQ 722
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FX99 | Y1497_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6106 | 0.9652 | 0.7541 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.IX.2217.1 | annotation not avaliable (645 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 518 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-56 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-37 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-36 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-35 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-30 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-30 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-26 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-25 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-25 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-25 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-23 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-17 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-04 | |
| COG2334 | 331 | COG2334, COG2334, Putative homoserine kinase type | 4e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.001 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.001 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 1e-56
Identities = 86/267 (32%), Positives = 124/267 (46%), Gaps = 56/267 (20%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFC 233
+G+GGFGTVY A+ G +A+K + K S + + REIE+L +L+H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 234 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 293
++ +L+ EY GSLKD L LS ++I + + LEYLH + HR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 294 DIKSSNILLDE-NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE-YVVTQELT 351
D+K NILLD N KLADFGL+ I GTP YM PE + +
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL----KTIVGTPAYMAPEVLLGKGYYS 172
Query: 352 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR 411
EKSD++S GV+L E+ P +KD
Sbjct: 173 EKSDIWSLGVILYEL--------------------------------PELKD-------- 192
Query: 412 TIVTIVRWCTQREGQARPSIKQVLRIL 438
++R Q++ + RPS K++L L
Sbjct: 193 ----LIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 5e-52
Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGS-----LIAVKRM--DKISEQVEGDFCREIELLARLHHR 224
+G+G FG VYK +AVK + D +Q+E +F RE ++ +L H
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIE-EFLREARIMRKLDHP 61
Query: 225 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
++V L G C E+ ++ EYM G L D+L LS + A+ +A +EYL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE- 120
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD--IRGTPGYMDP 342
HRD+ + N L+ EN V K++DFGL+ D ++ IR +M P
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKGGKLPIR----WMAP 173
Query: 343 EYVVTQELTEKSDVYSYGVVLLEIVT 368
E + + T KSDV+S+GV+L EI T
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 1e-51
Identities = 80/296 (27%), Positives = 127/296 (42%), Gaps = 68/296 (22%)
Query: 175 IIGQGGFGTVYKAQFSDGS----LIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVAL 229
+G+G FG VYK + +AVK + + SE+ DF +E ++ +L H ++V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHL-------HSPGRTPLSWQTRIQIAIDVANALEYL 282
G C E+ +L+ EYM G L D+L SP ++ LS + + AI +A +EYL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 283 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD-----IRGTP 337
HRD+ + N L+ E+ V K++DFGL S+D IR
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGL---SRDVYDDDYYRKKTGGKLPIR--- 172
Query: 338 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-------------ARRAVQDGKNLVESAQ 384
+M PE + T KSDV+S+GV+L EI T ++ G
Sbjct: 173 -WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-------- 223
Query: 385 VCMASESRLA--ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
RL E + + ++ C Q + + RP+ +++ L
Sbjct: 224 ------YRLPKPEYCPDELYE------------LMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 3e-50
Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGS-----LIAVKRMDKI-SEQVEGDFCREIELLARLHHRH 225
+G+G FG VYK + +AVK + + SEQ +F RE ++ +L H +
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
+V L G C E+ +++ EYM G L +L R LS + A+ +A +EYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN-RPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG---YMDP 342
HRD+ + N L+ EN V K++DFGL+ D RG +M P
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY------YRKRGGKLPIRWMAP 172
Query: 343 EYVVTQELTEKSDVYSYGVVLLEIVT 368
E + + T KSDV+S+GV+L EI T
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-49
Identities = 86/265 (32%), Positives = 124/265 (46%), Gaps = 19/265 (7%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRG 231
+G G FGTVYKA+ G ++AVK + K + + REI +L RL H ++V L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
+K +L+ EY G L D+L PLS +IA+ + LEYLH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQILRGLEYLH---SNGII 120
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE-YVVTQEL 350
HRD+K NILLDEN V K+ADFGLA S T GTP YM PE +
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSS----SSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 351 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 410
K DV+S GV+L E++T + L + + L S + + L
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236
Query: 411 RTIVTIVRWCTQREGQARPSIKQVL 435
++ C ++ RP+ +++L
Sbjct: 237 ------IKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 8e-49
Identities = 80/268 (29%), Positives = 125/268 (46%), Gaps = 29/268 (10%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRG 231
+G+G FG VY A+ G L+A+K + K I + E REI++L +L H ++V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRE-RILREIKILKKLKHPNIVRLYD 64
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
++ + +L+ EY G L D L GR + R + +ALEYLH +
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSED-EAR-FYLRQILSALEYLHSKG---IV 119
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 351
HRD+K NILLDE+ KLADFGLA G V GTP YM PE ++ +
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV-----GTPEYMAPEVLLGKGYG 174
Query: 352 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMA---SESRLAELVDPRIKDSFDME 408
+ D++S GV+L E++T + L+E + + P KD
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKD----- 229
Query: 409 QLRTIVTIVRWCTQREGQARPSIKQVLR 436
++R ++ + R + ++ L+
Sbjct: 230 -------LIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 4e-48
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 172 FSTIIGQGGFGTVYKA-----QFSDGSLIAVKRM-DKISEQVEGDFCREIELLARLHHRH 225
+G+G FG VYK + +AVK + + SE+ +F E ++ +L H +
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
+V L G C + +++ EYM G L D L G L+ + +Q+A+ +A +EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE-KLTLKDLLQMALQIAKGMEYLE-- 119
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLA--HASKD----GSICFEPVNTDIRGTPGY 339
HRD+ + N L+ EN V K++DFGL+ D P+ +
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK--------W 170
Query: 340 MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
M PE + + T KSDV+S+GV+L EI T
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 6e-42
Identities = 69/205 (33%), Positives = 108/205 (52%), Gaps = 18/205 (8%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMD---KISEQVEGDFCREIELLARLHHRHLVALR 230
++G+G FG+VY A D G L+AVK ++ E++E REI +L+ L H ++V
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA-LEREIRILSSLQHPNIVRYY 65
Query: 231 GFCIEKRERFL---MYEYMANGSLKDHLHSPGRTPLSWQTRIQI-AIDVANALEYLHFYC 286
G ++ + L + EY++ GSL L G+ P + I+ + L YLH
Sbjct: 66 GSERDEEKNTLNIFL-EYVSGGSLSSLLKKFGKLP---EPVIRKYTRQILEGLAYLH--- 118
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 346
+ HRDIK +NIL+D + V KLADFG A + G I +RGTP +M PE +
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGC--AKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 347 TQELTEKSDVYSYGVVLLEIVTARR 371
+E +D++S G ++E+ T +
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 64/196 (32%), Positives = 102/196 (52%), Gaps = 14/196 (7%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
IG+GGFG VYKA+ G +A+K + S++ + EI++L + H ++V G +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 235 EKRERFLMYEYMANGSLKDHL-HSPGRTPLSWQTRIQ-IAIDVANALEYLHFYCDPPLCH 292
+K E +++ E+ + GSLKD L + S I + ++ LEYLH + H
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ---IAYVCKELLKGLEYLHSN---GIIH 121
Query: 293 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 352
RDIK++NILL + KL DFGL+ D V GTP +M PE + +
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV-----GTPYWMAPEVINGKPYDY 176
Query: 353 KSDVYSYGVVLLEIVT 368
K+D++S G+ +E+
Sbjct: 177 KADIWSLGITAIELAE 192
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 89/333 (26%), Positives = 138/333 (41%), Gaps = 16/333 (4%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDK---ISEQVEGDFCREIELLARL-HHRHLVALRG 231
+G+G FG VY A+ D L+A+K + K + F REI++LA L H ++V L
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
F ++ +L+ EY+ GSL+D L GR PLS + I + +ALEYLH +
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGI 122
Query: 291 CHRDIKSSNILLDEN-FVAKLADFGLAHASKDGSICFEPVN--TDIRGTPGYMDPEYV-- 345
HRDIK NILLD + V KL DFGLA D + GTPGYM PE +
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 346 -VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404
+ SD++S G+ L E++T + KN ++Q + + S
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGR 464
+ +++ ++ + R S L + + + + +
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRL 302
Query: 465 PRTSQRKAHRSDPTFYSGDGRYLASSSSTSRSY 497
+A S + G L S
Sbjct: 303 SLPPSLEALISSLNSLAISGSDLKLDDSNFSKE 335
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 48/279 (17%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 232
IG+G FG VY + SDG L +K +D +SE+ D E+++L +L+H +++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 233 CIEKRERFLMYEYMANGSLKDHLHS--PGRTPLS----WQTRIQIAIDVANALEYLHFYC 286
EK + ++ EY G L + P +Q+ + AL+YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----ALKYLH--- 120
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMDPEYV 345
+ HRDIK NI L N + KL DFG++ S + T + GTP Y+ PE
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA----KTVV-GTPYYLSPELC 175
Query: 346 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD------- 398
+ KSD++S G VL E+ T + + G+N L EL
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFE-GEN--------------LLELALKILKGQY 220
Query: 399 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI 437
P I + E + +V Q++ + RPSI Q+L+
Sbjct: 221 PPIPSQYSSE----LRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 172 FSTIIGQGGFGTVYKA-QFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVA 228
+IG+G FG VYK G +A+K++ KI E+ +EI+LL L H ++V
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN---ALEYLHFY 285
G +++ EY NGSL+ + G P S +A+ V L YLH
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPES-----LVAVYVYQVLQGLAYLH-- 116
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEY 344
+ + HRDIK++NIL ++ V KLADFG+A + V GTP +M PE
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-----GTPYWMAPEV 170
Query: 345 VVTQELTEKSDVYSYGVVLLEIVT 368
+ + SD++S G ++E++T
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLT 194
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-33
Identities = 76/272 (27%), Positives = 127/272 (46%), Gaps = 33/272 (12%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRG 231
IG+G FG V + G +AVK + S + F E ++ L H +LV L G
Sbjct: 10 LGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLG 67
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
++ +++ EYMA GSL D+L S GR ++ ++ A+DV +EYL +
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVTQEL 350
HRD+ + N+L+ E+ VAK++DFGLA + D P + PE + ++
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEAS--------QGQDSGKLPVKWTAPEALREKKF 176
Query: 351 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 410
+ KSDV+S+G++L EI + R L + V P ++ + ME
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------------VVPHVEKGYRMEAP 221
Query: 411 RT----IVTIVRWCTQREGQARPSIKQVLRIL 438
+ +++ C + + RP+ KQ+ L
Sbjct: 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 86/294 (29%), Positives = 133/294 (45%), Gaps = 55/294 (18%)
Query: 176 IGQGGFGTVYKAQFS------DGSLIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 228
+G+G FG V+ + D L+AVK + + S DF RE ELL H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGR------------TPLSWQTRIQIAIDVA 276
G C E +++EYM +G L L S G L+ +QIA+ +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 277 NALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD- 332
+ + YL HF HRD+ + N L+ + V K+ DFG+ S+D TD
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGM---SRD------VYTTDY 177
Query: 333 --IRGTP----GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC 386
+ G +M PE ++ ++ T +SDV+S+GVVL EI T + G + E +
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC- 236
Query: 387 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440
++ RL L PR S + I+ C +R+ Q R +IK + L +
Sbjct: 237 -ITQGRL--LQRPRTCPSE-------VYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 61/193 (31%), Positives = 96/193 (49%), Gaps = 7/193 (3%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 235
+G G FG V++ + + +A+K + + DF +E++ L RL H+HL++L C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 295
+++ E M GSL L SP L + I +A VA + YL + HRD+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 296 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 355
+ NIL+ E+ V K+ADFGLA K+ + T PE + KSD
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA----PEAASHGTFSTKSD 186
Query: 356 VYSYGVVLLEIVT 368
V+S+G++L E+ T
Sbjct: 187 VWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 66/194 (34%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 235
+G G FG V+ ++ + +AVK + + E F +E +++ +L H LV L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 295
+ +++ EYM+ GSL D L S L + +A +A + YL HRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129
Query: 296 KSSNILLDENFVAKLADFGLAHASKDGSIC-FEPVNTDIRGTPGYMDPEYVVTQELTEKS 354
+ NIL+ EN V K+ADFGLA +D E I+ T PE T KS
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTA----PEAANYGRFTIKS 185
Query: 355 DVYSYGVVLLEIVT 368
DV+S+G++L EIVT
Sbjct: 186 DVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 88/287 (30%), Positives = 132/287 (45%), Gaps = 53/287 (18%)
Query: 176 IGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL 229
+G+G FG V+ A+ D L+AVK + + SE DF RE ELL L H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRT-------------PLSWQTRIQIAIDVA 276
G C E R +++EYM +G L L S G L+ + IA +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 277 NALEY---LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SKD----GSICFE 327
+ + Y LHF HRD+ + N L+ + V K+ DFG++ S D G
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCM 387
P+ +M PE ++ ++ T +SD++S+GVVL EI T + Q L + +
Sbjct: 187 PIR--------WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK--QPWYQLSNTEAIEC 236
Query: 388 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 434
++ R EL PR + I++ C QRE Q R IK +
Sbjct: 237 ITQGR--ELERPRTCPP-------EVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 73/220 (33%), Positives = 106/220 (48%), Gaps = 36/220 (16%)
Query: 176 IGQGGFGTVYKAQ------FSDGSLIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 228
IGQG FG V++A+ + +++AVK + ++ S ++ DF RE L+A H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLH--------------------SPGRTPLSWQTR 268
L G C + L++EYMA G L + L PLS +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 269 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SKDGSICF 326
+ IA VA + YL + HRD+ + N L+ EN V K+ADFGL+ S D
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEI 366
E IR +M PE + T +SDV++YGVVL EI
Sbjct: 190 ENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 23/210 (10%)
Query: 172 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRH 225
F +G+G FG V ++ + G +AVK ++ EQ DF REIE+L L H +
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 226 LVALRGFCIEKRER--FLMYEYMANGSLKDHL--HSPGRTPLSWQTRIQIAIDVANALEY 281
+V +G C + R L+ EY+ +GSL+D+L H ++ + + + + ++Y
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDY 124
Query: 282 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPG 338
L HRD+ + NIL++ + K++DFGLA KD EP + I
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF---- 177
Query: 339 YMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
+ PE + T + + SDV+S+GV L E+ T
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 65/228 (28%), Positives = 115/228 (50%), Gaps = 34/228 (14%)
Query: 164 ETKKATDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKISE-QVEGDFCREIE 216
E + F +G+G FG VYK + + +A+K + + +E +V+ +F +E E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 217 LLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHL--HSP------------GRTP 262
L++ L H ++V L G C +++ +++EY+A+G L + L +SP ++
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 263 LSWQTRIQIAIDVANALEYL--HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320
L + IAI +A +EYL H + HRD+ + N L+ E K++DFGL+
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHF-----VHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 321 DGSICFEPVNT--DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEI 366
+ +R +M PE ++ + T +SD++S+GVVL EI
Sbjct: 176 SADYYRVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 68/207 (32%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRM------DKISEQVEGDFCREIELLARLHHRHLVA 228
IG G FG VY A G L+AVK + K +++ E+++L L H +LV
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIA----DEMKVLELLKHPNLVK 63
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
G + + + ++ EY + G+L++ L GR R + + L YLH
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIR-VYTLQLLEGLAYLH---SH 118
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVT 347
+ HRDIK +NI LD N V KL DFG A K+ + E V + + GTP YM PE +
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS-LAGTPAYMAPEVITG 177
Query: 348 QELTEK---SDVYSYGVVLLEIVTARR 371
+ +D++S G V+LE+ T +R
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 24/265 (9%)
Query: 175 IIGQGGFG--TVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALR 230
++G+G FG T+Y+ D SL+ K ++ ++SE+ D EI +L+ L H +++A
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 231 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
++ + EY G+L D + + + + +A+ Y+H +
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGI 122
Query: 291 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 350
HRDIK+ NI L + + KL DFG++ E V GTP YM PE +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV----VGTPYYMSPELCQGVKY 178
Query: 351 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 410
KSD+++ G VL E++T +R D N + + + + E
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNYTP-------VVSVYSSE-- 228
Query: 411 RTIVTIVRWCTQREGQARPSIKQVL 435
++++V Q++ + RP+ +VL
Sbjct: 229 --LISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-27
Identities = 77/268 (28%), Positives = 126/268 (47%), Gaps = 30/268 (11%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 232
IG+G FG V+K + +D + A+K++D K++ + + E +LA+L +++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLS----WQTRIQIAIDVANALEYLHFYCDP 288
++K + ++ EY NG L L PL W+ IQI + L +LH
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GLAHLH---SK 120
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 348
+ HRDIKS N+ LD K+ D G+A D + NT I GTP Y+ PE +
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF---ANT-IVGTPYYLSPELCEDK 176
Query: 349 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408
EKSDV++ GVVL E T + D N + A + ++ V P + + +
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPF-DANN--QGALI-----LKIIRGVFPPVSQMYSQQ 228
Query: 409 QLRTIVTIVRWCTQREGQARPSIKQVLR 436
+ ++ C ++ + RP Q+LR
Sbjct: 229 ----LAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRGFC 233
IG+G FG VYK + +AVK R + F +E E+L + H ++V L G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIGVC 61
Query: 234 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC-H 292
++K+ +++ E + GSL L L+ + +Q+++D A +EYL C H
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN----CIH 116
Query: 293 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVTQELT 351
RD+ + N L+ EN V K++DFG++ + G V+ ++ P + PE + T
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGG---IYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 352 EKSDVYSYGVVLLEIVT 368
+SDV+SYG++L E +
Sbjct: 174 SESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKR--MDKISEQVEGDFCREIELLARLHHRHLVALRGF 232
IG G VY A + +A+KR ++K V+ + +E++ +++ +H ++V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVVKYYTS 67
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPP 289
+ E +L+ Y++ GSL D + S P IA +V LEYLH
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKS--SYPRGGLDEAIIATVLKEVLKGLEYLH---SNG 122
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
HRDIK+ NILL E+ K+ADFG++ + DG V GTP +M PE V+ Q
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQV 181
Query: 350 --LTEKSDVYSYGVVLLEIVTAR 370
K+D++S+G+ +E+ T
Sbjct: 182 HGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 87/295 (29%), Positives = 137/295 (46%), Gaps = 58/295 (19%)
Query: 176 IGQGGFGTVYKAQ------FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL 229
+G+G FG V+ A+ D L+AVK + + DF RE ELL L H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHL--HSP------------GRTPLSWQTRIQIAIDV 275
G C + +++EYM +G L L H P + L + IA +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 276 ANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SKD----GSICF 326
A+ + YL HF HRD+ + N L+ N + K+ DFG++ S D G
Sbjct: 133 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC 386
P+ +M PE ++ ++ T +SDV+S+GV+L EI T + Q L + +
Sbjct: 187 LPIR--------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGK--QPWFQLSNTEVIE 236
Query: 387 MASESRLAELVDPRI--KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439
++ R+ E PR+ K+ +D I+ C QRE Q R +IK++ +IL+
Sbjct: 237 CITQGRVLE--RPRVCPKEVYD---------IMLGCWQREPQQRLNIKEIYKILH 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 79/266 (29%), Positives = 131/266 (49%), Gaps = 37/266 (13%)
Query: 175 IIGQGGFGTVYKAQFSDGSLIAVKRMD-KISEQVEGDFCREIELLARLHHRHLVALRGFC 233
IIG+G FG V + +++ G +AVK + ++ Q F E ++ +LHH++LV L G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 234 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 293
+ +M E M+ G+L + L + GR +S +Q ++DVA +EYL L HR
Sbjct: 69 LHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHR 124
Query: 294 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVTQELTE 352
D+ + NIL+ E+ VAK++DFGLA + D P + PE + ++ +
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV--------GSMGVDNSKLPVKWTAPEALKHKKFSS 176
Query: 353 KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR- 411
KSDV+SYGV+L E+ + RA +L E V ++ + ME
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPYPKMSLKE---------------VKECVEKGYRMEPPEG 221
Query: 412 ---TIVTIVRWCTQREGQARPSIKQV 434
+ ++ C + E + RPS ++
Sbjct: 222 CPADVYVLMTSCWETEPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 60/198 (30%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 235
+G G FG V++ +++ + +AVK + + + DF E +++ +L H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL--HFYCDPPLCHR 293
+ +++ E M GSL ++L L I +A VA+ + YL Y HR
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY-----IHR 127
Query: 294 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 353
D+ + N+L+ EN + K+ADFGLA K+ +E + + PE + + K
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDI--YEA-REGAKFPIKWTAPEAALYNRFSIK 184
Query: 354 SDVYSYGVVLLEIVTARR 371
SDV+S+G++L EIVT R
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 72/272 (26%), Positives = 128/272 (47%), Gaps = 40/272 (14%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 232
+G+G +G+VYK + SD A+K +D +S++ D EI +LA ++H ++++ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 233 CIEKRERFLMYEYMANGSLKDHL--HSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
++ + ++ EY G L + R + Q +I I + L+ LH + +
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKI 124
Query: 291 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 350
HRD+KS+NILL N + K+ D G++ K T I GTP YM PE +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNM-----AKTQI-GTPHYMAPEVWKGRPY 178
Query: 351 TEKSDVYSYGVVLLEIVTAR-----RAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405
+ KSD++S G +L E+ T R++QD + V+ + P I +
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY-------------PPIPPIY 225
Query: 406 --DMEQLRTIVTIVRWCTQREGQARPSIKQVL 435
D++ +R Q + + RP+ ++L
Sbjct: 226 SQDLQN------FIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 72/272 (26%), Positives = 127/272 (46%), Gaps = 29/272 (10%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVAL 229
IG G FG V+ + + +A+K R +SE+ DF E +++ +L H LV L
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQL 64
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
G C E+ L++E+M +G L D+L + R S +T + + +DV + YL
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN--- 120
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP---GYMDPEYVV 346
+ HRD+ + N L+ EN V K++DFG+ + T GT + PE
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTR------FVLDDQYTSSTGTKFPVKWSSPEVFS 174
Query: 347 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406
+ + KSDV+S+GV++ E+ + + + ++ E + A L PR+
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF----RLYKPRLAS--- 227
Query: 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
+++ +++ C + + RPS +L L
Sbjct: 228 ----QSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 72/269 (26%), Positives = 129/269 (47%), Gaps = 31/269 (11%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 235
+G G FG V+ ++ +A+K + + + E DF E +++ +L H +LV L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 236 KRERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 294
+R F++ EYMANG L ++L G+ L + + + DV A+EYL HRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGK--LGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 295 IKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 353
+ + N L+ E+ V K++DFGLA + D + ++ P PE + K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAP----PEVFDYSRFSSK 181
Query: 354 SDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR-- 411
SDV+S+GV++ E+ + + + S S + E + + + + +
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERF-----------SNSEVVE----SVSAGYRLYRPKLA 226
Query: 412 --TIVTIVRWCTQREGQARPSIKQVLRIL 438
+ TI+ C + + RP+ K++L L
Sbjct: 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 170 DNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVA 228
N IG+G G VYKA + G +A+K+M ++ +Q + EI ++ H ++V
Sbjct: 22 KNLE-KIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVD 79
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHL-HSPGRTPLSWQTRIQIAI---DVANALEYLH- 283
+ E +++ EYM GSL D + + R QIA +V LEYLH
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP-----QIAYVCREVLQGLEYLHS 134
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPG 338
HRDIKS NILL ++ KLADFG A SK S+ GTP
Sbjct: 135 QNV----IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV---------GTPY 181
Query: 339 YMDPEYVVTQELTEKSDVYSYGVVLLEIV 367
+M PE + ++ K D++S G++ +E+
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 172 FSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARL-HHRHL 226
F IIG+G F TV A+ A+K +DK I E+ E E+L RL H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 227 VALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
+ L + + E + + EY NG L ++ G L + A ++ ALEYLH
Sbjct: 65 IKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLH-- 119
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLA---------HASKDGSICFEPVNTDIR-- 334
+ HRD+K NILLD++ K+ DFG A ++K + + R
Sbjct: 120 -SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 335 -----GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
GT Y+ PE + + + SD+++ G ++ +++T
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALR 230
+IG+G FG V Q D + A+K M+K + + + E +L L+H LV L
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 231 GFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
+ + E +L+ + + G L+ HL + Q + I ++ ALEYLH
Sbjct: 67 -YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-QVKFWIC-EIVLALEYLH---SKG 120
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
+ HRDIK NILLDE + DF +A ++ T GTPGYM PE + Q
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-----TTSTSGTPGYMAPEVLCRQG 175
Query: 350 LTEKSDVYSYGVVLLEIVTARR 371
+ D +S GV E + +R
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 87/290 (30%), Positives = 134/290 (46%), Gaps = 53/290 (18%)
Query: 176 IGQGGFGTVYKAQF------SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL 229
+G+G FG V+ A+ D L+AVK + S+ DF RE ELL L H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHL--HSP-------GRTP--LSWQTRIQIAIDVANA 278
G C+E +++EYM +G L L H P G P L+ + IA +A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 279 LEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG 335
+ YL HF HRD+ + N L+ EN + K+ DFG++ + +TD
Sbjct: 133 MVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSR---------DVYSTDYYR 177
Query: 336 TPG-------YMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMA 388
G +M PE ++ ++ T +SDV+S GVVL EI T + Q L + +
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK--QPWYQLSNNEVIECI 235
Query: 389 SESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
++ R+ L PR + + ++ C QRE R +IK++ +L
Sbjct: 236 TQGRV--LQRPRTCP-------KEVYDLMLGCWQREPHMRLNIKEIHSLL 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-25
Identities = 79/267 (29%), Positives = 136/267 (50%), Gaps = 37/267 (13%)
Query: 175 IIGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRGF 232
IG+G FG V + G+ +AVK + D ++ F E ++ +L H +LV L G
Sbjct: 13 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGV 67
Query: 233 CIE-KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
+E K +++ EYMA GSL D+L S GR+ L ++ ++DV A+EYL
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFV 124
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 351
HRD+ + N+L+ E+ VAK++DFGL +K+ S + ++ T PE + ++ +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGL---TKEASSTQDTGKLPVKWTA----PEALREKKFS 177
Query: 352 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ-- 409
KSDV+S+G++L EI + R V ++ L ++V PR++ + M+
Sbjct: 178 TKSDVWSFGILLWEIYSFGR--------VPYPRI------PLKDVV-PRVEKGYKMDAPD 222
Query: 410 --LRTIVTIVRWCTQREGQARPSIKQV 434
+ +++ C + RPS Q+
Sbjct: 223 GCPPVVYDVMKQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 21/198 (10%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRG 231
+G+G +G+VYKA G ++A+K +++ +++ +EI +L + ++V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII----KEISILKQCDSPYIVKYYG 65
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDP 288
+ + +++ EY GS+ D + +T L+ + +IA LEYLH
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIMKITNKT-LTEE---EIAAILYQTLKGLEYLH---SN 118
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 348
HRDIK+ NILL+E AKLADFG++ D NT I GTP +M PE +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT---MAKRNTVI-GTPFWMAPEVIQEI 174
Query: 349 ELTEKSDVYSYGVVLLEI 366
K+D++S G+ +E+
Sbjct: 175 GYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 71/221 (32%), Positives = 100/221 (45%), Gaps = 50/221 (22%)
Query: 176 IGQGGFGTVYKAQFS----DGSLIAVK---RMDKISEQVEGDFCREIELLARLHHRHLVA 228
+G G FG VY+ + D + V + SEQ E DF E ++++ +H+++V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLH----SPGR-TPLSWQTRIQIAIDVANALEYL- 282
L G E+ RF++ E MA G LK L P R + L+ + + A DVA +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 283 --HFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 337
HF HRDI + N LL VAK+ADFG+A DI
Sbjct: 134 ENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMAR--------------DIYRAS 173
Query: 338 GY------------MDPEYVVTQELTEKSDVYSYGVVLLEI 366
Y M PE + T K+DV+S+GV+L EI
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 82/275 (29%), Positives = 128/275 (46%), Gaps = 33/275 (12%)
Query: 175 IIGQGGFGTVYKAQFSDGSLIAVKRM-----DKISEQVE-GDFCREIELLARLHHRHLVA 228
++G+G +GTVY + G LIAVK++ + ++ + E E++LL L H ++V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP---LSWQTRIQIAIDVANALEYLHFY 285
G C++ + E++ GS+ L+ G P T+ QI VA YLH
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHNN 121
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFG----LAHASKDGSICFEPVNTDIRGTPGYMD 341
C + HRDIK +N++L N + KL DFG LA G+ + + GTP +M
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT--HSNMLKSMHGTPYWMA 176
Query: 342 PEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401
PE + KSD++S G + E+ T + + L +A + + L PR+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--AAMFYIGAHRGLM----PRL 230
Query: 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
DSF + V C R+ RPS Q+LR
Sbjct: 231 PDSFS----AAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 75/222 (33%), Positives = 111/222 (50%), Gaps = 39/222 (17%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSL---IAVKRM-DKISEQVEGDFCREIELLARL-HHRHL 226
F +IG+G FG V KA+ L A+KRM + S+ DF E+E+L +L HH ++
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 227 VALRGFCIEKRERFLMYEYMANGSLKDHL---------------HSPGRTPLSWQTRIQI 271
+ L G C + +L EY +G+L D L +S T LS Q +
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST-LSSQQLLHF 129
Query: 272 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331
A DVA ++YL HRD+ + NIL+ EN+VAK+ADFGL+ +
Sbjct: 130 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE----------V 176
Query: 332 DIRGTPGYMDPEYVVTQEL-----TEKSDVYSYGVVLLEIVT 368
++ T G + ++ + L T SDV+SYGV+L EIV+
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 65/200 (32%), Positives = 97/200 (48%), Gaps = 19/200 (9%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 231
+G+G FG V + G L A+K + K I + E +L+R++H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 232 FCIEKRER--FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
+ + E+ ++ EY G L HL GR R A ++ ALEYLH
Sbjct: 60 YAFQTEEKLYLVL-EYAPGGELFSHLSKEGRFSEER-ARFYAA-EIVLALEYLH---SLG 113
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 348
+ +RD+K NILLD + KL DFGLA S +GS GTP Y+ PE ++ +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-----GTPEYLAPEVLLGK 168
Query: 349 ELTEKSDVYSYGVVLLEIVT 368
+ D +S GV+L E++T
Sbjct: 169 GYGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 45/281 (16%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVAL-- 229
IG+G FGTV K + SDG ++ K +D ++E+ + E+ +L L H ++V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 230 RGFCIEKRERFLMYEYMANGSL--------KDHLHSPGRTPLSWQTRIQIAIDVANALEY 281
R + +++ EY G L K+ + W+ Q+ + AL
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEF--IWRILTQLLL----ALYE 120
Query: 282 LHF--YCDPPLCHRDIKSSNILLDENFVAKLADFGLA----HASKDGSICFEPVNTDIRG 335
H + HRD+K +NI LD N KL DFGLA H S G
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV--------G 172
Query: 336 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE 395
TP YM PE + EKSD++S G ++ E+ +N ++ A ++ E
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT-ARNQLQLAS-------KIKE 224
Query: 396 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
RI + +L ++ + RPS +++L+
Sbjct: 225 GKFRRIPYRYS-SELNEVIKS---MLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-24
Identities = 60/198 (30%), Positives = 106/198 (53%), Gaps = 16/198 (8%)
Query: 176 IGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
+G G +G VY+ + SL +AVK + + + +VE +F +E ++ + H +LV L G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPLC 291
+ +++ E+M G+L D+L R ++ + +A +++A+EYL +F
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF------I 126
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP-VNTDIRGTPGYMDPEYVVTQEL 350
HRD+ + N L+ EN + K+ADFGL+ + I+ T PE + +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 182
Query: 351 TEKSDVYSYGVVLLEIVT 368
+ KSDV+++GV+L EI T
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-24
Identities = 68/201 (33%), Positives = 108/201 (53%), Gaps = 12/201 (5%)
Query: 175 IIGQGGFGTVYKAQF--SDGSLI--AVKRMDKIS--EQVEGDFCREIELLARLHHRHLVA 228
+IG+G FG VY SDG I AVK +++I+ E+VE F +E ++ H ++++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE-QFLKEGIIMKDFSHPNVLS 60
Query: 229 LRGFCIEKR-ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 287
L G C+ ++ YM +G L++ + S P + + I + VA +EYL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP-TVKDLIGFGLQVAKGMEYL---AS 116
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 347
HRD+ + N +LDE+F K+ADFGLA D +T + +M E + T
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 348 QELTEKSDVYSYGVVLLEIVT 368
Q+ T KSDV+S+GV+L E++T
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 76/280 (27%), Positives = 137/280 (48%), Gaps = 26/280 (9%)
Query: 175 IIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC 233
+I +G G YK + + VK ++ ++ EI + +L H ++V L G C
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIGLC 752
Query: 234 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 293
++ +L++EY+ +L + L + LSW+ R +IAI +A AL +LH C P +
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 294 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 353
++ I++D L S G +C +T + Y+ PE T+++TEK
Sbjct: 808 NLSPEKIIIDGKDEPHLR------LSLPGLLC---TDTKCFISSAYVAPETRETKDITEK 858
Query: 354 SDVYSYGVVLLEIVTARRA--VQDGKN--LVESAQVCMASESRLAELVDPRIKD--SFDM 407
SD+Y +G++L+E++T + + G + +VE A+ C S+ L +DP I+ S +
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY-SDCHLDMWIDPSIRGDVSVNQ 917
Query: 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHS 447
++ ++ + CT + ARP VL+ L +S S
Sbjct: 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957
|
Length = 968 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 24/201 (11%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 232
IG+G FG VYKA ++A+K +D + +++E D +EI+ L++ ++ G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE-DIQQEIQFLSQCRSPYITKYYGS 67
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 292
++ + +++ EY GS D L PG L I +V LEYLH + H
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLD-LLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIH 121
Query: 293 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR-----GTPGYMDPEYVVT 347
RDIK++NILL E KLADFG++ G + +T + GTP +M PE +
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVS-----GQL----TSTMSKRNTFVGTPFWMAPEVIKQ 172
Query: 348 QELTEKSDVYSYGVVLLEIVT 368
EK+D++S G+ +E+
Sbjct: 173 SGYDEKADIWSLGITAIELAK 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 3e-23
Identities = 72/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDF----CREIELLARLHHRHLVA 228
++GQG G VYK + G + A+K KI + +F RE++ L ++V
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALK---KIHVDGDEEFRKQLLRELKTLRSCESPYVVK 63
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP---LSWQTRIQIAIDVANALEYLHFY 285
G ++ E ++ EYM GSL D L G+ P L+ IA + L+YLH
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHT- 117
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEY 344
+ HRDIK SN+L++ K+ADFG++ C V GT YM PE
Sbjct: 118 -KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPER 171
Query: 345 VVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404
+ + + +D++S G+ LLE + + + L
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPE 231
Query: 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
F R ++ C Q++ + RPS ++L+
Sbjct: 232 F-----RDFISA---CLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 81/292 (27%), Positives = 133/292 (45%), Gaps = 58/292 (19%)
Query: 172 FSTIIGQGGFGTVYKAQFS-DGSLI--AVKRMDKI-SEQVEGDFCREIELLARL-HHRHL 226
F +IG+G FG V +A DG + A+K + + SE DF E+E+L +L HH ++
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 227 VALRGFCIEKRERFLMYEYMANGSLKDHL---------------HSPGRTPLSWQTRIQI 271
+ L G C + ++ EY G+L D L H T L+ Q +Q
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST-LTSQQLLQF 124
Query: 272 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331
A DVA ++YL + HRD+ + N+L+ EN +K+ADFGL+ +
Sbjct: 125 ASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEE----------V 171
Query: 332 DIRGTPGYMDPEYVVTQEL-----TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC 386
++ T G + ++ + L T KSDV+S+GV+L EIV+ + C
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS-----------LGGTPYC 220
Query: 387 MASESRLAELVDPRIKDSFDMEQLRT----IVTIVRWCTQREGQARPSIKQV 434
+ + L E ++ + ME+ R + ++R C + RP Q+
Sbjct: 221 GMTCAELYE----KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 5e-23
Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 235
+G G FG V+ ++ + +A+K + + S E F E L+ +L H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYA-VVT 71
Query: 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 295
+ +++ EYM NGSL D L +P L+ I +A +A + ++ HRD+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128
Query: 296 KSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 354
+++NIL+ E K+ADFGLA +D E I+ T PE + T KS
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGTFTIKS 184
Query: 355 DVYSYGVVLLEIVTARR 371
DV+S+G++L EIVT R
Sbjct: 185 DVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 68/239 (28%), Positives = 105/239 (43%), Gaps = 73/239 (30%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDF----CREIELLARLHHRHLVAL 229
IG+G +G VYKA+ G L+A+K++ +E+ EG F REI+LL +L H ++V L
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEK-EG-FPITAIREIKLLQKLRHPNIVRL 63
Query: 230 RGFCIEKRER--FLMYEYMANGSLKDH-----LHSPGRTPLSWQTRIQIAID-------- 274
+ K + ++++EYM DH L SP ++
Sbjct: 64 KEIVTSKGKGSIYMVFEYM------DHDLTGLLDSPE---------VKFTESQIKCYMKQ 108
Query: 275 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 334
+ L+YLH + HRDIK SNIL++ + V KLADFGLA + N
Sbjct: 109 LLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLAR-------PYTKRN---- 154
Query: 335 GTPGYMDPEY---VVT-----QEL-------TEKSDVYSYGVVLLEIVTARRAVQDGKN 378
+Y V+T EL + D++S G +L E+ + + G
Sbjct: 155 ------SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL-GKPIFQGST 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 6e-23
Identities = 71/208 (34%), Positives = 105/208 (50%), Gaps = 24/208 (11%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMD------KISEQVEGDFCREIELLARLHHRHLV 227
++GQG FG VY D G +AVK++ + ++V C EI+LL L H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC-EIQLLKNLQHERIV 67
Query: 228 ALRGFCIEKRERFLMY-EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 286
G C+ E ++ EYM GS+KD L + G L+ + + +EYLH
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLH--- 121
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD-GSICFEPVNTDIR---GTPGYMDP 342
+ HRDIK +NIL D KL DFG ASK +IC T ++ GTP +M P
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFG---ASKRLQTICSS--GTGMKSVTGTPYWMSP 176
Query: 343 EYVVTQELTEKSDVYSYGVVLLEIVTAR 370
E + + K+DV+S G ++E++T +
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 7e-23
Identities = 80/273 (29%), Positives = 119/273 (43%), Gaps = 38/273 (13%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFC-----REIELLARLHHRHLVAL 229
+G G FG+VY+ DG AVK + + G +EI LL++L H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP---LSWQTRIQIAIDVANALEYLHFYC 286
G E+ ++ E + GSL L G P + TR QI + LEYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILL----GLEYLH--- 119
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYV 345
D HRDIK +NIL+D N V KLADFG+A + +G+P +M PE +
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA------KSFKGSPYWMAPEVI 173
Query: 346 V-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD-PRIKD 403
+D++S G +LE+ T + S +A+ ++ + P I D
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPW--------SQLEGVAAVFKIGRSKELPPIPD 225
Query: 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
E I C QR+ RP+ ++L
Sbjct: 226 HLSDEAKDFI----LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 80/272 (29%), Positives = 120/272 (44%), Gaps = 39/272 (14%)
Query: 176 IGQGGFGTVYKAQFS-DGSLIAVKRMD---KISEQVEGDFCREIELLARLHHRHLVALRG 231
IG G FG VY A+ ++A+K+M K S + D +E+ L +L H + + +G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 232 FCIEKRERFLMYEYMANGSLKDHL--HSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
+ + +L+ EY GS D L H + PL I L YLH +
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE--- 135
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ- 348
HRDIK+ NILL E KLADFG A S+ P N+ + GTP +M PE ++
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSA------SLV-SPANSFV-GTPYWMAPEVILAMD 187
Query: 349 --ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV--DPRIKDS 404
+ K DV+S G+ +E+ + + + M + S L + D S
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFN-----------MNAMSALYHIAQNDSPTLSS 236
Query: 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
D V C Q+ Q RPS +++L+
Sbjct: 237 NDWSD--YFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMD-KISEQVEGDFCREIELLARLHHRHLVALRGFC 233
+G G G V K G ++AVK + +I+E ++ RE+++L + + ++V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 234 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 293
+ + EYM GSL D + + + + +IA+ V L YLH + HR
Sbjct: 69 YNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLH--EKHKIIHR 125
Query: 294 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 353
D+K SNIL++ KL DFG++ G + T + GT YM PE + + + K
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLAKTFV-GTSSYMAPERIQGNDYSVK 179
Query: 354 SDVYSYGVVLLEIVTAR 370
SD++S G+ L+E+ T R
Sbjct: 180 SDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 74/283 (26%), Positives = 127/283 (44%), Gaps = 48/283 (16%)
Query: 174 TIIGQGGFGTVYKAQFSDGS----LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 228
+IG G FG V + + +A+K + S++ DF E ++ + H +++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHL-HSPGRTPLSWQTRIQIAIDVANALEYL--HFY 285
L G + R ++ EYM NGSL L + G+ + + + +A+ ++YL Y
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD------IRGTPGY 339
HRD+ + NIL++ N V K++DFGL+ +D E T IR T
Sbjct: 128 V-----HRDLAARNILVNSNLVCKVSDFGLSRRLED----SEATYTTKGGKIPIRWTA-- 176
Query: 340 MDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASES--RLAEL 396
PE + ++ T SDV+S+G+V+ E+++ R D N V A E RL
Sbjct: 177 --PEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----QDVIKAVEDGYRLPPP 230
Query: 397 VD-PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
+D P + ++ C Q++ RP+ Q++ L
Sbjct: 231 MDCP-----------SALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 172 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL 226
F +G+G FG+V ++ + G ++AVK++ + + DF REIE+L L H ++
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 227 VALRGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
V +G C +R L+ EY+ GSL+D+L R L + + A + +EYL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQICKGMEYLG- 125
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPGYMD 341
HRD+ + NIL++ K+ DFGL K+ EP + I +
Sbjct: 126 --SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----WYA 179
Query: 342 PEYVVTQELTEKSDVYSYGVVLLEIVT 368
PE + + + SDV+S+GVVL E+ T
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 3e-22
Identities = 57/195 (29%), Positives = 101/195 (51%), Gaps = 12/195 (6%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 235
+G G FG V ++ +A+K M K E +F E +++ +L H LV L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 295
+R +++ EYM+NG L ++L G+ Q +++ DV + YL HRD+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLE---SKQFIHRDL 126
Query: 296 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD--IRGTPGYMDPEYVVTQELTEK 353
+ N L+D+ K++DFGL+ D V + +R +P PE ++ + + K
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSP----PEVLLYSKFSSK 181
Query: 354 SDVYSYGVVLLEIVT 368
SDV+++GV++ E+ +
Sbjct: 182 SDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-22
Identities = 73/264 (27%), Positives = 126/264 (47%), Gaps = 20/264 (7%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 235
+G G FG V+ +++ + +AVK + + V+ F E L+ L H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 295
+ +++ EYMA GSL D L S + I + +A + Y+ HRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129
Query: 296 KSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 354
+++N+L+ E+ + K+ADFGLA +D E I+ T PE + T KS
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGSFTIKS 185
Query: 355 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIV 414
DV+S+G++L EIVT + G S M++ R + PR+++ D +
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGM----SNSDVMSALQRGYRM--PRMENCPD-----ELY 234
Query: 415 TIVRWCTQREGQARPSIKQVLRIL 438
I++ C + + + RP+ + +L
Sbjct: 235 DIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 38/217 (17%)
Query: 176 IGQGGFGTVYK---AQFSDGSL---IAVKRM---DKISEQVEGDFCREIELLARLHHRHL 226
+GQG FG VY+ G +A+K + + E++E F E ++ + H+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE--FLNEASVMKEFNCHHV 71
Query: 227 VALRGFCIEKRERFLMYEYMANGSLKDHL--------HSPGRTPLSWQTRIQIAIDVANA 278
V L G + ++ E MA G LK +L ++PG P + Q IQ+A ++A+
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 279 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-------HASKDGSICFEPVNT 331
+ YL HRD+ + N ++ E+ K+ DFG+ + K G PV
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PVR- 186
Query: 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
+M PE + T KSDV+S+GVVL E+ T
Sbjct: 187 -------WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVK---RMDKISEQVEGDFCREIELLARLHHRHLVALRG 231
I +G +G V+ A+ S G + A+K + D I + E ++L++ ++V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
K+ +L+ EY+ G L L + G RI IA ++ ALEYLH +
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV-ARIYIA-EIVLALEYLHSN---GII 115
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD----IRGTPGYMDPEYVVT 347
HRD+K NIL+D N KL DFGL+ + I GTP Y+ PE ++
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 348 QELTEKSDVYSYGVVLLEIVT 368
Q ++ D +S G +L E +
Sbjct: 176 QGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 7e-22
Identities = 79/277 (28%), Positives = 120/277 (43%), Gaps = 40/277 (14%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKR------MDKISEQVEGDFCREIELLARLHHRHLVA 228
IG+G F VYKA DG ++A+K+ MD + Q D +EI+LL +L H +++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLKQLDHPNVIK 66
Query: 229 LRGFCIEKRERFLMYEYMANGSLK---DHLHSPGRT---PLSWQTRIQIAIDVANALEYL 282
IE E ++ E G L H R W+ +Q+ +ALE++
Sbjct: 67 YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHM 122
Query: 283 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMD 341
H + HRDIK +N+ + V KL D GL S + V GTP YM
Sbjct: 123 H---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-----GTPYYMS 174
Query: 342 PEYVVTQELTEKSDVYSYGVVLLEIVTARRAV-QDGKNLVESAQVCMASESRLAELVDPR 400
PE + KSD++S G +L E+ + D NL + + P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD------YPPL 228
Query: 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI 437
D + E+LR +V+ C + + RP I VL++
Sbjct: 229 PADHYS-EELRDLVSR---CINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 2e-21
Identities = 66/213 (30%), Positives = 94/213 (44%), Gaps = 39/213 (18%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRG 231
+G+G +G VYKA+ G ++A+K R+D E + REI LL L H ++V L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH--FYCDPP 289
+R+ +L++EY LK +L PLS I + L Y H
Sbjct: 66 VIHTERKLYLVFEYCDM-DLKKYLDKR-PGPLSPNLIKSIMYQLLRGLAYCHSHRIL--- 120
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ- 348
HRD+K NIL++ + V KLADFGLA A P+ T E VVT
Sbjct: 121 --HRDLKPQNILINRDGVLKLADFGLARA------FGIPLRT--------YTHE-VVTLW 163
Query: 349 ----ELTEKSDVYSYGV-------VLLEIVTAR 370
E+ S YS V + E++T +
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 71/205 (34%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISE--QVEGDFCREIELLARLHHRHLVAL- 229
+G GGFG V + S A+K + K I E Q E F E E+L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
R F +K LM EY G L L G + R IA V A EYLH +
Sbjct: 60 RTFKDKKYIYMLM-EYCLGGELWTILRDRGLFD-EYTARFYIAC-VVLAFEYLH---NRG 113
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDG----SICFEPVNTDIRGTPGYMDPEYV 345
+ +RD+K N+LLD N KL DFG A K G + C GTP Y+ PE +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC---------GTPEYVAPEII 164
Query: 346 VTQELTEKSDVYSYGVVLLEIVTAR 370
+ + D +S G++L E++T R
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 6e-21
Identities = 67/200 (33%), Positives = 100/200 (50%), Gaps = 24/200 (12%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVE-GDFCREIELLARLHHRHLVALRGFC 233
IG G +G VYKA+ + G L+A+K + K+ + +EI +L H ++VA G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVI-KLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69
Query: 234 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPPL 290
+ + + +++ EY GSL+D R PLS QIA + L YLH +
Sbjct: 70 LRRDKLWIVMEYCGGGSLQDIYQV-TRGPLSEL---QIAYVCRETLKGLAYLH---ETGK 122
Query: 291 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 350
HRDIK +NILL E+ KLADFG++ A +I + I GTP +M PE V
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVS-AQLTATI--AKRKSFI-GTPYWMAPE--VAAVE 176
Query: 351 -----TEKSDVYSYGVVLLE 365
K D+++ G+ +E
Sbjct: 177 RKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 9e-21
Identities = 68/229 (29%), Positives = 101/229 (44%), Gaps = 53/229 (23%)
Query: 162 YKETKKATDNFSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFC---REIEL 217
YK K+ +G G FG+VY A+ G L+A+K+M K E C RE++
Sbjct: 1 YKVIKQ--------LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE--CMNLREVKS 50
Query: 218 LARL-HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVA 276
L +L H ++V L+ E E + ++EYM G+L + P S I +
Sbjct: 51 LRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQIL 109
Query: 277 NALEYLH---FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDI 333
L ++H F+ HRD+K N+L+ V K+ADFGLA +I
Sbjct: 110 QGLAHIHKHGFF------HRDLKPENLLVSGPEVVKIADFGLAR--------------EI 149
Query: 334 RGTPGYMDPEYVVTQ-----ELTEKSDVYS-------YGVVLLEIVTAR 370
R P Y D YV T+ E+ +S YS G ++ E+ T R
Sbjct: 150 RSRPPYTD--YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 176 IGQGGFGTVYKAQF--SDGSLI--AVK--RMDKISEQVEGDFCREIELLARLHHRHLVAL 229
+G G FG V + ++ S G +I AVK + DK+S+ ++ DF +E ++ L H +L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD-DFLKEAAIMHSLDHENLIRL 61
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
G + ++ E GSL D L T A+ +AN + YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVTQ 348
HRD+ + NILL + K+ DFGL A + V + P + PE + T+
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY--VMEEHLKVPFAWCAPESLRTR 175
Query: 349 ELTEKSDVYSYGVVLLEIVT 368
+ SDV+ +GV L E+ T
Sbjct: 176 TFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 74/277 (26%), Positives = 134/277 (48%), Gaps = 20/277 (7%)
Query: 176 IGQGGFGTV----YKAQFSD-GSLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVAL 229
+G+G FG V Y G ++AVK + + +Q + +EI +L L+H ++V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 230 RGFCIEKRER--FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 287
+G C E+ + L+ EY+ GSL+D+L + L+ + A + + YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLH---S 125
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 347
HRD+ + N+LLD + + K+ DFGLA A +G + V D + E +
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VREDGDSPVFWYAVECLKE 184
Query: 348 QELTEKSDVYSYGVVLLEIVTARRAVQDGK----NLVESAQVCMASESRLAELVDPRIKD 403
+ + SDV+S+GV L E++T + Q ++ Q M + RL EL++ ++
Sbjct: 185 NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM-TVVRLIELLERGMRL 243
Query: 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440
+ + +++ C + E + RP+ + ++ IL E
Sbjct: 244 PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 17/227 (7%)
Query: 163 KETKKATDNFSTIIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIE 216
+ K+ ++G G FGTVYK + +G + A+K + ++ S + + E
Sbjct: 2 RILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY 61
Query: 217 LLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVA 276
++A + H H+V L G C+ + + L+ + M G L D++ + + + Q + + +A
Sbjct: 62 VMASVDHPHVVRLLGICLSSQVQ-LITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIA 119
Query: 277 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIR 334
+ YL + L HRD+ + N+L+ K+ DFGLA + E I+
Sbjct: 120 KGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176
Query: 335 GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 381
+M E ++ + T KSDV+SYGV + E++T +G VE
Sbjct: 177 ----WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKI------SEQVEGDFCREIELLARLHHRHLV 227
+G G F + Y+A+ G+L+AVK++ + E+V +EI L+ARL+H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 228 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 287
+ G E L E+MA GS+ L G I + L YLH +
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLH---E 121
Query: 288 PPLCHRDIKSSNILLDEN-FVAKLADFGLA---HASKDGSICFEPVNTDIRGTPGYMDPE 343
+ HRD+K +N+L+D ++ADFG A A G+ F+ + GT +M PE
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ---GQLLGTIAFMAPE 178
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVTAR 370
+ ++ DV+S G V++E+ TA+
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 84/289 (29%), Positives = 134/289 (46%), Gaps = 58/289 (20%)
Query: 175 IIGQGGFGTVYKAQFSDGSL---IAVKRMDK-ISEQVEGDFCREIELLARL-HHRHLVAL 229
+IG+G FG V KA+ L A+KRM + S+ DF E+E+L +L HH +++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHL---------------HSPGRTPLSWQTRIQIAID 274
G C + +L EY +G+L D L +S T LS Q + A D
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST-LSSQQLLHFAAD 120
Query: 275 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 334
VA ++YL HRD+ + NIL+ EN+VAK+ADFGL+ + ++
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE----------VYVK 167
Query: 335 GTPGYMDPEYVVTQEL-----TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS 389
T G + ++ + L T SDV+SYGV+L EIV+ + C +
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----------LGGTPYCGMT 216
Query: 390 ESRLAELVDPRIKDSFDMEQLRT----IVTIVRWCTQREGQARPSIKQV 434
+ L E ++ + +E+ + ++R C + + RPS Q+
Sbjct: 217 CAELYE----KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 235
+G G FG V+ ++ + +AVK + + E F E +++ +L H LV L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYA-VVS 71
Query: 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 295
+ +++ EYM+ GSL D L L + +A VA + Y+ HRD+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDL 128
Query: 296 KSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 354
+S+NIL+ + V K+ADFGLA +D + I+ T PE + T KS
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFTIKS 184
Query: 355 DVYSYGVVLLEIVTARRAVQDGKN 378
DV+S+G++L E+VT R G N
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCR----------EIELLARLHH 223
+IG+G +G VY A + G ++AVK+++ + R EIE L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 224 RHLVALRGFCIEKRERFL--MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 281
++V GF E E +L EY+ GS+ L + GR Q V L Y
Sbjct: 68 LNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGR--FEEQLVRFFTEQVLEGLAY 123
Query: 282 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMD 341
LH + HRD+K+ N+L+D + + K++DFG++ S D + N ++G+ +M
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ--NMSMQGSVFWMA 178
Query: 342 PEYVVTQE--LTEKSDVYSYGVVLLEIVTARR 371
PE + + + K D++S G V+LE+ RR
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 5e-20
Identities = 70/228 (30%), Positives = 109/228 (47%), Gaps = 13/228 (5%)
Query: 164 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHH 223
E + + +G G FG V+ A ++ + +AVK M S VE F E ++ L H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQH 60
Query: 224 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 283
LV L + K +++ E+MA GSL D L S + I + +A + ++
Sbjct: 61 DKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDP 342
HRD++++NIL+ + V K+ADFGLA +D E I+ T P
Sbjct: 120 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----P 172
Query: 343 EYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE 390
E + T KSDV+S+G++L+EIVT R G + + +V A E
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG---MSNPEVIRALE 217
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 20/200 (10%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
+G G FG VYKAQ + G A K + SE+ DF EI++L+ H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPPLC 291
+ + +++ E+ G+L + R L T QI + AL +LH +
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELER-GL---TEPQIRYVCRQMLEALNFLH---SHKVI 125
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 351
HRD+K+ NILL + KLADFG++ +K + +T I GTP +M PE V +
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKST---LQKRDTFI-GTPYWMAPEVVACETFK 181
Query: 352 E-----KSDVYSYGVVLLEI 366
+ K+D++S G+ L+E+
Sbjct: 182 DNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 7e-20
Identities = 70/207 (33%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMD------KISEQVEGDFCREIELLARLHHRHLV 227
++GQG FG VY +D G +AVK++ + S++V C EI+LL L H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC-EIQLLKNLLHERIV 67
Query: 228 ALRGFCIEKRERFL--MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
G + ER L E+M GS+KD L S G L+ + + + YLH
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLH-- 123
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD-GSICFEPVN-TDIRGTPGYMDPE 343
+ HRDIK +NIL D KL DFG ASK +IC + GTP +M PE
Sbjct: 124 -SNMIVHRDIKGANILRDSVGNVKLGDFG---ASKRLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVTAR 370
+ + K+D++S G ++E++T +
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-20
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 28/213 (13%)
Query: 174 TIIGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHL 226
T +G+G FG V+ A+ +L+ VK + K ++ ++ +F RE+++ +L H+++
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70
Query: 227 VALRGFCIEKRERFLMYEYMANGSLKDHL-------HSPGRTPLSWQTRIQIAIDVANAL 279
V L G C E +++ EY G LK L PLS + ++ + +A +
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 280 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD--GSICFEPVNT--DIRG 335
++L + HRD+ + N L+ K++ L SKD S ++ N +R
Sbjct: 131 DHLS---NARFVHRDLAARNCLVSSQREVKVSLLSL---SKDVYNSEYYKLRNALIPLR- 183
Query: 336 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
++ PE V + + KSDV+S+GV++ E+ T
Sbjct: 184 ---WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 27/216 (12%)
Query: 175 IIGQGGFGTVYKAQFSD------GSLIAVKRM-DKISEQVEGDFCREIELLARL-HHRHL 226
+G+G FG V KA+ S +AVK + D +E+ D E+E++ + H+++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 227 VALRGFCIEKRERFLMYEYMANGSLKDHLHS--------------PGRTPLSWQTRIQIA 272
+ L G C ++ +++ EY A+G+L+D L + P L+ + + A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 273 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 332
VA +E+L HRD+ + N+L+ E+ V K+ADFGLA I + T+
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH--IDYYRKTTN 193
Query: 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
R +M PE + + T +SDV+S+GV+L EI T
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 8e-20
Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 170 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDK--ISE--QVEGDFCREIELLARLH 222
D+F I +G G FG V + G A+K + K I + QVE E +L +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVE-HVLNEKRILQSIR 59
Query: 223 HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 282
H LV L G + +L+ EY+ G L HL GR P R A V ALEYL
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP-VARFYAA-QVVLALEYL 117
Query: 283 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG--SICFEPVNTDIRGTPGYM 340
H D + +RD+K N+LLD + K+ DFG A K ++C GTP Y+
Sbjct: 118 H-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC---------GTPEYL 165
Query: 341 DPEYVVTQELTEKSDVYSYGVVLLEIV 367
PE ++++ + D ++ G+++ E++
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 9e-20
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 175 IIGQGGFGTVYKAQFS--DGSL--IAVKRM--DKISEQVEGDFCREIELLARLHHRHLVA 228
I+G+G FG+V + Q S DGS +AVK M D + +F E + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 229 LRGFCIEKRER------FLMYEYMANGSLKDHLHS------PGRTPLSWQTRIQIAIDVA 276
L G C E ++ +M +G L L P + PL QT ++ +D+A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDIA 123
Query: 277 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SKD----GSICFEPVN 330
+EYL + HRD+ + N +L E+ +ADFGL+ S D G I PV
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
++ E + + T KSDV+++GV + EI T
Sbjct: 181 --------WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 1e-19
Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 235
+GQG FG V+ ++ + +A+K + + E F +E +++ +L H LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA-VVS 71
Query: 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 295
+ +++ EYM+ GSL D L L + +A +A+ + Y+ HRD+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 128
Query: 296 KSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 354
+++NIL+ EN V K+ADFGLA +D + I+ T PE + T KS
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFTIKS 184
Query: 355 DVYSYGVVLLEIVTARR 371
DV+S+G++L E+ T R
Sbjct: 185 DVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 31/268 (11%)
Query: 176 IGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVE---GDFCREIELLARLHHRHLVALRG 231
IG G FG VY A S ++AVK+M +Q D +E++ L +L H + + +G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
+++ +L+ EY GS D L + PL I L YLH + +
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN---MI 143
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 351
HRDIK+ NILL E KLADFG A S P N+ + GTP +M PE ++ +
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKS-------SPANSFV-GTPYWMAPEVILAMDEG 195
Query: 352 E---KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408
+ K DV+S G+ +E+ + + + M++ +A+ P ++ + +
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNDSPTLQSNEWTD 247
Query: 409 QLRTIVTIVRWCTQREGQARPSIKQVLR 436
R V +C Q+ Q RP+ ++LR
Sbjct: 248 SFRGFVD---YCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 14/215 (6%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRG 231
+G+GGFG V Q G + A K++DK + E E ++L ++ R +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 232 FCIEKRERF-LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
+ E ++ L+ M G LK H+++ G I A + LE+LH +
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 291 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 350
+RD+K N+LLD++ +++D GLA K G GTPGYM PE + +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA-----GTPGYMAPEVLQGEVY 171
Query: 351 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 385
D ++ G L E++ R + K VE ++
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 26/206 (12%)
Query: 170 DNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVA 228
DNF IG+G G V A S G +AVK+MD +Q E+ ++ H ++V
Sbjct: 22 DNF-VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI---QIA---IDVANALEYL 282
+ + E +++ E++ G+L D + TR+ QIA + V AL +L
Sbjct: 81 MYSSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIATVCLAVLKALSFL 131
Query: 283 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMD 341
H + HRDIKS +ILL + KL+DFG A SK+ P + GTP +M
Sbjct: 132 H---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-----VPRRKSLVGTPYWMA 183
Query: 342 PEYVVTQELTEKSDVYSYGVVLLEIV 367
PE + + D++S G++++E+V
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 77/267 (28%), Positives = 124/267 (46%), Gaps = 25/267 (9%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRG 231
IG+G FG +Y A+ SD +K +D K+ + + +E+ LLA++ H ++V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
E F++ EY G L ++ S + + ++ L+++H D +
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKIL 123
Query: 292 HRDIKSSNILLDEN-FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 350
HRDIKS NI L +N VAKL DFG+A D E T + GTP Y+ PE +
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM---ELAYTCV-GTPYYLSPEICQNRPY 179
Query: 351 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA-QVCMASESRLAELVDPRIKDSFDMEQ 409
K+D++S G VL E+ T + + G NL + ++C A + P S D+
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFE-GNNLHQLVLKICQG---YFAP-ISPNF--SRDLRS 232
Query: 410 LRTIVTIVRWCTQREGQARPSIKQVLR 436
L + + + RPSI +L+
Sbjct: 233 L------ISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGF 232
+G+G +G V K + G ++A+K+ + E V+ RE+++L +L H ++V L+
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTP------LSWQTRIQIAIDVANALEYLHFYC 286
K +L++EY+ L+ SPG P WQ A+ Y H +
Sbjct: 69 FRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------LQAIAYCHSH- 119
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 346
+ HRDIK NIL+ E+ V KL DFG A A + TD T Y PE +V
Sbjct: 120 --NIIHRDIKPENILVSESGVLKLCDFGFARALRARP---ASPLTDYVATRWYRAPELLV 174
Query: 347 TQELTEKS-DVYSYGVVLLEIVTAR 370
K DV++ G ++ E++
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 78/292 (26%), Positives = 133/292 (45%), Gaps = 47/292 (16%)
Query: 176 IGQGGFGTVYKAQFSD------GSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHL 226
+GQG FG VY+ D + +AVK +++ + E++E F E ++ H+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 71
Query: 227 VALRGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQTRIQIAIDVANA 278
V L G + + ++ E MA+G LK +L S PGR P + Q IQ+A ++A+
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 279 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKDGSICFEPVNTD 332
+ YL+ HRD+ + N ++ +F K+ DFG+ + G PV
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 186
Query: 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR 392
+M PE + T SD++S+GVVL EI + L E +++E
Sbjct: 187 ------WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQPYQGLSNEQV 230
Query: 393 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 444
L ++D D D R + ++R C Q + RP+ +++ +L + P
Sbjct: 231 LKFVMDGGYLDQPDNCPER-VTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 47/224 (20%)
Query: 175 IIGQGGFGTVYKAQFSD-------GSLIAVKRMDK---ISEQVEGDFCREIELLARLHHR 224
+G G FG VY+ +D +AVK + K E+ E F +E L++ +H
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE--FLKEAHLMSNFNHP 59
Query: 225 HLVALRGFCIEKRERFLMYEYMANGSLKDHLH-----SPGRTPLSWQTRIQIAIDVANAL 279
++V L G C+ ++++ E M G L +L G L+ + + I +DVA
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 280 EYL---HFYCDPPLCHRDIKSSNILLDE-----NFVAKLADFGLA-------HASKDGSI 324
YL HF HRD+ + N L+ E + V K+ DFGLA + K+G
Sbjct: 120 VYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
PV +M PE ++ + T +SDV+S+GV++ EI+T
Sbjct: 174 LL-PVR--------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 47/288 (16%)
Query: 176 IGQGGFGTVY----KAQFSDG--SLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHL 226
+GQG FG VY K D + +A+K +++ + E++E F E ++ + H+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFNCHHV 71
Query: 227 VALRGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQTRIQIAIDVANA 278
V L G + + ++ E M G LK +L S P + P S + IQ+A ++A+
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 279 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKDGSICFEPVNTD 332
+ YL+ HRD+ + N ++ E+F K+ DFG+ + G PV
Sbjct: 132 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 186
Query: 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR 392
+M PE + T SDV+S+GVVL EI T L E M++E
Sbjct: 187 ------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQPYQGMSNEQV 230
Query: 393 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440
L +++ + D D + ++R C Q + RPS +++ + E
Sbjct: 231 LRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 235
+GQG FG V+ ++ + +A+K + + E F +E +++ +L H LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYA-VVS 71
Query: 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 295
+ +++ E+M GSL D L L + +A +A+ + Y+ HRD+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDL 128
Query: 296 KSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 354
+++NIL+ +N V K+ADFGLA +D + I+ T PE + T KS
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFTIKS 184
Query: 355 DVYSYGVVLLEIVTARR 371
DV+S+G++L E+VT R
Sbjct: 185 DVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 6e-19
Identities = 68/267 (25%), Positives = 125/267 (46%), Gaps = 27/267 (10%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 235
+G G FG V+ ++ +A+K +++ E DF E +++ +L H LV L G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 295
++ +++ E+M NG L ++L + LS + + DV +EYL HRD+
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQ-RQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDL 126
Query: 296 KSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 354
+ N L+ V K++DFG+ + D ++ +P PE + + KS
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSP----PEVFNFSKYSSKS 182
Query: 355 DVYSYGVVLLEIVTARRAVQDGKNLVESA---QVCMASESRLAELVDPRIKDSFDMEQLR 411
DV+S+GV++ E+ T +GK E +V + SR L P++
Sbjct: 183 DVWSFGVLMWEVFT------EGKMPFEKKSNYEV-VEMISRGFRLYRPKLAS-------M 228
Query: 412 TIVTIVRWCTQREGQARPSIKQVLRIL 438
T+ ++ C + + RP+ ++LR +
Sbjct: 229 TVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 14/197 (7%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
+G G FG VYKA+ + G+L A K ++ SE+ D+ EIE+LA +H ++V L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 294
+ ++M E+ G++ + R T QI + LE L + + HRD
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHSMKIIHRD 135
Query: 295 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE-- 352
+K+ N+LL + KLADFG+ S + ++ I GTP +M PE V+ + + +
Sbjct: 136 LKAGNVLLTLDGDIKLADFGV---SAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTP 191
Query: 353 ---KSDVYSYGVVLLEI 366
K+D++S G+ L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 64/222 (28%), Positives = 107/222 (48%), Gaps = 34/222 (15%)
Query: 172 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISE-QVEGDFCREIELLARLHHRH 225
F +G+ FG +YK L+A+K + I+ Q G+F +E L+A LHH +
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHL--HSPG-------------RTPLSWQTRIQ 270
+V L G +++ +++EY+ G L + L SP ++ L +
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 271 IAIDVANALEYL--HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SKDGSICF 326
IAI +A +EYL HF+ H+D+ + NIL+ E K++D GL+ S D +
Sbjct: 129 IAIQIAAGMEYLSSHFF-----VHKDLAARNILIGEQLHVKISDLGLSREIYSAD----Y 179
Query: 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
V +M PE ++ + + SD++S+GVVL EI +
Sbjct: 180 YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 9e-19
Identities = 68/212 (32%), Positives = 100/212 (47%), Gaps = 35/212 (16%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGF 232
+IG+G +G VYKA+ G L+A+K MD I ++ E + E +L + +H ++ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-EIKEEYNILRKYSNHPNIATFYGA 71
Query: 233 CIEKRER-------FLMYEYMANGSLKD----HLHSPGRTPLSWQTRIQIAI---DVANA 278
I+K +M E GS+ D R W IA +
Sbjct: 72 FIKKNPPGNDDQLWLVM-ELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETLRG 125
Query: 279 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 338
L YLH + + HRDIK NILL +N KL DFG++ A D ++ NT I GTP
Sbjct: 126 LAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS-AQLDSTL--GRRNTFI-GTPY 178
Query: 339 YMDPEYVVTQELTE-----KSDVYSYGVVLLE 365
+M PE + E + +SDV+S G+ +E
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 40/223 (17%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFC---REIELLARLHHRHLVALRG 231
IG+G +G VYKA+ G ++A+K++ K+ + EG REI+LL L+H +++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ-IAIDVANALEYLHFYCDPPL 290
K + +L++E+M + L L + L ++ I+ + L + H + +
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLY-KLIKDRQRGLP-ESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 291 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-- 348
HRD+K N+L++ V KLADFGLA + G+P YVVT+
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSF---------------GSPVRPYTHYVVTRWY 164
Query: 349 ---EL-------TEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 381
EL + D++S G + E+++ RR + GK+ ++
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLS-RRPLFPGKSEID 206
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 60/208 (28%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 175 IIGQGGFGTVYKAQFSDGSLIAVKR--MDKISEQVEGDFCREIELLARLHHRHLVALRGF 232
+G+G G+V K + + +I + + ++ RE+E+ ++V G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 233 CIEKRE---RFLMYEYMANGSL----KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
+++ M EY GSL K GR + +IA V L YLH
Sbjct: 68 FLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRI--GEKVLGKIAESVLKGLSYLH-- 122
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT---DIRGTPGYMDP 342
+ HRDIK SNILL KL DFG++ E VN+ GT YM P
Sbjct: 123 -SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG---------ELVNSLAGTFTGTSFYMAP 172
Query: 343 EYVVTQELTEKSDVYSYGVVLLEIVTAR 370
E + + + SDV+S G+ LLE+ R
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 34/274 (12%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMD------KISEQVEGDFCREIELLARLHHRHLV 227
++GQG FG VY D G +A K++ + S++V C EI+LL L H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC-EIQLLKNLQHERIV 67
Query: 228 ALRGFCIEKRERFL--MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
G ++ E+ L EYM GS+KD L + G L+ + + + YLH
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH-- 123
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD-GSICFEPVNT-DIRGTPGYMDPE 343
+ HRDIK +NIL D KL DFG ASK +IC + GTP +M PE
Sbjct: 124 -SNMIVHRDIKGANILRDSAGNVKLGDFG---ASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA-ELVDPRIK 402
+ + K+DV+S G ++E++T + + + MA+ ++A + +P++
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE--------AMAAIFKIATQPTNPQLP 231
Query: 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
S E R + C E + RPS +++LR
Sbjct: 232 -SHISEHARDFLG----CIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 175 IIGQGGFGTVYKAQFSDGS------LIAVKRMDKISEQVEGDFCREIELLARLHHRHLVA 228
++G+G FG V+ + I V++M K + E ++L L H +++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQN---ECQVLKLLSHPNIIE 63
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
+E + ++ EY G+L +++ + L T + + + AL ++H
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TK 120
Query: 289 PLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 347
+ HRD+K+ NILLD++ V K+ DFG++ S + V GTP Y+ PE
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV-----GTPCYISPELCEG 175
Query: 348 QELTEKSDVYSYGVVLLEIVTARRAVQDGKNL 379
+ +KSD+++ G VL E+ + +RA + NL
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAF-EAANL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGD---------FCREIELLARLHHR 224
+IG G FG+VY S G L+AVK+++ S REI LL L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 225 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLH 283
++V G ++ + EY+ GS+ L++ G +T ++ + + L YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE---ETLVRNFVRQILKGLNYLH 123
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE--PVNTDIRGTPGYMD 341
+ + HRDIK +NIL+D K++DFG++ + S+ + ++G+ +M
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 342 PEYVVTQELTEKSDVYSYGVVLLEIVTAR 370
PE V T K+D++S G +++E++T +
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 67/285 (23%), Positives = 126/285 (44%), Gaps = 33/285 (11%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQ--VEGDFCREIELLARLHHRHLVALRG 231
++G+G +G V K + + G ++A+K+ + + V+ REI +L +L H +LV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
K+ +L++E++ + L D P L + + +E+ H + +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSH---NII 122
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 350
HRDIK NIL+ ++ V KL DFG A + G + TD T Y PE +V
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-----TDYVATRWYRAPELLVGDTK 177
Query: 351 TEKS-DVYSYGVVLLEIVTAR-------------RAVQDGKNLVESAQVCMASESRLAEL 396
++ D+++ G ++ E++T ++ NL+ Q A +
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 397 VDPRIKDSFDMEQL-----RTIVTIVRWCTQREGQARPSIKQVLR 436
P +K+ +E+ ++ + + C + + RPS Q+L
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 65/197 (32%), Positives = 104/197 (52%), Gaps = 14/197 (7%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
+G G FG VYKAQ + G L A K +D SE+ D+ EI++LA H ++V L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 294
+ +++ E+ A G++ D + PL T QI + LE L++ + + HRD
Sbjct: 73 YENNLWILIEFCAGGAV-DAVMLELERPL---TEPQIRVVCKQTLEALNYLHENKIIHRD 128
Query: 295 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE-- 352
+K+ NIL + KLADFG+ S + + ++ I GTP +M PE V+ + +
Sbjct: 129 LKAGNILFTLDGDIKLADFGV---SAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRP 184
Query: 353 ---KSDVYSYGVVLLEI 366
K+DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 64/218 (29%), Positives = 112/218 (51%), Gaps = 31/218 (14%)
Query: 176 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HHRH 225
+G+G FG V +A+ +AVK + D +++ D E+EL+ + H++
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHS---PG-----------RTPLSWQTRIQI 271
++ L G C ++ +++ EY A G+L++ L + PG LS++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 272 AIDVANALEYLHFYCDPPLC-HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330
A VA +EYL + C HRD+ + N+L+ E+ V K+ADFGLA D I +
Sbjct: 140 AYQVARGMEYL----ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHD--IDYYKKT 193
Query: 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
++ R +M PE + + T +SDV+S+G+++ EI T
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 5e-18
Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 38/272 (13%)
Query: 176 IGQGGFG-TVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 232
IG+G FG + DG +K ++ K+S + + +E+ +L+ + H ++V +
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 233 CIEKRERFLMYEYMANGSLKDHLHS------PGRTPLSWQTRIQIAIDVANALEYLHFYC 286
E +++ +Y G L +++ P L W +QI + AL+++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW--FVQICL----ALKHVH--- 118
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 346
D + HRDIKS NI L ++ KL DFG+A E T I GTP Y+ PE
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS---TVELARTCI-GTPYYLSPEICE 174
Query: 347 TQELTEKSDVYSYGVVLLEIVTARRAVQDG--KNLVESAQVCMASESRLAELVDPRIKDS 404
+ KSD+++ G VL E+ T + A + G KNLV ++ S ++ S
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV--LKIIRGSYPPVS------SHYS 226
Query: 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
+D+ L V +R + RPS+ +L
Sbjct: 227 YDLRNL------VSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 73/286 (25%), Positives = 129/286 (45%), Gaps = 41/286 (14%)
Query: 172 FSTIIGQGGFGTVYKAQF-----SDGSL-IAVKRMDKISEQVEGD-FCREIELLARL-HH 223
F +G G FG V +A SD + +AVK + + E + E+++++ L +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 224 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 283
++V L G C ++ EY G L + L + L+ + + + VA + +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 284 FY-CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP----G 338
C HRD+ + N+LL + K+ DFGLA + S N ++G
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDS------NYVVKGNARLPVK 208
Query: 339 YMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD 398
+M PE + T +SDV+SYG++L EI + L + M +S+ +L
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS----------LGSNPYPGMPVDSKFYKL-- 256
Query: 399 PRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPSIKQVLRILYE 440
IK+ + M Q I I++ C + RP+ KQ+++++ +
Sbjct: 257 --IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 171 NFSTIIGQGGFGTVY------------KAQFSDGS-----LIAVK--RMDKISEQVEGDF 211
NF +G+G FG V+ KA + + L+AVK R D E DF
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE-DF 66
Query: 212 CREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLH---------SPGRTP 262
+E+++L+RL ++ L G C ++ EYM NG L L +
Sbjct: 67 LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126
Query: 263 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322
LS+ T + +A +A+ + YL HRD+ + N L+ +N+ K+ADFG++
Sbjct: 127 LSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183
Query: 323 SICFEPVNTDIRGTP----GYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARR 371
++G +M E V+ + T KSDV+++GV L EI+T R
Sbjct: 184 DYY------RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 29/217 (13%)
Query: 176 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HHRH 225
+G+G FG V A+ + +AVK + D +E+ D E+E++ + H++
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHS---PG-----------RTPLSWQTRIQI 271
++ L G C + +++ EY + G+L+++L + PG ++++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 272 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331
VA +EYL HRD+ + N+L+ EN V K+ADFGLA + I + T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN--IDYYKKTT 197
Query: 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
+ R +M PE + + T +SDV+S+GV++ EI T
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRM------DKISEQVEGDFCREIELLARLHHRHLV 227
++G+G FG VY +D G +AVK++ + S++V C EI+LL L H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC-EIQLLKNLRHDRIV 67
Query: 228 ALRGFCI---EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
G C+ E+++ + EYM GS+KD L + G L+ + + + YLH
Sbjct: 68 QYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLH- 123
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD-GSICFEPVN-TDIRGTPGYMDP 342
+ HRDIK +NIL D KL DFG ASK +IC + GTP +M P
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFG---ASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 343 EYVVTQELTEKSDVYSYGVVLLEIVTAR 370
E + + K+DV+S ++E++T +
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGF 232
++G G +G VYK + G L A+K MD ++E E + EI +L + HHR++ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 233 CIEKR------ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 286
I+K + +L+ E+ GS+ D + + L I ++ L +LH +
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH- 140
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 346
+ HRDIK N+LL EN KL DFG++ A D ++ NT I GTP +M PE +
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVS-AQLDRTVGRR--NTFI-GTPYWMAPEVIA 194
Query: 347 TQELTE-----KSDVYSYGVVLLEI 366
E + +SD++S G+ +E+
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 68/265 (25%), Positives = 116/265 (43%), Gaps = 40/265 (15%)
Query: 184 VYKAQFSDGSLIAVK--RMDKISEQVEGDFC-REIELLARLHHRHLVALRGFCIEKRERF 240
+YK F + + ++ + +V D EI+ L R+ +++ + GF I+ +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 241 ----LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIK 296
L+ EY G L++ L LS++T++ +AID L L+ Y + P ++++
Sbjct: 95 PRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 297 SSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV--VTQELTEKS 354
S + L+ EN+ K+ GL F+ VN + Y + + + E T K
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPP--FKNVNFMV-----YFSYKMLNDIFSEYTIKD 203
Query: 355 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS----FDMEQL 410
D+YS GVVL EI T GK E+ E+ D I + ++
Sbjct: 204 DIYSLGVVLWEIFT-------GKIPFENLTT--------KEIYDLIINKNNSLKLPLDCP 248
Query: 411 RTIVTIVRWCTQREGQARPSIKQVL 435
I IV CT + RP+IK++L
Sbjct: 249 LEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 76/299 (25%), Positives = 130/299 (43%), Gaps = 63/299 (21%)
Query: 174 TIIGQGGFGTVYKAQ------FSDGSLIAVKRMDKISEQVE-GDFCREIELLARLHHRHL 226
+G+G FG V KA + + +AVK + + + E D E LL +++H H+
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 227 VALRGFCIEKRERFLMYEYMANGSLKDHLH----------------------SPGRTPLS 264
+ L G C + L+ EY GSL+ L +P L+
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 265 WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324
I A ++ ++YL + L HRD+ + N+L+ E K++DFGL S+D
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGL---SRD--- 176
Query: 325 CFEPVNTDIRGTPG-----YMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL 379
+E ++ ++ + G +M E + T +SDV+S+GV+L EIVT L
Sbjct: 177 VYEE-DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----------L 225
Query: 380 VESAQVCMASESRLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPSIKQV 434
+ +A E RL L +K + ME+ + ++ C ++E RP+ +
Sbjct: 226 GGNPYPGIAPE-RLFNL----LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 72/264 (27%), Positives = 124/264 (46%), Gaps = 26/264 (9%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 232
IG+G FG VYK ++A+K +D + +++E D +EI +L++ ++ G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYITRYYGS 70
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 292
++ + +++ EY+ GS D L PG PL I ++ L+YLH H
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL-KPG--PLEETYIATILREILKGLDYLH---SERKIH 124
Query: 293 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 352
RDIK++N+LL E KLADFG+A D I NT + GTP +M PE +
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTFV-GTPFWMAPEVIKQSAYDF 180
Query: 353 KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT 412
K+D++S G+ +E+ D + R+ L+ + + + +
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHPM------------RVLFLIPKNSPPTLEGQYSKP 228
Query: 413 IVTIVRWCTQREGQARPSIKQVLR 436
V C ++ + RP+ K++L+
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 54/164 (32%), Positives = 77/164 (46%), Gaps = 35/164 (21%)
Query: 176 IGQGGFGTVYKAQ---FSDGSLIAVKRMDKISEQVEG---DFCREIELLARLHHRHLVAL 229
IG+G +G VYKA+ DG A+K+ EQ G CREI LL L H ++V+L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 230 RGFCIEKRER--FLMYEYMANGSL----KDHLHS-----PGRT--PLSWQTRIQIAIDVA 276
+E ++ +L+++Y A L K H + P L WQ +
Sbjct: 68 VEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--------IL 118
Query: 277 NALEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLA 316
N + YLH + HRD+K +NIL+ E V K+ D GLA
Sbjct: 119 NGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 76/226 (33%), Positives = 106/226 (46%), Gaps = 34/226 (15%)
Query: 166 KKATDNFSTI--IGQGGFGTVYKAQFSD-GSLIAVK--RMDKISEQVEGDFCREIELLAR 220
K+ D F I IG+G +G VYKA+ D G L+A+K R+D E REI++L +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 221 LHHRHLVALR----------GFCIEKRERFLMYEYMANGSLKDH----LHSPGRTPLSWQ 266
L+HR++V L+ F +K +L++EYM DH L G S
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM------DHDLMGLLESGLVHFSED 116
Query: 267 TRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA-SKDGSIC 325
+ L Y H HRDIK SNILL+ KLADFGLA + + S
Sbjct: 117 HIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 326 FEPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTAR 370
+ N I T Y PE ++ +E DV+S G +L E+ T +
Sbjct: 174 Y--TNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 65/249 (26%), Positives = 116/249 (46%), Gaps = 27/249 (10%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKR-MDKISEQVEGDFCREIELLARLHHRHLVALRGFC 233
IG+G FG V+ + +D + +AVK + + ++ F +E +L + H ++V L G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 234 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 293
+K+ +++ E + G L + G L + IQ+ + A +EYL HR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHR 118
Query: 294 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVTQELTE 352
D+ + N L+ E V K++DFG++ +DG ++ P + PE + +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDG---VYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 353 KSDVYSYGVVLLEIVT-------------ARRAVQDGKNLVESAQVCMASESRLAELV-- 397
+SDV+S+G++L E + R A++ G L ++C + RL E
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL-PCPELCPDAVYRLMERCWE 234
Query: 398 -DPRIKDSF 405
DP + SF
Sbjct: 235 YDPGQRPSF 243
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 55/201 (27%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 176 IGQGGFGTVYKAQF-----SDGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVAL 229
+G+G FG V ++ + G +AVK + S D +EIE+L L+H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 230 RGFCIEKRERF--LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 287
+G C E L+ E++ +GSLK++L + ++ + +++ A+ + ++YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLG---S 127
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 347
HRD+ + N+L++ K+ DFGL A + + V D+ + PE ++
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK-EYYTVKDDLDSPVFWYAPECLIQ 186
Query: 348 QELTEKSDVYSYGVVLLEIVT 368
+ SDV+S+GV L E++T
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 21/215 (9%)
Query: 171 NFSTI--IGQGGFGTVYKAQ-FSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRH 225
NF + IG+G +G VYKA+ G ++A+K R+D +E V REI LL L+H +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
+V L + + +L++E++ + LK + + +PLS I + L+ L F
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDA---SPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE-PVNTDIRG--TPGYMDP 342
+ HRD+K N+L++ KLADFGLA A F PV T T Y P
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARA-------FGVPVRTYTHEVVTLWYRAP 169
Query: 343 EYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 376
E ++ + + D++S G + E+VT RRA+ G
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 67/273 (24%), Positives = 123/273 (45%), Gaps = 29/273 (10%)
Query: 175 IIGQGGFGTVYKAQFS----DGSLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVAL 229
+IG G FG V++ +A+K + +E+ DF E ++ + H +++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
G + + ++ EYM NG+L +L S+Q + + +A ++YL D
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYL---SDMN 127
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKD---GSICFEPVNTDIRGTPGYMDPEYVV 346
HRD+ + NIL++ N K++DFGL+ +D G+ IR T PE +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA----PEAIA 183
Query: 347 TQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405
++ T SDV+S+G+V+ E+++ R D N M + + L P
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAINDGFRLPAP------ 232
Query: 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
M+ + ++ C Q++ RP ++ +L
Sbjct: 233 -MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRG 231
IG+G +G VY+A+ + G ++A+K RMD + + REI LL L H ++V L+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 232 FCIEKR--ERFLMYEYMAN--GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 287
+ K FL+ EY SL D++ +P Q + + + + L+YLH
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSES---QVKC-LMLQLLRGLQYLHENF- 128
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG-----YMDP 342
+ HRD+K SN+LL + K+ADFGLA + + TP Y P
Sbjct: 129 --IIHRDLKVSNLLLTDKGCLKIADFGLART-------YGLPAKPM--TPKVVTLWYRAP 177
Query: 343 EYVV-TQELTEKSDVYSYGVVLLEIVT 368
E ++ T D+++ G +L E++
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 79/290 (27%), Positives = 137/290 (47%), Gaps = 34/290 (11%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMD---KISEQVEGDFCREIELLARLHHRHLVALRG 231
IG G FG VY A+ ++A+K+M K S + D +E++ L R+ H + + +G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
+ + +L+ EY GS D L + PL ++IA AL+ L + +
Sbjct: 93 CYLREHTAWLVMEYCL-GSASDLLEV-HKKPLQ---EVEIAAITHGALQGLAYLHSHNMI 147
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 351
HRDIK+ NILL E KLADFG A + P N+ + GTP +M PE ++ +
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSASIA-------SPANSFV-GTPYWMAPEVILAMDEG 199
Query: 352 E---KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408
+ K DV+S G+ +E+ + + + M++ +A+ P ++ + +
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNESPTLQSNEWSD 251
Query: 409 QLRTIVTIVRWCTQREGQARPSIKQVLR---ILYESSDPMHSGFVQAVED 455
R V C Q+ Q RP+ +++L+ +L E + + +Q +D
Sbjct: 252 YFRNFVDS---CLQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQRTKD 298
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVALR 230
I +G FG+VY A+ S G A+K + K QV ++ + ++ L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 231 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
K +L+ EY+ G + + G P W Q +V +E LH +
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLH---QRGI 118
Query: 291 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 350
HRDIK N+L+D+ KL DFGL S++G N GTP Y+ PE ++
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGL---SRNGLE-----NKKFVGTPDYLAPETILGVGD 170
Query: 351 TEKSDVYSYGVVLLEIVTARR 371
+ SD +S G V+ E +
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGD-FCREIELLARLHH-RHLVALRGF 232
IG G G VYK +F G ++AVK+M + + E +++++ + H ++V G+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPP 289
I + F+ E M+ + D L + P+ ++ + + AL YL H
Sbjct: 83 FITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH-----G 135
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
+ HRD+K SNILLD + KL DFG++ G + T G YM PE + +
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGIS-----GRLVDSKAKTRSAGCAAYMAPERIDPPD 190
Query: 350 LTEK----SDVYSYGVVLLEIVTAR 370
K +DV+S G+ L+E+ T +
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 4e-17
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 21/205 (10%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGF 232
++G G +G VYK + G L A+K MD ++ E + +EI +L + HHR++ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 233 CIEKR------ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 286
I+K + +L+ E+ GS+ D + + L + I ++ L +LH +
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH- 130
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 346
+ HRDIK N+LL EN KL DFG++ A D ++ NT I GTP +M PE +
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVS-AQLDRTVGRR--NTFI-GTPYWMAPEVIA 184
Query: 347 TQELTE-----KSDVYSYGVVLLEI 366
E + KSD++S G+ +E+
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 15/195 (7%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFC-REIELLARLHHRHLVALRGFC 233
IGQG GTVY A + G +A+K+M+ + +Q + + EI ++ H ++V
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 234 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 293
+ E +++ EY+A GSL D + T + + + ALE+LH + HR
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLH---SNQVIHR 139
Query: 294 DIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 352
DIKS NILL + KL DFG A + + S + + GTP +M PE V +
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQS-----KRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 353 KSDVYSYGVVLLEIV 367
K D++S G++ +E+V
Sbjct: 195 KVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 29/217 (13%)
Query: 176 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HHRH 225
+G+G FG V A+ + +AVK + D +++ D E+E++ + H++
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHS---PG--------RTP---LSWQTRIQI 271
++ L G C + +++ EY + G+L+++L + PG + P L+++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 272 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331
A VA +EYL HRD+ + N+L+ E+ V K+ADFGLA + I + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN--IDYYKKTT 194
Query: 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
+ R +M PE + + T +SDV+S+GV+L EI T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMDK----ISEQVEGDFC-REIELLARLHHRHLVA 228
++G+G FG V A+ L AVK + K + VE + + LA H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQ 60
Query: 229 LRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 287
L C + ++R F + EY+ G L H+ GR + R A ++ L++LH +
Sbjct: 61 LHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-RARF-YAAEIVLGLQFLH---E 114
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 347
+ +RD+K N+LLD K+ADFG+ K+G I + GTP Y+ PE +
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKIADFGM---CKEG-ILGGVTTSTFCGTPDYIAPEILSY 170
Query: 348 QELTEKSDVYSYGVVLLEIVTAR 370
Q D ++ GV+L E++ +
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 7e-17
Identities = 52/193 (26%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 175 IIGQGGFGTVYKAQFSDGSLIAVKR-MDKISEQVEGDFCREIELLARLHHRHLVALRGFC 233
++G+G FG V+K D + +AVK + + ++++ F E +L + H ++V L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 234 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 293
+++ +++ E + G L + L + ++ A+D A + YL HR
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLE---SKNCIHR 117
Query: 294 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVTQELTE 352
D+ + N L+ EN V K++DFG++ DG ++ ++ P + PE + +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYS----SSGLKQIPIKWTAPEALNYGRYSS 173
Query: 353 KSDVYSYGVVLLE 365
+SDV+SYG++L E
Sbjct: 174 ESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 27/244 (11%)
Query: 170 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRM---DKISEQVEGDFCREIELLARLHH 223
D+ I +G G FG V+ + A+K M + I + E E +L + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 224 RHLVALRGFCIEKRERFL--MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 281
++ L F E +RFL + EY+ G L +L + GR S T + A ++ ALEY
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEY 116
Query: 282 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG--SICFEPVNTDIRGTPGY 339
LH + +RD+K NILLD+ KL DFG A +D ++C GTP Y
Sbjct: 117 LH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC---------GTPEY 164
Query: 340 MDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 399
+ PE + ++ + D ++ G+++ E++ D N + +A + +D
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKLEFPRHLDL 223
Query: 400 RIKD 403
KD
Sbjct: 224 YAKD 227
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 8e-17
Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 14/194 (7%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 232
IG+G FG V+K ++A+K +D + +++E D +EI +L++ ++ G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYGS 70
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 292
++ + +++ EY+ GS D L PG PL I ++ L+YLH H
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLE-PG--PLDETQIATILREILKGLDYLH---SEKKIH 124
Query: 293 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 352
RDIK++N+LL E+ KLADFG+A D I GTP +M PE +
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----KRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 353 KSDVYSYGVVLLEI 366
K+D++S G+ +E+
Sbjct: 181 KADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 20/198 (10%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMD---KISEQVEGDFCREIELLARLHHRHLVALRG 231
IG G FG VY A+ + ++A+K+M K S + D +E+ L +L H + + RG
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
+ + +L+ EY GS D L + PL ++IA AL+ L + +
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEV-HKKPLQ---EVEIAAVTHGALQGLAYLHSHNMI 137
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 351
HRD+K+ NILL E + KL DFG A SI P N + GTP +M PE ++ +
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSA------SI-MAPANXFV-GTPYWMAPEVILAMDEG 189
Query: 352 E---KSDVYSYGVVLLEI 366
+ K DV+S G+ +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 78/287 (27%), Positives = 129/287 (44%), Gaps = 44/287 (15%)
Query: 176 IGQGGFGTVYKAQFS-DGSLIAVKRM---DKISEQVEGDFCREIELLARLHHRHLVALRG 231
IG+G F VY+A DG +A+K++ D + + D +EI+LL +L+H +++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQTRIQIAIDVANALEYLH 283
IE E ++ E G L + P +T W+ +Q+ +ALE++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKT--VWKYFVQLC----SALEHMH 123
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMD 341
+ HRDIK +N+ + V KL D GL +SK + + GTP YM
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA------HSLVGTPYYMS 174
Query: 342 PEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQ-DGKNLVESAQVCMASESRLAELVDPR 400
PE + KSD++S G +L E+ + D NL +C ++ + P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLC----KKIEQCDYPP 227
Query: 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHS 447
+ E+LR +V + C + + RP I V Y+ + MH+
Sbjct: 228 LPSDHYSEELRQLVNM---CINPDPEKRPDITYV----YDVAKRMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 29/217 (13%)
Query: 176 IGQGGFGTVYKAQF--------SDGSLIAVKRMDK-ISEQVEGDFCREIELLARL-HHRH 225
+G+G FG V A+ + + +AVK + +E+ D E+E++ + H++
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHL-----------HSPGRTP---LSWQTRIQI 271
++ L G C + +++ EY + G+L+++L ++P + P LS++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 272 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331
A VA +EYL HRD+ + N+L+ E+ V K+ADFGLA I + T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--HIDYYKKTT 200
Query: 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
+ R +M PE + + T +SDV+S+GV+L EI T
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 175 IIGQGGFGTVYKAQFS----DGSLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVAL 229
+IG G FG V + + +A+K + +E+ DF E ++ + H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA---IDVANALEYLHFYC 286
G + R ++ E+M NG+L L R T IQ+ +A ++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFL----RQNDGQFTVIQLVGMLRGIAAGMKYL---S 123
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD-------IRGTPGY 339
+ HRD+ + NIL++ N V K++DFGL+ +D + +P T IR T
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS--DPTYTSSLGGKIPIRWTA-- 179
Query: 340 MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
PE + ++ T SDV+SYG+V+ E+++
Sbjct: 180 --PEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 84/318 (26%), Positives = 130/318 (40%), Gaps = 56/318 (17%)
Query: 139 PFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI-----IGQGGFGTVYKAQF-SDG 192
P PPP S S + A + S + IG G GTVYK G
Sbjct: 46 PLPPPSS------SSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTG 99
Query: 193 SLIAVKRM-----DKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247
L A+K + D + Q+ CREIE+L ++H ++V E ++ E+M
Sbjct: 100 RLYALKVIYGNHEDTVRRQI----CREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155
Query: 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV 307
GSL+ H L+ +A + + + YLH + HRDIK SN+L++
Sbjct: 156 GGSLEGT-HIADEQFLA-----DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKN 206
Query: 308 AKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE------KSDVYSYGV 361
K+ADFG+ S+ + +P N+ + GT YM PE + T +L D++S GV
Sbjct: 207 VKIADFGV---SRILAQTMDPCNSSV-GTIAYMSPERINT-DLNHGAYDGYAGDIWSLGV 261
Query: 362 VLLEIVTARRAVQDGKNLVESA---QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVR 418
+LE R G+ ++ +CM+ + +
Sbjct: 262 SILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRH------------FIS 309
Query: 419 WCTQREGQARPSIKQVLR 436
C QRE R S Q+L+
Sbjct: 310 CCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 58/194 (29%), Positives = 100/194 (51%), Gaps = 14/194 (7%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 232
IG+G FG V+K ++A+K +D + +++E D +EI +L++ ++ G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYGS 70
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 292
++ + +++ EY+ GS D L + T ++ ++ L+YLH H
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLH---SEKKIH 124
Query: 293 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 352
RDIK++N+LL E KLADFG+A D I NT + GTP +M PE +
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTFV-GTPFWMAPEVIQQSAYDS 180
Query: 353 KSDVYSYGVVLLEI 366
K+D++S G+ +E+
Sbjct: 181 KADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVALR 230
+G+GGFG V Q + G L A K+++K + EG E +LA++H R +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-EKRILAKVHSRFIVSLA 59
Query: 231 GFCIEKRERFLMYEYMANGSLKDHLHS-----PGRTPLSWQTRIQIAIDVANALEYLHFY 285
K + L+ M G L+ H+++ PG + + LE+LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG---FPEPRACFYTAQIISGLEHLH-- 114
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 345
+ +RD+K N+LLD + +++D GLA KDG + GTPG+M PE +
Sbjct: 115 -QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG----QSKTKGYAGTPGFMAPELL 169
Query: 346 VTQELTEKSDVYSYGVVLLEIVTAR 370
+E D ++ GV L E++ AR
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 28/208 (13%)
Query: 175 IIGQGGFGTV----YKAQFSDGSLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVAL 229
+IG G FG V K +A+K + +E+ DF E ++ + H +++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA---IDVANALEYLHFYC 286
G + + ++ EYM NGSL L R T IQ+ +A+ ++YL
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFL----RKHDGQFTVIQLVGMLRGIASGMKYL---S 123
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD------IRGTPGYM 340
D HRD+ + NIL++ N V K++DFGL+ +D E T IR T
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP---EAAYTTRGGKIPIRWTA--- 177
Query: 341 DPEYVVTQELTEKSDVYSYGVVLLEIVT 368
PE + ++ T SDV+SYG+V+ E+++
Sbjct: 178 -PEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-16
Identities = 56/192 (29%), Positives = 95/192 (49%), Gaps = 21/192 (10%)
Query: 195 IAVKRMDKISEQVE-GDFCREIELLARLHHRHLVAL--RGFCIEKRERFLMYEYMANGSL 251
I + R D E+ + F RE L ARL+H ++VAL G F ++EY+ +L
Sbjct: 8 IKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPGRTL 66
Query: 252 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVA 308
++ L + G L ++ + V +AL H + + HRD+K NI++ A
Sbjct: 67 REVLAADG--ALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 309 KLADFGL------AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVV 362
K+ DFG+ + ++ T++ GTP Y PE + + +T SD+Y++G++
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRT---TEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 363 LLEIVTARRAVQ 374
LE +T +R VQ
Sbjct: 179 FLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 65/198 (32%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFC---REIELLARLHHRHLVALRG 231
+G G +G VYKA+ G L AVK I + DF +EI ++ H ++VA G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVK---IIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
+ + + ++ EY GSL+D H G PLS +QIA L+ L +
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTG--PLS---ELQIAYVCRETLQGLAYLHSKGKM 128
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE-- 349
HRDIK +NILL +N KLADFG+A A +I GTP +M PE ++
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVA-AKITATIA---KRKSFIGTPYWMAPEVAAVEKNG 184
Query: 350 -LTEKSDVYSYGVVLLEI 366
+ D+++ G+ +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 8e-16
Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 25/154 (16%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEG-DFC--REIELLARLHHRHLVAL 229
+G+G + VYKA G ++A+K++ + E +G +F REI+LL L H +++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 230 RGFCIEKRERFLMYEYMANGSL------KDHLHSPGRTP-LSWQTRIQIAIDVANALEYL 282
K L++E+M L K + +P T LEYL
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT--------LRGLEYL 118
Query: 283 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 316
H + HRD+K +N+L+ + V KLADFGLA
Sbjct: 119 HSNW---ILHRDLKPNNLLIASDGVLKLADFGLA 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 66/211 (31%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 171 NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK---IS-EQVEGDFC--REIELLARLHH 223
++G+G FG V A++ G L A+K + K I+ ++VE C R E H
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERH 61
Query: 224 RHLVALRG-FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI-AIDVANALEY 281
LV L F E F+M EY A G L H+H+ + + R A V L+Y
Sbjct: 62 PFLVNLFACFQTEDHVCFVM-EYAAGGDLMMHIHTDVFS----EPRAVFYAACVVLGLQY 116
Query: 282 LHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLA-----HASKDGSICFEPVNTDIRG 335
LH + + +RD+K N+LLD E FV K+ADFGL + + C G
Sbjct: 117 LH---ENKIVYRDLKLDNLLLDTEGFV-KIADFGLCKEGMGFGDRTSTFC---------G 163
Query: 336 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEI 366
TP ++ PE + T D + GV++ E+
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 20/198 (10%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRM------DKISEQVEGDFCREIELLARLHHRHLVA 228
IG+G G V+KA+ G +A+K++ I Q REI+ L H ++V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA----LREIKALQACQHPYVVK 63
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
L L+ EYM L + L R PL + + Y+H
Sbjct: 64 LLDVFPHGSGFVLVMEYMP-SDLSEVLRDEER-PLPEAQVKSYMRMLLKGVAYMH---AN 118
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-T 347
+ HRD+K +N+L+ + V K+ADFGLA + + + T Y PE +
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE---PRLYSHQVATRWYRAPELLYGA 175
Query: 348 QELTEKSDVYSYGVVLLE 365
++ D+++ G + E
Sbjct: 176 RKYDPGVDLWAVGCIFAE 193
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 68/232 (29%), Positives = 96/232 (41%), Gaps = 46/232 (19%)
Query: 170 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDK----ISEQVEGDFCREIELLARLH 222
D+F I IG+G FG V+ + D G + A+K + K Q+ E ++LA
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQI-AHVRAERDILADAD 59
Query: 223 HRHLVALRGFCIEKRERFLMY--EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 280
+V L + + E L EYM G L + L P R IA V AL+
Sbjct: 60 SPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVL-ALD 115
Query: 281 YLH--FYCDPPLCHRDIKSSNILLDENFVAKLADFGLA---HASKDG---------SICF 326
+H + HRDIK NIL+D + KLADFGL + +KD +
Sbjct: 116 SVHKLGFI-----HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 327 EPVNTDIR-------------GTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 365
+ V R GTP Y+ PE + + D +S GV+L E
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 69/231 (29%), Positives = 105/231 (45%), Gaps = 29/231 (12%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRG 231
++G+G FG Q + A+K R+ K S VE D +E LLA++ H ++VA +
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVE-DSRKEAVLLAKMKHPNIVAFKE 65
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHS------PGRTPLSWQTRIQIAIDVANALEYLHFY 285
+++ EY G L + P T L W ++ + + +++H
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGV------QHIH-- 117
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMDPEY 344
+ + HRDIKS NI L +N KL DFG A + G+ V GTP Y+ PE
Sbjct: 118 -EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-----GTPYYVPPEI 171
Query: 345 VVTQELTEKSDVYSYGVVLLEIVTARRAVQDG--KNLVESAQVCMASESRL 393
KSD++S G +L E+ T + Q KNL+ +VC S L
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI--LKVCQGSYKPL 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 170 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVA 228
DNF I G+G G V A S G L+AVK+MD +Q E+ ++ H ++V
Sbjct: 23 DNFIKI-GEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
+ + E +++ E++ G+L D + T ++ + + + V AL LH
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLH---AQ 135
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 347
+ HRDIKS +ILL + KL+DFG A SK+ P + GTP +M PE +
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-----VPRRKSLVGTPYWMAPELISR 190
Query: 348 QELTEKSDVYSYGVVLLEIV 367
+ D++S G++++E+V
Sbjct: 191 LPYGPEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 67/278 (24%), Positives = 125/278 (44%), Gaps = 41/278 (14%)
Query: 176 IGQGGFGTVYKAQFSDG--SLIAVKRMD----------KISEQVEGDFCREIELL-ARLH 222
+G G FG VYK + + +L+A+K ++ + ++ GD E+ ++ +L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 223 HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHS----PGRTPLS--WQTRIQIAIDVA 276
H ++V +E +++ + + L +H +S R W +Q+ +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124
Query: 277 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 336
AL YLH + + HRD+ +NI+L E+ + DFGLA + E T + GT
Sbjct: 125 -ALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-----ESKLTSVVGT 176
Query: 337 PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL 396
Y PE V + EK+DV+++G +L ++ T + L + ++ A +
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA-------V 229
Query: 397 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 434
+P + + E + ++T C + +ARP I QV
Sbjct: 230 YEP-LPEGMYSEDVTDVIT---SCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 41/281 (14%)
Query: 172 FSTIIGQGGFGTVYKAQF-SDGSLIAVKRMD---------KISEQVEGDFCREIELLARL 221
F ++G+G +G V + +DG +K+++ K +EQ E +LL++L
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ-------EAQLLSQL 56
Query: 222 HHRHLVALR-GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 280
H ++VA R + E +++ + G L L L ++ + +A AL+
Sbjct: 57 KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116
Query: 281 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 340
YLH + + HRD+K+ N+ L + K+ D G+A ++ + + + GTP YM
Sbjct: 117 YLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC----DMASTLIGTPYYM 169
Query: 341 DPEYVVTQELTEKSDVYSYGVVLLEIVTARRA--VQDGKNLVESAQVCMASESRLAELVD 398
PE + KSDV++ G + E+ T + A +D +LV R+ E
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV----------YRIIEGKL 219
Query: 399 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439
P + + E + ++ + + RPS+K +LR Y
Sbjct: 220 PPMPKDYSPE----LGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 70/273 (25%), Positives = 124/273 (45%), Gaps = 42/273 (15%)
Query: 194 LIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL 251
L+AVK R D ++ DF +E+++L+RL +++ L G C+++ ++ EYM NG L
Sbjct: 48 LVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 252 KDHLHS-----------PGRTP------LSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 294
L S P +S+ + + +A+ +A+ ++YL HRD
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRD 163
Query: 295 IKSSNILLDENFVAKLADFGLA---HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 351
+ + N L+ EN K+ADFG++ +A I V IR +M E ++ + T
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAV-LPIR----WMAWECILMGKFT 218
Query: 352 EKSDVYSYGVVLLEIVTARRAVQDG----KNLVESAQVCMASESRLAELVDPRIKDSFDM 407
SDV+++GV L EI+ + G + ++E+A + R L P
Sbjct: 219 TASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCP---- 274
Query: 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440
+ + ++ C R+ + RPS + L E
Sbjct: 275 ---QGLYELMLQCWSRDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 175 IIGQGGFGTVYKAQF--SDGSL--IAVK--RMDKISEQVEGDFCREIELLARLHHRHLVA 228
++G+G FG+V +AQ DGS +AVK + D S +F RE + H +++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 229 LRGFCIEKRER------FLMYEYMANGSLKDHLHSP--GRTP--LSWQTRIQIAIDVANA 278
L G + R + ++ +M +G L L G P L QT ++ ID+A+
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 279 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA------SKDGSICFEPVNTD 332
+EYL HRD+ + N +L+EN +ADFGL+ + G PV
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK-- 180
Query: 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
++ E + T SDV+++GV + EI+T
Sbjct: 181 ------WLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 74/265 (27%), Positives = 130/265 (49%), Gaps = 25/265 (9%)
Query: 164 ETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH 222
+ ++ D+F I G+G G V A + G +AVK+MD +Q E+ ++ H
Sbjct: 19 DPREYLDSFIKI-GEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77
Query: 223 HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 282
H ++V + + E +++ E++ G+L D + T ++ + + + V AL YL
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYL 134
Query: 283 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMD 341
H + + HRDIKS +ILL + KL+DFG A SK+ P + GTP +M
Sbjct: 135 H---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE-----VPKRKSLVGTPYWMA 186
Query: 342 PEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401
PE + + D++S G++++E++ DG+ + A R+ + + PR+
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMI-------DGEPPYFNEPPLQAMR-RIRDNLPPRV 238
Query: 402 KDSFDMEQ-LRTI--VTIVRWCTQR 423
KDS + LR + +VR +QR
Sbjct: 239 KDSHKVSSVLRGFLDLMLVREPSQR 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 70/269 (26%), Positives = 117/269 (43%), Gaps = 18/269 (6%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFC 233
+G G G+V K + + K++ I V RE++++ ++V+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 234 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 293
+ + + E+M GSL G P+ + +IA+ V L YL Y + HR
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYL--YNVHRIMHR 128
Query: 294 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 353
DIK SNIL++ KL DFG++ G + +T + GT YM PE + + T K
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFV-GTSTYMSPERIQGGKYTVK 182
Query: 354 SDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD---PRIKDSFDMEQL 410
SDV+S G+ ++E+ + + M L ++V PR+ S E L
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDL 242
Query: 411 RTIVTIVRWCTQREGQARPSIKQVLRILY 439
R V C ++ RP+ +Q+ +
Sbjct: 243 RDFVDA---CLLKDPTERPTPQQLCAMPP 268
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFC---REIELLARLHHRHLVALRG 231
IG G +G VYKA+ + G L A+K I + DF +EI ++ H ++VA G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIK---VIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
+ + + ++ E+ GSL+D H G PLS QIA L+ L++
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTG--PLS---ESQIAYVSRETLQGLYYLHSKGKM 128
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE-- 349
HRDIK +NILL +N KLADFG++ A +I GTP +M PE +
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVS-AQITATIA---KRKSFIGTPYWMAPEVAAVERKG 184
Query: 350 -LTEKSDVYSYGVVLLEI 366
+ D+++ G+ +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 16/217 (7%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALR 230
++G+GGFG V Q + G + A K+++K + E E ++L +++ R +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL- 65
Query: 231 GFCIEKRERF-LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
+ E ++ L+ M G LK H++ G + A ++ LE LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QER 122
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 348
+ +RD+K NILLD++ +++D GLA H + +I GT GYM PE V +
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI------KGRVGTVGYMAPEVVKNE 176
Query: 349 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 385
T D ++ G +L E++ + Q K ++ +V
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 75/306 (24%), Positives = 126/306 (41%), Gaps = 58/306 (18%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVE-GDFCREIELLARLHH-RHLVALRG- 231
IG+G FGTV K G+++AVKR+ ++ E +++++ R ++V G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 232 --------FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEY 281
C+E LM + + P I +IA+ AL Y
Sbjct: 72 LFREGDCWICME-----LMDISLDKFYKYVYEVLKSVIP----EEILGKIAVATVKALNY 122
Query: 282 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR----GTP 337
L + + HRD+K SNILLD N KL DFG I + V++ + G
Sbjct: 123 LK--EELKIIHRDVKPSNILLDRNGNIKLCDFG---------ISGQLVDSIAKTRDAGCR 171
Query: 338 GYMDPEYVVTQELTE---KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 394
YM PE + +SDV+S G+ L E+ T + ++ + +L
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFD----------QLT 221
Query: 395 ELVD---PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI----LYESSDPMHS 447
++V P + +S + E + V + C ++ RP K++L YE + +
Sbjct: 222 QVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVA 281
Query: 448 GFVQAV 453
+VQ +
Sbjct: 282 AYVQRI 287
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 36/216 (16%)
Query: 176 IGQGGFGTVYKAQFS-DGSL--IAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVA 228
+G+G FG+V + Q + D S+ +AVK M KI+ ++E DF E + H +++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEME-DFLSEAVCMKEFDHPNVMR 64
Query: 229 LRGFCIEKRER------FLMYEYMANGSLKDHL--HSPGRTP--LSWQTRIQIAIDVANA 278
L G C++ E ++ +M +G L L G P L Q ++ D+A+
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 279 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA------SKDGSICFEPVNTD 332
+EYL HRD+ + N +L+EN +ADFGL+ + G I PV
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK-- 179
Query: 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
++ E + + T KSDV+S+GV + EI T
Sbjct: 180 ------WIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 4e-15
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEG-----DFCREIELLARLHHRHLVA 228
++G G FGTVYK + +G + + KI + G +F E ++A + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
L G C+ + L+ + M +G L D++H + + Q + + +A + YL +
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLE---ER 128
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVT 347
L HRD+ + N+L+ K+ DFGLA + + N D P +M E +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE---KEYNADGGKMPIKWMALECIHY 185
Query: 348 QELTEKSDVYSYGVVLLEIVTARRAVQDG 376
++ T +SDV+SYGV + E++T DG
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 74/270 (27%), Positives = 130/270 (48%), Gaps = 31/270 (11%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHH---RHLVA 228
+IG+G +G VY+ G ++A+K +D + V D RE+ LL++L ++
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS-DIQREVALLSQLRQSQPPNITK 66
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
G ++ +++ EY GS++ L G P++ + I +V AL+Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRT-LMKAG--PIAEKYISVIIREVLVALKYIH---KV 120
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT- 347
+ HRDIK++NIL+ KL DFG+A S + GTP +M PE V+T
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS----KRSTFVGTPYWMAPE-VITE 175
Query: 348 -QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406
+ K+D++S G+ + E+ T D V++ + M + + PR++D+
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSD----VDAFRAMML----IPKSKPPRLEDNGY 227
Query: 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
+ LR V C E + R S +++L+
Sbjct: 228 SKLLREFVAA---CLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 56/223 (25%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 176 IGQGGFGTVY--------------KAQFSDG-SLIAVKRM-DKISEQVEGDFCREIELLA 219
+G+G FG V+ +F L+AVK + +++ DF +EI++++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 220 RLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHL----------HSPGRTPLSWQTRI 269
RL + +++ L G C+ ++ EYM NG L L H+ +S +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 270 QIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329
+A+ +A+ ++YL HRD+ + N L+ ++ K+ADFG++ G
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY----- 184
Query: 330 NTDIRGTP----GYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
I+G +M E ++ + T SDV+++GV L E+ T
Sbjct: 185 -YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 48/146 (32%), Positives = 76/146 (52%), Gaps = 7/146 (4%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRGF 232
IG+G +G VYKA+ G ++A+K R++ E V REI LL L+H ++V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 292
+ + +L++E++ + LK ++ S T L + + Y H + + H
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLH 122
Query: 293 RDIKSSNILLDENFVAKLADFGLAHA 318
RD+K N+L+D KLADFGLA A
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 83/282 (29%), Positives = 124/282 (43%), Gaps = 42/282 (14%)
Query: 173 STIIGQGGFGTV-YKAQFSDGSLIAVKRMDKISEQVEGDFCR---EIELLARLHHRHLVA 228
S ++G G GTV + SDG AVK +D + E D R E+ L +V
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCDFFSIVK 95
Query: 229 LRGFCIEKRER--------FLMYEYMANGSLKDHLHSPGRT--PLSWQTRIQIAIDVANA 278
+K R L+ +Y G L+ + S +T + I V A
Sbjct: 96 CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA 155
Query: 279 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL-----AHASKDGSICFEPVNTDI 333
+ ++H + HRDIKS+NILL N + KL DFG A S D V
Sbjct: 156 VHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDD-------VGRTF 205
Query: 334 RGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 393
GTP Y+ PE + ++K+D++S GV+L E++T +R DG+N+ E L
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-DGENMEEVMH------KTL 258
Query: 394 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL 435
A DP + S E ++ IVT + + + RPS ++L
Sbjct: 259 AGRYDP-LPPSISPE-MQEIVTAL---LSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 32/208 (15%)
Query: 176 IGQGGFGTVYKA--QFSDGSLI--AVKRMDKISEQV-EGDFCREIELLARLHHRHLVALR 230
+G G FG+V K G + AVK + + + +F RE ++A+L H +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 231 GFCIEKRERFLMYEYMAN-GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYC 286
G C K E ++ +A G L +L P+S ++A VA + YL HF
Sbjct: 63 GVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVS--DLKELAHQVAMGMAYLESKHF-- 116
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG------YM 340
HRD+ + N+LL AK++DFG++ A GS R T +
Sbjct: 117 ----VHRDLAARNVLLVNRHQAKISDFGMSRALGAGS-------DYYRATTAGRWPLKWY 165
Query: 341 DPEYVVTQELTEKSDVYSYGVVLLEIVT 368
PE + + + KSDV+SYGV L E +
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 8e-15
Identities = 67/228 (29%), Positives = 106/228 (46%), Gaps = 40/228 (17%)
Query: 172 FSTIIGQGGFGTVY-----------KAQFS------DGSLIAVK--RMDKISEQVEGDFC 212
F +G+G FG V+ FS L+AVK R D ++ DF
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFL 67
Query: 213 REIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHL--HSPGRTP-------L 263
+EI++++RL +++ L CI ++ EYM NG L L H P +
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 264 SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323
S+ T I +A +A+ ++YL HRD+ + N L+ +N+ K+ADFG++ G
Sbjct: 128 SYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184
Query: 324 ---ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
I V IR +M E ++ + T SDV+++GV L EI+T
Sbjct: 185 YYRIQGRAV-LPIR----WMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 8e-15
Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 228
++G G FGTV+K + +G I A+K + D+ Q + + + L H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
L G C + L+ + GSL DH+ R L Q + + +A + YL +
Sbjct: 74 LLGICPGASLQ-LVTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEHR-- 129
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHA--SKDGSICFEPVNTDIRGTPGYMDPEYVV 346
+ HR++ + NILL + + ++ADFG+A D + T I+ +M E ++
Sbjct: 130 -MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK----WMALESIL 184
Query: 347 TQELTEKSDVYSYGVVLLEIVT 368
T +SDV+SYGV + E+++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 9e-15
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 12/214 (5%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGD---FCREIELLARLHHRHLVALRG 231
+G+GGFG V Q + G + A K++DK + + E E+L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
K L+ M G LK H+++ G L + I + + + +LH +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 351
+RD+K N+LLD+ +L+D GLA KDG + + T GT GYM PE + + +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDG----KTI-TQRAGTNGYMAPEILKEEPYS 172
Query: 352 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 385
D ++ G + E+V R +D K V ++
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 34/217 (15%)
Query: 173 STIIGQGGFGTVYKAQFSDGSL-----IAVKRM-DKISEQVEGDFCREIELLARLHHRHL 226
S ++ +G FG ++ D + VK + D SE +E LL L H+++
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 227 VALRGFCIEKRER-FLMYEYMANGSLKDHL----HSPGRTPLSWQTR--IQIAIDVANAL 279
+ + CIE E F++Y YM G+LK L P + T+ + +AI +A +
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 280 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNT 331
YLH + H+DI + N ++DE K+ D L+ H D N
Sbjct: 131 SYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE------NR 181
Query: 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
++ +M E +V +E + SDV+S+GV+L E++T
Sbjct: 182 PVK----WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 20/217 (9%)
Query: 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDK----ISEQVEGDFCREIELLARLHHRHLVAL 229
++G+G FG V+ A+ A+K + K + + VE + L H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 230 RGFCI--EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 287
+C K F + EY+ G L H+ S + L T A ++ L++LH
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQFLH---S 114
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 347
+ +RD+K NILLD + K+ADFG+ + G + GTP Y+ PE ++
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLG 170
Query: 348 QELTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVES 382
Q+ D +S+GV+L E++ + D + L +S
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS 207
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRGF 232
IG+G +G VYK + G ++A+K R++ E V REI LL L H ++V L+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 233 CIEKRERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
+++ +L++E+++ LK +L S P + + + + + H +
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVL 123
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE-PVN--TDIRGTPGYMDPEYVV-T 347
HRD+K N+L+D V KLADFGLA A F PV T T Y PE ++ +
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARA-------FGIPVRVYTHEVVTLWYRAPEVLLGS 176
Query: 348 QELTEKSDVYSYGVVLLEIVTAR 370
+ D++S G + E+ T +
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 82/257 (31%), Positives = 117/257 (45%), Gaps = 59/257 (22%)
Query: 161 SYKETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGD-F----CRE 214
Y+ K +G+G FG VYKA Q G ++A+K KI E D F RE
Sbjct: 9 DYEILGK--------LGEGTFGEVYKARQIKTGRVVALK---KILMHNEKDGFPITALRE 57
Query: 215 IELLARLHHRHLVALRGFCIEK-----RERFLMY---EYMANGSLKDHLHSPGRTPLSWQ 266
I++L +L H ++V L +E+ R+R +Y YM + L L +P L
Sbjct: 58 IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP-SVKL--- 112
Query: 267 TRIQIAIDVANALE---YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323
T QI + LE YLH + + HRDIK++NIL+D + K+ADFGLA DG
Sbjct: 113 TESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR-PYDGP 168
Query: 324 ICFEPVNTDIRGTPGYMDPEY---VVTQ-----EL-------TEKSDVYSYGVVLLEIVT 368
P G G +Y VVT+ EL T D++ G V E+ T
Sbjct: 169 P---PNPK---GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT 222
Query: 369 ARRAVQDGKNLVESAQV 385
RR + GK+ ++ +
Sbjct: 223 -RRPILQGKSDIDQLHL 238
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 59/194 (30%), Positives = 95/194 (48%), Gaps = 13/194 (6%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
IGQG GTV+ A + G +A+K+++ + + EI ++ L + ++V +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 294
E F++ EY+A GSL D + + QIA L+ L F + HRD
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQVIHRD 140
Query: 295 IKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 353
IKS N+LL + KL DFG A + + S + + GTP +M PE V + K
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQS-----KRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 354 SDVYSYGVVLLEIV 367
D++S G++ +E+V
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 66/244 (27%), Positives = 115/244 (47%), Gaps = 20/244 (8%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALR 230
++G+GGFG V Q + G + A K+++K + E E ++L +++ R +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 65
Query: 231 GFCIEKRERF-LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
+ E ++ L+ M G LK H+++ G + + A ++ LE LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RER 122
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
+ +RD+K NILLD+ +++D GLA +G E + + GT GYM PE V +
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG----ETIRGRV-GTVGYMAPEVVKNER 177
Query: 350 LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409
T D + G ++ E++ + + K V+ +V E R+ E D E
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV----ERRVKE--DQEEYSEKFSEA 231
Query: 410 LRTI 413
R+I
Sbjct: 232 ARSI 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 13/194 (6%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
IG+G G V A + G +AVK MD +Q E+ ++ H+++V + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 294
E +++ E++ G+L D + +T L+ + + V AL YLH + HRD
Sbjct: 89 VGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRD 142
Query: 295 IKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 353
IKS +ILL + KL+DFG A SKD P + GTP +M PE + +
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKD-----VPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 354 SDVYSYGVVLLEIV 367
D++S G++++E+V
Sbjct: 198 VDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 161 SYKETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLA 219
S + KK F I GQG GTVY A + G +A+++M+ + + EI ++
Sbjct: 14 SVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 220 RLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 279
+ ++V + E +++ EY+A GSL D + + QIA L
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECL 126
Query: 280 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPG 338
+ L F + HRDIKS NILL + KL DFG A + + S + + GTP
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-----KRSTMVGTPY 181
Query: 339 YMDPEYVVTQELTEKSDVYSYGVVLLEIV 367
+M PE V + K D++S G++ +E++
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 161 SYKETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLA 219
S + KK F I GQG GTVY A + G +A+K+M+ + + EI ++
Sbjct: 13 SVGDPKKKYTRFEKI-GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMR 71
Query: 220 RLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 279
+ ++V + E +++ EY+A GSL D + + QIA L
Sbjct: 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECL 125
Query: 280 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPG 338
+ L F + HRDIKS NILL + KL DFG A + + S + + GTP
Sbjct: 126 QALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-----KRSTMVGTPY 180
Query: 339 YMDPEYVVTQELTEKSDVYSYGVVLLEIV 367
+M PE V + K D++S G++ +E+V
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 14/216 (6%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALR 230
++G+GGFG V Q + G + A KR++K + E E ++L +++ + +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL- 65
Query: 231 GFCIEKRERF-LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
+ E ++ L+ M G LK H+++ G + + A ++ LE LH
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---REN 122
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
+RD+K NILLD+ +++D GLA +G V GT GYM PE + Q
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-----GTVGYMAPEVLNNQR 177
Query: 350 LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 385
T D + G ++ E++ + + K V+ +V
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKR--MDKISEQVEGDFCREIELLARLHHRHLVALRGF 232
IG+G +GTV+KA+ + ++A+KR +D E V REI LL L H+++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 292
++ L++EY + LK + S + + L + H + + H
Sbjct: 68 LHSDKKLTLVFEY-CDQDLKKYFDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH---NVLH 122
Query: 293 RDIKSSNILLDENFVAKLADFGLAHASKDGSICF--EPVNTDIRGTPGYMDPEYVVTQEL 350
RD+K N+L+++N KLADFGLA A C+ E V T Y P+ + +L
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV------TLWYRPPDVLFGAKL 176
Query: 351 TEKS-DVYSYGVVLLEIVTARRAVQDGKNL 379
S D++S G + E+ A R + G ++
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFPGNDV 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 36/275 (13%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRM---DKISEQVEGDFCREIELLARLHHRHLVALRG 231
IG+G F VY+A D +A+K++ + + + D +EI+LL +L+H +++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQTRIQIAIDVANALEYLH 283
IE E ++ E G L + P RT W+ +Q+ +A+E++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERT--VWKYFVQLC----SAVEHMH 123
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 343
+ HRDIK +N+ + V KL D GL + + GTP YM PE
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPE 176
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVTARRAV-QDGKNLVESAQVCMASESRLAELVDPRIK 402
+ KSD++S G +L E+ + D NL Q ++ + P +
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ-------KIEQCDYPPLP 229
Query: 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI 437
E+LR +V++ C + RP I V +I
Sbjct: 230 TEHYSEKLRELVSM---CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 170 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRH 225
D+F I +G G G V+K LI +++ +I + RE+++L + +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
+V G E + E+M GSL L GR P ++ IA V L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLRE- 121
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 345
+ HRD+K SNIL++ KL DFG++ G + N+ + GT YM PE +
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFV-GTRSYMSPERL 174
Query: 346 VTQELTEKSDVYSYGVVLLEIVTARRAV--QDGKNL 379
+ +SD++S G+ L+E+ R + D K L
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC 233
++G+G +G VY A+ S IA+K + + + EI L + L HR++V G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 234 IEKRERFLMYEYMANGSLKDHLHSP-GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 292
E + E + GSL L S G + QT I + L+YLH D + H
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVH 131
Query: 293 RDIKSSNILLDE-NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 351
RDIK N+L++ + V K++DFG SK + P GT YM PE V+ +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFG---TSKRLA-GINPCTETFTGTLQYMAPE-VIDKGPR 186
Query: 352 ---EKSDVYSYGVVLLEIVTAR 370
+D++S G ++E+ T +
Sbjct: 187 GYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 9e-14
Identities = 65/230 (28%), Positives = 101/230 (43%), Gaps = 51/230 (22%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVAL 229
IG G +G V A G +A+K++ + + + REI+LL L H +++ L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI--DAKRILREIKLLRHLRHENIIGL 64
Query: 230 RG-FCIEKRERF----LMYEYMANGSLKDHLHSPGRTPLSWQTRIQ-IAIDVANALEYLH 283
E F ++ E M L + SP PL+ IQ + L+YLH
Sbjct: 65 LDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ--PLTDD-HIQYFLYQILRGLKYLH 120
Query: 284 FYCDPPLC---HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 340
HRD+K SNIL++ N K+ DFGLA V+ D G++
Sbjct: 121 S------ANVIHRDLKPSNILVNSNCDLKICDFGLARG----------VDPDED-EKGFL 163
Query: 341 DPEYVVTQ-----EL-------TEKSDVYSYGVVLLEIVTARRAVQDGKN 378
EYVVT+ EL T+ D++S G + E++T R+ + G++
Sbjct: 164 T-EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPLFPGRD 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIELLARLHHRHLVALRG- 231
I+G G GTVYKA ++AVK + I+ +++ E+E+L + +++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
F +E R + E+M GSL + + P RI +A V L YL +
Sbjct: 68 FFVENRIS-ICTEFMDGGSLDVY----RKIPEHVLGRIAVA--VVKGLTYL---WSLKIL 117
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 351
HRD+K SN+L++ KL DFG++ + + GT YM PE + ++
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVS------TQLVNSIAKTYVGTNAYMAPERISGEQYG 171
Query: 352 EKSDVYSYGVVLLEIVTAR 370
SDV+S G+ +E+ R
Sbjct: 172 IHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 170 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRH 225
D+F + +G G G V K LI +++ I + RE+++L + +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
+V G E + E+M GSL L GR P + +I IA V L YL
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA--VLRGLTYLREK 118
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 345
+ HRD+K SNIL++ KL DFG++ G + N+ + GT YM PE +
Sbjct: 119 HK--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFV-GTRSYMSPERL 170
Query: 346 VTQELTEKSDVYSYGVVLLEIVTAR 370
T +SD++S G+ L+E+ R
Sbjct: 171 QGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 175 IIGQGGFGTVYKAQFSDGS-LIAVKRMDK----ISEQVEGDFCREIE---LLARLHHRHL 226
++G+G FG V A+ + A+K + K + VE C +E L H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVE---CTMVERRVLALAWEHPFL 58
Query: 227 VALRGFCI--EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
L FC K F + EY+ G L H+ S GR + + R A ++ L++LH
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA-RARF-YAAEIICGLQFLH- 113
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
+ +RD+K N+LLD++ K+ADFG+ + +G E + GTP Y+ PE
Sbjct: 114 --KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFCGTPDYIAPEI 167
Query: 345 VVTQELTEKSDVYSYGVVLLEIV 367
+ Q+ E D +S+GV+L E++
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 14/216 (6%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALR 230
++G+GGFG V Q + G + A K+++K + E E +L +++ R +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL- 65
Query: 231 GFCIEKRERF-LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
+ E ++ L+ M G LK H+++ G Q I A ++ LE L
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RER 122
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
+ +RD+K NILLD+ +++D GLA +G E V + GT GYM PE + ++
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG----ETVRGRV-GTVGYMAPEVINNEK 177
Query: 350 LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 385
T D + G ++ E++ + + K V+ +V
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 17/199 (8%)
Query: 175 IIGQGGFGTVYKAQF----SDGSLIAVKRMDKISEQVEGD-FCREIELLARLHHRHLVAL 229
IG+G FG VY+ + ++ +AVK + + F +E ++ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
G E +M E G L+ +L + L + I + ++ AL YL
Sbjct: 73 IGVITENPVWIVM-ELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLE---SKR 127
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT-P-GYMDPEYVVT 347
HRDI + N+L+ KL DFGL+ +D E +G P +M PE +
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-----ESYYKASKGKLPIKWMAPESINF 182
Query: 348 QELTEKSDVYSYGVVLLEI 366
+ T SDV+ +GV + EI
Sbjct: 183 RRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 26/204 (12%)
Query: 174 TIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREI----ELLARLHHRHLVA 228
T +GQGG+G V+ A+ D G ++A+KRM K S + + R + ++L LV
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKK-SLLFKLNEVRHVLTERDILTTTKSEWLVK 65
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA--IDVANALEYLHFYC 286
L + +L EY+ G + L++ G R +A + +AL L +
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGY-- 122
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SKDGSICFEPVNTDIRGTPGYMDPEY 344
HRD+K N L+D + KL DFGL+ + S+ G+P YM PE
Sbjct: 123 ----IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV---------GSPDYMAPEV 169
Query: 345 VVTQELTEKSDVYSYGVVLLEIVT 368
+ + D +S G +L E +
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 45/213 (21%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALR 230
IG+G F V KAQ G A+K M K EQV REI+ L RL H +++ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64
Query: 231 GFCIEKRERFL----------MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 280
+++ L +YE + K + PL + + +L+
Sbjct: 65 EVLFDRKTGRLALVFELMDMNLYELI-----KGR-----KRPLPEKRVKSYMYQLLKSLD 114
Query: 281 YLH----FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 336
++H F HRDIK NIL+ ++ + KLADFG I +P T+ T
Sbjct: 115 HMHRNGIF-------HRDIKPENILIKDD-ILKLADFGSCR-----GIYSKPPYTEYIST 161
Query: 337 PGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVT 368
Y PE ++T K D+++ G V EI++
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 170 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRH 225
D+F I +G G G V K Q LI +++ +I + RE+++L + +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
+V G E + E+M GSL L R P ++ IA V L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLRE- 121
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 345
+ HRD+K SNIL++ KL DFG++ G + N+ + GT YM PE +
Sbjct: 122 -KHQIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFV-GTRSYMSPERL 174
Query: 346 VTQELTEKSDVYSYGVVLLEIVTARRAV--QDGKNL 379
+ +SD++S G+ L+E+ R + D K L
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 40/208 (19%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVA-L 229
+G G FG V A+ G A+K + K +QV+ +E +L L H +V +
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQ-HVAQEKSILMELSHPFIVNMM 84
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN--------ALEY 281
F E R FL+ E++ G L HL GR P DVA A EY
Sbjct: 85 CSFQDENRVYFLL-EFVVGGELFTHLRKAGRFP----------NDVAKFYHAELVLAFEY 133
Query: 282 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG--SICFEPVNTDIRGTPGY 339
LH D + +RD+K N+LLD K+ DFG A D ++C GTP Y
Sbjct: 134 LH-SKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC---------GTPEY 181
Query: 340 MDPEYVVTQELTEKSDVYSYGVVLLEIV 367
+ PE + ++ + D ++ GV+L E +
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 29/207 (14%)
Query: 175 IIGQGGFGTVY---KAQFSD-GSLIAVKRMDKISEQVEGDFCR---EIELLARLHHRHLV 227
++GQG FG V+ K D G L A+K + K + +V D R E ++LA ++H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEVNHPFIV 61
Query: 228 ALR-GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 286
L F E + +L+ +++ G L L S + +A ++A AL++LH
Sbjct: 62 KLHYAFQTEGK-LYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-ELALALDHLH--- 115
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPGYMD 341
+ +RD+K NILLDE KL DFGL+ H K S C GT YM
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---------GTVEYMA 166
Query: 342 PEYVVTQELTEKSDVYSYGVVLLEIVT 368
PE V + T+ +D +S+GV++ E++T
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 49/159 (30%), Positives = 81/159 (50%), Gaps = 20/159 (12%)
Query: 173 STIIGQGGFGTVYKAQF-SDGSLIAVKR--MDKISEQVEGDFCREIELLARLHHRHLVAL 229
IGQG FG V+KA+ ++A+K+ M+ E REI++L L H ++V L
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 76
Query: 230 RGFCIEK-----RER---FLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVANAL 279
C K R + +L++E+ + L L + T + +++ + N L
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLL---NGL 132
Query: 280 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318
Y+H + HRD+K++NIL+ ++ + KLADFGLA A
Sbjct: 133 YYIHR---NKILHRDMKAANILITKDGILKLADFGLARA 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 15/224 (6%)
Query: 169 TDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK-ISEQVEGDFCREIE--LLARLHHR 224
NF ++G+G FG V A+ L A+K + K + Q + C +E +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 225 HLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 283
+ C + +R + + EY+ G L H+ G+ + A +++ L +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLH 118
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 343
+ +RD+K N++LD K+ADFG+ + GTP Y+ PE
Sbjct: 119 ---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT----TRTFCGTPDYIAPE 171
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCM 387
+ Q + D ++YGV+L E++ + DG++ E Q M
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPF-DGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 174 TIIGQGGFGTVYKAQF-SDGSLIAVKRMDKIS-----EQVEGDFCREIELLARLHHRHLV 227
+IG+G FG V A+ +DG AVK + K + EQ R + LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLV 59
Query: 228 ALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI-AIDVANALEYLHFY 285
L + + ++ + + +Y+ G L HL P + R + A ++A+AL YLH
Sbjct: 60 GLH-YSFQTADKLYFVLDYVNGGELFFHLQRERSFP---EPRARFYAAEIASALGYLH-- 113
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 345
+ +RD+K NILLD L DFGL K+G I + GTP Y+ PE +
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLC---KEG-IEHSKTTSTFCGTPEYLAPEVL 168
Query: 346 VTQELTEKSDVYSYGVVLLEIV 367
Q D + G VL E++
Sbjct: 169 RKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISE--QVEGDFCREIELLARLHHRHLVALRGF 232
IG+G +G V+K + + G ++A+K+ + + ++ REI +L +L H +LV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 233 CIEKRERFLMYEYMANGSLKDH--LHSPGRTP--LSWQTRIQIAIDVANALEYLHFY-CD 287
KR+ L++EY DH L+ + P + +I A+ + H + C
Sbjct: 69 FRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC- 121
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV- 346
HRD+K NIL+ + KL DFG A + TD T Y PE +V
Sbjct: 122 ---IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY----TDYVATRWYRAPELLVG 174
Query: 347 -TQELTEKSDVYSYGVVLLEIVT 368
TQ DV++ G V E++T
Sbjct: 175 DTQYGP-PVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 65/223 (29%), Positives = 99/223 (44%), Gaps = 26/223 (11%)
Query: 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDK----ISEQVEGDFCREIELLARLHHRHLVAL 229
++G+G FG V A+ G AVK + K I + VE + L + L L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
K F + E++ G L H+ GR L T A ++ L++LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFY--AAEIVCGLQFLH---SKG 116
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR-----GTPGYMDPEY 344
+ +RD+K N++LD + K+ADFG+ C E V D R GTP Y+ PE
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGM---------CKENVFGDNRASTFCGTPDYIAPEI 167
Query: 345 VVTQELTEKSDVYSYGVVLLEIVTARRAVQ--DGKNLVESAQV 385
+ + T D +S+GV+L E++ + D L ES +V
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 44/156 (28%), Positives = 84/156 (53%), Gaps = 16/156 (10%)
Query: 170 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDF----CREIELLARLH 222
D + + I +G +G VY+A+ G ++A+K++ K+ ++ EG F REI +L +L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEG-FPITSLREINILLKLQ 62
Query: 223 HRHLVALRGFCIEKRER--FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 280
H ++V ++ + +++ EY+ + LK L + P + + + + +
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKS-LMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 281 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 316
+LH D + HRD+K+SN+LL+ + K+ DFGLA
Sbjct: 121 HLH---DNWILHRDLKTSNLLLNNRGILKICDFGLA 153
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 67/276 (24%), Positives = 120/276 (43%), Gaps = 24/276 (8%)
Query: 176 IGQGGFGTVYKAQFSDGSLIA---VKRMDKISEQVEGD-FCREIELLARLHHRHLVALRG 231
IG G FG V + G A VK + + E F +E++ L+H +++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQ--IAIDVANALEYLHFYCDP 288
CIE L+ E+ G LK++L S G Q + +A +VA+ L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHAS--KDGSICFEPVNTDIRGT-PGYMDP--E 343
H D+ N L + K+ D+GLA +D I + +R P ++ +
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402
++ ++ T+KS+++S GV + E+ T A + D + QV + +L K
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP-------K 232
Query: 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
D++ ++++C RP+ ++V +L
Sbjct: 233 PQLDLKYSDRWYEVMQFCWLDPET-RPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 72/277 (25%), Positives = 123/277 (44%), Gaps = 38/277 (13%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDF--------CREIELLARLHHRHLV 227
+G+G FGTVY D +A +R+ + E G+ +E +LL++L H +V
Sbjct: 8 LGKGSFGTVYLV--KDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 228 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRT--PLSWQTRIQIAIDVANALEYLHFY 285
+E+ ++ EY L L T LS + I + + Y+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-- 123
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAH---ASKDGSICFEPVNTDIRGTPGYMDP 342
+ HRD+K+ NI L N + K+ DFG++ S D + T GTP YM P
Sbjct: 124 -QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCD-------LATTFTGTPYYMSP 174
Query: 343 EYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402
E + Q KSD++S G +L E+ A + G+N ++ R+ E P +
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFE-GQNF-------LSVVLRIVEGPTPSLP 226
Query: 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439
+++ R + +I++ ++ RPS ++LR +
Sbjct: 227 ETYS----RQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 72/294 (24%), Positives = 123/294 (41%), Gaps = 46/294 (15%)
Query: 177 GQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCR---EIELLARLHHRHLVALRGFC 233
+ K + +L+AVK+++ + + D EI +L H +++
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKIN-LDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 234 IEKRERFLMYEYMANGSLKDHL--HSPGRTPLSWQTRI-QIAIDVANALEYLHFYCDPPL 290
I E +++ MA GS +D L H P P + I I DV NAL+Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYIH---SKGF 122
Query: 291 CHRDIKSSNILLDENFVAKLADFG-----LAHASKDGSICFEPVNTDIRGTPGYMDPEYV 345
HR +K+S+ILL + L+ + H + + P + ++ P ++ PE V
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS-SVKNLP-WLSPE-V 179
Query: 346 VTQEL---TEKSDVYSYGVVLLEI---VTARRAVQDGKNLVESAQVCM----------AS 389
+ Q L EKSD+YS G+ E+ + + + L+E + +
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239
Query: 390 ESRLAE----LVDPRIKDSFDMEQLRTIVT----IVRWCTQREGQARPSIKQVL 435
E +++ P +DS D RT V C QR+ ++RPS Q+L
Sbjct: 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 176 IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRGF 232
IG+G +G VYKA+ IA+K R+++ E V REI LL + H ++V L+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 292
++ +L++EY+ + LK H+ S +P + I + L + + + H
Sbjct: 70 VHSEKRLYLVFEYL-DLDLKKHMDS---SPDFAKNPRLIKTYLYQILRGIAYCHSHRVLH 125
Query: 293 RDIKSSNILLDENFVA-KLADFGLAHASKDGSICFE-PVNTDIRG--TPGYMDPEYVV-T 347
RD+K N+L+D A KLADFGLA A F PV T T Y PE ++ +
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARA-------FGIPVRTFTHEVVTLWYRAPEILLGS 178
Query: 348 QELTEKSDVYSYGVVLLEIVTAR 370
+ + D++S G + E+V +
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 24/203 (11%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK----ISEQVEGDFC-REIELLARLHHRHLVA 228
++G+G FG V A+ G L AVK + K + VE + I LAR +H L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 60
Query: 229 LRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI-AIDVANALEYLHFYC 286
L C + +R F + E++ G L H+ R + R + A ++ +AL +LH
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARARFYAAEITSALMFLH--- 113
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 346
D + +RD+K N+LLD KLADFG+ K+G I + GTP Y+ PE +
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMC---KEG-IFNGKTTSTFCGTPDYIAPE--I 167
Query: 347 TQELTEKSDV--YSYGVVLLEIV 367
QE+ V ++ GV+L E++
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 167 KATD-NFSTIIGQGGFGTVYKAQFSDGS-LIAVKRMDKISEQVEGD---FCREIELLARL 221
KA D + +IG+G FG V + + A+K + K D F E +++A
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 222 HHRHLVALRGFCIEKRERFL--MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 279
+ +V L + +++L + EYM G L + L S P W R A +V AL
Sbjct: 101 NSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKW-ARFYTA-EVVLAL 155
Query: 280 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSI-CFEPVNTDIRGTP 337
+ +H HRD+K N+LLD++ KLADFG +G + C V GTP
Sbjct: 156 DAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-----GTP 207
Query: 338 GYMDPEYVVTQ----ELTEKSDVYSYGVVLLEIV 367
Y+ PE + +Q + D +S GV L E++
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 70/202 (34%), Positives = 97/202 (48%), Gaps = 22/202 (10%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKIS-----EQVEGDFCREIELLARLHHRHLVA 228
+IG+G FG V A+ SDGS AVK + K + EQ R + LL L H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVG 60
Query: 229 LRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 287
L + + E+ + + +Y+ G L HL R L + R A +VA+A+ YLH
Sbjct: 61 LH-YSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARF-YAAEVASAIGYLH---S 114
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR--GTPGYMDPEYV 345
+ +RD+K NILLD L DFGL K+G EP T GTP Y+ PE +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLC---KEG---VEPEETTSTFCGTPEYLAPEVL 168
Query: 346 VTQELTEKSDVYSYGVVLLEIV 367
+ D + G VL E++
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 176 IGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFC---REIELLARLHHRHLVALRG 231
+G+G + TV+K + +L+A+K + E EG C RE+ LL L H ++V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
+R L++EY+ + LK +L + G +I + L Y H +
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCH---KRKIL 125
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQEL 350
HRD+K N+L++E KLADFGLA A S+ + + ++ T Y P+ ++ + E
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAK---SVPTKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 351 TEKSDVYSYGVVLLEIVTAR 370
+ D++ G +L E+ T R
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 31/163 (19%)
Query: 173 STIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEG---DFCREIELLARL---HHRH 225
IG+G +GTVYKA+ + G +A+K++ ++ EG REI LL +L H +
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 226 LVALRGFCIEKR-ER----FLMYEYMAN--GSLKDHLHSPGRTP-----LSWQTRIQIAI 273
+V L C R +R L++E++ + PG P L Q
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQ------- 115
Query: 274 DVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 316
+ +++LH + + HRD+K NIL+ + K+ADFGLA
Sbjct: 116 -LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 25/203 (12%)
Query: 176 IGQGGFGTVYKAQFSDGSLI-AVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 231
IG+G FG V + + D I A+K + K +S E +LA+++ +V L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 232 FCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
F + E+ +L+ ++ G L HL GR LS + R A ++ ALE LH + +
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLS-RARFYTA-ELLCALENLHKF---NV 114
Query: 291 CHRDIKSSNILLDENFVAKLADFGL-----AHASKDGSICFEPVNTDIRGTPGYMDPEYV 345
+RD+K NILLD L DFGL K + C GTP Y+ PE +
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---------GTPEYLAPELL 165
Query: 346 VTQELTEKSDVYSYGVVLLEIVT 368
+ T+ D ++ GV+L E++T
Sbjct: 166 LGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 9e-12
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRH---------- 225
IG+G FG VY+ + D I M +S++ + E+ + R+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYA--MKVLSKKE---IVAKKEVAHTIGERNILVRTLLDES 55
Query: 226 --LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 283
+V L+ + +L+ +YM+ G L HL GR + + IA ++ ALE+LH
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-RAKFYIA-ELVLALEHLH 113
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SKDGSICFEPVNTDIRGTPGYMD 341
Y + +RD+K NILLD L DFGL+ A + + + NT GT Y+
Sbjct: 114 KY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-----TNT-FCGTTEYLA 164
Query: 342 PEYVVTQE-LTEKSDVYSYGVVLLEI 366
PE ++ ++ T+ D +S GV++ E+
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 9e-12
Identities = 67/274 (24%), Positives = 117/274 (42%), Gaps = 30/274 (10%)
Query: 176 IGQGGFGTVYKA----QFSDGSL----IAVKRMDKISEQVEGDFCREIELLARLHHRHLV 227
+GQG F ++K G L + +K +DK F ++++L H+HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 228 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRT-PLSWQTRIQIAIDVANALEYLHFYC 286
G C+ E ++ EY+ GSL +L +SW ++++A +A AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE--- 117
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG-SICFEPVNTDIRGTPGYMDPEYV 345
D L H ++ + N+LL K + S G SI P + P ++ PE +
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP-WVPPECI 176
Query: 346 V-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404
Q L+ +D +S+G L EI + + ++S + E R +L P+ +
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFS---GGDKPLSALDSQKKLQFYEDRH-QLPAPKWTE- 231
Query: 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
+ ++ C E RPS + ++R L
Sbjct: 232 --------LANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 63/249 (25%), Positives = 108/249 (43%), Gaps = 40/249 (16%)
Query: 175 IIGQGGFGTVYKAQFSD---GSLIAVKRMDK-ISEQ--VEGDFCREIELLARLHHRHLVA 228
+IG+GG G VY A D +A+K++ + +SE ++ F RE ++ A L H +V
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 229 LRGFCIEKRERFLMYEYMANGSLK---------DHLHSPGRTPLSWQTRIQIAIDVANAL 279
+ C + + Y+ +LK + L S + I + +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 280 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK------------DGSICFE 327
EY+H + HRD+K NILL + D+G A K + +IC+
Sbjct: 127 EYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 328 --PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA----RRAVQDGKNLVE 381
+ I GTP YM PE ++ +E +D+Y+ GV+L +++T RR + G+ +
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR--KKGRKISY 241
Query: 382 SAQVCMASE 390
+ E
Sbjct: 242 RDVILSPIE 250
|
Length = 932 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 176 IGQGGFGTVYK--AQFSDGSLIAVKRMDKISEQVEGDFC---REIELLARLHHRHLVALR 230
+G+G + TVYK ++ +D +L+A+K + E EG C RE+ LL L H ++V L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRL--EHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 231 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
++ L++EY+ + LK +L G + ++ + L Y H +
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKL-FLFQLLRGLNYCH---RRKV 125
Query: 291 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQE 349
HRD+K N+L++E KLADFGLA A SI + + ++ T Y P+ ++ + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAK---SIPTKTYSNEVV-TLWYRPPDILLGSTD 181
Query: 350 LTEKSDVYSYGVVLLEIVTAR 370
+ + D++ G + E+ T R
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 171 NFSTIIGQGGFGTVYKAQFSDGS--LIAVKRMDK----ISEQVEGDFCREIE--LLARLH 222
NF ++G+G FG V A+ G+ L A+K + K + VE C +E +LA
Sbjct: 3 NFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVE---CTMVEKRVLALPG 58
Query: 223 HRH-LVALRG-FCIEKRERFLMYEYMANGSLKDHLHSPG--RTPLSWQTRIQIAIDVANA 278
L L F R F+M EY+ G L H+ G + P + + A ++A
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVM-EYVNGGDLMYHIQQVGKFKEPHA----VFYAAEIAIG 113
Query: 279 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT-DIRGTP 337
L +LH + +RD+K N++LD K+ADFG+ K+ F T GTP
Sbjct: 114 LFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMC---KEN--IFGGKTTRTFCGTP 165
Query: 338 GYMDPEYVVTQELTEKSDVYSYGVVLLEIV 367
Y+ PE + Q + D +++GV+L E++
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 49/195 (25%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCREIELLARLHHRHLVALRG 231
++G+G +G V K + + ++A+K+ + +E+V+ RE+++L L ++V L+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
+ + +L++EY+ L+ P P ++ + ++ +H+ +
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE-----KVRSYIYQLIKAIHWCHKNDIV 122
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 351
HRDIK N+L+ N V KL DFG A +GS T+ T Y PE ++
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGS---NANYTEYVATRWYRSPELLLGAPYG 179
Query: 352 EKSDVYSYGVVLLEI 366
+ D++S G +L E+
Sbjct: 180 KAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 24/205 (11%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEG---DFCREIELLARLHHRHLVALRG 231
+G+G + TVYK + + G ++A+K + +E EG REI L+ L H ++V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHD 65
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
+ + L++EYM + LK ++ + G R L T + + + H + +
Sbjct: 66 VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRV 121
Query: 291 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE-PVNT---DIRGTPGYMDPEYVV 346
HRD+K N+L+++ KLADFGLA A F PVNT ++ T Y P+ ++
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARA-------FGIPVNTFSNEVV-TLWYRAPDVLL 173
Query: 347 TQELTEKS-DVYSYGVVLLEIVTAR 370
S D++S G ++ E++T R
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 24/173 (13%)
Query: 159 KFSYKETKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRM--DKISEQVEGDF---- 211
FS E +G+G +G V KA + G ++A+K++ +IS V D
Sbjct: 3 SFSISERYIQKGAH---LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVG 59
Query: 212 --------CREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPL 263
RE++++ + H +++ L +E L+ + MA LK + + L
Sbjct: 60 MCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR--KIRL 116
Query: 264 SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 316
+ I + + N L LH + HRD+ +NI ++ + K+ADFGLA
Sbjct: 117 TESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLA 166
|
Length = 335 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 71/280 (25%), Positives = 123/280 (43%), Gaps = 35/280 (12%)
Query: 170 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMD-KISEQVEGDFCREIELLAR-LHHR 224
D+ I +G+G +G V K + G+++AVKR+ ++ Q + ++++ R +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 225 HLVALRGFCIEKRERFLMYEYMANGSLKD---HLHSPGRT-PLSWQTRIQIAIDVANALE 280
+ V G + + ++ E M + SL ++ G T P +I A+ + ALE
Sbjct: 61 YTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKI--AVSIVKALE 117
Query: 281 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 340
YLH + HRD+K SN+L++ N KL DFG++ G + T G YM
Sbjct: 118 YLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS-----GYLVDSVAKTIDAGCKPYM 170
Query: 341 DPEYV----VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES-AQVCMASESRLAE 395
PE + + KSDV+S G+ ++E+ T R K + QV +L
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA 230
Query: 396 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL 435
+ F E V C ++ + RP+ ++L
Sbjct: 231 -------EKFSPE----FQDFVNKCLKKNYKERPNYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 21/198 (10%)
Query: 176 IGQGGFGTVYKA--QFSDGSLIAVKR-MDKISEQVEGDFC-REIELLARLHHRHLVALRG 231
+G G FG V A Q + G +A+K+ M S V RE++LL L H ++++L
Sbjct: 18 VGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76
Query: 232 FCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
I E + + E + L L S PL Q + L+Y+H +
Sbjct: 77 IFISPLEDIYFVTELLGT-DLHRLLTS---RPLEKQFIQYFLYQILRGLKYVH---SAGV 129
Query: 291 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QE 349
HRD+K SNIL++EN K+ DFGLA +P T T Y PE ++T Q+
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARIQ-------DPQMTGYVSTRYYRAPEIMLTWQK 182
Query: 350 LTEKSDVYSYGVVLLEIV 367
+ D++S G + E++
Sbjct: 183 YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 29/221 (13%)
Query: 161 SYKETKKATD------NFSTIIGQGGFGTVYKAQFSDGSL--IAVKRMDKI----SEQVE 208
S KE K+ NF +G G FG V A + + +A+KR +K +QV+
Sbjct: 17 STKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD 76
Query: 209 GDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTR 268
F E ++L ++H V L G ++ +L+ E++ G L R P
Sbjct: 77 HVF-SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND--VG 133
Query: 269 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SKDGSICF 326
A + EYL + +RD+K N+LLD++ K+ DFG A ++ ++C
Sbjct: 134 CFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC- 189
Query: 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 367
GTP Y+ PE ++ + +D ++ G+ + EI+
Sbjct: 190 --------GTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 34/221 (15%)
Query: 170 DNFSTI--IGQGGFGTVYKAQFSDG-SLIAVKRMDK----ISEQVEGDFCREIELLARLH 222
++F TI I G +G VY + + A+K+++K + Q++ F E ++L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAE 59
Query: 223 HRHLVALRGFC-IEKRERFLM-YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 280
+ +V++ FC E + M EY+ G L + G P+ R+ A V ALE
Sbjct: 60 NPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD-MARMYFAETVL-ALE 115
Query: 281 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA--------------HASKDGSICF 326
YLH Y + HRD+K N+L+ KL DFGL+ H KD
Sbjct: 116 YLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR--- 169
Query: 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 367
E ++ + GTP Y+ PE ++ Q + D ++ G++L E +
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 40/113 (35%), Positives = 58/113 (51%), Gaps = 11/113 (9%)
Query: 259 GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318
+ PL+ + I + VA +E+L HRD+ + NILL EN V K+ DFGLA
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR- 221
Query: 319 SKDGSICFEP---VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
I +P D R +M PE + + T +SDV+S+GV+L EI +
Sbjct: 222 ----DIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 54/228 (23%), Positives = 101/228 (44%), Gaps = 30/228 (13%)
Query: 164 ETKKATDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRM-DKISEQVEGDFCREIE 216
E +T F +G+ FG VYK +A+K + DK + +F E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 217 LLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHL--HSPG------------RTP 262
+ +RL H ++V L G +++ +++ Y ++ L + L SP ++
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 263 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SK 320
L + I +A +E+L + + H+D+ + N+L+ + K++D GL +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
D IR +M PE ++ + + SD++SYGVVL E+ +
Sbjct: 178 DYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 64/199 (32%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-----SEQVEGDFCREIELLARLHHRHLVA 228
+IG+G FG V A+ DG AVK + K EQ R + LL + H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVG 60
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
L + + + +++ G L HL R+ + R A ++A+AL YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAA-EIASALGYLH---SI 115
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 348
+ +RD+K NILLD L DFGL K+G I T GTP Y+ PE + Q
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLC---KEG-IAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 349 ELTEKSDVYSYGVVLLEIV 367
D + G VL E++
Sbjct: 172 PYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 175 IIGQGGFGTVYKAQFS-DGSLI----AVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 228
++G G FGTVYK + DG + A+K + + S + + E ++A + ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
L G C+ + L+ + M G L D++ + + Q + + +A + YL +
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLE---EV 128
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVT 347
L HRD+ + N+L+ K+ DFGLA I + D P +M E ++
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLL---DIDETEYHADGGKVPIKWMALESILH 185
Query: 348 QELTEKSDVYSYGVVLLEIVT 368
+ T +SDV+SYGV + E++T
Sbjct: 186 RRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 228
++G G FGTVYK + +G + A+K + + S + + E ++A + + H+
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSP-----GRTPLSWQTRIQIAIDVANALEYLH 283
L G C+ + L+ + M G L D++ + L+W + +A + YL
Sbjct: 74 LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 126
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMD 341
+ L HRD+ + N+L+ K+ DFGLA + + E I+ +M
Sbjct: 127 ---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK----WMA 179
Query: 342 PEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 385
E ++ + T +SDV+SYGV + E++T DG E + +
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 223
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 36/214 (16%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVAL 229
IG+G +G V A G +A+K++ Q FC REI++L R H +++ +
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT---FCQRTLREIKILRRFKHENIIGI 68
Query: 230 ------RGFCIEKRERFLMYEYMANGSLKDHLHSPGRT-PLSWQTRIQIAI-DVANALEY 281
F + +++ E M + L+ +T LS IQ + + L+Y
Sbjct: 69 LDIIRPPSFE-SFNDVYIVQELM-----ETDLYKLIKTQHLSND-HIQYFLYQILRGLKY 121
Query: 282 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH----ASKDGSICFEPVNTDIRGTP 337
+H + HRD+K SN+LL+ N K+ DFGLA E V T
Sbjct: 122 IH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV-----ATR 173
Query: 338 GYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 370
Y PE ++ + K+ D++S G +L E+++ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 15/214 (7%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISE--QVEGDFCREIELLARLHHRHLVALRG 231
IG G +G V A G +A+K++ + + RE+++L H +++A+R
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71
Query: 232 FCIEKRERF----LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 287
F ++ + M + L +HS PL+ + + L+Y+H
Sbjct: 72 ILRPPGADFKDVYVVMDLMES-DLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSAN- 127
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 347
+ HRD+K SN+L++E+ ++ DFG+A + T+ T Y PE +++
Sbjct: 128 --VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS 185
Query: 348 -QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV 380
E T D++S G + E++ RR + GKN V
Sbjct: 186 LPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYV 218
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALR 230
++G+G FG V + + G A+K + K I++ E +L H L AL+
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 231 -GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
F R F+M EY G L HL S R + R A ++ +AL YLH CD
Sbjct: 62 YSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA-EIVSALGYLH-SCD-- 115
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
+ +RD+K N++LD++ K+ DFGL K+G I GTP Y+ PE + +
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLC---KEG-ISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 350 LTEKSDVYSYGVVLLEIVTAR 370
D + GVV+ E++ R
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 26/204 (12%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQVEGDFCREIE-LLARLHHRHLVAL 229
+IG+G FG V A+ ++ AVK + K + ++ E E LL + H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 230 RGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
F + ++ + + +Y+ G L HL R L + R A ++A+AL YLH
Sbjct: 62 H-FSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARF-YAAEIASALGYLH---SL 115
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPGYMDPE 343
+ +RD+K NILLD L DFGL H + C GTP Y+ PE
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC---------GTPEYLAPE 166
Query: 344 YVVTQELTEKSDVYSYGVVLLEIV 367
+ Q D + G VL E++
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVK--RMDKISEQVEGDFCREIELLARLH---HRHLVAL 229
IG G +GTVYKA+ G +A+K R+ + + RE+ LL RL H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 230 RGFCIEKR-----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
C R + L++E++ + L+ +L L +T + L++LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
C + HRD+K NIL+ KLADFGLA + PV T Y PE
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYS-CQMALTPVVV----TLWYRAPEV 178
Query: 345 VVTQELTEKSDVYSYGVVLLEI 366
++ D++S G + E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 28/182 (15%)
Query: 197 VKRMDKISEQVEGDFCREIELLARLHHRHLVALR--------GFCIEKRERFLMYEYMAN 248
VK + + Q+E EI L RL+H +++ + + I ++ F +Y +M +
Sbjct: 200 VKAGSRAAIQLEN----EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255
Query: 249 GSL--KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF 306
+ KD PL QTR I + A+EY+H D L HRDIK NI L+ +
Sbjct: 256 EAFDWKD-------RPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDG 304
Query: 307 VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEI 366
L DFG A + F+ GT PE + E +D++S G++LL++
Sbjct: 305 KIVLGDFGTAMPFEKEREAFD---YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
Query: 367 VT 368
++
Sbjct: 362 LS 363
|
Length = 501 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 54/195 (27%), Positives = 81/195 (41%), Gaps = 47/195 (24%)
Query: 260 RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 319
++PL+ + I + VA +E+L HRD+ + NILL EN V K+ DFGLA
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-- 222
Query: 320 KDGSICFEPVNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIV 367
DI P Y M PE + + T +SDV+S+GV+L EI
Sbjct: 223 ------------DIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF 270
Query: 368 TARRAVQDGKNLVESAQVCM----ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQR 423
+ + G + E + C + R E P I I+ C Q
Sbjct: 271 SLGASPYPGVQINE--EFCQRLKDGTRMRAPENATPEIY------------RIMLACWQG 316
Query: 424 EGQARPSIKQVLRIL 438
+ + RP+ ++ IL
Sbjct: 317 DPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 175 IIGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQVEGD---FCREIELLARLHHRHLVALR 230
+IG+G FG V + + A+K + K D F E +++A + +V L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 231 GFCIEKRERFLMYEYMANGSLKDHLHS---PGRTPLSWQTRIQIAIDVANALEYLHFYCD 287
+ R +++ EYM G L + + + P + + + +A+D +++ ++H
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---- 165
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSI-CFEPVNTDIRGTPGYMDPEYV 345
RD+K N+LLD++ KLADFG +K+G + C V GTP Y+ PE +
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GTPDYISPEVL 215
Query: 346 VTQ----ELTEKSDVYSYGVVLLEIVTA 369
+Q + D +S GV L E++
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 169 TDNFSTI--IGQGGFGTVYK-AQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHR 224
TD + I IG+G +G VYK DGSL AVK +D IS+ V+ + E +L L +H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHP 79
Query: 225 HLVALRGFCIEKR-----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ---IAIDVA 276
++V G + + +L+ E GS+ + + + L R+ I+ +
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV----KGLLICGQRLDEAMISYILY 135
Query: 277 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 336
AL L + + HRD+K +NILL KL DFG++ + NT + GT
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL---RRNTSV-GT 191
Query: 337 PGYMDPEYVVTQELTEKS-----DVYSYGVVLLEI 366
P +M PE + ++ + S DV+S G+ +E+
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 49/193 (25%), Positives = 84/193 (43%), Gaps = 31/193 (16%)
Query: 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAK 309
KD + PL ++ + VA +++L HRD+ + N+LL + VAK
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAK 252
Query: 310 LADFGLAHASKDGSICFEPVNTDIRGTP----GYMDPEYVVTQELTEKSDVYSYGVVLLE 365
+ DFGLA + S N ++G +M PE + T +SDV+SYG++L E
Sbjct: 253 ICDFGLARDIMNDS------NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 306
Query: 366 IVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ----LRTIVTIVRWCT 421
I + GK+ + S+ ++ +K + M + I +I++ C
Sbjct: 307 IFSL------GKSPYPG----ILVNSKFYKM----VKRGYQMSRPDFAPPEIYSIMKMCW 352
Query: 422 QREGQARPSIKQV 434
E RP+ Q+
Sbjct: 353 NLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 68/257 (26%), Positives = 110/257 (42%), Gaps = 55/257 (21%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL---- 229
IIG+GGFG VY + +D G + A+K +DK +++ E LA L+ R +++L
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-----ETLA-LNERIMLSLVSTG 54
Query: 230 ---------RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 280
F + F++ + M G L HL G S A ++ LE
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLE 111
Query: 281 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTD 332
++H + + +RD+K +NILLDE+ +++D GLA HAS
Sbjct: 112 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------------ 156
Query: 333 IRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 391
GT GYM PE + + S D +S G +L +++ + K +
Sbjct: 157 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT--KDKHEI----D 208
Query: 392 RLAELVDPRIKDSFDME 408
R+ + + DSF E
Sbjct: 209 RMTLTMAVELPDSFSPE 225
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 66/250 (26%), Positives = 101/250 (40%), Gaps = 69/250 (27%)
Query: 170 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVE----GDFCREIELLARLH 222
D+F +I IG+G FG V Q D G + A+K++ K SE +E E ++LA
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILAEAD 59
Query: 223 HRHLVALRGFCIEKRERFLMYEYMANGSL------KDHLHSPGRTPLSWQTRIQI----- 271
+ +V L ++ +L+ EY+ G + KD +TR I
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-------ETRFYIAETIL 112
Query: 272 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL---------------- 315
AID + L Y+H RDIK N+LLD KL+DFGL
Sbjct: 113 AIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163
Query: 316 AHASKDGSICFEPVNTDIR------------------GTPGYMDPEYVVTQELTEKSDVY 357
+HA + F + GTP Y+ PE + ++ D +
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWW 223
Query: 358 SYGVVLLEIV 367
S GV++ E++
Sbjct: 224 SLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 176 IGQGGFGTVYK--AQFSDGSLIAVKRMDKISEQVEGDFC---REIELLARLHHRHLVALR 230
+G+G + TV+K ++ ++ +L+A+K + E EG C RE+ LL L H ++V L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRL--EHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 231 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
+ L++EY+ + LK ++ G +S + L Y H +
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNI-MSMHNVKIFLYQILRGLAYCH---RRKV 125
Query: 291 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQE 349
HRD+K N+L++E KLADFGLA A S+ + + ++ T Y P+ ++ + E
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAK---SVPTKTYSNEVV-TLWYRPPDVLLGSSE 181
Query: 350 LTEKSDVYSYGVVLLEIVTAR 370
+ + D++ G + E+ + R
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 21/159 (13%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHR-HLVALR 230
IG+G +G VYKA+ + G L+A+K R++ E + REI LL L ++V L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL- 66
Query: 231 GFCIEKRER-------FLMYEYMANGSLKDHLHSPGR---TPLSWQTRIQIAIDVANALE 280
+E E +L++EY+ + LK + S GR PL +T + +
Sbjct: 67 -LDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 281 YLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHA 318
+ H + + HRD+K N+L+D + + K+AD GL A
Sbjct: 125 HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 6e-10
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 17/214 (7%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALR 230
++G+G FG V + + G A+K + K I++ E +L H L +L+
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 231 -GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
F + R F+M EY+ G L HL S R +TR A ++ +AL+YLH
Sbjct: 62 YSFQTKDRLCFVM-EYVNGGELFFHL-SRERVFSEDRTRFYGA-EIVSALDYLH---SGK 115
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
+ +RD+K N++LD++ K+ DFGL K+G + T GTP Y+ PE + +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLC---KEGITDAATMKT-FCGTPEYLAPEVLEDND 171
Query: 350 LTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVE 381
D + GVV+ E++ R QD + L E
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 205
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 72/235 (30%), Positives = 106/235 (45%), Gaps = 20/235 (8%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALR 230
++G+G FG V + + G A+K + K I++ E +L H L AL+
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 231 -GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
F R F+M EY G L HL S R + R A ++ +ALEYLH
Sbjct: 62 YAFQTHDRLCFVM-EYANGGELFFHL-SRERVFTEERARFYGA-EIVSALEYLH---SRD 115
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
+ +RDIK N++LD++ K+ DFGL K+G I GTP Y+ PE + +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLC---KEG-ISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 350 LTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVESAQVCMASESRLAELVDPRIK 402
D + GVV+ E++ R QD + L E + M E R + P K
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE--LILM-EEIRFPRTLSPEAK 223
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 49/195 (25%), Positives = 96/195 (49%), Gaps = 12/195 (6%)
Query: 176 IGQGGFGTVYKAQFSDGSL---IAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRG 231
+G G FG V K + +A+K + +E+ V + RE E++ +L + ++V + G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
C + E ++ MA+G + S + ++ +++ V+ ++YL
Sbjct: 63 VC--EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 350
HRD+ + N+LL AK++DFGL+ A D S + + + + PE + ++
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDS--YYKARSAGKWPLKWYAPECINFRKF 175
Query: 351 TEKSDVYSYGVVLLE 365
+ +SDV+SYG+ + E
Sbjct: 176 SSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 167 KATD-NFSTIIGQGGFGTV----YKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL 221
KA D + +IG+G FG V +K+ ++ + + + I F E +++A
Sbjct: 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 222 HHRHLVALRGFCIEKRERFL--MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 279
+ +V L FC + +++L + EYM G L + L S P W + A +V AL
Sbjct: 101 NSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKW-AKFYTA-EVVLAL 155
Query: 280 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR-GTPG 338
+ +H L HRD+K N+LLD++ KLADFG + + V D GTP
Sbjct: 156 DAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM----VRCDTAVGTPD 208
Query: 339 YMDPEYVVTQ----ELTEKSDVYSYGVVLLEIVTA 369
Y+ PE + +Q + D +S GV L E++
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 48/228 (21%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDF-----CREIELLARLHHRHLVAL 229
IG+G +G V A+ S+ +A+K KI+ + REI+LL L H +++A+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIK---KIANAFDNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 230 RGFCI-EKRERF----LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
+ RE F ++YE M + L + S LS + L+Y+H
Sbjct: 70 KDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH- 125
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
+ HRD+K SN+LL+ N K+ DFGLA + + +M EY
Sbjct: 126 --SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--------------KGDFM-TEY 168
Query: 345 VVTQ------------ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV 380
VVT+ E T DV+S G + E++ R+ + GK+ V
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG-RKPLFPGKDYV 215
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 63/254 (24%), Positives = 106/254 (41%), Gaps = 36/254 (14%)
Query: 171 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHL 226
+ +++G+G FG V + + G + A+K M K ++++ F E ++L+ + +
Sbjct: 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWI 63
Query: 227 VALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAID-------VANAL 279
L+ +K +L+ EY G L LS R + D +A +
Sbjct: 64 PQLQYAFQDKDNLYLVMEYQPGGDL-----------LSLLNRYEDQFDEDMAQFYLAELV 112
Query: 280 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA-SKDGSI-CFEPVNTDIRGTP 337
+H HRDIK N+L+D KLADFG A + + + PV GTP
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-----GTP 167
Query: 338 GYMDPEYVVTQELTEKS------DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 391
Y+ PE + T K D +S GV+ E++ R +G ++ M +
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQR 226
Query: 392 RLAELVDPRIKDSF 405
L DP++ F
Sbjct: 227 FLKFPEDPKVSSDF 240
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 59/229 (25%), Positives = 93/229 (40%), Gaps = 45/229 (19%)
Query: 175 IIGQGGFGTVYKAQ----FSDGSLIAVKRMDKI-------------SEQVEGDFCREIEL 217
++G G +G V+ + G L A+K + K +E+ + R
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 218 LARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN 277
L LH+ F + + ++ +Y+ G L HL+ S + R+ IA ++
Sbjct: 67 LVTLHY-------AFQTDTKLHLIL-DYVNGGELFTHLYQREHFTES-EVRVYIA-EIVL 116
Query: 278 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD----I 333
AL++LH + +RDIK NILLD L DFGL SK+ F +
Sbjct: 117 ALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGL---SKE----FLAEEEERAYSF 166
Query: 334 RGTPGYMDPEYVVTQELTEKS--DVYSYGVVLLEIVTARR--AVQDGKN 378
GT YM PE + D +S GV+ E++T V +N
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 175 IIGQGGFGTVYKAQFSDGSLI-AVKRMDKIS----EQVEGDFC-REIELLARLHHRHLVA 228
++G+G FG V A+ + A+K + K + V+ + I LA H L A
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTA 60
Query: 229 LRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 287
L C + ++R F + EY+ G L + + ++R A +V AL +LH +
Sbjct: 61 LHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP-RSRF-YAAEVTLALMFLHRH-- 115
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 347
+ +RD+K NILLD KLADFG+ K+G I T GTP Y+ PE +
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMC---KEG-ILNGVTTTTFCGTPDYIAPEILQE 170
Query: 348 QELTEKSDVYSYGVVLLEIV 367
E D ++ GV++ E++
Sbjct: 171 LEYGPSVDWWALGVLMYEMM 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 172 FSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCR-EIELLARLHHRHLVAL 229
+T++G+ + A + SD V + ++++ + + R E+ LA H +V
Sbjct: 71 LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKH 130
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTR------IQIAIDVANALEYLH 283
+ L+ EY + G L + + L +Q QI + AL+ +H
Sbjct: 131 FDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVL----ALDEVH 186
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 343
+ HRD+KS+NI L + KL DFG + D S+ + V + GTP Y+ PE
Sbjct: 187 SRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD-SVSLD-VASSFCGTPYYLAPE 241
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVTARR 371
+ ++K+D++S GV+L E++T R
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 31/230 (13%)
Query: 171 NFSTIIGQGGFGTVYKAQFSDG-SLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVA 228
NF ++G+G FG V A+ L A+K + K + Q + C +E + ++A
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVE-------KRVLA 55
Query: 229 LRG---------FCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 278
L G C + +R + + EY+ G L + GR + A ++A
Sbjct: 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIG 113
Query: 279 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR-GTP 337
L +LH + +RD+K N++LD K+ADFG+ + ++ V T GTP
Sbjct: 114 LFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN-----MWDGVTTKTFCGTP 165
Query: 338 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCM 387
Y+ PE + Q + D +++GV+L E++ A +A +G++ E Q M
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEML-AGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 68/236 (28%), Positives = 107/236 (45%), Gaps = 21/236 (8%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALR 230
++G+G FG V + + G A+K + K +++ E +L H L AL+
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 231 -GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
F R F+M EY G L HL S R + R A ++ +AL+YLH +
Sbjct: 62 YSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA-EIVSALDYLH--SEKN 116
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHAS-KDGSICFEPVNTDIRGTPGYMDPEYVVTQ 348
+ +RD+K N++LD++ K+ DFGL KDG+ GTP Y+ PE +
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM-----KTFCGTPEYLAPEVLEDN 171
Query: 349 ELTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVESAQVCMASESRLAELVDPRIK 402
+ D + GVV+ E++ R QD + L E + + E R + P K
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---LILMEEIRFPRTLSPEAK 224
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 54/180 (30%), Positives = 82/180 (45%), Gaps = 17/180 (9%)
Query: 260 RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-A 318
+ L+ + I + VA +E+L HRD+ + NILL EN V K+ DFGLA
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229
Query: 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 378
KD + D R +M PE + + T +SDV+S+GV+L EI + + G
Sbjct: 230 YKDPDYVRK---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286
Query: 379 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
+ E + C RL E R D E +T++ C E RP+ +++ L
Sbjct: 287 IDE--EFC----RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 18/217 (8%)
Query: 176 IGQGGFGTVYKAQF---SDGSLIAVKRMDKI-SEQVEGDFC-REIELLARLH-HRHLVAL 229
+GQG +G V A+ S+ +A+K++ + S+++ RE++LL H+++ L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 230 RGFCIEKRERF---LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHFY 285
I F +YE + L + S PL+ Q I + L+Y+H
Sbjct: 68 YDMDIVFPGNFNELYLYEELMEADLHQIIRS--GQPLT-DAHFQSFIYQILCGLKYIH-- 122
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 345
+ HRD+K N+L++ + K+ DFGLA + T+ T Y PE +
Sbjct: 123 -SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181
Query: 346 VT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 381
++ Q T+ DV+S G +L E++ R+ V GK+ V+
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVD 217
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 7e-09
Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 14/196 (7%)
Query: 176 IGQGGFGTVYKAQFS---DGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALR 230
+G G FGTV K + +AVK + D ++ + RE ++ +L + ++V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 231 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
G C E L+ E G L L ++ + ++ V+ ++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLE---ETNF 116
Query: 291 CHRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
HRD+ + N+LL AK++DFGL+ A D + + T + + PE + +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADEN--YYKAKTHGKWPVKWYAPECMNYYK 174
Query: 350 LTEKSDVYSYGVVLLE 365
+ KSDV+S+GV++ E
Sbjct: 175 FSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 7e-09
Identities = 68/261 (26%), Positives = 111/261 (42%), Gaps = 51/261 (19%)
Query: 195 IAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDH 254
+ +K +D + F L++++ H HL + G C+ E ++ E++ +G L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106
Query: 255 LH-SPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADF 313
L GR P++W +I +A +A+AL YL D L H ++ + NIL LA
Sbjct: 107 LRKEKGRVPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNIL--------LARL 153
Query: 314 GLAHASK------DGSICFEPVNTDIR--GTPGYMDPEYVVT-QELTEKSDVYSYGVVLL 364
GLA + D + F ++ + R P ++ PE V L+ +D +S+G LL
Sbjct: 154 GLAEGTSPFIKLSDPGVSFTALSREERVERIP-WIAPECVPGGNSLSTAADKWSFGTTLL 212
Query: 365 EIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR-------TIVTIV 417
EI C E L E P K+ F ++ R + T++
Sbjct: 213 EI-------------------CFDGEVPLKERT-PSEKERFYEKKHRLPEPSCKELATLI 252
Query: 418 RWCTQREGQARPSIKQVLRIL 438
C E RPS + +LR L
Sbjct: 253 SQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 176 IGQGGFGTVYKAQ--FSDGSLIAVKRMDKISEQVEG---DFCREIELLARLH---HRHLV 227
IG+G +G V+KA+ + G +A+KR+ ++ EG RE+ +L L H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 228 ALRGFCIEKR-----ERFLMYEYMANG--SLKDHLHSPGRTPLSWQTRIQIAIDVANALE 280
L C R + L++E++ + D + PG +T + + L+
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLD 124
Query: 281 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 340
+LH + + HRD+K NIL+ + KLADFGLA F+ T + T Y
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS-----FQMALTSVVVTLWYR 176
Query: 341 DPEYVVTQELTEKSDVYSYGVVLLEIVTAR 370
PE ++ D++S G + E+ +
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 176 IGQGGFGTVYKAQFS-DGSLIAVKRMD-KISEQVEGDFCREIELLARLHHRHLVALRG-F 232
+G+G +G+VYK G +A+K + ++ E E+++L + ++V G F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 233 CIEKRERFLMYEYMANGSLKDHLH----SPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
IE M EYM GSL D L+ + P RI A V L++L +
Sbjct: 69 FIEGAVYMCM-EYMDAGSL-DKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLKE--EH 122
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV--- 345
+ HRD+K +N+L++ N KL DFG++ G++ T+I G YM PE +
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTNI-GCQSYMAPERIKSG 176
Query: 346 -VTQELTE--KSDVYSYGVVLLEIVTAR 370
Q T +SDV+S G+ +LE+ R
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 49/159 (30%), Positives = 71/159 (44%), Gaps = 35/159 (22%)
Query: 176 IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFC---REIELLARLHHRHLVAL 229
+G+G + TVYK + G L+A+K R+ E EG RE LL L H ++V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRL----EHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA----------L 279
K+ L++EY+ + LK ++ G + + N L
Sbjct: 69 HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGG-----------GLSMHNVRLFLFQLLRGL 116
Query: 280 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318
Y H + HRD+K N+L+ E KLADFGLA A
Sbjct: 117 AYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 37/214 (17%)
Query: 176 IGQGGFGTVYKAQFSD---GSLIAVKRM-DKISEQVEGD--FCREIELLARL-HHRHLVA 228
+G+G +G V+KA D ++A+K++ D + F REI L L H ++V
Sbjct: 15 LGKGAYGIVWKA--IDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIVK 71
Query: 229 LRGF--CIEKRERFLMYEYMAN--------GSLKDHLHSPGRTPLSWQTRIQIAIDVANA 278
L ++ +L++EYM L+D +H + I + A
Sbjct: 72 LLNVIKAENDKDIYLVFEYMETDLHAVIRANILED-VH-----------KRYIMYQLLKA 119
Query: 279 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE-PVNTDIRGTP 337
L+Y+H + HRD+K SNILL+ + KLADFGLA + + E PV TD T
Sbjct: 120 LKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 338 GYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTAR 370
Y PE ++ + T+ D++S G +L E++ +
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 15/152 (9%)
Query: 222 HHRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 280
+H LV L C + R F + EY+ G L H+ + P R A +++ AL
Sbjct: 54 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHARFYSA-EISLALN 110
Query: 281 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR--GTPG 338
YLH + + +RD+K N+LLD KL D+G+ K+G P +T GTP
Sbjct: 111 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEG---LRPGDTTSTFCGTPN 161
Query: 339 YMDPEYVVTQELTEKSDVYSYGVVLLEIVTAR 370
Y+ PE + ++ D ++ GV++ E++ R
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 20/151 (13%)
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 351
HRD+ + NILL + K+ DFGLA ++ S V + R +M PE + T
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIRNDSNYV--VKGNARLPVKWMAPESIFNCVYT 294
Query: 352 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR 411
+SDV+SYG++L EI + L S M +S+ ++ IK+ + M
Sbjct: 295 FESDVWSYGILLWEIFS----------LGSSPYPGMPVDSKFYKM----IKEGYRMLSPE 340
Query: 412 ----TIVTIVRWCTQREGQARPSIKQVLRIL 438
+ I++ C + RP+ KQ+++++
Sbjct: 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 53/218 (24%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL---- 229
IIG+GGFG VY + +D G + A+K +DK ++ ++ E LA L+ R +++L
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-----KQGETLA-LNERIMLSLVSTG 54
Query: 230 ---------RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 280
F + F++ + M G L HL G S + A ++ LE
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFIL-DLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLE 111
Query: 281 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTD 332
++H + + +RD+K +NILLDE+ +++D GLA HAS
Sbjct: 112 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------------ 156
Query: 333 IRGTPGYMDPEYVVTQELT---EKSDVYSYGVVLLEIV 367
GT GYM PE V Q+ T +D +S G +L +++
Sbjct: 157 --GTHGYMAPE--VLQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 46/148 (31%), Positives = 73/148 (49%), Gaps = 15/148 (10%)
Query: 226 LVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
LV L C + R FL+ EY+ G L H+ + P R A ++ AL +LH
Sbjct: 58 LVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLP-EEHARF-YAAEICIALNFLH- 113
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR--GTPGYMDP 342
+ + +RD+K N+LLD + KL D+G+ K+G P +T GTP Y+ P
Sbjct: 114 --ERGIIYRDLKLDNVLLDADGHIKLTDYGMC---KEG---LGPGDTTSTFCGTPNYIAP 165
Query: 343 EYVVTQELTEKSDVYSYGVVLLEIVTAR 370
E + +E D ++ GV++ E++ R
Sbjct: 166 EILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 40/214 (18%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMD---KISEQVEGDFCREIELLARLH-HRHLVALR 230
IG+G +G V+K +GS AVK +D I E++E ++ +L L H ++V
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEY----NILKALSDHPNVVKFY 81
Query: 231 GFCIEKRER-----FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ---IAIDVANALEYL 282
G +K + +L+ E GS+ D + + L R++ IA + AL L
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLV----KGFLKRGERMEEPIIAYILHEALMGL 137
Query: 283 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR-----GTP 337
HRD+K +NILL KL DFG++ + +T +R GTP
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA---------QLTSTRLRRNTSVGTP 188
Query: 338 GYMDPEYVVTQE-----LTEKSDVYSYGVVLLEI 366
+M PE + ++ + DV+S G+ +E+
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 34/211 (16%)
Query: 176 IGQGGFGTVYKA---QFSDGSLIA-------VKRMDKISEQVEGDFCREIELLARLHHRH 225
+GQG F +YK SD ++ V ++ + F L+++L H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLHF 284
LV L G C+ + E ++ EY+ G L LH L W ++ +A +A+AL YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE- 118
Query: 285 YCDPPLCHRDIKSSNILL-----DENFV--AKLADFGLAHASKDGSICFEPVNTDIRGTP 337
D L H ++ NIL+ +E +V KL+D G+ E + P
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-------P 169
Query: 338 GYMDPEYV--VTQELTEKSDVYSYGVVLLEI 366
++ PE + LT +D +S+G LLEI
Sbjct: 170 -WIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 48/185 (25%), Positives = 75/185 (40%), Gaps = 24/185 (12%)
Query: 209 GDFCREIELLARLHHRHLVAL-------RGFCIEKRE-RFLMYEYMANGSLKDHLHSPGR 260
REI++L + HR ++ L C+ + + ++ Y+
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYV-----------DRS 179
Query: 261 TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320
PL + I I + AL YLH + HRD+K+ NI LDE A L DFG A K
Sbjct: 180 GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGA--ACK 234
Query: 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV 380
+ P GT PE + K+D++S G+VL E+ + +
Sbjct: 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294
Query: 381 ESAQV 385
S+Q+
Sbjct: 295 SSSQL 299
|
Length = 392 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 176 IGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFC--REIELLARLHHRHLVALRGF 232
+G+G + TVYK + +G L+A+K + ++ E+ F RE LL L H ++V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 292
K L++EY+ + PG L + + L Y+H + H
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIH---QRYILH 126
Query: 293 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQELT 351
RD+K N+L+ + KLADFGLA A S + ++ T Y P+ ++ + E +
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTY----SNEVVTLWYRPPDVLLGSTEYS 182
Query: 352 EKSDVYSYGVVLLEIVTARRAVQDGKNL 379
D++ G + +E++ A K++
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAAFPGMKDI 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 30/214 (14%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEG-----DFCREIELLARLHHRHLVALR 230
+G+G +G VYKA+ DG D +Q+EG CREI LL L H ++++L+
Sbjct: 9 VGRGTYGHVYKAKRKDGK----DDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 64
Query: 231 GFCIEKRER--FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY-----LH 283
+ +R +L+++Y + H+ R + + +Q+ + +L Y +H
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 284 FYCDPPLCHRDIKSSNILL----DENFVAKLADFGLA---HASKDGSICFEPVNTDIRGT 336
+ + HRD+K +NIL+ E K+AD G A ++ +PV T
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV----T 178
Query: 337 PGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTA 369
Y PE ++ + T+ D+++ G + E++T+
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 29/210 (13%)
Query: 176 IGQGGFGTVYKAQFSDG---SLIAVKRMD-KISEQVEGDFCREIELLARLHHRHLVALRG 231
IG G FG V + + G + + VK + S Q + F E + L H +L+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRT------PLSWQTRIQIAIDVANALEYLHFY 285
C E L+ E+ G LK +L S + P + Q ++A ++A L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ---RMACEIALGLLHLH-- 117
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS--KDGSICFEPVNTDIRGTPGYMDPE 343
H D+ N LL + K+ D+GL+H +D + + + +R ++ PE
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----WIAPE 172
Query: 344 YV-------VTQELTEKSDVYSYGVVLLEI 366
V + + T++S+V+S GV + E+
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIELLARLHHRHLVALRGFC 233
+G+G + TVYK +G L+A+K + K E V RE LL L H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 234 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 293
K ++EYM + + PG + R+ + L Y+H + HR
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGGLH-PYNVRL-FMFQLLRGLAYIH---GQHILHR 127
Query: 294 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQELTE 352
D+K N+L+ KLADFGLA A SI + ++++ T Y P+ ++ + +
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAK---SIPSQTYSSEVV-TLWYRPPDVLLGATDYSS 183
Query: 353 KSDVYSYGVVLLEIVTARRAVQDGKNLVE 381
D++ G + +E++ + A ++ E
Sbjct: 184 ALDIWGAGCIFIEMLQGQPAFPGVSDVFE 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEG-----DFCREIELLARLHHRHLVALR 230
+G+G +G VYKA+ DG + +Q+EG CREI LL L H +++AL+
Sbjct: 9 VGRGTYGHVYKAKRKDGK----DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQ 64
Query: 231 GFCIEKRER--FLMYEYMANG---SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
+ +R +L+++Y + +K H S R + + L+ +H+
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 286 CDPPLCHRDIKSSNILL----DENFVAKLADFGLA---HASKDGSICFEPVNTDIRGTPG 338
+ HRD+K +NIL+ E K+AD G A ++ +PV T
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV----TFW 180
Query: 339 YMDPEYVV-TQELTEKSDVYSYGVVLLEIVTA 369
Y PE ++ + T+ D+++ G + E++T+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 50/175 (28%), Positives = 77/175 (44%), Gaps = 21/175 (12%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK-------ISEQVEGDFCREIELLARLHHRHLV 227
I +G FG VY + ++ L AVK + K + QV+ E + LA +V
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQA----ERDALALSKSPFIV 67
Query: 228 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 287
L +L+ EY+ G +K LH G + ++ +VA AL+YLH +
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRH-- 123
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 342
+ HRD+K N+L+ KL DFGL+ + + + DI TP P
Sbjct: 124 -GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNM----MDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 44/201 (21%), Positives = 87/201 (43%), Gaps = 16/201 (7%)
Query: 175 IIGQGGFGTVYKAQFSDGS----LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVAL 229
I+G G FG + + S +A+ + S++ F E L + H ++V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
G ++ EYM+NG+L L L + + +A+ ++YL +
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYL---SEMG 127
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG--YMDPEYVVT 347
H+ + + +L++ + V K++ F K E + T + G + PE +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK-----SEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 348 QELTEKSDVYSYGVVLLEIVT 368
+ SDV+S+G+V+ E+++
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 51/151 (33%), Positives = 67/151 (44%), Gaps = 19/151 (12%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCR---EIELLARLHHRHLVALRG 231
+G+G G V+ + G L A+K +DK R E E+LA L H L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 232 -FCIEKRERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLH----FY 285
F E +M +Y G L L PG+ LS + A +V ALEYLH Y
Sbjct: 69 SFQTETYLCLVM-DYCPGGELFRLLQRQPGKC-LSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLA 316
RD+K NILL E+ L+DF L+
Sbjct: 127 -------RDLKPENILLHESGHIMLSDFDLS 150
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 175 IIGQGGFGTVYKAQFSDGS----LIAVKRMDK---ISEQVEGDFCR-EIELLARLHHRHL 226
++G+GG+G V++ + G+ + A+K + K + Q + + E +L + H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 227 VALRGFCIEKRERFLMYEYMANGSLKDHLHSPG----RTPLSWQTRIQIAIDVANALEYL 282
V L + +L+ EY++ G L HL G T + + I +A LE+L
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA------LEHL 116
Query: 283 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS-KDGSICFEPVNTDIRGTPGYMD 341
H + +RD+K NILLD KL DFGL S +G+ V GT YM
Sbjct: 117 H---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-----VTHTFCGTIEYMA 168
Query: 342 PEYVVTQELTEKSDVYSYGVVLLEIVT 368
PE ++ + D +S G ++ +++T
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 59/234 (25%), Positives = 100/234 (42%), Gaps = 29/234 (12%)
Query: 175 IIGQGGFGTVYKAQFSDG-SLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALR 230
+IG+G FG V + + + A+K ++K + F E ++L ++ + L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 231 GFCIEKRERFLMYEYMANGSLKDHLHS-----PGRTPLSWQTRIQIAIDVANALEYLHFY 285
++ +L+ +Y G L L P + + IAID + L Y+H
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH-- 125
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFG-LAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
RDIK NIL+D N +LADFG +DG++ ++ GTP Y+ PE
Sbjct: 126 -------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV----QSSVAVGTPDYISPEI 174
Query: 345 VVTQE-----LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 393
+ E + D +S GV + E++ ++LVE+ M + R
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 59/241 (24%), Positives = 91/241 (37%), Gaps = 54/241 (22%)
Query: 176 IGQGGFGTVYKAQFSDGS-LIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 231
IG G FG V + D + L A+K + K + E ++LA + +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
+K + + +Y+ G + L G R IA ++ A+E +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-ARFYIA-ELTCAIESVH---KMGFI 123
Query: 292 HRDIKSSNILLDENFVAKLADFGLA----------------HASKDGSICFEPVNT---- 331
HRDIK NIL+D + KL DFGL H +D EP
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS---MEPSEEWSEI 180
Query: 332 ----------------------DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 369
+ GTP Y+ PE ++ T+ D +S GV+L E++
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240
Query: 370 R 370
+
Sbjct: 241 Q 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 211 FCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ 270
F ++ ++ H+H+V L G C+ E ++ E++ G L +H L+ + +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFK 109
Query: 271 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV-------AKLADFGLAHASKDGS 323
+A +A+AL YL D L H ++ + NILL + KL+D G+
Sbjct: 110 VAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ 166
Query: 324 ICFEPVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEI 366
C E + ++ PE V ++ L+ +D +S+G L EI
Sbjct: 167 ECVERIP--------WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 53/189 (28%), Positives = 85/189 (44%), Gaps = 31/189 (16%)
Query: 170 DNFST--IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGD---FCREIELLARLHH 223
D+F +IG+G FG V + + G + A+K ++K + F E ++L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 224 RHLVALRGFCIEKRERFLMYEYMANGSL-------KDHLHSPGRTPLSWQTRIQIAIDVA 276
R + L ++ +L+ +Y G L +D L P + + +AID
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL--PEDMARFYLAEMVLAIDSV 118
Query: 277 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG-LAHASKDGSICFEPVNTDIR- 334
+ L Y+H RDIK N+LLD+N +LADFG DG+ V +++
Sbjct: 119 HQLGYVH---------RDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-----VQSNVAV 164
Query: 335 GTPGYMDPE 343
GTP Y+ PE
Sbjct: 165 GTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 40/227 (17%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEG--DFCREIELLARLHHRHLVALRG 231
+IG+G +G V A G +A+K+++ + E V REI+LL L H +V ++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 232 FCI-----EKRERFLMYEYM---------ANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN 277
+ E ++ ++++E M AN L TP Q + +
Sbjct: 67 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDL---------TPEHHQFFL---YQLLR 114
Query: 278 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS--KDGSICFEPVNTDIRG 335
AL+Y+H + HRD+K NIL + + K+ DFGLA + + F TD
Sbjct: 115 ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW---TDYVA 168
Query: 336 TPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV 380
T Y PE + + T D++S G + E++T + + GKN+V
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVV 214
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 21/134 (15%)
Query: 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL 302
Y+ + +K+ L G L+ + VA +E+L HRD+ + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 303 DENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 354
+ + K+ DFGLA + SK + F PV +M PE + T S
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGST--FLPVK--------WMAPESIFDNLYTTLS 320
Query: 355 DVYSYGVVLLEIVT 368
DV+SYG++L EI +
Sbjct: 321 DVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 36/114 (31%), Positives = 56/114 (49%), Gaps = 21/114 (18%)
Query: 263 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA------ 316
LS+ + + VAN +E+L HRD+ + N+L+ E + K+ DFGLA
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 317 --HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
+ SK + F P+ +M PE + T SDV+S+G++L EI T
Sbjct: 293 SNYISKGST--FLPLK--------WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 61/241 (25%), Positives = 102/241 (42%), Gaps = 54/241 (22%)
Query: 170 DNFST--IIGQGGFGTVYKAQFSD-GSLIAVK---RMDKISEQVEGDFCREIELLARLHH 223
D+F + +IG+G FG V Q D G + A+K + D + ++ E ++L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 224 RHLVALRGFCIEKRERFLMYEYMANGSL------KDHLHSPGRTPLSWQTRIQIAIDVAN 277
+V + +KR +L+ E++ G + KD L S T + +AID +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTL-SEEATQF-YIAETVLAIDAIH 118
Query: 278 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL------AHASK---------DG 322
L ++H RDIK N+LLD KL+DFGL AH ++
Sbjct: 119 QLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169
Query: 323 SICFEPVNTDIR----------------GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEI 366
F+ +N+ + GTP Y+ PE + + D +S GV++ E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 367 V 367
+
Sbjct: 230 L 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 15/151 (9%)
Query: 223 HRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 281
H LV L C + R F + E+++ G L H+ + P R A +++ AL +
Sbjct: 55 HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLP-EEHARFYSA-EISLALNF 111
Query: 282 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR--GTPGY 339
LH + + +RD+K N+LLD KL D+G+ K+G P +T GTP Y
Sbjct: 112 LH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMC---KEG---IRPGDTTSTFCGTPNY 162
Query: 340 MDPEYVVTQELTEKSDVYSYGVVLLEIVTAR 370
+ PE + ++ D ++ GV++ E++ R
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 48/187 (25%), Positives = 71/187 (37%), Gaps = 24/187 (12%)
Query: 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVA 308
SL D L GR PL+ + +I L L HR KS NILL + +
Sbjct: 1 VSLADILEVRGR-PLNEE---EIWAVCLQCLGALRE------LHRQAKSGNILLTWDGLL 50
Query: 309 KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
KL DGS+ F+ R P +M PE + Q TEK+D+YS G+ L E +
Sbjct: 51 KL----------DGSVAFKTPEQS-RPDPYFMAPEVIQGQSYTEKADIYSLGITLYEAL- 98
Query: 369 ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQAR 428
+ E + + + + + + R+ +R C R Q R
Sbjct: 99 DYELPYN--EERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRR 156
Query: 429 PSIKQVL 435
+ L
Sbjct: 157 EAANHYL 163
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 21/159 (13%)
Query: 225 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI-AIDVANALEYLH 283
++V L + + + FL+ ++ G L H+ P + ++ A ++ AL+ LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP---EECVKRWAAEMVVALDALH 102
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 343
+ +C RD+ +NILLD+ +L F +D S E V Y PE
Sbjct: 103 R--EGIVC-RDLNPNNILLDDRGHIQLTYFSRWSEVED-SCDGEAVEN------MYCAPE 152
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES 382
E TE D +S G +L E++T GK LVE
Sbjct: 153 VGGISEETEACDWWSLGAILFELLT-------GKTLVEC 184
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 40/228 (17%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVK---RMDKISEQVEGDFCREIELLARLHHRHLVALR 230
+IG+G FG V Q D G + A+K + D + ++ G E ++L +V +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 231 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
+K +L+ E++ G + L T +T+ IA V A++ +H
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVL-AIDSIH---QLGF 122
Query: 291 CHRDIKSSNILLDENFVAKLADFGL------AHASK---------DGSICFEPVNTDIR- 334
HRDIK N+LLD KL+DFGL AH ++ F+ +N+ +
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 335 ---------------GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 367
GTP Y+ PE + + D +S GV++ E++
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 35/243 (14%)
Query: 170 DNFSTI--IGQGGFGTVYKAQFSDGSLI-AVKRMDK---ISEQVEGDFCREIELLARLHH 223
D+F I IG+G FG V + I A+K ++K + F E +L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 224 RHLVALRGFCIEKRERFLMYEYMANGSL-------KDHLHSPGRTPLSWQTRIQIAIDVA 276
+ + L ++ +L+ +Y G L +D L P + + +AI
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRL--PEDMARFYIAEMVLAIHSI 118
Query: 277 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG-LAHASKDGSICFEPVNTDIRG 335
+ L Y+H RDIK N+LLD N +LADFG ++DG++ ++ G
Sbjct: 119 HQLHYVH---------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV----QSSVAVG 165
Query: 336 TPGYMDPEYVVTQE-----LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE 390
TP Y+ PE + E + D +S GV + E++ ++LVE+ M E
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHE 224
Query: 391 SRL 393
R
Sbjct: 225 ERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 175 IIGQGGFGTVY---KAQFSD-GSLIAVKRMDK---ISEQVEGDFCR-EIELLARLHHRHL 226
++G G +G V+ K D G L A+K + K + + + R E ++L +
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 227 VALRGFCIEKRERF-LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHF 284
+ + + + L+ +Y+ G L HL R + +QI ++ ALE+LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLALEHLH- 122
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
+ +RDIK NILLD N L DFGL SK+ GT YM P+
Sbjct: 123 --KLGIIYRDIKLENILLDSNGHVVLTDFGL---SKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 345 VVTQELTEKS--DVYSYGVVLLEIVTA 369
V + D +S GV++ E++T
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVE---GDFCREIELLARLHHRHLV-ALR 230
+G G +G V A + G +A+K++ + + + RE+ LL + H +++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGLLD 81
Query: 231 GFC-IEKRERFLMYEYMANGSLKDHLHSPGRT-PLSWQTRIQIAI-DVANALEYLHFYCD 287
F E F Y+ + L++ + LS IQ + + L+Y+H
Sbjct: 82 VFTPASSLEDFQDV-YLVTHLMGADLNNIVKCQKLS-DDHIQFLVYQILRGLKYIH---S 136
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVV 346
+ HRD+K SNI ++E+ K+ DFGLA H + T T Y PE ++
Sbjct: 137 AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--------MTGYVATRWYRAPEIML 188
Query: 347 T-QELTEKSDVYSYGVVLLEIVTAR 370
+ D++S G ++ E++T +
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 50/218 (22%)
Query: 175 IIGQGGFGTVYKAQFSDGS-LIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGF- 232
IIG G FG VY+A D S +A+K++ + + RE+ ++ L+H +++ L+ +
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN----RELLIMKNLNHINIIFLKDYY 128
Query: 233 ---CIEKRER--FL----------MYEYMANGSLKDHLHSPGRTPL------SWQTRIQI 271
C +K E+ FL +++YM + + +H PL S+Q
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNH-----ALPLFLVKLYSYQ----- 178
Query: 272 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGSICFEPVN 330
+ AL Y+H +CHRD+K N+L+D N KL DFG A G +
Sbjct: 179 ---LCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232
Query: 331 TDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 367
+ Y PE ++ T D++S G ++ E++
Sbjct: 233 SRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 64/243 (26%), Positives = 99/243 (40%), Gaps = 54/243 (22%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDK----ISEQVEGDFCREIELLARLHHRHLVALR 230
+G G FG V A+ D +L A+K + K + QV E ++LA + +V L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQV-AHVKAERDILAEADNEWVVRLY 67
Query: 231 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
+K + + +Y+ G + L G P R IA ++ A+E +H
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL-ARFYIA-ELTCAVESVH---KMGF 122
Query: 291 CHRDIKSSNILLDENFVAKLADFGL------AHASK--------------------DGSI 324
HRDIK NIL+D + KL DFGL H SK D +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 325 C-----FEPVNT------------DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 367
C +P+ + GTP Y+ PE ++ T+ D +S GV+L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 368 TAR 370
+
Sbjct: 243 VGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (116), Expect = 6e-06
Identities = 53/244 (21%), Positives = 98/244 (40%), Gaps = 51/244 (20%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDK-----------ISEQVEGDFCREIELLARLHHR 224
IG G FG V+ L+ KR + + E+ + E+ ++ L H+
Sbjct: 21 IGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 225 HLVAL--RGFCIEKRERFLMYEYMANGSLKDHLHSPGRT--PLSWQTRIQIAIDVANALE 280
++V R ++ +++ E+ G L ++ + + + I + +AL
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 281 YLHFYCDPP----LCHRDIKSSNILLDENF-----------------VAKLADFGLAHAS 319
Y H D P + HRD+K NI L +AK+ DFGL+
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK-- 190
Query: 320 KDGSICFEPVNTDIRGTPGYMDPEYVV--TQELTEKSDVYSYGVVLLEIVTARRAVQDGK 377
+I E + GTP Y PE ++ T+ +KSD+++ G ++ E+ + +
Sbjct: 191 ---NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247
Query: 378 NLVE 381
N +
Sbjct: 248 NFSQ 251
|
Length = 1021 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 36/211 (17%)
Query: 176 IGQGGFGTV-YKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGF 232
+G G +GTV G+ +A+K++ + SE RE+ LL + H +++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 233 CI--EKRERF----LMYEYMAN--GSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLH 283
+RF L+ +M G L H LS + RIQ + + L+Y+H
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKH------EKLS-EDRIQFLVYQMLKGLKYIH 135
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG---TPGYM 340
+ HRD+K N+ ++E+ K+ DFGLA + ++++ G T Y
Sbjct: 136 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQT----------DSEMTGYVVTRWYR 182
Query: 341 DPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 370
PE ++ T+ D++S G ++ E++T +
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 8e-06
Identities = 38/155 (24%), Positives = 59/155 (38%), Gaps = 28/155 (18%)
Query: 222 HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 281
+ + + L + L+ +Y+ +G L D L G+ LS +I + AL
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEALND 124
Query: 282 LHFYCDPPLCHRDIKSSNILLDENFV-AKLADFGLAHASKDGSICFEPVNTDIRGTPG-- 338
LH + + H DIK N+L D L D+GL I GTP
Sbjct: 125 LHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK---------------IIGTPSCY 166
Query: 339 -----YMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
Y PE + D ++ GV+ E++T
Sbjct: 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 170 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGD----FCREIELLARLH 222
++F T+ IG+G FG V Q D G + A+K + K SE + D E ++LA
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLK-SEMFKKDQLAHVKAERDVLAESD 59
Query: 223 HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQ------TRIQIAIDVA 276
+V+L + + +L+ E++ G L L + + TR +A +
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML-------IKYDTFSEDVTRFYMA-ECV 111
Query: 277 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 316
A+E +H HRDIK NIL+D KL+DFGL+
Sbjct: 112 LAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 48/203 (23%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 174 TIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQV--EGDFCREIELLARLHHRHLVALR 230
+ +G G +G+V A G +AVK++ + + + RE+ LL + H +++ L
Sbjct: 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 231 G-FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHFYCDP 288
F + Y+ + L++ + +Q I + L+Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 139
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT- 347
+ HRD+K SN+ ++E+ K+ DFGLA + D T T Y PE ++
Sbjct: 140 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNW 192
Query: 348 QELTEKSDVYSYGVVLLEIVTAR 370
+ D++S G ++ E++T R
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 32/153 (20%), Positives = 52/153 (33%), Gaps = 28/153 (18%)
Query: 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH---HRHLV-ALR 230
++ G VY D + KI+ E RE E+ V +
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYVL-----KINPSREKGADREREVAILQLLARKGLPVPKVL 59
Query: 231 GFCIEKRERFLMYEYMANGSLKDHLHSPGRT--PLSWQTRIQIAIDVANALEYLH---FY 285
+L+ E++ G T +S + + IA +A L LH
Sbjct: 60 ASGESDGWSYLLMEWI-----------EGETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318
LCH D+ NIL+D+ + + D+ A
Sbjct: 109 V---LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 8/107 (7%)
Query: 261 TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320
PL + I + L YLH + HRD+K+ NI +++ + D G A
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP- 207
Query: 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 367
P + GT PE + + K+D++S G+VL E++
Sbjct: 208 ----VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 48/219 (21%)
Query: 175 IIGQGGFGTVY---KAQFSD-GSLIAVKRMDKI-------------SEQVEGDFCREIEL 217
++G G +G V+ K D G L A+K + K +E+ + R+
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 218 LARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW-QTRIQIAIDVA 276
L LH+ F E + L+ +Y++ G + HL+ R S + R ++
Sbjct: 67 LVTLHY-------AFQTEAKLH-LILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSG-EII 115
Query: 277 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA------HASKDGSICFEPVN 330
ALE+LH + +RDIK NILLD L DFGL+ + S C
Sbjct: 116 LALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC----- 167
Query: 331 TDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVT 368
GT YM PE + + K+ D +S G+++ E++T
Sbjct: 168 ----GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 174 TIIGQGGFGTVYKA-QFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALR 230
+G G +G+V A G +A+K++ + SE RE+ LL + H +++ L
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 231 GFCIEKRERFLMYE-YMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHFYCDP 288
+ Y+ ++ L PLS + ++Q + + L+Y+H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLS-EDKVQYLVYQMLCGLKYIH---SA 136
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVT 347
+ HRD+K N+ ++E+ K+ DFGLA HA + T T Y PE ++
Sbjct: 137 GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--------MTGYVVTRWYRAPEVILN 188
Query: 348 -QELTEKSDVYSYGVVLLEIVTAR 370
+ D++S G ++ E++T +
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 53/226 (23%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
+G G G V+ A SD +AVK++ Q REI+++ RL H ++V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ--IAIDVANALE------------ 280
+YE + T L+ +Q + D+AN LE
Sbjct: 67 -------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF 119
Query: 281 ---------YLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLA-----HASKDGSIC 325
Y+H + HRD+K +N+ ++ E+ V K+ DFGLA H S G +
Sbjct: 120 MYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176
Query: 326 FEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 370
V T Y P +++ T+ D+++ G + E++T +
Sbjct: 177 EGLV------TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 48/206 (23%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 176 IGQGGFGTVYKAQFSDGSLIA---VKRMD-KISEQVEGDFCREIELLARLHHRHLVALRG 231
IG G FG V ++ + +A VK + S + + +F ++ + L H +++ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPP 289
C+E L++EY G LK +L + Q + ++A ++A + ++H +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHA--SKDGSICFEPVNTDIRGTPGYMDPEYV-- 345
H D+ N L + K+ D+G+ + +D + +R ++ PE V
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WLAPELVGE 175
Query: 346 -----VTQELTEKSDVYSYGVVLLEI 366
+T E T+ S+V++ GV L E+
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 25/172 (14%)
Query: 214 EIELLARLHHRHLVALRG-FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA 272
E +L ++H ++ L+G F K ++ Y + L +L + + I+ +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRNIAICDILAIERS 190
Query: 273 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 332
V A++YLH + + HRDIK+ NI ++ L DFG A CF PV+ +
Sbjct: 191 --VLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAA--------CF-PVDIN 236
Query: 333 IR------GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV--QDG 376
GT PE + D++S G+VL E+ T ++ +DG
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288
|
Length = 391 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 60/242 (24%), Positives = 95/242 (39%), Gaps = 52/242 (21%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRM---DKISEQVEGDFCREIELLARLHHRHLVALRG 231
+G G FG V A D +L A+K + D ++ E ++LA + +V L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
+K + + +Y+ G + L P R IA ++ A+E +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFP-EVLARFYIA-ELTLAIESVH---KMGFI 123
Query: 292 HRDIKSSNILLDENFVAKLADFGL------AHASK----------------------DGS 323
HRDIK NIL+D + KL DFGL H SK
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNC 183
Query: 324 ICFEPVNT---------------DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
C + + T + GTP Y+ PE ++ + T+ D +S GV+L E++
Sbjct: 184 RCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLV 243
Query: 369 AR 370
+
Sbjct: 244 GQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 279 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF---EPVNTDIRG 335
L+YLH + HRDIK N+L++ N V K+ DFGLA + E V
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV------ 166
Query: 336 TPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTAR 370
T Y PE ++ ++ T D++S G + E++ R
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|225213 COG2334, COG2334, Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 24/108 (22%), Positives = 36/108 (33%), Gaps = 12/108 (11%)
Query: 212 CREI-ELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ 270
E+ +L RLH +ALRGF E+ E+ R
Sbjct: 124 LEELGRMLGRLH----LALRGFPFERPNALRRLEWDILEPRALLRL---DLVEPEDLRAA 176
Query: 271 IAIDVANALEYL--HF-YCDPPLCHRDIKSSNILLD-ENFVAKLADFG 314
+ + L L H + H D+ N+L D + V+ DF
Sbjct: 177 LLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFD 224
|
Length = 331 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMDK-ISEQVEGDFC-REIELLARLHHRHLVALRG- 231
IG G G V A G +AVK++ + Q RE+ LL ++H+++++L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 232 FCIEK-----RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 286
F +K ++ +L+ E M + +L +H L + + + +++LH
Sbjct: 89 FTPQKSLEEFQDVYLVMELM-DANLCQVIH----MELDHERMSYLLYQMLCGIKHLH--- 140
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 346
+ HRD+K SNI++ + K+ DFGLA + C + T T Y PE ++
Sbjct: 141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----CTNFMMTPYVVTRYYRAPEVIL 195
Query: 347 TQELTEKSDVYSYGVVLLEIV 367
E D++S G ++ E+V
Sbjct: 196 GMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 24/78 (30%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
+ HRD+K SNI++ + K+ DFGLA + S P T Y PE ++
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVV----TRYYRAPEVILGMG 201
Query: 350 LTEKSDVYSYGVVLLEIV 367
E D++S G ++ E++
Sbjct: 202 YKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 23/79 (29%), Positives = 38/79 (48%), Gaps = 5/79 (6%)
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 351
HRD+K SNI++ + K+ DFGLA + + T T Y PE ++
Sbjct: 141 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-----TPYVVTRYYRAPEVILGMGYK 195
Query: 352 EKSDVYSYGVVLLEIVTAR 370
E D++S G ++ E++
Sbjct: 196 ENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 21/216 (9%)
Query: 174 TIIGQG--GFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCR----EIELLARLHHRHL 226
T+IG+G TV A++ G + V+R++ E + E+ + +H ++
Sbjct: 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRIN--LEACTNEMVTFLQGELHVSKLFNHPNI 61
Query: 227 VALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 286
V R I E +++ +MA GS KD + + +S I V AL+Y+H
Sbjct: 62 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM- 120
Query: 287 DPPLCHRDIKSSNILLDEN---FVAKL-ADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 342
HR +K+S+IL+ + +++ L ++ + + + + + ++ P ++ P
Sbjct: 121 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP-WLSP 177
Query: 343 EYVVTQELT---EKSDVYSYGVVLLEIVTARRAVQD 375
E V+ Q L KSD+YS G+ E+ +D
Sbjct: 178 E-VLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 32/110 (29%), Positives = 49/110 (44%), Gaps = 17/110 (15%)
Query: 262 PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321
PL +A + +A++Y+H + HRDIK+ N+L++ L DFG A
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAA----- 307
Query: 322 GSICF------EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 365
CF P + I GT PE + T D++S G+V+ E
Sbjct: 308 ---CFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.002
Identities = 48/198 (24%), Positives = 87/198 (43%), Gaps = 16/198 (8%)
Query: 176 IGQGGFGTVYKAQFSDGSL---IAVKRMDK-ISEQVEGDFC-REIELLARLHHRHLVALR 230
IG G G V A D L +A+K++ + Q RE+ L+ ++H+++++L
Sbjct: 25 IGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 231 G-FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
F +K Y+ + +L + L + + + +++LH
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 139
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
+ HRD+K SNI++ + K+ DFGLA + S P T Y PE ++
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVV----TRYYRAPEVILGMG 194
Query: 350 LTEKSDVYSYGVVLLEIV 367
E D++S G ++ E+V
Sbjct: 195 YKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 17/46 (36%), Positives = 26/46 (56%), Gaps = 3/46 (6%)
Query: 271 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 316
I D+ LEY+H + + H DIK NI++D N + D+G+A
Sbjct: 131 IMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 518 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.28 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.15 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.06 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.97 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.86 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.78 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.75 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.73 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.54 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.49 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.47 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.38 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.36 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.32 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.28 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.17 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.14 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.08 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.01 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.0 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.99 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.98 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.9 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.89 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.87 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.86 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.65 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.53 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.38 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.28 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.14 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.07 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.07 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.93 | |
| PLN02236 | 344 | choline kinase | 96.75 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.73 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.62 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.6 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.42 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.3 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.24 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.23 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.18 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.1 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.89 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.88 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.74 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.44 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.07 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.02 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.86 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.48 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 94.48 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-59 Score=471.88 Aligned_cols=280 Identities=50% Similarity=0.857 Sum_probs=245.7
Q ss_pred cccccCHHHHHHHhhhhh--hhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeee
Q 010088 156 MFQKFSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC 233 (518)
Q Consensus 156 ~~~~~~~~~l~~a~~~f~--~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 233 (518)
....|++.++.+||++|+ ++||+|+||+||+|.+.+|..||||++.....+...+|.+|+++|++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456799999999999998 699999999999999999999999988765443145699999999999999999999999
Q ss_pred eecC-ceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEee
Q 010088 234 IEKR-ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLAD 312 (518)
Q Consensus 234 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 312 (518)
.+.+ +.+||||||++|+|.++|+.....+++|..|++||.++|+||+|||+.+.++|||||||++|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999 499999999999999999975543799999999999999999999998888999999999999999999999999
Q ss_pred ccccccCCC-CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccC-----CcchHHHHHHH
Q 010088 313 FGLAHASKD-GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQD-----GKNLVESAQVC 386 (518)
Q Consensus 313 fGla~~~~~-~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~-----~~~~~~~~~~~ 386 (518)
||||+.... ... ..+...||.+|+|||++..+..+.|+|||||||+|+||+||+++... ...+++|+...
T Consensus 221 FGLa~~~~~~~~~----~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 221 FGLAKLGPEGDTS----VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCcccCCccccc----eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 999976543 221 11111799999999999999999999999999999999999988763 23578888666
Q ss_pred HhhccccccccCCcCC-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 387 MASESRLAELVDPRIK-DSFDM-EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 387 ~~~~~~l~~~~d~~l~-~~~~~-~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
+... .+.+++|+.+. ..+.. +++..+..++.+|++.+|.+||+|.||++.|..
T Consensus 297 ~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~ 351 (361)
T KOG1187|consen 297 LEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG 351 (361)
T ss_pred HHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence 5554 89999999998 66664 789999999999999999999999999999844
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-50 Score=404.40 Aligned_cols=251 Identities=33% Similarity=0.534 Sum_probs=209.0
Q ss_pred hhhcceecceEEEEEEecCCcEEEEEEeccccc--hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC-ceEEEEEecCCC
Q 010088 173 STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISE--QVEGDFCREIELLARLHHRHLVALRGFCIEKR-ERFLMYEYMANG 249 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~~~g 249 (518)
.+.||+|+||+||+|.+.....||||++..... ...++|.+|+.+|.+++|||||+|+|+|.+.. ..++||||+++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 446999999999999996444499999975332 22568999999999999999999999999987 799999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-ceecccCCCcEEecCCC-cEEEeeccccccCCCCCcccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP-LCHRDIKSSNILLDENF-VAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-iiHrDlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~~ 327 (518)
+|.++|+......+++..+++|+.+||+||.||| +.+ |||||||++||||+.++ ++||+|||+++......
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~---- 198 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK---- 198 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc----
Confidence 9999998754567999999999999999999999 777 99999999999999997 99999999998765432
Q ss_pred cccccccCCCcccCccccc--cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVV--TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~--~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
...+...||+.|||||++. ...|+.|+||||||++||||+||+.||.+... .+.+....... .+...
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~----------~Rp~~ 267 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGG----------LRPPI 267 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcC----------CCCCC
Confidence 1234478999999999999 56999999999999999999999999987665 33332222111 11222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+..+...+..++..||+.||..||++.+++..|...
T Consensus 268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 223456789999999999999999999999998654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=381.58 Aligned_cols=258 Identities=29% Similarity=0.446 Sum_probs=215.5
Q ss_pred cCHHHHHHHhhhhhhhcceecceEEEEEEec-CCcEEEEEEecc-ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC
Q 010088 160 FSYKETKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR 237 (518)
Q Consensus 160 ~~~~~l~~a~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 237 (518)
.+..|+++ .+.||+|..|+|||++++ +++.+|+|.+.. ......+++.+|++++.+.+|||||.++|.|....
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 44455543 357999999999999987 588999999853 45566788999999999999999999999999998
Q ss_pred -ceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccc
Q 010088 238 -ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 316 (518)
Q Consensus 238 -~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla 316 (518)
...++||||++|||.+++...+ .+++...-+|+.+|++||.|||+ +++||||||||+|||++..|++||||||.+
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEecccccc
Confidence 4999999999999999998754 38999999999999999999994 389999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCC----cchHHHHHHHHhhccc
Q 010088 317 HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDG----KNLVESAQVCMASESR 392 (518)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~----~~~~~~~~~~~~~~~~ 392 (518)
+..... .....+||..|||||.+.+..|+.++||||||+.++|+++|+.|+... .+..+....+....
T Consensus 227 ~~lvnS------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p-- 298 (364)
T KOG0581|consen 227 GILVNS------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP-- 298 (364)
T ss_pred HHhhhh------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC--
Confidence 866543 346678999999999999999999999999999999999999999753 23333333222211
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 393 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 393 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.|.++.. ....++..++..||++||.+||+++|+++|.|...
T Consensus 299 -----pP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 299 -----PPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred -----CCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 1334433 23356999999999999999999999999987653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-49 Score=395.36 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=215.9
Q ss_pred HHHHHhhhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 164 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 164 ~l~~a~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
++.+....|.+.||+|.||.||.|.++....||+|.++... ...++|.+|+++|++|+|+|||+++|+|..++.++|||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 44445556788999999999999999877899999987643 33468999999999999999999999999989999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
|||++|+|.++|+..++..+...+.+.++.|||+||+||+ ++++|||||.++||||++++.+||+|||||+...++.
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 9999999999999866677999999999999999999999 9999999999999999999999999999999655443
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
.. ......-+..|.|||.+..+.++.|||||||||+||||+|-......+....+....+ ....+++
T Consensus 358 Y~---~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-e~GyRlp--------- 424 (468)
T KOG0197|consen 358 YT---ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-ERGYRLP--------- 424 (468)
T ss_pred ee---ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-hccCcCC---------
Confidence 21 2334445779999999999999999999999999999999544443455444444332 2233332
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+..++..+.++|..||+.+|++|||++.+...|...
T Consensus 425 -~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 425 -RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred -CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 2334557799999999999999999999888877553
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=371.45 Aligned_cols=252 Identities=27% Similarity=0.441 Sum_probs=205.3
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.||+|+||+||+|++. ++..||||.+.+. .....+....|+.+|+.++|||||+|++++..++..|||||||.|
T Consensus 14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g 93 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG 93 (429)
T ss_pred ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence 3456999999999999886 5899999998755 556667789999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC------CcEEEeeccccccCCCC
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN------FVAKLADFGLAHASKDG 322 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~------~~~kl~DfGla~~~~~~ 322 (518)
|+|.+||+.++ .+++.....++.|+|.||++|| +++||||||||.||||+.+ -.+||+|||+|+....+
T Consensus 94 GDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 94 GDLSDYIRRRG--RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 99999999865 4999999999999999999999 9999999999999999764 46899999999998876
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
. .....+|++-|||||++..++|+.|+|+||.|++||++++|+.||... ...+.... +.....+..
T Consensus 169 ~-----~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~-t~~eL~~~-~~k~~~~~~------- 234 (429)
T KOG0595|consen 169 S-----MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE-TPKELLLY-IKKGNEIVP------- 234 (429)
T ss_pred h-----HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc-CHHHHHHH-HhccccccC-------
Confidence 5 346788999999999999999999999999999999999999999643 33333322 121111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
..+......+.+++...++.++.+|-+..+-..+..-...
T Consensus 235 -~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 235 -VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred -chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 1111112234567777888888888887777666544433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=411.15 Aligned_cols=264 Identities=31% Similarity=0.480 Sum_probs=216.8
Q ss_pred CHHHHHHHhhhhhhhcceecceEEEEEEec------CCcEEEEEEeccccch-hHHHHHHHHHHHHHcCCCCeeeEeeee
Q 010088 161 SYKETKKATDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFC 233 (518)
Q Consensus 161 ~~~~l~~a~~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~ 233 (518)
...++.+....|.+.||+|.||.||+|+.. +...||||.+++.... ...+|.+|+++|..|+|||||+|+|.|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 344555556667889999999999999763 3468999999876554 778999999999999999999999999
Q ss_pred eecCceEEEEEecCCCCHHHHhcCCC--------CC----CCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEE
Q 010088 234 IEKRERFLMYEYMANGSLKDHLHSPG--------RT----PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 301 (518)
Q Consensus 234 ~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NIL 301 (518)
.+++..+||+|||..|||.+||...+ .. +|+..+.+.||.|||.||+||- ++.+|||||..+|+|
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCL 635 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhce
Confidence 99999999999999999999997422 22 3889999999999999999999 899999999999999
Q ss_pred ecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchH
Q 010088 302 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLV 380 (518)
Q Consensus 302 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~ 380 (518)
|.++..+||+||||++..-..+.. .......-..+||+||.+..++|+.+||||||||+|||++| |+.|+..-.+-
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYY--k~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~- 712 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYY--KVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ- 712 (774)
T ss_pred eccceEEEecccccchhhhhhhhh--cccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-
Confidence 999999999999999976544432 12223445789999999999999999999999999999998 77888643321
Q ss_pred HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 381 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 381 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+.... +. +..+ -..+..++.++.+||..||+.+|++||+++||-..|...
T Consensus 713 EVIe~-i~---------~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 713 EVIEC-IR---------AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred HHHHH-HH---------cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 21111 11 1122 244556678899999999999999999999999988654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=386.09 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=215.7
Q ss_pred hhhhhhcceecceEEEEEEe-cCCcEEEEEEecc---ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+...++||+|||++||+++. ..|..||+|++.+ ......+...+||++.+.|+|||||+++++|++.+..|||.|+
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLEL 99 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLEL 99 (592)
T ss_pred eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEe
Confidence 33456899999999999988 7899999999865 2345567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
|.+|+|.++++. +.++++.++..++.||+.||.||| +.+|||||||..|+||+++.++||+|||||.......
T Consensus 100 C~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-- 172 (592)
T KOG0575|consen 100 CHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-- 172 (592)
T ss_pred cCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc--
Confidence 999999999985 456999999999999999999999 9999999999999999999999999999998776432
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
......+||+.|+|||++....++..+||||+||+||-|+.|++||.. .++.+....+...+..++.
T Consensus 173 --Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y~~P~---------- 239 (592)
T KOG0575|consen 173 --ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEYSMPS---------- 239 (592)
T ss_pred --cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCccccc----------
Confidence 134667899999999999999999999999999999999999999963 4454555444444433332
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.......++|..+|+.||.+|||+++|+.+-++..
T Consensus 240 --~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 240 --HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred --ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 12234678999999999999999999999988744
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=372.32 Aligned_cols=259 Identities=26% Similarity=0.410 Sum_probs=209.0
Q ss_pred hhhhhhhcceecceEEEEEEe-cCCcEEEEEEecccc-----c--hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKIS-----E--QVEGDFCREIELLARLHHRHLVALRGFCIEKRERF 240 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 240 (518)
.+-.++.||+|+||.|-+|.. ++|+.||||++++.. . .......+|+++|++|+|||||++++++...+..|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 344567899999999999965 479999999986421 1 11233569999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC---CcEEEeeccccc
Q 010088 241 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN---FVAKLADFGLAH 317 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DfGla~ 317 (518)
|||||++||+|.+++-.++ .+.+....-+++|++.|+.||| +.||+||||||+|||+..+ ..+||+|||+|+
T Consensus 253 mVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999999999997654 3777778899999999999999 9999999999999999765 789999999999
Q ss_pred cCCCCCcccccccccccCCCcccCccccccCC---CCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccc
Q 010088 318 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE---LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 394 (518)
Q Consensus 318 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~ 394 (518)
..+++. .+...+||+.|.|||++.+.. +..++|+||+||+||-+++|.+||.+...-......+......+.
T Consensus 328 ~~g~~s-----fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~ 402 (475)
T KOG0615|consen 328 VSGEGS-----FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG 402 (475)
T ss_pred ccccce-----ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence 887654 457789999999999997654 334789999999999999999999865433322222222221111
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 010088 395 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM 445 (518)
Q Consensus 395 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~ 445 (518)
|.. ..+..++..++|.++|..||++||++.|+|+|.|....++
T Consensus 403 ----p~~----w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 403 ----PLQ----WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred ----Chh----hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 111 1234467889999999999999999999999999876554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=349.93 Aligned_cols=252 Identities=28% Similarity=0.437 Sum_probs=206.0
Q ss_pred hhhhhhcceecceEEEEEEe-cCCcEEEEEEec--cccchhHHHHHHHHHHHHHcCCCCeeeEeee-eeecCc-eEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF-CIEKRE-RFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~-~~~~~~-~~lV~e 244 (518)
+...++||+|+||+|||++. .+|..+|.|.+. ..+....++...|+.+|++|+|||||+++++ +.+..+ .++|||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 34456899999999999965 589999999876 3455667789999999999999999999994 444444 899999
Q ss_pred ecCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecccCCCcEEecCCCcEEEeeccccccCC
Q 010088 245 YMANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPP--LCHRDIKSSNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 245 ~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiHrDlk~~NILl~~~~~~kl~DfGla~~~~ 320 (518)
||.+|+|...++. ..+..+++..+++++.|++.||.++|+.- +. |+||||||.||+|+.+|.+||+||||++.+.
T Consensus 101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999863 34567999999999999999999999421 44 9999999999999999999999999999876
Q ss_pred CCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
.... .....+|||.||+||.+.+..|+.||||||+||++|||+.-+.||... ++.+....+-..+. |.
T Consensus 180 s~~t----fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~~KI~qgd~-------~~ 247 (375)
T KOG0591|consen 180 SKTT----FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLCKKIEQGDY-------PP 247 (375)
T ss_pred chhH----HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHHHHHHcCCC-------CC
Confidence 6542 456788999999999999999999999999999999999999999744 66665554332211 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI 437 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~ 437 (518)
+. +......+.+||..|+..|++.||+.-.++..
T Consensus 248 ~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 248 LP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred Cc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 11 23455678999999999999999985444443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=348.36 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=207.1
Q ss_pred hhcceecceEEEEEEecC-CcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 174 TIIGQGGFGTVYKAQFSD-GSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
.++|+|+||+|||++.++ |+.||||++.... ....+-.++|+++|++|+|+|+|.|+.+|..+..++||+|||+..-
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv 87 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV 87 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence 369999999999999874 8999999986433 3445567899999999999999999999999999999999999855
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCC-CCCcccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK-DGSICFEPV 329 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~-~~~~~~~~~ 329 (518)
|.++-+- ...++.....+++.|++.|+.|+| ++++|||||||+||||+.++.+||||||+|+... .+. .
T Consensus 88 L~eLe~~--p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-----~ 157 (396)
T KOG0593|consen 88 LHELERY--PNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-----N 157 (396)
T ss_pred HHHHHhc--cCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-----h
Confidence 5544333 234889999999999999999999 9999999999999999999999999999999876 333 4
Q ss_pred cccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhc-------------ccccc
Q 010088 330 NTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE-------------SRLAE 395 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~-------------~~l~~ 395 (518)
.+..+.|.+|.|||.+.+ .+|+..+||||.||++.||++|.+-|....++.+...+....+ ..+.-
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 577889999999999987 7899999999999999999999988876666555444322222 11111
Q ss_pred ccCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 396 LVDPRIKDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 396 ~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
+.-|.....-+ ......+++++..|++.||.+|++-+|++.|-++
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 11122111111 1223578999999999999999999999998876
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=388.41 Aligned_cols=268 Identities=25% Similarity=0.466 Sum_probs=221.8
Q ss_pred CCcccccCHHHHHHHhhhhh-----------hhcceecceEEEEEEec----CCcEEEEEEeccc-cchhHHHHHHHHHH
Q 010088 154 SPMFQKFSYKETKKATDNFS-----------TIIGQGGFGTVYKAQFS----DGSLIAVKRMDKI-SEQVEGDFCREIEL 217 (518)
Q Consensus 154 ~~~~~~~~~~~l~~a~~~f~-----------~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~ 217 (518)
....+.++|+|--.|..+|. ++||.|.||.||+|+++ ....||||.++.. .+....+|+.|+.|
T Consensus 604 k~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsI 683 (996)
T KOG0196|consen 604 KTYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASI 683 (996)
T ss_pred eeecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhh
Confidence 33455677776666665553 57999999999999986 2357999999853 45667899999999
Q ss_pred HHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCC
Q 010088 218 LARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 297 (518)
Q Consensus 218 l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~ 297 (518)
|.++.||||++|.|+....+..++|.|||+||+|+.||+.+.++ +++.+...++.+||.||+||- +.++|||||.+
T Consensus 684 MGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAA 759 (996)
T KOG0196|consen 684 MGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAA 759 (996)
T ss_pred cccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHh---hcCchhhhhhh
Confidence 99999999999999999999999999999999999999987765 999999999999999999999 99999999999
Q ss_pred CcEEecCCCcEEEeeccccccCCCCCcccccccccc--cCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCcccc
Q 010088 298 SNILLDENFVAKLADFGLAHASKDGSICFEPVNTDI--RGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQ 374 (518)
Q Consensus 298 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~ 374 (518)
+|||++.+..+|++||||++...++.. ...+.. .-..+|.|||.+...+++.++|||||||+|||+++ |.+||.
T Consensus 760 RNILVNsnLvCKVsDFGLSRvledd~~---~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW 836 (996)
T KOG0196|consen 760 RNILVNSNLVCKVSDFGLSRVLEDDPE---AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 836 (996)
T ss_pred hheeeccceEEEeccccceeecccCCC---ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence 999999999999999999998766541 122222 23679999999999999999999999999999876 889997
Q ss_pred CCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 375 DGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
+..+-.-. ..+..+.++ ..+.+++..|.+||.+||++|-.+||.+.||+..|..
T Consensus 837 dmSNQdVI--kaIe~gyRL----------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 837 DMSNQDVI--KAIEQGYRL----------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred ccchHHHH--HHHHhccCC----------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 65432111 112222232 2345667889999999999999999999999998854
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=357.23 Aligned_cols=258 Identities=30% Similarity=0.471 Sum_probs=206.8
Q ss_pred hhhhhcceecceEEEEEEecC-CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC--ceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR--ERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~e~~~ 247 (518)
...+.||+|+||+||++...+ |...|||.+........+.+.+|+.+|++++|||||+++|.....+ .++++|||++
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence 345689999999999998764 8999999887553333567899999999999999999999855555 5899999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-CCcEEEeeccccccCCCCCccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~ 326 (518)
+|+|.+++...+. .|++..+.+++.||++||+||| +++|+||||||+||||+. ++.+||+|||+++...... ..
T Consensus 100 ~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~-~~ 174 (313)
T KOG0198|consen 100 GGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG-TK 174 (313)
T ss_pred CCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc-cc
Confidence 9999999998776 6999999999999999999999 999999999999999999 7999999999998665311 11
Q ss_pred ccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
........||+.|||||++..+ ....++|||||||++.||+||+.||.+......+.... ..... -|.+....
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i-g~~~~-----~P~ip~~l 248 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI-GREDS-----LPEIPDSL 248 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH-hccCC-----CCCCCccc
Confidence 1234457899999999999864 33459999999999999999999997632222221111 11111 12333333
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
+ ....+++..|++.||++|||+.++|+|.+...+
T Consensus 249 s----~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 249 S----DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred C----HHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 3 457899999999999999999999999877654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=361.26 Aligned_cols=263 Identities=22% Similarity=0.364 Sum_probs=215.3
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhH-HHHHHHHHHHHHcC-CCCeeeEeeeeeecC-ceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVE-GDFCREIELLARLH-HRHLVALRGFCIEKR-ERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lV~e~ 245 (518)
|...+.||.|.||.||+|+-. .|..||||++++.-...+ ..=+||++.|++|+ ||||++|...+.+.+ .+++||||
T Consensus 12 Y~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~ 91 (538)
T KOG0661|consen 12 YTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEF 91 (538)
T ss_pred HHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHh
Confidence 445678999999999999754 689999999976544332 23478999999998 999999999999988 99999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
|+ .+|+++++.+ +.++++..++.|+.||+.||+|+| .+|+.|||+||+|||+..+..+||+||||||......
T Consensus 92 Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp-- 164 (538)
T KOG0661|consen 92 MD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP-- 164 (538)
T ss_pred hh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccCC--
Confidence 96 5999999987 668999999999999999999999 9999999999999999999999999999999776543
Q ss_pred cccccccccCCCcccCccccc-cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc------------
Q 010088 326 FEPVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR------------ 392 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~------------ 392 (518)
..+..+.|.+|.|||++. .+-|+.+.|+||+|||++||.+-++-|.+...+.+..+++-..+..
T Consensus 165 ---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 165 ---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred ---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 467888999999999885 5789999999999999999999998887666666666554332211
Q ss_pred ------cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 393 ------LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 393 ------l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
++......+..-.+ .......+++..|+..||.+|||+.|++++.+++..
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 11111111111111 245678999999999999999999999999987654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=351.22 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=206.0
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.++||+|+||+||.++.. .++.+|+|++++.. ....+...+|..+|.+++||.||+++..|++.+.+|||+||+
T Consensus 28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~ 107 (357)
T KOG0598|consen 28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL 107 (357)
T ss_pred eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence 34578999999999999765 58999999997532 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
.||.|..+|.+.+. +++..+.-++.+|+.||.||| +.+||||||||+|||||++|.++|+||||++..-...
T Consensus 108 ~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--- 179 (357)
T KOG0598|consen 108 NGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--- 179 (357)
T ss_pred CCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC---
Confidence 99999999987654 899999999999999999999 9999999999999999999999999999998654332
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
..+...+||+.|||||++.+..|+..+|.||+|+++|||++|.+||.. .+...+...+...... ....-.
T Consensus 180 -~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~~-------~~p~~l- 249 (357)
T KOG0598|consen 180 -DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKLP-------LPPGYL- 249 (357)
T ss_pred -CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcCC-------CCCccC-
Confidence 134567999999999999999999999999999999999999999974 4444444443322200 011111
Q ss_pred HHHHHHHHHHHHHccccCCCCCC----CHHHHHHHhhc
Q 010088 407 MEQLRTIVTIVRWCTQREGQARP----SIKQVLRILYE 440 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RP----s~~evl~~L~~ 440 (518)
.....+++...++.||++|. ++.+|-+|.++
T Consensus 250 ---s~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF 284 (357)
T KOG0598|consen 250 ---SEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFF 284 (357)
T ss_pred ---CHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccc
Confidence 24577899999999999995 56776666544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=358.66 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=213.3
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecc---ccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDK---ISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.|.++||+|+|++|++|+.. .++.||||++.+ ..+...+...+|-++|.+| .||.|++|+..|.+...+|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 347889999999999999765 589999999864 2334445677899999999 89999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|++||+|.++|++.+. |++.....++.+|+.||+||| +.|||||||||+|||||+|+.+||+|||-|+.+.....
T Consensus 155 ~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 155 YAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred ecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 9999999999998764 999999999999999999999 99999999999999999999999999999987654322
Q ss_pred c-----cccc----cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccc
Q 010088 325 C-----FEPV----NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE 395 (518)
Q Consensus 325 ~-----~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~ 395 (518)
. .... ...++||..|.+||.+..+..+..+|+|+|||+||+|+.|.+||...... ...+.++..+..+++
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-liFqkI~~l~y~fp~ 308 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-LIFQKIQALDYEFPE 308 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-HHHHHHHHhcccCCC
Confidence 1 1111 24588999999999999999999999999999999999999999765444 334444444333332
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 396 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 396 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.++ +.+.+|+.+.|..||.+|++.++|-+|.++.
T Consensus 309 --------~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~ 342 (604)
T KOG0592|consen 309 --------GFP----EDARDLIKKLLVRDPSDRLTSQQIKAHPFFE 342 (604)
T ss_pred --------CCC----HHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence 333 4577899999999999999999999998764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=365.37 Aligned_cols=258 Identities=27% Similarity=0.392 Sum_probs=218.8
Q ss_pred hhcceecceEEEEEEe-cCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHH
Q 010088 174 TIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK 252 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 252 (518)
.+||+|..|.||.|+. ..+..||||++........+-..+|+.+|+..+|+|||++++.+..++++|+|||||+||+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 4799999999999964 468899999998766666777899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccccc
Q 010088 253 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 332 (518)
Q Consensus 253 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 332 (518)
+.+... .+++.++..|+.+++.||+||| .++|+|||||.+|||++.+|.+||+|||+|....... .....
T Consensus 359 DvVt~~---~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~----~KR~T 428 (550)
T KOG0578|consen 359 DVVTKT---RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ----SKRST 428 (550)
T ss_pred hhhhcc---cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccccc----Ccccc
Confidence 999753 3899999999999999999999 9999999999999999999999999999998765433 24566
Q ss_pred ccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHH
Q 010088 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT 412 (518)
Q Consensus 333 ~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~ 412 (518)
.+||+.|||||++....|+.|.||||||++++||+-|.+||.++..+.....+.-... |.++ ........
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~--------P~lk--~~~klS~~ 498 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT--------PKLK--NPEKLSPE 498 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC--------CCcC--CccccCHH
Confidence 7899999999999999999999999999999999999999987766655544322221 2222 12233467
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCCcchhh
Q 010088 413 IVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQ 451 (518)
Q Consensus 413 l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~~ 451 (518)
+.+++.+||+.|+.+||+++|+|+|.+........++..
T Consensus 499 ~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ssL~p 537 (550)
T KOG0578|consen 499 LKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPESSLNP 537 (550)
T ss_pred HHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCHHHhHH
Confidence 999999999999999999999999988755444444433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=357.58 Aligned_cols=267 Identities=27% Similarity=0.386 Sum_probs=211.3
Q ss_pred hhhhcceecceEEEEEEe-cCCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEEEEEec
Q 010088 172 FSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMYEYM 246 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~ 246 (518)
-.++||+|.||.||||+. .+|+.||+|+++... +.......+||.+|++|+||||++|.+...+. ..+|||+|||
T Consensus 121 ki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM 200 (560)
T KOG0600|consen 121 KIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM 200 (560)
T ss_pred HHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc
Confidence 345899999999999975 479999999986433 44455678999999999999999999999887 6899999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++ +|..++...+ ..++..++..++.|++.||+|+| .++|+|||||.+|||||.+|.+||+|||||+.......
T Consensus 201 dh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~-- 273 (560)
T KOG0600|consen 201 DH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS-- 273 (560)
T ss_pred cc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCCC--
Confidence 88 9999987644 35999999999999999999999 99999999999999999999999999999997654432
Q ss_pred ccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc---------ccc--
Q 010088 327 EPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES---------RLA-- 394 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~---------~l~-- 394 (518)
...+..+-|.+|.|||.+.+ ..|+.++|+||.||||.||++|++.+.....+.+...++..-.. .++
T Consensus 274 -~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 274 -APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred -cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 23577788999999999987 57999999999999999999999988765555444333211111 111
Q ss_pred cccCCcCC--CCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCC
Q 010088 395 ELVDPRIK--DSF---DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMH 446 (518)
Q Consensus 395 ~~~d~~l~--~~~---~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~ 446 (518)
..+.+.-. ..+ ........++++..+|..||.+|.|+.++|+.-++..++..
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~ 409 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLP 409 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCC
Confidence 01111100 000 01112467889999999999999999999999888666544
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=349.45 Aligned_cols=268 Identities=22% Similarity=0.338 Sum_probs=214.9
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+++.++||.|..++||+|+.. .+..||||+++... ....+.+.+|+..++.++||||++++..|..+..+|+||.||.
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa 107 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA 107 (516)
T ss_pred eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence 456678999999999999874 57999999997433 2335789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+||+.++++..-...+++..+..|++++++||.||| .+|.||||||+.||||+++|.+||+|||......+......
T Consensus 108 ~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~ 184 (516)
T KOG0582|consen 108 GGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV 184 (516)
T ss_pred CCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence 999999998766667999999999999999999999 99999999999999999999999999998765443332111
Q ss_pred cccccccCCCcccCcccccc--CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.......||+.|||||++.. ..|+.|+||||||++..||.+|..||..-.........+-.. .+...-..+..+.
T Consensus 185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~---pp~~~t~~~~~d~ 261 (516)
T KOG0582|consen 185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND---PPTLLTSGLDKDE 261 (516)
T ss_pred EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC---CCCcccccCChHH
Confidence 11166789999999999654 469999999999999999999999998655443333332221 1111111111122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
.......+.+++..||+.||++|||+++++++-++...
T Consensus 262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 262 DKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred hhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 22334579999999999999999999999999877643
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=363.56 Aligned_cols=240 Identities=27% Similarity=0.470 Sum_probs=203.0
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHHHH
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDH 254 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 254 (518)
-||.|+.|.||+|++ .++.||||+++...+ .+|+-|++|+|+||+.|.|+|.....++||||||..|-|++.
T Consensus 131 WlGSGaQGAVF~Grl-~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 131 WLGSGAQGAVFLGRL-HNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhccCcccceeeeec-cCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 599999999999999 578999998764332 468889999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccccccc
Q 010088 255 LHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 334 (518)
Q Consensus 255 l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~ 334 (518)
|+.. .++.......|.++||.||.||| .+.|||||||+-||||+.+..+||+|||.++...+.. ....+.
T Consensus 203 Lka~--~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-----TkMSFa 272 (904)
T KOG4721|consen 203 LKAG--RPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-----TKMSFA 272 (904)
T ss_pred Hhcc--CccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhh-----hhhhhh
Confidence 9874 45888899999999999999999 8999999999999999999999999999998765543 345688
Q ss_pred CCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHH
Q 010088 335 GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIV 414 (518)
Q Consensus 335 gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~ 414 (518)
||..|||||++...+.++|+||||||||||||+||..||.+-... .+++..... .+.-..+..++.-+.
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVGsN-------sL~LpvPstcP~Gfk 341 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVGSN-------SLHLPVPSTCPDGFK 341 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEeccCC-------cccccCcccCchHHH
Confidence 999999999999999999999999999999999999999753322 122222222 122223334556688
Q ss_pred HHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 415 TIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 415 ~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
-+++.||+..|.+||++++++.||.....
T Consensus 342 lL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred HHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 89999999999999999999999976643
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=355.93 Aligned_cols=267 Identities=27% Similarity=0.431 Sum_probs=215.7
Q ss_pred HHHHHHhhhhhhhcceecceEEEEEEecCCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEE
Q 010088 163 KETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 163 ~~l~~a~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 241 (518)
+|.-+..-.|.++||+|-||.|..+....+..||||.++... .....+|.+|+++|.+|+||||++|+|+|..++.+++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 344444455678999999999999999888999999998654 4445899999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
|+|||++|+|.+||..+....+.-....+|+.|||.||+||. +.+++||||.++|+|++.++++||+|||+++..-.
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCccccccccc
Confidence 999999999999998765444566777889999999999999 89999999999999999999999999999997665
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh--CCccccCCc--chHHHHHHHHhhcccccccc
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT--ARRAVQDGK--NLVESAQVCMASESRLAELV 397 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t--G~~p~~~~~--~~~~~~~~~~~~~~~l~~~~ 397 (518)
+... ......+-..+|||+|.+..++++.++|||+||++|||+++ ...||.+.. ..++.....+.....-.-+.
T Consensus 690 g~yy--~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 690 GDYY--RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred CCce--eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence 5432 23334456789999999999999999999999999999865 567776432 22333333332222211111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
. +.-++..+.+++..||..|-++||+++++..+|.+.
T Consensus 768 ~-------P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 R-------PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred C-------CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2 223446788999999999999999999999988654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=355.46 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=200.4
Q ss_pred hhhhhhcceecceEEEEEEe------cCCcEEEEEEecccc-chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecC-ceE
Q 010088 170 DNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKR-ERF 240 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-~~~ 240 (518)
+.+.++||+|+||.||+|.+ .++..||||++.... ......+.+|+.+|.++ +||||++++++|...+ ..+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (338)
T cd05102 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM 88 (338)
T ss_pred ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence 45567899999999999974 235689999986432 23346799999999999 8999999999987654 578
Q ss_pred EEEEecCCCCHHHHhcCCC------------------------------------------------------------C
Q 010088 241 LMYEYMANGSLKDHLHSPG------------------------------------------------------------R 260 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~------------------------------------------------------------~ 260 (518)
+||||+++|+|.+++.... .
T Consensus 89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd05102 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK 168 (338)
T ss_pred EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence 9999999999999986421 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccccccCCCccc
Q 010088 261 TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 340 (518)
Q Consensus 261 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~ 340 (518)
.++++..+.+++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++........ .......++..|+
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~~~y~ 243 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGSARLPLKWM 243 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcch--hcccCCCCCcccc
Confidence 35889999999999999999999 899999999999999999999999999999865332211 1122345678899
Q ss_pred CccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHH
Q 010088 341 DPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRW 419 (518)
Q Consensus 341 aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~ 419 (518)
|||.+.+..++.++|||||||+||||++ |..||.............. ... .+.... .....+.+++..
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~------~~~~~~----~~~~~l~~li~~ 312 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK-DGT------RMRAPE----NATPEIYRIMLA 312 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh-cCC------CCCCCC----CCCHHHHHHHHH
Confidence 9999999999999999999999999997 8888865332222222211 111 111111 223468899999
Q ss_pred ccccCCCCCCCHHHHHHHhhcC
Q 010088 420 CTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 420 Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
||+.||++||++.++++.|...
T Consensus 313 cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 313 CWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=320.69 Aligned_cols=265 Identities=22% Similarity=0.300 Sum_probs=213.0
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
.++||+|.||.||+|+.. .|+.||||+++.. .+.......+||+.|+.++|+||+.+++++...+..-||+|||+.
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t- 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT- 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-
Confidence 457999999999999764 6999999998643 233345688999999999999999999999999999999999975
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|+..++... ..++..++..++.++++||+||| .+.|+||||||.|+|++++|.+||+|||||+....... .
T Consensus 86 dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~----~ 157 (318)
T KOG0659|consen 86 DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR----I 157 (318)
T ss_pred cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc----c
Confidence 9999998654 46999999999999999999999 99999999999999999999999999999998766542 2
Q ss_pred cccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc----ccc---cccCC--
Q 010088 330 NTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----RLA---ELVDP-- 399 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~----~l~---~~~d~-- 399 (518)
.+..+-|.+|.|||.+.+ ..|+..+|+||.||++.||+.|.+-+....++.+...++..-.. .++ .+.|.
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 344478999999998876 57999999999999999999887666665666555544332221 111 11110
Q ss_pred ------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCC
Q 010088 400 ------RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMH 446 (518)
Q Consensus 400 ------~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~ 446 (518)
...............+++..++..||.+|+++.|++++-++...|.+
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 01111222334557999999999999999999999999999876654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=363.14 Aligned_cols=258 Identities=25% Similarity=0.420 Sum_probs=209.2
Q ss_pred HhhhhhhhcceecceEEEEEEecC--C--cE-EEEEEecc---ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCce
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFSD--G--SL-IAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRER 239 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~~--g--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 239 (518)
....+.++||+|.||.||+|++.. + .. ||||..+. .......+|++|++++++++|||||+++|++..+...
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 334455789999999999998753 2 23 89998874 3456678899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccC
Q 010088 240 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 319 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~ 319 (518)
++|||+|.||+|.++|++.+. .++..++++++.++|.||+||| ++++|||||.++|+|++.++.+||+||||++..
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 999999999999999987654 5999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccC
Q 010088 320 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVD 398 (518)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d 398 (518)
..-. .......-..+|+|||.+....|+.++|||||||++||+++ |..|+.+.... +..+.+.....++
T Consensus 313 ~~~~----~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-~v~~kI~~~~~r~----- 382 (474)
T KOG0194|consen 313 SQYV----MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-EVKAKIVKNGYRM----- 382 (474)
T ss_pred ccee----eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-HHHHHHHhcCccC-----
Confidence 3111 11112246789999999999999999999999999999999 78888654443 3222221222111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCC
Q 010088 399 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 444 (518)
Q Consensus 399 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~ 444 (518)
..+...+..+..++..||..+|++||+|.++.+.+......
T Consensus 383 -----~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 383 -----PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred -----CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 12223445678889999999999999999999998765543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=340.43 Aligned_cols=256 Identities=29% Similarity=0.446 Sum_probs=197.7
Q ss_pred hhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHH--cCCCCeeeEeeeeeecC----ceEEEEEe
Q 010088 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLAR--LHHRHLVALRGFCIEKR----ERFLMYEY 245 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~e~ 245 (518)
+.++||+|+||.||||++. ++.||||++.. +..+.|..|-++.+. ++|+||++|+++-.... +++||++|
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 5678999999999999994 69999998864 445567777777665 58999999999866554 89999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhc------CCCCceecccCCCcEEecCCCcEEEeeccccccC
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY------CDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 319 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~ 319 (518)
.++|+|.++|..+ .++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||||..+
T Consensus 290 h~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 290 HPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred ccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 9999999999863 499999999999999999999963 4778999999999999999999999999999877
Q ss_pred CCCCcccccccccccCCCcccCccccccCC------CCccccchhhHHHHHHHHhCCccccC---------------Ccc
Q 010088 320 KDGSICFEPVNTDIRGTPGYMDPEYVVTQE------LTEKSDVYSYGVVLLEIVTARRAVQD---------------GKN 378 (518)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwS~Gvll~el~tG~~p~~~---------------~~~ 378 (518)
..+... ......+||.+|||||++.+.- .-.+.||||+|.|||||++....... ...
T Consensus 367 ~p~~~~--~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 367 EPGKPQ--GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred cCCCCC--cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 644321 2334578999999999996532 22468999999999999997544321 111
Q ss_pred hHHHHHHHHhhccccccccCCcCCCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 379 LVESAQVCMASESRLAELVDPRIKDSFD-MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 379 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~-~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
-.+..+.....+ ...|.+++..- ...+..+.+.+..||..|++.|.|+.=|-+++.+.
T Consensus 445 t~e~mq~~VV~k-----K~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 445 TLEEMQELVVRK-----KQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred CHHHHHHHHHhh-----ccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 122222222222 22333332221 14567899999999999999999998888877654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=360.58 Aligned_cols=265 Identities=26% Similarity=0.405 Sum_probs=208.0
Q ss_pred HHHHHHHhhhhhhhcceecceEEEEEEecCCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCce
Q 010088 162 YKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRER 239 (518)
Q Consensus 162 ~~~l~~a~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 239 (518)
+.|+......+.+.||+|+||+||+|+|. ..||||.++.. .....+.|++|+.+|++-+|.||+-|.|||.....
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 33444444445678999999999999995 36999998743 34466789999999999999999999999988766
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccC
Q 010088 240 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 319 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~ 319 (518)
.+|+-+|+|-+|+.+||... ..|+..+.+.||.|||.||.||| .++|||||||+.||+|.+++.+||+||||+...
T Consensus 463 AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 99999999999999999764 45999999999999999999999 999999999999999999999999999999754
Q ss_pred CCCCcccccccccccCCCcccCcccccc---CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccc
Q 010088 320 KDGSICFEPVNTDIRGTPGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL 396 (518)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~ 396 (518)
....- ........|...|||||+++. .+|+..+||||||+|+|||+||..||. ..+-.+.... ...+.-.++.
T Consensus 539 ~~w~g--~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifm-VGrG~l~pd~ 614 (678)
T KOG0193|consen 539 TRWSG--EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFM-VGRGYLMPDL 614 (678)
T ss_pred eeecc--ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEE-ecccccCccc
Confidence 32210 112233347889999999975 479999999999999999999999997 3222211110 1111111111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 397 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 397 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
.. ...++.+++.+|+..||..++++||.+.+|+..|.+...
T Consensus 615 s~------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 615 SK------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred hh------hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11 122455689999999999999999999999998876543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=352.77 Aligned_cols=245 Identities=28% Similarity=0.434 Sum_probs=211.1
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
..+.||+|+||.||||+.+ +.+.||+|.+.+. .+...+...+|++++++++||||+.++++|+...+.|+|.||+.|
T Consensus 6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g 85 (808)
T KOG0597|consen 6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG 85 (808)
T ss_pred HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh
Confidence 3468999999999999876 5789999998653 344567799999999999999999999999999999999999987
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
+|..+|...+. ++++.+..|+.++..||.||| +.+|+|||+||.||||+.++.+|+||||+|+....+. .
T Consensus 86 -~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t----~ 155 (808)
T KOG0597|consen 86 -DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT----S 155 (808)
T ss_pred -hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCc----e
Confidence 99999987554 999999999999999999999 9999999999999999999999999999999877654 3
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
..+.+.||+-|||||.+.+++|+..+|.||+||+|||+.+|++||.. ..+.+....+..+.... +..
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d~v~~------------p~~ 222 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKDPVKP------------PST 222 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcCCCCC------------ccc
Confidence 56778899999999999999999999999999999999999999963 34444444443322111 123
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
....+..++...+.+||..|.++.+++.|.+
T Consensus 223 ~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF 253 (808)
T KOG0597|consen 223 ASSSFVNFLQGLLIKDPAQRLTWTDLLGHPF 253 (808)
T ss_pred ccHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence 4466889999999999999999999999864
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=343.20 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=203.4
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
..+.||+|+||+||+|... +|+.||+|.+.... ......+.+|+.++.+++|+||+++++++.+.+..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence 3468999999999999874 68999999886432 2233468899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++.......
T Consensus 84 ~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05631 84 GGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---- 156 (285)
T ss_pred CCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----
Confidence 999999886544456999999999999999999999 8999999999999999999999999999998654332
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......||..|+|||.+.+..++.++|||||||++|||++|+.||............... +... .......
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----~~~~-~~~~~~~--- 227 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR----VKED-QEEYSEK--- 227 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH----hhcc-cccCCcc---
Confidence 123456899999999999999999999999999999999999999754332111111000 0000 0011112
Q ss_pred HHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhcC
Q 010088 408 EQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYES 441 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~~L~~~ 441 (518)
....+.+++..||+.||.+||+ ++++++|.+..
T Consensus 228 -~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~ 265 (285)
T cd05631 228 -FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265 (285)
T ss_pred -CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhc
Confidence 2346889999999999999997 89999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=341.50 Aligned_cols=243 Identities=24% Similarity=0.361 Sum_probs=198.5
Q ss_pred hhcceecceEEEEEEecCCcEEEEEEeccccch---hHHHHHHHHHHHHHcCCCCeeeEeeeeee----cCceEEEEEec
Q 010088 174 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ---VEGDFCREIELLARLHHRHLVALRGFCIE----KRERFLMYEYM 246 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~ 246 (518)
..||+|++|.||+|.+ +|+.||||+++..... ..+.|.+|+.+|.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 3699999999999998 7899999998754322 24678899999999999999999999877 34679999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
++|+|.+++... ..++|....+++.+++.||+||| . .+++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 999999999864 35899999999999999999999 5 488899999999999999999999999987653321
Q ss_pred cccccccccCCCcccCcccccc--CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .+........... +.+
T Consensus 178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-~~~~~~i~~~~~~------~~~-- 243 (283)
T PHA02988 178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-KEIYDLIINKNNS------LKL-- 243 (283)
T ss_pred -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCC------CCC--
Confidence 23458899999999976 6899999999999999999999999975432 2222222211111 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
+......+.+++.+||+.||++|||++++++.|..
T Consensus 244 --~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 244 --PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred --CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 11234568999999999999999999999998854
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=383.49 Aligned_cols=261 Identities=30% Similarity=0.500 Sum_probs=210.9
Q ss_pred HHHHHhhhhhhhcceecceEEEEEEecC--Cc----EEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec
Q 010088 164 ETKKATDNFSTIIGQGGFGTVYKAQFSD--GS----LIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEK 236 (518)
Q Consensus 164 ~l~~a~~~f~~~lG~G~~g~Vy~~~~~~--g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 236 (518)
++......|.+.||+|.||.||.|.+.+ |. .||||.+++. +.+...+|++|..+|++++|||||+++|+|.+.
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 3444555677899999999999998764 43 4999998764 466778999999999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHHhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEe
Q 010088 237 RERFLMYEYMANGSLKDHLHSPG-----RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA 311 (518)
Q Consensus 237 ~~~~lV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 311 (518)
...++++|||++|+|..||++.. ...++..+.+.++.+||+|+.||+ ++++|||||.++|+||+....+||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEc
Confidence 99999999999999999998641 345899999999999999999999 9999999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhc
Q 010088 312 DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASE 390 (518)
Q Consensus 312 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~ 390 (518)
|||||+........ .......-..+|||||.+..+.++.|+|||||||+|||++| |..||.+..+. +...... .+
T Consensus 845 DFGlArDiy~~~yy--r~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-~v~~~~~-~g 920 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYY--RKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-EVLLDVL-EG 920 (1025)
T ss_pred ccchhHhhhhchhe--eccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-HHHHHHH-hC
Confidence 99999965444322 11122344679999999999999999999999999999999 55666544333 2222112 22
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 391 SRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 391 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
++++ .+..++..+.++|..||+.+|++||++..+++.+...
T Consensus 921 gRL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 921 GRLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred CccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 2222 2234456788999999999999999999999966443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=351.81 Aligned_cols=251 Identities=24% Similarity=0.389 Sum_probs=210.8
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc----cc-hhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI----SE-QVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 242 (518)
+.+.+.||+|+||+|+.|... +|..||+|.+++. .. ...+.+.+|+.++++++ ||||++++.++......++|
T Consensus 19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~iv 98 (370)
T KOG0583|consen 19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIV 98 (370)
T ss_pred eeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEE
Confidence 445678999999999999764 6899999977542 11 33456778999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC-CcEEEeeccccccCC-
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASK- 320 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DfGla~~~~- 320 (518)
|||+.||+|.+++... ..+.+..+.+++.|++.|++|+| +++|+||||||+|||++.+ +++||+|||++....
T Consensus 99 mEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 99 MEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred EEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 9999999999999883 34888999999999999999999 9999999999999999999 999999999998773
Q ss_pred CCCcccccccccccCCCcccCccccccCC-CC-ccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccC
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQE-LT-EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD 398 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d 398 (518)
.+. .....+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||.+ .+.......+......+++.++
T Consensus 174 ~~~-----~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~~~p~~~~ 247 (370)
T KOG0583|consen 174 EDG-----LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEFKIPSYLL 247 (370)
T ss_pred CCC-----cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCccCCCCcC
Confidence 322 346778999999999999877 76 789999999999999999999987 3333444433333333333321
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 399 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 399 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
...+..++.+|+..||.+|+++.+++++.|...
T Consensus 248 -----------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 248 -----------SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -----------CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 245788999999999999999999999998886
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=344.55 Aligned_cols=246 Identities=22% Similarity=0.338 Sum_probs=202.2
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
+||+|+||.||+++.. +|+.||+|+++.. .......+.+|++++.+++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 6999999999999875 6899999998743 22334568899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 82 L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~----~~~ 152 (323)
T cd05571 82 LFFHLSRE--RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG----ATM 152 (323)
T ss_pred HHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC----Ccc
Confidence 99999764 35899999999999999999999 8999999999999999999999999999987532211 122
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 410 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 410 (518)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ........... ..+.... .
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~~~~~~--------~~~p~~~----~ 219 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEE--------IRFPRTL----S 219 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-HHHHHHHHcCC--------CCCCCCC----C
Confidence 345699999999999999999999999999999999999999965432 22222221111 1122222 3
Q ss_pred HHHHHHHHHccccCCCCCC-----CHHHHHHHhhcCC
Q 010088 411 RTIVTIVRWCTQREGQARP-----SIKQVLRILYESS 442 (518)
Q Consensus 411 ~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~~ 442 (518)
..+.+++.+||+.||++|| ++.++++|.+...
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 4578999999999999999 8999999887654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=325.21 Aligned_cols=265 Identities=21% Similarity=0.314 Sum_probs=210.4
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEEEEEecC
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMYEYMA 247 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~ 247 (518)
.+.|++|.||.||+|+.+ +++.||+|+++-.. ...--.-++||.+|.+++|||||.+..+.... +..|||||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 357999999999999875 58899999986432 22234568999999999999999999887643 57999999998
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+ +|..++.... +++...++.-+..|+++||+||| .+.|+|||||++|+|+++.|.+||+|||||+..+....
T Consensus 161 h-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k--- 232 (419)
T KOG0663|consen 161 H-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK--- 232 (419)
T ss_pred h-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCCcc---
Confidence 7 9999998754 57999999999999999999999 99999999999999999999999999999998876532
Q ss_pred cccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc----ccccccC----
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----RLAELVD---- 398 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~----~l~~~~d---- 398 (518)
..+..+.|.+|.|||.+.+. .|+...|+||+|||+.||+++++-|.....+.+..+++..-.. .++.+..
T Consensus 233 -~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 233 -PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred -cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 35677889999999999874 6999999999999999999999888766555554444322111 1111111
Q ss_pred ----------CcCCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCC
Q 010088 399 ----------PRIKDSFDME-QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMH 446 (518)
Q Consensus 399 ----------~~l~~~~~~~-~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~ 446 (518)
..++..|... ....-.+++...+..||.+|-|++|.|+|-|+...|.+
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence 1111112111 22567889999999999999999999999988876554
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=339.52 Aligned_cols=258 Identities=26% Similarity=0.445 Sum_probs=198.7
Q ss_pred hhhhhhcceecceEEEEEEecC-----------------CcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEee
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSD-----------------GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRG 231 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g 231 (518)
+.+.++||+|+||.||+|.+.+ +..||+|.+... ......+|.+|+++|.+++||||+++++
T Consensus 7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 86 (304)
T cd05096 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG 86 (304)
T ss_pred CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 4456789999999999997642 336999988653 2334567999999999999999999999
Q ss_pred eeeecCceEEEEEecCCCCHHHHhcCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecc
Q 010088 232 FCIEKRERFLMYEYMANGSLKDHLHSPG-----------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 294 (518)
Q Consensus 232 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrD 294 (518)
++.+.+..++||||+++|+|.+++.... ...++|..+.+++.||+.||+||| +.+|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH~d 163 (304)
T cd05096 87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRD 163 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccccC
Confidence 9999999999999999999999986421 124788999999999999999999 88999999
Q ss_pred cCCCcEEecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhC--Ccc
Q 010088 295 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA--RRA 372 (518)
Q Consensus 295 lk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG--~~p 372 (518)
|||+|||+++++.+||+|||+++........ .......++..|+|||++..+.++.++||||||+++|||+++ ..|
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYY--RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCcee--EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999865433211 122334567899999999888999999999999999999874 456
Q ss_pred ccCCcch--HHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 373 VQDGKNL--VESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 373 ~~~~~~~--~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
+...... .................. .+......+.+++.+||+.||++||++.+|.+.|.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLF-------RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhcccccccc-------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 6533221 111111111110000000 11122356899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=342.23 Aligned_cols=245 Identities=25% Similarity=0.349 Sum_probs=200.8
Q ss_pred cceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 176 IGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
||+|+||+||+|+.. ++..||+|.+... .......+.+|+.+|.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999876 5789999998642 233446788999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccc
Q 010088 252 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331 (518)
Q Consensus 252 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 331 (518)
.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~~ 151 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD----DKTN 151 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC----Cccc
Confidence 99997643 4899999999999999999999 8999999999999999999999999999987543221 1223
Q ss_pred cccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 010088 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR 411 (518)
Q Consensus 332 ~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 411 (518)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+.......... .+.... ..
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-~~~~~~~~~~~~~--------~~~~~~----~~ 218 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYRKILQEPL--------RFPDGF----DR 218 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-HHHHHHHHHcCCC--------CCCCcC----CH
Confidence 4569999999999999999999999999999999999999997543 2333332222111 111222 24
Q ss_pred HHHHHHHHccccCCCCCC---CHHHHHHHhhcCC
Q 010088 412 TIVTIVRWCTQREGQARP---SIKQVLRILYESS 442 (518)
Q Consensus 412 ~l~~li~~Cl~~dp~~RP---s~~evl~~L~~~~ 442 (518)
.+.+++..||+.||++|| ++.++++|.+...
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 578999999999999997 5788898877643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=382.24 Aligned_cols=263 Identities=27% Similarity=0.525 Sum_probs=212.4
Q ss_pred cCHHHHHHHhhhhhhhcceecceEEEEEEe-cCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCc
Q 010088 160 FSYKETKKATDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE 238 (518)
Q Consensus 160 ~~~~~l~~a~~~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 238 (518)
+++.++..+ ....++||+|+||.||+|+. .+|..||||+++..... ...|++.+++++|||||+++|+|.+.+.
T Consensus 683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 683 ITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 455555443 22346899999999999987 47899999988654322 2356889999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccccc
Q 010088 239 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318 (518)
Q Consensus 239 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~ 318 (518)
.++||||+++|+|.++++. ++|..+.+|+.|++.||+|||..++++|+||||||+||+++.++.+++. ||....
T Consensus 758 ~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred CEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 9999999999999999963 8999999999999999999997777899999999999999999988876 665543
Q ss_pred CCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccC----CcchHHHHHHHHhhccccc
Q 010088 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQD----GKNLVESAQVCMASESRLA 394 (518)
Q Consensus 319 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~----~~~~~~~~~~~~~~~~~l~ 394 (518)
... .....||..|||||++.+..++.++|||||||++|||+||+.|+.. .....+|.+.... .....
T Consensus 832 ~~~--------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 902 (968)
T PLN00113 832 LCT--------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS-DCHLD 902 (968)
T ss_pred ccc--------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC-ccchh
Confidence 211 1223688999999999999999999999999999999999999853 2345556554332 23345
Q ss_pred cccCCcCCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 395 ELVDPRIKDS--FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 395 ~~~d~~l~~~--~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
..+|+.+... .+.++...+.+++.+||+.||++||+|+||++.|....
T Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 5667766443 34567778999999999999999999999999997653
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=341.28 Aligned_cols=246 Identities=23% Similarity=0.342 Sum_probs=201.3
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
+||+|+||.||+++.. +|..||+|.++.. .......+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 6999999999999875 6899999998643 22334567889999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|..++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 82 L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~----~~ 152 (323)
T cd05595 82 LFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TM 152 (323)
T ss_pred HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC----cc
Confidence 999987543 5899999999999999999999 89999999999999999999999999999875322211 12
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 410 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 410 (518)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ........... .+...+ .
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~~~~~~~--------~~p~~~----~ 219 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEEI--------RFPRTL----S 219 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCC--------CCCCCC----C
Confidence 3456999999999999999999999999999999999999999654322 22222111111 112222 2
Q ss_pred HHHHHHHHHccccCCCCCC-----CHHHHHHHhhcCC
Q 010088 411 RTIVTIVRWCTQREGQARP-----SIKQVLRILYESS 442 (518)
Q Consensus 411 ~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~~ 442 (518)
..+.+++..||+.||++|| ++.++++|.+...
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 4578999999999999998 8999999877653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=346.64 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=204.3
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.+.||+|+||+||+|+.. +|+.||+|.+.... ......+.+|+.+|.+++||||+++++++.+.+..++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 345678999999999999886 58899999986422 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 100 VVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred CCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence 99999999997643 4889999999999999999999 8999999999999999999999999999998654322
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.... ............ +....
T Consensus 173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~--------~p~~~ 238 (329)
T PTZ00263 173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-RIYEKILAGRLK--------FPNWF 238 (329)
T ss_pred -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCCcC--------CCCCC
Confidence 2346899999999999999999999999999999999999999754432 222222111111 11112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhcCC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYESS 442 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~~L~~~~ 442 (518)
+ ..+.+++..||+.||.+||+ ++++++|.+...
T Consensus 239 ~----~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 239 D----GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred C----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 2 45789999999999999996 799999987653
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=347.73 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=200.9
Q ss_pred hhhhhhcceecceEEEEEEe------cCCcEEEEEEecccc-chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 241 (518)
+.+.+.||+|+||+||+|++ ..+..||||+++... ....+.+.+|+.+|..+ +||||++++++|.+.+..++
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 45678999999999999964 235689999986432 33446789999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCC--------------------------------------------------------------
Q 010088 242 MYEYMANGSLKDHLHSPG-------------------------------------------------------------- 259 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~-------------------------------------------------------------- 259 (518)
||||+++|+|.++++...
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 999999999999986421
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 260 -----------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 260 -----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
...++|..+++++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++........ .
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~--~ 271 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY--V 271 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc--c
Confidence 125789999999999999999999 899999999999999999999999999999865433211 1
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......++..|+|||.+.+..++.++|||||||++|||++ |..||............ +..... +....
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~-~~~~~~------~~~~~---- 340 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM-IKEGYR------MLSPE---- 340 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH-HHhCcc------CCCCC----
Confidence 1222345678999999999999999999999999999998 77787543322222221 111110 00111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.....+.+++.+||+.||++||++.+|++.|+.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 112468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=334.81 Aligned_cols=250 Identities=38% Similarity=0.610 Sum_probs=196.1
Q ss_pred hhhhcceecceEEEEEEec-----CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 172 FSTIIGQGGFGTVYKAQFS-----DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.||.|.||.||+|.+. .+..|+||.++.. .....+.|.+|++.+.+++||||++++|+|...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3467999999999999886 2578999999653 334468899999999999999999999999988889999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++|+|.++|+......+++..+.+|+.||+.||+||| +.+++|+||+++|||+++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 99999999998865567999999999999999999999 889999999999999999999999999999876322211
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
...........|+|||.+....++.++||||||+++|||++ |+.|+.+. +..+..... ...... .....
T Consensus 160 --~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~-~~~~~~------~~~~~ 229 (259)
T PF07714_consen 160 --KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKL-KQGQRL------PIPDN 229 (259)
T ss_dssp --EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHH-HTTEET------TSBTT
T ss_pred --cccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc-cccccc------eeccc
Confidence 12233457789999999999999999999999999999999 67887654 333333222 111111 11111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
....+.+++..||..+|++||++.++++.|
T Consensus 230 ----~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 230 ----CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 235688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=335.24 Aligned_cols=273 Identities=25% Similarity=0.378 Sum_probs=210.7
Q ss_pred cccccCHHHHHHHhhhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHc--CCCCeeeEeeee
Q 010088 156 MFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL--HHRHLVALRGFC 233 (518)
Q Consensus 156 ~~~~~~~~~l~~a~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~ 233 (518)
....+-.+...+.+..+.+.||+|.||.||+|+| .|+.||||++... .+..|.+|.++.... +|+||+.|++.-
T Consensus 199 SGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 199 SGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred CCchhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 3344555666666777788999999999999999 5899999998643 345688999998875 999999999986
Q ss_pred eecC----ceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCceecccCCCcEEecC
Q 010088 234 IEKR----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF-----YCDPPLCHRDIKSSNILLDE 304 (518)
Q Consensus 234 ~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~iiHrDlk~~NILl~~ 304 (518)
..+. .+|||.+|.++|||+|||.. ..++....++++..+|.||+|||. ..++.|.|||||+.|||+..
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 6543 67999999999999999986 459999999999999999999994 35788999999999999999
Q ss_pred CCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCC------CCccccchhhHHHHHHHHhC---------
Q 010088 305 NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE------LTEKSDVYSYGVVLLEIVTA--------- 369 (518)
Q Consensus 305 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwS~Gvll~el~tG--------- 369 (518)
++++.|+|+|||.................+||.+|||||++...- .-..+||||||+|+||++..
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 999999999999877665444444566788999999999986531 22468999999999999764
Q ss_pred -CccccCC----cchHHHHHHHHhhccccccccCCcCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 370 -RRAVQDG----KNLVESAQVCMASESRLAELVDPRIKDS-FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 370 -~~p~~~~----~~~~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+.||.+- .+..++ +... -.+-+.|.+... .+.+.+..+.++|+.||..+|..|-|+=.+-+.|.+.
T Consensus 432 y~~Pyyd~Vp~DPs~eeM-rkVV-----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 432 YQLPYYDVVPSDPSFEEM-RKVV-----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred hcCCcccCCCCCCCHHHH-hcce-----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 2444321 111111 1110 011122333322 2457789999999999999999999998887776543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=340.60 Aligned_cols=245 Identities=22% Similarity=0.352 Sum_probs=201.3
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
+||+|+||.||+++.. +|..||+|++... .......+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 6999999999999875 6899999998643 23344678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|..++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 82 L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~----~~~ 152 (328)
T cd05593 82 LFFHLSRE--RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA----ATM 152 (328)
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc----ccc
Confidence 99998754 35899999999999999999999 8999999999999999999999999999987532211 122
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 410 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 410 (518)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ........... ..+...++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-~~~~~~~~~~~--------~~~p~~~~---- 219 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMED--------IKFPRTLS---- 219 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-HHHHHHhccCC--------ccCCCCCC----
Confidence 345699999999999999999999999999999999999999965432 22222221111 11222222
Q ss_pred HHHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 411 RTIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 411 ~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
..+.+++.+||+.||++|| ++.++++|.+..
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~ 255 (328)
T cd05593 220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT 255 (328)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcC
Confidence 4578899999999999997 899999987764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=340.62 Aligned_cols=246 Identities=23% Similarity=0.318 Sum_probs=203.1
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||+||+|... +|+.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 83 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV 83 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence 34568999999999999876 68999999986422 233456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 84 PGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999999997643 5899999999999999999999 899999999999999999999999999998765432
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ............. +....
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~--------~~~~~- 221 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-FGIYEKILAGKLE--------FPRHL- 221 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCcC--------CCccC-
Confidence 1234689999999999998999999999999999999999999975432 2222222221111 11122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhcC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYES 441 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~~L~~~ 441 (518)
...+.+++.+||+.||.+||+ ++++++|.|..
T Consensus 222 ---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 258 (291)
T cd05612 222 ---DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258 (291)
T ss_pred ---CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence 245789999999999999995 99999988764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=337.19 Aligned_cols=256 Identities=28% Similarity=0.411 Sum_probs=212.0
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
+.||+|.||.||||... .++.||+|.+... .+...++..+|+.+|..++++||.+++|.+..+..+|++||||.||++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 57999999999999865 5889999999743 344567899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccc
Q 010088 252 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331 (518)
Q Consensus 252 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 331 (518)
.+.|.... .+++..+.-|+.+++.||.||| ..+.+|||||+.|||+..+|.+||+|||++........ ...
T Consensus 99 ~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~----rr~ 169 (467)
T KOG0201|consen 99 LDLLKSGN--ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK----RRK 169 (467)
T ss_pred hhhhccCC--CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh----ccc
Confidence 99998633 3577788889999999999999 89999999999999999999999999999987655432 236
Q ss_pred cccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 010088 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR 411 (518)
Q Consensus 332 ~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 411 (518)
..+||+.|||||++....|+.|+||||||++.+||++|.+|+.+-... ..-..+++-..|.+.+.+ ..
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--------rvlflIpk~~PP~L~~~~----S~ 237 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--------RVLFLIPKSAPPRLDGDF----SP 237 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc--------eEEEeccCCCCCcccccc----CH
Confidence 788999999999999889999999999999999999999999754331 111122333344454433 35
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCCcchh
Q 010088 412 TIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFV 450 (518)
Q Consensus 412 ~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~ 450 (518)
.+.+++..||+.||+.||++.++++|-+.......+.+.
T Consensus 238 ~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~L~ 276 (467)
T KOG0201|consen 238 PFKEFVEACLDKNPEFRPSAKELLKHKFIKRAKKTSELK 276 (467)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCchHHH
Confidence 699999999999999999999999987655543333333
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=332.50 Aligned_cols=254 Identities=20% Similarity=0.344 Sum_probs=202.0
Q ss_pred HhhhhhhhcceecceEEEEEEec----CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
..+.+.++||+|+||.||+|.+. .+..||+|.++... ......|.+|+.++.+++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 34556678999999999999764 35689999987542 33446799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+++|+|.+++.... ..++|..++.++.|++.||+||| +.+++||||||+|||++.++.+|++|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999997643 35899999999999999999999 899999999999999999999999999987654322
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||.+.... +..... .... ....
T Consensus 161 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-~~~~~~-~~~~------~~~~ 229 (266)
T cd05064 161 AIY---TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-DVIKAV-EDGF------RLPA 229 (266)
T ss_pred chh---cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHH-HCCC------CCCC
Confidence 111 1122345678999999999999999999999999999775 99998654322 222211 1110 1111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
. ......+.+++..||+.+|.+||+++++++.|..
T Consensus 230 ~----~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 230 P----RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred C----CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 1 1233568899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=339.93 Aligned_cols=246 Identities=23% Similarity=0.354 Sum_probs=200.0
Q ss_pred hhcceecceEEEEEEe----cCCcEEEEEEecccc----chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 174 TIIGQGGFGTVYKAQF----SDGSLIAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.||+|+||.||+++. .+++.||||.++... ......+.+|+++|+.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4799999999999975 357899999986421 22335678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++|+|.+++...+ .+.+..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-- 154 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence 99999999997643 4788899999999999999999 8999999999999999999999999999987533221
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ........... .+....
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-~~~~~~~~~~~--------~~~~~~ 223 (323)
T cd05584 155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-KTIDKILKGKL--------NLPPYL 223 (323)
T ss_pred --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-HHHHHHHcCCC--------CCCCCC
Confidence 1223456999999999999888999999999999999999999999754432 22222211111 111122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
...+.+++.+||+.||++|| ++.+++++.+..
T Consensus 224 ----~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~ 260 (323)
T cd05584 224 ----TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260 (323)
T ss_pred ----CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcC
Confidence 24578999999999999999 899999988764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=340.55 Aligned_cols=260 Identities=23% Similarity=0.325 Sum_probs=203.3
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
..+.||+|+||.||+++.. +|..+|+|.+... .......+.+|+++|.+++|+||+++++++...+..++||||+++|
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (331)
T cd06649 9 RISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 88 (331)
T ss_pred EEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence 3468999999999999876 5789999988643 2344567999999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP-PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
+|.+++.... .+++..+..++.|++.||+||| +. +|+||||||+|||+++++.+||+|||++.......
T Consensus 89 ~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----- 158 (331)
T cd06649 89 SLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----- 158 (331)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-----
Confidence 9999997643 4899999999999999999999 54 69999999999999999999999999987553321
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhh----ccccc----------
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS----ESRLA---------- 394 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~----~~~l~---------- 394 (518)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||..... .+........ .....
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-KELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhcccccccccCCccccCcccccc
Confidence 2345689999999999999999999999999999999999999964322 1211111000 00000
Q ss_pred ------------------c----ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 395 ------------------E----LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 395 ------------------~----~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
+ +................+.+++.+||+.||++||+++++++|.|....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0 000000000001123568999999999999999999999999887543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=340.25 Aligned_cols=245 Identities=22% Similarity=0.346 Sum_probs=200.2
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
+||+|+||+||+++.. +|..||+|.++.. .......+.+|++++..++|+||+++.+++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 6999999999999864 6899999998643 22334567889999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
|..++... ..+++..+..++.||+.||+||| + .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~----~ 152 (325)
T cd05594 82 LFFHLSRE--RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA----T 152 (325)
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc----c
Confidence 99998754 35899999999999999999999 6 7999999999999999999999999999875322211 1
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....||+.|+|||.+.+..++.++|||||||++|||+||+.||..... ............ .+....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-~~~~~~i~~~~~--------~~p~~~~--- 220 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEI--------RFPRTLS--- 220 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-HHHHHHHhcCCC--------CCCCCCC---
Confidence 2345699999999999999999999999999999999999999965432 222222211111 1122222
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 410 LRTIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
..+.+++.+||+.||++|+ ++.++++|.+..
T Consensus 221 -~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~ 256 (325)
T cd05594 221 -PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA 256 (325)
T ss_pred -HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcC
Confidence 4578899999999999996 999999988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=340.15 Aligned_cols=255 Identities=23% Similarity=0.315 Sum_probs=205.1
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||.||+|+.. +|+.||||+++... ......+.+|++++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV 83 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence 34568999999999999886 58899999986432 233456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 84 PGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 9999999997543 5899999999999999999999 89999999999999999999999999999975433
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+...........+. .+.... ..
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~---~~~~~~-~~ 226 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-NETWENLKYWKETLQ---RPVYDD-PR 226 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH-HHHHHHHHhcccccc---CCCCCc-cc
Confidence 12345699999999999999999999999999999999999999965432 222221111111111 111110 00
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
......+.+++..||+.+|.+||++++++++.+...
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 122356889999999999999999999999987653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=328.15 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=206.1
Q ss_pred HHhhhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 167 KATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 167 ~a~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
...+++.+.||+|++|.||+|.+.+++.||+|.++... ...++|.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 34456678999999999999998788899999986533 23567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++++|.+++.......++|..+..++.+++.||+||| +.+++||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence 9999999997655456899999999999999999999 899999999999999999999999999999866532210
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.......+..|+|||++.+..++.++||||||+++|||+| |+.|+......... ... ...... ..
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~-~~~~~~----------~~ 225 (261)
T cd05068 160 --AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL-QQV-DQGYRM----------PC 225 (261)
T ss_pred --ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHH-HcCCCC----------CC
Confidence 1122233468999999998999999999999999999999 88888643322111 111 111110 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
+......+.+++.+|++.+|.+||+++++++.|++
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11223568999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=333.65 Aligned_cols=261 Identities=21% Similarity=0.320 Sum_probs=201.5
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.||+|+||+||+|+.. ++..||||++... .....+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07848 4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE 83 (287)
T ss_pred eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence 34568999999999999886 5789999998643 23344678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
++.|..+... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 155 (287)
T cd07848 84 KNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN--- 155 (287)
T ss_pred CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc---
Confidence 8877665543 235899999999999999999999 89999999999999999999999999999986543321
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHh-------------hccccc
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMA-------------SESRLA 394 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~-------------~~~~l~ 394 (518)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||............... ......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 1123456899999999999889999999999999999999999999754433222211100 000000
Q ss_pred cccCCcCCCCC------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 395 ELVDPRIKDSF------DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 395 ~~~d~~l~~~~------~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
....+...... .......+.+++.+||+.||++|||++++++|.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~ 286 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA 286 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 00001110000 0112356899999999999999999999998865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=332.07 Aligned_cols=260 Identities=22% Similarity=0.312 Sum_probs=197.3
Q ss_pred hhhhhcceecceEEEEEEec--CCcEEEEEEecccc--chhHHHHHHHHHHHHHc---CCCCeeeEeeeeee-----cCc
Q 010088 171 NFSTIIGQGGFGTVYKAQFS--DGSLIAVKRMDKIS--EQVEGDFCREIELLARL---HHRHLVALRGFCIE-----KRE 238 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~~ 238 (518)
.+.+.||+|+||+||+|+.. +|..||+|.++... ......+.+|+.+++.+ +||||++++++|.. ...
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~ 83 (290)
T cd07862 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 83 (290)
T ss_pred ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCc
Confidence 45568999999999999863 46889999886432 22334567788887776 69999999999863 346
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccccc
Q 010088 239 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318 (518)
Q Consensus 239 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~ 318 (518)
.++||||+. ++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 84 LTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred EEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 899999996 69999997655556899999999999999999999 89999999999999999999999999999976
Q ss_pred CCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhc----cccc
Q 010088 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE----SRLA 394 (518)
Q Consensus 319 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~----~~l~ 394 (518)
..... ......||..|+|||.+.+..++.++|||||||++|||++|+.||................. ....
T Consensus 160 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 160 YSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred ccCCc-----ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 54321 23445689999999999888999999999999999999999999976544332222211100 0000
Q ss_pred c-------ccCCcCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 395 E-------LVDPRIKD---SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 395 ~-------~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
. ...+.... ....+....+.+++.+||+.||++||++.++++|.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~ 289 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence 0 00000000 000112245789999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=325.76 Aligned_cols=249 Identities=26% Similarity=0.461 Sum_probs=201.1
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
..+.+.||+|+||.||++++.++..+|+|.+... .....+|.+|+++|++++||||+++++++.+.+..++||||+++|
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG 84 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence 3455689999999999999988889999987643 233467899999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.++++... ..++|..++.++.+++.||+||| +.+|+||||||+||++++++.+||+|||+++........ .
T Consensus 85 ~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~---~ 157 (256)
T cd05114 85 CLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT---S 157 (256)
T ss_pred cHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee---c
Confidence 9999997543 25899999999999999999999 899999999999999999999999999998765432211 1
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+......... . ...+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-~~~~~~i~~~~-~---~~~~~~------- 225 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-YEVVEMISRGF-R---LYRPKL------- 225 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCC-C---CCCCCC-------
Confidence 122345678999999988899999999999999999999 8888864432 22222211111 1 111111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
....+.+++.+||+.+|++||++.++++.|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 124688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=317.52 Aligned_cols=232 Identities=25% Similarity=0.386 Sum_probs=199.9
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+...||.|+||.|.+++.+ +|..+|+|++++.. ....+...+|..+|+.+.||.++++.+.|.+....+|||||++
T Consensus 48 ~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~ 127 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVP 127 (355)
T ss_pred heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccC
Confidence 3457999999999999876 58899999997532 2334567899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
||-|..+|++.++ ++...+..+|.+|+.||+||| +.+|++|||||+|||||.+|.+||+|||+|+.....
T Consensus 128 GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----- 197 (355)
T KOG0616|consen 128 GGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----- 197 (355)
T ss_pred CccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-----
Confidence 9999999998554 999999999999999999999 999999999999999999999999999999876542
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
+...+||+.|+|||.+....++.++|.|||||++|||+.|.+||.+.... .....+...+-.++..+.
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-~iY~KI~~~~v~fP~~fs--------- 265 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-QIYEKILEGKVKFPSYFS--------- 265 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-HHHHHHHhCcccCCcccC---------
Confidence 45678999999999999999999999999999999999999999876664 444444444444443333
Q ss_pred HHHHHHHHHHHHccccCCCCC
Q 010088 408 EQLRTIVTIVRWCTQREGQAR 428 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~R 428 (518)
..+.+++...++.|-.+|
T Consensus 266 ---~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 266 ---SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---HHHHHHHHHHHhhhhHhh
Confidence 346679999999999999
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=347.85 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=201.4
Q ss_pred hhhhhhhcceecceEEEEEEec------CCcEEEEEEecccc-chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERF 240 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 240 (518)
.+.+.+.||+|+||.||+|+.. ++..||||+++... ......+.+|+++++.+ +|+||++++++|...+..+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 4456778999999999998742 34579999987533 33345688999999999 8999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCC-------------------------------------------------------------
Q 010088 241 LMYEYMANGSLKDHLHSPG------------------------------------------------------------- 259 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~------------------------------------------------------------- 259 (518)
+||||+++|+|.++++...
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 9999999999999985321
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccccc
Q 010088 260 -------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 332 (518)
Q Consensus 260 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 332 (518)
..++++..+++++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++........ .....
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~--~~~~~ 273 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY--VVKGN 273 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce--eeccC
Confidence 124788999999999999999999 899999999999999999999999999999765433211 11223
Q ss_pred ccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 010088 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR 411 (518)
Q Consensus 333 ~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 411 (518)
..++..|||||++.+..++.++|||||||++|||++ |+.||............. ... ..+...... ..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~-~~~------~~~~~~~~~----~~ 342 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV-KRG------YQMSRPDFA----PP 342 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH-Hcc------cCccCCCCC----CH
Confidence 345678999999998999999999999999999997 999986533222221111 111 011111111 25
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 412 TIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 412 ~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+.+++.+||+.||++||++.+|++.|.+.
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=342.98 Aligned_cols=248 Identities=21% Similarity=0.329 Sum_probs=203.4
Q ss_pred hhhhhhcceecceEEEEEEecC--CcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSD--GSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.+.+.||+|+||.||+|.+.+ +..||+|++... .......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 4456789999999999998653 368999988642 22334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 112 y~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 112 FVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 999999999997643 4899999999999999999999 899999999999999999999999999999765332
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......... +...
T Consensus 185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~~~i~~~~~~--------~p~~ 250 (340)
T PTZ00426 185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-YQKILEGIIY--------FPKF 250 (340)
T ss_pred -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-HHHHhcCCCC--------CCCC
Confidence 2345699999999999988899999999999999999999999976543322 2222111111 1112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcCC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS 442 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~~ 442 (518)
.+ ..+.+++.+|++.||++|+ +++++++|.|...
T Consensus 251 ~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 251 LD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred CC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 22 3477899999999999995 8999999987753
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=327.62 Aligned_cols=253 Identities=29% Similarity=0.436 Sum_probs=209.3
Q ss_pred hhhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.++||+|+||+||+|...++..+|+|.+.........++.+|+.+++.++|+||+++++++.+.+..++||||+++
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence 35566899999999999999988999999998766655567899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.++++......+++..+++++.+++.||+||| +.+++||||||+||++++++.+||+|||++........
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~---- 159 (261)
T cd05148 87 GSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY---- 159 (261)
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc----
Confidence 99999998765567999999999999999999999 89999999999999999999999999999976544321
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......++..|++||.+....++.++||||||+++|||++ |+.|+..... .+...... .... + ..+.
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-~~~~~~~~-~~~~------~----~~~~ 227 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-HEVYDQIT-AGYR------M----PCPA 227 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHH-hCCc------C----CCCC
Confidence 1223446778999999988899999999999999999998 7888854332 22222211 1101 1 1112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.....+.+++.+||+.||++||+++++++.|+.
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 233568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=346.52 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=209.2
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.||.|+-|.|-.|++. .|+.+|||.+.+.. ......+.+||-+|+-+.|||++++++++.+..++|+|.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 4567999999999999874 69999999997652 3334567899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+|-|.++|-..+ ++.+.++.+++.||+.|+.|+| ..+|+||||||+|+|||..+++||+|||+|.....+..
T Consensus 96 gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl--- 167 (786)
T KOG0588|consen 96 GGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL--- 167 (786)
T ss_pred CchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCcc---
Confidence 999999998755 4899999999999999999999 88999999999999999999999999999987766653
Q ss_pred cccccccCCCcccCccccccCCCC-ccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELT-EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
....+|.+.|.+||++.+.+|. .++||||+|||||.|+||+.||++ +++.............++. ..
T Consensus 168 --LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~MPs--------~I- 235 (786)
T KOG0588|consen 168 --LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFEMPS--------NI- 235 (786)
T ss_pred --ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCcccCCC--------cC-
Confidence 3567899999999999999985 689999999999999999999974 4443333332222222222 22
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..+..+++.+|+..||++|.|++||++|.+-.
T Consensus 236 ---s~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 236 ---SSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred ---CHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 24577899999999999999999999998654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=330.96 Aligned_cols=260 Identities=24% Similarity=0.318 Sum_probs=198.4
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.++||+|+||+||+|+.. ++..||+|.++... ......+.+|+.++++++|+||+++++++...+..++||||+++
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 87 (288)
T cd07871 8 VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS 87 (288)
T ss_pred eEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc
Confidence 34568999999999999875 68899999886432 23345678999999999999999999999999999999999975
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
+|.+++...+ ..+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 88 -~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~---- 158 (288)
T cd07871 88 -DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK---- 158 (288)
T ss_pred -CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc----
Confidence 9999986543 34789999999999999999999 89999999999999999999999999999975433221
Q ss_pred ccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc----ccc---------
Q 010088 329 VNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----RLA--------- 394 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~----~l~--------- 394 (518)
......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||.................. ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 1234568999999998865 56899999999999999999999999654322222111110000 000
Q ss_pred cccCCcCCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 395 ELVDPRIKDSF----DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 395 ~~~d~~l~~~~----~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
....+...... .........+++.+|++.||.+|||++|+++|.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~ 287 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence 01111110000 0011245789999999999999999999998865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.08 Aligned_cols=252 Identities=24% Similarity=0.400 Sum_probs=204.8
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
..+.+.||+|+||.||+|... .++.||+|.+... .....++.+|++++.+++|+||++++++|...+..++||||+++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 445678999999999999875 4889999988643 33356799999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|.+++.......+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||++.........
T Consensus 87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~--- 160 (263)
T cd05052 87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT--- 160 (263)
T ss_pred CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee---
Confidence 99999997655566999999999999999999999 899999999999999999999999999999866443211
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+... ...+........ ..+....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~-------~~~~~~~---- 228 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKG-------YRMERPE---- 228 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCC-------CCCCCCC----
Confidence 1122334678999999998999999999999999999998 88887543 333332222111 1111112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.....+.+++.+||+.+|++||++.++++.|..
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 223568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=329.10 Aligned_cols=254 Identities=26% Similarity=0.469 Sum_probs=202.7
Q ss_pred hhhhhhcceecceEEEEEEecC------CcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSD------GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
+.+.+.||+|+||.||+|.... ...||+|.+.... ......|.+|+.++.+++|+||+++++++...+..+++
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 3456789999999999997643 2579999886433 33456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcE
Q 010088 243 YEYMANGSLKDHLHSPGR--------------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVA 308 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 308 (518)
|||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+++||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCcE
Confidence 999999999999975321 45889999999999999999999 8999999999999999999999
Q ss_pred EEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHH
Q 010088 309 KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCM 387 (518)
Q Consensus 309 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~ 387 (518)
||+|||+++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .+......
T Consensus 164 ~L~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-~~~~~~i~ 240 (283)
T cd05048 164 KISDFGLSRDIYSADYY--RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-QEVIEMIR 240 (283)
T ss_pred EECCCcceeeccccccc--cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHH
Confidence 99999999765332211 12233456889999999998899999999999999999998 9989864332 22222111
Q ss_pred hhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 388 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 388 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
. . . ....+......+.+++.+||+.||.+||++.+|+++|..
T Consensus 241 ~-~-~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 S-R-Q---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred c-C-C---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 1 0 011122334678999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=326.13 Aligned_cols=252 Identities=25% Similarity=0.417 Sum_probs=204.2
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..+++|||+++|
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKG 86 (261)
T ss_pred eEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCC
Confidence 34557899999999999998888899999876433 23567999999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.++++......+++..++.++.+++.||+||| +.+++||||||+||++++++.+||+|||++......... .
T Consensus 87 ~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~---~ 160 (261)
T cd05072 87 SLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT---A 160 (261)
T ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCcee---c
Confidence 9999997655556899999999999999999999 899999999999999999999999999999865443211 1
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
.....++..|+|||++....++.++||||||+++|||+| |+.||...... ...... .... .......
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~~~-~~~~------~~~~~~~---- 228 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-DVMSAL-QRGY------RMPRMEN---- 228 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-HHHHHH-HcCC------CCCCCCC----
Confidence 223346778999999988889999999999999999998 88888643222 111111 1111 1111112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
....+.+++.+||..+|++||+++++.+.|+.
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 229 CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 22458899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=330.12 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=203.7
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
..++||+|+||+||++... +++.||||.+.... ......+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05605 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccC
Confidence 4568999999999999875 68999999986432 2233567889999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05605 84 GGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---- 156 (285)
T ss_pred CCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----
Confidence 999999987654556999999999999999999999 8999999999999999999999999999987654332
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||............... +.. ....++.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~----~~~-----~~~~~~~ 226 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR----VKE-----DQEEYSE 226 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH----hhh-----cccccCc
Confidence 123346899999999999889999999999999999999999999754322111111000 000 0011112
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 408 EQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
.....+.+++..||+.||.+|| ++++++++.+..
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~ 265 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCcc
Confidence 2335688999999999999999 899999987664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=328.18 Aligned_cols=256 Identities=29% Similarity=0.477 Sum_probs=205.1
Q ss_pred HHhhhhhhhcceecceEEEEEEecC------CcEEEEEEeccccch-hHHHHHHHHHHHHHcCCCCeeeEeeeeeecCce
Q 010088 167 KATDNFSTIIGQGGFGTVYKAQFSD------GSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIEKRER 239 (518)
Q Consensus 167 ~a~~~f~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 239 (518)
..++.+.+.||+|+||.||+|+..+ +..||||.++..... ....|.+|+++|++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3456677899999999999997643 478999998754433 457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc
Q 010088 240 FLMYEYMANGSLKDHLHSPG------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV 307 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 307 (518)
++||||+++|+|.+++...+ ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence 99999999999999997532 245889999999999999999999 899999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHH
Q 010088 308 AKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVC 386 (518)
Q Consensus 308 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~ 386 (518)
+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... +.....
T Consensus 161 ~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-~~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-EVIECI 237 (280)
T ss_pred EEECCcccceecccCcce--ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHH
Confidence 999999998754332211 11233446789999999999999999999999999999999 99998644322 222211
Q ss_pred HhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 387 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 387 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
. ..... .. +......+.+++..||+.||++||++.||++.|.
T Consensus 238 ~--~~~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T--QGRLL-----QR----PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H--cCCcC-----CC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 11111 01 1122356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=338.86 Aligned_cols=249 Identities=29% Similarity=0.370 Sum_probs=194.7
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.||+|+||+||+|+.. +|+.||||.+... .......+.+|++++++++|+||+++++++.+.+..++||||+++|
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 4568999999999999875 6899999998643 2334567899999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+.. ..++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++....... .
T Consensus 158 ~L~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~----~ 224 (353)
T PLN00034 158 SLEGTH------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD----P 224 (353)
T ss_pred cccccc------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc----c
Confidence 986532 2567788899999999999999 89999999999999999999999999999986543211 1
Q ss_pred cccccCCCcccCcccccc-----CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 330 NTDIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.....||..|+|||.+.. ...+.++|||||||++|||++|+.||..... .++......... ...+....
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-~~~~~~~~~~~~----~~~~~~~~- 298 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-GDWASLMCAICM----SQPPEAPA- 298 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-ccHHHHHHHHhc----cCCCCCCC-
Confidence 234569999999998743 2345689999999999999999999963221 111111100000 00111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.....+.+++.+||+.||++||++.|+++|.|...
T Consensus 299 ---~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 299 ---TASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred ---ccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 22356889999999999999999999999987654
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=335.23 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=202.9
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.++..++||+|+||.||++... +|..+|+|.+... .......+.+|++++++++|+||++++++|.+.+..++||||+
T Consensus 6 ~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (333)
T cd06650 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (333)
T ss_pred hhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecC
Confidence 3445678999999999999886 5788999987643 3334567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
++|+|.+++...+ .+++..+..++.+++.||+||| + .+|+||||||+|||+++++.+||+|||++......
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 86 DGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 9999999997643 4889999999999999999999 5 47999999999999999999999999998754322
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHh-hccccccc--------
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMA-SESRLAEL-------- 396 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~-~~~~l~~~-------- 396 (518)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ........ ........
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK-ELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh-HHHHHhcCcccCCccccccCcccCC
Confidence 123456899999999999889999999999999999999999998643221 11100000 00000000
Q ss_pred -------cCCcCC-----------------CCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 397 -------VDPRIK-----------------DSFD-MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 397 -------~d~~l~-----------------~~~~-~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
..+..+ .... ......+.+++.+||+.||++||+++|++++.+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000000 0000 0112458899999999999999999999999876543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=331.25 Aligned_cols=264 Identities=23% Similarity=0.289 Sum_probs=201.6
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.+.||+|+||+||+|+.. +|+.||||.+.... ......+.+|+.++++++|+||+++++++.+.+..++||||+.
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 344568999999999999876 68899999986433 2223467899999999999999999999999999999999995
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 87 -~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 157 (303)
T cd07869 87 -TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS---- 157 (303)
T ss_pred -cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC----
Confidence 68888886543 35889999999999999999999 8999999999999999999999999999987543221
Q ss_pred cccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc-----cccc-----
Q 010088 328 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR-----LAEL----- 396 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~-----l~~~----- 396 (518)
.......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....+.............. ....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 12234568999999998865 458899999999999999999999997654443332222110000 0000
Q ss_pred cCCc-CCC--CCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 397 VDPR-IKD--SFDM-------EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 397 ~d~~-l~~--~~~~-------~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.++. ... .... .....+.+++..||+.||++|||++|+++|.++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 0000 000 0000 01245779999999999999999999999988754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=325.01 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=214.2
Q ss_pred HHHhhhhhhhcceecceEEEEEEe-cCCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEE
Q 010088 166 KKATDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 166 ~~a~~~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 241 (518)
.+..++|.+.||+|.||.|-+|.. ..|+.||||.+++. +++..-.+.+||++|+.|+||||+.++.+|..++...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 345677888999999999999965 67999999998754 34445568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||..+|.|++|+.+.+ .|++.+...++.||..|+.|+| .++++|||||.+|||||+|+++||+||||+-...+
T Consensus 131 vMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999998755 4999999999999999999999 99999999999999999999999999999988776
Q ss_pred CCcccccccccccCCCcccCccccccCCCC-ccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELT-EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
+. ..+.++|++-|.+||++.+.+|. +.+|-|||||+||-|+.|..||+ +.+....++.+.....+ .|.
T Consensus 206 ~k-----fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD-G~Dhk~lvrQIs~GaYr-----EP~ 274 (668)
T KOG0611|consen 206 KK-----FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD-GRDHKRLVRQISRGAYR-----EPE 274 (668)
T ss_pred cc-----HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC-CchHHHHHHHhhccccc-----CCC
Confidence 65 34678999999999999998874 78999999999999999999995 55555555444333221 121
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
- +....-+|+|||-.+|++|-|+.+|..|-|..
T Consensus 275 ~--------PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 275 T--------PSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred C--------CchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 1 12355699999999999999999999997653
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=336.59 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=199.7
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+||+|+||+||+|+.. +|+.||+|.+... .......+..|.+++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 6999999999999876 4789999998643 223345678899999877 7999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|..++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~----~ 152 (321)
T cd05591 82 DLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----T 152 (321)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc----c
Confidence 9999987543 4899999999999999999999 89999999999999999999999999999875432211 2
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+........... .....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-~~~~~~i~~~~~~--------~p~~~~--- 220 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESILHDDVL--------YPVWLS--- 220 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCCC--------CCCCCC---
Confidence 2345689999999999999999999999999999999999999975432 2322222221111 111122
Q ss_pred HHHHHHHHHHccccCCCCCC-------CHHHHHHHhhcC
Q 010088 410 LRTIVTIVRWCTQREGQARP-------SIKQVLRILYES 441 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RP-------s~~evl~~L~~~ 441 (518)
..+.+++..||+.||++|| ++.+++++.+..
T Consensus 221 -~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~ 258 (321)
T cd05591 221 -KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFK 258 (321)
T ss_pred -HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccC
Confidence 4578999999999999999 899999988763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=325.14 Aligned_cols=245 Identities=27% Similarity=0.376 Sum_probs=194.5
Q ss_pred cceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 176 IGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
||+|+||+||+++.. +|+.||+|.+.... ......+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 58999999886321 22234566799999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccc
Q 010088 252 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331 (518)
Q Consensus 252 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 331 (518)
.+++.......+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++....... ...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-----~~~ 152 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-----TIT 152 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----eee
Confidence 99987665667999999999999999999999 8999999999999999999999999999987654432 123
Q ss_pred cccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 010088 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR 411 (518)
Q Consensus 332 ~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 411 (518)
...|+..|+|||++.+..++.++|||||||++|||++|+.||............... .+...... .... ...
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~-~~~~----~~~ 224 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR---TLEDEVKF-EHQN----FTE 224 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHH---hhcccccc-cccc----CCH
Confidence 346899999999999888999999999999999999999998643321111111000 00000000 0011 234
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 010088 412 TIVTIVRWCTQREGQARPSIKQVLR 436 (518)
Q Consensus 412 ~l~~li~~Cl~~dp~~RPs~~evl~ 436 (518)
.+.+++..||+.||++||+++|+++
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccchh
Confidence 5889999999999999999966553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=336.59 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=199.2
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+||+|+||+||+|+.. +++.||||.+... .......+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 6999999999999875 5789999998643 223445678899999887 6999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~----~~ 152 (320)
T cd05590 82 DLMFHIQKSR--RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KT 152 (320)
T ss_pred hHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC----Cc
Confidence 9999987643 4899999999999999999999 8999999999999999999999999999987532221 12
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+........... .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-~~~~~~i~~~~~~--------~~~~~---- 219 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAILNDEVV--------YPTWL---- 219 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-HHHHHHHhcCCCC--------CCCCC----
Confidence 2345699999999999999999999999999999999999999975432 2222222221111 11112
Q ss_pred HHHHHHHHHHccccCCCCCCCH------HHHHHHhhcC
Q 010088 410 LRTIVTIVRWCTQREGQARPSI------KQVLRILYES 441 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~------~evl~~L~~~ 441 (518)
...+.+++..||+.||++||++ +++++|.+..
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~ 257 (320)
T cd05590 220 SQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFK 257 (320)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcC
Confidence 2457899999999999999998 8888887664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=326.86 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=199.4
Q ss_pred cceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 176 IGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
||+|+||+||++... +|+.||+|.+.... ....+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 68899999986432 22335678899999999999999999999999999999999999999
Q ss_pred HHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 252 KDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 252 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++.....+.. .
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----~ 153 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----K 153 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc----c
Confidence 9887532 2346899999999999999999999 89999999999999999999999999999976544321 1
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.............. ....... .++...
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~-------~~~~~~~--~~~~~~ 224 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-------RILNDSV--TYPDKF 224 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH-------hhcccCC--CCcccC
Confidence 2345689999999999999999999999999999999999999965432211111000 0000000 111223
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 410 LRTIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
...+.+++..||+.||++|| +++++++|.|..
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~ 261 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFR 261 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhh
Confidence 35688999999999999999 789999987764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=333.78 Aligned_cols=246 Identities=23% Similarity=0.342 Sum_probs=197.9
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
++||+|+||.||+|+.. +|..||+|.++... ......+..|..++..+ +|+||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999876 58899999986432 23345567788888765 899999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|..++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~ 151 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD----N 151 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC----C
Confidence 9999999764 34899999999999999999999 8999999999999999999999999999987432221 1
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
......||..|+|||.+.+..++.++|||||||++|||++|+.||..... .+........ .+.+....+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-~~~~~~~~~~--------~~~~~~~~~-- 220 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRVD--------TPHYPRWIT-- 220 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhC--------CCCCCCCCC--
Confidence 23446799999999999999999999999999999999999999965432 2222222111 111222222
Q ss_pred HHHHHHHHHHHccccCCCCCCCH-HHHHHHhhcC
Q 010088 409 QLRTIVTIVRWCTQREGQARPSI-KQVLRILYES 441 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~-~evl~~L~~~ 441 (518)
..+.+++..||+.||++||++ +++++|.+..
T Consensus 221 --~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~ 252 (316)
T cd05620 221 --KESKDILEKLFERDPTRRLGVVGNIRGHPFFK 252 (316)
T ss_pred --HHHHHHHHHHccCCHHHcCCChHHHHcCCCcC
Confidence 457889999999999999998 5777777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=341.23 Aligned_cols=261 Identities=23% Similarity=0.402 Sum_probs=215.8
Q ss_pred CHHHHHHHhhhhhhhcceecceEEEEEEecC-CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCce
Q 010088 161 SYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRER 239 (518)
Q Consensus 161 ~~~~l~~a~~~f~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 239 (518)
...|+++......++||-|.||.||.|.|+. .-.||||.++... ...++|+.|+.+|+.++|||+|+|+|+|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3445555556667899999999999999974 6789999987544 3457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccC
Q 010088 240 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 319 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~ 319 (518)
|||+|||.+|+|.+||++..+..++-...+.++.||+.||+||. .+++|||||.++|+|+.++..+||+||||++..
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999888877888899999999999999999 999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccC
Q 010088 320 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVD 398 (518)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d 398 (518)
...... ......-...|.|||.+....++.|+|||+|||+||||.| |..|| .+.++.+.... +..+
T Consensus 416 tgDTYT---AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPY-PGidlSqVY~L-LEkg-------- 482 (1157)
T KOG4278|consen 416 TGDTYT---AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYGL-LEKG-------- 482 (1157)
T ss_pred cCCcee---cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCC-CCccHHHHHHH-Hhcc--------
Confidence 654321 1122234678999999999999999999999999999998 44555 45554433222 2222
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 399 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 399 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.+-+-+..++..+.++|+.||+..|++||++.|+-+.++.
T Consensus 483 --yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 483 --YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred --ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 2223344566789999999999999999999999877643
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=318.12 Aligned_cols=265 Identities=26% Similarity=0.336 Sum_probs=208.7
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEeccccc--hhHHHHHHHHHHHHHcCCCC-eeeEeeeeeecC------ceEEE
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE--QVEGDFCREIELLARLHHRH-LVALRGFCIEKR------ERFLM 242 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------~~~lV 242 (518)
.++||+|.||+||+|+.. +|+.||+|+++...+ .......+|+.+|++|+|+| |++|.+++...+ ..++|
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 457999999999999865 689999999875433 34456789999999999999 999999998877 78999
Q ss_pred EEecCCCCHHHHhcCCCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCC
Q 010088 243 YEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~ 320 (518)
+||++. +|..++..... ..++...+..++.|++.||+||| +++|+||||||.||||+++|.+||+|||+|+...
T Consensus 96 fe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred EEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 999965 99999986553 35777889999999999999999 9999999999999999999999999999999765
Q ss_pred CCCcccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhc----ccccc
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE----SRLAE 395 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~----~~l~~ 395 (518)
-... ..+..++|.+|.|||++.+. .|+...||||+||++.||++++.-|....+..+...+..... ..++.
T Consensus 172 ip~~----~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 172 IPMR----TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred CCcc----cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 4332 35667899999999999886 799999999999999999998888876655544444332211 11111
Q ss_pred ccC-CcCCCCC-----C----HHH---HHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 010088 396 LVD-PRIKDSF-----D----MEQ---LRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM 445 (518)
Q Consensus 396 ~~d-~~l~~~~-----~----~~~---~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~ 445 (518)
+.. +..+..+ . ... .....+++.+|++.+|.+|.|++.+++|.++...+.
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 110 1111000 0 000 136789999999999999999999999987765443
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=320.97 Aligned_cols=249 Identities=25% Similarity=0.440 Sum_probs=201.0
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.+.||+|+||+||+|++.++..+|+|.++... ....+|.+|+.++.+++||||++++++|.+.+..++||||+.+|
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 34567899999999999998777789999886433 33467999999999999999999999999989999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++..... .+++..+++++.|++.||+||| +.+++|+||||+||++++++.+||+|||+++........ .
T Consensus 85 ~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~---~ 157 (256)
T cd05113 85 CLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT---S 157 (256)
T ss_pred cHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee---e
Confidence 99999976433 5899999999999999999999 899999999999999999999999999998765433211 1
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
.....++..|++||.+.+..++.++||||||+++|||++ |..|+...... .......... . +.....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~~~~~-~------~~~~~~---- 225 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-ETVEKVSQGL-R------LYRPHL---- 225 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHHhcCC-C------CCCCCC----
Confidence 122345678999999988889999999999999999999 88888643322 1111111110 0 001111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
....+.+++.+||+.+|.+||++.++++.|
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 235689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=333.10 Aligned_cols=244 Identities=24% Similarity=0.356 Sum_probs=193.1
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHH-HHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIE-LLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+||+|+||+||+|+.. +|..||+|.+.... ......+.+|.. +++.++|+||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999875 58899999986432 222344555654 578899999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|..++... ..+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++...... ..
T Consensus 82 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----~~ 152 (321)
T cd05603 82 ELFFHLQRE--RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE----ET 152 (321)
T ss_pred CHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC----Cc
Confidence 999988653 34888899999999999999999 8999999999999999999999999999987532221 12
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ............ ..+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~--------~~~~~----~~ 219 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKP--------LQLPG----GK 219 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-HHHHHHHHhcCC--------CCCCC----CC
Confidence 234568999999999998899999999999999999999999997543 222222221111 01111 22
Q ss_pred HHHHHHHHHHccccCCCCCCCH----HHHHHHhhc
Q 010088 410 LRTIVTIVRWCTQREGQARPSI----KQVLRILYE 440 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~----~evl~~L~~ 440 (518)
...+.+++.+||+.||.+||+. .+++++.+.
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~ 254 (321)
T cd05603 220 TVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFF 254 (321)
T ss_pred CHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCc
Confidence 3468899999999999999875 466666654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=328.18 Aligned_cols=253 Identities=26% Similarity=0.454 Sum_probs=200.5
Q ss_pred hhhhhhcceecceEEEEEEe-----cCCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
..+.+.||+|+||+||+|.+ .++..||+|.+.... ......|.+|++++++++|+||+++++++...+..++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 44567899999999999975 246789999987433 334467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcE
Q 010088 244 EYMANGSLKDHLHSPG---------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVA 308 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 308 (518)
||+++|+|.+++.... ...+++.+.+.++.+++.||+||| +++++||||||+|||+++++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCCcE
Confidence 9999999999985321 234889999999999999999999 8999999999999999999999
Q ss_pred EEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHH
Q 010088 309 KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCM 387 (518)
Q Consensus 309 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~ 387 (518)
||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||..... ........
T Consensus 164 kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~~~~~~ 240 (283)
T cd05090 164 KISDLGLSREIYSADYY--RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEVIEMVR 240 (283)
T ss_pred EeccccccccccCCcce--ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHH
Confidence 99999999865433211 12233446778999999988889999999999999999999 8888854332 12222111
Q ss_pred hhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 388 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 388 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
. ... ...... ....+.+++.+||+.||++||++.+++++|.
T Consensus 241 ~-~~~------~~~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 241 K-RQL------LPCSED----CPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred c-CCc------CCCCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 1 110 111112 2356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=352.06 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=202.4
Q ss_pred hhhhhhcceecceEEEEEEec-C-CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-D-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.++||+|+||.||+|... + +..||+|.+..........+.+|+.+|+.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 445678999999999999754 3 67888887755554555678889999999999999999999999999999999999
Q ss_pred CCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 248 NGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 248 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+|+|.++|+.. ...++++..+..++.|++.||+||| +.+|+||||||+||||+.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~- 224 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS- 224 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc-
Confidence 99999988642 2346899999999999999999999 89999999999999999999999999999986543221
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.......... ++ ....
T Consensus 225 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-~~~~~~~~~~~~------~~-~~~~- 294 (478)
T PTZ00267 225 -LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-REIMQQVLYGKY------DP-FPCP- 294 (478)
T ss_pred -cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC------CC-CCcc-
Confidence 1123445699999999999999999999999999999999999999964332 222222221110 00 1111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRI 437 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~ 437 (518)
....+.+++..||+.||++||++.+++.+
T Consensus 295 ---~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 295 ---VSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ---CCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 22458899999999999999999999875
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=336.46 Aligned_cols=247 Identities=20% Similarity=0.338 Sum_probs=198.3
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+||+|+||.||+++.. ++..||+|.++.. .......+.+|..++.++ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 6999999999999875 5889999998743 223345688999999999 7999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~ 152 (329)
T cd05588 82 DLMFHMQRQ--RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG----DT 152 (329)
T ss_pred CHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC----Cc
Confidence 999998754 35999999999999999999999 8999999999999999999999999999987432211 12
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCC-------cchHHHHHHHHhhccccccccCCcCC
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDG-------KNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~-------~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
.....||..|+|||.+.+..++.++|||||||++|||++|+.||... .....+....+... ...+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~p 225 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-------QIRIP 225 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-------CCCCC
Confidence 23457999999999999999999999999999999999999999521 11111111111110 01122
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHHhhcC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPS------IKQVLRILYES 441 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs------~~evl~~L~~~ 441 (518)
...+ ..+.+++..||+.||.+||+ ++++++|.|..
T Consensus 226 ~~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~ 266 (329)
T cd05588 226 RSLS----VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266 (329)
T ss_pred CCCC----HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence 2222 45789999999999999987 78999888763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=336.82 Aligned_cols=264 Identities=21% Similarity=0.346 Sum_probs=197.2
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC-----ceEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR-----ERFLM 242 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV 242 (518)
.+.++||+|+||.||+|+.. +|..||||++... .......+.+|++++++++||||+++++++.... ..++|
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv 82 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 82 (338)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence 34568999999999999865 6899999998642 2233456889999999999999999999886432 47999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+. ++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 83 FELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 99995 69999987543 4899999999999999999999 899999999999999999999999999999754322
Q ss_pred CcccccccccccCCCcccCcccccc--CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHH--HHHhhc--------
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQ--VCMASE-------- 390 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~--~~~~~~-------- 390 (518)
... ........||..|+|||++.+ ..++.++|||||||++|||+||+.||........... ......
T Consensus 157 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 157 TPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred cCc-cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 110 012234579999999999865 6789999999999999999999999965432211110 000000
Q ss_pred --cc---cccccCCcCCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 391 --SR---LAELVDPRIKDSFD---MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 391 --~~---l~~~~d~~l~~~~~---~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.. ....+.......+. ......+.+++..||+.||++||+++|++++.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~ 294 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhh
Confidence 00 00000000000000 01124578999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=335.34 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=197.3
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
++||+|+||+||+|+.. +++.||+|.++.. .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999875 5789999998753 223345678899998887 799999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|..++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~----~ 151 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----D 151 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC----C
Confidence 9999988754 35899999999999999999999 8999999999999999999999999999987532211 1
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCC-------cchHHHHHH-HHhhccccccccCCc
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDG-------KNLVESAQV-CMASESRLAELVDPR 400 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~-------~~~~~~~~~-~~~~~~~l~~~~d~~ 400 (518)
......||..|+|||++.+..++.++|||||||++|||++|+.||... .....+... ..... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------~~ 223 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------IR 223 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--------CC
Confidence 223457899999999999999999999999999999999999998521 111111111 11111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHHhhcC
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPS------IKQVLRILYES 441 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs------~~evl~~L~~~ 441 (518)
+.... ...+.+++.+||+.||++||+ +.++++|.+..
T Consensus 224 ~p~~~----~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~ 266 (329)
T cd05618 224 IPRSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 266 (329)
T ss_pred CCCCC----CHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCC
Confidence 12222 245789999999999999998 67998887653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=342.21 Aligned_cols=257 Identities=24% Similarity=0.323 Sum_probs=200.9
Q ss_pred hhhhhhhcceecceEEEEEEec------CCcEEEEEEecccc-chhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERF 240 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 240 (518)
.+.+.++||+|+||+||+|+.. .+..||||+++... ....+.|.+|+++|.++. ||||++++++|.+.+..+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 3445678999999999999752 23479999986433 334467999999999996 999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCC-------------------------------------------------------------
Q 010088 241 LMYEYMANGSLKDHLHSPG------------------------------------------------------------- 259 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~------------------------------------------------------------- 259 (518)
+|||||++|+|.++|+...
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 9999999999999886421
Q ss_pred ---------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC
Q 010088 260 ---------------------------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF 306 (518)
Q Consensus 260 ---------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~ 306 (518)
...+++..+.+++.|++.||+||| +.+|+||||||+|||+++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCCC
Confidence 124788999999999999999999 89999999999999999999
Q ss_pred cEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHH
Q 010088 307 VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQV 385 (518)
Q Consensus 307 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~ 385 (518)
.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..|+............
T Consensus 275 ~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 275 IVKICDFGLARDIMHDSNY--VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred EEEEEeCCcceeccccccc--cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 9999999999865332211 11223456788999999998899999999999999999997 88888643221111111
Q ss_pred HHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 386 CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 386 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..... .+.. +......+.+++.+||+.||++||++.+|.+.|...
T Consensus 353 -~~~~~------~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 353 -IKSGY------RMAK----PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred -HhcCC------CCCC----CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 11110 1111 112335688999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=328.25 Aligned_cols=257 Identities=30% Similarity=0.484 Sum_probs=205.9
Q ss_pred hhhhhhcceecceEEEEEEec------CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
+.+.+.||+|+||.||+|+.. ++..+++|.+..........+.+|++++++++|+||+++++++...+..++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 345568999999999999742 35679999887666555678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEE
Q 010088 244 EYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAK 309 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 309 (518)
||+++++|.+++.... ...++|..++.++.|++.||+||| +++|+||||||+|||+++++.+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence 9999999999997532 234899999999999999999999 99999999999999999999999
Q ss_pred EeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHh
Q 010088 310 LADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMA 388 (518)
Q Consensus 310 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~ 388 (518)
|+|||++........ ........++..|+|||.+.+..++.++||||||+++|||+| |+.||...... +......
T Consensus 164 l~dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~~~- 239 (291)
T cd05094 164 IGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-EVIECIT- 239 (291)
T ss_pred ECCCCcccccCCCce--eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHh-
Confidence 999999976543321 112234456789999999999999999999999999999999 88888644332 1111111
Q ss_pred hccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 389 SESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 389 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
.....+ ... .....+.+++.+||+.+|++||++++|++.|.....
T Consensus 240 -~~~~~~-----~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 240 -QGRVLE-----RPR----VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -CCCCCC-----CCc----cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111111 111 223568899999999999999999999999977644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=333.40 Aligned_cols=253 Identities=23% Similarity=0.378 Sum_probs=198.9
Q ss_pred hhhhhhcceecceEEEEEEec-CCc----EEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGS----LIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
+...+.||+|+||+||+|++. +|. .||+|.++... ....++|.+|+.+++.++|+||++++|+|... ..++|+
T Consensus 9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~ 87 (316)
T cd05108 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 87 (316)
T ss_pred ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence 344568999999999999864 333 48999986433 34456799999999999999999999999764 578999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+++|+|.+++.... ..+++..+++++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 88 e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 88 QLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred ecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 9999999999998643 34889999999999999999999 8999999999999999999999999999998664432
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
... ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.+.. ..+..... .....+. ..
T Consensus 164 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-~~~~~~~~-~~~~~~~------~~ 233 (316)
T cd05108 164 KEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSIL-EKGERLP------QP 233 (316)
T ss_pred cce--eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHH-hCCCCCC------CC
Confidence 211 1122334678999999999999999999999999999998 888886432 22222221 1111111 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.. ....+.+++..||+.+|.+||++.+++..+...
T Consensus 234 ~~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 234 PI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred CC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 224588999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=322.00 Aligned_cols=253 Identities=25% Similarity=0.455 Sum_probs=202.5
Q ss_pred hhhhhhcceecceEEEEEEecC----CcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.+.+.||+|+||+||+|.+.. ...||||.++.. ......+|.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 4456789999999999998742 458999988643 33445679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++++|.+++..... .+++..+++++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 86 YMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred cCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 9999999999976433 5899999999999999999999 89999999999999999999999999999987642211
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+..... ..... ...... +
T Consensus 162 ~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-~~~~~-~~~~~~-----~---- 228 (266)
T cd05033 162 TY--TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-VIKAV-EDGYRL-----P---- 228 (266)
T ss_pred ce--eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-HHHHH-HcCCCC-----C----
Confidence 11 1122345678999999998899999999999999999998 988886543221 11111 111110 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.+......+.+++.+||+.+|++||++++|+++|..
T Consensus 229 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 229 -PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred -CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 111223568899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=333.19 Aligned_cols=244 Identities=24% Similarity=0.380 Sum_probs=195.0
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+||+|+||+||+|+.. +++.||+|.++... ......+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999875 47899999986432 23334566777777765 8999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----~~ 152 (316)
T cd05592 82 DLMFHIQSSG--RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----GK 152 (316)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----Cc
Confidence 9999997643 4899999999999999999999 8999999999999999999999999999997543222 12
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+......... +.+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-~~~~~~i~~~~--------~~~~~~~---- 219 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSILNDR--------PHFPRWI---- 219 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCC--------CCCCCCC----
Confidence 3445699999999999998999999999999999999999999975432 22222221111 1112222
Q ss_pred HHHHHHHHHHccccCCCCCCCHH-HHHHHhhc
Q 010088 410 LRTIVTIVRWCTQREGQARPSIK-QVLRILYE 440 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~~-evl~~L~~ 440 (518)
...+.+++..||+.||++||++. +++++.+.
T Consensus 220 ~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~ 251 (316)
T cd05592 220 SKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF 251 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHHcCccc
Confidence 24578899999999999999875 66676554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=319.01 Aligned_cols=247 Identities=24% Similarity=0.422 Sum_probs=196.8
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHH
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK 252 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 252 (518)
.||+|+||+||+|+.. +|+.+|+|.+... .......|.+|++++++++|+||++++++|...+..++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 6999999999999875 6899999987643 3344567999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccccc
Q 010088 253 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 332 (518)
Q Consensus 253 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 332 (518)
+++...+ ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......... .....
T Consensus 82 ~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~ 155 (252)
T cd05084 82 TFLRTEG-PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA--STGGM 155 (252)
T ss_pred HHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccccccccc--ccCCC
Confidence 9997543 35899999999999999999999 899999999999999999999999999998754432210 01111
Q ss_pred ccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 010088 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR 411 (518)
Q Consensus 333 ~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 411 (518)
...+..|+|||.+.++.++.++||||||+++|||++ |..|+....... .... .... .....+.....
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-~~~~-~~~~----------~~~~~~~~~~~ 223 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-TREA-IEQG----------VRLPCPELCPD 223 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-HHHH-HHcC----------CCCCCcccCCH
Confidence 223567999999998899999999999999999998 777775432211 1111 1110 01111112235
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 412 TIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 412 ~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.+.+++.+||+.+|++||++.++++.|.
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 6889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=320.20 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=204.9
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecc--ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.||+|++|.||+|... +|..|++|.+.. ........+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 35578999999999999875 689999998763 234456779999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+++|.++++......+++..++.++.+++.||.||| +.+++||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--- 156 (256)
T cd08529 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--- 156 (256)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc---
Confidence 999999998754557999999999999999999999 89999999999999999999999999999886544321
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......|+..|+|||++.+..++.++||||||+++|||++|+.||..... ......... ... +.+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~--~~~-----~~~~~---- 223 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-GALILKIIR--GVF-----PPVSQ---- 223 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHc--CCC-----CCCcc----
Confidence 12334688999999999999999999999999999999999999965432 222211111 111 11111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
.....+.+++.+||+.+|++||++.+++++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~ 254 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhhCC
Confidence 2335689999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=335.70 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=199.8
Q ss_pred hhhhhcceecceEEEEEEe----cCCcEEEEEEeccc----cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEE
Q 010088 171 NFSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKI----SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 241 (518)
.+.+.||+|+||+||+++. .+|..||+|++.+. .....+.+.+|+.++.++ +|+||+++++++...+..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 3457899999999999975 35789999998642 123345688999999999 59999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 83 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 83 ILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999999764 34899999999999999999999 89999999999999999999999999999976433
Q ss_pred CCcccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCc--c-hHHHHHHHHhhcccccccc
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGK--N-LVESAQVCMASESRLAELV 397 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~--~-~~~~~~~~~~~~~~l~~~~ 397 (518)
... .......||+.|+|||.+.+. .++.++|||||||++|||+||+.||.... . .......... .
T Consensus 158 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------~ 226 (332)
T cd05614 158 EEK---ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--------C 226 (332)
T ss_pred cCC---CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--------C
Confidence 221 122345699999999998765 47889999999999999999999996321 1 1111111111 1
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
++.+....+ ..+.+++.+||+.||++|| +++++++|.|..
T Consensus 227 ~~~~~~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 271 (332)
T cd05614 227 DPPFPSFIG----PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271 (332)
T ss_pred CCCCCCCCC----HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcC
Confidence 122222222 4578999999999999999 888999988764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=320.42 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=201.6
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.+.||+|+||+||+|...++..+|+|.+..... ....|.+|+.++++++|+|++++++++. ....+++|||++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (260)
T cd05070 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKG 85 (260)
T ss_pred hhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCC
Confidence 455678999999999999988888999998865332 3457999999999999999999999875 45689999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.++++......+++..++.++.+++.||+||| +.+++||||||+||++++++.+||+|||++......... .
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~---~ 159 (260)
T cd05070 86 SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT---A 159 (260)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc---c
Confidence 9999998655556899999999999999999999 889999999999999999999999999999765432211 1
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||.+... .+....... . ..+ ..+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~~~~~~-~------~~~----~~~~~ 227 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVER-G------YRM----PCPQD 227 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHc-C------CCC----CCCCc
Confidence 122345678999999988899999999999999999999 7788864332 222221111 1 011 11122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
....+.+++.+|++.+|++|||+.++.+.|.+
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 228 CPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 33568999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=306.74 Aligned_cols=249 Identities=25% Similarity=0.363 Sum_probs=211.3
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
+..+.||+|-||.||.|+.+ ++-.||+|++.+. ..+...++.+|+++-+.|+||||+++++++.+....||++||.
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 34678999999999999875 5789999998643 2344578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
.+|+|...|.......++......++.|+|.||.|+| .++||||||||+|+|++.++.+||+|||-+.....+
T Consensus 105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~---- 177 (281)
T KOG0580|consen 105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN---- 177 (281)
T ss_pred CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC----
Confidence 9999999999766667999999999999999999999 999999999999999999999999999998765432
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
.....+||..|.+||...+..++..+|+|++|++.||++.|.+||.... ..+..+.+...+ +.+| ...+
T Consensus 178 --kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~-----~~~p---~~is 246 (281)
T KOG0580|consen 178 --KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVD-----LKFP---STIS 246 (281)
T ss_pred --CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcc-----ccCC---cccC
Confidence 3456789999999999999999999999999999999999999997544 333333332222 2222 2222
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
....++|..|+..+|.+|....|+++|.|..
T Consensus 247 ----~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 247 ----GGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred ----hhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 4577899999999999999999999998753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=330.79 Aligned_cols=267 Identities=21% Similarity=0.299 Sum_probs=210.1
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
..+||+|+||.||+|+-+ .|..+|+|++++.. ....+..+.|-.+|....+++||+|+..|.+.+.+||||||++|
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 358999999999999765 59999999998643 33345678899999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC-----
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS----- 323 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 323 (518)
|++..+|...+ .|+...+..++.+++.|++-|| +.|+|||||||+|+|||..|.+||+||||+.......
T Consensus 226 GD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~ 300 (550)
T KOG0605|consen 226 GDMMTLLMRKD--TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY 300 (550)
T ss_pred ccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence 99999998744 5899999999999999999999 9999999999999999999999999999996321100
Q ss_pred ---------------cccc-----------------------cccccccCCCcccCccccccCCCCccccchhhHHHHHH
Q 010088 324 ---------------ICFE-----------------------PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 365 (518)
Q Consensus 324 ---------------~~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~e 365 (518)
.... ......+|||.|||||++.+..|+..+|.||||||+||
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyE 380 (550)
T KOG0605|consen 301 RLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYE 380 (550)
T ss_pred cchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHH
Confidence 0000 01123579999999999999999999999999999999
Q ss_pred HHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHHhhcCC
Q 010088 366 IVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARP---SIKQVLRILYESS 442 (518)
Q Consensus 366 l~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP---s~~evl~~L~~~~ 442 (518)
|+.|-+||........|..+ +.....+..-.+. ....+..++|.+|+. ||.+|. .++||-+|.++..
T Consensus 381 mLvGyPPF~s~tp~~T~rkI-~nwr~~l~fP~~~--------~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 381 MLVGYPPFCSETPQETYRKI-VNWRETLKFPEEV--------DLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHhCCCCCCCCCHHHHHHHH-HHHhhhccCCCcC--------cccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 99999999866555444433 2222111111111 112567889999999 999996 5899999886543
Q ss_pred ------CCCCcchhhhch
Q 010088 443 ------DPMHSGFVQAVE 454 (518)
Q Consensus 443 ------~~~~~~~~~~~~ 454 (518)
.....+|...+.
T Consensus 451 v~W~~l~~~~apfvP~v~ 468 (550)
T KOG0605|consen 451 VDWDHLREMPAPFVPQVN 468 (550)
T ss_pred CCcchhhcCCCCCCCCCC
Confidence 344455655443
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=336.39 Aligned_cols=248 Identities=28% Similarity=0.444 Sum_probs=205.5
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.||.|+||.||-|+.. +...||||++.-.. .....+++.|+..|.+++|||++.+.|+|......|||||||- |
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence 35999999999999865 57899999986433 3345678999999999999999999999999999999999995 5
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
|-.++|.-. +.++...++..|+.+.+.||+||| +.+.||||||+.||||++.|.+||+|||.|.....
T Consensus 111 SAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-------- 178 (948)
T KOG0577|consen 111 SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-------- 178 (948)
T ss_pred cHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc--------
Confidence 888877543 357999999999999999999999 89999999999999999999999999998875433
Q ss_pred cccccCCCcccCccccc---cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 330 NTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
...++|||.|||||++. .+.|+-|+||||||++..||.-.++|..+..-......+.-.. .|.+. .
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe--------sPtLq---s 247 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--------SPTLQ---S 247 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC--------CCCCC---C
Confidence 35678999999999985 5789999999999999999999999987654333333221111 23332 2
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM 445 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~ 445 (518)
.+....++.++..||++-|.+|||.+++++|.+...+..
T Consensus 248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 248 NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 355567999999999999999999999999987665443
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=332.67 Aligned_cols=245 Identities=26% Similarity=0.376 Sum_probs=195.5
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHH-HHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIE-LLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+||+|+||+||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 6999999999999875 68999999986422 222344555555 567789999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 82 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~----~~ 152 (323)
T cd05575 82 ELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS----KT 152 (323)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC----Cc
Confidence 999999763 35899999999999999999999 8999999999999999999999999999987532221 12
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+......... ..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~--------~~~~~~~---- 219 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYDNILNKP--------LRLKPNI---- 219 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-HHHHHHHHHcCC--------CCCCCCC----
Confidence 344569999999999999999999999999999999999999997533 333332222111 1111122
Q ss_pred HHHHHHHHHHccccCCCCCCCH----HHHHHHhhcC
Q 010088 410 LRTIVTIVRWCTQREGQARPSI----KQVLRILYES 441 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~----~evl~~L~~~ 441 (518)
...+.+++.+||+.||++||++ .+++++.+..
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~ 255 (323)
T cd05575 220 SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255 (323)
T ss_pred CHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcC
Confidence 3458899999999999999987 5777776653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=339.27 Aligned_cols=256 Identities=23% Similarity=0.304 Sum_probs=198.2
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.||+|+||+||+|+.. ++..||||++... .......+.+|++++.+++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 4568999999999999875 5789999998643 23344678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc--c
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI--C 325 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~--~ 325 (518)
+|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||||+.++.+||+|||+++....... .
T Consensus 85 gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 85 GGDMMSLLIRME--VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 999999997643 4889999999999999999999 89999999999999999999999999999864311000 0
Q ss_pred -----------------------------------------cccccccccCCCcccCccccccCCCCccccchhhHHHHH
Q 010088 326 -----------------------------------------FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLL 364 (518)
Q Consensus 326 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~ 364 (518)
.........||+.|+|||.+.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 000112357999999999999889999999999999999
Q ss_pred HHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHHHHHhhcC
Q 010088 365 EIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRW--CTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 365 el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~--Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
||+||+.||............ ......+. -+. ....+ ..+.+++.+ |+..++..||++.++++|.+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i-~~~~~~~~---~~~-~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~ 309 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKV-INWENTLH---IPP-QVKLS----PEAVDLITKLCCSAEERLGRNGADDIKAHPFFS 309 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHH-HccccccC---CCC-CCCCC----HHHHHHHHHHccCcccccCCCCHHHHhcCcccC
Confidence 999999999754432222221 11111000 000 01122 346667766 6667777799999999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=320.47 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=205.7
Q ss_pred HHHhhhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 166 KKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 166 ~~a~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
...++.+.++||+|+||.||+|...+++.||+|.+..... ...+|.+|+.++++++|+||+++++++ ..+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 3456667789999999999999988899999999875432 346799999999999999999999986 45678999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++|+|.+++.......+++.+++.++.|++.||+||| +.+++||||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 99999999997655567999999999999999999999 899999999999999999999999999999765432211
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
......++..|+|||.+....++.++||||||+++|||++ |+.||..... .+..... ... ........
T Consensus 159 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~-~~~------~~~~~~~~ 227 (260)
T cd05067 159 ---AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-PEVIQNL-ERG------YRMPRPDN 227 (260)
T ss_pred ---cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHH-HcC------CCCCCCCC
Confidence 1223346778999999988889999999999999999999 8988864432 2222211 111 01111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
....+.+++.+||+.+|++||+++++++.|..
T Consensus 228 ----~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 228 ----CPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 23468999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=336.21 Aligned_cols=246 Identities=26% Similarity=0.369 Sum_probs=198.5
Q ss_pred hhcceecceEEEEEEe----cCCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 174 TIIGQGGFGTVYKAQF----SDGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.||+|+||+||+++. .+|+.||+|++.... ......+.+|+++|++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999865 357899999987532 2233457789999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--- 153 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--- 153 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC---
Confidence 99999999753 35899999999999999999999 89999999999999999999999999999876543211
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +........... +....
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~~i~~~~~~--------~p~~~-- 221 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-ETMTMILKAKLG--------MPQFL-- 221 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-HHHHHHHcCCCC--------CCCCC--
Confidence 223457899999999999888999999999999999999999999754332 222222111111 11122
Q ss_pred HHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhcC
Q 010088 408 EQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYES 441 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~~L~~~ 441 (518)
...+.+++.+||+.||++||+ +.+++++.+..
T Consensus 222 --~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~ 258 (318)
T cd05582 222 --SPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFS 258 (318)
T ss_pred --CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcC
Confidence 245788999999999999999 56677766554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=333.52 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=197.3
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHH---HHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELL---ARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.+.||+|+||.||+|... +|+.||||.++... ....+.+.+|++++ .+++||||+++++++...+..++|||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E 82 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME 82 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence 4568999999999999875 58999999986432 22334566776665 45679999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++|+|..+++. ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05589 83 YAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG- 155 (324)
T ss_pred CCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence 9999999998864 35999999999999999999999 8999999999999999999999999999987532211
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .+.......... .....
T Consensus 156 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-~~~~~~i~~~~~--------~~p~~ 223 (324)
T cd05589 156 ---DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-EEVFDSIVNDEV--------RYPRF 223 (324)
T ss_pred ---CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC--------CCCCC
Confidence 122345799999999999999999999999999999999999999965432 222222221111 11122
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
. ...+.+++.+||+.||.+|| ++.+++++.+..
T Consensus 224 ~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~ 261 (324)
T cd05589 224 L----SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFR 261 (324)
T ss_pred C----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcC
Confidence 2 24578899999999999999 688888877653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=330.88 Aligned_cols=245 Identities=25% Similarity=0.380 Sum_probs=196.7
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
.||+|+||+||+|+.. ++..||||.++... ......+..|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 6999999999999876 47899999986531 23345567788888865 8999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~ 152 (316)
T cd05619 82 DLMFHIQSC--HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD----AK 152 (316)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC----Cc
Confidence 999999753 34899999999999999999999 8999999999999999999999999999987532221 12
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....||..|+|||.+.+..++.++|||||||++|||++|+.||..... .+........ .+.+....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-~~~~~~i~~~--------~~~~~~~~~--- 220 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-EELFQSIRMD--------NPCYPRWLT--- 220 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhC--------CCCCCccCC---
Confidence 2345689999999999999999999999999999999999999965432 2222221111 111111122
Q ss_pred HHHHHHHHHHccccCCCCCCCHH-HHHHHhhcC
Q 010088 410 LRTIVTIVRWCTQREGQARPSIK-QVLRILYES 441 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~~-evl~~L~~~ 441 (518)
..+.+++.+||+.||++||++. +++++.+..
T Consensus 221 -~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~ 252 (316)
T cd05619 221 -REAKDILVKLFVREPERRLGVKGDIRQHPFFR 252 (316)
T ss_pred -HHHHHHHHHHhccCHhhcCCChHHHHcCcccC
Confidence 4578899999999999999997 777776553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=319.87 Aligned_cols=249 Identities=28% Similarity=0.429 Sum_probs=200.1
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
..+.+.||+|+||.||+|.+.++..+|+|.+.... ....+|.+|++++++++|+||+++++++.+.+..++||||++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 34667899999999999998777889999886432 23457889999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++..... .++|..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||+++...+.... .
T Consensus 85 ~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~---~ 157 (256)
T cd05059 85 CLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT---S 157 (256)
T ss_pred CHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccc---c
Confidence 99999975433 5899999999999999999999 899999999999999999999999999998765432211 1
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +...... .. ....... .
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~-~~------~~~~~~~----~ 225 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-EVVESVS-AG------YRLYRPK----L 225 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-HHHHHHH-cC------CcCCCCC----C
Confidence 112234568999999998999999999999999999999 78888643332 2111111 11 1111111 2
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
....+.+++.+||+.+|++||++.++++.|
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 335689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=340.16 Aligned_cols=258 Identities=20% Similarity=0.253 Sum_probs=198.0
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||.||++... .++.||+|... ...+.+|+++|++++||||+++++++......++|+|++.
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~- 166 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK- 166 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence 445678999999999999875 58899999643 2356799999999999999999999999999999999995
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|..++... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 167 ~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~---~ 238 (391)
T PHA03212 167 TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA---N 238 (391)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc---c
Confidence 7899988754 34899999999999999999999 88999999999999999999999999999975332110 1
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcch------HHHHHHHHhhccc----------
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL------VESAQVCMASESR---------- 392 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~------~~~~~~~~~~~~~---------- 392 (518)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .......+...+.
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 223457999999999999999999999999999999999999887532210 0111111100000
Q ss_pred --cccc---------cCCcCCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 393 --LAEL---------VDPRIKDSF--DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 393 --l~~~---------~d~~l~~~~--~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+.+. ..+..+... .......+.+++.+||+.||.+|||++|++++.++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 0000 000000000 0123456889999999999999999999999988754
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=325.38 Aligned_cols=256 Identities=30% Similarity=0.496 Sum_probs=204.1
Q ss_pred hhhhhhhcceecceEEEEEEec------CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
.+.+.+.||+|+||+||++... ++..+|+|.+..........+.+|++++.+++|+||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 85 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 3445678999999999999752 3467999998776666667899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEe
Q 010088 243 YEYMANGSLKDHLHSPG-----------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA 311 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 311 (518)
|||+++++|.+++...+ ...+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEec
Confidence 99999999999997432 234899999999999999999999 8999999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhc
Q 010088 312 DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASE 390 (518)
Q Consensus 312 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~ 390 (518)
|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .........
T Consensus 163 dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-~~~~~i~~~- 238 (288)
T cd05093 163 DFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EVIECITQG- 238 (288)
T ss_pred cCCccccccCCcee--ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcC-
Confidence 99999755332211 11223446788999999998899999999999999999999 88887543321 211111111
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 391 SRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 391 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.. .......+ ..+.+++.+||+.||.+||++.++++.|...
T Consensus 239 -~~-----~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 239 -RV-----LQRPRTCP----KEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred -Cc-----CCCCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 10 11111222 4589999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=337.69 Aligned_cols=256 Identities=22% Similarity=0.277 Sum_probs=205.1
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||+||+|+.. +|+.||||+++... ......+.+|++++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (350)
T cd05573 4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM 83 (350)
T ss_pred eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence 34568999999999999876 68999999986432 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc--
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI-- 324 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 324 (518)
++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 84 ~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 84 PGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999865 35899999999999999999999 89999999999999999999999999999976543220
Q ss_pred -----------------------ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHH
Q 010088 325 -----------------------CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 381 (518)
Q Consensus 325 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~ 381 (518)
..........||+.|+|||.+.+..++.++|||||||+||||++|+.||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 000112345689999999999999999999999999999999999999976543322
Q ss_pred HHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHhhcC
Q 010088 382 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS-IKQVLRILYES 441 (518)
Q Consensus 382 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-~~evl~~L~~~ 441 (518)
+. ........ ..-+... . ....+.+++..|++ ||.+||+ +++++++.+..
T Consensus 239 ~~-~i~~~~~~---~~~p~~~-~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~ 289 (350)
T cd05573 239 YN-KIINWKES---LRFPPDP-P----VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289 (350)
T ss_pred HH-HHhccCCc---ccCCCCC-C----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcC
Confidence 22 21110000 1111111 1 23568889999997 9999999 99999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=324.83 Aligned_cols=257 Identities=26% Similarity=0.335 Sum_probs=201.2
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccc--------------hhHHHHHHHHHHHHHcCCCCeeeEeeeee
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE--------------QVEGDFCREIELLARLHHRHLVALRGFCI 234 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 234 (518)
+.+...||+|.||.|-+|+.. +++.||||++.+... ...+...+||.+|++++|+|||+|+.+..
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 444567999999999999875 689999999854211 12346889999999999999999999977
Q ss_pred ec--CceEEEEEecCCCCHHHHhcCCCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEe
Q 010088 235 EK--RERFLMYEYMANGSLKDHLHSPGRTP-LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA 311 (518)
Q Consensus 235 ~~--~~~~lV~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 311 (518)
+. +..|||+|||..|.+...= ...+ ++..++++++.++..||+||| .++||||||||+|+||+++|++||+
T Consensus 179 DP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred CcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEEee
Confidence 64 5889999999988875432 2334 999999999999999999999 8999999999999999999999999
Q ss_pred eccccccCCCCCcc-cccccccccCCCcccCccccccCC----CCccccchhhHHHHHHHHhCCccccCCcchHHHHHHH
Q 010088 312 DFGLAHASKDGSIC-FEPVNTDIRGTPGYMDPEYVVTQE----LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC 386 (518)
Q Consensus 312 DfGla~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~ 386 (518)
|||.+.....+... .........||+.|||||...++. .+.+.||||+||+||-|+.|+.||.+...+.... .+
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~-KI 331 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD-KI 331 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH-HH
Confidence 99998866332111 111233478999999999987643 3567899999999999999999997654433222 22
Q ss_pred HhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 387 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 387 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
+...+.-....+..+.+.++|.++|++||+.|.+..+|..|+|...+
T Consensus 332 ----------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 332 ----------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ----------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 22222111122445678999999999999999999999999987654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=341.32 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=203.7
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 244 (518)
.+|..+||+|+||+|+++.++ +++.+|||.+++. .....+..+.|.+++.... ||.+++++.++..+++.++|||
T Consensus 370 F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvme 449 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVME 449 (694)
T ss_pred eEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEE
Confidence 345679999999999999887 5789999999863 3445567888999988884 9999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+.||++..+.+. ..+++..+.-++..|+.||+||| +++|||||||.+|||||.+|.+||+||||++..-..
T Consensus 450 y~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-- 521 (694)
T KOG0694|consen 450 YVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-- 521 (694)
T ss_pred ecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCC--
Confidence 9999995544442 35999999999999999999999 999999999999999999999999999999854321
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
...+...+||+.|||||++.+..|+.++|.|||||+||||+.|..||.. .+..+....++..+. ....
T Consensus 522 --g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d~~--------~yP~- 589 (694)
T KOG0694|consen 522 --GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVNDEV--------RYPR- 589 (694)
T ss_pred --CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCC--------CCCC-
Confidence 1246778999999999999999999999999999999999999999963 333344444333322 1222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHhhcC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSI-----KQVLRILYES 441 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~-----~evl~~L~~~ 441 (518)
-...+..+|+++++.++|++|.-+ .+|.+|.++.
T Consensus 590 ---~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr 628 (694)
T KOG0694|consen 590 ---FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFR 628 (694)
T ss_pred ---cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccc
Confidence 223567889999999999999865 5666666543
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=335.61 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=202.2
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.++||+|+||+||+++.. +|..||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05596 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEY 124 (370)
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcC
Confidence 445578999999999999875 5889999998642 223345578999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++|+|.+++... .++...+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 125 ~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~- 197 (370)
T cd05596 125 MPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM- 197 (370)
T ss_pred CCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-
Confidence 9999999999753 3788888999999999999999 89999999999999999999999999999976543221
Q ss_pred cccccccccCCCcccCccccccC----CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQ----ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
.......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ............+ ..
T Consensus 198 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~------~~ 268 (370)
T cd05596 198 --VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMDHKNSL------TF 268 (370)
T ss_pred --ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHHcCCCcC------CC
Confidence 112345799999999998653 4789999999999999999999999754432 2222222111110 01
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHhhcCC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQA--RPSIKQVLRILYESS 442 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~--RPs~~evl~~L~~~~ 442 (518)
.. .......+.+++..||+.+|.+ |++++++++|.+...
T Consensus 269 ~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 269 PD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred CC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 11 0112356788999999999988 999999999987754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=319.31 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=202.1
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEecc--ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeee-----cCceEEEEEe
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRGFCIE-----KRERFLMYEY 245 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~lV~e~ 245 (518)
+.||+|+||.|+.+... +|..||||++.. ......+...+|+++|+.++|+||+.+.+.+.. -+..|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 46999999999999875 689999999863 334455678899999999999999999998865 3578999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
| ..+|...++.. ..|+......+..|+++||+|+| +.+|+||||||+|+|++.+..+||+|||||+..... .
T Consensus 108 M-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~--~ 179 (359)
T KOG0660|consen 108 M-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF--F 179 (359)
T ss_pred H-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeecccc--C
Confidence 9 56999999864 34999999999999999999999 999999999999999999999999999999987543 1
Q ss_pred cccccccccCCCcccCccccc-cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccc-----ccC-
Q 010088 326 FEPVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE-----LVD- 398 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~-----~~d- 398 (518)
.....+..+.|.+|.|||.+. ...|+...||||.||+|.||++|++-|.+.. .+...+.++..-+...+ +-.
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d-~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD-YVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc-hHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 123457788999999999886 4689999999999999999999998886433 33333322221111000 000
Q ss_pred ---------CcCC-CCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 399 ---------PRIK-DSF---DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 399 ---------~~l~-~~~---~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
|... ..+ -........+++.+||..||.+|+|++|+|+|.+..
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~ 314 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLA 314 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhh
Confidence 0000 000 011224578999999999999999999999998764
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=320.30 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=201.3
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.++||+|+||+||+|++.++..||+|.++... ...+.|.+|++++++++|+||+++++++. ....++||||+++|
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKG 85 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCC
Confidence 55677899999999999988777789999987433 23457899999999999999999999874 45689999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.......+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+++........ .
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~---~ 159 (262)
T cd05071 86 SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT---A 159 (262)
T ss_pred cHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc---c
Confidence 9999998654456899999999999999999999 899999999999999999999999999999765433211 1
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
.....++..|++||...+..++.++||||||+++|||+| |..||...... ........ .. .. ....+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-~~~~~~~~-~~------~~----~~~~~ 227 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVER-GY------RM----PCPPE 227 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-HHHHHHhc-CC------CC----CCccc
Confidence 123346778999999988899999999999999999999 77777543322 11111111 00 00 11223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
....+.+++.+|++.+|++||++.++++.|++
T Consensus 228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 228 CPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 44668899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=336.97 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=200.6
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.++||+|+||+||+|+.. +|+.||||++.... ......+.+|+++|..++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence 4568999999999999875 58999999986432 2334568899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc-
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF- 326 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~- 326 (518)
+|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..........
T Consensus 85 ~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 85 GGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 999999997643 5899999999999999999999 8999999999999999999999999999987543211000
Q ss_pred -c--------------------------------cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccc
Q 010088 327 -E--------------------------------PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV 373 (518)
Q Consensus 327 -~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~ 373 (518)
. .......||+.|+|||++....++.++|||||||++|||++|..||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 0 0011246999999999999999999999999999999999999999
Q ss_pred cCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHhhcC
Q 010088 374 QDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS---IKQVLRILYES 441 (518)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs---~~evl~~L~~~ 441 (518)
...... +...........+. .+.. ... ...+.+++..|+. +|.+|++ ++++++|.+..
T Consensus 240 ~~~~~~-~~~~~i~~~~~~~~---~~~~-~~~----s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~ 300 (364)
T cd05599 240 CSDNPQ-ETYRKIINWKETLQ---FPDE-VPL----SPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFK 300 (364)
T ss_pred CCCCHH-HHHHHHHcCCCccC---CCCC-CCC----CHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcC
Confidence 754432 22222211111110 0100 011 2457788888986 9999998 99999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=332.02 Aligned_cols=245 Identities=24% Similarity=0.367 Sum_probs=199.8
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+||+|+||+||+|+.. ++..||||.++.. .......+.+|++++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999876 4789999998743 223345678899999888 6999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|..++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++....... .
T Consensus 82 ~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (318)
T cd05570 82 DLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----T 152 (318)
T ss_pred CHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC----c
Confidence 9999987643 5999999999999999999999 89999999999999999999999999999875322211 1
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....||..|+|||.+.+..++.++|||||||++|||++|+.||.... ............ .......
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-~~~~~~~i~~~~--------~~~~~~~---- 219 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-EDELFQSILEDE--------VRYPRWL---- 219 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-HHHHHHHHHcCC--------CCCCCcC----
Confidence 233568999999999999999999999999999999999999996443 222222222111 1111122
Q ss_pred HHHHHHHHHHccccCCCCCCCH-----HHHHHHhhcC
Q 010088 410 LRTIVTIVRWCTQREGQARPSI-----KQVLRILYES 441 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~-----~evl~~L~~~ 441 (518)
...+.+++.+||+.||.+||++ .+++++.+..
T Consensus 220 ~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~ 256 (318)
T cd05570 220 SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256 (318)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcC
Confidence 2458899999999999999999 9999887664
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=323.00 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=202.7
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.||+|+||+||+|... +|+.+|+|.+.... ......+.+|+++|++++|+||+.+.+++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 457999999999999875 68899999886432 22334578899999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|.+++...+...+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++.......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~----- 156 (285)
T cd05632 85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----- 156 (285)
T ss_pred ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-----
Confidence 99999987655556999999999999999999999 8999999999999999999999999999987654322
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
......|+..|+|||.+.+..++.++||||||+++|||++|..||.............. ...+. .......
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~----~~~~~-~~~~~~~---- 227 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR----RVLET-EEVYSAK---- 227 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH----hhhcc-ccccCcc----
Confidence 12345689999999999989999999999999999999999999975443221111110 00000 0111112
Q ss_pred HHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhcCC
Q 010088 409 QLRTIVTIVRWCTQREGQARPS-----IKQVLRILYESS 442 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs-----~~evl~~L~~~~ 442 (518)
....+.+++..||+.||++||+ +.+++++.+...
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 2245789999999999999999 778888776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=322.15 Aligned_cols=254 Identities=22% Similarity=0.364 Sum_probs=201.4
Q ss_pred hhhhhhhcceecceEEEEEEecC------CcEEEEEEeccccc-hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFSD------GSLIAVKRMDKISE-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 241 (518)
.+.+.+.||+|+||+||+|...+ +..||+|+++.... .....|.+|+.++.+++|+||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 35566789999999999998642 47899999875432 334678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc
Q 010088 242 MYEYMANGSLKDHLHSP--------------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV 307 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 307 (518)
++||+.+++|.+++... ....+++..+.+++.|++.||+||| +.+|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence 99999999999998531 1235889999999999999999999 899999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHH
Q 010088 308 AKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVC 386 (518)
Q Consensus 308 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~ 386 (518)
+||+|||+++........ .......+++.|+|||.+.++.++.++||||||+++|||++ |..|+..... .+.....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~i 239 (283)
T cd05091 163 VKISDLGLFREVYAADYY--KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVIEMI 239 (283)
T ss_pred eEecccccccccccchhe--eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH
Confidence 999999998865433211 11233456789999999988889999999999999999998 7777754322 2222221
Q ss_pred HhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 387 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 387 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.... . ..... +....+.+++..||+.+|.+||++++|++.|+
T Consensus 240 ~~~~--~-----~~~~~----~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 240 RNRQ--V-----LPCPD----DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HcCC--c-----CCCCC----CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 1111 0 11112 23356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=322.63 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=199.1
Q ss_pred hhhhhhcceecceEEEEEEec------CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
+.+.+.||+|+||+||+|.+. .+..||||.+.... .....+|.+|+.+++.++|+||+++++++.+....++|
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 87 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence 445678999999999999753 25679999886432 23445789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecc
Q 010088 243 YEYMANGSLKDHLHSPG--------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG 314 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfG 314 (518)
|||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~dfg 164 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG 164 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEECCCC
Confidence 99999999999986522 134688999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhcccc
Q 010088 315 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRL 393 (518)
Q Consensus 315 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l 393 (518)
+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.... ........... ..
T Consensus 165 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~--~~ 239 (277)
T cd05062 165 MTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-NEQVLRFVMEG--GL 239 (277)
T ss_pred CccccCCccee--ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcC--Cc
Confidence 98765433221 11122345788999999998899999999999999999999 677775432 22222211111 11
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 394 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 394 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
. .... .....+.+++.+||+.+|++||++.|++++|.
T Consensus 240 ~-----~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 240 L-----DKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred C-----CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1 1111 22346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=334.92 Aligned_cols=250 Identities=25% Similarity=0.407 Sum_probs=211.4
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecc--ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCc-eEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE-RFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~e~ 245 (518)
+...+++|+|+||.++..+.+ ++..+++|.+.. ..........+|+.++++++|||||.+.+.+.+++. .++||+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 445678999999999999775 678999998863 344445578899999999999999999999999988 9999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
|+||+|.+.|.+..+..++++.+..|+.|++.|+.||| ++.|+|||||+.|||++.++.+||+|||+|+......
T Consensus 86 ~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-- 160 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-- 160 (426)
T ss_pred cCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch--
Confidence 99999999998877777999999999999999999999 9999999999999999999999999999999876643
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.......||+.||.||.+.+.+|+.|+|||||||++|||++-+++|... +.......+... .++ ..
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-~m~~Li~ki~~~------~~~-----Pl 226 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-NMSELILKINRG------LYS-----PL 226 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-chHHHHHHHhhc------cCC-----CC
Confidence 1345678999999999999999999999999999999999999999643 333333222211 111 12
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
+......+..++..|++.+|..||++.++|.+.
T Consensus 227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred CccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 234446788999999999999999999999874
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=333.29 Aligned_cols=254 Identities=22% Similarity=0.309 Sum_probs=202.9
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||+||+++.. +|+.||+|+++... ......+.+|+.++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ 83 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence 45578999999999999875 68999999987432 234456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~- 158 (330)
T cd05601 84 PGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV- 158 (330)
T ss_pred CCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-
Confidence 9999999997642 35899999999999999999999 899999999999999999999999999999865433211
Q ss_pred ccccccccCCCcccCccccc------cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 327 EPVNTDIRGTPGYMDPEYVV------TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
......||+.|+|||.+. ...++.++|||||||++|||++|+.||.......... ....... .... +.
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~-~i~~~~~-~~~~--~~ 232 (330)
T cd05601 159 --NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN-NIMNFQR-FLKF--PE 232 (330)
T ss_pred --eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH-HHHcCCC-ccCC--CC
Confidence 123346899999999986 4567899999999999999999999997654432222 2211111 0000 10
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.......+.+++..|++ +|++||++.++++|.+..
T Consensus 233 -----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~ 267 (330)
T cd05601 233 -----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFS 267 (330)
T ss_pred -----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcC
Confidence 01122457889999998 999999999999988764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=332.73 Aligned_cols=257 Identities=28% Similarity=0.404 Sum_probs=199.8
Q ss_pred hhhhhhhcceecceEEEEEEec------CCcEEEEEEecccc-chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeec-Cce
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEK-RER 239 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~~ 239 (518)
.+.+.++||+|+||.||+|... .++.||+|+++... ......+.+|+.++.++ +|+||++++++|... ...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 3456679999999999999642 24789999986432 23345688999999999 899999999988754 567
Q ss_pred EEEEEecCCCCHHHHhcCCC-----------------------------------------------------------C
Q 010088 240 FLMYEYMANGSLKDHLHSPG-----------------------------------------------------------R 260 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~-----------------------------------------------------------~ 260 (518)
+++|||+++|+|.+++.... .
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 89999999999999986421 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccccccCCCccc
Q 010088 261 TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 340 (518)
Q Consensus 261 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~ 340 (518)
.+++|..+.+++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++........ .......++..|+
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~--~~~~~~~~~~~y~ 242 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWM 242 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch--hhccCCCCCcccc
Confidence 26899999999999999999999 899999999999999999999999999999865433211 1122345677899
Q ss_pred CccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHH
Q 010088 341 DPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRW 419 (518)
Q Consensus 341 aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~ 419 (518)
|||++.+..++.++|||||||+||||++ |..||............ +..... +.. +......+.+++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~------~~~----~~~~~~~~~~l~~~ 311 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR-LKEGTR------MRA----PEYATPEIYSIMLD 311 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH-HhccCC------CCC----CccCCHHHHHHHHH
Confidence 9999999999999999999999999998 98888643221111111 111100 111 11223568899999
Q ss_pred ccccCCCCCCCHHHHHHHhhcC
Q 010088 420 CTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 420 Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
||+.+|++||++.|++++|...
T Consensus 312 cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=331.62 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=198.9
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCC-CCeeeEeeeeeecCceEEEEEe
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHH-RHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~ 245 (518)
.+.+.||+|+||.||+|+.. +++.||||++... .......+..|++++..+.| ++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 45678999999999999876 4689999998643 23344568889999999976 5688899999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-- 155 (324)
T cd05587 83 VNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-- 155 (324)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--
Confidence 99999999997643 4899999999999999999999 8999999999999999999999999999987432211
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+......... ..+....
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~~~~i~~~~--------~~~~~~~ 224 (324)
T cd05587 156 --KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSIMEHN--------VSYPKSL 224 (324)
T ss_pred --CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCC--------CCCCCCC
Confidence 112345689999999999999999999999999999999999999965432 22222222111 1111222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHhhcC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSI-----KQVLRILYES 441 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~-----~evl~~L~~~ 441 (518)
...+.+++..||+.||.+|++. +++++|.+..
T Consensus 225 ----~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~ 261 (324)
T cd05587 225 ----SKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFR 261 (324)
T ss_pred ----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcC
Confidence 2457899999999999999976 7788776553
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=316.57 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=194.9
Q ss_pred hhcceecceEEEEEEec----CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeee-cCceEEEEEecC
Q 010088 174 TIIGQGGFGTVYKAQFS----DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIE-KRERFLMYEYMA 247 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~ 247 (518)
++||+|+||+||+|.+. ++..+|+|++... .......+.+|+.+++.++||||++++++|.. +...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999863 2457999988543 23445678999999999999999999998764 456899999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|||+++++.+||+|||+++..........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999997543 23688888999999999999999 89999999999999999999999999999975433221100
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
.......++..|+|||.+.+..++.++||||||+++|||++|+.|+....+..+......... .+....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~---- 225 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-------RLLQPE---- 225 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-------CCCCCC----
Confidence 111234567789999999888999999999999999999996555433333333322221111 011111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..+..+.+++..||+.+|++||++.++++.|...
T Consensus 226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1234688999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=321.69 Aligned_cols=264 Identities=27% Similarity=0.454 Sum_probs=200.2
Q ss_pred hhhhhcceecceEEEEEEe-----cCCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLM 242 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 242 (518)
.+.+.||+|+||+||++.+ .++..||+|.++... ......|.+|+++|++++|+||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 3456899999999988653 357899999986533 33456789999999999999999999998764 357899
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+++|+|.+++... .+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++....+
T Consensus 87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999999753 4999999999999999999999 899999999999999999999999999999865443
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHH-HHHHHH--hhccccccccCC
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE-SAQVCM--ASESRLAELVDP 399 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~-~~~~~~--~~~~~l~~~~d~ 399 (518)
.... .......++..|+|||.+.+..++.++||||||+++|||+||..|+........ ...... .....+.+..+.
T Consensus 161 ~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 161 HEYY-RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred chhh-ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 2111 111223456779999999888999999999999999999999999854322111 000000 000011111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 400 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
......+......+.+++..||+.+|++||+++++++.|...
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111111222346799999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=315.08 Aligned_cols=246 Identities=23% Similarity=0.408 Sum_probs=198.8
Q ss_pred hcceecceEEEEEEecCCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHHH
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKD 253 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 253 (518)
+||+|+||.||+|...++..+|+|.+.... ......|.+|++++++++|+||++++++|...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 699999999999998889999999886543 3334578999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccccc
Q 010088 254 HLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDI 333 (518)
Q Consensus 254 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 333 (518)
++.... ..+++..++.++.+++.+|.||| +++++||||||+||++++++.+||+|||++.....+... .....
T Consensus 82 ~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~---~~~~~ 154 (250)
T cd05085 82 FLRKKK-DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS---SSGLK 154 (250)
T ss_pred HHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccc---cCCCC
Confidence 987543 35899999999999999999999 899999999999999999999999999998754332211 11222
Q ss_pred cCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHH
Q 010088 334 RGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT 412 (518)
Q Consensus 334 ~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~ 412 (518)
.++..|+|||++.+..++.++||||||+++||+++ |..||...... ...... .... ...... .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-~~~~~~-~~~~------~~~~~~----~~~~~ 222 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-QAREQV-EKGY------RMSCPQ----KCPDD 222 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHHH-HcCC------CCCCCC----CCCHH
Confidence 34678999999998899999999999999999998 88888644322 211111 1110 111111 22356
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 413 IVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 413 l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
+.+++.+|++.+|++||++.++++.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=315.61 Aligned_cols=251 Identities=24% Similarity=0.416 Sum_probs=201.5
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.+.||+|+||+||+|.+.++..+|+|.+.... ...+.|.+|++++++++|+|++++++++. .+..++||||+.+|
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 85 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKG 85 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence 44567899999999999998777789999876432 33467899999999999999999999875 46689999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.++++......++|..+..++.+++.||+||| +.+++||||||+||++++++.+||+|||++......... .
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~---~ 159 (260)
T cd05069 86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT---A 159 (260)
T ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc---c
Confidence 9999998655556899999999999999999999 899999999999999999999999999999765433211 1
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
.....++..|+|||...+..++.++||||||+++|||+| |+.|+.+....... .... ... .+. .+..
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~-~~~------~~~----~~~~ 227 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL-EQVE-RGY------RMP----CPQG 227 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHH-cCC------CCC----CCcc
Confidence 123346778999999988899999999999999999999 88888654332221 1111 110 011 1112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
....+.+++.+||+.||++||+++++++.|++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 34568999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.17 Aligned_cols=256 Identities=28% Similarity=0.418 Sum_probs=207.3
Q ss_pred hhhhcceecceEEEEEEecCC-cEEEEEEeccccchhHHHHHHHHHHHHHcC-CCCeeeEeee-eee------cCceEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFSDG-SLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGF-CIE------KRERFLM 242 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~~------~~~~~lV 242 (518)
..++|.+|||+.||.|+...+ ..||+|++-..++...+..++||++|++|+ |+|||.+++. ... .-+.+|.
T Consensus 41 V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL 120 (738)
T KOG1989|consen 41 VEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL 120 (738)
T ss_pred EEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence 346899999999999998766 999999997778888889999999999996 9999999993 222 1367999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
||||.||+|-+++..+....|++.++++|+.++++|+++||.+ .++|||||||-+||||+.++..||||||-|...-..
T Consensus 121 mEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~ 199 (738)
T KOG1989|consen 121 MEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILS 199 (738)
T ss_pred hhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCC
Confidence 9999999999999876555699999999999999999999966 788999999999999999999999999988643211
Q ss_pred Cccccc-----ccccccCCCcccCcccc---ccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccc
Q 010088 323 SICFEP-----VNTDIRGTPGYMDPEYV---VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 394 (518)
Q Consensus 323 ~~~~~~-----~~~~~~gt~~y~aPE~~---~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~ 394 (518)
...... ..-...-|+-|.|||.+ .+...++|+|||||||+||-|+....||.+...+.
T Consensus 200 ~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-------------- 265 (738)
T KOG1989|consen 200 PTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-------------- 265 (738)
T ss_pred CccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--------------
Confidence 100000 00112358999999987 46789999999999999999999999998654331
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 395 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 395 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
+++....-.-...+...+.+||..||+.||.+||++-||+..+.+...
T Consensus 266 -Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 266 -ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 222222111123667889999999999999999999999998877654
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=328.73 Aligned_cols=245 Identities=26% Similarity=0.355 Sum_probs=194.3
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHH-HHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIE-LLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+||+|+||+||+|+.. +|+.||+|++... .......+..|.. +++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 6999999999999875 6899999998643 2233345566665 467789999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|..++... ..+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 82 ~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~----~~ 152 (325)
T cd05604 82 ELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS----DT 152 (325)
T ss_pred CHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC----CC
Confidence 999998753 35899999999999999999999 8999999999999999999999999999987532211 12
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....||..|+|||.+.+..++.++|||||||++|||++|+.||.... ..+......... ..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-~~~~~~~~~~~~--------~~~~~~~---- 219 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-VAEMYDNILHKP--------LVLRPGA---- 219 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-HHHHHHHHHcCC--------ccCCCCC----
Confidence 244569999999999999999999999999999999999999997543 223322222111 0111112
Q ss_pred HHHHHHHHHHccccCCCCCCCHH----HHHHHhhcC
Q 010088 410 LRTIVTIVRWCTQREGQARPSIK----QVLRILYES 441 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~~----evl~~L~~~ 441 (518)
...+.+++..|++.+|.+||+++ +++++.+..
T Consensus 220 ~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~ 255 (325)
T cd05604 220 SLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFE 255 (325)
T ss_pred CHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcC
Confidence 24577899999999999999875 666665553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=333.29 Aligned_cols=256 Identities=22% Similarity=0.326 Sum_probs=195.8
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.||+|+||+||+++.. +++.||+|++.... ......+.+|+.++.+++|+||+++++.+.+....++||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 4568999999999999875 58899999986432 2334568889999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc--
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC-- 325 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-- 325 (518)
+|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 85 gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 85 GGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 999999997643 5899999999999999999999 899999999999999999999999999998754321100
Q ss_pred -----------------------------cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCC
Q 010088 326 -----------------------------FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDG 376 (518)
Q Consensus 326 -----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~ 376 (518)
.........||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 000112357999999999999999999999999999999999999999754
Q ss_pred cchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHHHHHhhcC
Q 010088 377 KNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRW--CTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 377 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~--Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
... +........... +..|.. ...+ ..+.+++.. |...++..||+++|+++|.+..
T Consensus 240 ~~~-~~~~~i~~~~~~---~~~p~~-~~~s----~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~ 297 (363)
T cd05628 240 TPQ-ETYKKVMNWKET---LIFPPE-VPIS----EKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFE 297 (363)
T ss_pred CHH-HHHHHHHcCcCc---ccCCCc-CCCC----HHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCC
Confidence 432 222222211111 111110 0122 234455554 3333445679999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=318.11 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=200.7
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||.||+|+.. +|..||+|++..........+.+|+.++.+++|+||+++++++...+..++||||+++
T Consensus 11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~ 90 (267)
T cd06646 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG 90 (267)
T ss_pred cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence 445668999999999999874 6889999998754444456788999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|.++++.. ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++........
T Consensus 91 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~---- 161 (267)
T cd06646 91 GSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA---- 161 (267)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc----
Confidence 9999999754 35899999999999999999999 89999999999999999999999999999976533211
Q ss_pred ccccccCCCcccCccccc---cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 329 VNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
......|+..|+|||.+. ...++.++|||||||++|||++|+.|+.+.......... .. .....+....
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~---~~---~~~~~~~~~~-- 233 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM---SK---SNFQPPKLKD-- 233 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee---ec---CCCCCCCCcc--
Confidence 123346889999999874 345788999999999999999999998644322111100 00 0011111111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.......+.+++..||+.+|++||++++++++|+
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 1122356889999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=324.07 Aligned_cols=255 Identities=28% Similarity=0.429 Sum_probs=201.8
Q ss_pred hhhhhhcceecceEEEEEEecC------CcEEEEEEeccc-cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSD------GSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 241 (518)
+.+.+.||+|+||.||++...+ ...+|+|.+... ......++.+|++++.++ +|+||+++++++...+..++
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 93 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV 93 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence 3445689999999999998642 368999988643 334446789999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc
Q 010088 242 MYEYMANGSLKDHLHSP--------------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV 307 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 307 (518)
+|||+++|+|.++++.. ....+++..+++++.|++.||+||| +.+|+||||||+|||+++++.
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCCCe
Confidence 99999999999999642 2346899999999999999999999 899999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHH
Q 010088 308 AKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVC 386 (518)
Q Consensus 308 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~ 386 (518)
+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..|+.... ..+.....
T Consensus 171 ~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~ 247 (293)
T cd05053 171 MKIADFGLARDIHHIDYY--RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFKLL 247 (293)
T ss_pred EEeCccccccccccccce--eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-HHHHHHHH
Confidence 999999999865443211 11222345678999999988899999999999999999998 888875432 22222221
Q ss_pred HhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 387 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 387 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
... .. + ..+......+.+++.+||+.+|++|||++++++.|...
T Consensus 248 ~~~-~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 248 KEG-YR------M----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HcC-Cc------C----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 111 00 0 11112235688999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=322.70 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=202.6
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
..++||+|+||+||++... +++.||||.+.... ......+.+|+.++.+++|+||+.+++.+.+.+..++||||++
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence 3468999999999999875 58899999886432 2223457889999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++.......
T Consensus 84 g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05630 84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---- 156 (285)
T ss_pred CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----
Confidence 999999997655556999999999999999999999 8999999999999999999999999999987544322
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHH--HHHHHhhccccccccCCcCCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES--AQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~--~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||......... ...... ... ......+
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~---~~~----~~~~~~~ 228 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK---EVQ----EEYSEKF 228 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh---hhh----hhcCccC
Confidence 112346899999999999999999999999999999999999999754321111 111000 000 1111222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhcC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYES 441 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~~L~~~ 441 (518)
...+.+++..||+.||++||+ ++|+++|.+..
T Consensus 229 ----~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~ 265 (285)
T cd05630 229 ----SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265 (285)
T ss_pred ----CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence 245789999999999999999 89999988764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=316.88 Aligned_cols=247 Identities=23% Similarity=0.386 Sum_probs=196.3
Q ss_pred hcceecceEEEEEEec---CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 175 IIGQGGFGTVYKAQFS---DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
.||+|+||.||+|.+. ++..+|+|+++... ....++|.+|+.+++++.|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 57899999886432 334567999999999999999999999885 45779999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++... ..+++..+.+++.|++.||+||| +++|+||||||+||++++++.+||+|||+++.......... .
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~ 154 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK-A 154 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee-e
Confidence 999999754 35899999999999999999999 89999999999999999999999999999986543321111 1
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
.....++..|+|||.+....++.++||||||+++|||++ |+.||..... .+...... .... +.....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~i~-~~~~------~~~~~~---- 222 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQMIE-SGER------MECPQR---- 222 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH-CCCC------CCCCCC----
Confidence 122334679999999988889999999999999999998 8889865332 22222211 1110 112222
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
....+.+++.+||+.||++||++.+|...|..
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 23568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=329.15 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=198.4
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEe
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
++.+.||+|+||+||+|+.. ++..||+|.+.... ......+..|..++..+ +|++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 34568999999999999876 47899999986432 22334577788888887 589999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~- 156 (323)
T cd05616 83 VNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV- 156 (323)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-
Confidence 99999999987643 4899999999999999999999 89999999999999999999999999999875432211
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
......||+.|+|||.+.+..++.++|||||||++|||+||+.||..... ............ .+...
T Consensus 157 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~--------~~p~~- 223 (323)
T cd05616 157 ---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIMEHNV--------AYPKS- 223 (323)
T ss_pred ---ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC--------CCCCc-
Confidence 22345699999999999999999999999999999999999999975432 222222221111 11112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHhhc
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSI-----KQVLRILYE 440 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~-----~evl~~L~~ 440 (518)
....+.+++.+|++.||++|++. ++++++.+.
T Consensus 224 ---~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~ 260 (323)
T cd05616 224 ---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 260 (323)
T ss_pred ---CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCc
Confidence 23457899999999999999984 777776554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=314.56 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=201.1
Q ss_pred hhcceecceEEEEEEecC--C--cEEEEEEeccccc-hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 174 TIIGQGGFGTVYKAQFSD--G--SLIAVKRMDKISE-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
++||+|++|+||+|.+.+ + ..||||.+..... ...+.|.+|+.++++++|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998753 3 3699999876554 556789999999999999999999999988 889999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.+++.......++|..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~- 155 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV- 155 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEecccccccccccccccee-
Confidence 99999998654356899999999999999999999 89999999999999999999999999999987644321111
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......++..|+|||++.+..++.++||||||+++|||++ |+.|+...... +........... . ..+.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~---~-------~~~~ 224 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-QILKKIDKEGER---L-------ERPE 224 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhcCCc---C-------CCCc
Confidence 1123457889999999998899999999999999999999 99998643322 222221111100 0 0111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.....+.+++.+||+.+|++||++.++++.|.
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 22356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=327.21 Aligned_cols=244 Identities=25% Similarity=0.367 Sum_probs=191.8
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHH-HHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIE-LLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
.||+|+||+||+|+.. ++..||+|++.... ......+..|.. +++.++|+||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 6999999999999876 57889999986422 222334455544 567789999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.... .+.+..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~----~~ 152 (325)
T cd05602 82 ELFYHLQRER--CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN----GT 152 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC----CC
Confidence 9999997643 4788888899999999999999 8999999999999999999999999999987532221 12
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+.......... .+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~--------~~~~~~---- 219 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNILNKPL--------QLKPNI---- 219 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-HHHHHHHHhCCc--------CCCCCC----
Confidence 3445799999999999999999999999999999999999999975433 232222221111 111112
Q ss_pred HHHHHHHHHHccccCCCCCCCHH----HHHHHhhc
Q 010088 410 LRTIVTIVRWCTQREGQARPSIK----QVLRILYE 440 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~~----evl~~L~~ 440 (518)
...+.+++..|++.||.+||++. +++++.+.
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~ 254 (325)
T cd05602 220 TNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFF 254 (325)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCccc
Confidence 24578999999999999999876 45544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=316.20 Aligned_cols=248 Identities=22% Similarity=0.386 Sum_probs=195.5
Q ss_pred hcceecceEEEEEEec---CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 175 IIGQGGFGTVYKAQFS---DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
.||+|+||.||+|.+. ++..||+|.+.... ....+.|.+|+.++++++|+||++++++|. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999764 35679999886543 334467999999999999999999999885 457899999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|.+++.... ..+++..+++++.|++.||+||| +.+++||||||+|||++.++.+||+|||++.......... ...
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~ 155 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KAR 155 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccce-ecc
Confidence 999997532 35899999999999999999999 8899999999999999999999999999997554332111 111
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
....++..|+|||.+....++.++||||||+++|||++ |..||.+.... +..... ..... + ..+...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~-~~~~~------~----~~~~~~ 223 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-EVMSFI-EQGKR------L----DCPAEC 223 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHH-HCCCC------C----CCCCCC
Confidence 22334678999999988889999999999999999996 99998654332 221111 11110 1 111223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 410 LRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...+.+++..||+.+|++||++.+|.+.|..
T Consensus 224 ~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 224 PPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 3568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=321.99 Aligned_cols=252 Identities=31% Similarity=0.488 Sum_probs=201.8
Q ss_pred hhhhhcceecceEEEEEEec------CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
.+.+.||+|+||.||++... ++..+|+|.+..........|.+|++++++++|+||+++++++...+..+++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 34568999999999999642 356899999887666667789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEe
Q 010088 245 YMANGSLKDHLHSPGR-------------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA 311 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 311 (518)
|+++|+|.+++..... ..+++..++.++.|++.||+||| +.+++||||||+|||+++++.+||+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEEEC
Confidence 9999999999975431 35899999999999999999999 8999999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhc
Q 010088 312 DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASE 390 (518)
Q Consensus 312 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~ 390 (518)
|||++......... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||....... .........
T Consensus 165 dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~~~~~~ 241 (280)
T cd05092 165 DFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-AIECITQGR 241 (280)
T ss_pred CCCceeEcCCCcee--ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-HHHHHHcCc
Confidence 99998754332211 11223345788999999998999999999999999999998 888886433321 111111110
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 391 SRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 391 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
....... ....+.+++.+||+.||++||++.+|++.|.
T Consensus 242 -------~~~~~~~----~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 242 -------ELERPRT----CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -------cCCCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0111112 2245889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=329.52 Aligned_cols=247 Identities=21% Similarity=0.319 Sum_probs=196.8
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+||+|+||+||+|+.. +++.||+|+++... ......+.+|+.++.++ +|+||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 6999999999999875 57899999987532 23345688999999998 6999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|..++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~ 152 (327)
T cd05617 82 DLMFHMQRQR--KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG----DT 152 (327)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC----Cc
Confidence 9999887533 5999999999999999999999 8999999999999999999999999999987532211 12
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCC-----cchHHHHHHHHhhccccccccCCcCCCC
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDG-----KNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~-----~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||... ....+......... ...+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~p~~ 225 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-------PIRIPRF 225 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-------CCCCCCC
Confidence 23456999999999999999999999999999999999999999521 11112211111110 0111112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHHhhcC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPS------IKQVLRILYES 441 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs------~~evl~~L~~~ 441 (518)
.+ ..+.+++.+||+.||++|++ +.++++|.++.
T Consensus 226 ~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~ 264 (327)
T cd05617 226 LS----VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFR 264 (327)
T ss_pred CC----HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCC
Confidence 22 45788999999999999998 56888887654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=314.84 Aligned_cols=247 Identities=29% Similarity=0.482 Sum_probs=203.0
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.+.||+|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||++++
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG 85 (256)
T ss_pred ccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCC
Confidence 44567899999999999987 488999999876544 4577999999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.......+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||+++......
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~------ 156 (256)
T cd05039 86 SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ------ 156 (256)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc------
Confidence 9999998765556999999999999999999999 8999999999999999999999999999998653321
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
....++..|+|||.+....++.++||||||+++|||++ |..||.... ........ .... ...... .
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~-~~~~------~~~~~~----~ 223 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPHV-EKGY------RMEAPE----G 223 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHH-hcCC------CCCCcc----C
Confidence 12335678999999988899999999999999999997 888886432 22221111 1110 011111 2
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
....+.+++.+||..+|++||+++++++.|..
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 224 CPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 23568899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=317.02 Aligned_cols=252 Identities=24% Similarity=0.403 Sum_probs=198.5
Q ss_pred hhhhcceecceEEEEEEecC----CcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCc------e
Q 010088 172 FSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE------R 239 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~ 239 (518)
+.+.||+|+||.||+|.+.. +..||+|+++.. .......+.+|++.++.++|+||+++++++...+. .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 45689999999999998742 367999998643 23445679999999999999999999999876554 7
Q ss_pred EEEEEecCCCCHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccc
Q 010088 240 FLMYEYMANGSLKDHLHSP----GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL 315 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGl 315 (518)
+++|||+++|+|..++... ....+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCccc
Confidence 9999999999999998532 2346899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccc
Q 010088 316 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLA 394 (518)
Q Consensus 316 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~ 394 (518)
++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..|+.+..+ .+.........
T Consensus 160 ~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~---- 232 (273)
T cd05035 160 SKKIYSGDYY--RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYLRHGN---- 232 (273)
T ss_pred eeeccccccc--cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCC----
Confidence 9865443211 11122335678999999988899999999999999999999 7777754332 22222111110
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 395 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 395 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.+.... .....+.+++.+||+.||++||++.++++.|.+
T Consensus 233 ---~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 233 ---RLKQPE----DCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred ---CCCCCc----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 111111 233568999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=314.96 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=203.9
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecc---ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||.||+|+.. +++.||||.+.. ........|.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence 45568999999999999875 689999998753 22344457899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 247 ANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 247 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
++|+|.+++... ....+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 999999988532 2345889999999999999999999 89999999999999999999999999999886543321
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCc-chHHHHHHHHhhccccccccCCcCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK-NLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~-~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.... +.......... ...+..
T Consensus 162 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~-- 228 (267)
T cd08228 162 ----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ-------CDYPPL-- 228 (267)
T ss_pred ----HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc-------CCCCCC--
Confidence 1223468899999999988889999999999999999999999986443 22222222111 001111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
........+.+++.+||+.+|++||++.+|++.+..
T Consensus 229 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~ 264 (267)
T cd08228 229 -PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264 (267)
T ss_pred -ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence 112233568999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=321.52 Aligned_cols=251 Identities=29% Similarity=0.430 Sum_probs=197.8
Q ss_pred hhhhcceecceEEEEEEecC------CcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFSD------GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.+.||+|+||.||+|.+.+ +..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 89 (277)
T cd05036 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLE 89 (277)
T ss_pred eeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEe
Confidence 45689999999999998753 5678999876433 3445679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC---cEEEeecccc
Q 010088 245 YMANGSLKDHLHSPGR-----TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF---VAKLADFGLA 316 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DfGla 316 (518)
|+++++|.+++..... ..++|..+++++.||+.||+||| +.+++||||||+||+++.++ .+||+|||++
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEeccCccc
Confidence 9999999999975431 35899999999999999999999 88999999999999998754 6999999999
Q ss_pred ccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhcccccc
Q 010088 317 HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAE 395 (518)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~ 395 (518)
+........ ........+..|+|||++.+..++.++|||||||++|||++ |..||..... ......... ...
T Consensus 167 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-~~~~~~~~~-~~~--- 239 (277)
T cd05036 167 RDIYRASYY--RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTG-GGR--- 239 (277)
T ss_pred cccCCccce--ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHc-CCc---
Confidence 865332211 11122234568999999999999999999999999999997 8888864332 222221111 111
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 396 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 396 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
+ ..+......+.+++.+||+.+|++||++.+|+++|.
T Consensus 240 ---~----~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 ---L----DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1 111122356889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=328.70 Aligned_cols=249 Identities=23% Similarity=0.348 Sum_probs=198.6
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 244 (518)
+++.++||+|+||+||+|+.. +|+.||+|.+... .......+..|+.++..+. |++|+++.+++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 456779999999999999875 5889999998643 2233456788999998885 5778889999999899999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++|+|.+++...+ .+++.+++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 82 y~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 82 YVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 999999999997643 4899999999999999999999 89999999999999999999999999999875432211
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+....... .....
T Consensus 157 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~~~~i~~~~~--------~~p~~ 223 (323)
T cd05615 157 ----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSIMEHNV--------SYPKS 223 (323)
T ss_pred ----cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC--------CCCcc
Confidence 12345689999999999999999999999999999999999999975432 222222222111 11112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHhhc
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSI-----KQVLRILYE 440 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~-----~evl~~L~~ 440 (518)
. ...+.+++.+||+.+|.+|++. +++++|.+.
T Consensus 224 ~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f 260 (323)
T cd05615 224 L----SKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFF 260 (323)
T ss_pred C----CHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCccc
Confidence 2 2457889999999999999974 566666544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=336.18 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=196.1
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.++||+|+||+||+|+.. +++.||+|.+.... ......+.+|++++++++|+||+++++.+.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 4568999999999999875 57899999986432 2334578899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc---
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI--- 324 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~--- 324 (518)
+|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 85 gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 85 GGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 999999997643 4888999999999999999999 89999999999999999999999999999853210000
Q ss_pred ----------------------------------------ccccccccccCCCcccCccccccCCCCccccchhhHHHHH
Q 010088 325 ----------------------------------------CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLL 364 (518)
Q Consensus 325 ----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~ 364 (518)
..........||+.|+|||++.+..++.++|||||||+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 0000112346999999999999999999999999999999
Q ss_pred HHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHhhcC
Q 010088 365 EIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS---IKQVLRILYES 441 (518)
Q Consensus 365 el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs---~~evl~~L~~~ 441 (518)
||++|+.||............ ......+. .|. ....+ ....+++..++ .+|.+|++ +.++++|.+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i-~~~~~~~~---~p~-~~~~s----~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~ 309 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKV-INWQTSLH---IPP-QAKLS----PEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFK 309 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHH-HccCCCcC---CCC-cccCC----HHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcC
Confidence 999999999754433222221 11111100 010 01122 34556666654 49999987 99999987664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=321.59 Aligned_cols=258 Identities=22% Similarity=0.396 Sum_probs=197.6
Q ss_pred hhhhhhhcceecceEEEEEEecC---------------CcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeee
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFSD---------------GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGF 232 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~~---------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 232 (518)
.+.+.+.||+|+||.||+++..+ ...||+|.+... .......|.+|++++++++|+||++++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 85 (295)
T cd05097 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV 85 (295)
T ss_pred hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 34556789999999999987632 235899988643 33345679999999999999999999999
Q ss_pred eeecCceEEEEEecCCCCHHHHhcCCC----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe
Q 010088 233 CIEKRERFLMYEYMANGSLKDHLHSPG----------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL 302 (518)
Q Consensus 233 ~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 302 (518)
+...+..++||||+++++|.+++.... ...++|..+++++.+++.||+||| +.+++||||||+||++
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nill 162 (295)
T cd05097 86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLV 162 (295)
T ss_pred EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEEE
Confidence 999999999999999999999986432 124789999999999999999999 8999999999999999
Q ss_pred cCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh--CCccccCCcchH
Q 010088 303 DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT--ARRAVQDGKNLV 380 (518)
Q Consensus 303 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t--G~~p~~~~~~~~ 380 (518)
++++.+||+|||++......... .......++..|+|||.+.++.++.++||||||+++|||++ |..||..... .
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-~ 239 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-E 239 (295)
T ss_pred cCCCcEEecccccccccccCcce--eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-H
Confidence 99999999999999765433211 11223345778999999998899999999999999999998 4556643221 1
Q ss_pred HHHHH---HHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 381 ESAQV---CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 381 ~~~~~---~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
+.... .......... ..... .....+.+++.+||+.||++||++.+|++.|.
T Consensus 240 ~~~~~~~~~~~~~~~~~~---~~~~~----~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTGEFFRNQGRQIY---LSQTP----LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHhhhhcccccc---CCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111 1111000000 00111 12356999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=316.42 Aligned_cols=250 Identities=26% Similarity=0.442 Sum_probs=198.8
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeec------CceEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEK------RERFLM 242 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------~~~~lV 242 (518)
+..+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +|+||+++++++... ...++|
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 44568999999999999875 57899999886543 3346788999999999 699999999998753 357999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+.+|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred EEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 99999999999998755556899999999999999999999 889999999999999999999999999998764332
Q ss_pred CcccccccccccCCCcccCccccc-----cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccccc
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 397 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 397 (518)
. .......|+..|+|||++. ...++.++|||||||++|||++|+.|+.+........... ........
T Consensus 165 ~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~ 237 (272)
T cd06637 165 V----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---RNPAPRLK 237 (272)
T ss_pred c----ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh---cCCCCCCC
Confidence 1 1223456899999999986 3458889999999999999999999996544332222111 00001111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.. .....+.+++.+||+.+|.+||++.+++++.|
T Consensus 238 ----~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (272)
T cd06637 238 ----SK----KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271 (272)
T ss_pred ----CC----CcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence 11 12246889999999999999999999998765
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=326.43 Aligned_cols=264 Identities=22% Similarity=0.297 Sum_probs=199.9
Q ss_pred hhhhccee--cceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 172 FSTIIGQG--GFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 172 f~~~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
+.++||+| +||+||+++.. +|..||+|+++... ......+.+|+++++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 78999999875 68999999986432 333456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc-
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC- 325 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~- 325 (518)
++|+|.+++.......+++..++.++.|++.||+||| +.+|+||||||+|||++.++.++++|||.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999997654456899999999999999999999 899999999999999999999999999865433211100
Q ss_pred --cccccccccCCCcccCcccccc--CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCC--
Q 010088 326 --FEPVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP-- 399 (518)
Q Consensus 326 --~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~-- 399 (518)
.........++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.......... .. .......+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~--~~~~~~~~~~~ 235 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LN--GTVPCLLDTTT 235 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hc--CCccccccccc
Confidence 0001122356788999999876 46899999999999999999999999643321111111 00 011111000
Q ss_pred -----------------cC-----------------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 400 -----------------RI-----------------KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 400 -----------------~l-----------------~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+ ...........+.+++.+||+.||++|||+++++++.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~ 311 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence 00 0001112235688999999999999999999999988764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=333.14 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=199.5
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.++||+|+||.||+++.. +++.+|+|.+.+. .......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEY 124 (370)
T ss_pred CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcC
Confidence 444568999999999999876 5789999998642 223345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++|+|.+++... .+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||++........
T Consensus 125 ~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~- 197 (370)
T cd05621 125 MPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM- 197 (370)
T ss_pred CCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc-
Confidence 9999999999753 4788999999999999999999 89999999999999999999999999999986543221
Q ss_pred cccccccccCCCcccCccccccC----CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQ----ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
.......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ............+ .+
T Consensus 198 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~------~~ 268 (370)
T cd05621 198 --VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GTYSKIMDHKNSL------NF 268 (370)
T ss_pred --eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCccc------CC
Confidence 112345699999999998654 3788999999999999999999999754332 2222222111110 01
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHhhcCC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQA--RPSIKQVLRILYESS 442 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~--RPs~~evl~~L~~~~ 442 (518)
.. .......+.+++..|++.++.+ |+++.|+++|.|...
T Consensus 269 p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 269 PE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred CC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 11 1112345778888999865543 899999999987754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=334.12 Aligned_cols=257 Identities=22% Similarity=0.297 Sum_probs=198.3
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||+||+++.. +|+.||||.+.... ......+.+|+++|.+++|+||+++++.+.+.+..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence 34568999999999999875 58999999986432 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc--
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI-- 324 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 324 (518)
++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|........
T Consensus 84 ~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 84 PGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999999997643 4888999999999999999999 89999999999999999999999999999853210000
Q ss_pred -------------------------------------ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHH
Q 010088 325 -------------------------------------CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 367 (518)
Q Consensus 325 -------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~ 367 (518)
..........||+.|||||++.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 0000112357999999999999999999999999999999999
Q ss_pred hCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHHhhcCC
Q 010088 368 TARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARP---SIKQVLRILYESS 442 (518)
Q Consensus 368 tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP---s~~evl~~L~~~~ 442 (518)
+|+.||........... ....... ...+. ....+ ..+.+++.+|+ .+|.+|+ ++.++++|.+...
T Consensus 239 ~G~~Pf~~~~~~~~~~~-i~~~~~~---~~~~~-~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 239 VGQPPFLADTPAETQLK-VINWETT---LHIPS-QAKLS----REASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred hCCCCCCCCCHHHHHHH-HhccCcc---ccCCC-CCCCC----HHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999975543222211 1111110 00010 11122 34666777765 4999999 9999999987653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=314.00 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=193.9
Q ss_pred hcceecceEEEEEEecC---CcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 175 IIGQGGFGTVYKAQFSD---GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
.||+|+||.||+|.+.+ +..+|+|.++... ......|.+|+.++++++|+||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998653 3579999886533 3344578999999999999999999999999999999999999999
Q ss_pred HHHHhcCCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 251 LKDHLHSPG---RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 251 L~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
|.++++... ....++..+..++.|++.||+||| +.+++||||||+||+++.++++||+|||+++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-- 156 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY-- 156 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence 999997532 234678888899999999999999 899999999999999999999999999998754332211
Q ss_pred cccccccCCCcccCccccccC-------CCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQ-------ELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDP 399 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~ 399 (518)
.......++..|+|||++.+. .++.++||||||+++|||++ |+.||.............. .......++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~ 233 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR---EQQLKLPKP 233 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh---cccCCCCCC
Confidence 112334578899999988542 35789999999999999996 9989865433222111111 111222233
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 400 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.+.... ...+.+++..|| .+|++||++++|++.|.
T Consensus 234 ~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 234 RLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 333222 235778999999 68999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=336.36 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=201.3
Q ss_pred HhhhhhhhcceecceEEEEEEec------CCcEEEEEEecccc-chhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCce
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRER 239 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 239 (518)
....+.++||+|+||.||+|++. .+..||||+++... ......+.+|+++|.++. |+||++++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 33445678999999999999863 24689999997542 233457899999999997 99999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC------------------------------------------------------------
Q 010088 240 FLMYEYMANGSLKDHLHSPG------------------------------------------------------------ 259 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------ 259 (518)
++||||+++|+|.++++...
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999999996432
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec
Q 010088 260 ------------------------------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD 303 (518)
Q Consensus 260 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~ 303 (518)
...++|..+..++.|++.||+||| +.+|+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEe
Confidence 124688889999999999999999 89999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHH
Q 010088 304 ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVES 382 (518)
Q Consensus 304 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~ 382 (518)
+++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred CCCEEEEEecCcceeccccccc--ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 9999999999999864332211 11223457889999999998889999999999999999998 88888543322221
Q ss_pred HHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 383 AQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 383 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
... +....+ +.... .....+.+++..||+.+|.+||++++|++.|..
T Consensus 352 ~~~-~~~~~~------~~~p~----~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 352 YNA-IKRGYR------MAKPA----HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred HHH-HHcCCC------CCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111 111111 11111 123568999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=320.65 Aligned_cols=259 Identities=24% Similarity=0.304 Sum_probs=195.7
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHc---CCCCeeeEeeeeeec-----CceE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARL---HHRHLVALRGFCIEK-----RERF 240 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~-----~~~~ 240 (518)
..+.||+|+||+||+|+.. +|+.||+|.++... ......+.+|+.+++++ +|+||+++++++... ...+
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~ 83 (288)
T cd07863 4 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVT 83 (288)
T ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEE
Confidence 4567999999999999876 58899999886432 22234566788877766 699999999988653 3579
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCC
Q 010088 241 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~ 320 (518)
+||||+. ++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++...
T Consensus 84 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 84 LVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred EEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 9999997 48999987655556899999999999999999999 8999999999999999999999999999997654
Q ss_pred CCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhh----cccccc-
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS----ESRLAE- 395 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~----~~~l~~- 395 (518)
... ......||..|+|||.+.+..++.++|||||||++|||++|+.||................ ...+..
T Consensus 160 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 160 CQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred Ccc-----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 322 1234568999999999998899999999999999999999999986543332222111100 000000
Q ss_pred ------ccCCcCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 396 ------LVDPRIK---DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 396 ------~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
...+... .....+....+.+++.+|++.||++||++.|++.|.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~ 287 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 0000000 0001122356789999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.33 Aligned_cols=253 Identities=28% Similarity=0.362 Sum_probs=201.2
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC--------c
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR--------E 238 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--------~ 238 (518)
+.+.++||+|+||+||+|+.. +|+.||||.+... .......+.+|+.++..++|+||+++...+...+ .
T Consensus 34 Y~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~ 113 (496)
T PTZ00283 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLM 113 (496)
T ss_pred EEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceE
Confidence 345678999999999999764 6899999998643 3444567889999999999999999988765432 3
Q ss_pred eEEEEEecCCCCHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccc
Q 010088 239 RFLMYEYMANGSLKDHLHSPG--RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 316 (518)
Q Consensus 239 ~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla 316 (518)
.++||||+++|+|.++++... ...+++..+..++.|++.||+||| +.+|+||||||+||||+.++.+||+|||++
T Consensus 114 i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred EEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 689999999999999997532 346899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccc
Q 010088 317 HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL 396 (518)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~ 396 (518)
+....... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||... +..+.........
T Consensus 191 ~~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-~~~~~~~~~~~~~------ 261 (496)
T PTZ00283 191 KMYAATVS--DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-NMEEVMHKTLAGR------ 261 (496)
T ss_pred eecccccc--ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHhcCC------
Confidence 76543211 11234457999999999999999999999999999999999999999643 3333332222111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 397 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 397 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.++ +... ....+.+++..||+.||.+||++.+++++.+
T Consensus 262 ~~~-~~~~----~~~~l~~li~~~L~~dP~~RPs~~ell~~p~ 299 (496)
T PTZ00283 262 YDP-LPPS----ISPEMQEIVTALLSSDPKRRPSSSKLLNMPI 299 (496)
T ss_pred CCC-CCCC----CCHHHHHHHHHHcccChhhCcCHHHHHhCHH
Confidence 111 1122 2356889999999999999999999998743
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.56 Aligned_cols=259 Identities=20% Similarity=0.327 Sum_probs=193.3
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--------CceE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK--------RERF 240 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~~~~ 240 (518)
+.+.++||+|+||+||+|... +++.||||++.... ....+|+.+|++++|+||+++++++... ...+
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 445678999999999999875 58899999885432 2345799999999999999999876432 1367
Q ss_pred EEEEecCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC-CcEEEeeccccc
Q 010088 241 LMYEYMANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAH 317 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DfGla~ 317 (518)
+||||+++ +|.+++.. .....+++..+..++.||+.||+||| +.+|+||||||+||||+.+ +.+||+|||+++
T Consensus 144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 89999975 78777642 22346899999999999999999999 8999999999999999865 479999999998
Q ss_pred cCCCCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc----
Q 010088 318 ASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR---- 392 (518)
Q Consensus 318 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~---- 392 (518)
....+. ......||+.|+|||.+.+ ..++.++|||||||+||||++|..||...................
T Consensus 220 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 220 NLLAGQ-----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred hccCCC-----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 654332 1234568999999998865 468999999999999999999999997554332222221110000
Q ss_pred -------cccccCCc-----CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 393 -------LAELVDPR-----IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 393 -------l~~~~d~~-----l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..++.-+. +...++......+.+++.+||+.||.+||++.|+++|.++.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~ 355 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence 00000011 11111112235688999999999999999999999998764
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=337.12 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=206.7
Q ss_pred hhhhcceecceEEEEEEec--CC--cEEEEEEeccccch-hHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 172 FSTIIGQGGFGTVYKAQFS--DG--SLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~--~g--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
+.++||+|.||.|++|.|. +| ..||||.++..... ...+|++|+.+|.+|+|+|+++|+|+..+ ....||||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 4568999999999999886 34 36899999865544 66899999999999999999999999887 7889999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
+.|||.+.|++..+..|-......++.|||.||+||. .+++|||||.++|+||-....+||+||||.+.++.+...+
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 9999999999866667888999999999999999999 9999999999999999999999999999999887665433
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhC-CccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA-RRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG-~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.+.....-...|+|||.+....++.++|||+|||+||||+|+ ..||.. ..-.+..+. +|..-+-.-
T Consensus 270 -vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G-~~g~qIL~~-----------iD~~erLpR 336 (1039)
T KOG0199|consen 270 -VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG-CRGIQILKN-----------IDAGERLPR 336 (1039)
T ss_pred -EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC-CCHHHHHHh-----------ccccccCCC
Confidence 223334457789999999999999999999999999999995 566653 333333222 221111223
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
+..+.+.+++|+..||..+|++||++..+.+.+
T Consensus 337 Pk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 337 PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 445668899999999999999999999997544
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=334.04 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=197.7
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.||+|+||+||+++.. +|+.||||++... .......+.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 4568999999999999765 6899999988642 22334568899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc---
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI--- 324 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~--- 324 (518)
+|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 85 GGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 99999999764 35889999999999999999999 89999999999999999999999999999963211000
Q ss_pred ---------ccc-------------------------------cccccccCCCcccCccccccCCCCccccchhhHHHHH
Q 010088 325 ---------CFE-------------------------------PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLL 364 (518)
Q Consensus 325 ---------~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~ 364 (518)
... .......||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 000 0001246999999999999999999999999999999
Q ss_pred HHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHHhhcC
Q 010088 365 EIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQAR---PSIKQVLRILYES 441 (518)
Q Consensus 365 el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~R---Ps~~evl~~L~~~ 441 (518)
||++|+.||...... +...........+ . +... ......+.+++..|++ +|.+| +++.++++|.+..
T Consensus 240 elltG~~Pf~~~~~~-~~~~~i~~~~~~~---~---~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~ 309 (377)
T cd05629 240 ECLIGWPPFCSENSH-ETYRKIINWRETL---Y---FPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFR 309 (377)
T ss_pred hhhcCCCCCCCCCHH-HHHHHHHccCCcc---C---CCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcC
Confidence 999999999754432 2222211111110 0 1110 0112457789999997 66664 6999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=317.67 Aligned_cols=254 Identities=25% Similarity=0.439 Sum_probs=201.0
Q ss_pred hhhhhhcceecceEEEEEEec-CC---cEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DG---SLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
++..+.||+|+||.||+|++. ++ ..+|+|.++.. ......++.+|++++++++|+||+++.+++...+..++|||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 344578999999999999875 23 37999988643 33445679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++++|.+++.... ..+++..++.++.+++.||+||| +.+++||||||+||++++++.+||+|||++........
T Consensus 87 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 87 YMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 999999999997543 35899999999999999999999 88999999999999999999999999999876543221
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
. .........+..|+|||++....++.++|||||||++|||++ |+.||..... .+...... .....
T Consensus 163 ~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-~~~~~~i~-~~~~~---------- 229 (268)
T cd05063 163 G-TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAIN-DGFRL---------- 229 (268)
T ss_pred c-ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHHHh-cCCCC----------
Confidence 1 001112223567999999988889999999999999999998 9999864332 22222211 11111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
....+....+.+++.+||+.+|++||++.+|++.|.+
T Consensus 230 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1111233568899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=314.17 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=191.3
Q ss_pred hcceecceEEEEEEecC---CcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 175 IIGQGGFGTVYKAQFSD---GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
.||+|+||+||+|...+ ...+|+|.+.... ......|.+|+.+++.++|+||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997643 3478888775432 3344678999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 251 LKDHLHSPGR---TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 251 L~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
|.+++..... ...++.....++.|++.||+||| +.+|+||||||+|||+++++++||+|||+++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 156 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY-- 156 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhe--
Confidence 9999975432 23568888999999999999999 899999999999999999999999999998754332211
Q ss_pred cccccccCCCcccCcccccc-------CCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVT-------QELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDP 399 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~ 399 (518)
.......++..|+|||++.. ..++.++|||||||++|||++ |..||....+........... ...+.++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~---~~~~~~~ 233 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ---DIKLPKP 233 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc---CccCCCC
Confidence 01123346778999998743 456889999999999999999 677776544332222221111 1122223
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 400 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
.+... ....+.+++..|| .||++||++++|++.|
T Consensus 234 ~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 234 QLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 22222 2355677889998 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=320.00 Aligned_cols=261 Identities=27% Similarity=0.445 Sum_probs=198.3
Q ss_pred hhhhcceecceEEEEEEec-----CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEEEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-----DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMYE 244 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e 244 (518)
+.+.||+|+||+||++.+. ++..||+|++........+.|.+|++++++++|+||+++++++... ...++|||
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 87 (284)
T cd05081 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87 (284)
T ss_pred eeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEE
Confidence 4568999999999999753 5789999998766666667899999999999999999999987543 46899999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++|+|.+++.... ..++|..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.......
T Consensus 88 ~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 88 YLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred ecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence 999999999997543 35899999999999999999999 89999999999999999999999999999986544321
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc-------ccccc
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR-------LAELV 397 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~-------l~~~~ 397 (518)
.. .......++..|+|||.+.+..++.++||||||+++|||++|..++..... .+... ...... +.+.+
T Consensus 164 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 164 YY-KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA--EFMRM-MGNDKQGQMIVYHLIELL 239 (284)
T ss_pred ce-eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch--hhhhh-cccccccccchHHHHHHH
Confidence 10 011122344569999999988999999999999999999998776542211 11100 000000 00001
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...............+.+++.+||+.+|++|||+++|++.|..
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 1000001111223568999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=313.54 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=204.2
Q ss_pred hhhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.++||+|+||+||+|..+++..+|||.+.... ....++.+|+.++++++|+||+++++++......++||||+++
T Consensus 7 ~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (261)
T cd05034 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSK 85 (261)
T ss_pred heeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCC
Confidence 345567899999999999998888899999887433 3346799999999999999999999999988999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|.+++.......+++..+..++.+++.||+||| +.+++|+||||+||++++++.+||+|||++.........
T Consensus 86 ~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~--- 159 (261)
T cd05034 86 GSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT--- 159 (261)
T ss_pred CCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhhh---
Confidence 99999998765556999999999999999999999 889999999999999999999999999998765432211
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ........ . . ......
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~-~--~----~~~~~~---- 227 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQVER-G--Y----RMPRPP---- 227 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHc-C--C----CCCCCC----
Confidence 1122335678999999998899999999999999999999 88888643322 22221111 0 0 001111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.....+.+++.+|++.+|++||+++++++.|.
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 228 NCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 12356899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=334.27 Aligned_cols=257 Identities=27% Similarity=0.428 Sum_probs=210.0
Q ss_pred hhhcceecceEEEEEEecC-CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 173 STIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
...||.|+||.||||..++ +...|.|.+...+....++|+-||+||..+.||+||+|++.|...+.+|++.|||.||-.
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV 116 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV 116 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence 3468999999999998765 455677888877888889999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccc
Q 010088 252 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331 (518)
Q Consensus 252 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 331 (518)
...+-.-+ .+|+..++.-++.+++.||.||| +++|||||||+.|||++-+|.++|+|||.+....... ....
T Consensus 117 DaimlEL~-r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~----qkRD 188 (1187)
T KOG0579|consen 117 DAIMLELG-RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR----QKRD 188 (1187)
T ss_pred hHHHHHhc-cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHH----hhhc
Confidence 98886654 36999999999999999999999 9999999999999999999999999999876433211 2345
Q ss_pred cccCCCcccCccccc-----cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 332 DIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 332 ~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
.+.||+.|||||+.. ..+|+.++||||||++|.||..+.+|..+-....-...+. ....+.+..|
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia---KSePPTLlqP------- 258 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPPTLLQP------- 258 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh---hcCCCcccCc-------
Confidence 678999999999875 4689999999999999999999999886543322222111 1111222222
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCCc
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHS 447 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~ 447 (518)
......+.+++..||..||..||++.++++|.|....+...
T Consensus 259 S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK 299 (1187)
T KOG0579|consen 259 SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNK 299 (1187)
T ss_pred chhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcch
Confidence 23346789999999999999999999999999988655443
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=329.24 Aligned_cols=245 Identities=24% Similarity=0.333 Sum_probs=193.3
Q ss_pred cceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHc---CCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 176 IGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL---HHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
||+|+||+||+|+.. +|..||||++.... ......+..|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 58999999986422 22233456677777766 699999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~----~ 151 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN----K 151 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----C
Confidence 99999987643 4899999999999999999999 8999999999999999999999999999987543221 1
Q ss_pred ccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......||..|+|||.+.+. .++.++|||||||++|||++|+.||.... ..+...........+. ....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~-------~~~~-- 221 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIAFGKVRFP-------KNVL-- 221 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-HHHHHHHHHcCCCCCC-------CccC--
Confidence 22345699999999998764 48999999999999999999999996533 2222222211111111 0111
Q ss_pred HHHHHHHHHHHHccccCCCCCC----CHHHHHHHhhcC
Q 010088 408 EQLRTIVTIVRWCTQREGQARP----SIKQVLRILYES 441 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RP----s~~evl~~L~~~ 441 (518)
...+.+++.+||+.||.+|| ++.++++|.+..
T Consensus 222 --~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~ 257 (330)
T cd05586 222 --SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA 257 (330)
T ss_pred --CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcccc
Confidence 24577899999999999998 688888887654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=313.75 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=204.3
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.+.||+|+||.||+|+.. +|..+|||.+... ......+|.+|+.+++.++|+||+++++++.+.+..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 445678999999999999864 7899999987542 233446789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 246 MANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 246 ~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
+++++|.+++.. .....+++..++.++.+++.||+||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999863 22346899999999999999999999 8999999999999999999999999999987654332
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcc-hHHHHHHHHhhccccccccCCcCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN-LVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~-~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
. ......|+..|+|||.+.+..++.++||||||+++|||++|..||..... ........ .....+.+.
T Consensus 161 ~----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~ 229 (267)
T cd08229 161 T----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-------EQCDYPPLP 229 (267)
T ss_pred c----ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhh-------hcCCCCCCC
Confidence 1 12334688999999999888899999999999999999999999864321 11211111 111111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
. ......+.+++.+||+.+|++||||.+|++.+.+
T Consensus 230 ~---~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 230 S---DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred c---ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 1 1233568899999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=319.11 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=204.6
Q ss_pred HhhhhhhhcceecceEEEEEEec-CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
..+.+.+.||+|+||+||++... +|..||+|.+... .......+.+|+++++.++|+||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 34556678999999999999875 5889999987643 234457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++++|.+++...+ .+++..+..++.+++.||.|||+ ..+++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999999987643 58999999999999999999993 2589999999999999999999999999986542221
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcch----------HHHHHHHHhhcccccc
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL----------VESAQVCMASESRLAE 395 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~----------~~~~~~~~~~~~~l~~ 395 (518)
.....|+..|+|||.+.+..++.++|||||||++|||+||+.||...... ...........
T Consensus 159 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 159 ----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred ----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 22346899999999998889999999999999999999999999743321 11111111100
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 396 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 396 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.+.+.. ......+.+++.+||+.||++||++.|++++++...
T Consensus 230 --~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 230 --PPRLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred --CCCCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 111111 123356889999999999999999999999887654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=319.73 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=195.4
Q ss_pred hhhhcceecceEEEEEEec-CCc----EEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGS----LIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.||+|+||+||+|.+. +|. .+++|.+.... .....++..|+.++++++|+||+++++++. ....++++||
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~ 89 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQL 89 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEe
Confidence 3468999999999999874 344 47778775432 233467888999999999999999999875 4567899999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++|+|.+++.... ..++|..+..|+.||+.||+||| +.+++||||||+|||+++++.+||+|||+++........
T Consensus 90 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 90 SPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred CCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 99999999997543 35899999999999999999999 899999999999999999999999999999865433211
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.......++..|++||.+.+..++.++||||||+++|||++ |+.|+..... ...... +...... ..+..
T Consensus 166 --~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~-~~~~~~~---~~~~~--- 235 (279)
T cd05111 166 --YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDL-LEKGERL---AQPQI--- 235 (279)
T ss_pred --cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHH-HHCCCcC---CCCCC---
Confidence 11234457789999999998899999999999999999998 9888864332 111111 1111111 11111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
....+.+++..||..+|++||++.|+++.|...
T Consensus 236 ----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 236 ----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred ----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 123577899999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=317.05 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=199.2
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.++||+|+||.||+|... ++..||+|.+... .......|.+|++++.+++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 34568999999999999864 6889999988643 333446799999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|..+. .+++..+..++.|++.||+||| +.+|+|+||||+|||++.++.+||+|||++......
T Consensus 84 ~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~------ 148 (279)
T cd06619 84 GSLDVYR------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------ 148 (279)
T ss_pred CChHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc------
Confidence 9997653 3788899999999999999999 899999999999999999999999999999765332
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcch------HHHHHHHHhhccccccccCCcCC
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL------VESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~------~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ...... .... ..+.+.
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~------~~~~~~ 221 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-IVDE------DPPVLP 221 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-Hhcc------CCCCCC
Confidence 123457899999999999989999999999999999999999998532111 011111 0000 011111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
. ......+.+++.+||+.+|++||++++++++.+....
T Consensus 222 ~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 222 V---GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred C---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 1 1122458899999999999999999999999877544
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=315.51 Aligned_cols=254 Identities=27% Similarity=0.401 Sum_probs=203.2
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
..+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++|+||+++++++...+..++||||+++++
T Consensus 9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~ 88 (282)
T cd06643 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 88 (282)
T ss_pred HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence 4457999999999999876 477889998876555566789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|..++.... .++++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........ ..
T Consensus 89 l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~----~~ 160 (282)
T cd06643 89 VDAVMLELE-RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ----RR 160 (282)
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc----cc
Confidence 999886532 36999999999999999999999 89999999999999999999999999999875433211 12
Q ss_pred ccccCCCcccCccccc-----cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 331 TDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
....++..|+|||++. +..++.++|||||||++|||++|+.|+............ .... ......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~-~~~~--~~~~~~------- 230 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI-AKSE--PPTLAQ------- 230 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH-hhcC--CCCCCC-------
Confidence 3356899999999884 345788999999999999999999998654322221111 1110 001111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
+......+.+++..||+.+|.+||++.+++++.+....
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 11123468899999999999999999999999876543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=315.40 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=197.6
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHH
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK 252 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 252 (518)
.+||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++...+..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 47999999999999865 57889999887665556678999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-CCcEEEeeccccccCCCCCcccccc
Q 010088 253 DHLHSPGRTPL--SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 253 ~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+++.... ..+ ++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++........ .
T Consensus 94 ~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~----~ 165 (268)
T cd06624 94 ALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP----C 165 (268)
T ss_pred HHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC----c
Confidence 9997532 234 88889999999999999999 899999999999999976 67999999999875533221 1
Q ss_pred cccccCCCcccCccccccC--CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 330 NTDIRGTPGYMDPEYVVTQ--ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~--~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
.....|+..|+|||++.+. .++.++||||||+++|||++|+.|+.............. .. -..+.+..
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~-----~~-~~~~~~~~---- 235 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG-----MF-KIHPEIPE---- 235 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh-----hh-ccCCCCCc----
Confidence 2234588999999998664 378899999999999999999999864332111110000 00 00111222
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.....+.+++.+||+.+|++||++.+++++.|
T Consensus 236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 267 (268)
T cd06624 236 SLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267 (268)
T ss_pred ccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence 22356889999999999999999999998865
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=320.32 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=199.4
Q ss_pred hhhhcceecceEEEEEEec------CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.++||+|+||+||+|... ....+++|.+.... .....++.+|+.+++.++||||+++++.|...+..++++|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 4568999999999999753 23578888876433 3345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC----------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe
Q 010088 245 YMANGSLKDHLHSP----------------------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL 302 (518)
Q Consensus 245 ~~~~gsL~~~l~~~----------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 302 (518)
|+.+|+|.+++... ....+++..++.++.|++.||+||| +.+++||||||+|||+
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheEEE
Confidence 99999999998642 1235889999999999999999999 8999999999999999
Q ss_pred cCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHH
Q 010088 303 DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVE 381 (518)
Q Consensus 303 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~ 381 (518)
++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.... ...
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~ 237 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSY--VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-PER 237 (290)
T ss_pred cCCCcEEeccccccccccCccch--hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-HHH
Confidence 99999999999999765332211 01123345778999999988889999999999999999999 888885432 222
Q ss_pred HHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 382 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 382 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..... ... ....... .....+.+++..||+.+|++||++.++++.|...
T Consensus 238 ~~~~~-~~~------~~~~~~~----~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 LFNLL-KTG------YRMERPE----NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred HHHHH-hCC------CCCCCCC----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 22211 111 0111111 2235688999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=319.28 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=203.9
Q ss_pred HhhhhhhhcceecceEEEEEEecC-----CcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeee-cCceE
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFSD-----GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIE-KRERF 240 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 240 (518)
..+.+.++||+|+||.||+|.+.+ +..|++|++... .......+.+|+.++++++|+||+++++++.. ....+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 344556789999999999998865 688999988643 33445678999999999999999999999876 46789
Q ss_pred EEEEecCCCCHHHHhcCCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecc
Q 010088 241 LMYEYMANGSLKDHLHSPGR------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG 314 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfG 314 (518)
+++||+++|+|.+++..... ..+++..++.++.+++.||+||| +.+++||||||+||++++++.+||+|||
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 99999999999999965321 45899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhcccc
Q 010088 315 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRL 393 (518)
Q Consensus 315 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l 393 (518)
+++........ .......++..|+|||.+.+..++.++||||||+++||+++ |+.|+..... .++.... .....+
T Consensus 163 ~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~-~~~~~~ 238 (280)
T cd05043 163 LSRDLFPMDYH--CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-FEMAAYL-KDGYRL 238 (280)
T ss_pred CcccccCCceE--EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-HHHHHHH-HcCCCC
Confidence 99865433211 11223346778999999988889999999999999999999 9998865432 2222211 111111
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 394 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 394 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.... .....+.+++.+||+.||++||++.++++.|...
T Consensus 239 ------~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 239 ------AQPI----NCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred ------CCCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111 1234688999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.66 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=206.3
Q ss_pred hcceecceEEEEEEecC-CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHHH
Q 010088 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKD 253 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 253 (518)
+||+|.||+||.|+..+ ...+|||.+........+-+..||.+-+.|+|+|||+++|.|.+++..-+.||-++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999998765 56899999876666666778899999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-CCcEEEeeccccccCCCCCccccccc
Q 010088 254 HLHSPGRTPL--SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 254 ~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
+|+..-+ ++ ++.++-.+.+||++||.||| ++.|||||||-+|||++- .|.+||+|||.++....- .+.+
T Consensus 662 LLrskWG-PlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi----nP~T 733 (1226)
T KOG4279|consen 662 LLRSKWG-PLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI----NPCT 733 (1226)
T ss_pred HHHhccC-CCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccC----Cccc
Confidence 9986422 35 77888889999999999999 999999999999999974 899999999998865432 3456
Q ss_pred ccccCCCcccCccccccC--CCCccccchhhHHHHHHHHhCCccccCCcch-HHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 331 TDIRGTPGYMDPEYVVTQ--ELTEKSDVYSYGVVLLEIVTARRAVQDGKNL-VESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~--~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~-~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
..+.||..|||||++..+ .|+.++|||||||++.||.||++||.+-.+. ..+.+.-+. .+.| ..+.
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy-------KvHP----~iPe 802 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY-------KVHP----PIPE 802 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce-------ecCC----CCcH
Confidence 778899999999999765 5899999999999999999999999764433 222222111 1123 3444
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+...+...+|.+|+.+||.+||+++++|+..+-..
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~ 837 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQH 837 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhccCccccc
Confidence 55677889999999999999999999998665443
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=309.92 Aligned_cols=249 Identities=29% Similarity=0.448 Sum_probs=202.8
Q ss_pred hhcceecceEEEEEEecC----CcEEEEEEeccccch-hHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 174 TIIGQGGFGTVYKAQFSD----GSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
++||+|+||.||+|.... +..|++|.+...... ..+.+.+|++++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999998764 789999998754333 367899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 249 GSLKDHLHSPG-------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 249 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
++|.+++.... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999998642 256999999999999999999999 89999999999999999999999999999987654
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
... ........++..|+|||.+....++.++||||||+++|||++ |..||.... ..+....... .. ...
T Consensus 158 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~~-~~------~~~ 227 (262)
T cd00192 158 DDY--YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-NEEVLEYLRK-GY------RLP 227 (262)
T ss_pred ccc--cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHc-CC------CCC
Confidence 321 012334567889999999988899999999999999999999 588886542 2222222111 10 111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
. +......+.+++.+||+.+|++||++.+++++|.
T Consensus 228 ~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 K----PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred C----CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1 1122356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=322.13 Aligned_cols=252 Identities=30% Similarity=0.429 Sum_probs=197.8
Q ss_pred hhhhhcceecceEEEEEEecC-Cc--EEEEEEeccc-cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEe
Q 010088 171 NFSTIIGQGGFGTVYKAQFSD-GS--LIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
.+.++||+|+||.||+|...+ +. .+++|.++.. .....+.|.+|++++.++ +||||+++++++.+.+..++|+||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 456689999999999998753 33 4788887643 334456799999999999 799999999999999999999999
Q ss_pred cCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEe
Q 010088 246 MANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA 311 (518)
Q Consensus 246 ~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 311 (518)
+++|+|.++++... ...+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeEEEC
Confidence 99999999997532 134889999999999999999999 8999999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhc
Q 010088 312 DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASE 390 (518)
Q Consensus 312 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~ 390 (518)
|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||..... .........
T Consensus 162 dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-~~~~~~~~~-- 233 (297)
T cd05089 162 DFGLSRGEEVYV-----KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-AELYEKLPQ-- 233 (297)
T ss_pred CcCCCcccccee-----ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHhc--
Confidence 999986432211 1112233567999999988899999999999999999998 9899864332 222221111
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 391 SRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 391 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
...+..... ....+.+++..||+.+|.+||++.++++.|....
T Consensus 234 -----~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 234 -----GYRMEKPRN----CDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred -----CCCCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011111112 2246889999999999999999999999886544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=320.21 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=204.3
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
..+.||+|+||.||+|... ++..||+|.+..........+.+|+.+++.++|+||+++++++......++||||+++++
T Consensus 24 ~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~ 103 (296)
T cd06654 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (296)
T ss_pred eEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCC
Confidence 4457999999999999864 688999999876555555778999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|.+++.. ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 104 L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~----~~ 173 (296)
T cd06654 104 LTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS----KR 173 (296)
T ss_pred HHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc----cc
Confidence 9999964 24899999999999999999999 89999999999999999999999999999875433221 12
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 410 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 410 (518)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||........+..... .. . +.+ ..+....
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~--~-----~~~--~~~~~~~ 243 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NG--T-----PEL--QNPEKLS 243 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CC--C-----CCC--CCccccC
Confidence 334688999999999888899999999999999999999999975543322221111 00 0 011 1111233
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 411 RTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 411 ~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
..+.+++.+||..+|++||++.+++++.+...
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 56889999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=315.08 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=196.2
Q ss_pred hhhhcceecceEEEEEEecCC-c--EEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec------CceE
Q 010088 172 FSTIIGQGGFGTVYKAQFSDG-S--LIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERF 240 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~g-~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 240 (518)
+.++||+|+||.||+|++.++ . .+|+|.++.. .....+.|.+|++++.+++|+||++++++|... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 456899999999999987643 2 6899987643 334456789999999999999999999988543 2468
Q ss_pred EEEEecCCCCHHHHhcC----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccc
Q 010088 241 LMYEYMANGSLKDHLHS----PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 316 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla 316 (518)
++|||+++|+|.+++.. .....+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999998742 12345899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhcccccc
Q 010088 317 HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAE 395 (518)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~ 395 (518)
+........ .......++..|++||.+.+..++.++||||||+++|||++ |+.||..... .+...... .....
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~-~~~~~-- 233 (272)
T cd05075 160 KKIYNGDYY--RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIYDYLR-QGNRL-- 233 (272)
T ss_pred cccCcccce--ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHH-cCCCC--
Confidence 865443211 11122346778999999999999999999999999999999 7778754332 22222111 11110
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 396 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 396 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.... .....+.+++.+||+.||++||++.++++.|..
T Consensus 234 ----~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 234 ----KQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred ----CCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0111 223458899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=313.67 Aligned_cols=246 Identities=29% Similarity=0.463 Sum_probs=198.5
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeee-cCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE-KRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||.||++.. .|..+|+|.++... ..+.|.+|+.++++++|+|++++++++.. .+..++||||+++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred CeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 34567899999999999987 47889999886432 34578999999999999999999997654 4578999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.++++......+++..+++++.+++.||+||| +.+++||||||+||++++++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----- 156 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 156 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC-----
Confidence 99999998765556899999999999999999999 8999999999999999999999999999987543221
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
....++..|+|||++.+..++.++||||||+++|||++ |+.|+... ............. .+....
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-~~~~~~~~~~~~~-------~~~~~~---- 222 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGY-------KMDAPD---- 222 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCC-------CCCCCC----
Confidence 22345678999999998899999999999999999998 88887532 2322222211110 011111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.....+.+++.+||+.+|++||++.++++.|..
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 223568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=329.76 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=196.9
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC------ceEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR------ERFL 241 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l 241 (518)
...+.||+|+||.||++... +|..||||++... .......+.+|+.+++.++||||+++++++...+ ..++
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 103 (359)
T cd07876 24 QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL 103 (359)
T ss_pred EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEE
Confidence 34568999999999999875 5899999998642 2334567889999999999999999999886543 4799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||+.+ +|.+.++. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 104 v~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 104 VMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred EEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 9999975 67776643 3888999999999999999999 89999999999999999999999999999975433
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc---------
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR--------- 392 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~--------- 392 (518)
.. ......||..|+|||.+.+..++.++|||||||++|||++|+.||........+..........
T Consensus 176 ~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 176 NF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred Cc-----cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 21 2244578999999999999999999999999999999999999997554332222111100000
Q ss_pred --ccccc--CCcCCC----------------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 393 --LAELV--DPRIKD----------------SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 393 --l~~~~--d~~l~~----------------~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..... .+.... ..+......+.+++.+||+.||++|||+.|+++|.+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 00000 000000 00111234678999999999999999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=312.61 Aligned_cols=249 Identities=27% Similarity=0.399 Sum_probs=197.1
Q ss_pred hhcceecceEEEEEEecC----CcEEEEEEeccccc-hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 174 TIIGQGGFGTVYKAQFSD----GSLIAVKRMDKISE-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
++||+|+||.||+|.+.. +..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 369999999999997632 26899998875433 34567999999999999999999999875 4578999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.+++.... .+++..++.++.|++.||+||| ..+++||||||+|||+++++.+||+|||+++......... .
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~-~ 153 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY-R 153 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc-c
Confidence 99999998644 5899999999999999999999 8899999999999999999999999999998664433211 1
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......++..|+|||.+.+..++.++||||||+++|||++ |..||...... +...... ..... ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-~~~~~~~-~~~~~------~~~~---- 221 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLE-SGERL------PRPE---- 221 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHH-cCCcC------CCCC----
Confidence 1122234568999999998899999999999999999998 88888654332 2222111 11110 1111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.....+.+++.+||+.+|++||++.++++.|...
T Consensus 222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 2235688999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=323.07 Aligned_cols=255 Identities=24% Similarity=0.380 Sum_probs=202.2
Q ss_pred hhhhhhcceecceEEEEEEec------CCcEEEEEEecccc-chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 241 (518)
+.+.+.||+|+||.||++... .+..||||.++... ....+.+.+|+++++++ +|+||+++++++...+..++
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence 455678999999999999742 34589999887543 33346789999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||+.+|+|.++++......+++.+++.++.+++.||+||| +.+|+|+||||+|||+++++.+||+|||+++....
T Consensus 117 v~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 999999999999997654445899999999999999999999 89999999999999999999999999999986543
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
.... .......++..|+|||.+.+..++.++|||||||++|||++ |..|+............ ..... .+.
T Consensus 194 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~-~~~~~------~~~ 264 (302)
T cd05055 194 DSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL-IKEGY------RMA 264 (302)
T ss_pred CCce--eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH-HHcCC------cCC
Confidence 3211 01223346788999999999899999999999999999998 88888643322221111 11110 011
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
... .....+.+++.+||+.+|++||++.++++.|..
T Consensus 265 ~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 265 QPE----HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 111 122568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=312.54 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=201.8
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc-----chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-----EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
..+.||+|++|.||+|... ++..+|+|.+.... ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 4568999999999999864 68999999875322 12235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++++|.+++...+ .+++..+.+++.+++.||+||| +.+|+||||||+||++++++.+||+|||+++........
T Consensus 86 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 86 MPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred CCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 99999999997643 4889999999999999999999 899999999999999999999999999998755332111
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
........|+..|+|||.+.+..++.++||||||+++|||++|+.||.+............ .. ..+.+..
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~------~~~~~~~-- 230 (263)
T cd06625 161 -GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT-QP------TNPQLPS-- 230 (263)
T ss_pred -cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-cC------CCCCCCc--
Confidence 0011234578899999999998899999999999999999999999976544333222111 10 0111222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.....+.+++..||..+|.+||++.+++++.+
T Consensus 231 --~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 231 --HVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred --cCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 22346889999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=316.93 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=195.4
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC-----ceEEEEEecC
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR-----ERFLMYEYMA 247 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e~~~ 247 (518)
+++|.|+||.||+|.+. ++..||||+.-...+. -.+|+++|+++.|||||+|+.++.... ...+|||||+
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 58999999999999876 4689999987543322 237999999999999999999887543 3468999998
Q ss_pred CCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC-CcEEEeeccccccCCCCCc
Q 010088 248 NGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 248 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DfGla~~~~~~~~ 324 (518)
. +|.+.++.. .+..++...+.-+..||.+||+||| ..+|+||||||.|+|+|.+ |.+||||||.|+....+..
T Consensus 106 ~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 106 E-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred H-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 6 999999742 2345777888889999999999999 8999999999999999975 9999999999998766542
Q ss_pred ccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc-----------c
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES-----------R 392 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~-----------~ 392 (518)
.....-|.-|.|||.+.+ ..|+.+.||||.|||+.||+-|+.-|.+.....+...++..-+. .
T Consensus 182 -----niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 182 -----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred -----ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 234456888999999876 57999999999999999999999888654433333222111110 0
Q ss_pred cccccCCcCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 393 LAELVDPRIKDS-----FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 393 l~~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..+...|.++.. +........++++.++++.+|.+|.++.|++.|.++.
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFd 310 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFD 310 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhH
Confidence 111122222211 1223346688999999999999999999999987653
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=337.87 Aligned_cols=249 Identities=25% Similarity=0.430 Sum_probs=207.2
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEE--Eecc--ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCc--eEEEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVK--RMDK--ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE--RFLMYE 244 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK--~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~e 244 (518)
|..+||+|+|-+||||-+. +|..||=- ++++ .+....+.|..|+.+|+.|+|+||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 5568999999999999764 47777632 1222 233445789999999999999999999999987654 789999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-CCcEEEeeccccccCCCCC
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DfGla~~~~~~~ 323 (518)
.+..|+|..|+++.++ ++...+..|+.||++||.|||.. .++|||||||.+||+|+. -|.+||+|+|||.......
T Consensus 124 L~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred cccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999988665 88889999999999999999976 799999999999999986 6899999999998765543
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc--ccccccCCcC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES--RLAELVDPRI 401 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~--~l~~~~d~~l 401 (518)
...+.|||.|||||.+. ..|++.+||||||+.++||+|+..||.+-.+-++..+....... .+..+-|
T Consensus 201 ------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d--- 270 (632)
T KOG0584|consen 201 ------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD--- 270 (632)
T ss_pred ------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC---
Confidence 24478999999999876 78999999999999999999999999988887777665543221 1222222
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
..+.+||.+|+.. .++|||+.|+|.+.++..+
T Consensus 271 ---------Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 271 ---------PEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ---------HHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 3577899999999 9999999999999887765
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.32 Aligned_cols=238 Identities=22% Similarity=0.413 Sum_probs=189.0
Q ss_pred hcceecceEEEEEEecC-------------CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEE
Q 010088 175 IIGQGGFGTVYKAQFSD-------------GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 241 (518)
.||+|+||.||+|.+.+ ...|++|.+..........|.+|+.++..++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 68999999999997632 23588898765555555678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc-------EEEeecc
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV-------AKLADFG 314 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~-------~kl~DfG 314 (518)
||||+++|+|..++.... ..+++..+++++.||+.||+||| +.+|+||||||+|||++.++. +|++|||
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999987543 35899999999999999999999 999999999999999987664 8999999
Q ss_pred ccccCCCCCcccccccccccCCCcccCccccc-cCCCCccccchhhHHHHHHHH-hCCccccCCcchHHHHHHHHhhccc
Q 010088 315 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV-TARRAVQDGKNLVESAQVCMASESR 392 (518)
Q Consensus 315 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~Gvll~el~-tG~~p~~~~~~~~~~~~~~~~~~~~ 392 (518)
++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+... ...+... .....
T Consensus 158 ~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~~-~~~~~-- 225 (262)
T cd05077 158 IPITVLSR--------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKER-FYEGQ-- 225 (262)
T ss_pred CCccccCc--------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-chhHHHH-HHhcC--
Confidence 98654321 2345788999999886 467899999999999999998 577776532 2222111 11110
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 393 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 393 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
.. ... .....+.+++..||+.||.+||++.++++.+
T Consensus 226 -~~-----~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 -CM-----LVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -cc-----CCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 011 1124578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.47 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=200.7
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++|+||+++++++...+..++||||+++
T Consensus 11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 90 (267)
T cd06645 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG 90 (267)
T ss_pred HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence 445678999999999999865 5889999998755444456788999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|.+++...+ .+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++....... .
T Consensus 91 ~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~----~ 161 (267)
T cd06645 91 GSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI----A 161 (267)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc----c
Confidence 99999987643 5899999999999999999999 8899999999999999999999999999987553321 1
Q ss_pred ccccccCCCcccCccccc---cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 329 VNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
......|+..|+|||.+. ...++.++|||||||++|||++|+.|+............. .. ....+......
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--~~----~~~~~~~~~~~ 235 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--KS----NFQPPKLKDKM 235 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--cc----CCCCCcccccC
Confidence 123456899999999874 4568899999999999999999999986543322221110 00 00111111100
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
.....+.+++..||+.+|++||++++++++.
T Consensus 236 --~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~ 266 (267)
T cd06645 236 --KWSNSFHHFVKMALTKNPKKRPTAEKLLQHP 266 (267)
T ss_pred --CCCHHHHHHHHHHccCCchhCcCHHHHhcCC
Confidence 1124578999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=313.83 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=202.5
Q ss_pred HhhhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
..+.+.+.||+|+||.||++.+.++..+|+|.+.... .....|.+|++++++++|+||+++.+++.+ ...+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 3455677899999999999998788889999876432 234678999999999999999999999887 78899999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+|+|.+++.......+++..++.++.+++.||+||| +.+++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 158 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-- 158 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc--
Confidence 999999998755556899999999999999999999 889999999999999999999999999999765433211
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
......++..|+|||++....++.++||||||+++||++| |+.||...... ...... ..... .....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~~~-~~~~~------~~~~~--- 226 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRAL-ERGYR------MPRPE--- 226 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-HHHHHH-hCCCC------CCCcc---
Confidence 1223345678999999988889999999999999999999 88888643321 111111 11100 01111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.....+.+++.+||+.+|++||++.++++.|.
T Consensus 227 -~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~ 258 (260)
T cd05073 227 -NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258 (260)
T ss_pred -cCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 22356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=318.11 Aligned_cols=260 Identities=26% Similarity=0.398 Sum_probs=200.0
Q ss_pred hhhhhhcceecceEEEEEEecC-----------------CcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEee
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSD-----------------GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRG 231 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g 231 (518)
+.+.+.||+|+||.||+|+..+ +..||+|.+.... ....+.|.+|++++.+++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (296)
T cd05051 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG 86 (296)
T ss_pred CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 3456789999999999997642 2468999886432 344567999999999999999999999
Q ss_pred eeeecCceEEEEEecCCCCHHHHhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe
Q 010088 232 FCIEKRERFLMYEYMANGSLKDHLHSPG---------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL 302 (518)
Q Consensus 232 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 302 (518)
+|..++..+++|||+++++|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Nili 163 (296)
T cd05051 87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhceee
Confidence 9999999999999999999999997543 125899999999999999999999 8999999999999999
Q ss_pred cCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh--CCccccCCcchH
Q 010088 303 DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT--ARRAVQDGKNLV 380 (518)
Q Consensus 303 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t--G~~p~~~~~~~~ 380 (518)
++++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..|+.......
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYY--RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred cCCCceEEccccceeecccCcce--eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 99999999999998765433211 12234456789999999988899999999999999999998 566665332211
Q ss_pred HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 381 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 381 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.+ ....... .. .+.......+......+.+++.+||+.||++||++.+|++.|.
T Consensus 242 ~~-~~~~~~~---~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 VI-ENAGHFF---RD-DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HH-HHHHhcc---cc-ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11 1111000 00 0000000011122356899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=316.30 Aligned_cols=238 Identities=24% Similarity=0.417 Sum_probs=187.9
Q ss_pred hcceecceEEEEEEecC-------------------------CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeE
Q 010088 175 IIGQGGFGTVYKAQFSD-------------------------GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL 229 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 229 (518)
.||+|+||.||+|.+.. ...||+|.+..........|.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997521 13588998865544455678999999999999999999
Q ss_pred eeeeeecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC---
Q 010088 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF--- 306 (518)
Q Consensus 230 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~--- 306 (518)
+++|.+....++||||+++|+|..++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999987532 35889999999999999999999 89999999999999997644
Q ss_pred ----cEEEeeccccccCCCCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHH-hCCccccCCcchH
Q 010088 307 ----VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIV-TARRAVQDGKNLV 380 (518)
Q Consensus 307 ----~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~-tG~~p~~~~~~~~ 380 (518)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~- 228 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS- 228 (274)
T ss_pred CccceeeecCCccccccccc--------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH-
Confidence 4899999987643221 22347788999998865 56899999999999999995 688888643321
Q ss_pred HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 381 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 381 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
+... ....... +.... ...+.+++..||+.+|++||+++++++.|
T Consensus 229 ~~~~-~~~~~~~--------~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 229 EKER-FYEKKHR--------LPEPS----CKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHH-HHHhccC--------CCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1111 1111111 11111 13588999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=312.82 Aligned_cols=258 Identities=24% Similarity=0.398 Sum_probs=210.0
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++|+||+++++++.+....++||||+++|
T Consensus 8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06640 8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence 3457999999999999875 58899999886432 344567999999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.. .++++.....++.+++.||+||| +.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 88 ~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----~ 157 (277)
T cd06640 88 SALDLLRA---GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----K 157 (277)
T ss_pred cHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc----c
Confidence 99999874 34889999999999999999999 89999999999999999999999999999976543321 1
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....++..|+|||.+.+..++.++||||||+++|||+||..|+.......... . .............
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-~-----------~~~~~~~~~~~~~ 225 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-L-----------IPKNNPPTLTGEF 225 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-h-----------hhcCCCCCCchhh
Confidence 233457889999999988889999999999999999999999986543221111 0 0011112233345
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCCcchhh
Q 010088 410 LRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQ 451 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~~ 451 (518)
...+.+++..||+.+|++||++.+++++.+.........+..
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~ 267 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLT 267 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchhhhHHH
Confidence 567899999999999999999999999988776655544443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=315.34 Aligned_cols=247 Identities=33% Similarity=0.469 Sum_probs=194.8
Q ss_pred hhcceecceEEEEEEecC-Cc--EEEEEEeccc-cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 174 TIIGQGGFGTVYKAQFSD-GS--LIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
++||+|+||.||+|++.+ |. .+++|.++.. .......+.+|++++.++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999998754 43 4688887643 334456789999999999 799999999999999999999999999
Q ss_pred CCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecc
Q 010088 249 GSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG 314 (518)
Q Consensus 249 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfG 314 (518)
|+|.++++... ...+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999997532 134889999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhcccc
Q 010088 315 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRL 393 (518)
Q Consensus 315 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l 393 (518)
++....... .......+..|+|||++....++.++||||||+++|||++ |..||.... .......... ..
T Consensus 158 l~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-~~~~~~~~~~-~~-- 228 (270)
T cd05047 158 LSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLPQ-GY-- 228 (270)
T ss_pred Cccccchhh-----hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-HHHHHHHHhC-CC--
Confidence 986322110 1112234668999999988899999999999999999997 888885432 2222221111 00
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 394 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 394 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...... .....+.+++.+||+.+|.+||++.++++.|..
T Consensus 229 ----~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 229 ----RLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred ----CCCCCC----cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 011111 122468899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=321.06 Aligned_cols=256 Identities=21% Similarity=0.299 Sum_probs=197.3
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||+||+++.. +++.||+|.+.+. .......|.+|+.++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY 83 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence 45678999999999999875 5899999998642 2233456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++|+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++.........
T Consensus 84 ~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 158 (331)
T cd05597 84 VGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV- 158 (331)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-
Confidence 9999999997532 34899999999999999999999 999999999999999999999999999998765433211
Q ss_pred ccccccccCCCcccCcccccc-----CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .+............. + +..
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-~~~~~~i~~~~~~~~--~-~~~ 232 (331)
T cd05597 159 --QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNHKEHFQ--F-PPD 232 (331)
T ss_pred --cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-HHHHHHHHcCCCccc--C-CCc
Confidence 1223468999999999863 4578899999999999999999999975432 222222221111110 0 111
Q ss_pred CCCCCHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHHhhcC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQR--EGQARPSIKQVLRILYES 441 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~--dp~~RPs~~evl~~L~~~ 441 (518)
.... ...+.+++.+|+.. ++..||+++++++|.|..
T Consensus 233 ~~~~----~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~ 270 (331)
T cd05597 233 VTDV----SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFE 270 (331)
T ss_pred cCCC----CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCC
Confidence 1112 24467777776654 444489999999998864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=322.73 Aligned_cols=263 Identities=23% Similarity=0.322 Sum_probs=199.3
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
...+.||+|+||+||+|+.. ++..||+|.++... ......+.+|++++++++|+||+++++++..++..++||||+++
T Consensus 9 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 88 (309)
T cd07872 9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK 88 (309)
T ss_pred EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC
Confidence 34568999999999999875 57889999986432 23334678999999999999999999999999999999999975
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
+|.+++...+ ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 89 -~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 159 (309)
T cd07872 89 -DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK---- 159 (309)
T ss_pred -CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc----
Confidence 8888886543 34889999999999999999999 89999999999999999999999999999875433221
Q ss_pred ccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc----cccc------c
Q 010088 329 VNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR----LAEL------V 397 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~----l~~~------~ 397 (518)
......++..|+|||.+.+ ..++.++|||||||++|||+||+.||................... ...+ .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1233467899999998865 568899999999999999999999996543222111111000000 0000 0
Q ss_pred C---CcCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 398 D---PRIKDS----FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 398 d---~~l~~~----~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+ +..... ........+.+++.+|++.||.+|||+.|++++.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 0 000000 00012245789999999999999999999999887753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=314.63 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=200.8
Q ss_pred hhhhhhcceecceEEEEEEecC------CcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSD------GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
+.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++..++|+||+++++++......++|
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 87 (277)
T cd05032 8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVV 87 (277)
T ss_pred eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEE
Confidence 3445689999999999997642 3689999986432 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecc
Q 010088 243 YEYMANGSLKDHLHSPG--------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG 314 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfG 314 (518)
|||+++|+|.+++.... ...++|..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECCcc
Confidence 99999999999996432 224789999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhcccc
Q 010088 315 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRL 393 (518)
Q Consensus 315 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l 393 (518)
+++........ .......++..|+|||.+.+..++.++|||||||++|||+| |..|+.... ..+...... .. .
T Consensus 165 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~~~~~-~~-~- 238 (277)
T cd05032 165 MTRDIYETDYY--RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-NEEVLKFVI-DG-G- 238 (277)
T ss_pred cchhhccCccc--ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-HHHHHHHHh-cC-C-
Confidence 98765433211 11233456789999999988889999999999999999998 888875432 222222211 11 1
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 394 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 394 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.+...... ...+.+++..||+.+|++|||+.++++.|.
T Consensus 239 ----~~~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 ----HLDLPENC----PDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ----CCCCCCCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11112222 356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.58 Aligned_cols=257 Identities=27% Similarity=0.400 Sum_probs=201.9
Q ss_pred HhhhhhhhcceecceEEEEEEec--------CCcEEEEEEeccc-cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecC
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFS--------DGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKR 237 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 237 (518)
..+.+.+.||+|+||.||+++.. ++..+|+|.++.. ......++.+|++++.++ +|+||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 34556778999999999999752 2357999988743 234456788999999999 7999999999999999
Q ss_pred ceEEEEEecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec
Q 010088 238 ERFLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD 303 (518)
Q Consensus 238 ~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~ 303 (518)
..++||||+++|+|.+++.... ...++|.++++++.|++.||+||| +.+++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence 9999999999999999997532 135899999999999999999999 89999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHH
Q 010088 304 ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVES 382 (518)
Q Consensus 304 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~ 382 (518)
+++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..|+.. .+..+.
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~~~~~~ 251 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEEL 251 (307)
T ss_pred CCCcEEECCCcccccccccchh--hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHH
Confidence 9999999999998765432211 11122234578999999998899999999999999999998 7777743 333333
Q ss_pred HHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 383 AQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 383 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
....... .. . ..+......+.+++..||+.+|++||++.++++.|.+.
T Consensus 252 ~~~~~~~-~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 252 FKLLKEG-HR------M----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HHHHHcC-CC------C----CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 3222111 00 0 11112235688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=322.43 Aligned_cols=252 Identities=33% Similarity=0.473 Sum_probs=197.2
Q ss_pred hhhhhhcceecceEEEEEEec-CCc--EEEEEEeccc-cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGS--LIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.+.+.||+|+||.||+|.+. +|. .+|+|.+... .......|.+|++++.++ +|+||+++++++.+.+..++|||
T Consensus 9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 88 (303)
T cd05088 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 88 (303)
T ss_pred ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEE
Confidence 345678999999999999875 444 4677777643 334456789999999999 89999999999999999999999
Q ss_pred ecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEE
Q 010088 245 YMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKL 310 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 310 (518)
|+++|+|.++++..+ ...+++.+++.++.|++.||+||| +.+++||||||+|||+++++.+||
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcEEe
Confidence 999999999997532 235889999999999999999999 899999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhh
Q 010088 311 ADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMAS 389 (518)
Q Consensus 311 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~ 389 (518)
+|||+++...... ......++..|+|||.+.+..++.++|||||||++|||+| |..||..... .+..... ..
T Consensus 166 ~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~-~~ 238 (303)
T cd05088 166 ADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKL-PQ 238 (303)
T ss_pred CccccCcccchhh-----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-HHHHHHH-hc
Confidence 9999986432111 1112234678999999988889999999999999999998 8888854322 2222111 10
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 390 ESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 390 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
. ....... .....+.+++.+||+.+|++||++.++++.|...
T Consensus 239 ~------~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 239 G------YRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred C------CcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0111111 1224588999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=329.98 Aligned_cols=263 Identities=24% Similarity=0.331 Sum_probs=199.5
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC-----ceEEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR-----ERFLMY 243 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~ 243 (518)
..+.||+|+||+||++... +|+.||||++... .......+.+|+++|+.++|+||+++++++...+ ..++||
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 3468999999999999864 6899999988643 2234467889999999999999999999998776 789999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+. ++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 84 e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 84 ELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred eccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 9996 5888888653 35899999999999999999999 8999999999999999999999999999998653322
Q ss_pred cccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhc-cccc-------
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE-SRLA------- 394 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~-~~l~------- 394 (518)
. .......++..|+|||.+.+. .++.++|||||||++|||++|+.||................. ....
T Consensus 158 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 158 S---KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred c---ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 1 122344688999999998764 578999999999999999999999965433222111100000 0000
Q ss_pred --------cccCC-cCCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 395 --------ELVDP-RIKD--SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 395 --------~~~d~-~l~~--~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
....+ .... .........+.+++.+||+.||++|||+.|++++.|....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 00000 0000 0011123568899999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.85 Aligned_cols=256 Identities=23% Similarity=0.320 Sum_probs=199.8
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
.+.+.+.||+|+||.||+++.. +++.+|+|.+... .......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (371)
T cd05622 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 123 (371)
T ss_pred hcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 4445678999999999999876 5789999998642 22334567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++|+|.+++... .++...+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 124 y~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 124 YMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred CCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 99999999999753 3788889999999999999999 99999999999999999999999999999986543221
Q ss_pred ccccccccccCCCcccCccccccC----CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQ----ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
.......||+.|+|||.+... .++.++|||||||++|||++|+.||...... .....+......+. .
T Consensus 198 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~~-~---- 268 (371)
T cd05622 198 ---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHKNSLT-F---- 268 (371)
T ss_pred ---ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCccc-C----
Confidence 112345799999999998654 3789999999999999999999999754332 22222221111110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHhhcCC
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQA--RPSIKQVLRILYESS 442 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~--RPs~~evl~~L~~~~ 442 (518)
.. .......+.+++..|+..++.+ |++++++++|++...
T Consensus 269 -~~--~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 269 -PD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred -CC--cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 00 0122345788999999844443 789999999987754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=315.23 Aligned_cols=251 Identities=27% Similarity=0.412 Sum_probs=203.4
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+...+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|++++++++|+||+++++++...+..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 334568999999999999865 57899999886432 3445678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+++|.+++.. ..+++..+..++.+++.||.||| +.+++|+||+|+||++++++.+||+|||++........
T Consensus 86 ~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--- 156 (277)
T cd06642 86 GGSALDLLKP---GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--- 156 (277)
T ss_pred CCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch---
Confidence 9999999864 35899999999999999999999 89999999999999999999999999999876543321
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.+....... .. +.....+.+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-~~-------~~~~~~~~~~~---- 223 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-FL-------IPKNSPPTLEG---- 223 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-hh-------hhcCCCCCCCc----
Confidence 122345889999999999889999999999999999999999998643322111 10 01111122222
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.....+.+++.+||+.+|++||++.+++++.+...
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 23456889999999999999999999999876543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=319.25 Aligned_cols=256 Identities=26% Similarity=0.428 Sum_probs=202.1
Q ss_pred hhhhhhhcceecceEEEEEEec--------CCcEEEEEEeccc-cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCc
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS--------DGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRE 238 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 238 (518)
.+.+.+.||+|+||.||+|+.. ++..||+|.+... .......+.+|+.+++.+ +|+||+++++++.....
T Consensus 16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (304)
T cd05101 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 95 (304)
T ss_pred HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCc
Confidence 3445678999999999999741 2457999988643 234456789999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC
Q 010088 239 RFLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE 304 (518)
Q Consensus 239 ~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~ 304 (518)
.++||||+++|+|.+++.... ...++|..++.++.||+.||+||| +.+|+||||||+||++++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili~~ 172 (304)
T cd05101 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTE 172 (304)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEEcC
Confidence 999999999999999997532 235789999999999999999999 899999999999999999
Q ss_pred CCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHH
Q 010088 305 NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESA 383 (518)
Q Consensus 305 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~ 383 (518)
++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..|+. +....+..
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~ 249 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-GIPVEELF 249 (304)
T ss_pred CCcEEECCCccceeccccccc--ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc-cCCHHHHH
Confidence 999999999999865433211 11223346778999999988889999999999999999998 666664 33333333
Q ss_pred HHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 384 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 384 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
...... ... ..+......+.+++..||+.+|++||++.++++.|...
T Consensus 250 ~~~~~~-~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 250 KLLKEG-HRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred HHHHcC-CcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 322111 110 01112335688999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=312.37 Aligned_cols=248 Identities=24% Similarity=0.354 Sum_probs=202.0
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.||+|+||.||+++.. ++..+|+|.++.. .....+.+.+|+.++++++|+||+++++.+..++..++||||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 34568999999999999875 5889999988542 334456788999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.+++.......+++..++.++.|++.||.||| +.+|+|+||||+||++++++.++|+|||++........
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~---- 155 (255)
T cd08219 83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA---- 155 (255)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc----
Confidence 99999987655556899999999999999999999 89999999999999999999999999999876543221
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... ........... ... .+.. .
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-~~~~~~~~~~~--~~~-----~~~~----~ 223 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-WKNLILKVCQG--SYK-----PLPS----H 223 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-HHHHHHHHhcC--CCC-----CCCc----c
Confidence 1234568899999999988889999999999999999999999997533 22222211111 110 0111 2
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRI 437 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~ 437 (518)
....+.+++.+||+.||++||++.++++.
T Consensus 224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 22458899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=315.34 Aligned_cols=239 Identities=23% Similarity=0.387 Sum_probs=190.3
Q ss_pred hcceecceEEEEEEecC--------CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 175 IIGQGGFGTVYKAQFSD--------GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.||+|+||+||+|.... ...+|+|.+........+.|.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 69999999999997642 2348888876555555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc--------EEEeecccccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV--------AKLADFGLAHA 318 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~--------~kl~DfGla~~ 318 (518)
++|+|.++++..+. .+++..++.++.||+.||+||| +.+|+||||||+||+++.++. +|++|||++..
T Consensus 82 ~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 82 KFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999976543 5899999999999999999999 899999999999999987765 69999998865
Q ss_pred CCCCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccccc
Q 010088 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 397 (518)
Q Consensus 319 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 397 (518)
.... ....++..|+|||++.+ ..++.++||||||+++|||++|..++............ ....
T Consensus 158 ~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~------- 221 (258)
T cd05078 158 VLPK--------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YEDR------- 221 (258)
T ss_pred cCCc--------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHcc-------
Confidence 4321 23457889999999976 45799999999999999999996444332222221111 1111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
..+... ....+.+++..||+.||++||+++++++.|
T Consensus 222 -~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 -HQLPAP----KWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -ccCCCC----CcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 111111 124588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=316.46 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=197.6
Q ss_pred hhhhhhcceecceEEEEEEec-CCc----EEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGS----LIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
..+.++||+|+||+||+|++. +|. .||+|.++.. .......+.+|+.++..++|+||++++++|.. ...++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~ 87 (279)
T cd05109 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVT 87 (279)
T ss_pred eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEE
Confidence 344578999999999999864 444 4899988643 33445678999999999999999999999875 4578999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+++|+|.++++... ..+++..++.++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++......
T Consensus 88 ~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 88 QLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 9999999999997643 35899999999999999999999 8999999999999999999999999999998654322
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
... ......++..|++||.+.+..++.++|||||||++|||++ |..|+...... ..... +...... ...
T Consensus 164 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~-~~~~~~~------~~~ 233 (279)
T cd05109 164 TEY--HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-EIPDL-LEKGERL------PQP 233 (279)
T ss_pred cee--ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH-HHCCCcC------CCC
Confidence 110 1122335678999999998899999999999999999998 88888643321 11111 1111110 111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
. .....+.+++..||+.||++||++.++++.|...
T Consensus 234 ~----~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 234 P----ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred c----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1 2234688999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=313.04 Aligned_cols=252 Identities=33% Similarity=0.533 Sum_probs=200.5
Q ss_pred hhhhhcceecceEEEEEEecC-CcEEEEEEeccccchhH--HHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVE--GDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.||+|+||+||+++... +..+|+|.+........ ....+|+.++.+++|+||+++++++.+....++||||+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 355789999999999998864 67899999976543322 234569999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+++|.+++.. ...+++..+..++.|++.||+||| +.+|+|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~---- 152 (260)
T PF00069_consen 82 GGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN---- 152 (260)
T ss_dssp TEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT----
T ss_pred cccccccccc--cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc----
Confidence 9999999983 345899999999999999999999 8899999999999999999999999999987531111
Q ss_pred cccccccCCCcccCccccc-cCCCCccccchhhHHHHHHHHhCCccccCCcch--HHHHHHHHhhccccccccCCcCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--VESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~--~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.......++..|+|||.+. +..++.++||||+|+++|+|++|..|+...... .......... .... ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~----~~~~- 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR--PLPS----SSQQ- 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT--HHHH----HTTS-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc--cccc----cccc-
Confidence 1234567899999999998 889999999999999999999999999865211 1111111110 0000 0000
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.......+.+++..||+.||++||++.+++++.|
T Consensus 226 -~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 226 -SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp -HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred -cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence 0001267999999999999999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=314.02 Aligned_cols=256 Identities=25% Similarity=0.442 Sum_probs=200.7
Q ss_pred hhhhhhhcceecceEEEEEEecC-C---cEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFSD-G---SLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
.+.+.+.||+|+||.||+|.+.. + ..||||.+... ......+|..|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 34567789999999999998753 3 36999998653 3444578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+++|+|.+++.... ..+++.+++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999997643 35899999999999999999999 8999999999999999999999999999987654322
Q ss_pred cccccc-cccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 324 ICFEPV-NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 324 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
...... ......+..|+|||.+.+..++.++||||||+++|||++ |..||...... ...... .....+ .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-~~~~~i-~~~~~~------~- 231 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVINAI-EQDYRL------P- 231 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-HHHHHH-HcCCcC------C-
Confidence 110000 011112457999999999999999999999999999886 98888643322 221111 111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.+.+....+.+++..||+.+|++||++++++..|..
T Consensus 232 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 232 ---PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 111223568899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.46 Aligned_cols=256 Identities=21% Similarity=0.280 Sum_probs=194.1
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
.+.||+|+||.||+|... .++.||||... ...+.+|+++|++++|+||+++++++...+..++|||++. ++|
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L 246 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDL 246 (461)
T ss_pred EEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence 457999999999999876 47889999532 2346789999999999999999999999999999999995 799
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccc
Q 010088 252 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331 (518)
Q Consensus 252 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 331 (518)
.+++.... ..++|..++.|+.|++.||+||| +.+|+||||||+||||+.++.+||+|||+++....... .....
T Consensus 247 ~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~ 320 (461)
T PHA03211 247 YTYLGARL-RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS--TPFHY 320 (461)
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc--ccccc
Confidence 99886533 35999999999999999999999 89999999999999999999999999999986533211 11223
Q ss_pred cccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCc------c-hHHHHHHHHhhcccccccc-------
Q 010088 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK------N-LVESAQVCMASESRLAELV------- 397 (518)
Q Consensus 332 ~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~------~-~~~~~~~~~~~~~~l~~~~------- 397 (518)
...||..|+|||++.+..++.++|||||||+||||++|..++.... . .....+.+........+..
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 4569999999999999999999999999999999999887653221 1 1111111111110000000
Q ss_pred ------------CCcCCC-CCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 398 ------------DPRIKD-SFD--MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 398 ------------d~~l~~-~~~--~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+.... .+. ......+.+++.+||+.||.+|||+.|+|+|.|+.
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~ 459 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ 459 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence 000000 000 01113578899999999999999999999998774
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=310.56 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=205.0
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecc---ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.+.||+|+||.||+|... +|+.||+|.++. ......+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 345678999999999999886 789999998753 2233356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 246 MANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 246 ~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
+++|+|.+++.. .....+++..++.++.+++.||+||| +.+|+||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999864 22356899999999999999999999 8999999999999999999999999999987554322
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCc-chHHHHHHHHhhccccccccCCcCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK-NLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~-~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.... +.......... .. . +.+.
T Consensus 161 ~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~----~-~~~~ 229 (267)
T cd08224 161 T----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK--CD----Y-PPLP 229 (267)
T ss_pred c----ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc--CC----C-CCCC
Confidence 1 1233458889999999998889999999999999999999999986433 22222211110 00 0 1111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.......+.+++.+||..+|++||++.+|++.|...
T Consensus 230 ---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 ---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 112335688999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=315.66 Aligned_cols=257 Identities=25% Similarity=0.443 Sum_probs=198.0
Q ss_pred hhhhhhcceecceEEEEEEec-----------------CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEee
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-----------------DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRG 231 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g 231 (518)
+.+.+.||+|+||+||++... ++..+|+|.+... ......+|.+|+.++++++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 445678999999999998542 2347899988643 3344568999999999999999999999
Q ss_pred eeeecCceEEEEEecCCCCHHHHhcCCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe
Q 010088 232 FCIEKRERFLMYEYMANGSLKDHLHSPGR---------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL 302 (518)
Q Consensus 232 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 302 (518)
++...+..++||||+++|+|.+++..... ..+++.++..++.|++.||+||| +.+++||||||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Nili 163 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheEEE
Confidence 99999999999999999999999975321 24788899999999999999999 8899999999999999
Q ss_pred cCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh--CCccccCCcchH
Q 010088 303 DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT--ARRAVQDGKNLV 380 (518)
Q Consensus 303 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t--G~~p~~~~~~~~ 380 (518)
++++.+||+|||+++........ .......++..|++||....+.++.++|||||||++|||++ |..|+..... .
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-~ 240 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-E 240 (296)
T ss_pred cCCCCEEeccCcccccccCCcce--eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-H
Confidence 99999999999999765433211 11222345678999999888899999999999999999998 6677753322 1
Q ss_pred HHHHH---HHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 381 ESAQV---CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 381 ~~~~~---~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
+.... ...... .....+. +......+.+++.+||+.||.+||++.+|++.|.
T Consensus 241 ~~~~~~~~~~~~~~--~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENTGEFFRDQG--RQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHhhcc--ccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 21111 111000 0000010 1122357889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=318.86 Aligned_cols=256 Identities=24% Similarity=0.340 Sum_probs=201.3
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.||+|+||.||++... +|..+|+|.+... ......++.+|++++.+++||||++++++|.+.+..++||||++++
T Consensus 5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~ 84 (308)
T cd06615 5 KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 84 (308)
T ss_pred EEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence 4568999999999999875 5788999987643 3334467889999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
+|.++++.. ..+++..+..++.|++.||+||| + .+++||||||+|||+++++.+||+|||++......
T Consensus 85 ~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------ 153 (308)
T cd06615 85 SLDQVLKKA--GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------ 153 (308)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccccc------
Confidence 999999764 35899999999999999999999 5 58999999999999999999999999998754332
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccc-------------
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE------------- 395 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~------------- 395 (518)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.... .................
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCCC
Confidence 1234568899999999988889999999999999999999999985332 11111111000000000
Q ss_pred -------------cc---CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 396 -------------LV---DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 396 -------------~~---d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
++ .+.+.. ......+.+++.+||+.+|++||++++++++.+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 00 000000 012345889999999999999999999999987743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=309.65 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=203.2
Q ss_pred hhhhhhcceecceEEEEEEecC-CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||.||+|...+ +..+++|.+..... ..++.+|++++++++|+||+++++++.+....++++||+.+
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 3456789999999999998865 78999998865432 57899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|.+++.... ..+++..+..++.|++.||+||| +.+++||||+|+||++++++.+||+|||++........
T Consensus 83 ~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 154 (256)
T cd06612 83 GSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA---- 154 (256)
T ss_pred CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc----
Confidence 99999997543 46899999999999999999999 88999999999999999999999999999886544321
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+............. ....+.+ ..+..
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~~--~~~~~ 224 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP--------NKPPPTL--SDPEK 224 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc--------cCCCCCC--Cchhh
Confidence 1233457889999999998899999999999999999999999987543322111110 0000111 11112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
....+.+++.+||+.+|++||++++++++.+
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~ 255 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence 2356889999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=308.39 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=198.9
Q ss_pred hhcceecceEEEEEEecCCcEEEEEEeccccc-hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHH
Q 010088 174 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISE-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK 252 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 252 (518)
++||+|+||.||++...+++.||+|.+..... .....|.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999987799999998865433 34567999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccccc
Q 010088 253 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 332 (518)
Q Consensus 253 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 332 (518)
+++.... ..+++..++.++.+++.||+||| +++++||||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~ 154 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT--VSDGL 154 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce--ecccc
Confidence 9997543 35889999999999999999999 899999999999999999999999999999765432211 11112
Q ss_pred ccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 010088 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR 411 (518)
Q Consensus 333 ~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 411 (518)
..++..|+|||.+.++.++.++||||||+++|||+| |..|+...... ....... .... . ..+.....
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-~~~~~~~-~~~~------~----~~~~~~~~ 222 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-QTRERIE-SGYR------M----PAPQLCPE 222 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-HHHHHHh-cCCC------C----CCCccCCH
Confidence 234667999999988899999999999999999999 77777543321 1111111 1000 0 11112335
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 412 TIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 412 ~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.+.+++.+||+.+|++||++.|+++.|.
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 7899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=312.41 Aligned_cols=252 Identities=26% Similarity=0.440 Sum_probs=201.7
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccc---------hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE---------QVEGDFCREIELLARLHHRHLVALRGFCIEKRERF 240 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 240 (518)
.+...||+|+||.||+|... ++..+|+|.+..... ...+.+.+|+.++++++|+||+++++++.+.+..+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 34568999999999999864 578999998854321 12256889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCC
Q 010088 241 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~ 320 (518)
+||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||+|+||++++++.+||+|||+++...
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 83 IFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 999999999999999764 35889999999999999999999 8899999999999999999999999999998664
Q ss_pred CCCccc--ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccC
Q 010088 321 DGSICF--EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD 398 (518)
Q Consensus 321 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d 398 (518)
...... ........|+..|+|||.+.+..++.++||||||+++|||++|+.||............ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~ 229 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI--------GENAS 229 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH--------hccCC
Confidence 321100 00112345889999999999888999999999999999999999999764433222111 11112
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 399 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 399 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
+.+.. .....+.+++.+||+.||.+||++.+++++.+
T Consensus 230 ~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 266 (267)
T cd06628 230 PEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266 (267)
T ss_pred CcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence 22222 22356889999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=319.89 Aligned_cols=256 Identities=21% Similarity=0.295 Sum_probs=199.1
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||+||+++.. +++.||+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~ 83 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY 83 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 34568999999999999876 5789999998642 2233455888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~- 158 (331)
T cd05624 84 VGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV- 158 (331)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-
Confidence 9999999997632 35899999999999999999999 899999999999999999999999999999765433211
Q ss_pred ccccccccCCCcccCcccccc-----CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
......||+.|+|||++.+ +.++.++|||||||+||||++|+.||...... +..........++. +...+
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~~--~p~~~ 233 (331)
T cd05624 159 --QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHEERFQ--FPSHI 233 (331)
T ss_pred --eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-HHHHHHHcCCCccc--CCCcc
Confidence 1223569999999999865 56889999999999999999999999754332 22222222111110 01111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHhhcC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQA--RPSIKQVLRILYES 441 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~--RPs~~evl~~L~~~ 441 (518)
. +....+.+++.+|+..++++ |++++++++|.++.
T Consensus 234 -~----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~ 270 (331)
T cd05624 234 -T----DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFE 270 (331)
T ss_pred -c----cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcC
Confidence 1 12346778898888866554 57899999988764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=309.68 Aligned_cols=253 Identities=29% Similarity=0.487 Sum_probs=201.9
Q ss_pred hhhhcceecceEEEEEEecCCcEEEEEEecccc------chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS------EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
..+.||+|+||+||+|...+|+.+|+|.++... ......+.+|++++++++|+||++++++|.+.+..++||||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 345799999999999988889999999876321 12235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc-
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI- 324 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 324 (518)
+++++|.+++.+.+ .+++..+..++.|++.||+||| +.+|+|+||+|+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 84 VPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999997643 4889999999999999999999 88999999999999999999999999999875432110
Q ss_pred -ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 325 -CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 325 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
..........|+..|+|||.+.+..++.++||||||+++|||++|+.||............. .... ..+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~-----~~~~~~~ 232 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRG-----LMPRLPD 232 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh-hccC-----CCCCCCC
Confidence 00112234568999999999998889999999999999999999999997544332222111 1101 1122222
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.+ ...+.+++.+||+.+|++||++.+++++.+
T Consensus 233 ~~----~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 264 (265)
T cd06631 233 SF----SAAAIDFVTSCLTRDQHERPSALQLLRHDF 264 (265)
T ss_pred CC----CHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 22 355889999999999999999999998654
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=328.02 Aligned_cols=257 Identities=18% Similarity=0.248 Sum_probs=192.7
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.+.||+|+||.||+|+.. ++..||+|..... ....|+.++++++|+||+++++++.+....++||||+.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 3455678999999999999876 4678999975332 23569999999999999999999999999999999995
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
++|.+++.... ..++|..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 141 -~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 211 (357)
T PHA03209 141 -SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---- 211 (357)
T ss_pred -CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc----
Confidence 68999886533 45999999999999999999999 8899999999999999999999999999997533221
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchH--HH-------HHHHHhhcc----ccc
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV--ES-------AQVCMASES----RLA 394 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~--~~-------~~~~~~~~~----~l~ 394 (518)
......||..|+|||.+.+..++.++|||||||++|||+++..++....... .. ....+.... .+.
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 2234568999999999999999999999999999999999776653321110 00 000000000 000
Q ss_pred ---------cccC--CcCCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 395 ---------ELVD--PRIKDSFD-------MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 395 ---------~~~d--~~l~~~~~-------~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..++ ...+..+. ......+.+++..||+.||++|||+.|+++|.|+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~ 355 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence 0000 00000000 01123455699999999999999999999998764
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=313.88 Aligned_cols=248 Identities=28% Similarity=0.461 Sum_probs=196.8
Q ss_pred hcceecceEEEEEEecC-------CcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 175 IIGQGGFGTVYKAQFSD-------GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.||+|+||.||+|+..+ +..+|+|.+.... ......|.+|+.++++++|+||++++++|...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 69999999999998643 2579999875432 334567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC-----cEEEeecccc
Q 010088 247 ANGSLKDHLHSPG-----RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-----VAKLADFGLA 316 (518)
Q Consensus 247 ~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-----~~kl~DfGla 316 (518)
++|+|.+++.... ...++|.+++.++.|++.||+||| +.+++|+||||+||+++.++ .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999997432 234889999999999999999999 89999999999999999877 8999999998
Q ss_pred ccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhcccccc
Q 010088 317 HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAE 395 (518)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~ 395 (518)
+........ .......++..|+|||++.+..++.++||||||+++|||+| |+.||....+. +..... .....+
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-~~~~~~-~~~~~~-- 232 (269)
T cd05044 159 RDIYKSDYY--RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-EVLQHV-TAGGRL-- 232 (269)
T ss_pred ccccccccc--ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-HHHHHH-hcCCcc--
Confidence 755432211 11222345788999999999999999999999999999998 89888644332 221111 111100
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 396 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 396 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.........+.+++.+||+.+|++||+++++++.|.
T Consensus 233 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 233 --------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred --------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111123456889999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=317.54 Aligned_cols=256 Identities=23% Similarity=0.414 Sum_probs=198.8
Q ss_pred hhhhhhcceecceEEEEEEe-----cCCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 241 (518)
+...+.||+|+||.||++++ .++..||+|.++... ......+.+|+.++++++|+||+++.+++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 33456799999999999975 257899999986443 34456799999999999999999999998875 56899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||+++++|.+++.+.. ..++|..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999996543 35899999999999999999999 89999999999999999999999999999986543
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcch-------------HHHHHHHHh
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL-------------VESAQVCMA 388 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~-------------~~~~~~~~~ 388 (518)
..... .......++..|+|||.+.+..++.++||||||+++|||+|++.|....... .........
T Consensus 162 ~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 162 DKEYY-TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred Cccce-eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 32111 1123345777899999998889999999999999999999987664321110 000000000
Q ss_pred hccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 389 SESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 389 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
... ...........+.+++.+||+.+|++||+++++++.+..
T Consensus 241 ~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 241 EGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred cCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 000 000111233579999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=323.27 Aligned_cols=255 Identities=25% Similarity=0.337 Sum_probs=213.3
Q ss_pred hhhhhhhcceecceEEEEEEecC-CcEEEEEEeccccc---hhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISE---QVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 243 (518)
.+.|.+.||+|.||.||+++... |+.+|+|.+.+... .......+|+.+|+++. |||||.+.+.+.+....++||
T Consensus 36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm 115 (382)
T KOG0032|consen 36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM 115 (382)
T ss_pred cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence 34566799999999999998875 99999999875433 23468999999999998 999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC----CCcEEEeeccccccC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE----NFVAKLADFGLAHAS 319 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~----~~~~kl~DfGla~~~ 319 (518)
|++.||.|.+.+... .+++..+..++.|++.+++||| +.+|+||||||+|+|+.. ++.+|++|||++...
T Consensus 116 EL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 116 ELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 999999999999765 2999999999999999999999 899999999999999964 357999999999987
Q ss_pred CCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCC
Q 010088 320 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 399 (518)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~ 399 (518)
..+. .....+||+.|+|||.+....|+..+||||+||++|.|++|..||............ ...+.
T Consensus 190 ~~~~-----~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i-~~~~~-------- 255 (382)
T KOG0032|consen 190 KPGE-----RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI-LRGDF-------- 255 (382)
T ss_pred cCCc-----eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH-HcCCC--------
Confidence 6632 346788999999999999999999999999999999999999999866544333322 22211
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 400 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
.+....-......+.+++..|+..||.+|+++.++++|.|....
T Consensus 256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 11222222334678899999999999999999999999886643
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=309.26 Aligned_cols=252 Identities=21% Similarity=0.358 Sum_probs=191.5
Q ss_pred hcceecceEEEEEEecCC---cEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 175 IIGQGGFGTVYKAQFSDG---SLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
.||+|+||+||+|+..++ ..+++|.+.... ....+.|.+|+.+++.++||||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999976543 345677665432 3445689999999999999999999999999999999999999999
Q ss_pred HHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 251 LKDHLHSPG--RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 251 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|.+++++.. ...+++..+..++.||+.||+||| +.+++||||||+|||++.++.+||+|||++........ ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~--~~ 156 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY--IE 156 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchh--hh
Confidence 999997532 234677788899999999999999 88999999999999999999999999999864322111 01
Q ss_pred ccccccCCCcccCcccccc-------CCCCccccchhhHHHHHHHHhC-CccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 329 VNTDIRGTPGYMDPEYVVT-------QELTEKSDVYSYGVVLLEIVTA-RRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwS~Gvll~el~tG-~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
......++..|+|||++.. ..++.++||||||+++|||+++ ..|+...... +........ ......++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~--~~~~~~~~~ 233 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKD--QQVKLFKPQ 233 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhh--cccccCCCc
Confidence 1234567899999998743 2457899999999999999975 5566543332 222221111 123344455
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
+...++ ..+.+++..|| .+|++||++++|++.|.
T Consensus 234 ~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 444333 45778999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=327.68 Aligned_cols=257 Identities=20% Similarity=0.283 Sum_probs=196.7
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec------CceEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERFLM 242 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV 242 (518)
..+.||+|+||.||++... .+..||||++... .......+.+|+.+++.++|+||+++++++... ...++|
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 100 (355)
T cd07874 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 100 (355)
T ss_pred EEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEE
Confidence 4568999999999999764 5889999998643 233446788999999999999999999988643 357999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+++ +|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 101 ~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 101 MELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred hhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 999965 67777653 3889999999999999999999 899999999999999999999999999999865432
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhc------------
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE------------ 390 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~------------ 390 (518)
. ......||..|+|||.+.+..++.++|||||||++|||++|+.||........+........
T Consensus 173 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 173 F-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred c-----ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 2 22345689999999999999999999999999999999999999975443322221111000
Q ss_pred ---------cccccccCCcC-----C---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 391 ---------SRLAELVDPRI-----K---DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 391 ---------~~l~~~~d~~l-----~---~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
........+.. . ..........+.+++.+||+.||++|||+.|+++|.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence 00000000000 0 001111235678999999999999999999999997664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=312.79 Aligned_cols=255 Identities=27% Similarity=0.382 Sum_probs=203.2
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||.||+|+.. ++..+++|.+..........+.+|+.+++.++|+||+++++++...+..++||||+++
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG 93 (292)
T ss_pred hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence 335568999999999999876 4889999998766666667899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|..++.+.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++....... .
T Consensus 94 ~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~----~ 165 (292)
T cd06644 94 GAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL----Q 165 (292)
T ss_pred CcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc----c
Confidence 99998886533 35899999999999999999999 8999999999999999999999999999987543221 1
Q ss_pred ccccccCCCcccCccccc-----cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 329 VNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
......++..|+|||++. ...++.++|||||||++|||++|+.|+........... ..... .+.+.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~-------~~~~~- 236 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK-IAKSE-------PPTLS- 236 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHH-HhcCC-------CccCC-
Confidence 123345888999999884 34578899999999999999999999865432221111 11110 11110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.+......+.+++.+||+.+|++||++++++++.+...
T Consensus 237 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 237 -QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred -CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 01122345889999999999999999999999876543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=314.66 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=199.4
Q ss_pred hhhhhhcceecceEEEEEEec------CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
+.+.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (288)
T cd05061 8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 87 (288)
T ss_pred ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 445678999999999999753 24589999876432 23345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecc
Q 010088 243 YEYMANGSLKDHLHSPG--------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG 314 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfG 314 (518)
|||+++|+|.+++.... ...+++..+.+++.|++.||+||| +++|+||||||+||++++++.+||+|||
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~Dfg 164 (288)
T cd05061 88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG 164 (288)
T ss_pred EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEECcCC
Confidence 99999999999996422 234678888999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhcccc
Q 010088 315 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRL 393 (518)
Q Consensus 315 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l 393 (518)
+++........ .......++..|+|||.+.++.++.++|||||||++|||++ |..|+... ...+......... .
T Consensus 165 ~~~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~-~~~~~~~~~~~~~--~ 239 (288)
T cd05061 165 MTRDIYETDYY--RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL-SNEQVLKFVMDGG--Y 239 (288)
T ss_pred ccccccccccc--cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCC--C
Confidence 99865432211 11122345778999999998899999999999999999999 67777532 2222222111110 0
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 394 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 394 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+.... .....+.+++.+||+.||++||++.++++.+....
T Consensus 240 -----~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 240 -----LDQPD----NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -----CCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111 22357999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=324.54 Aligned_cols=257 Identities=27% Similarity=0.381 Sum_probs=198.0
Q ss_pred hhhhhhhcceecceEEEEEEe------cCCcEEEEEEecccc-chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeec-Cce
Q 010088 169 TDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEK-RER 239 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~~ 239 (518)
.+.+.+.||+|+||+||+|.. .+++.||||+++... ......+.+|+.+|.++ +|+||++++++|... ...
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 87 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence 355678999999999999974 346899999987532 33346788999999999 689999999988754 467
Q ss_pred EEEEEecCCCCHHHHhcCCC------------------------------------------------------------
Q 010088 240 FLMYEYMANGSLKDHLHSPG------------------------------------------------------------ 259 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------ 259 (518)
++||||+++|+|.++++...
T Consensus 88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (343)
T cd05103 88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE 167 (343)
T ss_pred EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence 89999999999999986421
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccccccc
Q 010088 260 -----RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 334 (518)
Q Consensus 260 -----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~ 334 (518)
...++|..+.+++.|++.||+||| +.+|+||||||+|||+++++++||+|||++......... .......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~ 242 (343)
T cd05103 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGDAR 242 (343)
T ss_pred hhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch--hhcCCCC
Confidence 124788899999999999999999 899999999999999999999999999998765332211 0112234
Q ss_pred CCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHH
Q 010088 335 GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTI 413 (518)
Q Consensus 335 gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l 413 (518)
++..|+|||.+.+..++.++||||||+++|||++ |..|+............ ...... ....... ...+
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~------~~~~~~~----~~~~ 311 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTR------MRAPDYT----TPEM 311 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH-HhccCC------CCCCCCC----CHHH
Confidence 5678999999988899999999999999999997 88888643322121111 111111 1111111 2458
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 414 VTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 414 ~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+++..||+.||++||++.+|+++|...
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 8999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=313.91 Aligned_cols=260 Identities=25% Similarity=0.325 Sum_probs=198.0
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.||+|++|+||+|+.. +|..||+|.+... .......+.+|+.++.+++|+||+++++++.+++..++||||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (285)
T cd07861 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS- 82 (285)
T ss_pred EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence 4567999999999999875 6899999988643 22334678899999999999999999999999999999999997
Q ss_pred CCHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 249 GSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 249 gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
++|.+++.... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 155 (285)
T cd07861 83 MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV---- 155 (285)
T ss_pred CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc----
Confidence 68999886533 256899999999999999999999 8999999999999999999999999999987543321
Q ss_pred cccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc----------cc--
Q 010088 328 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR----------LA-- 394 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~----------l~-- 394 (518)
.......+++.|+|||.+.+ ..++.++||||||+++|||+||+.|+................... +.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 11233457899999998865 457899999999999999999999997544332222211100000 00
Q ss_pred -cccCCcCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 395 -ELVDPRIKDS---FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 395 -~~~d~~l~~~---~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
..++...... ........+.+++.+||+.||++|||+++|+++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~ 284 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence 0000000000 00012245789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=309.85 Aligned_cols=249 Identities=27% Similarity=0.484 Sum_probs=200.1
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
..+.+.||+|+||.||+|.+.++..+|+|.+.... ....+|.+|++++++++|+|++++++++......++||||++++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 34567899999999999988778899999886432 23457999999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.... ..+++..+..++.+++.||+||| +.+++||||||+||+++.++.+||+|||+++........ .
T Consensus 85 ~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~---~ 157 (256)
T cd05112 85 CLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT---S 157 (256)
T ss_pred cHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCccc---c
Confidence 9999997543 35899999999999999999999 889999999999999999999999999998765432211 1
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
.....++.+|+|||.+.+..++.++||||||+++|||++ |+.|+.... ........... .....+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~----~~~~~~~~------- 225 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-NSEVVETINAG----FRLYKPRL------- 225 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHhCC----CCCCCCCC-------
Confidence 122335678999999998899999999999999999998 888886433 22222221110 01111211
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
....+.+++.+||+.+|++||++.++++.|
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 125689999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=312.62 Aligned_cols=254 Identities=25% Similarity=0.433 Sum_probs=200.8
Q ss_pred hhhhhhcceecceEEEEEEec----CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.+.+.||+|+||.||+|++. .+..+|+|.++... ......|.+|+.++.+++||||+++++++...+..++|||
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (267)
T cd05066 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE 85 (267)
T ss_pred eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 445678999999999999864 23479999886432 3345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++++|.+++.... ..+++.+++.++.|++.||+||| +.+++||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 86 YMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999999997643 35899999999999999999999 89999999999999999999999999999986644321
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
.. .......++..|++||.+.+..++.++||||||+++||+++ |..||.+.... +..... ..... ...
T Consensus 162 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-~~~~~~-~~~~~------~~~-- 230 (267)
T cd05066 162 AA-YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-DVIKAI-EEGYR------LPA-- 230 (267)
T ss_pred ee-eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-HHHHHH-hCCCc------CCC--
Confidence 10 01122234568999999998899999999999999999887 99998654322 111111 11111 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.......+.+++.+|++.+|.+||++.++++.|..
T Consensus 231 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 231 --PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred --CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 11223568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=308.76 Aligned_cols=237 Identities=26% Similarity=0.428 Sum_probs=189.4
Q ss_pred hhcceecceEEEEEEecCCc-----------EEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 174 TIIGQGGFGTVYKAQFSDGS-----------LIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36999999999999886433 5778876543333 6789999999999999999999999988 788999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC-------cEEEeeccc
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-------VAKLADFGL 315 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-------~~kl~DfGl 315 (518)
|||+++|+|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999986432 5899999999999999999999 89999999999999999887 799999999
Q ss_pred cccCCCCCcccccccccccCCCcccCccccccC--CCCccccchhhHHHHHHHHhC-CccccCCcchHHHHHHHHhhccc
Q 010088 316 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ--ELTEKSDVYSYGVVLLEIVTA-RRAVQDGKNLVESAQVCMASESR 392 (518)
Q Consensus 316 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwS~Gvll~el~tG-~~p~~~~~~~~~~~~~~~~~~~~ 392 (518)
+...... ....++..|+|||++... .++.++||||||+++|||++| ..|+.... ......... ....
T Consensus 155 a~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~-~~~~ 224 (259)
T cd05037 155 PITVLSR--------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQ-DQHR 224 (259)
T ss_pred ccccccc--------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHh-cCCC
Confidence 8764331 223467789999998776 789999999999999999995 56664432 222211111 1000
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 393 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 393 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
... .....+.+++..||..+|.+||++.++++.|
T Consensus 225 --------~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 225 --------LPM----PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred --------CCC----CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000 0015688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=315.70 Aligned_cols=251 Identities=26% Similarity=0.364 Sum_probs=205.3
Q ss_pred hhhhcceecceEEEEEEe-cCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 172 FSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
+.+.||.|+||+||+|.. .+|+.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||+++++
T Consensus 23 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 102 (296)
T cd06655 23 RYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS 102 (296)
T ss_pred EEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCc
Confidence 446799999999999976 4689999999876555556778999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|.+++.. ..+++.++..++.+++.||+||| +.+++||||||+||+++.++.+||+|||++........ ..
T Consensus 103 L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~----~~ 172 (296)
T cd06655 103 LTDVVTE---TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS----KR 172 (296)
T ss_pred HHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc----cC
Confidence 9999864 24899999999999999999999 89999999999999999999999999999876543321 12
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 410 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 410 (518)
....++..|+|||.+.+..++.++|||||||++|||++|+.||.............. .. ..... .+....
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~-~~--~~~~~-------~~~~~~ 242 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NG--TPELQ-------NPEKLS 242 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cC--CcccC-------CcccCC
Confidence 334688999999999988899999999999999999999999976544332222111 10 01100 111222
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 411 RTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 411 ~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
..+.+++.+||+.||++||++.+++.+-+...
T Consensus 243 ~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 243 PIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 45888999999999999999999999887754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=317.76 Aligned_cols=259 Identities=20% Similarity=0.313 Sum_probs=188.3
Q ss_pred hhcceecceEEEEEEec---CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeee--cCceEEEEEecCC
Q 010088 174 TIIGQGGFGTVYKAQFS---DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE--KRERFLMYEYMAN 248 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~ 248 (518)
.+||+|+||+||+|+.. ++..||+|.+.... ....+.+|+.+|++++||||+++++++.. ....++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 57999999999999864 45789999886432 23457899999999999999999998864 346789999986
Q ss_pred CCHHHHhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe----cCCCcEEEeeccccc
Q 010088 249 GSLKDHLHSP-------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLAH 317 (518)
Q Consensus 249 gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DfGla~ 317 (518)
++|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 5888887532 1235889999999999999999999 8999999999999999 456799999999998
Q ss_pred cCCCCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcch--------HHHHHHHHh
Q 010088 318 ASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--------VESAQVCMA 388 (518)
Q Consensus 318 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~--------~~~~~~~~~ 388 (518)
........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .........
T Consensus 161 ~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 161 LFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred ccCCCCcc-ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 65432211 012234578999999999876 45899999999999999999999998532210 000000000
Q ss_pred hcc-----------ccc---cc---cCCcCCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 389 SES-----------RLA---EL---VDPRIKDSFD---------MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 389 ~~~-----------~l~---~~---~d~~l~~~~~---------~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
..+ .+. .. .......... ......+.+++..||+.||.+|||++|+++|.|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 000 000 00 0000000000 000134778999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=310.23 Aligned_cols=250 Identities=24% Similarity=0.394 Sum_probs=203.8
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.||+|+||+||+++.. +|+.||+|.+... ......++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE 82 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence 34568999999999999765 6889999988642 33445678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+++|.+++.......+++..+++++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--- 156 (256)
T cd08218 83 GGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--- 156 (256)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh---
Confidence 999999997654456899999999999999999999 89999999999999999999999999999976543321
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......|+..|+|||.+.+..++.++||||||++++||++|+.|+...... +......... . +....
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-~~~~~~~~~~--~-----~~~~~---- 223 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-NLVLKIIRGS--Y-----PPVSS---- 223 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-HHHHHHhcCC--C-----CCCcc----
Confidence 122345888999999999889999999999999999999999998754332 2222111111 0 11111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.....+.+++.+||+.+|.+||++.+|+++.+
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~ 255 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence 22346889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=312.11 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=204.0
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||+||+|... ++..+|+|.+..........|.+|++++++++|+||+++++++......++||||+++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 345568999999999999875 5889999998766556667899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|.+++...+ ..+++..+..++.|++.||+||| +.+|+|+||||+||+++.++.+||+|||++........
T Consensus 87 ~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---- 158 (280)
T cd06611 87 GALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ---- 158 (280)
T ss_pred CcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc----
Confidence 99999987543 35999999999999999999999 89999999999999999999999999999875433221
Q ss_pred ccccccCCCcccCccccc-----cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 329 VNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
......++..|++||.+. ...++.++||||||+++|||++|+.|+............ .... .+.+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~-------~~~~~- 229 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI-LKSE-------PPTLD- 229 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH-hcCC-------CCCcC-
Confidence 123346899999999875 345778999999999999999999999654332221111 1100 01110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+......+.+++..||+.+|.+||++.+++++.+..
T Consensus 230 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 266 (280)
T cd06611 230 -QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVS 266 (280)
T ss_pred -CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhc
Confidence 0111224588999999999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=308.43 Aligned_cols=258 Identities=25% Similarity=0.416 Sum_probs=205.2
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
++.+.||.|+||+||+|... ++..+|+|++.... ......+.+|+++++.++|+||+++++.+...+..++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG 83 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence 45678999999999999865 57899999986432 23557899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 249 GSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 249 gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
++|.+++..... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||++...........
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 84 GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred CcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 999999975432 46899999999999999999999 89999999999999999999999999999876544332111
Q ss_pred cccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
.......|+..|++||.+... .++.++||||||+++|||++|+.||............ .... .+.+.....
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~-~~~~-------~~~~~~~~~ 232 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT-LQND-------PPSLETGAD 232 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH-hcCC-------CCCcCCccc
Confidence 122344689999999998776 7899999999999999999999999754332222211 1111 111111110
Q ss_pred -HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 407 -MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 407 -~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
......+.+++..||+.||++||++++++++.+
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~ 266 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence 123356889999999999999999999998764
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=310.94 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=205.5
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.||.|+||.||+|+.. ++..||+|.+.... ......+.+|++++++++|+||+++++++.+....++|+||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (274)
T cd06609 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG 83 (274)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence 45568999999999999875 58899999886432 34456788999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|.+++... .+++..+..++.|++.||.||| +.+++||||+|+||++++++.++|+|||+++.......
T Consensus 84 ~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---- 153 (274)
T cd06609 84 GSCLDLLKPG---KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS---- 153 (274)
T ss_pred CcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc----
Confidence 9999999753 6899999999999999999999 89999999999999999999999999999986654321
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
......++..|+|||++.+..++.++||||||+++|||+||+.|+...... ........ ...+.+... .
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~-------~~~~~~~~~---~ 222 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-RVLFLIPK-------NNPPSLEGN---K 222 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-HHHHHhhh-------cCCCCCccc---c
Confidence 123446888999999999888999999999999999999999998643322 11111111 111111111 0
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
....+.+++..||..+|++||++++++++.+....
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 23458899999999999999999999998877543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.52 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=197.8
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.||+|+||+||+++.. +|+.||+|.+... .......+.+|+.++..++|+||+++++.+.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 4568999999999999875 5899999998642 22334568889999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc--
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC-- 325 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-- 325 (518)
+|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.........
T Consensus 85 gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 85 GGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred CccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 999999997643 4899999999999999999999 999999999999999999999999999998754321100
Q ss_pred -----------------------------cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCC
Q 010088 326 -----------------------------FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDG 376 (518)
Q Consensus 326 -----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~ 376 (518)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 000112356999999999999999999999999999999999999999754
Q ss_pred cchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHHhhcC
Q 010088 377 KNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARP---SIKQVLRILYES 441 (518)
Q Consensus 377 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP---s~~evl~~L~~~ 441 (518)
... ............+ .+.+.. ..+ ..+.+++..|+. ||.+|+ ++.++++|.|..
T Consensus 240 ~~~-~~~~~i~~~~~~~--~~p~~~--~~s----~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~ 297 (360)
T cd05627 240 TPQ-ETYRKVMNWKETL--VFPPEV--PIS----EKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFE 297 (360)
T ss_pred CHH-HHHHHHHcCCCce--ecCCCC--CCC----HHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCC
Confidence 432 2222222111110 011110 112 346677777664 999998 478999988764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=315.16 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=204.8
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
.+.+.||+|+||.||+|... +|..||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||++++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (297)
T cd06656 22 TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 101 (297)
T ss_pred eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCC
Confidence 34568999999999999864 68999999987655555567899999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.+ ..+++..+..++.+++.||.||| +.+++||||||+|||++.++.+||+|||++........ .
T Consensus 102 ~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~----~ 171 (297)
T cd06656 102 SLTDVVTE---TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS----K 171 (297)
T ss_pred CHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc----C
Confidence 99999964 34889999999999999999999 89999999999999999999999999999876543221 1
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||.............. . . .+.+ ..+...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~--~-~-----~~~~--~~~~~~ 241 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--N-G-----TPEL--QNPERL 241 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc--C-C-----CCCC--CCcccc
Confidence 2334688999999999988899999999999999999999999965433211111000 0 0 0000 011122
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 410 LRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
...+.+++.+||+.+|++||++++++++.+....
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 3557899999999999999999999998876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=316.24 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=204.1
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHH
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK 252 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 252 (518)
..||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 36999999999999875 58899999987655555667899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccccc
Q 010088 253 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 332 (518)
Q Consensus 253 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 332 (518)
+++.. ..+++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||++....... .....
T Consensus 108 ~~~~~---~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~----~~~~~ 177 (292)
T cd06658 108 DIVTH---TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV----PKRKS 177 (292)
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc----ccCce
Confidence 99854 24899999999999999999999 8899999999999999999999999999987543221 11233
Q ss_pred ccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHH
Q 010088 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT 412 (518)
Q Consensus 333 ~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~ 412 (518)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||........... . ...+.+.+... ......
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~-------~~~~~~~~~~~--~~~~~~ 247 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-I-------RDNLPPRVKDS--HKVSSV 247 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-H-------HhcCCCccccc--cccCHH
Confidence 4688999999999888899999999999999999999999975443322111 1 11111111111 112245
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 010088 413 IVTIVRWCTQREGQARPSIKQVLRILYESSDPM 445 (518)
Q Consensus 413 l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~ 445 (518)
+.+++..||+.||++||++++++++.+......
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 788999999999999999999999877665433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=307.46 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=204.0
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.++||+|+||.||.++.. ++..+++|.+... ......++.+|++++++++|+||+++++++.+.+..+++|||++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 34568999999999998764 5889999987643 34445678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+|+|.+++.......+++..+..++.|++.||+||| +.+++||||+|+||++++++.+||+|||++........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 156 (256)
T cd08221 83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--- 156 (256)
T ss_pred CCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence 999999998654456899999999999999999999 88999999999999999999999999999876543321
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+..... .+........ .... ...
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-~~~~~~~~~~--~~~~---------~~~ 223 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-LNLVVKIVQG--NYTP---------VVS 223 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHcC--CCCC---------Ccc
Confidence 12345689999999999888899999999999999999999999864332 2222222111 1111 011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.....+.+++.+||+.+|.+||++++++++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~ 255 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence 22356889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=336.54 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=192.9
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCC------CCeeeEeeeeeec-CceEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHH------RHLVALRGFCIEK-RERFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~~~-~~~~l 241 (518)
+.+.++||+|+||+||+|... .+..||||+++... ....++..|+.++.+++| .+++++++++... ...++
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~i 209 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCI 209 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEE
Confidence 445578999999999999875 57899999986432 223456678888888765 4588899888764 46889
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCceecccCCCcEEecCCC--------------
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENF-------------- 306 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiHrDlk~~NILl~~~~-------------- 306 (518)
|||++ +++|.+++... ..+++..+..|+.||+.||+||| . .+||||||||+|||++.++
T Consensus 210 v~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 210 VMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred EEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 99988 77999988764 35999999999999999999999 6 5999999999999998765
Q ss_pred --cEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHH
Q 010088 307 --VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQ 384 (518)
Q Consensus 307 --~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~ 384 (518)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....+......
T Consensus 284 ~~~vkl~DfG~~~~~~~-------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 284 PCRVRICDLGGCCDERH-------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CceEEECCCCccccCcc-------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 499999998764322 22456799999999999999999999999999999999999999975443322111
Q ss_pred HHHhhccccc-------------cccCC--cCCCCCC---------------HHHHHHHHHHHHHccccCCCCCCCHHHH
Q 010088 385 VCMASESRLA-------------ELVDP--RIKDSFD---------------MEQLRTIVTIVRWCTQREGQARPSIKQV 434 (518)
Q Consensus 385 ~~~~~~~~l~-------------~~~d~--~l~~~~~---------------~~~~~~l~~li~~Cl~~dp~~RPs~~ev 434 (518)
. ....+.++ ++++. .+..... ......+.+|+..||+.||.+|||++|+
T Consensus 357 i-~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 357 M-EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred H-HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 1 11000000 00000 0000000 0112457899999999999999999999
Q ss_pred HHHhhcCC
Q 010088 435 LRILYESS 442 (518)
Q Consensus 435 l~~L~~~~ 442 (518)
++|.|...
T Consensus 436 L~Hp~~~~ 443 (467)
T PTZ00284 436 TTHPYVLK 443 (467)
T ss_pred hcCccccc
Confidence 99988754
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=325.67 Aligned_cols=258 Identities=19% Similarity=0.287 Sum_probs=197.5
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec------CceEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERFL 241 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 241 (518)
.+.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++|+||+++++++... ...++
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~l 106 (364)
T cd07875 27 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106 (364)
T ss_pred eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEE
Confidence 34568999999999999865 5889999998643 233446788999999999999999999987543 35799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||+++ +|.+++.. .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 107 v~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 107 VMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred EEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 9999965 78777753 3889999999999999999999 89999999999999999999999999999986543
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccc-----
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL----- 396 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~----- 396 (518)
.. ......||..|+|||.+.+..++.++|||||||++|||++|+.||........+............+.
T Consensus 179 ~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 179 SF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred CC-----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 22 22345689999999999999999999999999999999999999975443332222111000000000
Q ss_pred ------c--CCcCC----------------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 397 ------V--DPRIK----------------DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 397 ------~--d~~l~----------------~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+ .+... ..........+.+++.+|++.||.+|||+.++++|.+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 0 00000 000111224678999999999999999999999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=315.35 Aligned_cols=252 Identities=31% Similarity=0.487 Sum_probs=198.7
Q ss_pred hhhhhcceecceEEEEEEec------CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
.+.+.||+|+||.||+|... ++..||+|.+.... .....+|.+|+.++++++|+||++++++|.+.+..++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (288)
T cd05050 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF 87 (288)
T ss_pred eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEE
Confidence 34568999999999999863 46789999886432 344567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec
Q 010088 244 EYMANGSLKDHLHSPG--------------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD 303 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~ 303 (518)
||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+++||||||+||+++
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~nil~~ 164 (288)
T cd05050 88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVG 164 (288)
T ss_pred ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhheEec
Confidence 9999999999996421 134789999999999999999999 89999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHH
Q 010088 304 ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVES 382 (518)
Q Consensus 304 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~ 382 (518)
+++.+||+|||++......... ........+..|+|||.+.+..++.++|||||||++|||++ |..|+.... ..+.
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~-~~~~ 241 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYY--KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA-HEEV 241 (288)
T ss_pred CCCceEECccccceecccCccc--cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-HHHH
Confidence 9999999999998754332211 11122335678999999988899999999999999999998 777875332 2222
Q ss_pred HHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 383 AQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 383 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
..... .. ... .... .....+.+++.+||+.+|++||++.|+++.|.
T Consensus 242 ~~~~~-~~-~~~-----~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 242 IYYVR-DG-NVL-----SCPD----NCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHh-cC-CCC-----CCCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 22211 11 110 0111 22356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=308.08 Aligned_cols=250 Identities=24% Similarity=0.434 Sum_probs=201.3
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec-CceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK-RERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~ 246 (518)
.+.+.||+|++|.||++... +++.+|+|++... .....+.+.+|++++++++|+|++++++.+... ...+++|||+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence 45678999999999999875 5789999998642 234456788999999999999999999987644 4578999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++++|.+++.......+++.++..++.+++.||+||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--- 156 (257)
T cd08223 83 EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--- 156 (257)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC---
Confidence 9999999998654556899999999999999999999 8999999999999999999999999999987653321
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
.......+++.|+|||.+.+..++.++||||||++++||++|+.|+.... ........... .+ +.+.
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-~~~~~~~~~~~--~~-----~~~~---- 223 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-MNSLVYRIIEG--KL-----PPMP---- 223 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhc--CC-----CCCc----
Confidence 12234568899999999999999999999999999999999999986433 22222222111 11 1111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
......+.+++.+|++.+|++||++.+++++.+
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 256 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 123356889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=318.01 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=199.2
Q ss_pred hhhhhhcceecceEEEEEEec--------CCcEEEEEEeccc-cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCce
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS--------DGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRER 239 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 239 (518)
+.+.+.||+|+||.||+++.. .+..+|+|.++.. ......++.+|++++.++ +|+||++++++|...+..
T Consensus 14 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 93 (314)
T cd05099 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPL 93 (314)
T ss_pred eeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCce
Confidence 345678999999999999742 2457999988643 234456789999999999 699999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC
Q 010088 240 FLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 305 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 305 (518)
++||||+++|+|.+++.... ...++|.++++++.|++.||+||| +.+++||||||+|||++++
T Consensus 94 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~ 170 (314)
T cd05099 94 YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTED 170 (314)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEcCC
Confidence 99999999999999996532 235899999999999999999999 8999999999999999999
Q ss_pred CcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHH
Q 010088 306 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQ 384 (518)
Q Consensus 306 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~ 384 (518)
+.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.. ....+...
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-~~~~~~~~ 247 (314)
T cd05099 171 NVMKIADFGLARGVHDIDYY--KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG-IPVEELFK 247 (314)
T ss_pred CcEEEccccccccccccccc--cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC-CCHHHHHH
Confidence 99999999999865432211 01122234568999999998899999999999999999999 7777753 22222222
Q ss_pred HHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 385 VCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 385 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
... .... ..... .....+.+++.+||+.+|++||++.++++.|...
T Consensus 248 ~~~-~~~~------~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 248 LLR-EGHR------MDKPS----NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HHH-cCCC------CCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 211 1110 01111 2234688999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=320.18 Aligned_cols=256 Identities=21% Similarity=0.297 Sum_probs=197.7
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.++||+|+||+||+++.. .++.+|+|.+.+. .......|.+|+.++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~ 83 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY 83 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence 34578999999999999876 4688999998642 2223345889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++|+|.++++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 84 ~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-- 157 (332)
T cd05623 84 VGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-- 157 (332)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc--
Confidence 9999999997532 35899999999999999999999 89999999999999999999999999999875433221
Q ss_pred ccccccccCCCcccCccccc-----cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 327 EPVNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+..........+.. -+..
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~~~~~~~~---~p~~ 232 (332)
T cd05623 158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNHKERFQ---FPAQ 232 (332)
T ss_pred -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-HHHHHHHhCCCcccc---CCCc
Confidence 1123356999999999986 34688999999999999999999999975433 233332222111110 0111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCC--CCCCHHHHHHHhhcC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQ--ARPSIKQVLRILYES 441 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~--~RPs~~evl~~L~~~ 441 (518)
... ....+.+++.+|+..++. .|++++++++|.+..
T Consensus 233 ~~~----~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~ 270 (332)
T cd05623 233 VTD----VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFT 270 (332)
T ss_pred ccc----CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcC
Confidence 111 224577788887755444 478999999998764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=311.70 Aligned_cols=260 Identities=24% Similarity=0.336 Sum_probs=200.4
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
++...||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++|+||+++++++......++||||++
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 83 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD 83 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence 34568999999999999886 58999999885432 2334568899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+++|..++.... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--- 155 (286)
T cd07847 84 HTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--- 155 (286)
T ss_pred ccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc---
Confidence 999988876533 4899999999999999999999 89999999999999999999999999999986544321
Q ss_pred cccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc-------------c
Q 010088 328 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR-------------L 393 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~-------------l 393 (518)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||................... .
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 1223457889999999876 567899999999999999999999997544332221111000000 0
Q ss_pred ccccCCcCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 394 AELVDPRIKDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 394 ~~~~d~~l~~~~~~-----~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.....+......+. .....+.+++.+||+.+|++||++.|++.+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~ 285 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence 00011111100111 11356889999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=310.91 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=200.3
Q ss_pred hhhhhhhcceecceEEEEEEecC----CcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
.+.+.+.||+|+||.||+|.+.+ ...||||...... ....+.|.+|+.++++++|+||+++++++.+ +..++||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~ 85 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVM 85 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEE
Confidence 34566789999999999998643 2468999876543 4455689999999999999999999999875 5678999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+++|+|.+++.... ..+++..++.++.+++.||+||| +.+++||||||+||+++.++.+||+|||+++......
T Consensus 86 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 86 ELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999997643 35899999999999999999999 8999999999999999999999999999987654432
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
.. ......++..|+|||.+....++.++||||||+++|||++ |..||......... .... ....+ ...
T Consensus 162 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~~~~-~~~~~------~~~ 230 (270)
T cd05056 162 YY---KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GRIE-NGERL------PMP 230 (270)
T ss_pred ce---ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHH-cCCcC------CCC
Confidence 11 1122335578999999988889999999999999999986 99998654432222 1111 11111 111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
. .....+.+++.+|+..+|++||++.++++.|.+.
T Consensus 231 ~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 231 P----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2 2235688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=308.46 Aligned_cols=245 Identities=30% Similarity=0.504 Sum_probs=197.4
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.+.||+|+||.||++.. .+..||+|.++... ....+.+|+.++++++|+|++++++++.. +..++||||+++|
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~~ 83 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKG 83 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCCC
Confidence 45567899999999999975 67889999886432 33578999999999999999999999865 4579999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.......+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~------ 154 (254)
T cd05083 84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV------ 154 (254)
T ss_pred CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC------
Confidence 9999998765556899999999999999999999 8999999999999999999999999999987543221
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+..... ..... +.... .
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~~-~~~~~------~~~~~----~ 221 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECV-EKGYR------MEPPE----G 221 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-HHHHHHHH-hCCCC------CCCCC----c
Confidence 22334678999999988899999999999999999998 888886433 22222211 11110 11111 2
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
....+.+++.+||+.+|++||+++++++.|.+
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 23568899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=298.53 Aligned_cols=249 Identities=25% Similarity=0.411 Sum_probs=205.7
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEeccc-----c---chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEE
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-----S---EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 242 (518)
.++||.|..++|-++..+ .|...|+|++... + ....+.-.+|+.+|+++ .||||+.+.+++......++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 458999999999998765 5789999988532 1 12234567899999999 599999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
+|.|+.|.|.++|.+ ...+++....+|+.|+.+|++||| ..+|+||||||+|||++++.++||+|||++.....+
T Consensus 102 Fdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 999999999999986 446999999999999999999999 999999999999999999999999999999988877
Q ss_pred CcccccccccccCCCcccCcccccc------CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccc
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVT------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL 396 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~ 396 (518)
.. ....+||++|.|||.+.. ..|+..+|+||+||+||.|+.|.+||...+.+... +.++.....+.
T Consensus 177 ek-----LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML-R~ImeGkyqF~-- 248 (411)
T KOG0599|consen 177 EK-----LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLML-RMIMEGKYQFR-- 248 (411)
T ss_pred hh-----HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHH-HHHHhcccccC--
Confidence 63 467889999999999854 35888999999999999999999999765544322 22222222111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 397 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 397 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.|.. .+......++|.+||+.||++|.|++|+|+|.++
T Consensus 249 -speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 249 -SPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred -Ccch-----hhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 1111 1334568899999999999999999999999877
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=310.74 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=201.8
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+++.+.||+|+||.||++... +|..||+|.+... .......+.+|++++.+++|+||+++++++...+..++||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 345678999999999999886 6899999988643 33345679999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 248 NGSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 248 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
+++|..++.... ...+++..+..++.+++.||.|||. +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 157 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--- 157 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---
Confidence 999999987532 2368999999999999999999993 2589999999999999999999999999987553321
Q ss_pred ccccccccCCCcccCccccccC------CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQ------ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ........ ......+.
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~----~~~~~~~~ 229 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-NIFAQLSA----IVDGDPPT 229 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-hHHHHHHH----HhhcCCCC
Confidence 2334588899999998544 3588999999999999999999999643321 11111000 00001111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+. ......+.+++.+||+.+|++||++++++++.+...
T Consensus 230 ~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~ 267 (286)
T cd06622 230 LP----SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267 (286)
T ss_pred CC----cccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhh
Confidence 22 223456889999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=313.84 Aligned_cols=260 Identities=25% Similarity=0.302 Sum_probs=199.2
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.||+|+||.||+|+.. +|..+|+|++... .......+.+|++++++++|+||+++++++.+.+..++|+||+.
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 34568999999999999875 6899999988642 22233567889999999999999999999999999999999997
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
++|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 -~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--- 154 (284)
T cd07839 83 -QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--- 154 (284)
T ss_pred -CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC---
Confidence 58888876533 35899999999999999999999 89999999999999999999999999999976543221
Q ss_pred cccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc--------cccccC
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR--------LAELVD 398 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~--------l~~~~d 398 (518)
......++..|+|||.+.+. .++.++|||||||++|||+||+.|+..+.+..+........... +.+..+
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 12334578999999988764 47899999999999999999999976555443333222111000 000000
Q ss_pred ----CcCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 399 ----PRIKDSF-----DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 399 ----~~l~~~~-----~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
+...... .......+.+++..||+.||.+|||+++++++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~ 283 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence 0000000 0112356789999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=314.63 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=204.9
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHH
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK 252 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 252 (518)
..||+|+||.||++... ++..||+|.+........+.+.+|+.++..++||||+++++++...+..++||||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 36999999999999875 68999999986544455567889999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccccc
Q 010088 253 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 332 (518)
Q Consensus 253 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 332 (518)
+++.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........ ....
T Consensus 107 ~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~----~~~~ 176 (297)
T cd06659 107 DIVSQ---TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----KRKS 176 (297)
T ss_pred HHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc----cccc
Confidence 98864 34899999999999999999999 89999999999999999999999999999875433221 1233
Q ss_pred ccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHH
Q 010088 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT 412 (518)
Q Consensus 333 ~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~ 412 (518)
..|+..|+|||++.+..++.++||||||+++|||++|+.||.......... ...... .+... ........
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~-------~~~~~--~~~~~~~~ 246 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSP-------PPKLK--NAHKISPV 246 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHhccC-------CCCcc--ccCCCCHH
Confidence 568999999999998899999999999999999999999997544332221 111100 00000 00112245
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCCc
Q 010088 413 IVTIVRWCTQREGQARPSIKQVLRILYESSDPMHS 447 (518)
Q Consensus 413 l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~ 447 (518)
+.+++..||+.+|++||++++++++.+........
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~ 281 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLDHPFLLQTGLPE 281 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhChhhccCCCcc
Confidence 78999999999999999999999988776554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=316.47 Aligned_cols=259 Identities=21% Similarity=0.333 Sum_probs=188.2
Q ss_pred hhcceecceEEEEEEecC---CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeee--cCceEEEEEecCC
Q 010088 174 TIIGQGGFGTVYKAQFSD---GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE--KRERFLMYEYMAN 248 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~ 248 (518)
.+||+|+||+||+|+..+ +..||+|.+.... ....+.+|+++|++++||||+++++++.. ....++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 479999999999998753 5789999886532 23467899999999999999999998854 4577999999864
Q ss_pred CCHHHHhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe----cCCCcEEEeeccccc
Q 010088 249 GSLKDHLHSP-------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLAH 317 (518)
Q Consensus 249 gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DfGla~ 317 (518)
+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 788777421 1235889999999999999999999 8999999999999999 567899999999998
Q ss_pred cCCCCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcch---------HHHHHHHH
Q 010088 318 ASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNL---------VESAQVCM 387 (518)
Q Consensus 318 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~---------~~~~~~~~ 387 (518)
......... .......||..|+|||.+.+ ..++.++|||||||++|||+||+.||...... ........
T Consensus 161 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 161 LFNSPLKPL-ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred ccCCCcccc-cccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 654332110 11234568999999999876 45899999999999999999999998632210 00000000
Q ss_pred hhc-------------cccccccC----CcCC--------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 388 ASE-------------SRLAELVD----PRIK--------DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 388 ~~~-------------~~l~~~~d----~~l~--------~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
... ........ .... ..........+.+++.+|++.||.+|||+.|+++|.|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY 316 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 000 00000000 0000 0000011235788999999999999999999998865
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=299.35 Aligned_cols=255 Identities=23% Similarity=0.352 Sum_probs=209.0
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEec--cccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
+.+.+.||+|.|+.||++... .|+.+|+|.++ +.+....+++.+|+.+-+.|+|||||+|.+...+....|||+|+|
T Consensus 13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m 92 (355)
T KOG0033|consen 13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 92 (355)
T ss_pred hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence 344568999999999999654 68999999875 344556788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC---CCcEEEeeccccccCCCCC
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DfGla~~~~~~~ 323 (518)
+|++|..-+-.+ .-+++..+-..+.||+++|.|+| .++|||||+||.|+||.. .--+||+|||+|.....+.
T Consensus 93 ~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~ 167 (355)
T KOG0033|consen 93 TGGELFEDIVAR--EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE 167 (355)
T ss_pred cchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence 999998776543 34677788889999999999999 999999999999999953 3469999999999887543
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
......||++|||||++...+|+..+|||+.||+||-|+.|..||.+.... ...+.++.....+ ++.-.+
T Consensus 168 -----~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-rlye~I~~g~yd~----~~~~w~ 237 (355)
T KOG0033|consen 168 -----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYEQIKAGAYDY----PSPEWD 237 (355)
T ss_pred -----ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHHhccccCC----CCcccC
Confidence 456788999999999999999999999999999999999999999864332 2333333333222 222222
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
... +...+++++||..||.+|.|+.|.|+|.|....
T Consensus 238 ~is----~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 238 TVT----PEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred cCC----HHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 333 457789999999999999999999999987654
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=315.32 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=199.2
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.||+|+||.||+|+.. ++..||+|.++... ......+.+|+.++++++|+||+++++++...+..++||||+.
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~- 87 (301)
T cd07873 9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 87 (301)
T ss_pred EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-
Confidence 34568999999999999875 57899999886432 2334567899999999999999999999999999999999997
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++........
T Consensus 88 ~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---- 159 (301)
T cd07873 88 KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK---- 159 (301)
T ss_pred cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC----
Confidence 59999887543 35899999999999999999999 89999999999999999999999999999875433221
Q ss_pred ccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhh-----ccccccccC----
Q 010088 329 VNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS-----ESRLAELVD---- 398 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~-----~~~l~~~~d---- 398 (518)
......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||...... +........ ...+..+.+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChhhchhhhccccc
Confidence 1233457899999998865 45788999999999999999999998654322 211111110 000011100
Q ss_pred -----CcCCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 399 -----PRIKDSF----DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 399 -----~~l~~~~----~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+...... .......+.+++.+|++.||.+|||++|++++.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~ 290 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 1110000 011234578999999999999999999999998774
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=306.24 Aligned_cols=248 Identities=24% Similarity=0.395 Sum_probs=201.3
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.||+|+||.||++... ++..+|+|.+... .......+.+|+++|++++|+||+++++.+...+..++||||++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP 82 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence 34568999999999999875 6789999988643 33445679999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC-CcEEEeeccccccCCCCCccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DfGla~~~~~~~~~~ 326 (518)
+++|.+++.......+++..+++++.+++.||+||| +.+++|+||||+||+++++ +.+||+|||++.......
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (256)
T cd08220 83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--- 156 (256)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---
Confidence 999999998755556899999999999999999999 8999999999999999854 568999999998654432
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ........... .. .+...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~--~~-----~~~~~-- 224 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-PALVLKIMSGT--FA-----PISDR-- 224 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-HHHHHHHHhcC--CC-----CCCCC--
Confidence 12234688999999999988899999999999999999999999864432 22222211110 01 11111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
....+.+++..||+.+|++||++.|++++.
T Consensus 225 --~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p 254 (256)
T cd08220 225 --YSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254 (256)
T ss_pred --cCHHHHHHHHHHccCChhhCCCHHHHhhCC
Confidence 234588999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=307.26 Aligned_cols=247 Identities=30% Similarity=0.473 Sum_probs=200.6
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc-----chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-----EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
..+.||+|+||+||+|... ++..|++|.+.... ....+.+.+|+.++++++|+||+++++++......+++|||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 3468999999999999886 78999999875432 23456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++++|.+++.... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 84 VPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 99999999997643 4899999999999999999999 8999999999999999999999999999987654322
Q ss_pred cccccccccCCCcccCccccccCC-CCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQE-LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
......|+..|++||.+.... ++.++|+||||+++|||++|+.||............ ...... +.+..
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~--~~~~~~-----~~~~~- 225 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI--GRSKEL-----PPIPD- 225 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH--HhcccC-----CCcCC-
Confidence 123456889999999987766 899999999999999999999999755422221111 110111 11111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.....+.+++.+||+.+|.+||++.+++.+.+
T Consensus 226 ---~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 257 (258)
T cd06632 226 ---HLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257 (258)
T ss_pred ---CcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence 12355788999999999999999999998753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=322.11 Aligned_cols=256 Identities=20% Similarity=0.313 Sum_probs=194.6
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec------CceEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERFLM 242 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV 242 (518)
..+.||+|+||+||+|... ++..||||++.... ......+.+|+++|++++|+||+++++++... ...+++
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 98 (343)
T cd07878 19 NLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLV 98 (343)
T ss_pred hheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEE
Confidence 3467999999999999864 67899999986432 22345678999999999999999999987543 356899
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
++++ +++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 99 ~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 99 TNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred eecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 9988 7899988864 34999999999999999999999 899999999999999999999999999999865432
Q ss_pred CcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccC---
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD--- 398 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d--- 398 (518)
.....||..|+|||.+.+ ..++.++|||||||++|||++|+.||.....................+...
T Consensus 172 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 172 -------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred -------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 234568999999999876 578999999999999999999999996543322221111000000000000
Q ss_pred --------CcCCCCCCH--------HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 399 --------PRIKDSFDM--------EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 399 --------~~l~~~~~~--------~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
..+. ..+. .....+.+++.+|++.||.+|||+.|+++|.+...
T Consensus 245 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 245 SEHARKYIQSLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred hhhHHHHhhccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 0000 0000 01134779999999999999999999999987653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.99 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=203.4
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++|+||+++++++.+.+..+++|||++++
T Consensus 6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~ 85 (262)
T cd06613 6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85 (262)
T ss_pred EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence 45568999999999999875 57889999987655555678999999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.... ..+++..+..++.|++.||+||| +.+|+|+||||+||++++++.+||+|||++....... ..
T Consensus 86 ~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~----~~ 157 (262)
T cd06613 86 SLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI----AK 157 (262)
T ss_pred cHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh----hc
Confidence 9999987642 35899999999999999999999 8999999999999999999999999999987544321 11
Q ss_pred cccccCCCcccCccccccC---CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 330 NTDIRGTPGYMDPEYVVTQ---ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~---~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
.....++..|+|||.+.+. .++.++||||||+++|||+||+.|+............. .. ....+.+ ...
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~-~~-----~~~~~~~--~~~ 229 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS-KS-----NFPPPKL--KDK 229 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hc-----cCCCccc--cch
Confidence 2345688899999999776 88999999999999999999999997544322221111 00 0001111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
......+.+++.+||+.+|.+||++.+++.+-
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~ 261 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 23446789999999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=306.67 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=196.0
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc-----chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-----EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMY 243 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 243 (518)
..+.||+|+||.||+|... +|..||+|.+.... ......+.+|+.++++++|+||+++++++.+. ...++++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 3468999999999999875 58999999875321 12345688999999999999999999988753 5678999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+++++|.+++...+ .+++...+.++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 86 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 86 EYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 9999999999997643 4899999999999999999999 8999999999999999999999999999987543211
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
.. ........++..|+|||.+.+..++.++|||||||++|||++|+.||............. . ....+.+..
T Consensus 161 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~-~------~~~~~~~~~ 232 (266)
T cd06651 161 MS-GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA-T------QPTNPQLPS 232 (266)
T ss_pred cc-CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh-c------CCCCCCCch
Confidence 10 011123458899999999998889999999999999999999999997554332222111 0 011122222
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.....+.+++ .||..+|++||+++||++|.+.
T Consensus 233 ----~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~ 264 (266)
T cd06651 233 ----HISEHARDFL-GCIFVEARHRPSAEELLRHPFA 264 (266)
T ss_pred ----hcCHHHHHHH-HHhcCChhhCcCHHHHhcCccc
Confidence 2224456666 6888999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=327.11 Aligned_cols=263 Identities=21% Similarity=0.259 Sum_probs=199.7
Q ss_pred HhhhhhhhcceecceEEEEEEec---CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFS---DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
..+.+.+.||+|+||.||++... .+..||+|.+... ..+.+|+++|++++|+||+++++++......++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 34556678999999999999753 3578999987542 235689999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+. ++|.+++.. ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 167 ~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 167 KYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 995 689998854 345999999999999999999999 89999999999999999999999999999976543321
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcch--HHHHHHHHhhcc----cccc---
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--VESAQVCMASES----RLAE--- 395 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~--~~~~~~~~~~~~----~l~~--- 395 (518)
. .......||..|+|||++.+..++.++|||||||++|||++|+.||...... ..........-. .+..
T Consensus 241 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 241 T--PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred c--ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 1 1223457999999999999999999999999999999999999998643211 111111110000 0000
Q ss_pred --------ccCCcCCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 396 --------LVDPRIKDSFD-------MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 396 --------~~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
......+..+. ......+.+++.+||+.||++||++.|++++.++...
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 00000000000 0112457789999999999999999999999887644
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=312.87 Aligned_cols=266 Identities=23% Similarity=0.313 Sum_probs=203.8
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccc-----hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-----QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
.+.+.||+|+||.||+|... +|+.||||.+..... .....+..|++++++++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 34568999999999999875 689999999865332 234557789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+ +|+|.+++.... ..+++..++.++.||++||+||| +.+|+|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 83 FM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred cc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 99 899999997644 36999999999999999999999 89999999999999999999999999999986544321
Q ss_pred ccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc----------cc
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----------RL 393 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~----------~l 393 (518)
......++..|+|||.+.+ ..++.++|||||||++|||++|..++....+............. .+
T Consensus 158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 158 ----KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred ----cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence 1233456788999998854 46789999999999999999997777544433322222110000 00
Q ss_pred ccccCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 010088 394 AELVDPRIKDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM 445 (518)
Q Consensus 394 ~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~ 445 (518)
............+ ......+.+++.+||+.+|++||+++|++++-+....+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 0000000000111 122357889999999999999999999999887765543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=318.31 Aligned_cols=260 Identities=26% Similarity=0.414 Sum_probs=203.6
Q ss_pred HHHhhhhhhhcceecceEEEEEEec--------CCcEEEEEEeccc-cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeee
Q 010088 166 KKATDNFSTIIGQGGFGTVYKAQFS--------DGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIE 235 (518)
Q Consensus 166 ~~a~~~f~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 235 (518)
....+.+.+.||+|+||.||+++.. .+..||+|.++.. ......++.+|++++.++ +|+||++++++|..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3345567789999999999999752 1236899987643 233456899999999999 79999999999999
Q ss_pred cCceEEEEEecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEE
Q 010088 236 KRERFLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 301 (518)
Q Consensus 236 ~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NIL 301 (518)
.+..+++|||+++|+|.+++.... ...++|.+++.++.|++.||+||| +++|+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEE
Confidence 999999999999999999997532 235889999999999999999999 899999999999999
Q ss_pred ecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchH
Q 010088 302 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLV 380 (518)
Q Consensus 302 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~ 380 (518)
+++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.. .+..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~ 243 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVE 243 (334)
T ss_pred EcCCCcEEECCcccceeccccccc--ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-CCHH
Confidence 999999999999999865432211 11222334578999999999999999999999999999998 7777753 3333
Q ss_pred HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 381 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 381 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+......... . ..... .....+.+++..||+.+|.+||++.++++.|....
T Consensus 244 ~~~~~~~~~~-~------~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 ELFKLLKEGH-R------MDKPA----NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHHcCC-C------CCCCC----CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 3332221110 0 01111 22346889999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=322.25 Aligned_cols=259 Identities=26% Similarity=0.436 Sum_probs=210.6
Q ss_pred HHHHHhhhhhhhcceecceEEEEEEecC---C--cEEEEEEecc-ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC
Q 010088 164 ETKKATDNFSTIIGQGGFGTVYKAQFSD---G--SLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR 237 (518)
Q Consensus 164 ~l~~a~~~f~~~lG~G~~g~Vy~~~~~~---g--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 237 (518)
++.++...+.++||+|-||.||+|.+.+ | -.||||.-+. ......+.|+.|..+|++++||||++|+|+|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 3445566677899999999999998743 3 3688898765 334557789999999999999999999999976 6
Q ss_pred ceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 238 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 238 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
..|+|||.++-|.|..||+.+. ..|+......++.||..+|+||| +..+|||||.++|||+...-.+||+||||++
T Consensus 464 P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhh
Confidence 7899999999999999998754 45888999999999999999999 9999999999999999999999999999999
Q ss_pred cCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccc
Q 010088 318 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAEL 396 (518)
Q Consensus 318 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~ 396 (518)
...+.... ..+...-...|||||.+.-..++.++|||-|||.+||+++ |..||+.-.+..- +..+
T Consensus 540 ~~ed~~yY---kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-----------I~~i 605 (974)
T KOG4257|consen 540 YLEDDAYY---KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-----------IGHI 605 (974)
T ss_pred hccccchh---hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------EEEe
Confidence 88776543 2233445778999999999999999999999999999976 8889875332110 1111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 397 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 397 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
...-+...+..++..+..++.+||..||.+||.+.++...|.+..
T Consensus 606 -EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 606 -ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred -cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 111122334566678999999999999999999999988876543
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=310.78 Aligned_cols=266 Identities=27% Similarity=0.439 Sum_probs=201.7
Q ss_pred hhhhhhcceecceEEEEEEec-----CCcEEEEEEeccccch-hHHHHHHHHHHHHHcCCCCeeeEeeeeee--cCceEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-----DGSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIE--KRERFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 241 (518)
..+.+.||+|+||.||+|++. ++..+|||.+...... ....|.+|++++++++|+||+++++++.. ....++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 345578999999999999864 3689999998754433 46789999999999999999999999887 557899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||+++++|.+++..... .+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 86 v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999999976432 4999999999999999999999 89999999999999999999999999999987653
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHH-HHHHH--hhccccccccC
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES-AQVCM--ASESRLAELVD 398 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~-~~~~~--~~~~~l~~~~d 398 (518)
..... .......++..|++||.+.+..++.++||||||+++|||+||+.|+......... ..... .....+.+.+.
T Consensus 162 ~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYY-YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcce-eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 32111 1112234566799999998889999999999999999999999887532211000 00000 00000000111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 399 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 399 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.......+......+.+++.+||+.+|++||++.||++.|..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 111111112233568999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=317.97 Aligned_cols=256 Identities=23% Similarity=0.268 Sum_probs=204.2
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccccc---hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE---QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.||+|+||+||+|... ++..+|+|.+..... .....+.+|++++..++|+||+++++.+.+.+..++||||+.
T Consensus 5 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (316)
T cd05574 5 KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCP 84 (316)
T ss_pred EeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecC
Confidence 4568999999999999876 489999998864322 244678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+++|.+++.......+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++...........
T Consensus 85 ~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (316)
T cd05574 85 GGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161 (316)
T ss_pred CCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence 999999998655567999999999999999999999 89999999999999999999999999999875432211000
Q ss_pred -------------------------cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHH
Q 010088 328 -------------------------PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES 382 (518)
Q Consensus 328 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~ 382 (518)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||........+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 241 (316)
T cd05574 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF 241 (316)
T ss_pred cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHH
Confidence 0112346889999999999888999999999999999999999999654432222
Q ss_pred HHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHHHhhcC
Q 010088 383 AQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS----IKQVLRILYES 441 (518)
Q Consensus 383 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs----~~evl~~L~~~ 441 (518)
... ...... .. ........+.+++.+||+.||++||+ +++++++.+..
T Consensus 242 ~~~-~~~~~~--------~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~ 293 (316)
T cd05574 242 SNI-LKKEVT--------FP--GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293 (316)
T ss_pred HHH-hcCCcc--------CC--CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhh
Confidence 211 111100 11 01113467999999999999999999 88888876654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=309.21 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=195.1
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeee-----cCceEEEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIE-----KRERFLMYE 244 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-----~~~~~lV~e 244 (518)
+.+.||+|+||.||++... +++.+|+|.++... ....++.+|+.++.++ +|+||+++++++.. .+..++|||
T Consensus 22 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 100 (286)
T cd06638 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100 (286)
T ss_pred eeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence 3468999999999999875 57899999876432 2345688999999999 69999999998853 356899999
Q ss_pred ecCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 245 YMANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 245 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|+++++|.++++.. ....+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 177 (286)
T cd06638 101 LCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177 (286)
T ss_pred ecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCceeecccC
Confidence 99999999987532 2345889999999999999999999 899999999999999999999999999998765432
Q ss_pred CcccccccccccCCCcccCcccccc-----CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccccc
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 397 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 397 (518)
.. ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+.+........... ........
T Consensus 178 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~ 250 (286)
T cd06638 178 RL----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP---RNPPPTLH 250 (286)
T ss_pred CC----ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc---ccCCCccc
Confidence 21 1233468999999998853 457889999999999999999999987554332221110 00001111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
++. .....+.+++.+||+.||++||+++|++++++
T Consensus 251 ~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 251 QPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred CCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 111 11245889999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=312.21 Aligned_cols=259 Identities=24% Similarity=0.333 Sum_probs=199.0
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
..+.||+|++|.||+|+.. +|..||||++.... ......+.+|++++++++|+||+++++++.+.+..++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence 3457999999999999875 68999999886432 2234578899999999999999999999999999999999995
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|.+++.......+++..+..++.|++.||+||| +.+++||||+|+||++++++.+||+|||++........
T Consensus 83 ~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~---- 155 (284)
T cd07860 83 QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR---- 155 (284)
T ss_pred cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc----
Confidence 68999987655567999999999999999999999 89999999999999999999999999999875543221
Q ss_pred ccccccCCCcccCccccccCC-CCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCC--------
Q 010088 329 VNTDIRGTPGYMDPEYVVTQE-LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP-------- 399 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~-------- 399 (518)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||..........+........ .+...+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP-DEVVWPGVTSLPDY 234 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC-ChhhhhhhhHHHHH
Confidence 123345788999999887644 6889999999999999999999997554433322221111000 000000
Q ss_pred -----cCCC-CC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 400 -----RIKD-SF---DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 400 -----~l~~-~~---~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.... .. .......+.+++.+||+.||++||++++++++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 283 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence 0000 00 0011245778999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=309.76 Aligned_cols=250 Identities=24% Similarity=0.431 Sum_probs=197.8
Q ss_pred hhhcceecceEEEEEEec------CCcEEEEEEeccccch-hHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 173 STIIGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
.+.||+|+||+||+|+.. +...|++|.+...... ....|.+|++++++++|+||+++++++.+.+..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 357999999999999864 2467999988654433 456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccccc
Q 010088 246 MANGSLKDHLHSPGR-------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~ 318 (518)
+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+|++|||++..
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcccccccc
Confidence 999999999975441 25899999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhcccccccc
Q 010088 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELV 397 (518)
Q Consensus 319 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 397 (518)
...... .......++..|++||.+.+..++.++||||||+++|||++ |..||...... ......... .+.
T Consensus 167 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-~~~~~~~~~--~~~--- 237 (275)
T cd05046 167 VYNSEY---YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-EVLNRLQAG--KLE--- 237 (275)
T ss_pred cCcccc---cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-HHHHHHHcC--CcC---
Confidence 432211 11223356778999999988889999999999999999999 67777543221 222111111 111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
..... .....+.+++.+||+.+|++||++.++++.|.
T Consensus 238 -~~~~~----~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 -LPVPE----GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -CCCCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00111 22356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=310.13 Aligned_cols=262 Identities=22% Similarity=0.293 Sum_probs=202.4
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.||+|+||.||+|+.. +|..||+|++.... ......+.+|+.++++++|+||+++++++......++||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~- 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM- 81 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence 35568999999999999875 68999999986533 344567999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+++|.+++.... ..+++.+++.++.|++.||+||| +.+++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--- 154 (286)
T cd07832 82 PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--- 154 (286)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC---
Confidence 999999987543 46999999999999999999999 89999999999999999999999999999886544321
Q ss_pred cccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc----c---------c
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----R---------L 393 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~----~---------l 393 (518)
.......|+..|+|||.+.+. .++.++||||||+++|||++|..++....+...+......... . .
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 112345689999999998654 4689999999999999999997777544333222221110000 0 0
Q ss_pred ccccCCcCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 394 AELVDPRIKD----SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 394 ~~~~d~~l~~----~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
..+..+.... ....+....+.+++.+|++.+|++||+++++++|.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence 0000000000 0001223678999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.28 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=199.5
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEeccccc----------hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEE
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE----------QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 241 (518)
.+.||+|+||.||+|... +|+.+|+|.++.... ...+.+.+|+.++++++|+|++++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 457999999999999764 689999998753111 112467889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||+|+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 86 FLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred EEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 99999999999999865 35899999999999999999999 89999999999999999999999999999976433
Q ss_pred CCcccccccccccCCCcccCccccccCC--CCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCC
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQE--LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 399 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~ 399 (518)
... ........|+..|+|||.+.... ++.++||||||+++|||++|..|+.............. ......++.
T Consensus 161 ~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~ 235 (272)
T cd06629 161 IYD--NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN---KRSAPPIPP 235 (272)
T ss_pred ccc--ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---cccCCcCCc
Confidence 211 11123456889999999987654 88999999999999999999999965444332221110 011111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 400 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
. ...+....+.+++..||+.+|++||++++|+++.+
T Consensus 236 ~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (272)
T cd06629 236 D----VSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271 (272)
T ss_pred c----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence 1 11123456889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=305.88 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=200.5
Q ss_pred hhhcceecceEEEEEEe-cCCcEEEEEEecccc------chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 173 STIIGQGGFGTVYKAQF-SDGSLIAVKRMDKIS------EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
.++||+|+||.||+|.. .++..+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 45799999999999976 468999999886432 12346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC-cEEEeeccccccCCCCCc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-VAKLADFGLAHASKDGSI 324 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DfGla~~~~~~~~ 324 (518)
+++++|.+++... .++++..+..++.|++.||+||| +.+++|+||||+||+++.++ .+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 85 MAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred cCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 9999999999753 35899999999999999999999 89999999999999998765 699999999876543321
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
..........|+..|+|||.+.+..++.++||||+|+++|||++|+.|+............ .... .....+ .
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~---~~~~~~----~ 231 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI-FKIA---SATTAP----S 231 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH-HHHh---ccCCCC----C
Confidence 1111223346889999999998888999999999999999999999998643321111111 0000 000111 2
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.+......+.+++.+|++.+|++||++.+++++.+.
T Consensus 232 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~ 267 (268)
T cd06630 232 IPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267 (268)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCccc
Confidence 222334568899999999999999999999987653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=304.04 Aligned_cols=254 Identities=29% Similarity=0.454 Sum_probs=202.5
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccccc--hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE--QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
..+.||+|+||.||+|... ++..|++|.+..... .....+.+|++++++++|+||+++++++...+..++|+||+++
T Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06626 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSG 83 (264)
T ss_pred eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCC
Confidence 3468999999999999875 688999999865433 3567899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|.+++... ..+++..+..++.+++.||+||| +.+|+|+||+|+||++++++.+||+|||++............
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 84 GTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999999764 34889999999999999999999 899999999999999999999999999999876543321111
Q ss_pred ccccccCCCcccCccccccCC---CCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 329 VNTDIRGTPGYMDPEYVVTQE---LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
......++..|++||.+.+.. .+.++||||||+++|||++|+.||....+.......... . ..+.+....
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~-----~~~~~~~~~ 231 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--G-----HKPPIPDSL 231 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--C-----CCCCCCccc
Confidence 122356789999999998766 889999999999999999999999654332222211111 0 111111111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.....+.+++.+||+.+|.+||++.+++.+-|
T Consensus 232 --~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~ 263 (264)
T cd06626 232 --QLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263 (264)
T ss_pred --ccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 11355789999999999999999999987643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=306.74 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=204.4
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.+.||+|+||.||+|... ++..+|+|.+.... ......|.+|++++.+++|+||+++++++..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 345568999999999999864 68899999876432 3344678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+++|.+++.. ..+++..+..++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--- 156 (277)
T cd06641 86 GGSALDLLEP---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--- 156 (277)
T ss_pred CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh---
Confidence 9999999864 34899999999999999999999 89999999999999999999999999999876543221
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......++..|++||.+.+..++.++|||||||++|||++|..|+...... ........ . ..+.+..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~--~-----~~~~~~~---- 223 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-KVLFLIPK--N-----NPPTLEG---- 223 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-HHHHHHhc--C-----CCCCCCc----
Confidence 122346788999999998888999999999999999999999998643321 11111110 0 0111222
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM 445 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~ 445 (518)
.....+.+++.+||+.+|.+||++.+++++.+......
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence 22356889999999999999999999999876654433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=344.46 Aligned_cols=256 Identities=25% Similarity=0.316 Sum_probs=197.1
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.++||+|+||+||+|+.. +|+.||+|++... .....+.|.+|++++++++||||+++++++.+.+..++||||++
T Consensus 6 Ii~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~e 85 (932)
T PRK13184 6 IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIE 85 (932)
T ss_pred EEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence 4568999999999999875 5899999998642 22335679999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccccc
Q 010088 248 NGSLKDHLHSP---------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318 (518)
Q Consensus 248 ~gsL~~~l~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~ 318 (518)
||+|.+++... ....+++..+++++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecCccee
Confidence 99999998631 1234678888999999999999999 89999999999999999999999999999986
Q ss_pred CCCCCcc------------c--ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHH
Q 010088 319 SKDGSIC------------F--EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQ 384 (518)
Q Consensus 319 ~~~~~~~------------~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~ 384 (518)
....... . ........||+.|||||.+.+..++.++|||||||++|||+||+.||...........
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~ 242 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh
Confidence 5211000 0 0011235699999999999999999999999999999999999999965322111111
Q ss_pred HHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHhhc
Q 010088 385 VCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS-IKQVLRILYE 440 (518)
Q Consensus 385 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-~~evl~~L~~ 440 (518)
.. +.++.-.. ...+....+.+++.+|++.||++||+ ++++++.|..
T Consensus 243 ~~---------i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 243 DV---------ILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hh---------ccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 00110000 00122356889999999999999965 6666666544
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=312.03 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=200.2
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
++.++||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence 34568999999999999886 48999999875432 2234678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+++|.++.... ..++|..++.++.|++.||+||| +.+++||||+|+||++++++.+||+|||++........
T Consensus 84 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--- 155 (286)
T cd07846 84 HTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--- 155 (286)
T ss_pred ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc---
Confidence 99999887653 24899999999999999999999 88999999999999999999999999999876543321
Q ss_pred cccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccc----c-------
Q 010088 328 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA----E------- 395 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~----~------- 395 (518)
......++..|+|||++.+ ..++.++||||||+++|||++|+.|+........+....... ..+. +
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCL-GNLIPRHQEIFQKNPL 233 (286)
T ss_pred -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHh-CCCchhhHHHhccchH
Confidence 1233457899999999865 457889999999999999999998886544332222211100 0000 0
Q ss_pred ---ccCCcCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 396 ---LVDPRIKDSF-----DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 396 ---~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
+..+...... .......+.+++.+||+.+|++||++.+++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 285 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence 0011111000 0122356899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=305.47 Aligned_cols=250 Identities=25% Similarity=0.441 Sum_probs=198.7
Q ss_pred hhhhhcceecceEEEEEEecC--CcEEEEEEeccc----------cchhHHHHHHHHHHHHH-cCCCCeeeEeeeeeecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFSD--GSLIAVKRMDKI----------SEQVEGDFCREIELLAR-LHHRHLVALRGFCIEKR 237 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~ 237 (518)
.+.+.||+|+||.||+|.+.. +..+|+|.+... ......++.+|+.++.+ ++|+||+++++++.+.+
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 345689999999999998865 688999987521 22334567889998876 69999999999999999
Q ss_pred ceEEEEEecCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCceecccCCCcEEecCCCcEEEeecc
Q 010088 238 ERFLMYEYMANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFG 314 (518)
Q Consensus 238 ~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiHrDlk~~NILl~~~~~~kl~DfG 314 (518)
..++||||+++++|.+++.. .....+++..+++++.|++.||.||| . .+++|+||||+||++++++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEeccc
Confidence 99999999999999998753 22345899999999999999999999 5 689999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccc
Q 010088 315 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 394 (518)
Q Consensus 315 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~ 394 (518)
++....... ......|+..|++||.+.+..++.++||||||+++|||++|+.|+...... ......... ..
T Consensus 160 ~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~--~~- 230 (269)
T cd08528 160 LAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-SLATKIVEA--VY- 230 (269)
T ss_pred ceeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-HHHHHHhhc--cC-
Confidence 997654332 223456889999999999888999999999999999999999998644322 222111111 00
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 395 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 395 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.+.... .....+.+++.+||+.||++||++.|+..+++
T Consensus 231 ---~~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 ---EPLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---CcCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111 12256889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=345.06 Aligned_cols=255 Identities=21% Similarity=0.361 Sum_probs=198.9
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEEEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMY 243 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 243 (518)
.+.+.+.||+|+||+||+++.. .+..+|+|.+... .......|..|+.+|.+|+|||||++++++... ...||||
T Consensus 14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVM 93 (1021)
T PTZ00266 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM 93 (1021)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEE
Confidence 3445678999999999999875 4678999987642 334456799999999999999999999988654 4689999
Q ss_pred EecCCCCHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcC----CCCceecccCCCcEEecC-------------
Q 010088 244 EYMANGSLKDHLHSPG--RTPLSWQTRIQIAIDVANALEYLHFYC----DPPLCHRDIKSSNILLDE------------- 304 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~iiHrDlk~~NILl~~------------- 304 (518)
||+++|+|.++|.... ...+++..++.|+.||+.||+|||... ..+||||||||+||||+.
T Consensus 94 EY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~ 173 (1021)
T PTZ00266 94 EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173 (1021)
T ss_pred eCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccc
Confidence 9999999999997521 246999999999999999999999432 146999999999999964
Q ss_pred ----CCcEEEeeccccccCCCCCcccccccccccCCCcccCcccccc--CCCCccccchhhHHHHHHHHhCCccccCCcc
Q 010088 305 ----NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKN 378 (518)
Q Consensus 305 ----~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~ 378 (518)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||+||+.||.....
T Consensus 174 n~ng~~iVKLsDFGlAr~l~~~s-----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 174 NLNGRPIAKIGDFGLSKNIGIES-----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred ccCCCCceEEccCCccccccccc-----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 3358999999998654332 2234579999999999854 4588999999999999999999999976555
Q ss_pred hHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 379 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 379 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.......... . +.+.. ......+.+||..||+.+|.+||++.|++.+.+.
T Consensus 249 ~~qli~~lk~-~--------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i 298 (1021)
T PTZ00266 249 FSQLISELKR-G--------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQII 298 (1021)
T ss_pred HHHHHHHHhc-C--------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence 4443332211 1 11110 0112458899999999999999999999976554
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=310.14 Aligned_cols=260 Identities=26% Similarity=0.398 Sum_probs=200.5
Q ss_pred HHHHHHhhhh--hhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeec--
Q 010088 163 KETKKATDNF--STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEK-- 236 (518)
Q Consensus 163 ~~l~~a~~~f--~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-- 236 (518)
.++.+++.+| .+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|+|++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 3333344444 468999999999999874 68899999886432 2345678899999999 799999999998754
Q ss_pred ---CceEEEEEecCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEe
Q 010088 237 ---RERFLMYEYMANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA 311 (518)
Q Consensus 237 ---~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 311 (518)
+..++||||+++|+|.++++.. ....+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEe
Confidence 3589999999999999988632 2346899999999999999999999 8899999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccCCCcccCccccccC-----CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHH
Q 010088 312 DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-----ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC 386 (518)
Q Consensus 312 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~ 386 (518)
|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.|+.............
T Consensus 171 dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 246 (291)
T cd06639 171 DFGVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP 246 (291)
T ss_pred ecccchhcccccc----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence 9999876543221 12234688999999988543 36889999999999999999999987544332222211
Q ss_pred HhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 387 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 387 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
......+.+ ..+....+.+++.+||+.+|++||++.+++++.+.
T Consensus 247 ---~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~ 290 (291)
T cd06639 247 ---RNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290 (291)
T ss_pred ---cCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence 011111111 11223468899999999999999999999998653
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=309.39 Aligned_cols=260 Identities=24% Similarity=0.332 Sum_probs=196.5
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccc-hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.||+|++|+||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||+.+
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT 87 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC
Confidence 34568999999999999876 689999999864322 2234577899999999999999999999999999999999985
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
+|.+++..... .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++.......
T Consensus 88 -~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~---- 158 (291)
T cd07844 88 -DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK---- 158 (291)
T ss_pred -CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc----
Confidence 99999876433 6899999999999999999999 89999999999999999999999999999875432211
Q ss_pred ccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc-----cccc------
Q 010088 329 VNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR-----LAEL------ 396 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~-----l~~~------ 396 (518)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......+........... ....
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1122346889999998865 568899999999999999999999996544222222111110000 0000
Q ss_pred cC--------CcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 397 VD--------PRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 397 ~d--------~~l~~~~-~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.. ..+.... .......+.+++.+|++.+|++||++.+++++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~ 290 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 00 0000000 0011256789999999999999999999998765
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=301.71 Aligned_cols=249 Identities=29% Similarity=0.477 Sum_probs=200.7
Q ss_pred hhhhcceecceEEEEEEecC-----CcEEEEEEeccccch-hHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 172 FSTIIGQGGFGTVYKAQFSD-----GSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.||+|+||.||+++..+ +..||+|.+...... ....+.+|+.++.+++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45689999999999998754 388999998654433 567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++++|.+++.......+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 99999999997644333899999999999999999999 899999999999999999999999999999876554221
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
......++..|+|||.+.+..++.++||||||++++||++ |..|+.. .............. . .....
T Consensus 160 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~-~------~~~~~- 227 (258)
T smart00219 160 ---KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGY-R------LPKPE- 227 (258)
T ss_pred ---ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCC-C------CCCCC-
Confidence 1112337889999999988889999999999999999999 6666653 33223222221111 0 01111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
.....+.+++.+|+..+|++|||+.++++.|
T Consensus 228 ---~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 228 ---NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1335688999999999999999999999764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=303.64 Aligned_cols=250 Identities=26% Similarity=0.398 Sum_probs=196.5
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc-----chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-----EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMY 243 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 243 (518)
..++||+|+||.||+|... +|..||+|.+.... ......+.+|+.++++++|+||+++++++.+. ...+++|
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 3568999999999999875 58999999875321 12345788999999999999999999988764 4678999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+++++|.+++.... .+++...++++.|++.||+||| +.+++|+||||+||++++++.+||+|||+++......
T Consensus 86 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 86 EHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 9999999999997543 4788999999999999999999 8899999999999999999999999999987553321
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.............. . ...+
T Consensus 161 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~-----~~~~---- 228 (265)
T cd06652 161 LSG-TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT--Q-----PTNP---- 228 (265)
T ss_pred ccc-cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc--C-----CCCC----
Confidence 110 112334588999999999888899999999999999999999999975433332221110 0 0111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
..+......+.+++..|+. +|++||++++++++.+
T Consensus 229 ~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~ 263 (265)
T cd06652 229 VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF 263 (265)
T ss_pred CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence 1222334567788999985 9999999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=304.84 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=204.7
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.||+|+||.||++... +++.+|+|++.... .....++.+|++++++++|+||+++++++...+..++++||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 45568999999999999886 58899999886543 34556799999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
++|.+++.... ..+++..+.+++.|++.||+||| + .+++|+||||+||++++++.+||+|||++.......
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~---- 155 (265)
T cd06605 84 GSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---- 155 (265)
T ss_pred CcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----
Confidence 99999997643 46899999999999999999999 7 899999999999999999999999999986543221
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCc----chHHHHHHHHhhccccccccCCcCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK----NLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~----~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+.... ......+..... ..+.+..
T Consensus 156 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~ 226 (265)
T cd06605 156 --AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-------PPPRLPS 226 (265)
T ss_pred --hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC-------CCCCCCh
Confidence 112568899999999998899999999999999999999999986542 222222221111 0111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
. .....+.+++..||..+|++||++.+++.+.+..
T Consensus 227 ~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~ 261 (265)
T cd06605 227 G---KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261 (265)
T ss_pred h---hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence 1 1335688999999999999999999999987663
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=308.72 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=199.9
Q ss_pred hhhhhhcceecceEEEEEEecC-Cc----EEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSD-GS----LIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~-g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
+.+.+.||+|+||+||+|.+.+ |. .+|+|.+.... ......+.+|+.++.+++|+||++++++|.. ...++||
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence 3455789999999999998643 33 58999876543 3445678999999999999999999999987 7889999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+++|+|.+++..... .+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||+++......
T Consensus 88 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 88 QLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred ecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 99999999999976433 4899999999999999999999 8999999999999999999999999999998665332
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
... ......++..|+|||.+....++.++||||||+++|||++ |+.||... ...+........ ... ...
T Consensus 164 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~-~~~------~~~ 233 (279)
T cd05057 164 KEY--HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKG-ERL------PQP 233 (279)
T ss_pred cce--ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhCC-CCC------CCC
Confidence 111 1112234678999999988899999999999999999999 99988643 222333222111 100 001
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.. ....+.+++..||..+|.+||++.++++.|...
T Consensus 234 ~~----~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 234 PI----CTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11 124578899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=304.37 Aligned_cols=256 Identities=25% Similarity=0.323 Sum_probs=210.0
Q ss_pred hhhhcceecceEEEEEEecC-CcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.||+|.-|+||++++.+ +..+|+|++.+.. .........|-+||+.+.||.+..|++.+..++..+++||||+
T Consensus 81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp 160 (459)
T KOG0610|consen 81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP 160 (459)
T ss_pred HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence 45689999999999999875 5899999997643 3344567789999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC------
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD------ 321 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~------ 321 (518)
||+|..+++++....++...+..++.+|+-||+||| ..|||+|||||+||||.++|.+.|+||.|+.....
T Consensus 161 GGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~ 237 (459)
T KOG0610|consen 161 GGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVK 237 (459)
T ss_pred CccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeec
Confidence 999999999888888999999999999999999999 99999999999999999999999999998753210
Q ss_pred -CC---------------ccc------------------------------ccccccccCCCcccCccccccCCCCcccc
Q 010088 322 -GS---------------ICF------------------------------EPVNTDIRGTPGYMDPEYVVTQELTEKSD 355 (518)
Q Consensus 322 -~~---------------~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sD 355 (518)
.. .++ .......+||-.|.|||++.+...+.++|
T Consensus 238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVD 317 (459)
T KOG0610|consen 238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVD 317 (459)
T ss_pred cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhh
Confidence 00 000 01123467999999999999999999999
Q ss_pred chhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC----H
Q 010088 356 VYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS----I 431 (518)
Q Consensus 356 VwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs----~ 431 (518)
.|+|||+||||+.|..||....+......+ +.....+++ .........++|++.|.+||++|.. +
T Consensus 318 WWtfGIflYEmLyG~TPFKG~~~~~Tl~NI-v~~~l~Fp~----------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 318 WWTFGIFLYEMLYGTTPFKGSNNKETLRNI-VGQPLKFPE----------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCchhhHHHH-hcCCCcCCC----------CCcchhHHHHHHHHHhccChhhhhccccch
Confidence 999999999999999999865554443333 222222221 1133467889999999999999998 8
Q ss_pred HHHHHHhhcC
Q 010088 432 KQVLRILYES 441 (518)
Q Consensus 432 ~evl~~L~~~ 441 (518)
.||-+|.++.
T Consensus 387 ~eIK~HpFF~ 396 (459)
T KOG0610|consen 387 AEIKRHPFFE 396 (459)
T ss_pred HHhhcCcccc
Confidence 8999887654
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=306.55 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=203.0
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHH
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK 252 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 252 (518)
+.||+|++|.||++... ++..+++|++........+.+.+|+.+++.++|+||+++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 48999999999999864 68899999887555555567899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccccc
Q 010088 253 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 332 (518)
Q Consensus 253 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 332 (518)
+++.. ..+++..+..++.|++.||+||| +.+|+||||+|+||+++.++.+||+|||++....... .....
T Consensus 105 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~----~~~~~ 174 (285)
T cd06648 105 DIVTH---TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV----PRRKS 174 (285)
T ss_pred HHHHh---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC----ccccc
Confidence 99976 34899999999999999999999 8999999999999999999999999999887543321 11233
Q ss_pred ccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHH
Q 010088 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT 412 (518)
Q Consensus 333 ~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~ 412 (518)
..|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... .......... .+.+.. .......
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~~~~~~~~~~-------~~~~~~--~~~~~~~ 244 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMKRIRDNL-------PPKLKN--LHKVSPR 244 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHhcC-------CCCCcc--cccCCHH
Confidence 45889999999998888999999999999999999999998654432 2222111110 111111 0112246
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 413 IVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 413 l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+.+++.+||+.+|++||++.+++++.+...
T Consensus 245 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 245 LRSFLDRMLVRDPAQRATAAELLNHPFLAK 274 (285)
T ss_pred HHHHHHHHcccChhhCcCHHHHccCccccc
Confidence 899999999999999999999999876644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=309.33 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=200.9
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+...+.||+|+||+||+|... +|+.||+|.+.... .....++.+|+++++.++||||+++.++|.+.+..++||||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 344568999999999999875 68999999886432 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+. |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||+|+||++++++.+||+|||++......
T Consensus 97 ~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 97 CL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred hC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 97 57877775432 35899999999999999999999 899999999999999999999999999998754322
Q ss_pred cccccccccCCCcccCccccc---cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
....++..|+|||.+. ...++.++||||||+++|||+||+.|+.............. . . .+.+.
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-~--~-----~~~~~ 235 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-N--D-----SPTLS 235 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-C--C-----CCCCC
Confidence 2345788999999874 45688999999999999999999999865443222111110 0 0 01111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM 445 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~ 445 (518)
.......+.+++.+||+.+|++||++.+++.+.+......
T Consensus 236 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 275 (307)
T cd06607 236 ---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP 275 (307)
T ss_pred ---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence 1123456899999999999999999999999988766543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.42 Aligned_cols=250 Identities=26% Similarity=0.443 Sum_probs=197.3
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeee------cCceEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIE------KRERFLM 242 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~------~~~~~lV 242 (518)
.+.+.||+|+||.||+|+.. +++.+|+|.+.... ....++..|+.++.++ +|+||+++++++.. ....+++
T Consensus 19 ~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 97 (282)
T cd06636 19 ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLV 97 (282)
T ss_pred hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEE
Confidence 34568999999999999874 57899999886433 3345688999999999 69999999999863 3578999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+++|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++......
T Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~ 174 (282)
T cd06636 98 MEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174 (282)
T ss_pred EEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence 99999999999997655556889999999999999999999 899999999999999999999999999998754321
Q ss_pred CcccccccccccCCCcccCccccc-----cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccccc
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 397 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 397 (518)
. .......|+..|+|||.+. ...++.++|||||||++|||++|+.||.+........... ...
T Consensus 175 ~----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~--------~~~ 242 (282)
T cd06636 175 V----GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------RNP 242 (282)
T ss_pred c----cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh--------hCC
Confidence 1 1123356899999999875 3468889999999999999999999996544322221110 000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.+.+. .......+.+++.+||+.||.+||++.|++++.|
T Consensus 243 ~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~ 281 (282)
T cd06636 243 PPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281 (282)
T ss_pred CCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence 11111 1122356899999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=308.70 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=197.6
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEEecCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.||+|+||.||++... +|..+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||+..
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 3468999999999999875 58999999886432 234567899999999996 99999999999999999999999864
Q ss_pred CCHHHH---hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 249 GSLKDH---LHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 249 gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+|.++ +.......+++..+..++.+++.||+|||+ ..+++||||||+||+++.++.+||+|||+++......
T Consensus 88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 162 (288)
T cd06616 88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI-- 162 (288)
T ss_pred -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC--
Confidence 55543 333333569999999999999999999992 2589999999999999999999999999987543322
Q ss_pred cccccccccCCCcccCccccccC---CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQ---ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
......|+..|+|||.+.+. .++.++|||||||++|||++|+.||.......+........ ..+.+.
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~ 232 (288)
T cd06616 163 ---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG-------DPPILS 232 (288)
T ss_pred ---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCC-------CCCcCC
Confidence 12334588999999998765 68999999999999999999999986544322222111111 111222
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..........+.+++.+||+.+|++||++++|+++.+..
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 271 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 222122345689999999999999999999999987764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=317.50 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=211.5
Q ss_pred hhhhhhhcceecceEEEEEEecCCcEEEEEEec--cccchhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEEe
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
.++..++||+||.+.||++...+.+.+|+|++. ..+.+....|++|+.+|.+|+ |.+|++|++|-..++.+||||||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence 344456899999999999998888899998764 345666788999999999995 99999999999999999999997
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
- ..+|..+|++.......| .++.+..|++.++.++| ..||||.||||.|+|+- .|.+||+|||+|.........
T Consensus 442 G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 442 G-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred c-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence 6 469999999877776777 77889999999999999 99999999999999985 469999999999987765533
Q ss_pred cccccccccCCCcccCccccccC-----------CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccc
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQ-----------ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 394 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~ 394 (518)
......+||+.||+||.+... +.+.++||||+|||||+|+.|+.||..-.+... ++.
T Consensus 516 --I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a----------Kl~ 583 (677)
T KOG0596|consen 516 --IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA----------KLH 583 (677)
T ss_pred --eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH----------HHH
Confidence 245667899999999998542 266899999999999999999999975433222 234
Q ss_pred cccCCcCCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCCc
Q 010088 395 ELVDPRIKDSFDME-QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHS 447 (518)
Q Consensus 395 ~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~ 447 (518)
.+.||...-+|+.- ....+.++|+.||+.||.+||++.++|++.+-...+.+.
T Consensus 584 aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~ 637 (677)
T KOG0596|consen 584 AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPV 637 (677)
T ss_pred hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccc
Confidence 45555443333211 112289999999999999999999999998876655543
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=308.08 Aligned_cols=259 Identities=25% Similarity=0.326 Sum_probs=199.3
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
..+.||+|++|+||+|... +|..||+|++.... ......+.+|++++++++|+|++++++++.+.+..+++|||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 3467999999999999875 68999999886432 2334578899999999999999999999999999999999995
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|.+++.......+++..++.++.|++.||+||| +.+++||||+|+||++++++.+||+|||++........
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---- 154 (283)
T cd07835 82 LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR---- 154 (283)
T ss_pred cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc----
Confidence 69999997655456999999999999999999999 88999999999999999999999999999875432211
Q ss_pred ccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc----------cccc-
Q 010088 329 VNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR----------LAEL- 396 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~----------l~~~- 396 (518)
......++..|+|||++.+. .++.++||||||+++|||++|+.||.......+........... +.+.
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 12233568899999987654 57889999999999999999999987554433322211110000 0000
Q ss_pred ------cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 397 ------VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 397 ------~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
...... .........+.+++.+||+.+|++||++++++++.|
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 282 (283)
T cd07835 235 PTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282 (283)
T ss_pred hhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence 000000 001112256889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=307.66 Aligned_cols=253 Identities=26% Similarity=0.362 Sum_probs=204.8
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
.+.+.||+|+||+||++... ++..||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||++++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (293)
T cd06647 22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGG 101 (293)
T ss_pred eeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCC
Confidence 34568999999999999764 67899999986554455577899999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.+. .+++..+..++.+++.||.||| +.+++||||||+||+++.++.+||+|||++........ .
T Consensus 102 ~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~----~ 171 (293)
T cd06647 102 SLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS----K 171 (293)
T ss_pred cHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc----c
Confidence 999999753 4889999999999999999999 89999999999999999999999999999875443221 1
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....|+..|++||.+....++.++||||||+++||+++|+.||............. ... .+.. ......
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~-~~~-------~~~~--~~~~~~ 241 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNG-------TPEL--QNPEKL 241 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-cCC-------CCCC--CCcccc
Confidence 233468889999999988889999999999999999999999997543322111100 000 0001 111123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 410 LRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
...+.+++..||+.+|++||++.+++.+.+....
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 3568899999999999999999999999877544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=318.10 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=204.8
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcC-C-----CCeeeEeeeeeecCceEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-H-----RHLVALRGFCIEKRERFL 241 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 241 (518)
.+...++||+|+||.|-||... .++.||||+++... ....+-..|+.+|..|+ | -|+|++++++..+++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 4455679999999999999764 58999999997543 33456678999999997 4 499999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC--CcEEEeeccccccC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN--FVAKLADFGLAHAS 319 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~--~~~kl~DfGla~~~ 319 (518)
|+|.+. -+|+++|+.+.-.+++...+..|+.||+.||.+|| +.+|||+||||+||||.+- ..+||+|||.+...
T Consensus 266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999985 59999999888888999999999999999999999 9999999999999999753 48999999999876
Q ss_pred CCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhc---------
Q 010088 320 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE--------- 390 (518)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~--------- 390 (518)
.... ....-+..|.|||++.+.+|+.+.||||||||++||++|.+-|. +.+..+....+...-
T Consensus 342 ~q~v-------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp-G~ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 342 SQRV-------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP-GDNEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred CCcc-------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC-CCCHHHHHHHHHHHhCCCCHHHHH
Confidence 5432 13456788999999999999999999999999999999966554 443333322211110
Q ss_pred --cccccccCC---------------------------------cCC-CC------CCHHHHHHHHHHHHHccccCCCCC
Q 010088 391 --SRLAELVDP---------------------------------RIK-DS------FDMEQLRTIVTIVRWCTQREGQAR 428 (518)
Q Consensus 391 --~~l~~~~d~---------------------------------~l~-~~------~~~~~~~~l~~li~~Cl~~dp~~R 428 (518)
.+....++. ... +. .....-..+.+++++|+..||.+|
T Consensus 414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R 493 (586)
T KOG0667|consen 414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER 493 (586)
T ss_pred hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence 000011111 000 00 011223578999999999999999
Q ss_pred CCHHHHHHHhhcCC
Q 010088 429 PSIKQVLRILYESS 442 (518)
Q Consensus 429 Ps~~evl~~L~~~~ 442 (518)
+|..|+++|.+...
T Consensus 494 ~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 494 ITPAQALNHPFLTG 507 (586)
T ss_pred CCHHHHhcCccccc
Confidence 99999999988764
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=305.70 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=205.8
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
+.+.||+|+||.||+|.+. ++..+++|.+..... ....+.+|++++++++|+|++++++++...+..++|+||+++++
T Consensus 23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 101 (286)
T cd06614 23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS 101 (286)
T ss_pred HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCc
Confidence 4468999999999999886 688999999875443 45678999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|.+++.... ..+++..+..++.+++.||+||| +.+++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 102 L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----~~ 173 (286)
T cd06614 102 LTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS----KR 173 (286)
T ss_pred HHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh----hh
Confidence 999998754 36999999999999999999999 89999999999999999999999999998865433211 12
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 410 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 410 (518)
....++..|++||.+.+..++.++||||||+++|||++|+.|+.............. .......+ .....
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~-------~~~~~ 243 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT---KGIPPLKN-------PEKWS 243 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cCCCCCcc-------hhhCC
Confidence 234578899999999888899999999999999999999999875544332222111 11111111 11123
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 411 RTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 411 ~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
..+.+++.+||+.+|.+||++.+++++.+...
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 56889999999999999999999999877653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=306.32 Aligned_cols=261 Identities=21% Similarity=0.328 Sum_probs=198.6
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e 244 (518)
+.+.+.||+|+||.||+|... +++.+|+|.++... ......+.+|+.++.+++||||+++++++... ...++|||
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 344568999999999999886 58899999886432 22334678899999999999999999999877 88999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+. ++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||++........
T Consensus 87 ~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 87 YVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred hcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 997 59999987643 35899999999999999999999 88999999999999999999999999999986554321
Q ss_pred ccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhc-------------
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE------------- 390 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~------------- 390 (518)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||.................
T Consensus 162 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 162 ----PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred ----ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 12334578899999988654 468999999999999999999999865433222111100000
Q ss_pred -----cccccccCCcCCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 391 -----SRLAELVDPRIKDSFDME-QLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 391 -----~~l~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
..........+...+... ....+.+++..||+.+|++||++.|++++-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~ 292 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence 000000011111111111 2456889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=299.84 Aligned_cols=251 Identities=26% Similarity=0.391 Sum_probs=206.3
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccc-hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
++.+.||+|++|.||+|+.. +|..|+||++..... .....+.+|+..+.+++|+||+++++++...+..++||||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 34578999999999999887 489999999875443 4467899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
++|.+++... ..+++..+..++.|++.||+||| + .+++||||+|+||+++.++.++|+|||++........
T Consensus 84 ~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--- 155 (264)
T cd06623 84 GSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--- 155 (264)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC---
Confidence 9999999764 45899999999999999999999 8 9999999999999999999999999999886543321
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCc--chHHHHHHHHhhccccccccCCcCCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK--NLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~--~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
......++..|+|||.+.+..++.++||||||+++|||+||+.|+.... ...+....... ...+.+...
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~- 226 (264)
T cd06623 156 -QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-------GPPPSLPAE- 226 (264)
T ss_pred -cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-------CCCCCCCcc-
Confidence 1124467899999999998899999999999999999999999997554 32222222111 011111111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.....+.+++..||..+|++||++.+++++.+.
T Consensus 227 --~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~ 259 (264)
T cd06623 227 --EFSPEFRDFISACLQKDPKKRPSAAELLQHPFI 259 (264)
T ss_pred --cCCHHHHHHHHHHccCChhhCCCHHHHHhCHHH
Confidence 033578999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.39 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=202.5
Q ss_pred hhhcceecceEEEEEEec-CC----cEEEEEEecc-ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 173 STIIGQGGFGTVYKAQFS-DG----SLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
..+||+|+||+||||.|- +| .+||+|++.. ...+...++++|+-+|.+|+|||+++|+|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 458999999999999773 33 4789998864 34555678999999999999999999999998765 88999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
+.|+|.+|++.+. ..+--+..+.|..|||+||.||| ++.++||||.++|||+..-..+||.|||+++........+
T Consensus 780 P~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 780 PLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred ccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999998753 45888999999999999999999 9999999999999999999999999999999876655332
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
......-.+.|||-|.+....|+.++|||||||++||++| |..|++ +....+.- ..+....++ ..
T Consensus 856 --~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~-gi~~~eI~-dlle~geRL----------sq 921 (1177)
T KOG1025|consen 856 --SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYD-GIPAEEIP-DLLEKGERL----------SQ 921 (1177)
T ss_pred --cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccC-CCCHHHhh-HHHhccccC----------CC
Confidence 2233445778999999999999999999999999999998 777775 33333322 222222222 22
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
+.-+...+..++.+||..|+..||+++++.....+
T Consensus 922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 922 PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 33344568889999999999999999999876543
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=311.85 Aligned_cols=250 Identities=25% Similarity=0.409 Sum_probs=194.8
Q ss_pred hhhcceecceEEEEEEec-CCc----EEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 173 STIIGQGGFGTVYKAQFS-DGS----LIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.||+|+||.||+|.+. +|. .||+|.+.... .....++.+|+.++++++|+||++++|+|... ..++++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~ 90 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM 90 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence 357999999999999864 343 57888876433 23344789999999999999999999998754 567999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++........
T Consensus 91 ~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~- 165 (303)
T cd05110 91 PHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE- 165 (303)
T ss_pred CCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCcccc-
Confidence 9999999997643 35899999999999999999999 899999999999999999999999999999865432211
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ...... .......+. ...
T Consensus 166 -~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-~~~~~~-~~~~~~~~~------~~~-- 234 (303)
T cd05110 166 -YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-TREIPD-LLEKGERLP------QPP-- 234 (303)
T ss_pred -cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHH-HHHCCCCCC------CCC--
Confidence 11223345778999999998999999999999999999998 888885432 111111 111111111 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.....+.+++..||..+|++||+++++++.|...
T Consensus 235 --~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 235 --ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred --CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1224588999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=306.10 Aligned_cols=253 Identities=24% Similarity=0.382 Sum_probs=196.3
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHH-HHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIEL-LARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.||+|+||.||+++.. +|+.||+|+++... .....++..|+.. ++.++|+||+++++++...+..+++|||++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~- 83 (283)
T cd06617 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD- 83 (283)
T ss_pred EEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-
Confidence 4568999999999999876 58999999986532 2334566677775 555689999999999999999999999996
Q ss_pred CCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 249 GSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDP-PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 249 gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
|+|.+++... ....+++..+..++.|++.||+||| ++ +++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (283)
T cd06617 84 TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-- 158 (283)
T ss_pred ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc--
Confidence 6888887542 2346899999999999999999999 76 99999999999999999999999999987653321
Q ss_pred cccccccccCCCcccCcccccc----CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVT----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
..+...|+..|+|||.+.+ ..++.++|+||||+++|||++|+.|+.......+........ ..+.+
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~ 228 (283)
T cd06617 159 ---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE-------PSPQL 228 (283)
T ss_pred ---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc-------CCCCC
Confidence 1233468899999998864 456889999999999999999999986533322222111111 01111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
.. ......+.+++..||..+|++||++.+++++.+....
T Consensus 229 ~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 229 PA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred Cc---cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 10 1123568899999999999999999999998776554
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=308.53 Aligned_cols=246 Identities=24% Similarity=0.391 Sum_probs=202.6
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV 83 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence 35568999999999999875 58999999886422 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++++|.+++... ..+++..+..++.|++.||+||| +.+++||||+|+||++++++.+||+|||++......
T Consensus 84 ~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 84 PGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999999764 35899999999999999999999 899999999999999999999999999998865433
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
.....|++.|+|||.+.+...+.++||||||+++|||++|+.||...... .......... ..+....
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~--------~~~~~~~- 221 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEKILEGK--------VRFPSFF- 221 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCC--------ccCCccC-
Confidence 23346889999999998888999999999999999999999999754422 2122111111 1111222
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
...+.+++.+||+.||.+|+ ++++++++.+..
T Consensus 222 ---~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~ 258 (290)
T cd05580 222 ---SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA 258 (290)
T ss_pred ---CHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccc
Confidence 25688999999999999999 889999887653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.02 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=201.2
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+...+.||+|+||.||+|+.. +|..+|+|.+... .......+.+|++++++++|+|++++++++.+.+..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 344568999999999999875 6889999988643 223345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+. |+|.+++... ..+++|..+..++.+++.||.||| +.+|+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 97 5888877543 345899999999999999999999 899999999999999999999999999998654322
Q ss_pred cccccccccCCCcccCccccc---cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
....|+..|+|||.+. .+.++.++|||||||++|||++|+.|+............. .... +..
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~-~~~~-------~~~- 244 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNES-------PTL- 244 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-hccC-------CCC-
Confidence 2345888999999874 4578899999999999999999999986543322222111 1100 000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMH 446 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~ 446 (518)
........+.+++.+||+.+|.+||++.+++++++.......
T Consensus 245 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 245 --QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred --CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 011223468899999999999999999999999887665443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=301.95 Aligned_cols=246 Identities=26% Similarity=0.373 Sum_probs=201.2
Q ss_pred cceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 176 IGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
||.|+||.||+++.. ++..+|+|.+.... ....+.+.+|+.++++++|+||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999886 48899999986432 23446799999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccc
Q 010088 252 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331 (518)
Q Consensus 252 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 331 (518)
.+++.+.. .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-----~~~ 150 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----KTW 150 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----ccc
Confidence 99997643 4899999999999999999999 8999999999999999999999999999998665432 122
Q ss_pred cccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcc-hHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 010088 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN-LVESAQVCMASESRLAELVDPRIKDSFDMEQL 410 (518)
Q Consensus 332 ~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~-~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 410 (518)
...++..|++||.+....++.++|+||||+++|||++|..|+..... ............. .+ .++....
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------~~----~~~~~~~ 220 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG------KL----EFPNYID 220 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC------CC----CCCcccC
Confidence 34688999999999888899999999999999999999999975441 2222222111000 11 1111223
Q ss_pred HHHHHHHHHccccCCCCCCC-----HHHHHHHhhcC
Q 010088 411 RTIVTIVRWCTQREGQARPS-----IKQVLRILYES 441 (518)
Q Consensus 411 ~~l~~li~~Cl~~dp~~RPs-----~~evl~~L~~~ 441 (518)
..+.+++..||+.+|++||+ ++|++++.|..
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~ 256 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence 56899999999999999999 89999988764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=302.85 Aligned_cols=251 Identities=27% Similarity=0.440 Sum_probs=198.6
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecC------ceEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKR------ERFLM 242 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~------~~~lV 242 (518)
.+.+.||+|++|+||+|... ++..+++|.+..... ...+|.+|+.+++++ +|+||+++++++.... ..++|
T Consensus 9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv 87 (275)
T cd06608 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV 87 (275)
T ss_pred eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence 34568999999999999885 578999998865433 346799999999999 6999999999997654 48999
Q ss_pred EEecCCCCHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCC
Q 010088 243 YEYMANGSLKDHLHSPG--RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~ 320 (518)
|||+++++|.+++.... ...+++..+..++.|++.||+||| +.+++|+||+|+||++++++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 99999999999987533 456899999999999999999999 8999999999999999999999999999987543
Q ss_pred CCCcccccccccccCCCcccCcccccc-----CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccc
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE 395 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~ 395 (518)
.... ......|+..|+|||.+.. ..++.++||||||+++|||++|+.||.+........+.. . ..
T Consensus 165 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~--~~--- 234 (275)
T cd06608 165 STLG----RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP-R--NP--- 234 (275)
T ss_pred cchh----hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh-c--cC---
Confidence 3221 1234568899999998753 357789999999999999999999997543322222211 0 00
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 396 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 396 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.+.+. ........+.+++.+||..||++|||+.+++++.|
T Consensus 235 --~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 235 --PPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred --CCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 11111 11223457889999999999999999999998754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=310.42 Aligned_cols=263 Identities=21% Similarity=0.249 Sum_probs=198.3
Q ss_pred hccee--cceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 175 IIGQG--GFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 175 ~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
.||+| +||+||+++.. +|+.||+|.+... .....+.+.+|+.+++.++|+||+++++++..++..++|+||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 57776 99999999875 6899999998642 2333467889999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc--
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE-- 327 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~-- 327 (518)
+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++||+.+...........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 9999998755556899999999999999999999 89999999999999999999999999986543221110000
Q ss_pred -cccccccCCCcccCcccccc--CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc-------------
Q 010088 328 -PVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES------------- 391 (518)
Q Consensus 328 -~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~------------- 391 (518)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||..................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 00111235677999999876 35789999999999999999999999754332222111100000
Q ss_pred ---------------------ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 392 ---------------------RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 392 ---------------------~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
....+.+..+...........+.+++.+||+.||++|||++|++++.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence 0000111111112223445678999999999999999999999998875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=301.57 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=201.2
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecc--ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeee--cCceEEEEEec
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRGFCIE--KRERFLMYEYM 246 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~ 246 (518)
+.+.||.|+||.||++... +|..+|+|.+.. ......+.+.+|++++++++|+||+++++++.. ....+++|||+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~ 83 (265)
T cd08217 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC 83 (265)
T ss_pred eeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence 4567999999999999764 678999998863 233445678899999999999999999998764 34679999999
Q ss_pred CCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 247 ANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYC--DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 247 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
++++|.+++... ....+++..++.++.+++.||+|||..+ +.+++|+||||+||++++++.+||+|||++......
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 84 EGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred cCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 999999998643 2346999999999999999999999554 678999999999999999999999999999876543
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
.. ......++..|++||.+.+..++.++||||||+++|+|++|+.|+.... ........... ..+.+
T Consensus 164 ~~----~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~-------~~~~~- 230 (265)
T cd08217 164 SS----FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QLQLASKIKEG-------KFRRI- 230 (265)
T ss_pred cc----cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-HHHHHHHHhcC-------CCCCC-
Confidence 31 1233468999999999998889999999999999999999999997543 22222221110 01112
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
+......+.+++.+|++.+|++||++++|+++.
T Consensus 231 ---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~ 263 (265)
T cd08217 231 ---PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263 (265)
T ss_pred ---ccccCHHHHHHHHHHccCCcccCCCHHHHhhCC
Confidence 223335688999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=302.87 Aligned_cols=251 Identities=25% Similarity=0.450 Sum_probs=201.5
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcC---CCCeeeEeeeeeecCceEEEEEe
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLH---HRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
.+.+.||+|+||.||+|... +|..||+|.+... ......++.+|+.++++++ |+|++++++++.++...++||||
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83 (277)
T ss_pred hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence 34568999999999999874 6899999988643 3344567889999999997 99999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++++|.+++... .+++..++.++.+++.||.||| +.+|+||||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06917 84 AEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS- 156 (277)
T ss_pred CCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-
Confidence 9999999998653 5899999999999999999999 89999999999999999999999999999976544321
Q ss_pred cccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..... ......+.+...
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~-------~~~~~~~~~~~~ 225 (277)
T cd06917 157 ---KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-RAMML-------IPKSKPPRLEDN 225 (277)
T ss_pred ---ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-hhhhc-------cccCCCCCCCcc
Confidence 1233468899999998865 45789999999999999999999999654321 11110 011111222211
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.....+.+++..||+.||++||++.+++++.+...
T Consensus 226 ---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 226 ---GYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred ---cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 13356889999999999999999999999876643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=303.79 Aligned_cols=249 Identities=27% Similarity=0.384 Sum_probs=198.6
Q ss_pred cceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 176 IGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
||+|+||+||++... +|+.+|+|.+.... ......+.+|+++|++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999765 68999999886422 22345678899999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccc
Q 010088 252 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331 (518)
Q Consensus 252 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 331 (518)
.+++.......+++..+..++.|++.||.||| +.+++||||+|+||++++++.+||+|||++....... ...
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-----~~~ 152 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-----KIK 152 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-----ccc
Confidence 99998765556999999999999999999999 8999999999999999999999999999987654321 123
Q ss_pred cccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 010088 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR 411 (518)
Q Consensus 332 ~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 411 (518)
...++..|++||.+.+..++.++||||||+++|+|++|+.||............... ... ........+ ..
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~--~~~~~~~~~----~~ 223 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR---TLE--MAVEYPDKF----SP 223 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc---ccc--ccccCCccC----CH
Confidence 345788999999998888999999999999999999999999654321111111000 000 011111122 34
Q ss_pred HHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 412 TIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 412 ~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
.+.+++..||+.+|++|| ++.+++++.+..
T Consensus 224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~ 258 (277)
T cd05577 224 EAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258 (277)
T ss_pred HHHHHHHHHccCChhHccCCCcccHHHHHhChhhh
Confidence 688999999999999999 788888877663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=294.72 Aligned_cols=248 Identities=29% Similarity=0.476 Sum_probs=203.9
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
..+.||+|++|.||++... ++..+++|++..........+.+|++++++++|+|++++++++......++++||+++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 3467999999999999886 688999999876554556789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|.+++.... ..+++..+..++.+++.||+||| ..+++||||+|+||++++++.++|+|||++........ .
T Consensus 84 L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-----~ 154 (253)
T cd05122 84 LKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-----R 154 (253)
T ss_pred HHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-----c
Confidence 999997643 46899999999999999999999 89999999999999999999999999999876654321 2
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 410 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 410 (518)
....++..|++||.+.+..++.++||||||+++++|++|+.|+.............. .......++ ....
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~-------~~~~ 224 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPGLRNP-------EKWS 224 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---cCCCCcCcc-------cccC
Confidence 345688999999999888899999999999999999999999875432222211110 111111111 0113
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 411 RTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 411 ~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
..+.+++..||+.||++||++.+++++.
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~~~ 252 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLKHP 252 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 5688999999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=288.08 Aligned_cols=260 Identities=24% Similarity=0.335 Sum_probs=201.8
Q ss_pred hhhhhhcceecceEEEEEE-ecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC-----ceEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR-----ERFLMY 243 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~ 243 (518)
+.+.+.||+|||.-||.++ ..++..+|+|++.-.+.+..+..++|++..++++|||++++++++..+. +.|+++
T Consensus 23 yri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~ 102 (302)
T KOG2345|consen 23 YRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLL 102 (302)
T ss_pred EEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEe
Confidence 3456789999999999997 4578999999997766677788999999999999999999999887544 589999
Q ss_pred EecCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 244 EYMANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 244 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
+|...|||.+.+... ++..+++.+.+.|+.+|.+||++||.. .+++.||||||.|||+.+++.++|.|||.+....-
T Consensus 103 Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i 181 (302)
T KOG2345|consen 103 PYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPI 181 (302)
T ss_pred ehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccce
Confidence 999999999998743 345699999999999999999999944 34599999999999999999999999998875421
Q ss_pred CCcc----cc-cccccccCCCcccCccccc---cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccc
Q 010088 322 GSIC----FE-PVNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 393 (518)
Q Consensus 322 ~~~~----~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l 393 (518)
.-.. .. .......-|..|.|||.+. +...++++|||||||+||+|+.|..||.... ..++.+
T Consensus 182 ~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~----------~~GgSl 251 (302)
T KOG2345|consen 182 QIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY----------QQGGSL 251 (302)
T ss_pred EeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh----------hcCCeE
Confidence 1100 00 0112234688999999884 4578899999999999999999999995210 011111
Q ss_pred -ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 394 -AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 394 -~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
..+..+.+...-+....+.+.+++++|++.||.+||++.+++.++..
T Consensus 252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 11122222111111245679999999999999999999999998754
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=303.85 Aligned_cols=256 Identities=25% Similarity=0.335 Sum_probs=200.8
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~ 247 (518)
+.+.||.|++|.||++... +++.+|+|.+.... ......+.+|++++++++|+||++++++|.+. +..++||||++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 3468999999999999885 57899999886432 24456799999999999999999999998654 36899999999
Q ss_pred CCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 248 NGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 248 ~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++|.+++.. .....+++..+..++.|++.||+||| +.+++|+||+|+||++++++.+||+|||++.......
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 159 (287)
T cd06621 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-- 159 (287)
T ss_pred CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccccc--
Confidence 9999988753 22345889999999999999999999 8999999999999999999999999999987543321
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCc----chHHHHHHHHhhccccccccCCcC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK----NLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~----~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+.... ...+....... .....+.+. .
T Consensus 160 ----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-~ 232 (287)
T cd06621 160 ----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN--MPNPELKDE-P 232 (287)
T ss_pred ----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc--CCchhhccC-C
Confidence 123457889999999998999999999999999999999999997542 11222211111 011111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
. ........+.+++.+||+.+|++||++.|++++.+..
T Consensus 233 ~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~ 270 (287)
T cd06621 233 G--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270 (287)
T ss_pred C--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccc
Confidence 0 0012345689999999999999999999999988764
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=304.47 Aligned_cols=259 Identities=22% Similarity=0.285 Sum_probs=194.7
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.||+|+||.||+|... +|..||+|++.... ......+.+|+++++.++|+||+++.+++...+..++||||+. +
T Consensus 9 ~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07870 9 NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-T 87 (291)
T ss_pred EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence 3568999999999999764 68899999986432 2333467899999999999999999999999999999999995 6
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.... ..+.+..+..++.|++.||+||| +.+|+|+||||+||+++.++++||+|||+++....... .
T Consensus 88 ~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~----~ 159 (291)
T cd07870 88 DLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ----T 159 (291)
T ss_pred CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC----C
Confidence 8877765432 34788899999999999999999 88999999999999999999999999999875432211 1
Q ss_pred cccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc-----------cccccc
Q 010088 330 NTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES-----------RLAELV 397 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~-----------~l~~~~ 397 (518)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||.......+.......... .++...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 2334578999999998754 5788999999999999999999999754432222111110000 000000
Q ss_pred CCcC----CCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 398 DPRI----KDSF-----DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 398 d~~l----~~~~-----~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.... .... .......+.+++.+|++.||++|||++|++.+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~ 290 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence 0000 0000 0011346789999999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=305.71 Aligned_cols=262 Identities=24% Similarity=0.396 Sum_probs=201.0
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
+++.+.||+|+||.||+|... ++..||+|.++.. .......+.+|++++++++|+||+++++++...+..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 345678999999999999876 5789999988642 2334467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
+++.+..++... ..+++..+..++.+++.||+||| +.+++||||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 83 ERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--
Confidence 987777666543 34899999999999999999999 88999999999999999999999999999886554321
Q ss_pred ccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHH--hh-----------ccc
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCM--AS-----------ESR 392 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~--~~-----------~~~ 392 (518)
.......++..|+|||++.+. .++.++||||||+++|||++|+.|+.............. .. ...
T Consensus 156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 122345678999999999887 889999999999999999999998865433221111100 00 000
Q ss_pred -----cccccCCcC-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 393 -----LAELVDPRI-KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 393 -----l~~~~d~~l-~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
+.+..++.. ...++......+.+++..||..+|++||++++++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 287 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence 000000000 00011112467899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=302.37 Aligned_cols=250 Identities=28% Similarity=0.437 Sum_probs=201.6
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.||+|+||.||+|... +|..+|+|.+... .....+.+.+|++++++++|+||+++++++......++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 34568999999999999876 5789999988542 22344578899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC-cEEEeeccccccCCCCCccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-VAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~ 326 (518)
+++|.+++.......+++..+..++.+++.||+||| +.+++|+||||+||++++++ .+||+|||++........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (257)
T cd08225 83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-- 157 (257)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--
Confidence 999999997655556899999999999999999999 88999999999999999875 569999999876543321
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.... ..+....... ..+. + +..
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~--~~~~----~-~~~--- 224 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVLKICQ--GYFA----P-ISP--- 224 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHhc--ccCC----C-CCC---
Confidence 1223458899999999988889999999999999999999999986432 2222222111 1111 1 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.....+.+++.+||+.+|++||++.+++++.|
T Consensus 225 -~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~ 256 (257)
T cd08225 225 -NFSRDLRSLISQLFKVSPRDRPSITSILKRPF 256 (257)
T ss_pred -CCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence 12246889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=303.05 Aligned_cols=246 Identities=25% Similarity=0.330 Sum_probs=191.6
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHH---cCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLAR---LHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+||+|+||.||++... +|+.+|+|.+.... ......+.+|..++.. .+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 58999999886432 1222334555544444 479999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 999999987643 5999999999999999999999 8999999999999999999999999999987543321
Q ss_pred cccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcc-hHHHHHHHHhhccccccccCCcCCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKN-LVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~-~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|..||..... ......... ...+..+..
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-------~~~~~~~~~-- 220 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-------LTVNVELPD-- 220 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-------hcCCcCCcc--
Confidence 123468999999998864 5688999999999999999999999964321 111111100 001112222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcCC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS 442 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~~ 442 (518)
.....+.+++..||+.||++|| +++++++|.++..
T Consensus 221 --~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 221 --SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred --ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 2335688999999999999999 6999999987753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=300.93 Aligned_cols=255 Identities=26% Similarity=0.419 Sum_probs=211.6
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
...+||+|+||.||||.++ .|..+|||.+.- +...+++..|+.++.++..+++|+++|.+.....+|+|||||..|+
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 3468999999999999775 699999998754 3446789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
+.+.++.+. .+|++.++..++...++||+||| ...-||||||+.||||+-+|.+||+|||.|-.+.+.- ...
T Consensus 115 iSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM----AKR 186 (502)
T KOG0574|consen 115 ISDIMRARR-KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM----AKR 186 (502)
T ss_pred HHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH----Hhh
Confidence 999998654 57999999999999999999999 7778999999999999999999999999997654422 134
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 410 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 410 (518)
..+.||+.|||||++..-.|..++||||||++..||.-|++||.+-....... +.. ..-.|.++. +....
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---MIP-----T~PPPTF~K--PE~WS 256 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---MIP-----TKPPPTFKK--PEEWS 256 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---ecc-----CCCCCCCCC--hHhhh
Confidence 56789999999999999999999999999999999999999998643321111 111 111122221 33445
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCC
Q 010088 411 RTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMH 446 (518)
Q Consensus 411 ~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~ 446 (518)
..+.++++.||-..|++|-|+-++++|.+....+..
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGC 292 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence 679999999999999999999999999877665543
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.38 Aligned_cols=257 Identities=21% Similarity=0.288 Sum_probs=199.7
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||.||++... .++.||+|.+.... ......+.+|+++++.++|+||+++++.+..++..++||||+
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV 83 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence 34568999999999999875 47899999886532 233457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc--
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI-- 324 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 324 (518)
++++|.+++...+ .+++..+..++.+++.||+||| +.+++||||||+||++++++.+||+|||+++.......
T Consensus 84 ~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 84 EGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999997643 5899999999999999999999 89999999999999999999999999999864211000
Q ss_pred ---------ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccc
Q 010088 325 ---------CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE 395 (518)
Q Consensus 325 ---------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~ 395 (518)
..........++..|+|||.+.+..++.++||||||+++|||++|..||.... ..+.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-~~~~~~~~~~~~----- 232 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-PEELFGQVISDD----- 232 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcc-----
Confidence 00001123457889999999988889999999999999999999999996433 222222211111
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHhhcCC
Q 010088 396 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS---IKQVLRILYESS 442 (518)
Q Consensus 396 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs---~~evl~~L~~~~ 442 (518)
...+..... ....+.+++.+||+.+|++||+ +.+++++.+...
T Consensus 233 ~~~~~~~~~----~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 233 IEWPEGDEA----LPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred cCCCCcccc----CCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 111111111 2245789999999999999998 577777766543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=301.87 Aligned_cols=247 Identities=27% Similarity=0.370 Sum_probs=202.1
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 34568999999999999876 58999999886432 234578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
.+++|.+++... .++++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--- 154 (258)
T cd05578 83 LGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--- 154 (258)
T ss_pred CCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---
Confidence 999999999764 36899999999999999999999 8899999999999999999999999999987654432
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcc--hHHHHHHHHhhccccccccCCcCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN--LVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~--~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+..... .......... ..+ .
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~----~ 220 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--------ADV----L 220 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--------ccc----c
Confidence 12345688899999999888899999999999999999999999975443 1221111110 001 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH--HHHHHHhh
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSI--KQVLRILY 439 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~--~evl~~L~ 439 (518)
.+......+.+++.+||+.||.+||++ +|++++.+
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~ 257 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPY 257 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCC
Confidence 111223568899999999999999999 88876643
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.53 Aligned_cols=264 Identities=22% Similarity=0.245 Sum_probs=198.4
Q ss_pred hhcceecceEEEEEEecCCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 174 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
+.+|.|+++.||++.. +|+.||||++... .......+.+|++++++++|+||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3455556666666654 6899999998643 344556799999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc---cccc
Q 010088 252 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI---CFEP 328 (518)
Q Consensus 252 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~---~~~~ 328 (518)
.+++.......+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+........ ....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 99998654556899999999999999999999 89999999999999999999999999998875432211 0111
Q ss_pred ccccccCCCcccCcccccc--CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc------c-------c
Q 010088 329 VNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES------R-------L 393 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~------~-------l 393 (518)
......++..|+|||.+.. ..++.++|||||||++|||++|+.||.+................ . +
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 1233457889999999865 45889999999999999999999999765433222221110000 0 0
Q ss_pred cc----ccCCcCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 394 AE----LVDPRIK----DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 394 ~~----~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.. ..++... ..........+.+++..||+.||++||++++++++.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~ 299 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence 00 0000000 011122235688999999999999999999999988764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=300.19 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=195.2
Q ss_pred hhhhcceecceEEEEEEec----CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC------ce
Q 010088 172 FSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR------ER 239 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~ 239 (518)
+.++||+|+||+||+|.+. .+..||||++... .....+++.+|++++++++||||+++++++...+ ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4568999999999999763 3688999988643 2344567899999999999999999999886542 24
Q ss_pred EEEEEecCCCCHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccc
Q 010088 240 FLMYEYMANGSLKDHLHSP----GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL 315 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGl 315 (518)
++++||+.+|+|.+++... ....+++...++++.|++.||+||| +.+|+||||||+||++++++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcccc
Confidence 7889999999999887532 1234789999999999999999999 88999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccc
Q 010088 316 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLA 394 (518)
Q Consensus 316 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~ 394 (518)
++........ .......++..|++||.+....++.++||||||+++|||++ |+.|+..... ........ ....+
T Consensus 160 ~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~~~~~-~~~~~- 234 (273)
T cd05074 160 SKKIYSGDYY--RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLI-KGNRL- 234 (273)
T ss_pred cccccCCcce--ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHHHHHH-cCCcC-
Confidence 9865433211 11123345678999999988889999999999999999999 7777754322 22222111 11111
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 395 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 395 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.. +......+.+++.+||+.+|++||++.++++.|..
T Consensus 235 -----~~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 235 -----KQ----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred -----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 01 11223578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.16 Aligned_cols=250 Identities=28% Similarity=0.431 Sum_probs=204.8
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEEEEEecC
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMYEYMA 247 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~ 247 (518)
.+.||+|++|.||+|... ++..|++|.+.... ....+.+.+|++++++++|+||+++++++.+. ...++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 467999999999999886 68999999886543 24467899999999999999999999999988 88999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+++|.+++.... .+++..+..++.+++.||+||| +.+++|+||+|+||++++++.+||+|||.+.........
T Consensus 85 ~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 157 (260)
T cd06606 85 GGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-- 157 (260)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence 999999998654 6999999999999999999999 899999999999999999999999999998866543310
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
.......++..|++||.+.....+.++||||||+++++|++|+.||....+.......... .......+.
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------~~~~~~~~~ 227 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS----------SGEPPEIPE 227 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc----------cCCCcCCCc
Confidence 0123456889999999998888999999999999999999999999765432222211110 000111122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.....+.+++.+|++.+|++||++.+++++.+
T Consensus 228 ~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~ 259 (260)
T cd06606 228 HLSEEAKDFLRKCLRRDPKKRPTADELLQHPF 259 (260)
T ss_pred ccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence 22467899999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=302.41 Aligned_cols=250 Identities=23% Similarity=0.382 Sum_probs=201.6
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHH
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK 252 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 252 (518)
.+||+|+||.||++... +|..||||++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 47999999999999875 68999999886555555667999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccccc
Q 010088 253 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 332 (518)
Q Consensus 253 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 332 (518)
+++... .+++.....++.|++.||+||| +.+++||||+|+||++++++.++|+|||++........ ....
T Consensus 106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~----~~~~ 175 (292)
T cd06657 106 DIVTHT---RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP----RRKS 175 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc----cccc
Confidence 988542 4899999999999999999999 88999999999999999999999999999875433211 1233
Q ss_pred ccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHH
Q 010088 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT 412 (518)
Q Consensus 333 ~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~ 412 (518)
..|+..|++||.+.+..++.++||||||+++|||++|..||...... ........ ...+.+.. .......
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-~~~~~~~~-------~~~~~~~~--~~~~~~~ 245 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMKMIRD-------NLPPKLKN--LHKVSPS 245 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh-------hCCcccCC--cccCCHH
Confidence 45889999999998888999999999999999999999998643322 21111110 01111110 0112245
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 413 IVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 413 l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
+.+++.+||+.+|.+||++.+++++-+....
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence 7889999999999999999999998765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=304.62 Aligned_cols=262 Identities=24% Similarity=0.309 Sum_probs=198.0
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.||+|++|+||+|... +|+.||+|.+.... ......+.+|++++++++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD 84 (294)
T ss_pred EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence 34568999999999999876 68899999885432 2334578899999999999999999999999999999999996
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-CCcEEEeeccccccCCCCCccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++|.+++.......+++..+..++.||+.||+||| +.+++||||+|+||+++. ++.+||+|||++........
T Consensus 85 -~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-- 158 (294)
T PLN00009 85 -LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-- 158 (294)
T ss_pred -ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc--
Confidence 58888886655445788889999999999999999 899999999999999985 56799999999975433211
Q ss_pred ccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccC-------
Q 010088 327 EPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD------- 398 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d------- 398 (518)
......++..|+|||++.+ ..++.++||||||+++|||+||+.||........................+
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 159 --TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred --ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1233457899999998866 457899999999999999999999997554433332221100000000000
Q ss_pred -----CcCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 399 -----PRIKDS----FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 399 -----~~l~~~----~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
+..... ........+.+++.+|++.+|++||++.+++++.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~ 287 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchH
Confidence 000000 001122457899999999999999999999997654
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=304.72 Aligned_cols=261 Identities=24% Similarity=0.294 Sum_probs=196.0
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCc-----eEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRE-----RFLM 242 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~-----~~lV 242 (518)
..+.||+|+||.||+|... +|+.||+|.++... ......+.+|+.++++++ |+||+++++++...+. .++|
T Consensus 5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 4568999999999999875 68999999876432 223457889999999995 6999999999887665 8999
Q ss_pred EEecCCCCHHHHhcCCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-CCcEEEeecccccc
Q 010088 243 YEYMANGSLKDHLHSPG---RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHA 318 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DfGla~~ 318 (518)
|||+++ +|.+++.... ...+++..++.++.||+.||+||| +.+|+||||||+||+++. ++.+||+|||+++.
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 999985 8988886432 246899999999999999999999 899999999999999998 89999999999875
Q ss_pred CCCCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc----cc
Q 010088 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----RL 393 (518)
Q Consensus 319 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~----~l 393 (518)
...... ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||.................. ..
T Consensus 161 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 161 FSIPVK----SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cCCCcc----ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 432211 1223356889999998865 45789999999999999999999998755444333222111000 00
Q ss_pred ccccC-------CcCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 394 AELVD-------PRIKD----SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 394 ~~~~d-------~~l~~----~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
....+ +.... .........+.+++..||+.||++||+++|++.+.|.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~ 294 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCc
Confidence 00000 00000 0001223568899999999999999999999987653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=302.52 Aligned_cols=259 Identities=27% Similarity=0.392 Sum_probs=198.8
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEEEEEec
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMYEYM 246 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~ 246 (518)
+.+.||+|+||.||+|+.. +|..+|+|++.... ......+.+|++++++++|+|++++++++... +..++||||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 3467999999999999876 48899999987542 33445788999999999999999999999988 8999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++ +|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 83 DH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred cc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 75 8999987643 36899999999999999999999 88999999999999999999999999999986544321
Q ss_pred ccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc-----ccccccC--
Q 010088 327 EPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES-----RLAELVD-- 398 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~-----~l~~~~d-- 398 (518)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......... ....... ......+
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE-KIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCchhhccccccch
Confidence 11233456889999998765 467899999999999999999999986544322211 1111000 0000000
Q ss_pred ------Cc------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 399 ------PR------IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 399 ------~~------l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
+. +...+.......+.+++..||+.+|++||++++++++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~ 286 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence 00 000000112467899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=304.09 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=193.9
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC--------c
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKR--------E 238 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--------~ 238 (518)
+...+.||+|+||.||+|... ++..||||.+.... ......+.+|++++++++||||++++++|...+ .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 334568999999999999875 58999999885432 223345678999999999999999999987654 3
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccccc
Q 010088 239 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318 (518)
Q Consensus 239 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~ 318 (518)
.++||||+. ++|.+++.... ..+++.++..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 94 ~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 94 FYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred EEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 499999996 48888886543 35899999999999999999999 88999999999999999999999999999976
Q ss_pred CCCCCcccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccccc
Q 010088 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 397 (518)
Q Consensus 319 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 397 (518)
................++..|+|||.+.+. .++.++||||||+++|||++|+.|+................ ..+...+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 247 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC-GSITPEV 247 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCChhh
Confidence 543221111122334578899999988654 47889999999999999999999886543322111110000 0000000
Q ss_pred CCc-----------CCCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 398 DPR-----------IKDSF---------DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 398 d~~-----------l~~~~---------~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.+. +.... .......+.+++.+||+.||.+||++++++++.|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~ 309 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence 000 00000 0001245678999999999999999999998865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=300.16 Aligned_cols=256 Identities=24% Similarity=0.300 Sum_probs=193.7
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcC-CCCeeeEeeeeeec--CceEEEEEec
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLH-HRHLVALRGFCIEK--RERFLMYEYM 246 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e~~ 246 (518)
+.+.||+|+||.||+|... ++..||+|+++... ........+|+.++.++. |+||+++++++.+. +..++||||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 4567999999999999865 68899999886532 222334568999999995 99999999999987 8899999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
+ |+|.+++.... ..++|..+..++.|++.||+||| +.+++||||||+||+++. +.+||+|||+++......
T Consensus 83 ~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--- 153 (282)
T cd07831 83 D-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--- 153 (282)
T ss_pred C-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC---
Confidence 7 58888886533 35899999999999999999999 889999999999999999 999999999998654322
Q ss_pred ccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccc----------c
Q 010088 327 EPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA----------E 395 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~----------~ 395 (518)
......++..|+|||.+.. ..++.++|||||||++|||++|..||...... +............. .
T Consensus 154 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 154 --PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-DQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred --CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-HHHHHHHHHcCCCCHHHHHhhcccc
Confidence 1123457899999997654 56788999999999999999999999644322 11111111000000 0
Q ss_pred ccCCcCCCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 396 LVDPRIKDS-------FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 396 ~~d~~l~~~-------~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
..+...... ........+.+++.+||+.+|++||++++++++.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~ 281 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence 000000000 01123467999999999999999999999998764
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=311.65 Aligned_cols=265 Identities=21% Similarity=0.340 Sum_probs=199.2
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeee----cCceEEEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIE----KRERFLMYE 244 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e 244 (518)
+.+.||+|+||.||+|... +|..||+|++.... ......+.+|+.+|.+++|+||+++++++.. ....++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 9 PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence 4568999999999999875 58999999986432 2334567889999999999999999998763 346899999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+. |+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++........
T Consensus 89 ~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 89 LME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred hhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 995 69999987643 4899999999999999999999 89999999999999999999999999999976543221
Q ss_pred ccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccc-------
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL------- 396 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~------- 396 (518)
..........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.....................++
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 11112234568999999998865 5689999999999999999999999965433221111110000000000
Q ss_pred -----cC-CcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 397 -----VD-PRIKDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 397 -----~d-~~l~~~~~-----~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.+ ........ ......+.+++..||+.+|++||++.+++.+.|...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence 00 00000111 122467899999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=310.21 Aligned_cols=256 Identities=20% Similarity=0.295 Sum_probs=196.5
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec------CceEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERFLM 242 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV 242 (518)
..+.||+|+||+||+|+.. +|+.||+|.+... .......+.+|+.++++++|+||+++++++... ...++|
T Consensus 20 ~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 99 (353)
T cd07850 20 NLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99 (353)
T ss_pred EEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEE
Confidence 3468999999999999875 6899999988642 233445678899999999999999999988643 357999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+. ++|.+.+... +++..+..++.|++.||+||| ..+|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 100 MELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred EeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 99996 5888888642 889999999999999999999 889999999999999999999999999999865432
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc----------
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR---------- 392 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~---------- 392 (518)
. ......++..|+|||.+.+..++.++|||||||++|+|++|+.||........+..........
T Consensus 172 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 172 F-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred C-----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 2 1233457899999999999999999999999999999999999986544332222111000000
Q ss_pred ----------------cccccCCcC----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 393 ----------------LAELVDPRI----KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 393 ----------------l~~~~d~~l----~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
+.+.....+ ...........+.+++.+||+.||++||++.|++++.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~ 314 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI 314 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence 000000000 000011234567899999999999999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=287.34 Aligned_cols=251 Identities=25% Similarity=0.422 Sum_probs=202.0
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
...||.|..|+|+++++. .|..+|||.+.+.. ....+.++..++++.+-+ .|+||+.+|||......++.||.|. .
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence 446999999999999886 58999999997644 344567888888887775 8999999999999999999999984 3
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
.+..+|... ..++++.-+-++...+..||.||.+ .++|||||+||+|||+|+.|++|+||||++-...+.. .
T Consensus 176 C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-----A 247 (391)
T KOG0983|consen 176 CAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-----A 247 (391)
T ss_pred HHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc-----c
Confidence 555665543 3468888888999999999999986 6799999999999999999999999999987655443 4
Q ss_pred cccccCCCcccCcccccc---CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 330 NTDIRGTPGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
.+...|.+.|||||.+.- .+|+.++||||||+.|+||.||+.||.......+.....+..+. |.+....
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-------P~L~~~~- 319 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-------PLLPGHM- 319 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-------CCCCccc-
Confidence 466789999999999964 47889999999999999999999999865555555444444322 2232211
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.....+.+++..||++|+.+||...++++|.+..
T Consensus 320 -gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~ 353 (391)
T KOG0983|consen 320 -GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIK 353 (391)
T ss_pred -CcCHHHHHHHHHHhhcCcccCcchHHHhcCccee
Confidence 1234589999999999999999999999987543
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=298.58 Aligned_cols=258 Identities=25% Similarity=0.315 Sum_probs=197.0
Q ss_pred hhhhcceecceEEEEEEecC-CcEEEEEEecccc--chhHHHHHHHHHHHHHc---CCCCeeeEeeeeeecCc-----eE
Q 010088 172 FSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKIS--EQVEGDFCREIELLARL---HHRHLVALRGFCIEKRE-----RF 240 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~-----~~ 240 (518)
+.+.||+|+||.||+|+... +..||+|+++... ......+.+|+.++.++ +|+||+++++++...+. .+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 45689999999999999864 8999999986322 22234577788887776 59999999999998776 89
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCC
Q 010088 241 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~ 320 (518)
++|||+. ++|.+++.......+++..++.++.|++.||+||| +.+++|+||+|+||++++++.+||+|||++....
T Consensus 83 l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 83 LVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred EEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999997 58999887654446999999999999999999999 8899999999999999999999999999987654
Q ss_pred CCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccc-----
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE----- 395 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~----- 395 (518)
... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... +.....+........
T Consensus 159 ~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 159 FEM-----ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred CCc-----ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcCC
Confidence 332 112345788999999999989999999999999999999998888644332 222222111000000
Q ss_pred -------ccCCcCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 396 -------LVDPRIK---DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 396 -------~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
....... .....+....+.+++.+||+.||++||++++++++-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~ 286 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence 0000000 0111123466789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=301.22 Aligned_cols=259 Identities=26% Similarity=0.413 Sum_probs=197.9
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccccc-hhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEEecCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-QVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.||+|++|+||+|+.. +++.|+||++..... .......+|+..+.+++ |+||+++++++..++..++||||+ +
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 81 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E 81 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence 4568999999999999986 478999998864322 22334567999999999 999999999999999999999999 8
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.+++.......+++..++.++.|++.+|+||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~----- 153 (283)
T cd07830 82 GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP----- 153 (283)
T ss_pred CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-----
Confidence 89999998755456899999999999999999999 8999999999999999999999999999987654322
Q ss_pred ccccccCCCcccCccccc-cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc----------cccccc
Q 010088 329 VNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----------RLAELV 397 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~----------~l~~~~ 397 (518)
......++..|+|||.+. ...++.++||||||+++|||++|+.||.................. .+...+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 123345788999999875 456789999999999999999999888644322221111100000 000000
Q ss_pred CCcCCCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 398 DPRIKDS-------FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 398 d~~l~~~-------~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
+..+... ........+.+++.+||+.+|++||+++|++.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~ 282 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence 1000000 00011356889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=306.90 Aligned_cols=264 Identities=22% Similarity=0.348 Sum_probs=195.3
Q ss_pred hhhhhcceecceEEEEEEecC---CcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFSD---GSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLM 242 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 242 (518)
.+.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.++.+++||||+++++++.+. +..++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 345689999999999998754 7899999987532 33446688999999999999999999999988 789999
Q ss_pred EEecCCCCHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC----CCcEEEeeccc
Q 010088 243 YEYMANGSLKDHLHSP---GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE----NFVAKLADFGL 315 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~----~~~~kl~DfGl 315 (518)
|||+++ +|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||+
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999975 777776432 1236889999999999999999999 899999999999999999 99999999999
Q ss_pred cccCCCCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchH---------HHHHH
Q 010088 316 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV---------ESAQV 385 (518)
Q Consensus 316 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~---------~~~~~ 385 (518)
+......... ........++..|+|||.+.+ ..++.++||||||++++||++|+.||....... .....
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 159 ARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred ccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9865433211 111234567899999998866 457899999999999999999999986332111 00000
Q ss_pred --HHh-----------hccccccccCCcCCCCCC---H--------HHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 386 --CMA-----------SESRLAELVDPRIKDSFD---M--------EQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 386 --~~~-----------~~~~l~~~~d~~l~~~~~---~--------~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.+. .........+......++ . .....+.+++.+||+.||++|||+.|++++.|
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 000 000000000000000011 0 12246889999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.24 Aligned_cols=260 Identities=24% Similarity=0.344 Sum_probs=197.9
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.||+|++|+||+|+.. +|..||||.++... ......+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 82 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK- 82 (284)
T ss_pred EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence 4568999999999999885 58899999886533 22345678899999999999999999999999999999999985
Q ss_pred CHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 250 SLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 250 sL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
+|.+++.... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||++........
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~---- 155 (284)
T cd07836 83 DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN---- 155 (284)
T ss_pred cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc----
Confidence 8998886543 346899999999999999999999 88999999999999999999999999999975433211
Q ss_pred ccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhh----ccccccccC-CcCC
Q 010088 329 VNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS----ESRLAELVD-PRIK 402 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~----~~~l~~~~d-~~l~ 402 (518)
......++..|++||.+.+ ..++.++||||||+++|||++|+.||................ ...+..+.+ +.+.
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 1233457889999998865 457889999999999999999999986543322211111000 000000000 0000
Q ss_pred CC-----------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 403 DS-----------FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 403 ~~-----------~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.. ........+.+++.+|++.||.+||++.+++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~ 283 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 00 01122356889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=297.44 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=198.4
Q ss_pred cceecceEEEEEEecC-CcEEEEEEeccccc---hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISE---QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
||+|+||.||+++..+ |..+++|.+..... .....+.+|++++.+++|+||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999864 89999999864332 4456789999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc----cc
Q 010088 252 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC----FE 327 (518)
Q Consensus 252 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~----~~ 327 (518)
.+++...+ .+++..+..++.|++.||+||| +.+++||||+|+||++++++.+||+|||++......... ..
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997644 5899999999999999999999 899999999999999999999999999998754332110 00
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
.......++..|++||.......+.++||||||+++|||++|..||..... .+............ ....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~--------~~~~-- 224 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-EEIFQNILNGKIEW--------PEDV-- 224 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCCcCC--------Cccc--
Confidence 122345678899999999888899999999999999999999999864432 22222221111100 0000
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH---HHHHHHhhc
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSI---KQVLRILYE 440 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~---~evl~~L~~ 440 (518)
.....+.+++..||+.+|++||++ .+++++.+.
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~ 260 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence 013568899999999999999999 776766554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=308.68 Aligned_cols=247 Identities=25% Similarity=0.368 Sum_probs=206.6
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
++||+||||.||-++.. .|+.+|.|++.+. ....+.-.++|-.+|++++.+.||.+-..+..++.+++|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 58999999999999775 5999999988642 2344556789999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.-+|.+.+...+++..++.++.+|+.||++|| +.+||+|||||+|||||+.|.++|+|+|||....++..
T Consensus 271 DLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~----- 342 (591)
T KOG0986|consen 271 DLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP----- 342 (591)
T ss_pred ceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCCc-----
Confidence 9999999888778999999999999999999999 99999999999999999999999999999998877753
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHH---HHHHHhhccccccccCCcCCCCCC
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES---AQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~---~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
....+||.+|||||++.+..|+...|.|||||+||||+.|+.||.....-+.+ .+....... .+.+.++
T Consensus 343 ~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~--------ey~~kFS 414 (591)
T KOG0986|consen 343 IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPE--------EYSDKFS 414 (591)
T ss_pred cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchh--------hcccccC
Confidence 24458999999999999999999999999999999999999999754443333 222221111 1122333
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhc
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYE 440 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~~L~~ 440 (518)
+...+|.+..|+.||.+|.- +.+|-+|..+
T Consensus 415 ----~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfF 449 (591)
T KOG0986|consen 415 ----EEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFF 449 (591)
T ss_pred ----HHHHHHHHHHHccCHHHhccCCCcCcchhhhCccc
Confidence 45778889999999999864 5577777644
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=295.09 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=197.9
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc-----cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-----SEQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLM 242 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 242 (518)
.+.+.||+|+||.||+|... +|..||+|.+... .......+.+|++++++++|+||+++++++.+. ...+++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 35678999999999999875 5899999987421 223445788999999999999999999998764 457899
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
+||+++++|.+++...+ .+++....+++.|++.||+||| +.+++|+||||+||++++++.++|+|||+++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 85 VEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999999997543 4889999999999999999999 899999999999999999999999999999865321
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
... ........++..|+|||.+.+..++.++|||||||++|||++|+.||.+........+..... ..+.+
T Consensus 160 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~- 230 (264)
T cd06653 160 CMS-GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP-------TKPML- 230 (264)
T ss_pred ccc-CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCC-------CCCCC-
Confidence 110 011233568899999999988889999999999999999999999997654333222211100 11112
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
+......+.+++..||+ ++..||+..++++|.+
T Consensus 231 ---p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~ 263 (264)
T cd06653 231 ---PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF 263 (264)
T ss_pred ---CcccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence 22233568899999999 5799999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=303.29 Aligned_cols=265 Identities=24% Similarity=0.350 Sum_probs=198.5
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEEEEEe
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMYEY 245 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~ 245 (518)
+..++||+|+||.||+|... +|..||+|.++... ......+.+|+.++.+++|+||+++++++... +..++||||
T Consensus 10 ~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (309)
T cd07845 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY 89 (309)
T ss_pred eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence 34568999999999999875 58999999886332 22234567899999999999999999998765 468999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+. ++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||++........
T Consensus 90 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~- 163 (309)
T cd07845 90 CE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK- 163 (309)
T ss_pred CC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC-
Confidence 97 48988887532 46999999999999999999999 89999999999999999999999999999986543321
Q ss_pred cccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccc----ccC--
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE----LVD-- 398 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~----~~d-- 398 (518)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...................... ..+
T Consensus 164 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 164 ---PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred ---CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 1223346788999998865 567899999999999999999999997544332221111100000000 000
Q ss_pred ----CcCCCC-C-C-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCC
Q 010088 399 ----PRIKDS-F-D-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 444 (518)
Q Consensus 399 ----~~l~~~-~-~-----~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~ 444 (518)
..+... . . ......+.+++.+|++.||++||+++++++|.|....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 000000 0 0 01235678999999999999999999999998886443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=293.76 Aligned_cols=247 Identities=28% Similarity=0.464 Sum_probs=203.3
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccc--hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE--QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.||+|++|.||+++.. ++..|++|.+..... .....+.+|++++++++|+|++++++++.+.+..+++|||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence 34568999999999999875 578999999875443 455679999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (254)
T cd06627 83 NGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--- 154 (254)
T ss_pred CCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc---
Confidence 99999999764 45899999999999999999999 89999999999999999999999999999986654332
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......++..|+|||...+..++.++||||||+++|||++|+.|+.............. .. .+.+...
T Consensus 155 -~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~-----~~~~~~~--- 222 (254)
T cd06627 155 -DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ---DD-----HPPLPEG--- 222 (254)
T ss_pred -cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc---cC-----CCCCCCC---
Confidence 12334688999999999888889999999999999999999999875543322222111 00 1111112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
....+.+++.+||..+|++||++.+++.+-
T Consensus 223 -~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~ 252 (254)
T cd06627 223 -ISPELKDFLMQCFQKDPNLRPTAKQLLKHP 252 (254)
T ss_pred -CCHHHHHHHHHHHhCChhhCcCHHHHhcCC
Confidence 235688999999999999999999999764
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.92 Aligned_cols=263 Identities=22% Similarity=0.341 Sum_probs=196.2
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC-----ceEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKR-----ERFLMY 243 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~ 243 (518)
.+.++||+|+||.||+|... +|..||+|.+.... ......+.+|+.++++++|+||+++++++.... ..++|+
T Consensus 8 ~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 87 (336)
T cd07849 8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQ 87 (336)
T ss_pred EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEe
Confidence 34568999999999999864 68999999986432 334466889999999999999999999876543 579999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+. ++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 88 e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 88 ELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred hhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 9997 488888864 35999999999999999999999 8999999999999999999999999999987654322
Q ss_pred cccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHH--Hhhc--cccccccC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC--MASE--SRLAELVD 398 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~--~~~~--~~l~~~~d 398 (518)
.. ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........+.... +... ..+..+.+
T Consensus 161 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 161 DH-TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred cc-cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 111233568999999998754 568999999999999999999999996543221111110 0000 00000000
Q ss_pred Cc---------CCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 399 PR---------IKDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 399 ~~---------l~~~~~-----~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.. .....+ ......+.+++.+||+.+|++||++.+++++.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~ 296 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 00 000000 01235688999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=302.10 Aligned_cols=253 Identities=25% Similarity=0.426 Sum_probs=196.8
Q ss_pred hhhhhcceecceEEEEEEecC-CcEEEEEEecccc-chhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKIS-EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.||+|+||.||+|.+.+ +..||||.++... ......+.+|+.++.++. |+||++++++|.+....+++|||+.
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 455789999999999999875 8999999986532 233456777888777775 9999999999999999999999985
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++|.+++.... ..+++..+.+++.+++.||+||| + .+|+||||+|+||++++++.+||+|||++.......
T Consensus 98 -~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~--- 169 (296)
T cd06618 98 -TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK--- 169 (296)
T ss_pred -cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC---
Confidence 47777765432 36999999999999999999999 5 589999999999999999999999999987654322
Q ss_pred ccccccccCCCcccCccccccCC----CCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQE----LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.||.......+......... .. .+.
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~-----~~~ 240 (296)
T cd06618 170 --AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--PP-----SLP 240 (296)
T ss_pred --cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--CC-----CCC
Confidence 122345788999999987543 88899999999999999999999965333222222221111 01 111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.. ......+.+++.+||+.||++||++.+++++.+...
T Consensus 241 ~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 241 PN--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred CC--CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 00 012356889999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=300.10 Aligned_cols=261 Identities=28% Similarity=0.393 Sum_probs=196.7
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC---------
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKR--------- 237 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--------- 237 (518)
+.+.+.||+|+||+||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 88 (302)
T cd07864 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDK 88 (302)
T ss_pred hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccC
Confidence 344578999999999999886 58899999986432 233456788999999999999999999987655
Q ss_pred -ceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccc
Q 010088 238 -ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 316 (518)
Q Consensus 238 -~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla 316 (518)
..++|+||+++ +|..++... ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++
T Consensus 89 ~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 89 GAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred CcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999986 777777654 335899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc---
Q 010088 317 HASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR--- 392 (518)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~--- 392 (518)
........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...................
T Consensus 164 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 164 RLYNSEES---RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred ccccCCcc---cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 86543321 11223346788999998764 457889999999999999999999997554332222211110000
Q ss_pred -cccccC--------C------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 393 -LAELVD--------P------RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 393 -l~~~~d--------~------~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.+++.. + .....+ ......+.+++..||+.+|++||++++++++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 301 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301 (302)
T ss_pred hcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 011100 0 000000 012356899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=298.25 Aligned_cols=258 Identities=22% Similarity=0.323 Sum_probs=200.6
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEeccccc--hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE--QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
.+.||+|++|.||+|... +|..+++|++..... .....+.+|++++++++|+||+++++++..++..++||||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT- 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence 457999999999999875 688999998864332 3456788999999999999999999999999999999999975
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.... ..+++..++.++.+++.||+||| +.+|+|+||||+||++++++.+||+|||.+........ .
T Consensus 83 ~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~----~ 154 (283)
T cd05118 83 DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR----P 154 (283)
T ss_pred CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc----c
Confidence 8888887643 46899999999999999999999 89999999999999999999999999999876544321 1
Q ss_pred cccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc----ccccccC------
Q 010088 330 NTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----RLAELVD------ 398 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~----~l~~~~d------ 398 (518)
.....++..|+|||.+.+. .++.++||||||+++|+|+||+.||.................. .+....+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2234578899999998776 7899999999999999999999998655443322221111000 0000000
Q ss_pred CcCC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 399 PRIK-------DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 399 ~~l~-------~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.... ..........+.+++..||+.||.+||++.+++.+.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~ 282 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence 0000 0011123467899999999999999999999998764
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=295.09 Aligned_cols=244 Identities=25% Similarity=0.338 Sum_probs=191.2
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHH---HHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIEL---LARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+||+|+||.||++... +|+.||+|.+.... ......+..|..+ ++...|+||+.+++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 58899999886432 1222234445444 444579999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 99999998753 35999999999999999999999 8999999999999999999999999999987543221
Q ss_pred cccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcch--HHHHHHHHhhccccccccCCcCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--VESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~--~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.....|+..|+|||.+.++ .++.++||||||+++|||++|+.||...... ........ ..++.+...
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 221 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--------TMAVELPDS 221 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh--------ccCCCCCCc
Confidence 1234689999999998754 6899999999999999999999999754221 11111110 111222222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
. ...+.+++..|+..+|.+|| ++.+++++.+..
T Consensus 222 ~----s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~ 259 (278)
T cd05606 222 F----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR 259 (278)
T ss_pred C----CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcccc
Confidence 2 35688999999999999999 999999887664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=300.24 Aligned_cols=249 Identities=27% Similarity=0.430 Sum_probs=197.8
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
..+.||+|+||+||+|+.. ++..+|+|.+... ......++.+|+++++.++|+|++++++++......++||||+.
T Consensus 19 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 98 (308)
T cd06634 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (308)
T ss_pred HHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC
Confidence 3467999999999999875 5789999987532 22334578899999999999999999999999999999999996
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
|+|.+++.... .++++..+..++.+++.||.||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 99 -~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----- 168 (308)
T cd06634 99 -GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168 (308)
T ss_pred -CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----
Confidence 68888775433 35899999999999999999999 889999999999999999999999999998754322
Q ss_pred cccccccCCCcccCccccc---cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
....++..|+|||.+. ...++.++|||||||++|||++|+.|+.+.......... . . ... +...
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~-~-~~~-----~~~~-- 235 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-A-Q-NES-----PALQ-- 235 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH-h-h-cCC-----CCcC--
Confidence 2345788999999874 356788999999999999999999998654322111111 1 0 000 1111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 444 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~ 444 (518)
.......+.+++.+||+.+|.+||++.+++++.+.....
T Consensus 236 -~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 236 -SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred -cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 112235688999999999999999999999998876653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=305.82 Aligned_cols=267 Identities=22% Similarity=0.295 Sum_probs=200.2
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEeccccchh--------------HHHHHHHHHHHHHcCCCCeeeEeeeeeecC
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQV--------------EGDFCREIELLARLHHRHLVALRGFCIEKR 237 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 237 (518)
.+.||+|+||+||+|... +|+.||||.+....... ...+.+|++++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 457999999999999865 68999999885432211 125789999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 238 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 238 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
..++||||+. |+|.+++... ..+++.....++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCcccee
Confidence 9999999997 6999998753 34899999999999999999999 8999999999999999999999999999997
Q ss_pred cCCCCCcc----------cccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHH
Q 010088 318 ASKDGSIC----------FEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC 386 (518)
Q Consensus 318 ~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~ 386 (518)
........ .........++..|+|||.+.+. .++.++||||||+++|||++|+.||....+........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 65411100 00111233468899999998764 46899999999999999999999997555433222211
Q ss_pred Hhhccc----cccccC--------CcCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 010088 387 MASESR----LAELVD--------PRIKDS---FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM 445 (518)
Q Consensus 387 ~~~~~~----l~~~~d--------~~l~~~---~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~ 445 (518)
...... +.+..+ ...... ........+.+++..||+.+|++||+++|++.+.+....+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 110000 000000 000000 00112356889999999999999999999999998876543
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=304.16 Aligned_cols=264 Identities=25% Similarity=0.347 Sum_probs=196.9
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeec--CceEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARL-HHRHLVALRGFCIEK--RERFLMY 243 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~lV~ 243 (518)
+.+.+.||+|+||.||+|... +|..+|+|++... .......+.+|+.++.++ +|+||++++++|... ...++||
T Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07852 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF 88 (337)
T ss_pred HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence 445678999999999999875 5789999988532 223345678899999999 999999999998654 3689999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+. ++|.+++... .++|..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++.......
T Consensus 89 e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 89 EYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred cccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 9997 5999998753 5899999999999999999999 8999999999999999999999999999998654332
Q ss_pred ccc-ccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc---------
Q 010088 324 ICF-EPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR--------- 392 (518)
Q Consensus 324 ~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~--------- 392 (518)
... ........|+..|+|||.+.+ ..++.++||||||+++|||+||+.||...................
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 110 012234568999999998765 467889999999999999999999986443322211111000000
Q ss_pred ---cccccC----CcCC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 393 ---LAELVD----PRIK--DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 393 ---l~~~~d----~~l~--~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
..++++ .... ..........+.+++.+||+.||++||++.+++++.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~ 298 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhh
Confidence 000000 0000 00001123568899999999999999999999997644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=341.13 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=201.5
Q ss_pred hhcceecceEEEEEEe-cCCcEEEEEEecc--ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 174 TIIGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
..||.|.||.||-|.. ++|...|+|.++. ........+.+|+.+|..|+|||+|+++|+-.+.+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 4799999999999975 4689999997753 224445678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|.+.+...+ -+++.....+..|++.|++||| +.|||||||||.||+|+.+|.+|++|||.|..............
T Consensus 1321 La~ll~~gr--i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1321 LASLLEHGR--IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred HHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 999997532 2555556677899999999999 99999999999999999999999999999987765432223334
Q ss_pred ccccCCCcccCccccccC---CCCccccchhhHHHHHHHHhCCccccCCcchHHHH-HHHHhhccccccccCCcCCCCCC
Q 010088 331 TDIRGTPGYMDPEYVVTQ---ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA-QVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~---~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~-~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
....||+.|||||++.+. ...-++||||+|||++||+||++||.+-.+..... ....... | .++
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~--------P----q~P 1463 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK--------P----QIP 1463 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC--------C----CCc
Confidence 567899999999999764 35678999999999999999999997654432222 1111111 2 222
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
......-.+++..|++.||++|+++.|++++-+..
T Consensus 1464 ~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1464 ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 23445678899999999999999999999987654
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=298.61 Aligned_cols=248 Identities=30% Similarity=0.458 Sum_probs=198.3
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.||+|+||+||+|+.. +|..|++|.+.... ......+.+|++++++++|+|++++++++.+.+..++||||+. |
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 105 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G 105 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence 46999999999999875 58899999886422 2334568899999999999999999999999999999999996 5
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.... .++++.+++.++.|++.||+||| +.+++||||+|+||++++++.+||+|||++.....
T Consensus 106 ~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-------- 173 (313)
T cd06633 106 SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------- 173 (313)
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--------
Confidence 8888776432 45899999999999999999999 88999999999999999999999999999864322
Q ss_pred cccccCCCcccCccccc---cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 330 NTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
.....|+..|+|||.+. ...++.++||||||+++|||++|..|+............... ....... .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~----~--- 243 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---DSPTLQS----N--- 243 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---CCCCCCc----c---
Confidence 22346889999999984 456888999999999999999999998765433322222111 1111111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM 445 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~ 445 (518)
.....+.+++.+||+.+|.+||++.+++++.+....+.
T Consensus 244 -~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 244 -EWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred -ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 12245889999999999999999999999988766543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=291.17 Aligned_cols=244 Identities=23% Similarity=0.289 Sum_probs=190.2
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEeccccc---hhHHHHHHHHHHHH-HcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE---QVEGDFCREIELLA-RLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
.||+|+||.||+|... +|+.||+|.+..... .....+..|..++. ..+|+|++++++++...+..++|+||++++
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG 82 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence 5899999999999875 588999999864321 22234455555544 458999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++...+ .+++..+..++.|++.||.||| +.+++||||+|+||++++++.+||+|||+++....
T Consensus 83 ~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-------- 149 (260)
T cd05611 83 DCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-------- 149 (260)
T ss_pred CHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc--------
Confidence 9999997643 5889999999999999999999 88999999999999999999999999999875432
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....++..|++||.+.+..++.++||||||+++|||++|..|+...... ............. ..... ...
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~----~~~~~----~~~ 220 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-AVFDNILSRRINW----PEEVK----EFC 220 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhcccCC----CCccc----ccC
Confidence 12345888999999998888999999999999999999999999654332 2222111111000 01111 122
Q ss_pred HHHHHHHHHHccccCCCCCCCH---HHHHHHhhc
Q 010088 410 LRTIVTIVRWCTQREGQARPSI---KQVLRILYE 440 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~---~evl~~L~~ 440 (518)
...+.+++.+||+.+|++||++ +|++.+.+.
T Consensus 221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 221 SPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred CHHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 3568899999999999999955 677776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.37 Aligned_cols=254 Identities=27% Similarity=0.435 Sum_probs=190.4
Q ss_pred HHhhhhh--hhcceecceEEEEEEec-CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec------
Q 010088 167 KATDNFS--TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEK------ 236 (518)
Q Consensus 167 ~a~~~f~--~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 236 (518)
+...+|. ++||+||||.|||++.+ ||+.||||++... +........+|+..|++|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3444555 47999999999999887 8999999998643 445556789999999999999999998221100
Q ss_pred --------------------------------------------------------------------------------
Q 010088 237 -------------------------------------------------------------------------------- 236 (518)
Q Consensus 237 -------------------------------------------------------------------------------- 236 (518)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 010088 237 ---------------------------------RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 283 (518)
Q Consensus 237 ---------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH 283 (518)
..+|+-||||+..+|.++++.+.... .....++++.+|++||+|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 01478899999988888887643211 46778899999999999999
Q ss_pred hcCCCCceecccCCCcEEecCCCcEEEeeccccccCC----CC----------CcccccccccccCCCcccCccccccC-
Q 010088 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK----DG----------SICFEPVNTDIRGTPGYMDPEYVVTQ- 348 (518)
Q Consensus 284 ~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~----~~----------~~~~~~~~~~~~gt~~y~aPE~~~~~- 348 (518)
+.|||||||||.||+|++++.+||+|||+|.... .. ........+..+||.-|+|||.+.+.
T Consensus 715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9999999999999999999999999999998621 00 00001134567899999999999764
Q ss_pred --CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCC--CCCHHHHHHHHHHHHHccccC
Q 010088 349 --ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD--SFDMEQLRTIVTIVRWCTQRE 424 (518)
Q Consensus 349 --~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~--~~~~~~~~~l~~li~~Cl~~d 424 (518)
+|+.|+|+||+||||+||+. ||.....-+..... +-++.+.. .+..+....-..+|.++++.|
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~----------LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTN----------LRKGSIPEPADFFDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHh----------cccCCCCCCcccccccchHHHHHHHHHhcCC
Confidence 59999999999999999984 45443322222221 11222221 223344455678999999999
Q ss_pred CCCCCCHHHHHHH
Q 010088 425 GQARPSIKQVLRI 437 (518)
Q Consensus 425 p~~RPs~~evl~~ 437 (518)
|++|||+.|+|+.
T Consensus 859 P~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 859 PSKRPTATELLNS 871 (1351)
T ss_pred CccCCCHHHHhhc
Confidence 9999999999985
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=291.90 Aligned_cols=249 Identities=29% Similarity=0.481 Sum_probs=203.7
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.||+|+||.||++... ++..+++|++.... ......+.+|++++++++|+|++++++.+...+..++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence 3467999999999999875 58899999986543 24556789999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 249 GSLKDHLHSPG--RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 249 gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++|.+++.... ...+++..+..++.+++.||+||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 158 (258)
T cd08215 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-- 158 (258)
T ss_pred CcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCcc--
Confidence 99999997643 356999999999999999999999 88999999999999999999999999999976544321
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
......|++.|+|||.+.+..++.++||||||+++++|++|+.|+.... ........... .. +.+..
T Consensus 159 --~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~~--~~-----~~~~~--- 225 (258)
T cd08215 159 --LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELALKILKG--QY-----PPIPS--- 225 (258)
T ss_pred --eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-HHHHHHHHhcC--CC-----CCCCC---
Confidence 2233468889999999988889999999999999999999999986443 22222221111 11 11111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.....+.+++.+||..+|++||++.+++++.+
T Consensus 226 -~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 257 (258)
T cd08215 226 -QYSSELRNLVSSLLQKDPEERPSIAQILQSPF 257 (258)
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence 22356889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=305.05 Aligned_cols=254 Identities=22% Similarity=0.379 Sum_probs=191.5
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC------ceEEEE
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR------ERFLMY 243 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV~ 243 (518)
.+.||+|+||.||+|+.. +|..||||++... .......+.+|+.++++++|+||+++++++.... ..++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 358999999999999864 6899999988642 2233456889999999999999999999987543 469999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+.. +|..++. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++.....
T Consensus 100 e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~- 170 (342)
T cd07879 100 PYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE- 170 (342)
T ss_pred ccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence 99964 7877663 24899999999999999999999 889999999999999999999999999998754321
Q ss_pred cccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccc------
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL------ 396 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~------ 396 (518)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....................+++
T Consensus 171 ------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 171 ------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred ------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 123457889999999876 4688999999999999999999999975443322221111000000000
Q ss_pred ------cC--CcC-CCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 397 ------VD--PRI-KDSFD---MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 397 ------~d--~~l-~~~~~---~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+ +.. +.... ......+.+++..||+.||.+||++.+++.+.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~ 301 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchh
Confidence 00 000 00000 01224578999999999999999999999986553
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=325.87 Aligned_cols=253 Identities=26% Similarity=0.433 Sum_probs=201.9
Q ss_pred hhhhhcceecceEEEEEEec----C----CcEEEEEEeccc-cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS----D----GSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERF 240 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~----~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 240 (518)
.+.+.||+|.||.|++|... . ...||||.++.. .....+.+..|+++|..+ +|+||+.++|+|..++..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 45568999999999999753 1 357999998753 335567899999999999 6999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCC------C--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC
Q 010088 241 LMYEYMANGSLKDHLHSPG------R--------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF 306 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~------~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~ 306 (518)
+|+||+.+|+|.++|+... . ..++....+.++.|||.|++||+ +.++|||||.++|||++++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCC
Confidence 9999999999999998644 0 23889999999999999999999 89999999999999999999
Q ss_pred cEEEeeccccccCCCCCccccccccccc--CCCcccCccccccCCCCccccchhhHHHHHHHHhC-CccccCCcchHHHH
Q 010088 307 VAKLADFGLAHASKDGSICFEPVNTDIR--GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA-RRAVQDGKNLVESA 383 (518)
Q Consensus 307 ~~kl~DfGla~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG-~~p~~~~~~~~~~~ 383 (518)
.+||+|||+|+......... ..... -...|||||.+....|+.|+|||||||+||||+|. ..|+.+-....+..
T Consensus 456 ~~kIaDFGlar~~~~~~~y~---~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYR---TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred EEEEccccceeccCCCCceE---ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 99999999999765543221 11112 35579999999999999999999999999999994 55665422122222
Q ss_pred HHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 384 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 384 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
. .+....++ ..+..+..++.++|+.||+.+|++||++.++.+.+..
T Consensus 533 ~-~l~~G~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 533 E-FLKEGNRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred H-HHhcCCCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 2 23332222 2222334678899999999999999999999998865
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=299.06 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=210.4
Q ss_pred hhhhhhcceecceEEEEEEe-cCCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 170 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
|++.+.||+|.|..|-+|++ -.|..||||++.+.. ......+.+|++.|+.++|||||+|+.+......+|||+|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 45566899999999999975 379999999997643 444567899999999999999999999998889999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec-CCCcEEEeeccccccCCCCCcc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DfGla~~~~~~~~~ 325 (518)
.+|+|++||.++.. .+.+....+++.||+.|+.|+| +..+|||||||+||.+- .-|-+||.|||++-.+..+.
T Consensus 100 D~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-- 173 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-- 173 (864)
T ss_pred CCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc--
Confidence 99999999987643 5999999999999999999999 88899999999998775 57899999999998777665
Q ss_pred cccccccccCCCcccCccccccCCCC-ccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELT-EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
..+..+|...|-|||++.+..|+ +++||||||||||-|++|+.||+...+-.. +..++|- +-.
T Consensus 174 ---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-----------LTmImDC--KYt 237 (864)
T KOG4717|consen 174 ---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-----------LTMIMDC--KYT 237 (864)
T ss_pred ---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-----------hhhhhcc--ccc
Confidence 34667899999999999999987 478999999999999999999986544322 2223332 112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.+.....+..++|..||..||.+|-+.+||..+.|-+.
T Consensus 238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence 33445567889999999999999999999999877553
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=291.40 Aligned_cols=246 Identities=25% Similarity=0.384 Sum_probs=201.0
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.||+|+||.||+++.. ++..+|+|.+... .......+.+|++++++++|+||+++++++.+....++||||+++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd08530 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPF 83 (256)
T ss_pred EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCC
Confidence 4568999999999999765 6789999988643 234456788999999999999999999999999999999999999
Q ss_pred CCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 249 GSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 249 gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++|.+++... ....+++..+..++.+++.||+||| +.+++|+||+|+||++++++.+||+|||++.......
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~--- 157 (256)
T cd08530 84 GDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--- 157 (256)
T ss_pred CCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC---
Confidence 9999998652 2346899999999999999999999 8999999999999999999999999999998665431
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
.....++..|++||.+.+..++.++|+||||+++|||++|+.|+..... .+...... ..... ...
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~--~~~~~---------~~~ 222 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-QDLRYKVQ--RGKYP---------PIP 222 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHh--cCCCC---------CCc
Confidence 1234578899999999998999999999999999999999999965432 22211111 11111 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
......+.+++..|++.+|++||++.+++++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence 23345689999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=297.05 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=197.3
Q ss_pred hhhhcceecceEEEEEEe----cCCcEEEEEEecccc----chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEE
Q 010088 172 FSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKIS----EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 242 (518)
+.+.||+|+||.||+++. .+|..||+|++.... ....+.+.+|+.++.++ +|+||+++++++......++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 456899999999999976 368899999986432 22345688999999999 599999999999998899999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+|||+++++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 84 LDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999764 35889999999999999999999 899999999999999999999999999999765433
Q ss_pred CcccccccccccCCCcccCccccccC--CCCccccchhhHHHHHHHHhCCccccCCc---chHHHHHHHHhhcccccccc
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQ--ELTEKSDVYSYGVVLLEIVTARRAVQDGK---NLVESAQVCMASESRLAELV 397 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwS~Gvll~el~tG~~p~~~~~---~~~~~~~~~~~~~~~l~~~~ 397 (518)
... ......|+..|+|||.+.+. .++.++||||||+++|||++|+.|+.... .............
T Consensus 159 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------- 228 (290)
T cd05613 159 EVE---RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE------- 228 (290)
T ss_pred ccc---ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-------
Confidence 211 12235688999999998753 46789999999999999999999986322 1222222211111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
+.... .....+.+++..||+.||++|| ++++++.+.+..
T Consensus 229 -~~~~~----~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~ 272 (290)
T cd05613 229 -PPYPQ----EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272 (290)
T ss_pred -CCCCc----cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccc
Confidence 11111 2235678999999999999997 888998876653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=318.44 Aligned_cols=269 Identities=20% Similarity=0.251 Sum_probs=189.5
Q ss_pred HhhhhhhhcceecceEEEEEEecC--CcEEEEEE--------------ec---cccchhHHHHHHHHHHHHHcCCCCeee
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFSD--GSLIAVKR--------------MD---KISEQVEGDFCREIELLARLHHRHLVA 228 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~~--g~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~H~niv~ 228 (518)
..+.+.+.||+|+||+||++.+.. +..+++|. +. .........+.+|+.+|.+++|+||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 345556789999999999987642 22222221 10 111223456889999999999999999
Q ss_pred EeeeeeecCceEEEEEecCCCCHHHHhcCCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC
Q 010088 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPG---RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 305 (518)
Q Consensus 229 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 305 (518)
+++++...+..++|++++. ++|.+++.... ........+..|+.|++.||+||| +.+|+||||||+||||+.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCC
Confidence 9999999999999999985 57888775422 112345667789999999999999 8999999999999999999
Q ss_pred CcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccc-cCCc-c-hHHH
Q 010088 306 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV-QDGK-N-LVES 382 (518)
Q Consensus 306 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~-~~~~-~-~~~~ 382 (518)
+.+||+|||+++....... .......||..|+|||++.+..++.++|||||||++|||++|+.++ .... . ....
T Consensus 304 ~~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKERE---AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCEEEEeCCCceecCcccc---cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999986644321 1223457999999999999999999999999999999999998644 3221 1 1111
Q ss_pred HHHHHhhccccccccCC-----------cC---CCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 383 AQVCMASESRLAELVDP-----------RI---KDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 383 ~~~~~~~~~~l~~~~d~-----------~l---~~~~~-----~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
............++.++ .+ ..... ......+.+++.+||+.||.+||++.|++++.++...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 11111000000000000 00 00000 0011346778999999999999999999999887654
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=303.89 Aligned_cols=263 Identities=22% Similarity=0.324 Sum_probs=201.9
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC-----ceEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKR-----ERFLM 242 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV 242 (518)
.+.+.||+|+||.||+|+.. +|..+|+|++.... ....+.+.+|+.+++.++|+||+++++++...+ ..++|
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 34568999999999999876 48999999987543 344567899999999999999999999988775 78999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+. ++|.+++.... .+++..++.++.+++.||+||| +.+|+||||||+|||++.++.++|+|||++......
T Consensus 83 ~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 83 TELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred ecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99997 58999987643 6999999999999999999999 899999999999999999999999999999865443
Q ss_pred CcccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc-ccc-----
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR-LAE----- 395 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~-l~~----- 395 (518)
... ........++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... +........... ..+
T Consensus 157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 157 EDE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-DQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHhcCCCChhHhhhc
Confidence 210 0112344578899999999887 8899999999999999999999998654322 211111111000 000
Q ss_pred -------ccCC-cCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 396 -------LVDP-RIKDSF-----DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 396 -------~~d~-~l~~~~-----~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+.. ...... .......+.+++..||+.+|.+||++++++++.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 293 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA 293 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHH
Confidence 0000 000000 011235688999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=290.72 Aligned_cols=237 Identities=19% Similarity=0.257 Sum_probs=185.4
Q ss_pred cceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCCCCHHH
Q 010088 176 IGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANGSLKD 253 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 253 (518)
||+|+||.||+++.. ++..+|+|.+....... .|+.....+ +|+||+++++++...+..++||||+++|+|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 599999999999865 57889999876432111 123233223 69999999999999999999999999999999
Q ss_pred HhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC-cEEEeeccccccCCCCCccccccccc
Q 010088 254 HLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-VAKLADFGLAHASKDGSICFEPVNTD 332 (518)
Q Consensus 254 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~ 332 (518)
++.... .++|..+..++.|++.||+||| +.+++||||||+||+++.++ .++|+|||++...... ..
T Consensus 99 ~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--------~~ 165 (267)
T PHA03390 99 LLKKEG--KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--------SC 165 (267)
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--------cc
Confidence 997643 6999999999999999999999 89999999999999999988 9999999998754322 22
Q ss_pred ccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchH-HHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 010088 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV-ESAQVCMASESRLAELVDPRIKDSFDMEQLR 411 (518)
Q Consensus 333 ~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~-~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 411 (518)
..++..|+|||++.+..++.++||||||+++|||++|+.||....... ........... ...... ....
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~----~~~~ 235 (267)
T PHA03390 166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK------KLPFIK----NVSK 235 (267)
T ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc------cCCccc----ccCH
Confidence 358899999999998899999999999999999999999996432211 11111000000 001111 2335
Q ss_pred HHHHHHHHccccCCCCCCC-HHHHHHHhhc
Q 010088 412 TIVTIVRWCTQREGQARPS-IKQVLRILYE 440 (518)
Q Consensus 412 ~l~~li~~Cl~~dp~~RPs-~~evl~~L~~ 440 (518)
.+.+++..||+.+|.+||+ +++++++-|.
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~h~~~ 265 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIKHPFL 265 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhcCCcc
Confidence 6889999999999999995 6999988764
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=293.80 Aligned_cols=258 Identities=27% Similarity=0.355 Sum_probs=199.6
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.||+|+||.||+|+.. +++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 3457999999999999886 48999999987542 3344678899999999999999999999999999999999997
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|.+++.... ..+++..+.+++.+++.||+||| +.+|+||||+|+||++++++.+||+|||+++.......
T Consensus 82 ~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---- 153 (282)
T cd07829 82 MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR---- 153 (282)
T ss_pred cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc----
Confidence 59999998643 35999999999999999999999 88999999999999999999999999999876543321
Q ss_pred ccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc-----ccc---cc--c
Q 010088 329 VNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES-----RLA---EL--V 397 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~-----~l~---~~--~ 397 (518)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||............ ..... ... ++ .
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI-FQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-HHHhCCCcHHHHHhhcccccc
Confidence 12234467889999998766 8899999999999999999999888654432222111 11000 000 00 0
Q ss_pred CCcCCC---C----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 398 DPRIKD---S----FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 398 d~~l~~---~----~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
+..... . ........+.+++..||+.+|++||++.+++.+.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~ 281 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence 000000 0 00011356899999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=294.23 Aligned_cols=251 Identities=26% Similarity=0.364 Sum_probs=202.6
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEEe
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
.+.+.||+|+||.||+|... +|..||+|.+... .......+.+|++++.+++ |+||+++++++...+..++||||
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY 83 (280)
T ss_pred eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence 34568999999999999875 6899999988642 2334467889999999998 99999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++++|.+++...+ .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 84 ~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 84 APNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999998643 5999999999999999999999 899999999999999999999999999998865432210
Q ss_pred c----------------ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhh
Q 010088 326 F----------------EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS 389 (518)
Q Consensus 326 ~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~ 389 (518)
. ........++..|++||.+.+..++.++||||||++++|+++|+.|+....... ..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-TFQKILKL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhc
Confidence 0 012233457899999999988889999999999999999999999997544221 11211111
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHHHhh
Q 010088 390 ESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSI----KQVLRILY 439 (518)
Q Consensus 390 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~----~evl~~L~ 439 (518)
. . .++......+.+++..||+.+|++||++ ++++++.+
T Consensus 238 ~--------~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 238 E--------Y----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred C--------C----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 1 1 1111223568899999999999999999 99988764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=295.18 Aligned_cols=258 Identities=21% Similarity=0.240 Sum_probs=180.9
Q ss_pred hhhhhhcceecceEEEEEEecC----CcEEEEEEeccccchhH-----------HHHHHHHHHHHHcCCCCeeeEeeeee
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKISEQVE-----------GDFCREIELLARLHHRHLVALRGFCI 234 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~g~~~ 234 (518)
+.+.++||+|+||+||+|.+.+ +..+|+|.......... .....+...+..+.|+|++++++++.
T Consensus 14 y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 93 (294)
T PHA02882 14 WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGS 93 (294)
T ss_pred eEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeee
Confidence 3456789999999999998754 34566665332221110 11223344556678999999999776
Q ss_pred ecC----ceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEE
Q 010088 235 EKR----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKL 310 (518)
Q Consensus 235 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 310 (518)
... ..++++|++. .++.+.+... ...++..+..|+.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 94 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 94 FKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEEE
Confidence 544 3467778764 4677666542 23678889999999999999999 899999999999999999999999
Q ss_pred eeccccccCCCCCccc---ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHH
Q 010088 311 ADFGLAHASKDGSICF---EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCM 387 (518)
Q Consensus 311 ~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~ 387 (518)
+|||+++......... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||..............
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 9999998653221110 0112334699999999999999999999999999999999999999975422211111100
Q ss_pred hhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 388 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 388 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
. ..+..+..+.+.. ......+.+++..|++.+|++||++.++++.+
T Consensus 248 ~--~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 248 C--DFIKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred H--HHHHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0 0001111111100 01235688999999999999999999999865
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.78 Aligned_cols=257 Identities=23% Similarity=0.340 Sum_probs=194.9
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec-----CceEEEEE
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK-----RERFLMYE 244 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e 244 (518)
.+.||+|+||+||+|+.. +|..||||.+... .......+.+|+.+++.++|+||+++++++... ...++|||
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence 458999999999999865 6899999988642 233345678899999999999999999988654 34799999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+. ++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 163 (337)
T cd07858 90 LMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163 (337)
T ss_pred CCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence 996 6899998764 35999999999999999999999 89999999999999999999999999999986543321
Q ss_pred ccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhh-cc----cccccc-
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS-ES----RLAELV- 397 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~-~~----~l~~~~- 397 (518)
......++..|+|||.+.. ..++.++|||||||++|||++|+.||...... ......... .. .+..+.
T Consensus 164 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 164 ----FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred ----cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCChHHhhhcCc
Confidence 1233457889999998865 46889999999999999999999998643221 111110000 00 000000
Q ss_pred --------------CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 398 --------------DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 398 --------------d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
++.... ........+.+++.+||+.+|++||++++++++.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~ 295 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295 (337)
T ss_pred hhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence 000000 0012235688999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=300.41 Aligned_cols=264 Identities=22% Similarity=0.336 Sum_probs=193.7
Q ss_pred hhhhhcceecceEEEEEEec-C--CcEEEEEEeccc--cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeec----CceE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-D--GSLIAVKRMDKI--SEQVEGDFCREIELLARL-HHRHLVALRGFCIEK----RERF 240 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~--g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~~~ 240 (518)
.+.+.||+|+||.||+++.. . +..||+|++... .......+.+|++++.++ +|+||+++++++... ...+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 34568999999999999875 3 779999988642 222345788999999999 599999999976533 4578
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCC
Q 010088 241 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~ 320 (518)
+++||+. ++|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++...
T Consensus 83 ~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 83 LYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 8889886 6999998653 35899999999999999999999 8999999999999999999999999999998654
Q ss_pred CCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc----cccc
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----RLAE 395 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~----~l~~ 395 (518)
..............|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.................. .+.+
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 332211112234568999999998765 56899999999999999999999988644322111111000000 0000
Q ss_pred ccCCc-----------CCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 396 LVDPR-----------IKDS---FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 396 ~~d~~-----------l~~~---~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
+.++. -... ........+.+++.+|++.||++||++.+++.+.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~ 295 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 00000 0000 000113568899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=290.58 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=195.3
Q ss_pred hhhhhcceecceEEEEEEecC-CcEEEEEEeccc-----cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKI-----SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
.+.+.||+|+||+||+++... +..+++|.++.. ......++.+|+.++++++||||+++++++.+....++|||
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE 82 (260)
T ss_pred eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence 355789999999999998753 445556555431 22334467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 245 YMANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 245 ~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|+++++|.+++.. .....+++..++.++.|++.||+||| +.+++|+||||+||++++ +.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 83 YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred eCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 9999999998864 22346999999999999999999999 899999999999999976 56999999998765432
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
.. ......|+..|+|||.+.+..++.++||||||+++|+|++|..|+...... ......... ..+.
T Consensus 159 ~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-~~~~~~~~~-------~~~~-- 224 (260)
T cd08222 159 CD----LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-SVVLRIVEG-------PTPS-- 224 (260)
T ss_pred cc----cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHcC-------CCCC--
Confidence 21 223345788999999998888899999999999999999999998644322 222211111 1111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.+......+.+++.+||+.+|++||++.+++++.+
T Consensus 225 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 225 --LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred --CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence 12233457889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=285.54 Aligned_cols=242 Identities=26% Similarity=0.380 Sum_probs=197.9
Q ss_pred cceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 176 IGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
||+|+||.||++... +++.+|+|.+.... ......+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 48999999886532 22455789999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccc
Q 010088 252 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331 (518)
Q Consensus 252 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 331 (518)
.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~----~~~ 151 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS----RTN 151 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC----ccc
Confidence 99997643 5899999999999999999999 89999999999999999999999999999876544321 123
Q ss_pred cccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 010088 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR 411 (518)
Q Consensus 332 ~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 411 (518)
...++..|++||.+.+...+.++|+||||+++|||++|+.||..... ........... ..+... ...
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~~--------~~~~~~----~~~ 218 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKILKDP--------LRFPEF----LSP 218 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHhcCC--------CCCCCC----CCH
Confidence 45688899999999888889999999999999999999999964432 22222221111 111111 135
Q ss_pred HHHHHHHHccccCCCCCCCH---HHHHHHhh
Q 010088 412 TIVTIVRWCTQREGQARPSI---KQVLRILY 439 (518)
Q Consensus 412 ~l~~li~~Cl~~dp~~RPs~---~evl~~L~ 439 (518)
.+.+++..||..||++||++ ++++++.+
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~ 249 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCcccHHHHHhCCC
Confidence 68899999999999999999 78777654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=282.21 Aligned_cols=269 Identities=25% Similarity=0.350 Sum_probs=207.2
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEec--cccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--------CceEE
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGFCIEK--------RERFL 241 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~~~~l 241 (518)
..+||+|.||.||+|+.. .|+.||+|++- ...+..-....+|+++|..|+|+|++.++..|... ...|+
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 347999999999999876 47788988642 23333445678999999999999999999998754 24799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||++|++ +|..+|.... ..++..++.+++.++..||.|+| ...|+|||+|+.|+||+.+|.+||+|||+++.+..
T Consensus 102 Vf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred eHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 9999987 8999987643 45899999999999999999999 99999999999999999999999999999987655
Q ss_pred CCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhh----ccccccc
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS----ESRLAEL 396 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~----~~~l~~~ 396 (518)
......+..+..+.|.+|.+||.+.+ ..|+++.|||.-||++.||+||.+-++...+......+...- ...++++
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~ 256 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV 256 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence 44443445677778999999999876 579999999999999999999988776554433322211100 0111111
Q ss_pred cCCc---------C-CCCCC--HHHH------HHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCC
Q 010088 397 VDPR---------I-KDSFD--MEQL------RTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMH 446 (518)
Q Consensus 397 ~d~~---------l-~~~~~--~~~~------~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~ 446 (518)
..-. + ++.+. .+.+ ...++++..++..||.+|+++.++++|-++..++++
T Consensus 257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 1100 0 01100 0111 256789999999999999999999999999999987
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=296.65 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=193.9
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC--------ce
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKR--------ER 239 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--------~~ 239 (518)
.+.+.||+|+||.||+|... ++..+|+|++.... ......+.+|++++++++|+||+++++++.+.. ..
T Consensus 11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 90 (311)
T cd07866 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV 90 (311)
T ss_pred EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence 34568999999999999875 58899999885432 222346789999999999999999999876543 46
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccC
Q 010088 240 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 319 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~ 319 (518)
++|+||+.+ +|...+.... ..+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++..
T Consensus 91 ~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 91 YMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred EEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 999999965 7877776533 35999999999999999999999 899999999999999999999999999999755
Q ss_pred CCCCccc-------ccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc
Q 010088 320 KDGSICF-------EPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 391 (518)
Q Consensus 320 ~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (518)
....... ....+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~-~~~~~~~~ 244 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL-HLIFKLCG 244 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhC
Confidence 3322110 011234467889999998765 45889999999999999999999998654433222 11111100
Q ss_pred -----------ccccccCCcCCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 392 -----------RLAELVDPRIKDSFD-------MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 392 -----------~l~~~~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.+....+.......+ ......+.+++.+||+.||++||++.+++.+.|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~ 310 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence 001111000000000 011256889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=294.29 Aligned_cols=247 Identities=22% Similarity=0.296 Sum_probs=193.5
Q ss_pred hhhhcceecceEEEEEEe----cCCcEEEEEEecccc----chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEE
Q 010088 172 FSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKIS----EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 242 (518)
+.+.||+|+||.||+++. .++..||||.++... ......+.+|++++.++ +|+||+++++.+......++|
T Consensus 4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 456899999999999975 257889999886422 22345688999999999 599999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+++|+|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 84 LDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999998753 35899999999999999999999 899999999999999999999999999998765432
Q ss_pred CcccccccccccCCCcccCccccccCC--CCccccchhhHHHHHHHHhCCccccCCcch---HHHHHHHHhhcccccccc
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQE--LTEKSDVYSYGVVLLEIVTARRAVQDGKNL---VESAQVCMASESRLAELV 397 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwS~Gvll~el~tG~~p~~~~~~~---~~~~~~~~~~~~~l~~~~ 397 (518)
.. .......|+..|++||.+.+.. .+.++||||||+++|||++|..|+...... .+........
T Consensus 159 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------- 227 (288)
T cd05583 159 EE---ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-------- 227 (288)
T ss_pred cc---cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--------
Confidence 21 1122345889999999987654 788999999999999999999998633221 1111111111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
.+.....++ ..+.+++.+||+.+|++|||++++.+.|
T Consensus 228 ~~~~~~~~~----~~l~~li~~~l~~~p~~R~t~~~~~~~l 264 (288)
T cd05583 228 KPPFPKTMS----AEARDFIQKLLEKDPKKRLGANGADEIK 264 (288)
T ss_pred CCCCCcccC----HHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence 111222222 4578899999999999999977665544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=298.68 Aligned_cols=266 Identities=22% Similarity=0.330 Sum_probs=197.1
Q ss_pred HHHHHHHhhhh--hhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec
Q 010088 162 YKETKKATDNF--STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK 236 (518)
Q Consensus 162 ~~~l~~a~~~f--~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 236 (518)
..++...+++| .+.||+|+||.||+|... +|..||+|++.... ....+.+.+|++++.+++|+||+++.+++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 34444444444 357999999999999764 68999999986432 22345688999999999999999999988643
Q ss_pred ------CceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEE
Q 010088 237 ------RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKL 310 (518)
Q Consensus 237 ------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 310 (518)
...+++++++ +++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEE
Confidence 3467888876 78999888642 4899999999999999999999 899999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhh
Q 010088 311 ADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS 389 (518)
Q Consensus 311 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~ 389 (518)
+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||................
T Consensus 162 ~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 162 LDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred eccccccccccc-------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999998754322 233467899999998866 568899999999999999999999986443322111110000
Q ss_pred cccccccc---------------CCcCCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 390 ESRLAELV---------------DPRIKDSFD---MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 390 ~~~l~~~~---------------d~~l~~~~~---~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.....++. +......+. ......+.+++..|++.||.+||++.+++++.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~ 304 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence 00000000 000000000 01124578999999999999999999999998765
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=282.42 Aligned_cols=271 Identities=22% Similarity=0.339 Sum_probs=201.2
Q ss_pred hhhhhcceecceEEEEEEecC-----CcEEEEEEeccccc--hhHHHHHHHHHHHHHcCCCCeeeEeeeeee-cCceEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFSD-----GSLIAVKRMDKISE--QVEGDFCREIELLARLHHRHLVALRGFCIE-KRERFLM 242 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV 242 (518)
+....||+|.||.||||.-.+ ...+|+|+++.... ......++|+.+++.++||||+.|..++.+ +...+|+
T Consensus 27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~ 106 (438)
T KOG0666|consen 27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL 106 (438)
T ss_pred hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence 344579999999999995432 23799999875432 223467899999999999999999999887 7789999
Q ss_pred EEecCCCCHHHHhcCCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC----CcEEEeeccc
Q 010088 243 YEYMANGSLKDHLHSPG---RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN----FVAKLADFGL 315 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~----~~~kl~DfGl 315 (518)
+||.++ +|...|+-+. ...++...+..|+.||+.|+.||| ++=|+||||||.|||+..+ |.+||+|||+
T Consensus 107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 999987 8998886322 346888999999999999999999 8899999999999999887 8999999999
Q ss_pred cccCCCCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCc------ch--HHHHHHH
Q 010088 316 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGK------NL--VESAQVC 386 (518)
Q Consensus 316 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~------~~--~~~~~~~ 386 (518)
++.....-... .....++.|.+|.|||.+.+ ..|+.+.||||.||++.||+|-++-|...+ +- .+....+
T Consensus 183 aR~~~~plkpl-~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 183 ARLFNNPLKPL-ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHhhcccccc-ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 99876543211 12345678999999999987 579999999999999999999877664211 00 1111111
Q ss_pred Hhh-----ccccccccC-Cc-----------CCCCCCHHH--------HHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 387 MAS-----ESRLAELVD-PR-----------IKDSFDMEQ--------LRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 387 ~~~-----~~~l~~~~d-~~-----------l~~~~~~~~--------~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+.. +..++++.. |. ......... ...-.+++..+|+.||.+|.|+++.+++.++.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 111 111111110 00 001110000 12367899999999999999999999999999
Q ss_pred CCCCC
Q 010088 442 SDPMH 446 (518)
Q Consensus 442 ~~~~~ 446 (518)
.++.+
T Consensus 342 ~d~lp 346 (438)
T KOG0666|consen 342 EDPLP 346 (438)
T ss_pred cCCCC
Confidence 88665
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=300.15 Aligned_cols=255 Identities=22% Similarity=0.342 Sum_probs=194.4
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC------ceEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR------ERFLM 242 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV 242 (518)
..+.||+|+||+||+|... +|..||||++... .......+.+|+++|++++|+||+++++++.... ..++|
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07880 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98 (343)
T ss_pred EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence 3467999999999999764 6899999988542 2233456889999999999999999999887653 45899
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+ +++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 99 ~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 99 MPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred EecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 9999 7799988864 35899999999999999999999 899999999999999999999999999998754332
Q ss_pred CcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccC---
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD--- 398 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d--- 398 (518)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........... ...........+.
T Consensus 172 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 172 -------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME-IMKVTGTPSKEFVQKL 243 (343)
T ss_pred -------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcCCCCHHHHHhh
Confidence 123457889999998875 4588999999999999999999999975443222211 1111100000000
Q ss_pred ------------CcCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 399 ------------PRIKD----SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 399 ------------~~l~~----~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+.... .........+.+++.+|++.||++||++.+++.+.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~ 302 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHh
Confidence 00000 00011224588999999999999999999999887654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=298.57 Aligned_cols=262 Identities=21% Similarity=0.282 Sum_probs=194.9
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec-------------
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK------------- 236 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------------- 236 (518)
.+.+.||+|+||.||+|... +|..||+|.+........+.+.+|++++++++|+||+++++++...
T Consensus 8 ~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (342)
T cd07854 8 MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTE 87 (342)
T ss_pred EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccc
Confidence 34568999999999999875 5889999998765555567788999999999999999999876543
Q ss_pred -CceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec-CCCcEEEeecc
Q 010088 237 -RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFG 314 (518)
Q Consensus 237 -~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DfG 314 (518)
...++||||+. ++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||
T Consensus 88 ~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 88 LNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 35789999997 599988864 24889999999999999999999 88999999999999997 46689999999
Q ss_pred ccccCCCCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc-
Q 010088 315 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR- 392 (518)
Q Consensus 315 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~- 392 (518)
+++........ ........++..|+|||.+.. ..++.++|||||||++|||++|+.||............ ......
T Consensus 161 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~-~~~~~~~ 238 (342)
T cd07854 161 LARIVDPHYSH-KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI-LESVPVV 238 (342)
T ss_pred cceecCCcccc-ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHhcCCC
Confidence 98754322110 011123457889999997654 56888999999999999999999999755433222111 110000
Q ss_pred -----------cccccC-CcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 393 -----------LAELVD-PRIKDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 393 -----------l~~~~d-~~l~~~~~-----~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+..... .......+ ......+.+++..||+.||.+||++.+++++.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 000000 00000000 01224688999999999999999999999988775
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=282.96 Aligned_cols=250 Identities=22% Similarity=0.347 Sum_probs=203.6
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
.+|.++||+|.||+|-+++-+ .|+.+|+|++++.- ......-+.|-++|...+||.+..|...+...+.+++||||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 346789999999999999865 68999999987532 33334567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
..||.|.-+|... ..+++.....+...|..||.||| +.+||+||||.+|.|||.+|.+||+||||++..-..
T Consensus 250 anGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~--- 321 (516)
T KOG0690|consen 250 ANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY--- 321 (516)
T ss_pred ccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccc---
Confidence 9999999999763 34888888899999999999999 999999999999999999999999999999853221
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
...+...+||+.|.|||++....|+.++|.|.+||++|||++|+.||.+... ......++..+-+++. ..
T Consensus 322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-~kLFeLIl~ed~kFPr--------~l 391 (516)
T KOG0690|consen 322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-EKLFELILMEDLKFPR--------TL 391 (516)
T ss_pred -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-hHHHHHHHhhhccCCc--------cC
Confidence 2245678999999999999999999999999999999999999999975433 2233333322222222 22
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
. .+...++...|.+||.+|. .++||.++-++.
T Consensus 392 s----~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~ 428 (516)
T KOG0690|consen 392 S----PEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFA 428 (516)
T ss_pred C----HHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhc
Confidence 2 3456788899999999995 478888876554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=285.50 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=199.5
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEeccccc-hhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-QVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
.||.|+||+|+|-.++ .|+..|||+++.... ....+++.|.+...+- +.||||+++|.+..++..|+-||.|. .||
T Consensus 71 ~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~Sl 149 (361)
T KOG1006|consen 71 EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISL 149 (361)
T ss_pred HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhH
Confidence 5999999999999876 699999999986543 5567789999887766 68999999999999999999999995 466
Q ss_pred HHHh---cCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 252 KDHL---HSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 252 ~~~l---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
..+- ....+..+++.-.-.|+.....||.||.+ ...|||||+||+||||+..|.+||||||++-.+.+. .
T Consensus 150 DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-----i 222 (361)
T KOG1006|consen 150 DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-----I 222 (361)
T ss_pred HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH-----H
Confidence 5543 23334458888888899999999999986 678999999999999999999999999998655432 2
Q ss_pred ccccccCCCcccCcccccc--CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 329 VNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
..+.-.|...|||||.+.. ..|+.+|||||||++|+|+.||+.|+..-.+..+........+. +.+..+ ...
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdp--p~l~~~----~~~ 296 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDP--PILLFD----KEC 296 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCC--CeecCc----ccc
Confidence 3456679999999999964 34889999999999999999999999866666555444333322 111111 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
.+....+..++..|+.+|-++||.+.+++++.+
T Consensus 297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f 329 (361)
T KOG1006|consen 297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF 329 (361)
T ss_pred cccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence 234467899999999999999999999988653
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=293.65 Aligned_cols=257 Identities=24% Similarity=0.351 Sum_probs=194.2
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeee-cCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE-KRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~ 247 (518)
+.+.||+|+||.||++... +|..||||++... .......+.+|++++.+++||||+++.+++.. ....++|+||+
T Consensus 14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~- 92 (328)
T cd07856 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92 (328)
T ss_pred EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-
Confidence 3468999999999999865 6899999987532 22334678899999999999999999998876 56789999998
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+++|.++++. .++++.....++.|++.||+||| +.+|+||||+|+||++++++.+||+|||++......
T Consensus 93 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~----- 161 (328)
T cd07856 93 GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----- 161 (328)
T ss_pred ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-----
Confidence 5699998864 24788889999999999999999 899999999999999999999999999998754321
Q ss_pred cccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHH--HHHhh----------ccccc
Q 010088 328 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQ--VCMAS----------ESRLA 394 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~--~~~~~----------~~~l~ 394 (518)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........... ..... .....
T Consensus 162 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 162 --MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred --cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 123457889999998765 5689999999999999999999999864432111110 00000 00000
Q ss_pred ccc-CCcCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 395 ELV-DPRIKDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 395 ~~~-d~~l~~~~~~-----~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+.+ +-......+. .....+.+++.+||+.+|++||++.+++.+.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 000 0000001111 12356889999999999999999999999876643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.89 Aligned_cols=246 Identities=27% Similarity=0.423 Sum_probs=203.2
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
....||+|.|++|..|++. .|..||+|.+++.. ......+.+|+++|..|+|||||+++.+......+|+||||+.+
T Consensus 60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence 3458999999999999875 58999999987643 23335588999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|.++++|..+++ .....+..++.|+..+++||| .+.|+|||||++||||+.+.++||+|||++..+..+.
T Consensus 140 ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~----- 209 (596)
T KOG0586|consen 140 GELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL----- 209 (596)
T ss_pred chhHHHHHhccc--chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecccc-----
Confidence 999999998765 455888899999999999999 9999999999999999999999999999998776544
Q ss_pred ccccccCCCcccCccccccCCC-CccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
.....+|++.|.|||++.+.+| ++.+|+||+|++||-|+.|..||. +.++.+.-...+....+++..+.
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD-G~~lk~Lr~rvl~gk~rIp~~ms--------- 279 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD-GQNLKELRPRVLRGKYRIPFYMS--------- 279 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC-Ccccccccchheeeeecccceee---------
Confidence 3466789999999999998775 578999999999999999999996 34443332222222222222221
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
....+++++++-.+|.+|++++++..+-|.
T Consensus 280 ---~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 280 ---CDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred ---chhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 234578999999999999999999887543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=256.47 Aligned_cols=259 Identities=25% Similarity=0.323 Sum_probs=204.9
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEecc--ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
++||+|.||+|+||+.. .++.||+|+++. ..+.......+|+-+|+.++|+|||++++....++..-+|+|||. .+
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qd 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QD 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HH
Confidence 47999999999999865 578999998763 334445678899999999999999999999999999999999996 48
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|..+..+-.+ .++.+....++.|+++||.|+| ++++.||||||.|.||+.+|++|++|||+++.++-.-.+ .
T Consensus 87 lkkyfdslng-~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrc----y 158 (292)
T KOG0662|consen 87 LKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC----Y 158 (292)
T ss_pred HHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe----e
Confidence 8888866443 4899999999999999999999 999999999999999999999999999999987665433 3
Q ss_pred ccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc--------cccccCCcC
Q 010088 331 TDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR--------LAELVDPRI 401 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~--------l~~~~d~~l 401 (518)
...+.|.+|.+|.++.+. -|+.+.|+||-||++.|+.....|...+.+..+....++..-+. +..+-|...
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 445679999999999875 58899999999999999999888887777766655544332111 112222111
Q ss_pred CCCCC----HH-----HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 402 KDSFD----ME-----QLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 402 ~~~~~----~~-----~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
-..++ .. ....-.+++...+.-+|..|.++++.+++.++.
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~ 287 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFS 287 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccc
Confidence 11111 11 112346777788888999999999999998764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=299.38 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=195.9
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCc------eEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE------RFLM 242 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~lV 242 (518)
..+.||+|+||+||+|+.. ++..||||++... .......+.+|+.++++++|+||+++++++...+. .++|
T Consensus 19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98 (343)
T ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence 3468999999999999886 5789999987642 22334567889999999999999999998776554 8999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
+||+ +++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 99 ~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 99 THLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred EecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 9998 6799999875 35999999999999999999999 899999999999999999999999999999765432
Q ss_pred CcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccc-cc---
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE-LV--- 397 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~-~~--- 397 (518)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ............+ +.
T Consensus 172 -------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 172 -------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ-LKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred -------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCHHHHhhc
Confidence 233457889999998865 4678999999999999999999999975443322 2211111100000 00
Q ss_pred ---------C---CcCCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 398 ---------D---PRIKDSFD---MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 398 ---------d---~~l~~~~~---~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
. ......+. ......+.+++.+||+.+|++|||+.+|+++.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~ 302 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcc
Confidence 0 00000000 01235688999999999999999999999987664
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=283.73 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=202.7
Q ss_pred hhhhhhcceecceEEEEEEec------CCcEEEEEEecc-ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec-CceEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVALRGFCIEK-RERFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~l 241 (518)
..++.++-+|.||.||+|.|. +.+.|-||.++. .+.-....|+.|.-+|..+.|||+..+.+++.+. ...++
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V 365 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFV 365 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceE
Confidence 344567999999999999664 334566776653 3444456789999999999999999999999875 46788
Q ss_pred EEEecCCCCHHHHhcC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccc
Q 010088 242 MYEYMANGSLKDHLHS------PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL 315 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGl 315 (518)
+|.++.-|+|..||.. ...+.++..+...++.|++.|++||| +.++||.||.++|++||+..++||+|-.|
T Consensus 366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaL 442 (563)
T KOG1024|consen 366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSAL 442 (563)
T ss_pred EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchh
Confidence 9999999999999972 22355788889999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccc
Q 010088 316 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLA 394 (518)
Q Consensus 316 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~ 394 (518)
++..-.++.. ....+...+..||+||.+.+..|+.++|||||||+||||+| |+.|+.+-+. .+... ++.++.++.
T Consensus 443 SRDLFP~DYh--cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-fEm~~-ylkdGyRla 518 (563)
T KOG1024|consen 443 SRDLFPGDYH--CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-FEMEH-YLKDGYRLA 518 (563)
T ss_pred ccccCccccc--ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-HHHHH-HHhccceec
Confidence 9976555432 23344456789999999999999999999999999999988 7778764333 23322 233333333
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 395 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 395 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
+ +..++.++..+|..||..+|++||+++|++.-|.+
T Consensus 519 Q----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 519 Q----------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred C----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 2 23455679999999999999999999999998865
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=303.67 Aligned_cols=195 Identities=35% Similarity=0.545 Sum_probs=170.6
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC------ceEEEEE
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKR------ERFLMYE 244 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV~e 244 (518)
.+.||+|+||.||+|+.+ .|+.||||.++... ....+.+.+|+++|++|+|+|||++++.-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 458999999999999964 79999999987643 345577999999999999999999999755433 5689999
Q ss_pred ecCCCCHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec--CCC--cEEEeeccccccC
Q 010088 245 YMANGSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD--ENF--VAKLADFGLAHAS 319 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~--~~~--~~kl~DfGla~~~ 319 (518)
||.+|||...|.+.. ...|+..+.+.++.++..||.||| +++|+||||||.||++- .+| .-||+|||.|+..
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 999999999998754 356999999999999999999999 99999999999999994 233 5799999999988
Q ss_pred CCCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccC
Q 010088 320 KDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQD 375 (518)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~ 375 (518)
.++. ..+..+||..|.+||.+.. +.|+..+|.|||||++||.+||..||-.
T Consensus 175 ~d~s-----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 175 DDNS-----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred CCCC-----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 8776 3467889999999999984 8899999999999999999999999964
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=281.10 Aligned_cols=227 Identities=20% Similarity=0.218 Sum_probs=181.2
Q ss_pred ecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHHHHhcC
Q 010088 179 GGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHS 257 (518)
Q Consensus 179 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 257 (518)
|.||.||+++.. +|+.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999875 68899999986533 234555666666799999999999999999999999999999999876
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccccccCCC
Q 010088 258 PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 337 (518)
Q Consensus 258 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~ 337 (518)
.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++|||++....... ....++.
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-------~~~~~~~ 146 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-------DGEAVEN 146 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-------ccCCcCc
Confidence 43 4899999999999999999999 8999999999999999999999999999876543321 2334677
Q ss_pred cccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHH
Q 010088 338 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIV 417 (518)
Q Consensus 338 ~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li 417 (518)
.|+|||.+....++.++||||+|+++|||++|+.++....... .......+... ....+.+++
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~~~~~~~~~~----~~~~~~~li 209 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NTHTTLNIPEW----VSEEARSLL 209 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------ccccccCCccc----CCHHHHHHH
Confidence 8999999988889999999999999999999998764321100 00000111122 224688999
Q ss_pred HHccccCCCCCCCH-----HHHHHHhh
Q 010088 418 RWCTQREGQARPSI-----KQVLRILY 439 (518)
Q Consensus 418 ~~Cl~~dp~~RPs~-----~evl~~L~ 439 (518)
.+|++.||++||++ +++++|.|
T Consensus 210 ~~~l~~dp~~R~~~~~~~~~~~~~h~~ 236 (237)
T cd05576 210 QQLLQFNPTERLGAGVAGVEDIKSHPF 236 (237)
T ss_pred HHHccCCHHHhcCCCccchHHHHcCCC
Confidence 99999999999996 66666543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=294.26 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=209.3
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
++||+|.||+||-|++. +|+.||||++.+. ....+.++.+|+.+|.+++||.||.|.-.|+..+..++|||-+. |+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-ch
Confidence 68999999999999765 7999999999753 34556789999999999999999999999999999999999995 56
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC---CcEEEeeccccccCCCCCcccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN---FVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DfGla~~~~~~~~~~~ 327 (518)
..+.+-...+..|+...-..+..||+.||.||| .++|+|+||||+||||.+. -++||||||+|+..++..
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---- 721 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---- 721 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh----
Confidence 666655444556888888889999999999999 8999999999999999643 389999999999988765
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccC-CcCCCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD-PRIKDSFD 406 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d-~~l~~~~~ 406 (518)
....++||+.|.|||++++..|...-|+||.||++|--++|.-||.++.++.+..+. ..++. +.-..+
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN--------AaFMyPp~PW~e-- 790 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN--------AAFMYPPNPWSE-- 790 (888)
T ss_pred -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhc--------cccccCCCchhh--
Confidence 346788999999999999999999999999999999999999999988887666543 12222 222222
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
......++|...|+..-++|-+.++-+.|.|-+..
T Consensus 791 --is~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 791 --ISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred --cCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 23457789999999999999999999998876543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=315.17 Aligned_cols=141 Identities=30% Similarity=0.439 Sum_probs=126.7
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.++||+|+||+||+|... +++.||||+++... ......+.+|+.++..++|+||+++++++......++||||+.
T Consensus 8 i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~ 87 (669)
T cd05610 8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLI 87 (669)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCC
Confidence 4568999999999999876 68999999986432 2334678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
+++|.+++...+ .+++..+++|+.||+.||+||| ..+|+||||||+||||+.++.+||+|||+++
T Consensus 88 g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 88 GGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999997643 4889999999999999999999 8899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=274.03 Aligned_cols=266 Identities=23% Similarity=0.373 Sum_probs=207.3
Q ss_pred CHHHHHHHhhhhhhhcceecceEEEEEE-ecCCcEEEEEEeccccchhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCc
Q 010088 161 SYKETKKATDNFSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRE 238 (518)
Q Consensus 161 ~~~~l~~a~~~f~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 238 (518)
+++++.+-|. ++||+|+|+.|--+. +.+|.++|||++++..........+|++++...+ |+||++|+.|+.++..
T Consensus 74 ~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 4566666554 489999999999885 4689999999999887777888999999999995 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC---cEEEeeccc
Q 010088 239 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF---VAKLADFGL 315 (518)
Q Consensus 239 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DfGl 315 (518)
.|||||-|.||+|..+|+++ ..+++.++.++.++|+.||.||| .+||.||||||+|||-.+.. -+||+||.|
T Consensus 151 FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecccc
Confidence 99999999999999999874 45999999999999999999999 99999999999999997543 589999999
Q ss_pred cccCCCCCccc---ccccccccCCCcccCccccc-----cCCCCccccchhhHHHHHHHHhCCccccCCcc---------
Q 010088 316 AHASKDGSICF---EPVNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKN--------- 378 (518)
Q Consensus 316 a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~--------- 378 (518)
+.......... .+.....+|+..|||||+.. ...|+.++|.||||||||-|++|..||.....
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 86543322111 12233457888999999873 34688999999999999999999999963211
Q ss_pred hHHHHH-HHHhhccccccccCCcCCCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 379 LVESAQ-VCMASESRLAELVDPRIKDSFDM----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 379 ~~~~~~-~~~~~~~~l~~~~d~~l~~~~~~----~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.-...+ .++. .+-+. +-+|+. .......+++...+..|+.+|.++.+++++.|...
T Consensus 306 ~Cr~CQ~~LFe------sIQEG--kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 306 VCRVCQNKLFE------SIQEG--KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred ccHHHHHHHHH------HHhcc--CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence 111111 1110 00000 112222 22356678888999999999999999999887654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=285.98 Aligned_cols=246 Identities=25% Similarity=0.361 Sum_probs=200.1
Q ss_pred HHHHHHhhhhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecC
Q 010088 163 KETKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL-HHRHLVALRGFCIEKR 237 (518)
Q Consensus 163 ~~l~~a~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 237 (518)
..++.+..||..+||+|+||.|.+|..+ ..+.+|||++++.- ....+--+.|-++|... +-|.+++++.++..-+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 3455666789999999999999999765 35789999987532 22223345677777666 5689999999999999
Q ss_pred ceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 238 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 238 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
.+|+||||+.||+|.-++++.++ +.+..+..+|.+||-||-||| +++||+||||.+|||||.+|.+||+|||+++
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccc
Confidence 99999999999999999998765 778888999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccccc
Q 010088 318 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 397 (518)
Q Consensus 318 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 397 (518)
..--+. ..+...+||+.|+|||++..++|+.++|.|||||+||||+.|+.||. +.+..+..+.+....-
T Consensus 499 Eni~~~----~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd-GeDE~elF~aI~ehnv------ 567 (683)
T KOG0696|consen 499 ENIFDG----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD-GEDEDELFQAIMEHNV------ 567 (683)
T ss_pred ccccCC----cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHHccC------
Confidence 543222 24567899999999999999999999999999999999999999996 4455555554433221
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS 430 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs 430 (518)
.++.....+..++....+...|.+|..
T Consensus 568 ------syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 568 ------SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ------cCcccccHHHHHHHHHHhhcCCccccC
Confidence 233334456778999999999999954
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=298.39 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=210.9
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeee-----cCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIE-----KRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-----~~~~~lV 242 (518)
..|.++||+|.+|.||+++.. +|+.+|||++.-.. ...++...|.++|+.+ .|||++.++|++.. ++.+|||
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 345678999999999999764 68899999876433 3345677899999998 69999999999875 3689999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
||||.+||..++++...+..+.|..+..|+..++.||++|| .+.++|||||-.||||+.++.+||+|||++......
T Consensus 100 MEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred eeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 99999999999998766777999999999999999999999 999999999999999999999999999998765443
Q ss_pred CcccccccccccCCCcccCcccccc-----CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccccc
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 397 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 397 (518)
. .......||+.|||||++.. ..|+..+|+||||++..||.-|.+|+.+.........+ +.
T Consensus 177 ~----grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I--------pR-- 242 (953)
T KOG0587|consen 177 V----GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--------PR-- 242 (953)
T ss_pred c----ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC--------CC--
Confidence 2 23456789999999999964 35778999999999999999999999876544333221 11
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCC
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 444 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~ 444 (518)
.|..+..-+....+.+.++|..||.+|..+||++.++++|.+....+
T Consensus 243 NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 243 NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 12222223455668899999999999999999999999998776444
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=298.18 Aligned_cols=261 Identities=20% Similarity=0.249 Sum_probs=180.7
Q ss_pred hhhhhcceecceEEEEEEe-----------------cCCcEEEEEEeccccchhHHH--------------HHHHHHHHH
Q 010088 171 NFSTIIGQGGFGTVYKAQF-----------------SDGSLIAVKRMDKISEQVEGD--------------FCREIELLA 219 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~E~~~l~ 219 (518)
...++||+|+||+||+|.+ .+++.||||++........++ +..|+.++.
T Consensus 148 ~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~ 227 (507)
T PLN03224 148 QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCA 227 (507)
T ss_pred eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHH
Confidence 3457899999999999964 235689999986543332233 345777888
Q ss_pred HcCCCCe-----eeEeeeeee--------cCceEEEEEecCCCCHHHHhcCCC----------------------CCCCC
Q 010088 220 RLHHRHL-----VALRGFCIE--------KRERFLMYEYMANGSLKDHLHSPG----------------------RTPLS 264 (518)
Q Consensus 220 ~l~H~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~----------------------~~~l~ 264 (518)
+++|.|+ ++++++|.. ++..+|||||+++|+|.++|+... ...++
T Consensus 228 ~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~ 307 (507)
T PLN03224 228 KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD 307 (507)
T ss_pred HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence 8877655 678888764 357899999999999999987421 12357
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccc
Q 010088 265 WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344 (518)
Q Consensus 265 ~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 344 (518)
|..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....+... ......+|+.|+|||.
T Consensus 308 ~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~---~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 308 INVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF---NPLYGMLDPRYSPPEE 381 (507)
T ss_pred HHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc---CccccCCCcceeChhh
Confidence 8889999999999999999 889999999999999999999999999999755432211 1122345889999998
Q ss_pred cccCC--------------------C--CccccchhhHHHHHHHHhCCc-cccCCcchHHHHHHHHhhcccc----cccc
Q 010088 345 VVTQE--------------------L--TEKSDVYSYGVVLLEIVTARR-AVQDGKNLVESAQVCMASESRL----AELV 397 (518)
Q Consensus 345 ~~~~~--------------------~--~~~sDVwS~Gvll~el~tG~~-p~~~~~~~~~~~~~~~~~~~~l----~~~~ 397 (518)
+.... + ..+.||||+||+++||++|.. |+.+.................+ ....
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~ 461 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY 461 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence 75432 1 234799999999999999975 5532111111100000000000 0001
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHHhhcC
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREG---QARPSIKQVLRILYES 441 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp---~~RPs~~evl~~L~~~ 441 (518)
+-...+ .......+++.+++..+| .+|+|++|+++|.|+.
T Consensus 462 ~~~~~d----~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 462 DFSLLD----RNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred Cccccc----ccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 111111 122457789999998766 6899999999998874
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=280.27 Aligned_cols=261 Identities=26% Similarity=0.372 Sum_probs=197.9
Q ss_pred hhhhhhcceecceEEEEEE-ecCCcEEEEEEec---cccchh----HHHHHHHHHHHHHcCCCCeeeEeeeee-ecCceE
Q 010088 170 DNFSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMD---KISEQV----EGDFCREIELLARLHHRHLVALRGFCI-EKRERF 240 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~---~~~~~~----~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~ 240 (518)
+-+.++||+|||+.||||- +...+.||||+-. .+.+.. .+..++|.++-+.|.||.||++++++. +.+.++
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence 3345789999999999994 4567899999753 222221 234689999999999999999999986 557889
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec---CCCcEEEeeccccc
Q 010088 241 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAH 317 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DfGla~ 317 (518)
-|+|||+|.+|.-+|+.+. .+++.++..|++||..||.||.+. .++|||-||||.||||- ..|.+||.||||++
T Consensus 545 TVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred eeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 9999999999999998754 489999999999999999999866 78999999999999994 46899999999999
Q ss_pred cCCCCCccc---ccccccccCCCcccCcccccc----CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhc
Q 010088 318 ASKDGSICF---EPVNTDIRGTPGYMDPEYVVT----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE 390 (518)
Q Consensus 318 ~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~ 390 (518)
...+..... -..+....||.+|++||++.- .+.+.|+||||.||++|..+.|+.||.....-.+..+..-..
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl- 700 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL- 700 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh-
Confidence 876544321 113455689999999999853 368899999999999999999999997654332222210000
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 391 SRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 391 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.-.++--|. +. ....+...+|++||+..-++|.+..++..+.+.
T Consensus 701 -kAtEVqFP~-KP----vVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyl 744 (775)
T KOG1151|consen 701 -KATEVQFPP-KP----VVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYL 744 (775)
T ss_pred -cceeccCCC-CC----ccCHHHHHHHHHHHHhhhhhhhhHHHHccCccc
Confidence 001110110 11 112456789999999999999988887765443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=270.02 Aligned_cols=240 Identities=32% Similarity=0.464 Sum_probs=196.0
Q ss_pred cceEEEEEEecC-CcEEEEEEeccccchh-HHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHHHHhcC
Q 010088 180 GFGTVYKAQFSD-GSLIAVKRMDKISEQV-EGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHS 257 (518)
Q Consensus 180 ~~g~Vy~~~~~~-g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 257 (518)
+||.||+|...+ |..+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999874 8999999987554433 67899999999999999999999999999999999999999999999976
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccccccCCC
Q 010088 258 PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 337 (518)
Q Consensus 258 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~ 337 (518)
... +++..+..++.+++.+|.||| +.+++|+||+|+||++++++.++|+|||++....... ......++.
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~ 150 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----LLTTFVGTP 150 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----ccccccCCc
Confidence 433 899999999999999999999 8899999999999999999999999999998655432 223456888
Q ss_pred cccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHH
Q 010088 338 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIV 417 (518)
Q Consensus 338 ~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li 417 (518)
.|++||.+....++.++||||||+++++|++|..|+....+............... ..........+.+++
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~i 221 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF---------PPPEWKISPEAKDLI 221 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC---------ccccccCCHHHHHHH
Confidence 99999999888899999999999999999999999865333333322211111000 000000235688999
Q ss_pred HHccccCCCCCCCHHHHHHHh
Q 010088 418 RWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 418 ~~Cl~~dp~~RPs~~evl~~L 438 (518)
.+|+..+|++||++.+++++.
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~~~ 242 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQHP 242 (244)
T ss_pred HHHccCCchhccCHHHHhhCC
Confidence 999999999999999999864
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=269.66 Aligned_cols=249 Identities=20% Similarity=0.286 Sum_probs=198.8
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeee----cCceEEEEEecC
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIE----KRERFLMYEYMA 247 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~lV~e~~~ 247 (518)
++||-|-.|.|-.+..+ .|+.+|+|++... ....+|+++--.. .|+|||.+++++.. ...+++|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 58999999999999765 6889999988643 2345788876665 59999999998764 357799999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC---CCcEEEeeccccccCCCCCc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DfGla~~~~~~~~ 324 (518)
||.|...+.+++...+++.++-+|..||..|+.||| +.+|.||||||+|+|.+. |-.+||+|||+|+......
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~- 218 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG- 218 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCCCc-
Confidence 999999999999889999999999999999999999 999999999999999964 5689999999998765432
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchH--H-HHHHHHhhccccccccCCcC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV--E-SAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~--~-~~~~~~~~~~~l~~~~d~~l 401 (518)
....-+-|+.|.|||++...+|+...|+||+||++|-|++|-+||....... . +-..+......+
T Consensus 219 ----~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F-------- 286 (400)
T KOG0604|consen 219 ----DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF-------- 286 (400)
T ss_pred ----cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC--------
Confidence 2244567999999999999999999999999999999999999997543221 0 111111111110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
....-....+...++|+.+|..+|++|.|+.+++++.|....
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 100001234668899999999999999999999999987653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=308.92 Aligned_cols=258 Identities=24% Similarity=0.337 Sum_probs=207.0
Q ss_pred HHhhhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 167 KATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 167 ~a~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
+..+.+.++||+|+||.|..++++ .++.||.|+++++ ......-|..|-++|..-+.+-|++++..|.+..++|||
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 344555689999999999999886 5889999999873 334456688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCC-C
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK-D 321 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~-~ 321 (518)
||||+||+|-.+|.+.+ .++...+..++..|..||.-|| +.|+|||||||+|||||.+|.+||+|||.|-... +
T Consensus 154 MdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 99999999999998876 5888888899999999999999 9999999999999999999999999999987665 4
Q ss_pred CCcccccccccccCCCcccCcccccc-----CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccc
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL 396 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~ 396 (518)
|.. .....+|||.|++||++.. +.|+..+|.||+||++|||+.|..||.. ..+++-...++.....+.-
T Consensus 229 G~V----~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~F- 302 (1317)
T KOG0612|consen 229 GTV----RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSF- 302 (1317)
T ss_pred CcE----EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCC-
Confidence 432 3456789999999999952 5799999999999999999999999974 4455544444433221110
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHhhcCCC
Q 010088 397 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS---IKQVLRILYESSD 443 (518)
Q Consensus 397 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs---~~evl~~L~~~~~ 443 (518)
| +. .+......++|+..+. +|+.|.. ++++-.|+++...
T Consensus 303 --P---~~--~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 303 --P---DE--TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred --C---cc--cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 1 00 1233456667766543 6777777 9999999877543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=299.85 Aligned_cols=263 Identities=26% Similarity=0.356 Sum_probs=205.3
Q ss_pred hhcceecceE-EEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 174 TIIGQGGFGT-VYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 174 ~~lG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
+++|.|+-|+ ||+|.+ +|+.||||++-.. ...-..+|+..|..- +|||||++++.-.+....|+..|.|. .+|
T Consensus 515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL 589 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSL 589 (903)
T ss_pred HHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhH
Confidence 5899999887 799999 6899999987532 223456899999988 69999999988888889999999995 699
Q ss_pred HHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-----CCcEEEeeccccccCCCCCc
Q 010088 252 KDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-----NFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 252 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~kl~DfGla~~~~~~~~ 324 (518)
.+++... ......-...+.+..|++.||++|| +.+||||||||.||||+. ...++|+|||+++....+..
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 9999873 1111121445788899999999999 899999999999999975 25899999999998877665
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhC-CccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA-RRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG-~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
.+.. .....||-+|+|||.+....-+.++||+|+|||+|+.++| ..||.+. +...+. ++.....+..+..
T Consensus 667 S~~r-~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~N-Il~~~~~L~~L~~----- 737 (903)
T KOG1027|consen 667 SFSR-LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQAN-ILTGNYTLVHLEP----- 737 (903)
T ss_pred hhhc-ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhhh-hhcCccceeeecc-----
Confidence 5444 5667899999999999998888999999999999999998 6788642 222222 2222222222111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCCcchhhhchhhh
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEE 457 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~ 457 (518)
..++ ...++|.+|+..+|..||++.+|+.|..+...+..-.|.+.+.++-
T Consensus 738 --~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRv 787 (903)
T KOG1027|consen 738 --LPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRV 787 (903)
T ss_pred --CchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhh
Confidence 1111 5778999999999999999999999999988887777777765543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=273.45 Aligned_cols=268 Identities=20% Similarity=0.295 Sum_probs=207.3
Q ss_pred HHHHHHhhhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCC--C----CeeeEeeeeee
Q 010088 163 KETKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHH--R----HLVALRGFCIE 235 (518)
Q Consensus 163 ~~l~~a~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~g~~~~ 235 (518)
.+.....+.....+|+|.||.|-++... .+..||||+++..... .+..+-|+++|.++.+ | -+|.+.+|+.-
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 3333444445568999999999999654 4789999998765543 3456679999999942 2 36788889999
Q ss_pred cCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-----------
Q 010088 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE----------- 304 (518)
Q Consensus 236 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~----------- 304 (518)
.++.++|+|.+ |-|+.++|..++-.+++...+..|+.|++++++||| +.+++|-||||+|||+.+
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCC
Confidence 99999999988 569999999888888999999999999999999999 999999999999999921
Q ss_pred ---------CCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccC
Q 010088 305 ---------NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQD 375 (518)
Q Consensus 305 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~ 375 (518)
+..+||+|||-|+...+.. ..++.|..|.|||++.+-.++..+||||+||||.||.||..-|+.
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h-------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH-------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc-------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 3368999999998765443 456789999999999999999999999999999999999999876
Q ss_pred CcchHHHHHHHHhhccccccccCCc----------C-------C----------------CCCCHHHHHHHHHHHHHccc
Q 010088 376 GKNLVESAQVCMASESRLAELVDPR----------I-------K----------------DSFDMEQLRTIVTIVRWCTQ 422 (518)
Q Consensus 376 ~~~~~~~~~~~~~~~~~l~~~~d~~----------l-------~----------------~~~~~~~~~~l~~li~~Cl~ 422 (518)
..+....+......+.....++... + . ......+...|.++++.+|.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 6554433222111111111111110 0 0 00122345679999999999
Q ss_pred cCCCCCCCHHHHHHHhhcCC
Q 010088 423 REGQARPSIKQVLRILYESS 442 (518)
Q Consensus 423 ~dp~~RPs~~evl~~L~~~~ 442 (518)
.||.+|+|+.|++.|.++..
T Consensus 392 fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 392 FDPARRITLREALSHPFFAR 411 (415)
T ss_pred cCccccccHHHHhcCHHhhc
Confidence 99999999999999988754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=287.73 Aligned_cols=240 Identities=25% Similarity=0.290 Sum_probs=194.5
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
++|...+|.|+|+.|-++... ++...+||++.+.. .+-.+|+.++... +|+||+++.+.+.+..+.|+|||++.
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred hccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 445567999999999999765 57899999987542 2334677777776 69999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe-cCCCcEEEeeccccccCCCCCccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL-DENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl-~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
+|-|.+.+.... ....++..|+.+|+.++.||| .+|++||||||+|||+ ++.++++|+|||.++.....
T Consensus 400 g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 400 GGELLRRIRSKP---EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred ccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence 998888876533 222777789999999999999 8999999999999999 58999999999999876543
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
....+-|..|.|||++....|++++|+||||++||+|++|+.|+....+-.+....+ -.+ .++
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----------~~~----~~s 532 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----------QMP----KFS 532 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----------cCC----ccc
Confidence 122346889999999999999999999999999999999999997554432222211 111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
........+++.+||+.||.+||+|.++..+.|.
T Consensus 533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 533 ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 2333567899999999999999999999999888
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.14 Aligned_cols=262 Identities=22% Similarity=0.310 Sum_probs=170.9
Q ss_pred hhhhhhcceecceEEEEEEec-C----CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeee------eeecCc
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-D----GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGF------CIEKRE 238 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~~~~~ 238 (518)
+.+.++||+|+||+||+|++. + +..||||++...... +.+..| .+....+.++..++.. +.....
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence 345578999999999999875 4 689999987643221 111111 1222222333322221 245568
Q ss_pred eEEEEEecCCCCHHHHhcCCCCC------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcE
Q 010088 239 RFLMYEYMANGSLKDHLHSPGRT------------------PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 300 (518)
Q Consensus 239 ~~lV~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NI 300 (518)
.++||||+.+++|.++++..... ......+..++.|++.||+||| +.+|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHE
Confidence 99999999999999998753210 0123345679999999999999 89999999999999
Q ss_pred EecC-CCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccC----------------------CCCccccch
Q 010088 301 LLDE-NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ----------------------ELTEKSDVY 357 (518)
Q Consensus 301 Ll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDVw 357 (518)
|+++ ++.+||+|||+|+....+.. .......++++|||||.+... .++.++|||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~---~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccc---cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9986 68999999999986543321 123456789999999965322 244567999
Q ss_pred hhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccc---ccccCCcC----CCCCC--HHHHHHHHHHHHHccccCCCCC
Q 010088 358 SYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL---AELVDPRI----KDSFD--MEQLRTIVTIVRWCTQREGQAR 428 (518)
Q Consensus 358 S~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l---~~~~d~~l----~~~~~--~~~~~~l~~li~~Cl~~dp~~R 428 (518)
||||+||||+++..+..+ ...............+ ...+.+.. ...+. ........+++.+||+.||++|
T Consensus 364 SlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 999999999997665432 2222211111111111 11111111 00000 0011235589999999999999
Q ss_pred CCHHHHHHHhhcCCC
Q 010088 429 PSIKQVLRILYESSD 443 (518)
Q Consensus 429 Ps~~evl~~L~~~~~ 443 (518)
||++++++|.|....
T Consensus 442 ~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 442 ISAKAALAHPYFDRE 456 (566)
T ss_pred CCHHHHhCCcCcCCC
Confidence 999999999987643
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-33 Score=279.85 Aligned_cols=246 Identities=22% Similarity=0.320 Sum_probs=206.6
Q ss_pred hcceecceEEEEEEecCCc-EEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 175 IIGQGGFGTVYKAQFSDGS-LIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
.||-||||.|=+....+.. .+|+|.+++. .....+....|-++|..++.+.||+++..+.+.+..|++||-|-||.
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE 506 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE 506 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence 4899999999999875433 4888887653 33444567889999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|...|+.++. ++..+...++..+.+|++||| .++||+|||||+|.+|+.+|-+||.|||+|+....+. .+
T Consensus 507 lWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-----KT 576 (732)
T KOG0614|consen 507 LWTILRDRGS--FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-----KT 576 (732)
T ss_pred hhhhhhhcCC--cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC-----ce
Confidence 9999998654 888899999999999999999 9999999999999999999999999999999887765 45
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 410 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 410 (518)
..++||+.|.|||++.+...+.++|.||||++++||++|.+||........+-.++...+ ...++....
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid-----------~i~~Pr~I~ 645 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID-----------KIEFPRRIT 645 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh-----------hhhcccccc
Confidence 788999999999999999999999999999999999999999986665554443322111 112333344
Q ss_pred HHHHHHHHHccccCCCCCCC-----HHHHHHHhhcC
Q 010088 411 RTIVTIVRWCTQREGQARPS-----IKQVLRILYES 441 (518)
Q Consensus 411 ~~l~~li~~Cl~~dp~~RPs-----~~evl~~L~~~ 441 (518)
+...++++..+..+|.+|.. +.++-+|-|+.
T Consensus 646 k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 646 KTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred hhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 56778999999999999976 67888887763
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=241.91 Aligned_cols=203 Identities=26% Similarity=0.412 Sum_probs=168.1
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEecc-ccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDK-ISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
..||+|++|.|-+-++. +|...|+|++.. ...+..+..++|+++..+. .+|.+|.++|........|+.||.|. .|
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tS 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TS 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hh
Confidence 35999999999888764 799999999874 3455567788999987776 68999999999999999999999996 48
Q ss_pred HHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 251 LKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 251 L~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|..+-.+ ..+..+++.-+-+|+..+.+||.|||+ +..+||||+||+||||+.+|++|+||||++-.+.+.-
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi----- 203 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI----- 203 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh-----
Confidence 8776542 123458888899999999999999996 6799999999999999999999999999987654432
Q ss_pred ccccccCCCcccCcccccc----CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHH
Q 010088 329 VNTDIRGTPGYMDPEYVVT----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQ 384 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~----~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~ 384 (518)
..+...|...|||||.+.. ..|+-|+||||||+++.||.+++.|+.......+...
T Consensus 204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLk 263 (282)
T KOG0984|consen 204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLK 263 (282)
T ss_pred HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHH
Confidence 2344568899999999853 3689999999999999999999999987655444443
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=271.37 Aligned_cols=253 Identities=24% Similarity=0.336 Sum_probs=190.9
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.||-|+||.|.+++-- ....+|.|.+++.+ .......+.|-+||.....+-||+|+..|.+++.+|+||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 45999999999999654 46789999887643 233345778999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCC---------
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK--------- 320 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~--------- 320 (518)
++..+|-+.+ -+.+..+..++.++..|+++.| ..|+|||||||+|||||.+|.+||.|||||..+.
T Consensus 715 DmMSLLIrmg--IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 715 DMMSLLIRMG--IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred cHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 9999998754 3788888889999999999999 9999999999999999999999999999996331
Q ss_pred CCCc------cc-----------------------ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCc
Q 010088 321 DGSI------CF-----------------------EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARR 371 (518)
Q Consensus 321 ~~~~------~~-----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~ 371 (518)
+++. .. .......+||+.|+|||++....++..+|.||.|||||||+.|+.
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~ 869 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP 869 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence 1100 00 011234579999999999999999999999999999999999999
Q ss_pred cccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHHhhcC
Q 010088 372 AVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARP---SIKQVLRILYES 441 (518)
Q Consensus 372 p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP---s~~evl~~L~~~ 441 (518)
||-+........+. ..+...++-......+.++...+.+ .|.. ++.|. -.++|-.|.++.
T Consensus 870 pf~~~tp~~tq~kv-----~nw~~~l~~~~~~~ls~e~~~li~k---Lc~s--ad~RLGkng~d~vKaHpfFk 932 (1034)
T KOG0608|consen 870 PFLADTPGETQYKV-----INWRNFLHIPYQGNLSKEALDLIQK---LCCS--ADSRLGKNGADQVKAHPFFK 932 (1034)
T ss_pred CccCCCCCcceeee-----eehhhccccccccccCHHHHHHHHH---HhcC--hhhhhcccchhhhhcCcccc
Confidence 99755443222111 1223333434445556565544333 3443 34443 345576666553
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=240.20 Aligned_cols=211 Identities=39% Similarity=0.632 Sum_probs=184.3
Q ss_pred cceecceEEEEEEecC-CcEEEEEEeccccch-hHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHHH
Q 010088 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKD 253 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 253 (518)
||+|++|.||++...+ |..+++|.+...... ....+.+|++.++.++|++|+++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998864 899999998754432 34679999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-CCcEEEeeccccccCCCCCccccccccc
Q 010088 254 HLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASKDGSICFEPVNTD 332 (518)
Q Consensus 254 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~ 332 (518)
++.... ..+++..+..++.+++.+|+||| +.+++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~ 152 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----LLKT 152 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----hhhc
Confidence 997642 35899999999999999999999 889999999999999999 89999999999976544321 1233
Q ss_pred ccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 010088 333 IRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR 411 (518)
Q Consensus 333 ~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 411 (518)
..+...|++||.+... ..+.+.|+|++|+++++| .
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------~ 188 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------P 188 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------H
Confidence 4578899999998877 888999999999999999 3
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 412 TIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 412 ~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
.+.+++..|++.+|++||++.++++++
T Consensus 189 ~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 189 ELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 477899999999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=251.47 Aligned_cols=236 Identities=22% Similarity=0.374 Sum_probs=188.4
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecC
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.++||+|+|.+|..+++. ..+.+|+|++++. ......-...|-.+.... +||.+|.+..++..+..+++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 468999999999999886 4688999988652 122222344566666666 79999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccC-CCCCccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS-KDGSICF 326 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~-~~~~~~~ 326 (518)
||+|.-++++.. .|+++.+..+..+|..||.||| +.|||+||||.+|||||..|.+||.|+|+++.. ..++
T Consensus 335 ggdlmfhmqrqr--klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd--- 406 (593)
T KOG0695|consen 335 GGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD--- 406 (593)
T ss_pred Ccceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCCCc---
Confidence 999998887644 4999999999999999999999 999999999999999999999999999999854 3333
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCcccc------CCcchHHH-HHHHHhhccccccccCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQ------DGKNLVES-AQVCMASESRLAELVDP 399 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~------~~~~~~~~-~~~~~~~~~~l~~~~d~ 399 (518)
.+...+||+.|+|||++++..|+.++|.|++||+++||+.|+.||. ...+..++ .+.++...-+++
T Consensus 407 --~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip----- 479 (593)
T KOG0695|consen 407 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP----- 479 (593)
T ss_pred --ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc-----
Confidence 4567899999999999999999999999999999999999999995 12233333 333333222222
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 010088 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPS 430 (518)
Q Consensus 400 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs 430 (518)
...+ .+...+++.-+.+||.+|..
T Consensus 480 ---rsls----vkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 480 ---RSLS----VKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ---ceee----hhhHHHHHHhhcCCcHHhcC
Confidence 1222 33556888899999999853
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=249.05 Aligned_cols=261 Identities=22% Similarity=0.344 Sum_probs=193.2
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec-----CceEEEEEe
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK-----RERFLMYEY 245 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e~ 245 (518)
+-||-|+||.||..+.. +|+.||+|++...- -...+.+.+|+++|..++|.|++..+++..-. ++.|+++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 36999999999999764 79999999886432 23456789999999999999999998876543 367888998
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
|.. +|...+-+ .++++-..+.-+..||++||+||| +.+|.||||||.|.|++.|..+||||||||+.......
T Consensus 139 mQS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~- 211 (449)
T KOG0664|consen 139 MQS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR- 211 (449)
T ss_pred HHh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhhh-
Confidence 854 78777765 456888999999999999999999 99999999999999999999999999999997654321
Q ss_pred cccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHH--HHh----------hccc
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV--CMA----------SESR 392 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~--~~~----------~~~~ 392 (518)
...+..+.|..|.|||.+.+ ..|+.+.||||.||++.||+..+--|+....+.+...+ .+. -++.
T Consensus 212 --~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 212 --LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred --hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 23455567889999999987 57999999999999999999777666543333222111 000 0111
Q ss_pred cccccC-----CcCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 393 LAELVD-----PRIKD----SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 393 l~~~~d-----~~l~~----~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
-..++. |.+.. ......-..-+.+...++..||++|.+..+.+.++++...
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 111111 11110 0011112345567788899999999999999998876543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=233.27 Aligned_cols=256 Identities=20% Similarity=0.326 Sum_probs=194.7
Q ss_pred hhhhhhcceecceEEEEEEe-cCCcEEEEEEeccccchhHHHHHHHHHHHHHcC-CCCeeeEeeeeeec--CceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEK--RERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e~ 245 (518)
+++.+++|+|.|+.|+.|.. .++..++||.++... .+.+.+|+.+|..|. ||||++|++...+. ....||+||
T Consensus 40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred HHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 34556899999999999964 467899999987533 456889999999997 99999999998765 467899999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-CCcEEEeeccccccCCCCCc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DfGla~~~~~~~~ 324 (518)
+.|.+...+-.. |+...+...+.+++.||.|+| +.||+|||+||.||+||. ...++|+|+|||.....+..
T Consensus 117 v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 117 VNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred hccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence 999888776543 777888999999999999999 999999999999999996 56899999999987765542
Q ss_pred ccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHH----HHHHHHhhc-----cccc
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE----SAQVCMASE-----SRLA 394 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~----~~~~~~~~~-----~~l~ 394 (518)
....+.+.-|.-||.+.. +.|+.+-|+|||||+|.+|+..+.||..+.+..+ .+...-..+ ....
T Consensus 189 -----YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 189 -----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred -----eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 233345667888998865 5688999999999999999999999976554322 222210000 0000
Q ss_pred cccCCcCCC--------CC-------CHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 395 ELVDPRIKD--------SF-------DME-QLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 395 ~~~d~~l~~--------~~-------~~~-~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
-.+||.+.+ .. +.. ...+..+++...|..|-++|+|++|.+.|.++.
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 012222211 00 000 125678999999999999999999999988763
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=235.78 Aligned_cols=197 Identities=35% Similarity=0.541 Sum_probs=171.1
Q ss_pred hhhhcceecceEEEEEEecC-CcEEEEEEeccccch-hHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.||+|++|+||++...+ +..+|+|.+...... ....+.+|++.+.+++|+|++++++++......++++||++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45689999999999998875 889999998765444 5678999999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++...... +++.....++.+++.+|.||| +.+++|+||+++||+++.++.++|+|||++........ ..
T Consensus 83 ~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~---~~ 155 (225)
T smart00221 83 DLFDYLRKKGGK-LSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA---AL 155 (225)
T ss_pred CHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc---cc
Confidence 999999764322 889999999999999999999 88999999999999999999999999999886644320 01
Q ss_pred cccccCCCcccCcccc-ccCCCCccccchhhHHHHHHHHhCCccccC
Q 010088 330 NTDIRGTPGYMDPEYV-VTQELTEKSDVYSYGVVLLEIVTARRAVQD 375 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~-~~~~~~~~sDVwS~Gvll~el~tG~~p~~~ 375 (518)
.....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2334578899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=266.19 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=201.6
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
++.+.+|.|.||.|||++.. .++..|||.++........-..+|+-+++..+|+||+.++|.+...+..|+.||||.+|
T Consensus 18 ellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycggg 97 (829)
T KOG0576|consen 18 ELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGG 97 (829)
T ss_pred hheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence 34568999999999999875 68999999998766666667788999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|++.-+..+ ++++.++..+.++.++||+||| +.+=+|||||-.|||+++.|.+|++|||.+-.....- ..
T Consensus 98 slQdiy~~Tg--plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati----~K 168 (829)
T KOG0576|consen 98 SLQDIYHVTG--PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI----AK 168 (829)
T ss_pred cccceeeecc--cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhh----hh
Confidence 9999887644 6999999999999999999999 8999999999999999999999999999876443211 12
Q ss_pred cccccCCCcccCcccc---ccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 330 NTDIRGTPGYMDPEYV---VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~---~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
...+.||+.|||||+. +.+.|..++|||+.|+...|+---+.|..+......... .-.....- |.+++..
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L-mTkS~~qp-----p~lkDk~- 241 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL-MTKSGFQP-----PTLKDKT- 241 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH-hhccCCCC-----CcccCCc-
Confidence 3557899999999987 356799999999999999999887777655332211111 11111111 2233221
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
.....+-++++.|+..+|++||+++.++.|.
T Consensus 242 -kws~~fh~fvK~altknpKkRptaeklL~h~ 272 (829)
T KOG0576|consen 242 -KWSEFFHNFVKGALTKNPKKRPTAEKLLQHP 272 (829)
T ss_pred -cchHHHHHHHHHHhcCCCccCCChhhheece
Confidence 2235688999999999999999999988764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=237.11 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=192.1
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec------CceEEEEEe
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERFLMYEY 245 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~e~ 245 (518)
.+|.|.- .|.-+-.. .++.||+|++... .....+...+|..++..++|+||++++.++.-. .+.|+||||
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 4677766 45444322 5789999987432 223345667899999999999999999998754 367999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
|. ++|...++- .++-.++..|..|++.|++||| +.+|+||||||+||++..+..+||.|||+|+.....
T Consensus 103 m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--- 171 (369)
T KOG0665|consen 103 MD-ANLCQVILM----ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--- 171 (369)
T ss_pred hh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc---
Confidence 95 599988872 3677888999999999999999 999999999999999999999999999999865433
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc-------------
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR------------- 392 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~------------- 392 (518)
-..+..+.|.-|.|||++.+..+.+.+||||.||++.||++|+--|.....+.+|.+..-..+..
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 14567788999999999998889999999999999999999998887555555555443211110
Q ss_pred -------------ccccc-CCcCCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 393 -------------LAELV-DPRIKD--SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 393 -------------l~~~~-d~~l~~--~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+.+.+ |..... +.+.-......+++.+||..||++|-+++++|+|.+..
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 00000 000000 01112234578899999999999999999999998764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=255.47 Aligned_cols=191 Identities=27% Similarity=0.385 Sum_probs=164.7
Q ss_pred hhcceecceEEEEEEecC-CcEEEEEEecccc--------chhHHHHHHHHHHHHHcC---CCCeeeEeeeeeecCceEE
Q 010088 174 TIIGQGGFGTVYKAQFSD-GSLIAVKRMDKIS--------EQVEGDFCREIELLARLH---HRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~l 241 (518)
+.+|+|+||.|+.|.++. ...|+||.+.+.. .......-.||.+|..|+ |+||++++++|++.+.+||
T Consensus 567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl 646 (772)
T KOG1152|consen 567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL 646 (772)
T ss_pred eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence 579999999999998874 5688899875421 122233556999999997 9999999999999999999
Q ss_pred EEEec-CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCC
Q 010088 242 MYEYM-ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 242 V~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~ 320 (518)
+||-. ++.+|.+++.... .+++.++.-|++||+.|+++|| +.+|||||||-+||.++.+|-+||+|||.|...+
T Consensus 647 ~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 647 ETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK 721 (772)
T ss_pred EecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccchhhhc
Confidence 99975 5789999997643 4899999999999999999999 9999999999999999999999999999998777
Q ss_pred CCCcccccccccccCCCcccCccccccCCCC-ccccchhhHHHHHHHHhCCccccC
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQELT-EKSDVYSYGVVLLEIVTARRAVQD 375 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwS~Gvll~el~tG~~p~~~ 375 (518)
.+. ....+||.+|.|||++.+.+|- ..-|||++|++||.++....||.+
T Consensus 722 sgp------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 722 SGP------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred CCC------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 664 3567899999999999998874 568999999999999988888753
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=250.97 Aligned_cols=273 Identities=22% Similarity=0.294 Sum_probs=210.7
Q ss_pred ccccCHHHHHHHhhhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcC------CCCeeeE
Q 010088 157 FQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH------HRHLVAL 229 (518)
Q Consensus 157 ~~~~~~~~l~~a~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l 229 (518)
+-++.+-|+....|......|+|-|++|.+|... .|..||||++... +...+.=+.|+++|.+|+ --|.++|
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 3345666777666766667899999999999865 4789999999753 333345568999999996 3589999
Q ss_pred eeeeeecCceEEEEEecCCCCHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-CCc
Q 010088 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFV 307 (518)
Q Consensus 230 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~ 307 (518)
+-.|...+++|||+|-+. -+|.+.|+..+. ..|....+..++.|+.-||..|. ..+|+|.||||.|||+++ ...
T Consensus 500 ~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcce
Confidence 999999999999999874 599999987653 46888899999999999999999 889999999999999987 568
Q ss_pred EEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHH
Q 010088 308 AKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCM 387 (518)
Q Consensus 308 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~ 387 (518)
+||||||.|....+..+ +....+..|.|||++.+-+|+...|+||.||+||||.||+-.|....+. .+....+
T Consensus 576 LKLCDfGSA~~~~enei------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN-~MLrl~m 648 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEI------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN-QMLRLFM 648 (752)
T ss_pred eeeccCccccccccccc------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH-HHHHHHH
Confidence 99999999987665542 3344567899999999999999999999999999999999888644332 2222222
Q ss_pred hhcccccc-------------------------------------ccCCc------CCC--CC---CHHHHHHHHHHHHH
Q 010088 388 ASESRLAE-------------------------------------LVDPR------IKD--SF---DMEQLRTIVTIVRW 419 (518)
Q Consensus 388 ~~~~~l~~-------------------------------------~~d~~------l~~--~~---~~~~~~~l~~li~~ 419 (518)
...+.++. .+.|. +.. .+ ....+..|.+|+..
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 11111110 01110 000 01 23445789999999
Q ss_pred ccccCCCCCCCHHHHHHHhhcC
Q 010088 420 CTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 420 Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
|+..||++|.+..++|.|.+.+
T Consensus 729 ml~LdP~KRit~nqAL~HpFi~ 750 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALKHPFIT 750 (752)
T ss_pred HhccChhhcCCHHHHhcCCccc
Confidence 9999999999999999998764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=222.99 Aligned_cols=242 Identities=20% Similarity=0.337 Sum_probs=180.9
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeee-eeecCceEEEEEec
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGF-CIEKRERFLMYEYM 246 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~e~~ 246 (518)
++..+.||+|.||.+-+++++ ..+.+++|.+... .....+|.+|...=-.| .|.||+.-++. +...+.+++++||+
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 445678999999999999886 4678999977542 33457899998875556 58999987764 55567888999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec--CCCcEEEeeccccccCCCCCc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD--ENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~--~~~~~kl~DfGla~~~~~~~~ 324 (518)
+.|+|..-+... .+.+....+++.|++.|+.||| ++++||||||.+||||- +...+||||||+.+..+..
T Consensus 105 P~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-- 176 (378)
T KOG1345|consen 105 PRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-- 176 (378)
T ss_pred ccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce--
Confidence 999999888653 3778888999999999999999 99999999999999993 3458999999998754321
Q ss_pred ccccccccccCCCcccCccccccC-----CCCccccchhhHHHHHHHHhCCcccc----CCcchHHHHHHHHhhcccccc
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQ-----ELTEKSDVYSYGVVLLEIVTARRAVQ----DGKNLVESAQVCMASESRLAE 395 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwS~Gvll~el~tG~~p~~----~~~~~~~~~~~~~~~~~~l~~ 395 (518)
......+..|.+||..... ...+.+|||.||++++..+||+.||+ ......+|.+..-.....+++
T Consensus 177 -----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 177 -----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred -----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 1223346679999977432 35678999999999999999999997 234455555543333333332
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 010088 396 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 434 (518)
Q Consensus 396 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~ev 434 (518)
.+. .+. ..+..+.++-+..++++|-...++
T Consensus 252 ~F~-----~fs----~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 252 KFN-----PFS----EKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred hhc-----ccC----HHHHHHHHHhcCCcccccchhHHH
Confidence 222 222 346678888899999999444443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=231.29 Aligned_cols=131 Identities=22% Similarity=0.327 Sum_probs=110.2
Q ss_pred HhhhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcC-----C---CCeeeEeeeeeec--
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-----H---RHLVALRGFCIEK-- 236 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~~-- 236 (518)
+.|-..++||=|.|+|||++... +.+.||+|+.+... .-.+..+.||++|++++ | .+||+|+++|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 34445678999999999999654 56899999887543 23456789999999994 2 5799999999764
Q ss_pred --CceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe
Q 010088 237 --RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL 302 (518)
Q Consensus 237 --~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 302 (518)
.+.+||+|++ |.+|..+|....-+.++...+.+|+.||+.||.|||. +.+|||-||||+||||
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 4889999998 6799999987766779999999999999999999997 4599999999999999
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=272.72 Aligned_cols=203 Identities=17% Similarity=0.232 Sum_probs=143.9
Q ss_pred HcCC-CCeeeEeeee-------eecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCce
Q 010088 220 RLHH-RHLVALRGFC-------IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291 (518)
Q Consensus 220 ~l~H-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii 291 (518)
.++| +||++++++| .+.+..++++||+ +++|.++|... ...+++.+++.++.||+.||+||| +++|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH---SQGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 4456 6888888887 2334677888987 56999999754 345999999999999999999999 89999
Q ss_pred ecccCCCcEEecCCC-------------------cEEEeeccccccCCCCCc----c--------cccccccccCCCccc
Q 010088 292 HRDIKSSNILLDENF-------------------VAKLADFGLAHASKDGSI----C--------FEPVNTDIRGTPGYM 340 (518)
Q Consensus 292 HrDlk~~NILl~~~~-------------------~~kl~DfGla~~~~~~~~----~--------~~~~~~~~~gt~~y~ 340 (518)
||||||+||||+..+ .+|++|||+++....... . .........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996544 455556665543211000 0 000011245889999
Q ss_pred CccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHc
Q 010088 341 DPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWC 420 (518)
Q Consensus 341 aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~C 420 (518)
|||++.+..++.++|||||||+||||++|..|+............ ....+.. .........++.+|
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~---------~~~~~~~-----~~~~~~~~~~~~~~ 248 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRH---------RVLPPQI-----LLNWPKEASFCLWL 248 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHH---------hhcChhh-----hhcCHHHHHHHHHh
Confidence 999999999999999999999999999998876432211111100 0111111 11123456788999
Q ss_pred cccCCCCCCCHHHHHHHhhcC
Q 010088 421 TQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 421 l~~dp~~RPs~~evl~~L~~~ 441 (518)
|+.+|.+||+|.|++++.+..
T Consensus 249 L~~~P~~Rps~~eil~h~~~~ 269 (793)
T PLN00181 249 LHPEPSCRPSMSELLQSEFIN 269 (793)
T ss_pred CCCChhhCcChHHHhhchhhh
Confidence 999999999999999987754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=232.85 Aligned_cols=259 Identities=27% Similarity=0.374 Sum_probs=193.8
Q ss_pred hhhcceecceEEEEEEec----CCcEEEEEEeccccchhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEEecC
Q 010088 173 STIIGQGGFGTVYKAQFS----DGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.++||+|.|++||++.+. .++.||+|.+...+.. ....+|+++|..+. +.||+++.+++...+...+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 368999999999999754 3678999988765433 45789999999995 8999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-CCcEEEeeccccccCC------
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASK------ 320 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DfGla~~~~------ 320 (518)
+....++... ++...+..++..++.||+++| .+|||||||||+|+|.+. .+.-.|.|||||....
T Consensus 119 H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~ 190 (418)
T KOG1167|consen 119 HDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE 190 (418)
T ss_pred ccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence 9999999875 778899999999999999999 999999999999999985 5678999999997110
Q ss_pred -----------C--CCc-cc--------------------ccccccccCCCcccCcccccc-CCCCccccchhhHHHHHH
Q 010088 321 -----------D--GSI-CF--------------------EPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLE 365 (518)
Q Consensus 321 -----------~--~~~-~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~e 365 (518)
. +.. .. ........||+||.|||++.. ...+.++||||.|||++-
T Consensus 191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls 270 (418)
T KOG1167|consen 191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS 270 (418)
T ss_pred hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence 0 000 00 011223569999999999864 568899999999999999
Q ss_pred HHhCCccccCCc----chHHHHHHH--------Hhhccc--ccc---------c------cC-CcCCC---------CCC
Q 010088 366 IVTARRAVQDGK----NLVESAQVC--------MASESR--LAE---------L------VD-PRIKD---------SFD 406 (518)
Q Consensus 366 l~tG~~p~~~~~----~~~~~~~~~--------~~~~~~--l~~---------~------~d-~~l~~---------~~~ 406 (518)
+++++.||.... .+.+.+... -...+. +.+ . ++ ..+.. ...
T Consensus 271 lls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~ 350 (418)
T KOG1167|consen 271 LLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGS 350 (418)
T ss_pred hhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccc
Confidence 999999986322 222222111 000011 000 0 00 00000 000
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
......+++++.+|+..||.+|.++++.|+|.++.
T Consensus 351 d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 351 DVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred ccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 01123689999999999999999999999998775
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=213.95 Aligned_cols=167 Identities=28% Similarity=0.321 Sum_probs=128.4
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|||.++++..+ .+++|.++..|+.|++.||+||| +.+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc------
Confidence 78999997643 45999999999999999999999 555 999999999999999 9998765332
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
...||+.|||||++.+..++.++|||||||++|||+||+.||................... . ++... .....
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---~-~~~~~-~~~~~ 134 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA---D-DPRDR-SNLES 134 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc---C-Ccccc-ccHHH
Confidence 1258999999999999999999999999999999999999997554433333322211110 0 01000 01112
Q ss_pred HHH--HHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 409 QLR--TIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 409 ~~~--~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
... .+.+++..||+.+|.+||++.|++++++..
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 222 589999999999999999999999998763
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=218.60 Aligned_cols=261 Identities=24% Similarity=0.258 Sum_probs=193.6
Q ss_pred hhhhhhcceecceEEEEEEecCC--cEEEEEEeccccchhHHHHHHHHHHHHHcCC----CCeeeEeeee-eecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDG--SLIAVKRMDKISEQVEGDFCREIELLARLHH----RHLVALRGFC-IEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~lV 242 (518)
+...+.||+|+||.||++...+. ..+|+|.-..........+..|+.++..+.. .++..+++.. ......++|
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV 99 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV 99 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence 34567899999999999987553 4788887654433322367889999999973 6899999988 477788999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC-----CcEEEeeccccc
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-----FVAKLADFGLAH 317 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-----~~~kl~DfGla~ 317 (518)
|+.+ |.+|.++........++..+.++|+.|++.+|++|| +.|++||||||.|+++... ..+.|.|||+++
T Consensus 100 M~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 100 MSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred Eecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9977 789999886655567999999999999999999999 9999999999999999764 469999999998
Q ss_pred --cCCCCCc----ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc
Q 010088 318 --ASKDGSI----CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 391 (518)
Q Consensus 318 --~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (518)
....... .........+||.+|++++...+...+.+.|+||++.++.|++.|..||.................
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~- 254 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR- 254 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh-
Confidence 3222111 111112456799999999999999999999999999999999999999965443222111110000
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 392 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 392 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
...... +.......+.++...+-..+..++|....+...+....
T Consensus 255 --~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 255 --KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred --hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 001110 11112245666777777789999999999988875543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-26 Score=211.90 Aligned_cols=249 Identities=19% Similarity=0.383 Sum_probs=191.1
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEec--cccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
-+|..+|.+...|..|+|+|+ |..+++|++. .......++|..|.-.|+-+.||||+.++|.|.......++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 345668999999999999996 4455566653 4445556789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
.|+|+..|++.....++-.++.+++.++|+|++|||+. ++-|.---|.+..|+||++.+++|+--. ++. .+
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad-~kf------sf- 341 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMAD-TKF------SF- 341 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheeccc-cee------ee-
Confidence 99999999987766678889999999999999999975 4555556799999999999998885211 111 11
Q ss_pred cccccccCCCcccCccccccCCCC---ccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELT---EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~---~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
......-.+.||+||.++..+-+ .++|+|||.++||||.|...||.+-.+..--.... . + .++..
T Consensus 342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia--l-----e----glrv~ 409 (448)
T KOG0195|consen 342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA--L-----E----GLRVH 409 (448)
T ss_pred -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh--h-----c----ccccc
Confidence 11223347899999999775533 57999999999999999999998654432111111 1 1 12223
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.++.....+.+++.-|+..||.+||.+..++-.|+.
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 333444678899999999999999999999887753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=221.95 Aligned_cols=173 Identities=18% Similarity=0.155 Sum_probs=130.2
Q ss_pred hhhhhhcceecceEEEEEEec--CCcEEEEEEeccc-----cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS--DGSLIAVKRMDKI-----SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
+.+.++||+|+||+||+|++. ++..||||++... .......|.+|+++|.+++|+|++..+.. .+..++|
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LV 96 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLV 96 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEE
Confidence 345668999999999999875 5778899986532 12234569999999999999999853322 2468999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceeccc-CCCcEEecCCCcEEEeeccccccCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI-KSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl-k~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
|||++|++|... ... . ...++.+++.+|+||| +.+|+|||| ||+|||++.++.+||+|||+|+....
T Consensus 97 mE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 97 RGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred EEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 999999999732 211 1 1467889999999999 899999999 99999999999999999999987654
Q ss_pred CCcccc----cccccccCCCcccCccccccCC------CCccccch
Q 010088 322 GSICFE----PVNTDIRGTPGYMDPEYVVTQE------LTEKSDVY 357 (518)
Q Consensus 322 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVw 357 (518)
...... ...+...+++.|+|||++.... .+..+|-|
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 331111 1124567899999999986432 23346666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-22 Score=201.83 Aligned_cols=258 Identities=32% Similarity=0.471 Sum_probs=196.6
Q ss_pred hhhhcceecceEEEEEEecCCcEEEEEEeccccch---hHHHHHHHHHHHHHcCCC-CeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ---VEGDFCREIELLARLHHR-HLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
..+.||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ |++++.+++......+++++|+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 3457999999999999876 78899988643322 467899999999999988 79999999977777899999999
Q ss_pred CCCHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC-cEEEeeccccccCCCCCcc
Q 010088 248 NGSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-VAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 248 ~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~ 325 (518)
+++|.+++..... ..+.......+..+++.+++|+| ..+++|||+||+||+++..+ .++++|||+++........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999977765432 25888999999999999999999 88999999999999999988 7999999999855443211
Q ss_pred cc--cccccccCCCcccCcccccc---CCCCccccchhhHHHHHHHHhCCccccCCcc---hHHHHHHHHhhcccccccc
Q 010088 326 FE--PVNTDIRGTPGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGKN---LVESAQVCMASESRLAELV 397 (518)
Q Consensus 326 ~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~---~~~~~~~~~~~~~~l~~~~ 397 (518)
.. .......|+..|++||.+.+ ..+....|+||+|++++++++|..|+..... .............. ..
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~ 235 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---SL 235 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---cc
Confidence 11 12356779999999999987 5788999999999999999999999754443 22222222211111 00
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI 437 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~ 437 (518)
...............+.+++..|+..+|..|.++.+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0011111001223568889999999999999999987765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-23 Score=226.09 Aligned_cols=260 Identities=22% Similarity=0.228 Sum_probs=188.9
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEec-----cccchh-HHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMD-----KISEQV-EGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~-----~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
.+++|.|.+|.|+..... .....+.|... ...... ...+..|+.+-..++|+|++..+..+.+....+-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 458999999977776432 33434444322 111111 11255677788888999999988888887777777999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
|++ +|..++...+ .++..++..++.|+..|++||| ..||.|||||++|++++.+|.+||+|||.+....-+...
T Consensus 403 ~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 403 CPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred ccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 999 9999998642 4888889999999999999999 999999999999999999999999999999866544322
Q ss_pred cccccccccCCCcccCccccccCCCCcc-ccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEK-SDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.........|...|+|||.+.+..|.+. .||||.|+++..|++|+.||............ .... .+.....-...
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-~~~~---~~~~~~~~~~~ 552 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-NNYS---DQRNIFEGPNR 552 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-hccc---cccccccChHH
Confidence 2235567889999999999999999874 79999999999999999999632221111000 0000 00000000001
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
...........++.++|+.||.+|-++++|++.-|...
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 11233456788999999999999999999999776654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-22 Score=185.08 Aligned_cols=138 Identities=20% Similarity=0.204 Sum_probs=107.5
Q ss_pred hhcceecceEEEEEEecCCcEEEEEEeccccch--h-------HHH-----------------HHHHHHHHHHcCCCCee
Q 010088 174 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ--V-------EGD-----------------FCREIELLARLHHRHLV 227 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~niv 227 (518)
..||+|+||.||+|...+|+.||||+++..... . ... ..+|++.|.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 479999999999999888999999998643210 0 112 23499999999887764
Q ss_pred eEeeeeeecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCceecccCCCcEEecCCC
Q 010088 228 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL-HFYCDPPLCHRDIKSSNILLDENF 306 (518)
Q Consensus 228 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDlk~~NILl~~~~ 306 (518)
....+. ....++||||+++++|...+.. ..++++....+++.|++.+|.|| | ..+|+||||||+|||++ ++
T Consensus 83 ~p~~~~--~~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 83 CPEPIL--LKSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCcEEE--ecCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence 332221 2234899999999877655332 23588999999999999999999 7 78999999999999998 47
Q ss_pred cEEEeeccccccC
Q 010088 307 VAKLADFGLAHAS 319 (518)
Q Consensus 307 ~~kl~DfGla~~~ 319 (518)
.++|+|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-22 Score=182.30 Aligned_cols=263 Identities=21% Similarity=0.298 Sum_probs=194.7
Q ss_pred HhhhhhhhcceecceEEEEEEe-cCCcEEEEEEeccccchhHHHHHHHHHHHHHcCC-CCeeeEeeeeeecCceEEEEEe
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHH-RHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~ 245 (518)
..+.+.+.||.|+||.+|.|.. .+|..||||.=.. .....++..|.++...|+| ..|..+..|..+++.-.+|||.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 3455667899999999999964 5799999996433 2333567889999999975 7788888888899999999998
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec---CCCcEEEeeccccccCCCC
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DfGla~~~~~~ 322 (518)
+ |.||.++..-.. ..++..+.+-++-|++.-++|+| .+++|||||||+|+|.. ....+.++|||||+...+.
T Consensus 93 L-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred c-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 8 789999886433 24889999999999999999999 89999999999999996 3457899999999866443
Q ss_pred Cccc---ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCC
Q 010088 323 SICF---EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 399 (518)
Q Consensus 323 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~ 399 (518)
.... ........||.+|.+-....+...+.+.|+-|+|.+|.....|..||++-.............+..+.-.+ .
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i-e 246 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI-E 246 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH-H
Confidence 2111 11234567999999999888888899999999999999999999999864332221111111111111000 1
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH---HHHHhhcCC
Q 010088 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQ---VLRILYESS 442 (518)
Q Consensus 400 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~e---vl~~L~~~~ 442 (518)
.+...++ .++.-.+..|-....++-|+..- +.+.|+...
T Consensus 247 ~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 247 VLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred HHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 1222333 45777889999999999999754 445555443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-22 Score=204.99 Aligned_cols=215 Identities=27% Similarity=0.414 Sum_probs=162.6
Q ss_pred HHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCc-eecccC
Q 010088 218 LARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL-CHRDIK 296 (518)
Q Consensus 218 l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-iHrDlk 296 (518)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+... ...++|.-...+.++|+.||+||| ..+| .|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeec
Confidence 35678999999999999999999999999999999999863 456999999999999999999999 5555 899999
Q ss_pred CCcEEecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccC-------CCCccccchhhHHHHHHHHhC
Q 010088 297 SSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-------ELTEKSDVYSYGVVLLEIVTA 369 (518)
Q Consensus 297 ~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDVwS~Gvll~el~tG 369 (518)
++|+++|..+.+||+|||+........ .........-..-|.|||.+... ..+.+.||||||++++|+++.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~--~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETA--EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccc--cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 999999999999999999987654210 00111222345579999998763 146789999999999999999
Q ss_pred CccccCCcchH---HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 370 RRAVQDGKNLV---ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 370 ~~p~~~~~~~~---~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
+.||....... +....... .-...+.|.+.... +....+..++..||..+|.+||+++++-..+.....
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~---~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK---GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHh---cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99997533222 22222111 11222333332111 333468999999999999999999999887765443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=186.19 Aligned_cols=253 Identities=21% Similarity=0.293 Sum_probs=188.3
Q ss_pred hhhhcceecceEEEEEEe-cCCcEEEEEEeccccchhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 172 FSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
..++||+|+||..+.|+. -+++.||||.=...+ ...++..|.+..+.|. .++|..++.|..++..-.||+|.+ |-
T Consensus 32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP 108 (449)
T KOG1165|consen 32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP 108 (449)
T ss_pred eccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence 456899999999999964 479999999543322 2346778888888885 699999999988888999999988 77
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-----CCcEEEeeccccccCCCCCc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-----NFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~kl~DfGla~~~~~~~~ 324 (518)
||+++..-.+ ..++..++..||+|++.-++|+| ++.+|+|||||+|+||.. ...+.|+|||+|+...+...
T Consensus 109 SLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 109 SLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred CHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 9988876443 35999999999999999999999 999999999999999963 44789999999997755442
Q ss_pred ccc---cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCc--chHHHHHHHHhhccccccccCC
Q 010088 325 CFE---PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK--NLVESAQVCMASESRLAELVDP 399 (518)
Q Consensus 325 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~--~~~~~~~~~~~~~~~l~~~~d~ 399 (518)
... .......||.+||+-....+.+.+.+.|+-|+|-+++..+.|..||+.-+ +..+..+.+ ....+...+ .
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI-Ge~Kr~T~i--~ 261 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI-GETKRSTPI--E 261 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh-ccccccCCH--H
Confidence 211 12334679999999999999999999999999999999999999998533 222222211 111110000 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 400 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
.+...+ +.++...+...-..+..+-|+.+-+...+
T Consensus 262 ~Lc~g~----P~efa~Yl~yvR~L~F~E~PDYdylr~Lf 296 (449)
T KOG1165|consen 262 VLCEGF----PEEFATYLRYVRRLDFFETPDYDYLRKLF 296 (449)
T ss_pred HHHhcC----HHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 111222 34566666666677889999986554443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=184.79 Aligned_cols=168 Identities=15% Similarity=0.163 Sum_probs=129.1
Q ss_pred hhhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhH---HH------HHHHHHHHHHcCCCCeeeEeeeeeec---
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVE---GD------FCREIELLARLHHRHLVALRGFCIEK--- 236 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~---~~------~~~E~~~l~~l~H~niv~l~g~~~~~--- 236 (518)
.+...++||.|+||.||.... ++..+|||.+........ .. |.+|+..+.+++|++|..+.+++...
T Consensus 32 ~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~ 110 (232)
T PRK10359 32 NIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERK 110 (232)
T ss_pred ceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccc
Confidence 344457899999999999765 577899999864322221 22 68999999999999999998886543
Q ss_pred -----CceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEe
Q 010088 237 -----RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA 311 (518)
Q Consensus 237 -----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 311 (518)
...++||||++|.+|.++.. ++. ....+++.+|..+| ..+++|||+||+||++++++ ++|+
T Consensus 111 ~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 111 TLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred cccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEE
Confidence 35799999999999988742 222 34568999999999 99999999999999999988 9999
Q ss_pred eccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHH
Q 010088 312 DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 367 (518)
Q Consensus 312 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~ 367 (518)
|||........... ..++....+..++|+|+||+++.-+.
T Consensus 177 Dfg~~~~~~e~~a~----------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAK----------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhH----------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99987654322110 01344556778999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.4e-21 Score=177.57 Aligned_cols=139 Identities=22% Similarity=0.237 Sum_probs=110.0
Q ss_pred hhcceecceEEEEEEecCCcEEEEEEeccccch--------------------------hHHHHHHHHHHHHHcCCCCee
Q 010088 174 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ--------------------------VEGDFCREIELLARLHHRHLV 227 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~H~niv 227 (518)
..||+|+||+||+|+..+|+.||||+++..... ....+.+|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 469999999999999878999999998643210 012245799999999999875
Q ss_pred eEeeeeeecCceEEEEEecCCCCHHHH-hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCceecccCCCcEEecCC
Q 010088 228 ALRGFCIEKRERFLMYEYMANGSLKDH-LHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDEN 305 (518)
Q Consensus 228 ~l~g~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiHrDlk~~NILl~~~ 305 (518)
....+... ..+|||||++++++... +.. ..++.....+++.+++.+|.+|| . .+|+||||||+|||++ +
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence 44443332 34899999998865443 432 34778889999999999999999 7 8999999999999999 8
Q ss_pred CcEEEeeccccccCCC
Q 010088 306 FVAKLADFGLAHASKD 321 (518)
Q Consensus 306 ~~~kl~DfGla~~~~~ 321 (518)
+.++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-22 Score=217.41 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=179.2
Q ss_pred hhhhhcceecceEEEEEEecCCcEEEEEEecccc-chhHHHHHHHHHH--HHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS-EQVEGDFCREIEL--LARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.||++.|=+|.+|+.++|. |+||++-+.. .-..+.|.++++- ...++|||.+++..+-......|||-+|..
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk 104 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK 104 (1431)
T ss_pred eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence 45678999999999999997776 8889875432 3334445444443 445589999999988777778899999996
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccC--CC-CCc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS--KD-GSI 324 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~--~~-~~~ 324 (518)
+ +|+|.|..+ .-+...+.+-|+.|++.||..+| ..+|+|||||.+||||+.-+-+.|+||.--+.. .+ ...
T Consensus 105 h-nLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 105 H-NLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred h-hhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 6 999999763 34677788889999999999999 999999999999999999999999999755421 11 111
Q ss_pred ccccccccccCCCcccCccccccC----------C-CCccccchhhHHHHHHHHhCCccccCCcchHHHHHH-HHhhccc
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQ----------E-LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV-CMASESR 392 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~-~~~~~~~ 392 (518)
.+.........-..|+|||.+... . .+++.||||+||+++||++-..|..+-..+..+... ....+.-
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 111122233345689999988541 2 678899999999999999865554332222221111 0001111
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 393 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 393 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+.++-|+ .+..++..|++.||++|.++++.|+.-...
T Consensus 259 Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 259 LEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred HHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 2222222 467899999999999999999999974433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.9e-20 Score=170.81 Aligned_cols=184 Identities=17% Similarity=0.123 Sum_probs=137.0
Q ss_pred hhcceecceEEEEEEecCCcEEEEEEeccccchh----HHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEEecCC
Q 010088 174 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQV----EGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
..|++|+||+||.+.. ++..++.+.+.....-. ...|.+|+++|.+|. |+++.+++++ +..+++|||+.|
T Consensus 8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 4799999999997765 67888877776433211 124789999999995 5889999886 457999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceeccc-CCCcEEecCCCcEEEeeccccccCCCCCcc--
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI-KSSNILLDENFVAKLADFGLAHASKDGSIC-- 325 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl-k~~NILl~~~~~~kl~DfGla~~~~~~~~~-- 325 (518)
.+|...+.. ....++.+++.+|+++| ..||+|||| ||.|||++.++.++|+|||+|.........
T Consensus 83 ~~L~~~~~~---------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 83 AAMYQRPPR---------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred ccHHhhhhh---------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 999765421 11357789999999999 999999999 799999999999999999999865433210
Q ss_pred ---ccc----ccccccCCCcccCccccccC-CCC-ccccchhhHHHHHHHHhCCcccc
Q 010088 326 ---FEP----VNTDIRGTPGYMDPEYVVTQ-ELT-EKSDVYSYGVVLLEIVTARRAVQ 374 (518)
Q Consensus 326 ---~~~----~~~~~~gt~~y~aPE~~~~~-~~~-~~sDVwS~Gvll~el~tG~~p~~ 374 (518)
... ...-...++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+..
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 000 01122367778888754321 222 45688899999999999998764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-21 Score=198.88 Aligned_cols=225 Identities=24% Similarity=0.313 Sum_probs=178.8
Q ss_pred hcceecceEEEEEE----ecCCcEEEEEEeccccch--hHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEEecC
Q 010088 175 IIGQGGFGTVYKAQ----FSDGSLIAVKRMDKISEQ--VEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
++|+|.||.|+.++ .+.|..+|.|.+++.... .......|..++..++ |+.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999763 235778899887653321 1124567888999997 9999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+|.|...+.... .++......+...++-+++++| +.+|+|||+|++||+++.+|.+|+.|||+.+..-+...
T Consensus 81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 999999887643 4777777788889999999999 99999999999999999999999999999986544331
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
.+||..|||||++. .....+|.||||++++||+||..||.. +....+...+ -.++.
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~------------~~~p~ 208 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAE------------LEMPR 208 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhc------------cCCch
Confidence 27999999999987 567889999999999999999999975 2233222221 12333
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSI 431 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~ 431 (518)
+......+++..++..+|.+|--.
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 444556778888888899888654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=169.26 Aligned_cols=132 Identities=15% Similarity=0.185 Sum_probs=104.3
Q ss_pred hhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHc-----CCCCeeeEeeeeeecC---c-eEEEEE
Q 010088 174 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL-----HHRHLVALRGFCIEKR---E-RFLMYE 244 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~lV~e 244 (518)
+.||+|+||.||. .-.++.. +||++........+.+.+|+.++..+ .||||++++|++.++. . ..+|+|
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 4799999999996 2224444 79988654444567899999999999 5799999999998864 3 337899
Q ss_pred e--cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCceecccCCCcEEecC----CCcEEEeeccc
Q 010088 245 Y--MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL-EYLHFYCDPPLCHRDIKSSNILLDE----NFVAKLADFGL 315 (518)
Q Consensus 245 ~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~iiHrDlk~~NILl~~----~~~~kl~DfGl 315 (518)
| +.+|+|.+++.+. .+++. ..++.+++.++ +||| +.+|+||||||+|||++. ++.++|+||+.
T Consensus 86 ~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 86 FDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred CCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 9 5589999999652 25555 35678888888 9999 999999999999999973 34899999553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-19 Score=173.30 Aligned_cols=228 Identities=21% Similarity=0.277 Sum_probs=146.1
Q ss_pred hhhcceecceEEEEEEecC-CcEEEEEEecc---ccchhHHHHHHHHHHHHHcCC----------CCeeeEeeeee----
Q 010088 173 STIIGQGGFGTVYKAQFSD-GSLIAVKRMDK---ISEQVEGDFCREIELLARLHH----------RHLVALRGFCI---- 234 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~~---- 234 (518)
.+.||.|+++.||.+++.+ |+.+|||.... ......+++.+|.-....+.+ -.++--++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 4589999999999999864 89999998742 233445667777655555322 12222222111
Q ss_pred -----ecC--------ceEEEEEecCCCCHHHHhcC---CC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccC
Q 010088 235 -----EKR--------ERFLMYEYMANGSLKDHLHS---PG--RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIK 296 (518)
Q Consensus 235 -----~~~--------~~~lV~e~~~~gsL~~~l~~---~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk 296 (518)
... ..+++|+-+ .+||.+++.. .. ...+....++.+..|+.+.+++|| ..|++|+|||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecccc
Confidence 111 336677777 4688887541 11 123445567788899999999999 8999999999
Q ss_pred CCcEEecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCcccccc--------CCCCccccchhhHHHHHHHHh
Q 010088 297 SSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT--------QELTEKSDVYSYGVVLLEIVT 368 (518)
Q Consensus 297 ~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDVwS~Gvll~el~t 368 (518)
|+|++++.+|.++|+||+.....+... .....+..|.+||.... -.++.+.|.|++|+++|.|++
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~-------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRY-------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEE-------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred eeeEEEcCCCCEEEcChHHHeecCcee-------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 999999999999999999776543321 11334578999997643 257889999999999999999
Q ss_pred CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCC
Q 010088 369 ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQAR 428 (518)
Q Consensus 369 G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~R 428 (518)
|+.|+........ . +..+. .+. +.++.+..+|..+|+.+|.+|
T Consensus 246 ~~lPf~~~~~~~~------------~---~~~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEAD------------P---EWDFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGST------------S---GGGGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCcccc------------c---cccch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999974321100 0 00122 333 667889999999999999988
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=165.03 Aligned_cols=134 Identities=21% Similarity=0.327 Sum_probs=113.6
Q ss_pred hhcceecceEEEEEEecCCcEEEEEEeccccc--------hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 174 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISE--------QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.||+|++|.||+|.+ +|..+++|+...... .....+.+|++++..++|+|+.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 3699999999999987 677899997643221 1124578899999999999998877777777889999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccccc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~ 318 (518)
++|++|.+++... .+ .+..++.+++.+|++|| ..+++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998642 22 78899999999999999 89999999999999999 78999999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-18 Score=162.17 Aligned_cols=130 Identities=22% Similarity=0.322 Sum_probs=107.3
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccc--------hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISE--------QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
+||+|+||+||+|.+ +|..+++|....... .....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 678899998643211 11255778999999999887665555666677789999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~ 318 (518)
+|++|.+++..... .++.+++.+|++|| +.+++|||++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998864211 78999999999999 89999999999999999 78999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.8e-18 Score=165.40 Aligned_cols=140 Identities=19% Similarity=0.169 Sum_probs=108.6
Q ss_pred hhhhhhcceecceEEEEEE--ecCCcEEEEEEeccccch------------------------hHHHHHHHHHHHHHcCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQ--FSDGSLIAVKRMDKISEQ------------------------VEGDFCREIELLARLHH 223 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H 223 (518)
+.+.+.||+|+||.||+|. ..+|+.||+|.++..... ....+.+|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3455789999999999998 458999999988632110 11235689999999975
Q ss_pred C--CeeeEeeeeeecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-ceecccCCCcE
Q 010088 224 R--HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP-LCHRDIKSSNI 300 (518)
Q Consensus 224 ~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-iiHrDlk~~NI 300 (518)
. .+.+++++ ...++||||+++++|...+... ..+.......++.|++.+|+||| ..+ |+||||||+||
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI 180 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI 180 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence 3 34445543 2358999999998887765322 23556667899999999999999 888 99999999999
Q ss_pred EecCCCcEEEeeccccccC
Q 010088 301 LLDENFVAKLADFGLAHAS 319 (518)
Q Consensus 301 Ll~~~~~~kl~DfGla~~~ 319 (518)
+++ ++.++|+|||++...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 889999999998743
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=167.65 Aligned_cols=199 Identities=23% Similarity=0.331 Sum_probs=140.7
Q ss_pred CCCCeeeEeeeeeec---------------------------CceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHH
Q 010088 222 HHRHLVALRGFCIEK---------------------------RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAID 274 (518)
Q Consensus 222 ~H~niv~l~g~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 274 (518)
+|||||++.++|.+. ...|+||.-.+. +|.+++-.+. .+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence 599999999887642 246899987754 9999997543 556667778999
Q ss_pred HHHHHHHHhhcCCCCceecccCCCcEEe--cCCC--cEEEeeccccccCCCCCcc--cccccccccCCCcccCccccccC
Q 010088 275 VANALEYLHFYCDPPLCHRDIKSSNILL--DENF--VAKLADFGLAHASKDGSIC--FEPVNTDIRGTPGYMDPEYVVTQ 348 (518)
Q Consensus 275 ia~gL~yLH~~~~~~iiHrDlk~~NILl--~~~~--~~kl~DfGla~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~ 348 (518)
+++|+.||| .++|.|||+|++|||| |+|+ .+.|+|||.+-........ +..-.....|...-||||+....
T Consensus 350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999 9999999999999998 3444 6789999988644332211 12223345678889999988543
Q ss_pred C------CCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccc
Q 010088 349 E------LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQ 422 (518)
Q Consensus 349 ~------~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~ 422 (518)
+ --.|+|.|+.|.+.||+++...||..........+. ..+---|.+.+..+ ..+.+++...++
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-------Yqe~qLPalp~~vp----p~~rqlV~~lL~ 495 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-------YQESQLPALPSRVP----PVARQLVFDLLK 495 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-------hhhhhCCCCcccCC----hHHHHHHHHHhc
Confidence 2 235899999999999999999999752211111111 11111133333333 457889999999
Q ss_pred cCCCCCCCHHHHHHHh
Q 010088 423 REGQARPSIKQVLRIL 438 (518)
Q Consensus 423 ~dp~~RPs~~evl~~L 438 (518)
.||++|++..-..+.|
T Consensus 496 r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 496 RDPSKRVSPNIAANVL 511 (598)
T ss_pred CCccccCCccHHHhHH
Confidence 9999999976555544
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=5e-18 Score=159.53 Aligned_cols=137 Identities=17% Similarity=0.160 Sum_probs=108.5
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccc----------------------hhHHHHHHHHHHHHHcCCCC--
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISE----------------------QVEGDFCREIELLARLHHRH-- 225 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~n-- 225 (518)
+...+.||+|+||.||++...+|+.||||++..... .....+.+|+.++..+.|.+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 445678999999999999988899999998653210 01123678999999998874
Q ss_pred eeeEeeeeeecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC
Q 010088 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 305 (518)
Q Consensus 226 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 305 (518)
+...++. ...++||||+++++|...... .....++.+++.++.++| ..+|+||||||+||+++++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCC
Confidence 4445443 456899999999999776431 245678899999999999 8999999999999999999
Q ss_pred CcEEEeeccccccCCC
Q 010088 306 FVAKLADFGLAHASKD 321 (518)
Q Consensus 306 ~~~kl~DfGla~~~~~ 321 (518)
+.++|+|||++.....
T Consensus 162 ~~~~liDfg~~~~~~~ 177 (198)
T cd05144 162 EKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcEEEEECCccccCCC
Confidence 9999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.7e-18 Score=182.83 Aligned_cols=131 Identities=21% Similarity=0.328 Sum_probs=108.7
Q ss_pred hhhcceecceEEEEEEecCCcEEEEEE-eccc-c------chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 173 STIIGQGGFGTVYKAQFSDGSLIAVKR-MDKI-S------EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~~g~~vavK~-~~~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
.++||+|+||+||+|.+.+.. +++|+ +.+. . ......+.+|++++.+++|+|++....++......++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 468999999999999885443 44443 2211 1 1123568899999999999999988888888788899999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccccc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~ 318 (518)
|+++++|.+++. ....++.+++.+|+||| +.+++||||||+|||+ +++.++|+|||+++.
T Consensus 417 ~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 417 YIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999885 35688999999999999 8999999999999999 677999999999874
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.7e-18 Score=186.50 Aligned_cols=238 Identities=19% Similarity=0.252 Sum_probs=170.7
Q ss_pred hhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcC---CCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 173 STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH---HRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
...||+|+||+||+|...+|+.||+|+=+..+. -+|.-=.+++.+|+ -+-|..+...+.-.+..+||+||.+.|
T Consensus 703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~G 779 (974)
T KOG1166|consen 703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYG 779 (974)
T ss_pred EeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccc
Confidence 357999999999999998899999997543221 12222234445554 234444555555667889999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec-------CCCcEEEeeccccccC---
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-------ENFVAKLADFGLAHAS--- 319 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-------~~~~~kl~DfGla~~~--- 319 (518)
+|.++++. ...++|...+.++.|+++.+++|| ..+|||+||||+|+||. ++..++|+|||.+-..
T Consensus 780 tlld~~N~--~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lf 854 (974)
T KOG1166|consen 780 TLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLF 854 (974)
T ss_pred cHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEc
Confidence 99999984 345999999999999999999999 89999999999999993 3457999999988643
Q ss_pred CCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCC
Q 010088 320 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 399 (518)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~ 399 (518)
.++. .....++|-.+-.+|...+..++..+|.|.|..+++-|+-|+..-. .... ...++.
T Consensus 855 p~~~-----~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~------------~~g~---~~~~~~ 914 (974)
T KOG1166|consen 855 PDGT-----KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV------------KNGS---SWMVKT 914 (974)
T ss_pred CCCc-----EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh------------cCCc---ceeccc
Confidence 2321 3355678899999999999999999999999999999999965321 0010 111222
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 400 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.++..+..+ .+-++...+|..|-..=|...++...+++.
T Consensus 915 ~~~Ry~~~~---~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 915 NFPRYWKRD---MWNKFFDLLLNPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred cchhhhhHH---HHHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence 222222222 344566666665555557777777766554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.7e-19 Score=178.33 Aligned_cols=173 Identities=25% Similarity=0.404 Sum_probs=130.2
Q ss_pred ceEEEEEecCCCCHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccc
Q 010088 238 ERFLMYEYMANGSLKDHLHSP-GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 316 (518)
Q Consensus 238 ~~~lV~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla 316 (518)
..|+.|++|...+|.++|... .....+|.....++.|++.|++| ++.+|||+||.||+...+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999643 34557889999999999999999 58999999999999999999999999998
Q ss_pred ccCCCCCccc--ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhcccc
Q 010088 317 HASKDGSICF--EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRL 393 (518)
Q Consensus 317 ~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l 393 (518)
.......... ....+...||..||+||.+.+..|+.|+||||||++|+||++ -...+.. . ..+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------~--------~t~ 469 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------I--------ATL 469 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------H--------Hhh
Confidence 7654433110 113456789999999999999999999999999999999997 2222210 0 011
Q ss_pred ccc----cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 010088 394 AEL----VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL 435 (518)
Q Consensus 394 ~~~----~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl 435 (518)
.++ ++|....+++ .=..++.+++...|.+||++.++.
T Consensus 470 ~d~r~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 470 TDIRDGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hhhhcCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHHh
Confidence 122 2222222222 234689999999999999555543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=140.37 Aligned_cols=133 Identities=23% Similarity=0.256 Sum_probs=113.3
Q ss_pred hhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCC--CCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 174 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHH--RHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++.+++++....+..+++|||+.++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 468999999999999854 7899998765433 4678999999999976 5999999988888889999999998777
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccccc
Q 010088 252 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318 (518)
Q Consensus 252 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~ 318 (518)
..+ ++.....++.+++.+|++||.....+++|+|++|+||++++++.+++.|||++..
T Consensus 81 ~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 644 5567778899999999999954446899999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=147.26 Aligned_cols=136 Identities=21% Similarity=0.215 Sum_probs=98.3
Q ss_pred hhhcceecceEEEEEEecCCcEEEEEEeccccch--hHHH----------------------HHHHHHHHHHcCCCC--e
Q 010088 173 STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ--VEGD----------------------FCREIELLARLHHRH--L 226 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--i 226 (518)
.+.||+|+||+||+|...+|+.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3579999999999999888999999987642211 1111 135666666665432 4
Q ss_pred eeEeeeeeecCceEEEEEecCCCCHHH-HhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCceecccCCCcEEecC
Q 010088 227 VALRGFCIEKRERFLMYEYMANGSLKD-HLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDE 304 (518)
Q Consensus 227 v~l~g~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiHrDlk~~NILl~~ 304 (518)
.+.+++ ...++||||++++++.. .+.... .. .....++.+++.++.++| . .+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-
Confidence 444443 34689999999954332 121110 11 567789999999999999 7 8999999999999999
Q ss_pred CCcEEEeeccccccCC
Q 010088 305 NFVAKLADFGLAHASK 320 (518)
Q Consensus 305 ~~~~kl~DfGla~~~~ 320 (518)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=9.1e-17 Score=174.01 Aligned_cols=204 Identities=25% Similarity=0.434 Sum_probs=140.8
Q ss_pred hhcceecceEEEEEEecC-CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHH
Q 010088 174 TIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK 252 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 252 (518)
++|-.|+||.||..+++. .+.+|.| +++..- +| +||..+-+ ..+.| |+-.
T Consensus 89 klisngAygavylvrh~~trqrfa~k-iNkq~l-----------il-----Rnilt~a~------npfvv------gDc~ 139 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----------IL-----RNILTFAG------NPFVV------GDCA 139 (1205)
T ss_pred EeeccCCCCceeeeeccccccchhhc-ccccch-----------hh-----hccccccC------Cccee------chhh
Confidence 478999999999998864 4667774 322110 11 12222221 22222 6666
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCC--------CCCc
Q 010088 253 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK--------DGSI 324 (518)
Q Consensus 253 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~--------~~~~ 324 (518)
..++..+..+.+ ++.+++||| +.+|+|||+||+|.+|+.-|.+|+.|||+.+... .+.+
T Consensus 140 tllk~~g~lPvd----------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 140 TLLKNIGPLPVD----------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred hhcccCCCCcch----------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 677664443322 278999999 9999999999999999999999999999987421 1111
Q ss_pred cc---ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 325 CF---EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 325 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
.. +-....++||+.|+|||++..+.|+..+|.|++|+|+||.+-|..||..+.. .+.+...+..+..++|- |..+
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelfg~visd~i~wpE~-dea~ 284 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDIEWPEE-DEAL 284 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHHhhhhhhhcccccc-CcCC
Confidence 10 1122346899999999999999999999999999999999999999975432 33333333333333332 2222
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARP 429 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RP 429 (518)
..+..+++...|+.+|..|-
T Consensus 285 --------p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 285 --------PPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred --------CHHHHHHHHHHHHhChHhhc
Confidence 24578899999999999994
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.9e-16 Score=148.23 Aligned_cols=134 Identities=22% Similarity=0.250 Sum_probs=105.7
Q ss_pred hhcc-eecceEEEEEEecCCcEEEEEEecccc-------------chhHHHHHHHHHHHHHcCCCCe--eeEeeeeeecC
Q 010088 174 TIIG-QGGFGTVYKAQFSDGSLIAVKRMDKIS-------------EQVEGDFCREIELLARLHHRHL--VALRGFCIEKR 237 (518)
Q Consensus 174 ~~lG-~G~~g~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~ 237 (518)
.+|| .||.|+||++.. ++..++||+++... ......+.+|++++.+|+|++| +..+++...+.
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 3788 899999999987 47789999874311 1223467889999999998875 67777654432
Q ss_pred c----eEEEEEecCC-CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEee
Q 010088 238 E----RFLMYEYMAN-GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLAD 312 (518)
Q Consensus 238 ~----~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 312 (518)
. .++||||++| .+|.+++... .++.. .+.+++.+|.+|| +.||+||||||.|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 3599999997 6999998642 34443 3568999999999 99999999999999999989999999
Q ss_pred cccccc
Q 010088 313 FGLAHA 318 (518)
Q Consensus 313 fGla~~ 318 (518)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.6e-15 Score=145.51 Aligned_cols=208 Identities=23% Similarity=0.358 Sum_probs=145.2
Q ss_pred HHHHHHcCCCCeeeEeeeeeecC-----ceEEEEEecCCCCHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 010088 215 IELLARLHHRHLVALRGFCIEKR-----ERFLMYEYMANGSLKDHLHSPG--RTPLSWQTRIQIAIDVANALEYLHFYCD 287 (518)
Q Consensus 215 ~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 287 (518)
..-|-.+.|-|||+++.|+.+.+ ...++.|||..|+|..+|++.. ...+......+|+-||+.||.|||.+ .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 34455667999999999987654 5689999999999999998532 33466777789999999999999976 8
Q ss_pred CCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHH
Q 010088 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 367 (518)
Q Consensus 288 ~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~ 367 (518)
++|+|+++..+-|++..+|-+|+.----......-............+.++|.+||+-...+.+..+|||+||...+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 99999999999999999998887421111000000000011122345678999999988888888999999999999998
Q ss_pred hCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 368 TARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 368 tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
-+.--..++...+...... ...+.-+-++.- ..++..|++.+|..||+|++++.|+
T Consensus 277 ilEiq~tnseS~~~~ee~i---a~~i~~len~lq------------r~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENI---ANVIIGLENGLQ------------RGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccCCCcceeehhhhh---hhheeeccCccc------------cCcCcccccCCCCCCcchhhhhcCc
Confidence 8865433332221111000 000111111111 2378899999999999999998874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.8e-14 Score=151.01 Aligned_cols=140 Identities=23% Similarity=0.233 Sum_probs=100.8
Q ss_pred hhcceecceEEEEEEecCCcEEEEEEeccccch----------------------------------------hHHHHHH
Q 010088 174 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ----------------------------------------VEGDFCR 213 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----------------------------------------~~~~~~~ 213 (518)
+.||.|++|.||+|++.+|+.||||+.+..... .+-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 369999999999999999999999987532100 0113566
Q ss_pred HHHHHHHcC----CCCeeeEeeeee-ecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHH-HHHHHhhcCC
Q 010088 214 EIELLARLH----HRHLVALRGFCI-EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN-ALEYLHFYCD 287 (518)
Q Consensus 214 E~~~l~~l~----H~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~~ 287 (518)
|+..+.+++ |.+-+.+-..+. .....+|||||++|++|.+++..... .+ .+.+++..++. .+..+| .
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHH---h
Confidence 777666663 333334333332 23467999999999999887643211 12 23456666666 467888 8
Q ss_pred CCceecccCCCcEEecCCCcEEEeeccccccCC
Q 010088 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 288 ~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~ 320 (518)
.|++|+|+||.||+++++++++++|||++....
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 899999999999999999999999999987553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.6e-16 Score=167.38 Aligned_cols=259 Identities=25% Similarity=0.266 Sum_probs=185.5
Q ss_pred hhhhcceecceEEEEEEecC--CcEEEEEEecccc--chhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEEec
Q 010088 172 FSTIIGQGGFGTVYKAQFSD--GSLIAVKRMDKIS--EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |.|++.+++...+.+..+++.+|.
T Consensus 24 ~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s 103 (601)
T KOG0590|consen 24 LSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYS 103 (601)
T ss_pred ccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcc
Confidence 44469999999998876533 4456666654332 222333445777777776 999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC-cEEEeeccccccCCC-CCc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-VAKLADFGLAHASKD-GSI 324 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DfGla~~~~~-~~~ 324 (518)
.++++.+.+........+....-.+..|+..++.|+|. ..++.|||+||+|.+++..+ ..|++|||+|..... ...
T Consensus 104 ~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~ 181 (601)
T KOG0590|consen 104 DGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGA 181 (601)
T ss_pred cccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccCCc
Confidence 99999999832222245566677889999999999995 56899999999999999999 999999999987655 221
Q ss_pred ccccccccccC-CCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 325 CFEPVNTDIRG-TPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 325 ~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
........| ++.|+|||...+. -.....|+||.|+++.-+++|..|+.................. .......
T Consensus 182 --~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~ 255 (601)
T KOG0590|consen 182 --ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKG----RFTQLPW 255 (601)
T ss_pred --ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccc----ccccCcc
Confidence 123344567 9999999998874 4567899999999999999999998643221111000000000 0001111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
. .......++...++..+|..|.+.+++-..-+...
T Consensus 256 ~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 256 N----SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred c----cCChhhhhcccccccCCchhccccccccccccccc
Confidence 1 12234667888899999999999999877655443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3e-14 Score=147.72 Aligned_cols=256 Identities=22% Similarity=0.206 Sum_probs=183.7
Q ss_pred HHHHHhhhhhhhcce--ecceEEEEEEe---cCCcEEEEEEecc--ccchhHHHHHHHHHHHHHcC-CCCeeeEeeeeee
Q 010088 164 ETKKATDNFSTIIGQ--GGFGTVYKAQF---SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLH-HRHLVALRGFCIE 235 (518)
Q Consensus 164 ~l~~a~~~f~~~lG~--G~~g~Vy~~~~---~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 235 (518)
+......+....+|. |.+|.||.+.. .++..+|+|+-+. ........=.+|+....+++ |+|.++....+..
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 344444556678999 99999999987 3678899997432 11122223346677777774 9999998888889
Q ss_pred cCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCceecccCCCcEEecCC-CcEEE
Q 010088 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN----ALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKL 310 (518)
Q Consensus 236 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl 310 (518)
.+..++-+|++. .+|..+.+.... .++......+..+... ||.++| ..+++|-|+||.||++..+ ..+++
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred CCcceeeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeec
Confidence 999999999885 799999886543 2555666667777777 999999 9999999999999999999 89999
Q ss_pred eeccccccCCCCCcccccc-cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhh
Q 010088 311 ADFGLAHASKDGSICFEPV-NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS 389 (518)
Q Consensus 311 ~DfGla~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~ 389 (518)
.|||+......+....... .....|...|++||.. .+-++..+|+|++|.+.+|..++......+.+. .|.+
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~----- 337 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQ----- 337 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-Cccc-----
Confidence 9999998887765332111 1222678899999976 456788999999999999999998776544211 1111
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010088 390 ESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI 437 (518)
Q Consensus 390 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~ 437 (518)
+.... +..++.......+...+..+++.++..|++.+.+.++
T Consensus 338 ---~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 338 ---LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ---ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 01111 1111211222345558889999999999999887764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.2e-12 Score=119.28 Aligned_cols=125 Identities=21% Similarity=0.205 Sum_probs=94.3
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCee-eEeeeeeecCceEEEEEecCCCCHHH
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLV-ALRGFCIEKRERFLMYEYMANGSLKD 253 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~gsL~~ 253 (518)
.|+.|.++.||+++.. |..+++|....... ....+.+|+.++..+.+.+++ +++++. ....++||||++|.++..
T Consensus 5 ~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 5 PLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred ecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 5789999999999874 78899998754321 223567899999999765554 444443 334689999999988764
Q ss_pred HhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----ceecccCCCcEEecCCCcEEEeeccccc
Q 010088 254 HLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP-----LCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 254 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
.. . ....++.+++++|+.|| ..+ ++|+|+++.||+++ ++.++++|||.+.
T Consensus 81 ~~-------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 81 ED-------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cc-------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 30 1 11345678999999999 555 59999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.8e-12 Score=133.83 Aligned_cols=139 Identities=18% Similarity=0.216 Sum_probs=92.4
Q ss_pred hhcceecceEEEEEEecC-CcEEEEEEeccccc----------------------------------hhH------HHHH
Q 010088 174 TIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISE----------------------------------QVE------GDFC 212 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~----------------------------------~~~------~~~~ 212 (518)
+-||+|++|.||+|++.+ |+.||||+.+..-. ... -+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 369999999999999987 99999998863210 001 1245
Q ss_pred HHHHHHHHcC----CCCeeeEeeeeee-cCceEEEEEecCCCCHHHH--hcCCCCCCCCHHHHHHHHHHHHH-HHHHHhh
Q 010088 213 REIELLARLH----HRHLVALRGFCIE-KRERFLMYEYMANGSLKDH--LHSPGRTPLSWQTRIQIAIDVAN-ALEYLHF 284 (518)
Q Consensus 213 ~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~--l~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~ 284 (518)
+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.|.++ +...+ .+.. .++...+. -+..+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d~~---~la~~~v~~~~~Qif- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TDMK---LLAERGVEVFFTQVF- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CCHH---HHHHHHHHHHHHHHH-
Confidence 5665555553 3444443333332 4567899999999999874 32221 2222 22222222 123334
Q ss_pred cCCCCceecccCCCcEEecCCC----cEEEeeccccccCCC
Q 010088 285 YCDPPLCHRDIKSSNILLDENF----VAKLADFGLAHASKD 321 (518)
Q Consensus 285 ~~~~~iiHrDlk~~NILl~~~~----~~kl~DfGla~~~~~ 321 (518)
..|++|+|+||.||+++.++ ++++.|||++.....
T Consensus 278 --~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 --RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred --hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 67999999999999999888 999999999876543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=3e-11 Score=114.96 Aligned_cols=141 Identities=23% Similarity=0.294 Sum_probs=111.5
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccc-hhHHHHHHHHHHHHHcCC--CCeeeEeeeeeecC---ceEEEEEecCC
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISE-QVEGDFCREIELLARLHH--RHLVALRGFCIEKR---ERFLMYEYMAN 248 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~e~~~~ 248 (518)
.|+.|..+.||+++..+|..+++|....... ....++.+|++++..+++ .++.+++.++.... ..++||||++|
T Consensus 5 ~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G 84 (223)
T cd05154 5 QLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDG 84 (223)
T ss_pred ecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCC
Confidence 5899999999999887778999998754322 234578899999999975 44677888776643 56899999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC------------------------------------------ 286 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------ 286 (518)
+++.+.+.. ..++...+..++.++++.|.+||...
T Consensus 85 ~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 85 RVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred EecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 988876542 24778888889999999999998421
Q ss_pred -----------CCCceecccCCCcEEecC--CCcEEEeecccccc
Q 010088 287 -----------DPPLCHRDIKSSNILLDE--NFVAKLADFGLAHA 318 (518)
Q Consensus 287 -----------~~~iiHrDlk~~NILl~~--~~~~kl~DfGla~~ 318 (518)
...++|+|+++.||++++ ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.7e-11 Score=123.34 Aligned_cols=227 Identities=17% Similarity=0.179 Sum_probs=150.8
Q ss_pred ecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHH
Q 010088 189 FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTR 268 (518)
Q Consensus 189 ~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~ 268 (518)
..++..|.|...+...........+-++.|+.++||||++++....+++..|+|+|-+. -|..++.+. .....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHHH
Confidence 34788888888776555444557788899999999999999999999999999999884 577777653 34556
Q ss_pred HHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccC
Q 010088 269 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 348 (518)
Q Consensus 269 ~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 348 (518)
.-.+.||+.||.|||+ +.+++|++|.-+.|+++..|..||++|.++........ ......--..|..|+.+...
T Consensus 107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----ccccchhhhcccChhhcCcc
Confidence 6678899999999985 66899999999999999999999999998764332110 01111122346666654322
Q ss_pred CCCccccchhhHHHHHHHHhCCccccCC---cchHH-HHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccC
Q 010088 349 ELTEKSDVYSYGVVLLEIVTARRAVQDG---KNLVE-SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQRE 424 (518)
Q Consensus 349 ~~~~~sDVwS~Gvll~el~tG~~p~~~~---~~~~~-~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~d 424 (518)
. -..|.|-||++++|++.|..+-... ..... .....+. ..+.....+. .. .++++..|....
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~-----k~~~~~~~~r------~n-~~~~~~~~~~~~ 246 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYC-----KKLGATELKR------PN-KLRFILECRLLG 246 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHH-----HHhccccccc------cc-hhhHHHHHHhcc
Confidence 2 3569999999999999993221100 00000 0000000 0000000000 01 455777777777
Q ss_pred CCCCCCHHHHHHHhhcCC
Q 010088 425 GQARPSIKQVLRILYESS 442 (518)
Q Consensus 425 p~~RPs~~evl~~L~~~~ 442 (518)
+--|=.+-+++..|++..
T Consensus 247 gff~n~fvd~~~fLeel~ 264 (690)
T KOG1243|consen 247 GFFRNDFVDTLLFLEELR 264 (690)
T ss_pred ccccchHHHHHHHHHhcc
Confidence 777777777777776643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.7e-10 Score=107.03 Aligned_cols=135 Identities=15% Similarity=0.167 Sum_probs=98.4
Q ss_pred hcceecceEEEEEEecC-------CcEEEEEEeccc-------------c---------chhHHHHH----HHHHHHHHc
Q 010088 175 IIGQGGFGTVYKAQFSD-------GSLIAVKRMDKI-------------S---------EQVEGDFC----REIELLARL 221 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~~l 221 (518)
.||.|--+.||.|.-.+ +..+|||..+.. . ......+. +|++.|.++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 68999999999997543 479999975310 0 01122233 799999999
Q ss_pred CC--CCeeeEeeeeeecCceEEEEEecCCCCHHH-HhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCceecccCC
Q 010088 222 HH--RHLVALRGFCIEKRERFLMYEYMANGSLKD-HLHSPGRTPLSWQTRIQIAIDVANALEYL-HFYCDPPLCHRDIKS 297 (518)
Q Consensus 222 ~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDlk~ 297 (518)
.. -++...+++ ..-++||||+.++.+.. .++. ..++..+...+..+++.+|.+| | ..+|+|+||++
T Consensus 84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~ 153 (197)
T cd05146 84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE 153 (197)
T ss_pred HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence 53 566667664 56789999997654422 2322 1244556677889999999999 7 88999999999
Q ss_pred CcEEecCCCcEEEeeccccccCC
Q 010088 298 SNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 298 ~NILl~~~~~~kl~DfGla~~~~ 320 (518)
.|||+++ +.+.|+|||.+....
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEEC-CcEEEEECCCceeCC
Confidence 9999974 679999999887544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=7.3e-12 Score=130.12 Aligned_cols=241 Identities=20% Similarity=0.242 Sum_probs=172.4
Q ss_pred hhhhcceecceEEEEEEec--CCcEEEEEEeccccchhHHH--HHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEec
Q 010088 172 FSTIIGQGGFGTVYKAQFS--DGSLIAVKRMDKISEQVEGD--FCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
+...||.|.|+.|++...+ ++..|++|.+.+.......+ -..|+.+...+ .|.++++....+..-...|+--|||
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 3457999999999998644 57899999876533322222 34677777777 4899998887777777888999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC-CcEEEeeccccccCCCCCcc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DfGla~~~~~~~~~ 325 (518)
+++++...+.- ...++...++++..+++.++.++| ++.++|+|+||+||++..+ +..++.|||++....-..
T Consensus 349 ~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-- 421 (524)
T KOG0601|consen 349 EGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-- 421 (524)
T ss_pred cCcchhhhhHH--HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccceec--
Confidence 99998877632 334777888999999999999999 9999999999999999886 889999999986422111
Q ss_pred cccccccccCCCccc--CccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 326 FEPVNTDIRGTPGYM--DPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
....+.-+++ +++......+..+.|++|||.-+.|.+++..--..+..+ ..+ ..-.-+....
T Consensus 422 -----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i--------~~~~~p~~~~ 485 (524)
T KOG0601|consen 422 -----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTI--------RSGDTPNLPG 485 (524)
T ss_pred -----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eee--------ecccccCCCc
Confidence 1122334444 455555678889999999999999999986543332221 110 1101111221
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.. ..+..+.+.+...++..||.+.++..+..+
T Consensus 486 ----~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 486 ----LK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ----hH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11 446677788889999999999988776654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.1e-10 Score=103.20 Aligned_cols=131 Identities=26% Similarity=0.374 Sum_probs=100.3
Q ss_pred hcceecceEEEEEEecCCcEEEEEE-ecccc-------chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKR-MDKIS-------EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~-~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+++|+-+.+|.+.+. |..+++|. +.+.- .-......+|+.+|.+++--.|.--.=+..+.+...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999774 44466663 22211 111234678999999997655554444556778889999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccC
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 319 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~ 319 (518)
+|..|.+.+... ...++..+-.-+.-|| ..+|+|+||.++||++..+. +.++||||+...
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999998753 2466777888888999 99999999999999998765 999999998743
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3e-10 Score=101.65 Aligned_cols=141 Identities=25% Similarity=0.323 Sum_probs=105.4
Q ss_pred hhcceecceEEEEEEecCCcEEEEEE-eccc-c------chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 174 TIIGQGGFGTVYKAQFSDGSLIAVKR-MDKI-S------EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~g~~vavK~-~~~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
.+|-+|+-+.|+++.+ .|+...||. +.+. . .-......+|+++|.+++--.|.--.-++.+...-.++|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 4688999999999998 577777774 3221 1 11234578899999999755555444455666777899999
Q ss_pred cCC-CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC---cEEEeecccccc
Q 010088 246 MAN-GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF---VAKLADFGLAHA 318 (518)
Q Consensus 246 ~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DfGla~~ 318 (518)
++| -++.+++...............++..|-+.+.-|| .++|||+||..+||+|.+++ .+.++|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 976 58888887544333344444788899999999999 99999999999999997654 458999999754
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.06 E-value=7e-09 Score=106.04 Aligned_cols=217 Identities=18% Similarity=0.237 Sum_probs=149.7
Q ss_pred cceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeee----cCceEEEEEecCC-CCHHH
Q 010088 180 GFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE----KRERFLMYEYMAN-GSLKD 253 (518)
Q Consensus 180 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~~~-gsL~~ 253 (518)
--.+.||+... ||..|++|++.....+.......-+++++++.|.|||+|..++.. +..+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34678999654 899999999954433333334456889999999999999998763 3478999999986 78887
Q ss_pred HhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCC
Q 010088 254 HLHSP-------------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 254 ~l~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~ 320 (518)
+-... .....++..++.++.|+..||.++| +.|+..+-|.+++||++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 64321 1234678899999999999999999 8999999999999999999999999888765543
Q ss_pred CCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
.... |-+. --.+-|.=.||.+++.|.||..--.............
T Consensus 445 ~d~~------------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------------- 489 (655)
T KOG3741|consen 445 EDPT------------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-------------- 489 (655)
T ss_pred CCCC------------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH--------------
Confidence 3220 1111 1235788899999999999965422111111110000
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
+.. .....+.+++......++++ -++.+++.+..
T Consensus 490 I~~----~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~ 523 (655)
T KOG3741|consen 490 ITT----TYSTDLRNVVEYLESLNFRE-KSIQDLLPMIG 523 (655)
T ss_pred hhh----hhhHHHHHHHHHHHhcCccc-ccHHHHHHHHH
Confidence 011 12233556666666777766 56777766553
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.6e-09 Score=103.53 Aligned_cols=139 Identities=19% Similarity=0.159 Sum_probs=100.9
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccch-hH----------HHHHHHHHHHHHcCCC--CeeeEeeeeee-----c
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-VE----------GDFCREIELLARLHHR--HLVALRGFCIE-----K 236 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~H~--niv~l~g~~~~-----~ 236 (518)
.+-+.....|++..+ +|+.+.||+....... .. ..+.+|...+.+|... .....+++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 343333445667766 6788999977432211 11 1478999999998533 33455556543 2
Q ss_pred CceEEEEEecCCC-CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-------CCcE
Q 010088 237 RERFLMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-------NFVA 308 (518)
Q Consensus 237 ~~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-------~~~~ 308 (518)
...++|+|++++. +|.+++......+.+...+..++.+++..+.-|| ..||+|+|++++|||++. ++.+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceE
Confidence 3578999999986 8999986432234566677899999999999999 999999999999999975 5689
Q ss_pred EEeeccccc
Q 010088 309 KLADFGLAH 317 (518)
Q Consensus 309 kl~DfGla~ 317 (518)
.++||+.+.
T Consensus 185 ~LIDl~r~~ 193 (268)
T PRK15123 185 SVIDLHRAQ 193 (268)
T ss_pred EEEECCccc
Confidence 999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.1e-09 Score=96.80 Aligned_cols=126 Identities=24% Similarity=0.281 Sum_probs=84.0
Q ss_pred EEEEEEecCCcEEEEEEeccc--------------cc------------hhHHHHHHHHHHHHHcCCC--CeeeEeeeee
Q 010088 183 TVYKAQFSDGSLIAVKRMDKI--------------SE------------QVEGDFCREIELLARLHHR--HLVALRGFCI 234 (518)
Q Consensus 183 ~Vy~~~~~~g~~vavK~~~~~--------------~~------------~~~~~~~~E~~~l~~l~H~--niv~l~g~~~ 234 (518)
.||.|...+|..+|||..+.. .. .......+|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 489999889999999976321 00 0112357899999999765 56666654
Q ss_pred ecCceEEEEEecC--CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCceecccCCCcEEecCCCcEEEe
Q 010088 235 EKRERFLMYEYMA--NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY-LHFYCDPPLCHRDIKSSNILLDENFVAKLA 311 (518)
Q Consensus 235 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 311 (518)
....+||||++ |..+..+.... ++......++.+++..+.. +| ..+|+|+||.+.|||++++ .+.|+
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE-
T ss_pred --eCCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEE
Confidence 24579999998 65554443321 2234556777888885555 57 8899999999999999988 99999
Q ss_pred eccccccCC
Q 010088 312 DFGLAHASK 320 (518)
Q Consensus 312 DfGla~~~~ 320 (518)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999887544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.86 E-value=6.8e-08 Score=90.02 Aligned_cols=138 Identities=20% Similarity=0.156 Sum_probs=106.0
Q ss_pred cceecceEEEEEEecCCcEEEEEEecc-----cc-chhHHHHHHHHHHHHHcCC--CCeeeEeeeeeecC----ceEEEE
Q 010088 176 IGQGGFGTVYKAQFSDGSLIAVKRMDK-----IS-EQVEGDFCREIELLARLHH--RHLVALRGFCIEKR----ERFLMY 243 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~~g~~vavK~~~~-----~~-~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~lV~ 243 (518)
-|+||.+-|++-.+. |..+-+|+-.. .. ......|.+|+..|.+|.. -.+.+.+.+...+. .-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 377999999998874 55788997652 11 3356789999999999953 33555553322222 368999
Q ss_pred EecCC-CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc--EEEeeccccc
Q 010088 244 EYMAN-GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV--AKLADFGLAH 317 (518)
Q Consensus 244 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~--~kl~DfGla~ 317 (518)
|-+.| -+|.+++.+....+.+...+..+..+++..+.-|| ..++.|+|+.+.|||++.++. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97764 69999987655445677888899999999999999 999999999999999986666 9999998654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.9e-09 Score=117.98 Aligned_cols=242 Identities=19% Similarity=0.194 Sum_probs=157.1
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEecc---ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
-+-+|.++.+..+.-. .|...+.|.... ......+....+-.++-..++|-++....-+......+|+++|+.+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 3567788888766432 233333333221 111111112222222222344666655544445678899999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC-----C---
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD-----G--- 322 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~-----~--- 322 (518)
|...|+..+ ..+.+-.......+...++||| ...+.|||++|.|.|+..++..+++|||+...... +
T Consensus 891 ~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg 965 (1205)
T KOG0606|consen 891 LPSKLHNSG--CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSG 965 (1205)
T ss_pred chhhhhcCC--CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccCcCCccc
Confidence 999998755 3555555666777889999999 77799999999999999999999999984432110 0
Q ss_pred C---------------cccc----cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHH
Q 010088 323 S---------------ICFE----PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA 383 (518)
Q Consensus 323 ~---------------~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~ 383 (518)
. .... .......||+.|.+||...+......+|.|++|++++|.++|..|+.....- ...
T Consensus 966 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq-~~f 1044 (1205)
T KOG0606|consen 966 PSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ-QIF 1044 (1205)
T ss_pred ccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh-hhh
Confidence 0 0000 1234467899999999999999999999999999999999999999753321 111
Q ss_pred HHHHhhccccccccCCcCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 010088 384 QVCMASESRLAELVDPRIK-DSFDMEQLRTIVTIVRWCTQREGQARPSIK 432 (518)
Q Consensus 384 ~~~~~~~~~l~~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~ 432 (518)
+.+.. ..+. .....+......+++...+..++.+|-.+.
T Consensus 1045 ~ni~~----------~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1045 ENILN----------RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hcccc----------CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 11111 1111 011122234566788888899999998776
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.9e-08 Score=92.58 Aligned_cols=137 Identities=22% Similarity=0.170 Sum_probs=99.1
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEecc----------cc------------chhHHHHHHHHHHHHHcCCC--C
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDK----------IS------------EQVEGDFCREIELLARLHHR--H 225 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~----------~~------------~~~~~~~~~E~~~l~~l~H~--n 225 (518)
+.+++.||-|--+.||.|...+|..+|||.-+. .. ........+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 445678999999999999998999999994321 00 01123457899999999754 7
Q ss_pred eeeEeeeeeecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC
Q 010088 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 305 (518)
Q Consensus 226 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 305 (518)
+.+.+++ +.-.+||||++|--|...- ++....-.++..|+.-+.-+- ..||||+|+..-||++++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecC
Confidence 7777665 4668999999986554432 123333445555555555554 6789999999999999999
Q ss_pred CcEEEeeccccccCC
Q 010088 306 FVAKLADFGLAHASK 320 (518)
Q Consensus 306 ~~~kl~DfGla~~~~ 320 (518)
|.+.++||-.+....
T Consensus 239 g~~~vIDwPQ~v~~~ 253 (304)
T COG0478 239 GDIVVIDWPQAVPIS 253 (304)
T ss_pred CCEEEEeCcccccCC
Confidence 999999998765433
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=5e-08 Score=103.33 Aligned_cols=141 Identities=21% Similarity=0.203 Sum_probs=94.2
Q ss_pred hhcceecceEEEEEEecCCcEEEEEEeccccch----------------------------------------hHHHHHH
Q 010088 174 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ----------------------------------------VEGDFCR 213 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----------------------------------------~~~~~~~ 213 (518)
+-|+.++-|.||+|++++|+.||||+.+..-.. .+-+|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 469999999999999999999999976421100 1123556
Q ss_pred HHHHHHHcC----CCCeeeEeeeee-ecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHH-HHHHhhcCC
Q 010088 214 EIELLARLH----HRHLVALRGFCI-EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA-LEYLHFYCD 287 (518)
Q Consensus 214 E~~~l~~l~----H~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~~~ 287 (518)
|+.-+.+++ +..-+.+=..|. -.....|+|||++|-.+.+...-.. ..++... ++..++++ +..+- .
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~---~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLL---R 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHH---h
Confidence 766666663 222233333333 3467899999999998888742111 2355333 33333222 22222 5
Q ss_pred CCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 288 ~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
.|++|.|.+|.||+++.+|.+.+.|||+.....+
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 6999999999999999999999999999875543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=4.6e-09 Score=110.99 Aligned_cols=159 Identities=19% Similarity=0.269 Sum_probs=108.8
Q ss_pred HHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc-----ccccccCCCcccCccccc
Q 010088 272 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP-----VNTDIRGTPGYMDPEYVV 346 (518)
Q Consensus 272 ~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~ 346 (518)
+.+++.||.|+|. +.++||++|.|++|.++.++..||+.|+.+.....+....-. ...-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455699999996 679999999999999999999999999998765442211100 111122356799999999
Q ss_pred cCCCCccccchhhHHHHHHHHhCCccccCCc-chHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCC
Q 010088 347 TQELTEKSDVYSYGVVLLEIVTARRAVQDGK-NLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREG 425 (518)
Q Consensus 347 ~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~-~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp 425 (518)
+...+.++|+||+|+++|-+..|+.+..... ............+ .. .-.++.+.+.++.+=+.+.+..+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~--~~-------~~~~s~~~p~el~~~l~k~l~~~~ 253 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLN--AG-------AFGYSNNLPSELRESLKKLLNGDS 253 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccc--cc-------cccccccCcHHHHHHHHHHhcCCc
Confidence 9889999999999999999996655543222 2211111111000 00 011122344568888889999999
Q ss_pred CCCCCHHHHHHHhhcC
Q 010088 426 QARPSIKQVLRILYES 441 (518)
Q Consensus 426 ~~RPs~~evl~~L~~~ 441 (518)
.-||++.++....++.
T Consensus 254 ~~rp~~~~l~~~~ff~ 269 (700)
T KOG2137|consen 254 AVRPTLDLLLSIPFFS 269 (700)
T ss_pred ccCcchhhhhcccccC
Confidence 9999998887766554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.1e-07 Score=89.71 Aligned_cols=106 Identities=24% Similarity=0.267 Sum_probs=85.4
Q ss_pred HHHHHHHHHHHHHcC--CCCeeeEeeeeeecC----ceEEEEEecCC-CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 010088 208 EGDFCREIELLARLH--HRHLVALRGFCIEKR----ERFLMYEYMAN-GSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 280 (518)
Q Consensus 208 ~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~----~~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~ 280 (518)
.....+|...+.+|. .-...+.+++..... ..++|+|++++ .+|.+++..... .+......++.+++..++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 346788999888885 344566677766533 45899999988 489999976332 556677899999999999
Q ss_pred HHhhcCCCCceecccCCCcEEecCCC---cEEEeecccccc
Q 010088 281 YLHFYCDPPLCHRDIKSSNILLDENF---VAKLADFGLAHA 318 (518)
Q Consensus 281 yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DfGla~~ 318 (518)
-|| ..||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 133 ~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999 99999999999999999877 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.1e-06 Score=84.09 Aligned_cols=137 Identities=17% Similarity=0.148 Sum_probs=84.4
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCC--eeeEeeeeeecCceEEEEEecCCCC-H
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRH--LVALRGFCIEKRERFLMYEYMANGS-L 251 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gs-L 251 (518)
.||+|..+.||+. .|..+++|...... ......+|.+++..+..-. +.+.++++...+...+|||+++|.+ +
T Consensus 8 ~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 8 QTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 6899999999984 25567788765422 2345688999999986443 4677788777777889999999863 2
Q ss_pred HHH---------------------hcCCCCCCCCHHHHHH-HHH----------HHHH-HHHHHhh-cCCCCceecccCC
Q 010088 252 KDH---------------------LHSPGRTPLSWQTRIQ-IAI----------DVAN-ALEYLHF-YCDPPLCHRDIKS 297 (518)
Q Consensus 252 ~~~---------------------l~~~~~~~l~~~~~~~-i~~----------~ia~-gL~yLH~-~~~~~iiHrDlk~ 297 (518)
... ||.............. +.. .+.. ...+|.. .....++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 211 1211101111111000 000 0001 1122221 1134678999999
Q ss_pred CcEEecCCCcEEEeeccccc
Q 010088 298 SNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 298 ~NILl~~~~~~kl~DfGla~ 317 (518)
.||++++++ +.|+||+.+.
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcEEEcCCC-cEEEechhcC
Confidence 999999988 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.6e-07 Score=95.78 Aligned_cols=140 Identities=22% Similarity=0.257 Sum_probs=91.8
Q ss_pred hhcceecceEEEEEEecCCcEEEEEEeccccch-------------------------------------hHHHHHHHHH
Q 010088 174 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-------------------------------------VEGDFCREIE 216 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-------------------------------------~~~~~~~E~~ 216 (518)
+-||.-+.|.||+|++++|+.||||+-+..-+. .+-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 469999999999999999999999975321100 1123566666
Q ss_pred HHHHc----CCCCe---eeEeeeee-ecCceEEEEEecCCCCHHHH--hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 010088 217 LLARL----HHRHL---VALRGFCI-EKRERFLMYEYMANGSLKDH--LHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 286 (518)
Q Consensus 217 ~l~~l----~H~ni---v~l~g~~~-~~~~~~lV~e~~~~gsL~~~--l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 286 (518)
-..++ .|-++ |.+-.++. -...+.|+||||+|..+.+. |.+.+ ++...+..-+.++..-+-+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~~~qIf----- 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAYLEQIF----- 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHHHHHHH-----
Confidence 55544 35551 11222222 23478999999999877665 33332 5555444433333222222
Q ss_pred CCCceecccCCCcEEecC----CCcEEEeeccccccCCC
Q 010088 287 DPPLCHRDIKSSNILLDE----NFVAKLADFGLAHASKD 321 (518)
Q Consensus 287 ~~~iiHrDlk~~NILl~~----~~~~kl~DfGla~~~~~ 321 (518)
..|++|.|-+|.||+++. ++.+.+.|||+......
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 458999999999999983 67999999999876543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.4e-06 Score=87.52 Aligned_cols=259 Identities=15% Similarity=0.178 Sum_probs=153.2
Q ss_pred hhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeee------eec-CceEEEEE
Q 010088 173 STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFC------IEK-RERFLMYE 244 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~------~~~-~~~~lV~e 244 (518)
+.-||+|+-+.+|-.- +-...+.|+...-...... +.+..|.+. .||-+-.-+.|= -++ ....++|.
T Consensus 16 gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecc--hhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 4469999999999642 1112234655443322221 223334444 455433212211 112 22567777
Q ss_pred ecCCC-CHHHHhcC----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccC
Q 010088 245 YMANG-SLKDHLHS----PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 319 (518)
Q Consensus 245 ~~~~g-sL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~ 319 (518)
.+.+. -...+++- ..-...+|.-.++++..+|.+.+-|| +.|.+-+|+.++|+|+.+++.+.|.|-.--...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeec
Confidence 77653 22333321 11234799999999999999999999 889999999999999999999999985533322
Q ss_pred CCCCcccccccccccCCCcccCccccc-----cCCCCccccchhhHHHHHHHHhC-CccccCC------c-chH-HHHHH
Q 010088 320 KDGSICFEPVNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTA-RRAVQDG------K-NLV-ESAQV 385 (518)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvll~el~tG-~~p~~~~------~-~~~-~~~~~ 385 (518)
..+. ....-+|...|.+||.-. +..-+...|-|.||+++++|+.| +.||..- . ... ..+.-
T Consensus 168 ~ng~-----~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 168 ANGT-----LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred cCCc-----eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 2222 234456889999999653 34556789999999999999988 7787521 1 111 11111
Q ss_pred HHhhccccccccCCcCCCCCCHHH-HHHHHHHHHHccccC--CCCCCCHHHHHHHhhcCCCCC
Q 010088 386 CMASESRLAELVDPRIKDSFDMEQ-LRTIVTIVRWCTQRE--GQARPSIKQVLRILYESSDPM 445 (518)
Q Consensus 386 ~~~~~~~l~~~~d~~l~~~~~~~~-~~~l~~li~~Cl~~d--p~~RPs~~evl~~L~~~~~~~ 445 (518)
.+.....-..-..| -....+... ...+..+...|+... +.-||+++..+..|-+..+.+
T Consensus 243 ~f~ya~~~~~g~~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 243 RFAYASDQRRGLKP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred eeeechhccCCCCC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 11000000000000 012222222 245777788888764 568999999888776554443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.3e-07 Score=99.06 Aligned_cols=181 Identities=18% Similarity=0.130 Sum_probs=132.0
Q ss_pred hhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCC-eeeEeeeeeecCceEEEEEecCCC-CH
Q 010088 174 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRH-LVALRGFCIEKRERFLMYEYMANG-SL 251 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~g-sL 251 (518)
+-+++|+++++||.+-...+...++.+... ....-++++|.+++||| .+..++-+..+...+++++|+.++ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 357899999999997654444455554322 34456899999999999 777777777778889999999877 22
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccc
Q 010088 252 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331 (518)
Q Consensus 252 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 331 (518)
...... ....+...+...+...-+++|+||| +..=+||| ||+..+ +..|..||+......... ...
T Consensus 323 ~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-----~~~ 388 (829)
T KOG0576|consen 323 ALEMTV-SEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-----KPR 388 (829)
T ss_pred cccCCh-hhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc-----ccc
Confidence 211111 0112333344556677788999999 55568998 887766 578999999887665432 235
Q ss_pred cccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccc
Q 010088 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV 373 (518)
Q Consensus 332 ~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~ 373 (518)
...+|+.|+|||......+..+.|+|++|+--.++.-|-.|-
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 567999999999999999999999999998777777776554
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.6e-06 Score=77.61 Aligned_cols=127 Identities=17% Similarity=0.186 Sum_probs=79.7
Q ss_pred cceecceEEEEEEecCCcEEEEEEeccccchhHHH---------HHHHHHHHHHcCC---CCeeeEeeeeee-----cCc
Q 010088 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGD---------FCREIELLARLHH---RHLVALRGFCIE-----KRE 238 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~H---~niv~l~g~~~~-----~~~ 238 (518)
+-......|.+-.. +|..+.+|..+.......+. ..+++..+.+++- .....++.+... ...
T Consensus 39 ~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~ 117 (229)
T PF06176_consen 39 FKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSS 117 (229)
T ss_pred ecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeE
Confidence 33333344444444 67888888775433222222 2344554555532 233332322222 235
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 239 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 239 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
.+|+|||++|..|.++.. ++. .++..+..++.-|| ..|+.|+|.+|+|+++++++ +++.||+..+
T Consensus 118 ~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 118 YVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred EEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 578999999988876542 222 34566778899999 99999999999999998654 8999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.32 E-value=5.3e-06 Score=79.13 Aligned_cols=140 Identities=22% Similarity=0.259 Sum_probs=84.3
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCC--CeeeEeeeeeec---CceEEEEEecCCC
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHR--HLVALRGFCIEK---RERFLMYEYMANG 249 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lV~e~~~~g 249 (518)
.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++.++... ...+++|+++++.
T Consensus 4 ~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 4 PLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred cCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 58899999999999866 69999986543 4456778899999888533 355666654332 3468999999998
Q ss_pred CHHH----------------Hh---cCC--CCCCCCHHHH---------HHH------------HHHHHH-HHHHHhh--
Q 010088 250 SLKD----------------HL---HSP--GRTPLSWQTR---------IQI------------AIDVAN-ALEYLHF-- 284 (518)
Q Consensus 250 sL~~----------------~l---~~~--~~~~l~~~~~---------~~i------------~~~ia~-gL~yLH~-- 284 (518)
.+.. .+ +.. ...++.+... ... ...+.. .++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8877 11 111 1111111110 000 111222 3333332
Q ss_pred --cCCCCceecccCCCcEEec-CCCcEEEeeccccc
Q 010088 285 --YCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAH 317 (518)
Q Consensus 285 --~~~~~iiHrDlk~~NILl~-~~~~~kl~DfGla~ 317 (518)
.....++|+|+.+.|||++ +++.+.|.||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1356799999999999999 56666899998654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.32 E-value=7.3e-06 Score=79.40 Aligned_cols=134 Identities=17% Similarity=0.138 Sum_probs=83.4
Q ss_pred cceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEEecCCCCHHHHh---
Q 010088 180 GFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMANGSLKDHL--- 255 (518)
Q Consensus 180 ~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l--- 255 (518)
.-..||+.... +..+.||+..... ..+..+|++++..+. +--+.+++++....+..++|||+++|.+|....
T Consensus 11 ~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~ 86 (244)
T cd05150 11 SGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEEL 86 (244)
T ss_pred CcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhccc
Confidence 34889999764 4778888775432 345678999998884 444567788777666789999999998876432
Q ss_pred ----------------cCCC--CCCCC--HHHHHHHHH--------------------HHHHHHHHHhh----cCCCCce
Q 010088 256 ----------------HSPG--RTPLS--WQTRIQIAI--------------------DVANALEYLHF----YCDPPLC 291 (518)
Q Consensus 256 ----------------~~~~--~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~~~~~ii 291 (518)
|... ..++. +........ .+...+..|-. .....++
T Consensus 87 ~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 166 (244)
T cd05150 87 EPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVT 166 (244)
T ss_pred CHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEE
Confidence 1111 00111 001110000 01111222210 1145689
Q ss_pred ecccCCCcEEecCCCcEEEeeccccc
Q 010088 292 HRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 292 HrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
|+|+.+.|||++++....|+||+.+.
T Consensus 167 HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 167 HGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCCCCCccEEEeCCcEEEEEEccccc
Confidence 99999999999998888999999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.28 E-value=3.3e-06 Score=78.33 Aligned_cols=101 Identities=27% Similarity=0.311 Sum_probs=82.2
Q ss_pred HHHHHHHHHcCC-CCeeeEeeeeeecCceEEEEEecCCCCHHHH---hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 010088 212 CREIELLARLHH-RHLVALRGFCIEKRERFLMYEYMANGSLKDH---LHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 287 (518)
Q Consensus 212 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 287 (518)
..|.-+|..+.+ +++.+++|+| ..++|.||...+++... +.. -..-+|..|.+||.++++.+.+|++...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 357888999976 6999999999 45789999987766432 111 1136899999999999999999996555
Q ss_pred CCceecccCCCcEEecCCCcEEEeecccccc
Q 010088 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHA 318 (518)
Q Consensus 288 ~~iiHrDlk~~NILl~~~~~~kl~DfGla~~ 318 (518)
..+.-.|++++|+-+++++++|+.|...+..
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 6688899999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.7e-05 Score=73.94 Aligned_cols=136 Identities=22% Similarity=0.245 Sum_probs=90.8
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchh-------------------HH-----HHHHHHHHHHHcC--CCCeee
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQV-------------------EG-----DFCREIELLARLH--HRHLVA 228 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-------------------~~-----~~~~E~~~l~~l~--H~niv~ 228 (518)
.|..|--..||+|.-.++..+|||+.+...... .. -..+|..-|.++. +=.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 467778889999988789999999874311110 00 1245777777773 444444
Q ss_pred EeeeeeecCceEEEEEecCCC-CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc
Q 010088 229 LRGFCIEKRERFLMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV 307 (518)
Q Consensus 229 l~g~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 307 (518)
-+++. .-.|||||+... .-.-.|.. .++...+...+..++++.+.-|-. ..++||+||..=|||+. ++.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCe
Confidence 44442 458999999643 11112221 123333566677778888877762 47999999999999999 789
Q ss_pred EEEeeccccccCC
Q 010088 308 AKLADFGLAHASK 320 (518)
Q Consensus 308 ~kl~DfGla~~~~ 320 (518)
+.|+|||.|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999887554
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.14 E-value=3e-05 Score=88.28 Aligned_cols=77 Identities=17% Similarity=0.311 Sum_probs=56.4
Q ss_pred hcceecceEEEEEEecCC---cEEEEEEecccc-chhHHHHHHHHHHHHHcC-CCCe--eeEeeeeeec---CceEEEEE
Q 010088 175 IIGQGGFGTVYKAQFSDG---SLIAVKRMDKIS-EQVEGDFCREIELLARLH-HRHL--VALRGFCIEK---RERFLMYE 244 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV~e 244 (518)
.|+.|.++.+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++++|.+. +..|+|||
T Consensus 45 ~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME 124 (822)
T PLN02876 45 QFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIME 124 (822)
T ss_pred EeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEE
Confidence 578899999999877654 367777654321 122356889999999995 6665 7888888764 46789999
Q ss_pred ecCCCCH
Q 010088 245 YMANGSL 251 (518)
Q Consensus 245 ~~~~gsL 251 (518)
|++|..+
T Consensus 125 ~v~G~~~ 131 (822)
T PLN02876 125 YLEGRIF 131 (822)
T ss_pred ecCCccc
Confidence 9988643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.4e-05 Score=70.78 Aligned_cols=135 Identities=24% Similarity=0.411 Sum_probs=95.2
Q ss_pred CcccccCHHHHHHHhhhhhhhcceecc-eEEEEEEecCCcEEEEEEeccc------------cc---------hhHHHHH
Q 010088 155 PMFQKFSYKETKKATDNFSTIIGQGGF-GTVYKAQFSDGSLIAVKRMDKI------------SE---------QVEGDFC 212 (518)
Q Consensus 155 ~~~~~~~~~~l~~a~~~f~~~lG~G~~-g~Vy~~~~~~g~~vavK~~~~~------------~~---------~~~~~~~ 212 (518)
+....|.... +..+|.+.||.|.- |.|||+++ +|..+|+|.++.. .. .-..-|.
T Consensus 27 PKL~~F~~h~---~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~ 102 (207)
T PF13095_consen 27 PKLEPFTHHG---DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFN 102 (207)
T ss_pred CCcCCcCCCC---CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHH
Confidence 3344566522 56677889999999 99999998 6889999984210 00 1123478
Q ss_pred HHHHHHHHcC---CCCe--eeEeeeeeec------------------CceEEEEEecCCCCHHHHhcCCCCCCCCHHHHH
Q 010088 213 REIELLARLH---HRHL--VALRGFCIEK------------------RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI 269 (518)
Q Consensus 213 ~E~~~l~~l~---H~ni--v~l~g~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~ 269 (518)
.|.+...+|+ +.++ |+.+||..-. ..+.+|.||++... .+..
T Consensus 103 ~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~---- 167 (207)
T PF13095_consen 103 CECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI---- 167 (207)
T ss_pred HHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----
Confidence 8999888885 4566 8999987422 12467888876533 1222
Q ss_pred HHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccc
Q 010088 270 QIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 316 (518)
Q Consensus 270 ~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla 316 (518)
+-+.+|.+-|..+| ..+|+-+|+++.|.. .-||+|||.+
T Consensus 168 ~~~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 RDIPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hHHHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 33456777888899 999999999999986 4589999854
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.01 E-value=4.5e-05 Score=73.51 Aligned_cols=137 Identities=20% Similarity=0.307 Sum_probs=76.4
Q ss_pred hcceecce-EEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCC---CeeeEeeeeeecC---ceEEEEEecC
Q 010088 175 IIGQGGFG-TVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHR---HLVALRGFCIEKR---ERFLMYEYMA 247 (518)
Q Consensus 175 ~lG~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~---~~~lV~e~~~ 247 (518)
.|+.|+.. .||+. +..+++|..... ....++.+|+++|..+... -+.++++.+...+ ..+++|++++
T Consensus 4 ~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 4 PVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 46766665 58875 235677765431 2345788999999888532 3444454443322 3488999999
Q ss_pred CCCHHHH------------------hcCCCCC--CC-------------CHHHHH--HHH-------HHHHHH-HH-HHh
Q 010088 248 NGSLKDH------------------LHSPGRT--PL-------------SWQTRI--QIA-------IDVANA-LE-YLH 283 (518)
Q Consensus 248 ~gsL~~~------------------l~~~~~~--~l-------------~~~~~~--~i~-------~~ia~g-L~-yLH 283 (518)
|.++.+. ||..... +. .|.... .+. .+.+.. ++ +++
T Consensus 78 G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 157 (235)
T cd05155 78 GETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAALR 157 (235)
T ss_pred CCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHhc
Confidence 8776422 2221100 00 121110 000 011111 11 111
Q ss_pred h--cCCCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 284 F--YCDPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 284 ~--~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
. .....++|+|+.+.||+++++...-|.||+.+.
T Consensus 158 ~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 158 APWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 1 124558999999999999977666799999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.4e-05 Score=67.63 Aligned_cols=128 Identities=18% Similarity=0.231 Sum_probs=87.4
Q ss_pred hhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHH
Q 010088 173 STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK 252 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 252 (518)
.+.||+|.+|.||+|.+. |..+|+|.-+.. .....+..|+++|..+.-.++.+=+-++ +..++.|||+.|-.|.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~L~ 100 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcchh
Confidence 347999999999999995 568888865543 3346788999999999877775433322 2334559999998887
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCC--CcEEecCCCcEEEeeccccccC
Q 010088 253 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS--SNILLDENFVAKLADFGLAHAS 319 (518)
Q Consensus 253 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~--~NILl~~~~~~kl~DfGla~~~ 319 (518)
+.-... +-.+.. .+++.---|. ..||-|+.|.- .||++. ++.+.|+||.-|+..
T Consensus 101 ~~~~~~-----~rk~l~----~vlE~a~~LD---~~GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~k 156 (201)
T COG2112 101 KLEIGG-----DRKHLL----RVLEKAYKLD---RLGIEHGELSRPWKNVLVN-DRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhcc-----cHHHHH----HHHHHHHHHH---HhccchhhhcCCceeEEec-CCcEEEEEccchhhc
Confidence 765431 222333 3444433344 67899999874 455554 448999999988743
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00015 Score=67.72 Aligned_cols=127 Identities=24% Similarity=0.285 Sum_probs=91.1
Q ss_pred hhcceecceEEEEEEecCCcEEEEEEecccc----------------chhHHHHHHHHHHHHHcC------CCCeeeEee
Q 010088 174 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS----------------EQVEGDFCREIELLARLH------HRHLVALRG 231 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l~g 231 (518)
..||+|+.=.||.- .+.....||++.... .....++.+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 37999999999974 455667888776443 223466778888777776 889999999
Q ss_pred eeeecCceEEEEEecCC------CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC
Q 010088 232 FCIEKRERFLMYEYMAN------GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 305 (518)
Q Consensus 232 ~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 305 (518)
+..++....+|+|.+.+ -+|.+++.... ++. ...+.+. +-..||- +..|+.+||+|+||++...
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~---~f~~~l~---~~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALD---EFKRYLL---DHHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHH---HHHHHHH---HcCCeecCCCcccEEEEec
Confidence 99999999999998743 36888885432 544 3333333 3345565 7789999999999999532
Q ss_pred --C--cEEEee
Q 010088 306 --F--VAKLAD 312 (518)
Q Consensus 306 --~--~~kl~D 312 (518)
+ .+.|+|
T Consensus 155 ~~~~~~lvlID 165 (199)
T PF10707_consen 155 DSGEFRLVLID 165 (199)
T ss_pred CCCceEEEEEe
Confidence 2 567776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00011 Score=73.30 Aligned_cols=74 Identities=15% Similarity=0.117 Sum_probs=55.5
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCC---CCeeeEeeeeeec---CceEEEEEecCC
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHH---RHLVALRGFCIEK---RERFLMYEYMAN 248 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~e~~~~ 248 (518)
-||.|..+.||+....++ .+.+|..+.. .....|..|.+.|+.|.- -.+.+++++|... +..++|||++++
T Consensus 21 ~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 21 CISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred ecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 599999999999876555 4666764331 123578899999999953 3678888887643 568999999998
Q ss_pred CCH
Q 010088 249 GSL 251 (518)
Q Consensus 249 gsL 251 (518)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.90 E-value=7.3e-05 Score=73.02 Aligned_cols=136 Identities=18% Similarity=0.204 Sum_probs=79.2
Q ss_pred cceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCe-eeEeeeeeecCceEEEEEecCCCCHHHH
Q 010088 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL-VALRGFCIEKRERFLMYEYMANGSLKDH 254 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~~ 254 (518)
+..|-.+.+|+... +|..+++|..........-+..+|.++++.+....+ .++++.+ .-++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence 45677889999874 577888887543322221246789999999864333 3444443 23799999998765321
Q ss_pred -----------------hcCCC--CCCCCHHHH-HHHHHH---------HHHHHHHHhhc-----CCCCceecccCCCcE
Q 010088 255 -----------------LHSPG--RTPLSWQTR-IQIAID---------VANALEYLHFY-----CDPPLCHRDIKSSNI 300 (518)
Q Consensus 255 -----------------l~~~~--~~~l~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~iiHrDlk~~NI 300 (518)
||... ..+++.... ..+..+ +...+..+-.. ....++|+|+.+.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 22211 112222211 111111 11112222111 134689999999999
Q ss_pred EecCCCcEEEeeccccc
Q 010088 301 LLDENFVAKLADFGLAH 317 (518)
Q Consensus 301 Ll~~~~~~kl~DfGla~ 317 (518)
++++++ +.|+||+.|.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999877 7899999775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.89 E-value=6.8e-05 Score=84.20 Aligned_cols=201 Identities=18% Similarity=0.205 Sum_probs=139.7
Q ss_pred HHHHHHHHHHcCCCCeeeEeeeeeecCceE----EEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 010088 211 FCREIELLARLHHRHLVALRGFCIEKRERF----LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 286 (518)
Q Consensus 211 ~~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 286 (518)
...|.+.+.++.|+|++.+++|-.++.... +..+|+..-++...+...+ .++..+.+.+..++..||+|+|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h--- 303 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLH--- 303 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHH---
Confidence 455777888899999999999987765443 3457888888888887644 4778888889999999999999
Q ss_pred CCCceecccCCC---cEEecCCCcEEEe--eccccccCCCCCcccccccccccCCCcccCccccccCCCCc--cccchhh
Q 010088 287 DPPLCHRDIKSS---NILLDENFVAKLA--DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE--KSDVYSY 359 (518)
Q Consensus 287 ~~~iiHrDlk~~---NILl~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDVwS~ 359 (518)
.....|.-|..+ +...+.++...++ ||+..+....... .....-+..|.++|......+.. ..|+|++
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-----~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-----SFSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCccc-----chhhcCccccccccccccccchhhhhhHHHHH
Confidence 555556555555 4445666777777 8887765544321 11223455678888776655444 4799999
Q ss_pred HHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 360 GVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 360 Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
|.++..+..|..+....... ..+++.. +. ..+.+....|+..+.++|++..+++.+.+
T Consensus 379 gll~~~~~~~~~i~~~~~~~--------------~~~l~~~----~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAVP--------------VSLLDVL----ST----SELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred HHHHhhhhhcCcccccccch--------------hhhhccc----cc----hhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 99999999886544321111 1111111 11 13567888999999999999999999886
Q ss_pred cCCC
Q 010088 440 ESSD 443 (518)
Q Consensus 440 ~~~~ 443 (518)
....
T Consensus 437 ~~~~ 440 (1351)
T KOG1035|consen 437 LRFP 440 (1351)
T ss_pred cccc
Confidence 5543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00016 Score=69.52 Aligned_cols=138 Identities=22% Similarity=0.257 Sum_probs=80.6
Q ss_pred hcceecceEEEEEEecC--CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCe-eeEeeeeeecCceEEEEEecCCCCH
Q 010088 175 IIGQGGFGTVYKAQFSD--GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL-VALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
.|..|-...+|+....+ +..|++|........ ..+..+|+.++..+...++ .++++.+. ..+||||++|.++
T Consensus 5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 46778888999998764 678888876532221 1234578999998854333 44444332 2489999998776
Q ss_pred HHH-----------------hcCCCCC---------CC-CHHHHHHHHHH----------------------HHHHHHHH
Q 010088 252 KDH-----------------LHSPGRT---------PL-SWQTRIQIAID----------------------VANALEYL 282 (518)
Q Consensus 252 ~~~-----------------l~~~~~~---------~l-~~~~~~~i~~~----------------------ia~gL~yL 282 (518)
... +|..... .. -|..+..+... +...+..|
T Consensus 80 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 159 (235)
T cd05157 80 EPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWL 159 (235)
T ss_pred CHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHH
Confidence 321 1111100 11 12222222111 11111111
Q ss_pred ----hh-cCCCCceecccCCCcEEecC-CCcEEEeeccccc
Q 010088 283 ----HF-YCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAH 317 (518)
Q Consensus 283 ----H~-~~~~~iiHrDlk~~NILl~~-~~~~kl~DfGla~ 317 (518)
-. .....++|+|+.+.|||+++ ++.+.|+||..|.
T Consensus 160 ~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 160 KELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 11 02356999999999999998 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00033 Score=72.42 Aligned_cols=74 Identities=15% Similarity=0.165 Sum_probs=53.7
Q ss_pred hcceecceEEEEEEecCC-cEEEEEEeccc----c---chhHHHHHHHHHHHHHcC---CCCeeeEeeeeeecCceEEEE
Q 010088 175 IIGQGGFGTVYKAQFSDG-SLIAVKRMDKI----S---EQVEGDFCREIELLARLH---HRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g-~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 243 (518)
.||.|.+..||++...+| +.++||.-... . ....+.+..|.+.|..+. ..++.+++.+ +.+..++||
T Consensus 33 elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVM 110 (401)
T PRK09550 33 EIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVM 110 (401)
T ss_pred EcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEE
Confidence 589999999999998877 48999974311 1 123456778888888873 3456777776 345678999
Q ss_pred EecCCCC
Q 010088 244 EYMANGS 250 (518)
Q Consensus 244 e~~~~gs 250 (518)
||+++..
T Consensus 111 E~L~~~~ 117 (401)
T PRK09550 111 EDLSDHK 117 (401)
T ss_pred ecCCCcc
Confidence 9998744
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00022 Score=71.09 Aligned_cols=139 Identities=19% Similarity=0.173 Sum_probs=84.6
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCC--CeeeEeee------eeecCceEEEEEec
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHR--HLVALRGF------CIEKRERFLMYEYM 246 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~------~~~~~~~~lV~e~~ 246 (518)
.|..|....+|+.... +..+++|+... ........|++++..+.+. .+.+++.. ....+..++|++|+
T Consensus 21 ~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 21 GISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred cccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 4677777899998764 45788887754 2234566788888888543 24454432 12234568999999
Q ss_pred CCCCHHH----H----------hcCC----C-----CCCCCHHHHHH----------HHHHHHHHHHHHhh----cCCCC
Q 010088 247 ANGSLKD----H----------LHSP----G-----RTPLSWQTRIQ----------IAIDVANALEYLHF----YCDPP 289 (518)
Q Consensus 247 ~~gsL~~----~----------l~~~----~-----~~~l~~~~~~~----------i~~~ia~gL~yLH~----~~~~~ 289 (518)
+|..+.. . +|.. . .....|..... ....+...+.++.. ....+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 9876532 1 1110 0 01123332210 11123334444442 12357
Q ss_pred ceecccCCCcEEecCCCcEEEeeccccc
Q 010088 290 LCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 290 iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
++|+|+.|.||++++++.+.|.||+.+.
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhc
Confidence 9999999999999998778999999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00056 Score=68.45 Aligned_cols=138 Identities=28% Similarity=0.328 Sum_probs=82.4
Q ss_pred hcceecceEEEEEEecC-------CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCe-eeEeeeeeecCceEEEEEec
Q 010088 175 IIGQGGFGTVYKAQFSD-------GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL-VALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~ 246 (518)
.|..|-...+|+....+ +..+++|...... ....+..+|.+++..+....+ .++++++. -.+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhee
Confidence 35556667899988755 4788889865433 222456788888888854333 34555543 24689999
Q ss_pred CCCCHHHH-----------------hcCCCCC---------CCCHHHHHHH--------------------------HHH
Q 010088 247 ANGSLKDH-----------------LHSPGRT---------PLSWQTRIQI--------------------------AID 274 (518)
Q Consensus 247 ~~gsL~~~-----------------l~~~~~~---------~l~~~~~~~i--------------------------~~~ 274 (518)
+|..+... +|..... +.-|....++ ...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 98776431 1211111 0111111111 111
Q ss_pred HHHHHHHHhh------cCCCCceecccCCCcEEecCC----CcEEEeeccccc
Q 010088 275 VANALEYLHF------YCDPPLCHRDIKSSNILLDEN----FVAKLADFGLAH 317 (518)
Q Consensus 275 ia~gL~yLH~------~~~~~iiHrDlk~~NILl~~~----~~~kl~DfGla~ 317 (518)
+..-+.+|-. .....++|+|+.+.||+++++ +.++++||..|.
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 2222333321 135678999999999999985 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0029 Score=63.85 Aligned_cols=139 Identities=16% Similarity=0.220 Sum_probs=76.9
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCC--CeeeEee------eeeecCceEEEEEec
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHR--HLVALRG------FCIEKRERFLMYEYM 246 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g------~~~~~~~~~lV~e~~ 246 (518)
.|+.|...++|+....+| .+++|+.+... ......|+.++..|... .+.+.+. +....+..+++++|+
T Consensus 29 ~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 29 GIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred hhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 466777789999887555 68888875222 23334455666665321 2333332 112245678999999
Q ss_pred CCCCHH-----------HH---hcCCC---------CCCCCH-HHHHHHH-------------HHHHHHHHHHhhc----
Q 010088 247 ANGSLK-----------DH---LHSPG---------RTPLSW-QTRIQIA-------------IDVANALEYLHFY---- 285 (518)
Q Consensus 247 ~~gsL~-----------~~---l~~~~---------~~~l~~-~~~~~i~-------------~~ia~gL~yLH~~---- 285 (518)
+|..+. +. +|... ...+.| .....-. ..+...++.+...
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 987431 11 12110 011222 2211111 1111122222210
Q ss_pred CCCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 286 ~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
-..++||+|+++.||+++++...-|.||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 24589999999999999977666899999764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0027 Score=63.73 Aligned_cols=140 Identities=18% Similarity=0.203 Sum_probs=81.8
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCC--CeeeEeeee------eecCceEEEEEec
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHR--HLVALRGFC------IEKRERFLMYEYM 246 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~------~~~~~~~lV~e~~ 246 (518)
.++.|....+|+....+| .+++|...... ...+...|++++..|... ++.+++... ...+..+++++|+
T Consensus 29 ~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 29 GIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred ccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 467777789999876545 57788765421 123455677777777422 244444421 1234578999999
Q ss_pred CCCCHH-----------H---HhcCCCC-------C---CCCHHHHHH------------HHHHHHHHHHHHhh----cC
Q 010088 247 ANGSLK-----------D---HLHSPGR-------T---PLSWQTRIQ------------IAIDVANALEYLHF----YC 286 (518)
Q Consensus 247 ~~gsL~-----------~---~l~~~~~-------~---~l~~~~~~~------------i~~~ia~gL~yLH~----~~ 286 (518)
+|..+. . .+|.... . .-.|..... ....+...++++.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 885532 1 1221100 0 012221110 11123344555532 22
Q ss_pred CCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 287 ~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
..+++|+|+++.||++++++...|.||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 5789999999999999998877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0044 Score=61.25 Aligned_cols=31 Identities=32% Similarity=0.481 Sum_probs=25.6
Q ss_pred CCceecccCCCcEEecCCCc-EEEeecccccc
Q 010088 288 PPLCHRDIKSSNILLDENFV-AKLADFGLAHA 318 (518)
Q Consensus 288 ~~iiHrDlk~~NILl~~~~~-~kl~DfGla~~ 318 (518)
..++|+|+++.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997554 56999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0047 Score=61.24 Aligned_cols=71 Identities=23% Similarity=0.298 Sum_probs=47.7
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcC---CCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH---HRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
.|+.|....+|+.. .++..+.||.-. ......|..|.+-|+.|. --.+.+++++....+..+||+||++.+
T Consensus 24 ~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 24 PVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred ecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 57889999999987 578899999765 333456889999999984 456778888887777889999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.00092 Score=65.86 Aligned_cols=136 Identities=15% Similarity=0.156 Sum_probs=92.0
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEec--cccc--------------------hhHHHHHHHHHHHHHcC-C-CC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMD--KISE--------------------QVEGDFCREIELLARLH-H-RH 225 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~--~~~~--------------------~~~~~~~~E~~~l~~l~-H-~n 225 (518)
..+.+.||-|--+.||.+...+|+..++|.-+ ..+- -..-...+|...|+.|. | --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 44568999999999999999899999998421 1000 01112456888888884 2 23
Q ss_pred eeeEeeeeeecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC
Q 010088 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 305 (518)
Q Consensus 226 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 305 (518)
+.+.+++ +..++|||++.+-.|...-+- .+..++..-++++ +--|- ..|+||+|..-=||+++++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~~---Iv~la---~~GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMGL---IVRLA---NHGLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeec-----CChHHHHHHHHHH---HHHHH---HcCceecccchheeEEecC
Confidence 4444544 356889999988777654332 2333443333333 33343 7899999999999999999
Q ss_pred CcEEEeeccccccCC
Q 010088 306 FVAKLADFGLAHASK 320 (518)
Q Consensus 306 ~~~kl~DfGla~~~~ 320 (518)
+.++++||-.+....
T Consensus 239 ~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 239 DKIVVIDFPQMVSTS 253 (465)
T ss_pred CCEEEeechHhhccC
Confidence 999999998665443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0093 Score=59.66 Aligned_cols=120 Identities=23% Similarity=0.279 Sum_probs=73.4
Q ss_pred CcEEEEEEec-cccchhHHHHHHHHHHHHHcCC--CCeeeEeeeeeecC--ceEEEEEecCCCCHHHHhcCCCCCCCCHH
Q 010088 192 GSLIAVKRMD-KISEQVEGDFCREIELLARLHH--RHLVALRGFCIEKR--ERFLMYEYMANGSLKDHLHSPGRTPLSWQ 266 (518)
Q Consensus 192 g~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l~~~~~~~l~~~ 266 (518)
++.+++.+-. ...........+|..+++.+.- --+...+++|.++. ..+.||+|++|..+.+.+.... ..
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~---~~-- 122 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPES---LG-- 122 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCccc---ch--
Confidence 6667776221 1122233456678888888743 33455677777766 6799999999854433222110 00
Q ss_pred HHHHHH-HHHHHHHHHHhh--------------------------------------------------c-----CCCCc
Q 010088 267 TRIQIA-IDVANALEYLHF--------------------------------------------------Y-----CDPPL 290 (518)
Q Consensus 267 ~~~~i~-~~ia~gL~yLH~--------------------------------------------------~-----~~~~i 290 (518)
.+++ ..+++.|+-||. . ....+
T Consensus 123 --~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~l 200 (321)
T COG3173 123 --RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVL 200 (321)
T ss_pred --HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCcee
Confidence 0111 133333333332 1 13469
Q ss_pred eecccCCCcEEecCCCcEEEeecccccc
Q 010088 291 CHRDIKSSNILLDENFVAKLADFGLAHA 318 (518)
Q Consensus 291 iHrDlk~~NILl~~~~~~kl~DfGla~~ 318 (518)
+|+|+++.|++++++.-+=|.||+++..
T Consensus 201 vHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 201 VHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeCCcccCCEEEeCCCeeEEEecccccc
Confidence 9999999999999988899999999864
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.017 Score=58.99 Aligned_cols=137 Identities=18% Similarity=0.244 Sum_probs=80.2
Q ss_pred cceecceEEEEEEecC-----CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCee-eEeeeeeecCceEEEEEecCCC
Q 010088 176 IGQGGFGTVYKAQFSD-----GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLV-ALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~g 249 (518)
|-.|-...+|+..+.+ +..|++|......... -+-.+|..++..+...++. ++++++.. ..|++|+++.
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~----g~v~efi~g~ 118 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPN----GRVEEFIHAR 118 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECC----ceEEEeeCCC
Confidence 4346677889887542 3578888765433222 2346789999888644443 45555422 2589999887
Q ss_pred CHHHH-----------------hcCCC----CCCCCHHHHHHHHHHH-----------------HHHHHHHh----h-cC
Q 010088 250 SLKDH-----------------LHSPG----RTPLSWQTRIQIAIDV-----------------ANALEYLH----F-YC 286 (518)
Q Consensus 250 sL~~~-----------------l~~~~----~~~l~~~~~~~i~~~i-----------------a~gL~yLH----~-~~ 286 (518)
+|... +|... ....-|.+..++..++ ...+..|. . ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 76421 22211 1122244333333221 11122221 1 22
Q ss_pred CCCceecccCCCcEEecC-CCcEEEeeccccc
Q 010088 287 DPPLCHRDIKSSNILLDE-NFVAKLADFGLAH 317 (518)
Q Consensus 287 ~~~iiHrDlk~~NILl~~-~~~~kl~DfGla~ 317 (518)
...++|+|+++.|||+++ ++.++++||..+.
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 457899999999999986 5789999999875
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.012 Score=58.88 Aligned_cols=30 Identities=30% Similarity=0.459 Sum_probs=25.9
Q ss_pred CCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 287 ~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
..+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 468999999999999988 578899999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.022 Score=57.85 Aligned_cols=80 Identities=15% Similarity=0.118 Sum_probs=51.4
Q ss_pred hcceecceEEEEEEecCC-cEEEEEEecc----c---cchhHHHHHHHHHHHHHcC--CC-CeeeEeeeeeecCceEEEE
Q 010088 175 IIGQGGFGTVYKAQFSDG-SLIAVKRMDK----I---SEQVEGDFCREIELLARLH--HR-HLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g-~~vavK~~~~----~---~~~~~~~~~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~lV~ 243 (518)
.||.|....||++...+| +.|+||.-.. . -.-......-|.+.|.... -| .+.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999998655 6899997431 1 1222344557788887763 34 34445443 456677999
Q ss_pred EecCC-CCHHHHhc
Q 010088 244 EYMAN-GSLKDHLH 256 (518)
Q Consensus 244 e~~~~-gsL~~~l~ 256 (518)
|+++. ..|.+.|-
T Consensus 80 EdL~~~~ilR~~Li 93 (370)
T TIGR01767 80 EDLSHHKIARKGLI 93 (370)
T ss_pred hhCccchHHHHHHH
Confidence 99954 44545443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.033 Score=57.63 Aligned_cols=78 Identities=18% Similarity=0.183 Sum_probs=52.0
Q ss_pred hcceecceEEEEEEecCCcEEEEEEecc----ccc---hhHHHHHHHHHHHHHcC---CCCeeeEeeeeeecCceEEEEE
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDK----ISE---QVEGDFCREIELLARLH---HRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~----~~~---~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e 244 (518)
.||.|....||+... ++..++||+-.. ... .....-..|++.|..+. ..++.+++.+|. +..+++||
T Consensus 39 eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvME 115 (418)
T PLN02756 39 EVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGMR 115 (418)
T ss_pred EcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEEe
Confidence 589999999999876 456788997541 111 12233345577776664 357888888886 45688999
Q ss_pred ecCC--CCHHHHh
Q 010088 245 YMAN--GSLKDHL 255 (518)
Q Consensus 245 ~~~~--gsL~~~l 255 (518)
|+++ ..+.+-+
T Consensus 116 ~L~~~~~ilr~~L 128 (418)
T PLN02756 116 YLEPPHIILRKGL 128 (418)
T ss_pred ecCCcceehhhhh
Confidence 9976 3454444
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.015 Score=59.73 Aligned_cols=79 Identities=18% Similarity=0.195 Sum_probs=51.8
Q ss_pred hcceecceEEEEEEecC-CcEEEEEEecc---cc---chhHHHHHHHHHHHHHcC--CC-CeeeEeeeeeecCceEEEEE
Q 010088 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMDK---IS---EQVEGDFCREIELLARLH--HR-HLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~---~~---~~~~~~~~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~lV~e 244 (518)
.||-|.-..||++...+ ++.|+||.-.. .. .-..+...-|.+.|+.+. -| ++.+++.+ +.+...+|||
T Consensus 36 eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vME 113 (409)
T PRK12396 36 EIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVME 113 (409)
T ss_pred EcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHHH
Confidence 58999999999998743 57899996421 11 223345667888888763 34 44555544 4566788999
Q ss_pred ecCC-CCHHHHh
Q 010088 245 YMAN-GSLKDHL 255 (518)
Q Consensus 245 ~~~~-gsL~~~l 255 (518)
+++. ..|.+.|
T Consensus 114 dL~~~~ilR~~L 125 (409)
T PRK12396 114 DLSDHTILRTAL 125 (409)
T ss_pred hCcccHHHHHHH
Confidence 9854 3354444
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.028 Score=57.02 Aligned_cols=137 Identities=18% Similarity=0.237 Sum_probs=78.6
Q ss_pred cceecceEEEEEEecC----CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCee-eEeeeeeecCceEEEEEecCCCC
Q 010088 176 IGQGGFGTVYKAQFSD----GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLV-ALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
|..|-...+|+....+ +..|++|........ .-+-.+|..++..+..-++. ++++++. . . +|.+|+++.+
T Consensus 22 l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~-G--~i~~fi~g~~ 96 (330)
T PLN02421 22 ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-N-G--MIQSFINART 96 (330)
T ss_pred eCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-C-c--EeehhhcCCC
Confidence 4446667889886543 237888876543322 23446889999998655553 5555542 2 2 5899998766
Q ss_pred HHH-----------------HhcCCC----CCCCCHHHHHHHHHHH----------------------HHHHHHHhh---
Q 010088 251 LKD-----------------HLHSPG----RTPLSWQTRIQIAIDV----------------------ANALEYLHF--- 284 (518)
Q Consensus 251 L~~-----------------~l~~~~----~~~l~~~~~~~i~~~i----------------------a~gL~yLH~--- 284 (518)
|.. .+|... ..+--|..+.++..++ ..-+..+..
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~ 176 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD 176 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence 521 112211 1111244333332222 111222211
Q ss_pred --cCCCCceecccCCCcEEecC-CCcEEEeeccccc
Q 010088 285 --YCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAH 317 (518)
Q Consensus 285 --~~~~~iiHrDlk~~NILl~~-~~~~kl~DfGla~ 317 (518)
....-++|+|+.+.|||+++ ++.++++||..|.
T Consensus 177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11234789999999999975 5789999999874
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.046 Score=55.24 Aligned_cols=138 Identities=22% Similarity=0.288 Sum_probs=81.1
Q ss_pred cceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCC------eeeEeeee--eecC--ceEEEEEe
Q 010088 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRH------LVALRGFC--IEKR--ERFLMYEY 245 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~--~~~~--~~~lV~e~ 245 (518)
|.+ .-..||+....+|.. ++|..+.. ....+...|+..|..|.-.+ +..+=|-. .-.. ..+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 456799998877776 88877654 33456667778887774222 12221211 1123 67889999
Q ss_pred cCCCCHHH-----H----------hcC----CC------CCCCCHHH-------------HHHHHHHHHHHHHHHhh---
Q 010088 246 MANGSLKD-----H----------LHS----PG------RTPLSWQT-------------RIQIAIDVANALEYLHF--- 284 (518)
Q Consensus 246 ~~~gsL~~-----~----------l~~----~~------~~~l~~~~-------------~~~i~~~ia~gL~yLH~--- 284 (518)
++|..+.. . ||. .. .....|.. ......++...+..+..
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99987772 1 111 00 11234431 01123344444444442
Q ss_pred -cC-CCC--ceecccCCCcEEecCCCc-EEEeeccccc
Q 010088 285 -YC-DPP--LCHRDIKSSNILLDENFV-AKLADFGLAH 317 (518)
Q Consensus 285 -~~-~~~--iiHrDlk~~NILl~~~~~-~kl~DfGla~ 317 (518)
.- ..+ +||+|+.+.||+++++.. +.+.|||-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11 223 999999999999998874 8999999764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.044 Score=55.02 Aligned_cols=32 Identities=25% Similarity=0.260 Sum_probs=28.5
Q ss_pred CCCceecccCCCcEEecCCCcEEEeecccccc
Q 010088 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318 (518)
Q Consensus 287 ~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~ 318 (518)
..+++|+|+.+.|||+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45899999999999999999999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.0071 Score=63.13 Aligned_cols=49 Identities=24% Similarity=0.282 Sum_probs=38.6
Q ss_pred HHHHHHHHHHHHcCCCCeeeEeeeeeecCc-eEEEEEecCCCCHHHHhcCC
Q 010088 209 GDFCREIELLARLHHRHLVALRGFCIEKRE-RFLMYEYMANGSLKDHLHSP 258 (518)
Q Consensus 209 ~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~e~~~~gsL~~~l~~~ 258 (518)
.++.....+++.+.|+|+...+++...+.+ ..+|+|++ +.||++.+..+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 346667789999999999999998776544 56788988 56999988753
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.00081 Score=77.64 Aligned_cols=159 Identities=13% Similarity=-0.005 Sum_probs=110.2
Q ss_pred HHHHHHHHHHcCCCCeeeEeeeee--ecCceEEEEEecCCCCHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhh--
Q 010088 211 FCREIELLARLHHRHLVALRGFCI--EKRERFLMYEYMANGSLKDHLHSPG--RTPLSWQTRIQIAIDVANALEYLHF-- 284 (518)
Q Consensus 211 ~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~-- 284 (518)
...|.+.++...|+++.....-.. +..+.+.+++|+.+|.+.+.|-+.. ..+++..-+...-.+......-+|.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344555566678988876654333 2346789999999999999886432 2233333332222332444444442
Q ss_pred cCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHH
Q 010088 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLL 364 (518)
Q Consensus 285 ~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~ 364 (518)
....-.+|++||+-|.+|..+..+|++++|+.+...... .......+++-|+.|+....-.++.++|+|..|+.+|
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~----sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL----SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchH----hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 223457899999999999999999999999998322211 1233455778899999888888999999999999999
Q ss_pred HHHhCCccc
Q 010088 365 EIVTARRAV 373 (518)
Q Consensus 365 el~tG~~p~ 373 (518)
++.-|..++
T Consensus 1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred HHhcccHHH
Confidence 998876655
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.099 Score=61.04 Aligned_cols=139 Identities=17% Similarity=0.199 Sum_probs=77.9
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcC-------CCCeeeEe-e----eeee-cC--ce
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH-------HRHLVALR-G----FCIE-KR--ER 239 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-------H~niv~l~-g----~~~~-~~--~~ 239 (518)
.|+ |..-.+|+.+..+|..+++|+.+.... ......|..+|..|. -|.+++-. | .... .+ ..
T Consensus 32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 32 PLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred ecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 354 456788998887888999999875322 223334555555442 23333322 1 1111 12 45
Q ss_pred EEEEEecCCCCHHHHh-----------------c----CC----CCCCCCHHH-----------------HHHHHHHHHH
Q 010088 240 FLMYEYMANGSLKDHL-----------------H----SP----GRTPLSWQT-----------------RIQIAIDVAN 277 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l-----------------~----~~----~~~~l~~~~-----------------~~~i~~~ia~ 277 (518)
+-+++|++|..|.+.. + .. ....+.|.. ...++..+..
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 6789999998776511 1 00 012234432 1122222222
Q ss_pred HHH-----HHhhcCCCCceecccCCCcEEecCCC--cEE-Eeeccccc
Q 010088 278 ALE-----YLHFYCDPPLCHRDIKSSNILLDENF--VAK-LADFGLAH 317 (518)
Q Consensus 278 gL~-----yLH~~~~~~iiHrDlk~~NILl~~~~--~~k-l~DfGla~ 317 (518)
..+ .+.. ...++||+|+.+.|||++.+. .+. |+|||-+.
T Consensus 189 ~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 189 RFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 221 1221 256799999999999999875 455 99999775
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.018 Score=54.33 Aligned_cols=30 Identities=37% Similarity=0.626 Sum_probs=21.3
Q ss_pred CCceecccCCCcEEe-cCCCcEEEeeccccc
Q 010088 288 PPLCHRDIKSSNILL-DENFVAKLADFGLAH 317 (518)
Q Consensus 288 ~~iiHrDlk~~NILl-~~~~~~kl~DfGla~ 317 (518)
.-++|+||.+.|||+ +.++.++++||..|.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 467899999999999 888999999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.19 Score=50.85 Aligned_cols=71 Identities=17% Similarity=0.144 Sum_probs=44.2
Q ss_pred ecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCC--CeeeEe---e--eeeecCceEEEEEecCCCC
Q 010088 179 GGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHR--HLVALR---G--FCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 179 G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~---g--~~~~~~~~~lV~e~~~~gs 250 (518)
+.-..||+....+|..+++|..+.. .....+...|++.+..|... .++..+ | +...++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 3456799998878888999977522 22345666788887777321 122211 2 1222456788999998764
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.12 Score=53.43 Aligned_cols=72 Identities=17% Similarity=0.251 Sum_probs=43.3
Q ss_pred cceecceEEEEEEecCC--cE-----EEEEEeccccchhHHHHHHHHHHHHHcCCCCee-eEeeeeeecCceEEEEEecC
Q 010088 176 IGQGGFGTVYKAQFSDG--SL-----IAVKRMDKISEQVEGDFCREIELLARLHHRHLV-ALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~~g--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~ 247 (518)
|..|-...+|++...++ .. |.++.... .....-+-.+|++++..+...++- ++++.+. -++|+||++
T Consensus 58 l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~efIe 132 (383)
T PTZ00384 58 MNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEWVE 132 (383)
T ss_pred eCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEEec
Confidence 44577788999876543 22 33332211 111122345789999999766555 4444442 369999999
Q ss_pred CCCHH
Q 010088 248 NGSLK 252 (518)
Q Consensus 248 ~gsL~ 252 (518)
|.+|.
T Consensus 133 Gr~l~ 137 (383)
T PTZ00384 133 GNTMG 137 (383)
T ss_pred cccCC
Confidence 87764
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.064 Score=54.83 Aligned_cols=62 Identities=18% Similarity=0.110 Sum_probs=44.6
Q ss_pred ceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC
Q 010088 238 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE 304 (518)
Q Consensus 238 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~ 304 (518)
...|+-+|+.|.++..++...+ .++.-+.+++.-.+++|-.+-. -.+++|.|+.|.||++.-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEe
Confidence 3467778999999999987543 3344566666666666655443 458999999999999953
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.12 Score=48.66 Aligned_cols=138 Identities=17% Similarity=0.183 Sum_probs=86.0
Q ss_pred EEEEEeccccch-hHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHH
Q 010088 195 IAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI 273 (518)
Q Consensus 195 vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ 273 (518)
..+|++....-. ....|..+.+++.+++ .|+++..= ......++.|+|-... . ...-.|..
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------------i--~~~N~i~a 149 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------------I--NFSNFITA 149 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc------------c--chhHHHHH
Confidence 445655543333 3456788899998885 46666621 3346678999884311 1 01111222
Q ss_pred HHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCcc
Q 010088 274 DVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 353 (518)
Q Consensus 274 ~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 353 (518)
+ +..|.-.|.. ..+.+|+|-.|+||+-|..|.+||.|=+.... .+.-|.--| ....+.+
T Consensus 150 g-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~----------------~~V~~vN~~---Y~~lT~~ 208 (308)
T PF07387_consen 150 G-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE----------------NQVNMVNIE---YESLTQE 208 (308)
T ss_pred h-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh----------------heeeEEeee---ccccChH
Confidence 1 3566677744 67899999999999999999999999874321 112232212 1345777
Q ss_pred ccchhhHHHHHHHHhCCc
Q 010088 354 SDVYSYGVVLLEIVTARR 371 (518)
Q Consensus 354 sDVwS~Gvll~el~tG~~ 371 (518)
+.+-+|=.-+++++...+
T Consensus 209 aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 209 AEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred HHHHHHHHHHHHHHHHHh
Confidence 888888777888776543
|
The function of this family is unknown. |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.16 Score=50.44 Aligned_cols=30 Identities=40% Similarity=0.527 Sum_probs=24.8
Q ss_pred CCceecccCCCcEEecCC--C---cEEEeeccccc
Q 010088 288 PPLCHRDIKSSNILLDEN--F---VAKLADFGLAH 317 (518)
Q Consensus 288 ~~iiHrDlk~~NILl~~~--~---~~kl~DfGla~ 317 (518)
.-++|||++..|||+..+ | .+++.||-+++
T Consensus 215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred eEEEcCccCHHhEeEccccccccccceeecccccc
Confidence 358999999999999654 3 68999998765
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.27 Score=49.77 Aligned_cols=139 Identities=19% Similarity=0.206 Sum_probs=89.3
Q ss_pred hhcceecceEEEEEEecCCcEEEEEEeccc-------cch------------------hHHH-HHHHHHHHHHcCCCCee
Q 010088 174 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKI-------SEQ------------------VEGD-FCREIELLARLHHRHLV 227 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~-------~~~------------------~~~~-~~~E~~~l~~l~H~niv 227 (518)
..|..|--..||-+.-.+|..+|||+.+.. ... ..+. ...|++-|.+|+.-.|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 367788888999999999999999976420 000 0011 23577778887643332
Q ss_pred eEeeeeeecCceEEEEEecCCCC-HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC
Q 010088 228 ALRGFCIEKRERFLMYEYMANGS-LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF 306 (518)
Q Consensus 228 ~l~g~~~~~~~~~lV~e~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~ 306 (518)
----+. =..-.|||+|+.... -.-.|+ ...++...+..+-.+++.-|--|.+ ..++||.||.-=|+|+. +|
T Consensus 230 ~PePIl--Lk~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyh-dG 301 (520)
T KOG2270|consen 230 CPEPIL--LKNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYH-DG 301 (520)
T ss_pred CCCcee--eecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEE-CC
Confidence 100000 023479999995321 111222 2346666777777777777777765 45899999999999985 46
Q ss_pred cEEEeeccccccCC
Q 010088 307 VAKLADFGLAHASK 320 (518)
Q Consensus 307 ~~kl~DfGla~~~~ 320 (518)
.+.|+|-+.+....
T Consensus 302 ~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 302 KLYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEEccccccCC
Confidence 89999998776443
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.011 Score=39.18 Aligned_cols=32 Identities=22% Similarity=0.399 Sum_probs=18.3
Q ss_pred cceeeehhhHHHHHHHHHHHHHHHHHHHHHHc
Q 010088 91 PYHLTLIPGIGIAVTAVAVILLMVLIILIRRK 122 (518)
Q Consensus 91 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~r~~ 122 (518)
+...++..++++.++++++++++++++++||+
T Consensus 8 ~~~vaIa~~VvVPV~vI~~vl~~~l~~~~rR~ 39 (40)
T PF08693_consen 8 SNTVAIAVGVVVPVGVIIIVLGAFLFFWYRRK 39 (40)
T ss_pred CceEEEEEEEEechHHHHHHHHHHhheEEecc
Confidence 34455666666666666666655555544443
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 518 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-51 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-49 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-37 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-27 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-21 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-04 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 8e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-129
Identities = 120/291 (41%), Positives = 164/291 (56%), Gaps = 17/291 (5%)
Query: 158 QKFSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREI 215
+ + ++AT+NF +IG G FG VYK DG+ +A+KR S Q +F EI
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 216 ELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLH--SPGRTPLSWQTRIQIAI 273
E L+ H HLV+L GFC E+ E L+Y+YM NG+LK HL+ +SW+ R++I I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 274 DVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP-VNTD 332
A L YLH + HRD+KS NILLDENFV K+ DFG+ SK G+ + ++T
Sbjct: 147 GAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGI---SKKGTELDQTHLSTV 200
Query: 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK-----NLVESAQVCM 387
++GT GY+DPEY + LTEKSDVYS+GVVL E++ AR A+ NL E A
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 388 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
+ +L ++VDP + D E LR C + RPS+ VL L
Sbjct: 261 NNG-QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 375 bits (965), Expect = e-128
Identities = 119/293 (40%), Positives = 180/293 (61%), Gaps = 16/293 (5%)
Query: 158 QKFSYKETKKATDNFST--IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-VEGDFCRE 214
++FS +E + A+DNFS I+G+GGFG VYK + +DG+L+AVKR+ + Q E F E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 215 IELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLH--SPGRTPLSWQTRIQIA 272
+E+++ HR+L+ LRGFC+ ER L+Y YMANGS+ L + PL W R +IA
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 273 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 332
+ A L YLH +CDP + HRD+K++NILLDE F A + DFGLA K V T
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA---KLMDYKDTHVTTA 194
Query: 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV-------QDGKNLVESAQV 385
+RGT G++ PEY+ T + +EK+DV+ YGV+LLE++T +RA D L++ +
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 386 CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
+ E +L LVD ++ ++ E++ ++ + CTQ RP + +V+R+L
Sbjct: 255 -LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 354 bits (911), Expect = e-120
Identities = 112/304 (36%), Positives = 169/304 (55%), Gaps = 24/304 (7%)
Query: 151 EGPSPMFQKFSYKETKKATDNFST--------IIGQGGFGTVYKAQFSDGSLIAVKRM-- 200
E F FS+ E K T+NF +G+GGFG VYK + + +AVK++
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 201 --DKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSP 258
D +E+++ F +EI+++A+ H +LV L GF + + L+Y YM NGSL D L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 259 -GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH 317
G PLSW R +IA AN + +LH + HRDIKS+NILLDE F AK++DFGLA
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 318 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV---Q 374
AS+ + + + I GT YM PE + E+T KSD+YS+GVVLLEI+T AV +
Sbjct: 182 ASEKFAQ--TVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 375 DGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 434
+ + L++ + E + + +D ++ D D + + ++ C + RP IK+V
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 435 LRIL 438
++L
Sbjct: 298 QQLL 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 4e-80
Identities = 74/307 (24%), Positives = 117/307 (38%), Gaps = 35/307 (11%)
Query: 160 FSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEL 217
+ + + +G FG V+KAQ +AVK +Q E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQ-SWQNEYEVYS 71
Query: 218 LARLHHRHLVALRGFCIE----KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI 273
L + H +++ G + +L+ + GSL D L +SW IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHIAE 128
Query: 274 DVANALEYLH-------FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326
+A L YLH P + HRDIKS N+LL N A +ADFGLA + G
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS-- 186
Query: 327 EPVNTDIRGTPGYMDPEYV-----VTQELTEKSDVYSYGVVLLEIVTARRA----VQDGK 377
GT YM PE + ++ + D+Y+ G+VL E+ + A V +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 378 NLVESAQVCMASESRLAELV-----DPRIKDSFD-MEQLRTIVTIVRWCTQREGQARPSI 431
E S + E+V P ++D + + + + C + +AR S
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 432 KQVLRIL 438
V +
Sbjct: 307 GCVGERI 313
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 1e-66
Identities = 69/269 (25%), Positives = 127/269 (47%), Gaps = 24/269 (8%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRG 231
++G+G FG V KA++ +A+K+++ SE F E+ L+R++H ++V L G
Sbjct: 12 VEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTP-LSWQTRIQIAIDVANALEYLHFYCDPPL 290
C+ L+ EY GSL + LH P + + + + + YLH L
Sbjct: 69 ACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 291 CHRDIKSSNILLDENF-VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
HRD+K N+LL V K+ DFG A + T+ +G+ +M PE
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-------TNNKGSAAWMAPEVFEGSN 179
Query: 350 LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409
+EK DV+S+G++L E++T R+ + + + +R P + +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR------PPLIKNLPKP- 232
Query: 410 LRTIVTIVRWCTQREGQARPSIKQVLRIL 438
I +++ C ++ RPS++++++I+
Sbjct: 233 ---IESLMTRCWSKDPSQRPSMEEIVKIM 258
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 2e-66
Identities = 81/270 (30%), Positives = 133/270 (49%), Gaps = 20/270 (7%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRM--DKISEQVEGDFCREIELLARLHHRHLVAL 229
IG G FGTV++A++ GS +AVK + + +F RE+ ++ RL H ++V
Sbjct: 41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDP 288
G + ++ EY++ GSL LH G R L + R+ +A DVA + YLH +P
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 348
P+ HR++KS N+L+D+ + K+ DFGL+ + + GTP +M PE + +
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL----SSKSAAGTPEWMAPEVLRDE 214
Query: 349 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408
EKSDVYS+GV+L E+ T ++ + A V + I + + +
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-------LEIPRNLNPQ 267
Query: 409 QLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
+ I+ C E RPS ++ +L
Sbjct: 268 ----VAAIIEGCWTNEPWKRPSFATIMDLL 293
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 215 bits (548), Expect = 1e-65
Identities = 67/319 (21%), Positives = 122/319 (38%), Gaps = 48/319 (15%)
Query: 160 FSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIE- 216
+ E DN +IG+G +G VYK D +AVK + Q +F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 217 -LLARLHHRHLVALRGFCIE-----KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ 270
+ + H ++ + E L+ EY NGSL +L W + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 271 IAIDVANALEYLH------FYCDPPLCHRDIKSSNILLDENFVAKLADFGLA----HASK 320
+A V L YLH + P + HRD+ S N+L+ + ++DFGL+
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 321 DGSICFEPVNTDIRGTPGYMDPEY-------VVTQELTEKSDVYSYGVVLLEIVTARRAV 373
+ GT YM PE + ++ D+Y+ G++ EI +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 374 QDGKNLVESAQVCMASE-------SRLAELVD-----PRIKDSF--DMEQLRTIVTIVRW 419
G++ V Q+ +E + LV P+ +++ + +R++ +
Sbjct: 236 FPGES-VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 420 CTQREGQARPSIKQVLRIL 438
C ++ +AR + + +
Sbjct: 295 CWDQDAEARLTAQXAEERM 313
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 7e-65
Identities = 55/276 (19%), Positives = 111/276 (40%), Gaps = 31/276 (11%)
Query: 171 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRM--DKISEQVEGDFCREIELLARLHHRHLVA 228
NF T + + G ++K ++ G+ I VK + S + DF E L H +++
Sbjct: 13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 229 LRGFCIEKRERFLMY--EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 286
+ G C +M GSL + LH + ++ A+D+A + +LH
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-L 130
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 346
+P + + S ++++DE+ A+++ + F + P ++ PE +
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVK---------FSFQSPGRMYAPAWVAPE-AL 180
Query: 347 TQE----LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402
++ +D++S+ V+L E+VT D N+ +V + R P I
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL-R------PTIP 233
Query: 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
+ +++ C + RP ++ IL
Sbjct: 234 PGISPH----VSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-64
Identities = 72/282 (25%), Positives = 130/282 (46%), Gaps = 35/282 (12%)
Query: 172 FSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEG-------DFCREIELLARLHH 223
+ IG+GGFG V+K + D S++A+K + + E +F RE+ +++ L+H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 224 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 283
++V L G ++ E++ G L L P+ W ++++ +D+A +EY+
Sbjct: 83 PNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQ 139
Query: 284 FYCDPPLCHRDIKSSNILLDE-----NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 338
+PP+ HRD++S NI L AK+ADFGL+ S + + G
Sbjct: 140 -NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV-------SGLLGNFQ 191
Query: 339 YMDPEYVVTQEL--TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL 396
+M PE + +E TEK+D YS+ ++L I+T D + + + M E L
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILT-GEGPFDEYSYGKIKFINMIREEGLR-- 248
Query: 397 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
P I + + ++ C + + RP +++ L
Sbjct: 249 --PTIPEDCPPR----LRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-61
Identities = 76/279 (27%), Positives = 121/279 (43%), Gaps = 33/279 (11%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRM----DKISEQVEGDFCREIELLARLHHRHLV 227
IIG GGFG VY+A + G +AVK D+ Q + +E +L A L H +++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 228 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 287
ALRG C+++ L+ E+ G L L + + A+ +A + YLH
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 288 PPLCHRDIKSSNILLDE--------NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGY 339
P+ HRD+KSSNIL+ + N + K+ DFGLA + G +
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK------MSAAGAYAW 180
Query: 340 MDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 399
M PE + ++ SDV+SYGV+L E++T G + + A ++
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLT-GEVPFRGIDGLAVAYGVAMNKLA------L 233
Query: 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
I + ++ C + +RPS +L L
Sbjct: 234 PIPSTCPEP----FAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-60
Identities = 66/293 (22%), Positives = 127/293 (43%), Gaps = 33/293 (11%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEL--LARLHHRHLVAL 229
+G+G +G V++ + G +AVK S + E + RE EL L H +++
Sbjct: 12 LLECVGKGRYGEVWRGSW-QGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 230 RGFCIEKR----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH-- 283
+ R + +L+ Y GSL D+L T L + ++I + +A+ L +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 284 ---FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 340
P + HRD+KS NIL+ +N +AD GLA + + N GT YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 341 DPE------YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 394
PE V + ++ D++++G+VL E+ + ++ + ++
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 395 ELVD--------PRIKDSFDMEQ-LRTIVTIVRWCTQREGQARPSIKQVLRIL 438
++ P I + + + L ++ +++ C + AR + ++ + L
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 5e-60
Identities = 64/276 (23%), Positives = 111/276 (40%), Gaps = 29/276 (10%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
+G+G FG K G ++ +K + + E+ + F +E++++ L H +++ G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 294
+ + + EY+ G+L+ + S W R+ A D+A+ + YLH + HRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133
Query: 295 IKSSNILLDENFVAKLADFGLA----------HASKDGSICFEPVNTDIRGTPGYMDPEY 344
+ S N L+ EN +ADFGLA + + G P +M PE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 345 VVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA--ELVDPRIK 402
+ + EK DV+S+G+VL EI+ A D + + P
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFF 253
Query: 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
I C + + RPS ++ L
Sbjct: 254 P------------ITVRCCDLDPEKRPSFVKLEHWL 277
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 6e-60
Identities = 76/333 (22%), Positives = 132/333 (39%), Gaps = 37/333 (11%)
Query: 136 SLKPFPPPRSLRKFQEG----PSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD 191
S+ PP SLR E S + T IG+G +G V+ ++
Sbjct: 1 SMTYIPPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-R 59
Query: 192 GSLIAVKRMDKISEQVEGDFCREIE--LLARLHHRHLVALRGFCIEKRER----FLMYEY 245
G +AVK E + RE E + H +++ I+ +L+ +Y
Sbjct: 60 GEKVAVK---VFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116
Query: 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH-----FYCDPPLCHRDIKSSNI 300
NGSL D+L T L ++ +++A + L +LH P + HRD+KS NI
Sbjct: 117 HENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI 173
Query: 301 LLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE------YVVTQELTEKS 354
L+ +N +AD GLA + + GT YM PE + +
Sbjct: 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA 233
Query: 355 DVYSYGVVLLEIVT---ARRAVQDGKNLVESAQVCMASESRLAELVD-----PRIKDSFD 406
D+YS+G++L E+ + V++ + S + E+V P + +
Sbjct: 234 DMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWS 293
Query: 407 MEQ-LRTIVTIVRWCTQREGQARPSIKQVLRIL 438
++ LR + ++ C +R + +V + L
Sbjct: 294 SDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 3e-57
Identities = 68/271 (25%), Positives = 121/271 (44%), Gaps = 27/271 (9%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRM--DKISEQVEGDFCREIELLARLHHRHLVALRGFC 233
IG G FGTVYK ++ +AVK + + Q F E+ +L + H +++ G+
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 234 IEKRERFLMY---EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
+ + ++ SL HLH+ T + I IA A ++YLH +
Sbjct: 90 TAPQ----LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH---AKSI 141
Query: 291 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 350
HRD+KS+NI L E+ K+ DFGLA S + G+ +M PE + Q+
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG--SHQFEQLSGSILWMAPEVIRMQDS 199
Query: 351 ---TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407
+ +SDVY++G+VL E++T + + N Q+ +++ +
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIEMVGRGSLSPDLSKVRSNCPK 256
Query: 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
+ ++ C +++ RPS ++L +
Sbjct: 257 R----MKRLMAECLKKKRDERPSFPRILAEI 283
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 9e-57
Identities = 73/293 (24%), Positives = 128/293 (43%), Gaps = 33/293 (11%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIE--LLARLHHRHLVAL 229
IG+G FG V++ ++ G +AVK S + E + RE E L H +++
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGF 101
Query: 230 RGFCIEKR----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH-- 283
+ + +L+ +Y +GSL D+L+ R ++ + I++A+ A+ L +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 284 ---FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 340
P + HRD+KS NIL+ +N +AD GLA + + GT YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 341 DPE------YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 394
PE + E +++D+Y+ G+V EI ++ + S+ +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 395 ELVD--------PRIKDSFDM-EQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
E+ P I + + E LR + I+R C G AR + ++ + L
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-55
Identities = 53/279 (18%), Positives = 104/279 (37%), Gaps = 30/279 (10%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVAL 229
+IG+G FG VY ++ +A++ +++ +E F RE+ + H ++V
Sbjct: 37 IGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
G C+ ++ +L + + L QIA ++ + YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN-TDIRGTPGYMDPEYVVTQ 348
+ H+D+KS N+ D V + DFGL S G ++ PE +
Sbjct: 151 ILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 349 EL---------TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 399
++ SDV++ G + E+ + Q+ + +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM--GTGMKP-----N 262
Query: 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
+ E I I+ +C E + RP+ +++ +L
Sbjct: 263 LSQIGMGKE----ISDILLFCWAFEQEERPTFTKLMDML 297
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-46
Identities = 63/273 (23%), Positives = 113/273 (41%), Gaps = 34/273 (12%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRG 231
IG+G F TVYK +A + K+++ F E E+L L H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 232 FCIEKRER-----FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 286
+ + E M +G+LK +L + + + L++LH
Sbjct: 93 SWESTVKGKKCIVLVT-ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLH-TR 148
Query: 287 DPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 345
PP+ HRD+K NI + K+ D GLA ++ + GTP +M PE +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA------TLKRASFAKAVIGTPEFMAPE-M 201
Query: 346 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE--SRLAELVDPRIKD 403
++ E DVY++G+ +LE+ T+ + +N + + + + ++ P +K+
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261
Query: 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
I+ C ++ R SIK +L
Sbjct: 262 ------------IIEGCIRQNKDERYSIKDLLN 282
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 71/298 (23%), Positives = 129/298 (43%), Gaps = 48/298 (16%)
Query: 161 SYKETKKATDNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEL 217
++ K+ +F I IG GGFG V+KA+ DG +KR+ +E+ E RE++
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKA 57
Query: 218 LARLHHRHLVALRGFCIEKRERFLMY----------------EYMANGSLKDHLHSPGRT 261
LA+L H ++V G E+ G+L+ +
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 262 PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321
L +++ + ++Y+H L +RD+K SNI L + K+ DFGL + K+
Sbjct: 118 KLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174
Query: 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 381
T +GT YM PE + +Q+ ++ D+Y+ G++L E++ +
Sbjct: 175 DG-----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT 229
Query: 382 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439
+L D I D FD ++ + T+++ ++ + RP+ ++LR L
Sbjct: 230 -------------DLRDGIISDIFD-KKEK---TLLQKLLSKKPEDRPNTSEILRTLT 270
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 62/276 (22%), Positives = 109/276 (39%), Gaps = 28/276 (10%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
+G+GGF V + DG A+KR+ +Q + RE ++ +H +++ L +C+
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 235 EKRER----FLMYEYMANGSLKDHL--HSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
+R +L+ + G+L + + L+ + + + + LE +H
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AK 153
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPGYMDPE 343
HRD+K +NILL + L D G H R T Y PE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 344 YVVTQ---ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 400
Q + E++DV+S G VL ++ +S V +A +++L+ PR
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--VALAVQNQLSIPQSPR 271
Query: 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
S + QL + + RP I +L
Sbjct: 272 H--SSALWQL------LNSMMTVDPHQRPHIPLLLS 299
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-42
Identities = 67/273 (24%), Positives = 111/273 (40%), Gaps = 29/273 (10%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRG 231
IG G +G K + SDG ++ K +D ++E + E+ LL L H ++V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 232 FCIEKRERFL---MYEYMANGSLKDHL--HSPGRTPLSWQTRIQIAIDVANALEYLHFYC 286
I++ L M EY G L + + R L + +++ + AL+ H
Sbjct: 73 RIIDRTNTTLYIVM-EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 287 DPPLC--HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
D HRD+K +N+ LD KL DFGLA + T + GTP YM PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF---AKTFV-GTPYYMSPEQ 187
Query: 345 VVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE-SAQVCMASESRLAELVDPRIKD 403
+ EKSD++S G +L E+ + E + ++ R+ + +
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREGKFRRIPYRYSDELNE 246
Query: 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
I+ + RPS++++L
Sbjct: 247 ------------IITRMLNLKDYHRPSVEEILE 267
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 62/266 (23%), Positives = 115/266 (43%), Gaps = 24/266 (9%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRG 231
IG+G FG + DG +K ++ ++S + + RE+ +LA + H ++V R
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
E +++ +Y G L +++ + + + AL+++H D +
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 351
HRDIKS NI L ++ +L DFG+A E I GTP Y+ PE +
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV---ELARACI-GTPYYLSPEICENKPYN 203
Query: 352 EKSDVYSYGVVLLEIVTARRAVQDGKNLVE-SAQVCMASESRLAELVDPRIKDSFDMEQL 410
KSD+++ G VL E+ T + A + ++ ++ S ++ ++
Sbjct: 204 NKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISGSFPPVSLHYSYDLRS------- 255
Query: 411 RTIVTIVRWCTQREGQARPSIKQVLR 436
+V +R + RPS+ +L
Sbjct: 256 -----LVSQLFKRNPRDRPSVNSILE 276
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 5e-41
Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 22/202 (10%)
Query: 176 IGQGGFGTVYKAQFSDGSL-IAVKRM-DKISEQVEGDFCREIELLARLHHRHLVALRGFC 233
IG+G FG V+ + + +AVK + + ++ F +E +L + H ++V L G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 234 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 293
+K+ +++ E + G L + G L +T +Q+ D A +EYL HR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLE---SKCCIHR 237
Query: 294 DIKSSNILLDENFVAKLADFGLA-------HASKDGSICFEPVNTDIRGTPGYMDPEYVV 346
D+ + N L+ E V K++DFG++ +A+ G P ++ T PE +
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV-P----VKWTA----PEALN 288
Query: 347 TQELTEKSDVYSYGVVLLEIVT 368
+ +SDV+S+G++L E +
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 74/324 (22%), Positives = 133/324 (41%), Gaps = 48/324 (14%)
Query: 127 EDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYK 186
E + + + F P ++LR G + + ++ KK IG+G F VY+
Sbjct: 3 EQSQGMQGPPVPQFQPQKALRP-DMGYNTLAN---FRIEKK--------IGRGQFSEVYR 50
Query: 187 AQ-FSDGSLIAVKRMD---KISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242
A DG +A+K++ + + D +EI+LL +L+H +++ IE E ++
Sbjct: 51 AACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110
Query: 243 YEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 300
E G L + + + +T + + + +ALE++H + HRDIK +N+
Sbjct: 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANV 167
Query: 301 LLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYG 360
+ V KL D GL + S ++ + GTP YM PE + KSD++S G
Sbjct: 168 FITATGVVKLGDLGLG---RFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLG 223
Query: 361 VVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM-------EQLRTI 413
+L E+ + + L L + + E+LR
Sbjct: 224 CLLYEMAALQSPFY-------------GDKMNLYSLCKKIEQCDYPPLPSDHYSEELR-- 268
Query: 414 VTIVRWCTQREGQARPSIKQVLRI 437
+V C + + RP + V +
Sbjct: 269 -QLVNMCINPDPEKRPDVTYVYDV 291
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-40
Identities = 63/285 (22%), Positives = 109/285 (38%), Gaps = 42/285 (14%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMD-KISEQVEGDFCREIELLARLHHRHLVALRGFC 233
+G+GGFG V++A+ D A+KR+ E RE++ LA+L H +V
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 234 IEKRERF-------------LMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANAL 279
+EK M + +LKD ++ + I + +A A+
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQM-QLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 280 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNT 331
E+LH L HRD+K SNI + V K+ DFGL + + +T
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 391
GT YM PE + + K D++S G++L E++ +
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRT------------ 236
Query: 392 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
L ++ + + F ++ +V+ RP ++
Sbjct: 237 -LTDVRNLKFPPLFT-QKYPCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 65/341 (19%), Positives = 132/341 (38%), Gaps = 40/341 (11%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDK--ISEQVEGDFCREIELLARL--HHRHLVALRG 231
IG GG V++ + A+K ++ Q + EI L +L H ++ L
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
+ I + +++ E N L L + R ++ A+ +H +
Sbjct: 77 YEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIH---QHGIV 130
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE-------- 343
H D+K +N L+ + + KL DFG+A+ + + V GT YM PE
Sbjct: 131 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSV--VKDSQVGTVNYMPPEAIKDMSSS 187
Query: 344 ---YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA--ELVD 398
+++ KSDV+S G +L + + Q N + + + ++ +
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 247
Query: 399 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR--ILYESSDPMHSGFVQAVEDE 456
++D +++ C +R+ + R SI ++L + + P++ E+
Sbjct: 248 KDLQD------------VLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEM 295
Query: 457 EYEETDGRPRTSQRKAHRSDPTFYSGDGRYLASSSSTSRSY 497
+Y S ++ T Y + +SS+S+++
Sbjct: 296 KYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTF 336
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-39
Identities = 70/288 (24%), Positives = 112/288 (38%), Gaps = 41/288 (14%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFC 233
+ +GGF VY+AQ G A+KR+ E+ +E+ + +L H ++V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 234 IEKRER-------FLMYEYMANGSLKDHL-HSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
+E FL+ + G L + L R PLS T ++I A++++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-R 154
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLA---------HASKDGSICFEPVNTDIRGT 336
PP+ HRD+K N+LL KL DFG A S E T T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT-RNTT 213
Query: 337 PGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGKNL-VESAQVCMASESR 392
P Y PE + + EK D+++ G +L + + +DG L + + + +
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDT 273
Query: 393 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440
L +R Q + R SI +V+ L E
Sbjct: 274 Q----------YTVFHSL------IRAMLQVNPEERLSIAEVVHQLQE 305
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 74/316 (23%), Positives = 120/316 (37%), Gaps = 58/316 (18%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC 233
++GQG FG V KA+ D A+K++ E++ E+ LLA L+H+++V
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQYVVRYYAAW 71
Query: 234 IEKRERFLMY-------------EYMANGSLKDHLHSPGRTP---LSWQTRIQIAIDVAN 277
+E+R EY NG+L D +HS W+ QI
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL----E 127
Query: 278 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR--- 334
AL Y+H + HRD+K NI +DE+ K+ DFGLA + + ++
Sbjct: 128 ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 335 -------GTPGYMDPEYVVTQELT--EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 385
GT Y+ E V+ EK D+YS G++ E++ G V +
Sbjct: 185 DNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYPF---STGMERVNILKK 240
Query: 386 CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM 445
+ P D+ + + I+R + RP + +L
Sbjct: 241 LRSVSIEF----PPDFDDNKMKVEKK----IIRLLIDHDPNKRPGARTLLN--------- 283
Query: 446 HSGFVQAVEDEEYEET 461
+DE +E
Sbjct: 284 SGWLPVKHQDEVIKEA 299
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 74/324 (22%), Positives = 114/324 (35%), Gaps = 46/324 (14%)
Query: 127 EDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKAT---DNFSTI--IGQGGF 181
ENL S+ P R F+ S Q Y ++ + +F + +G G +
Sbjct: 13 LGTENLYFQSMHQLQPRR--VSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSY 70
Query: 182 GTVYKAQ-FSDGSLIAVKRMDK--ISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKR 237
G V+K + DG L AVKR + E+ ++ H V L E
Sbjct: 71 GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130
Query: 238 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 297
+L E SL+ H + G L D AL +LH L H D+K
Sbjct: 131 ILYLQTEL-CGPSLQQHCEAWGA-SLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKP 185
Query: 298 SNILLDENFVAKLADFGLA----HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 353
+NI L KL DFGL A G P YM PE ++
Sbjct: 186 ANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---------GDPRYMAPE-LLQGSYGTA 235
Query: 354 SDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD-PRIKDSFDMEQLRT 412
+DV+S G+ +LE+ G+ +L + P E LR
Sbjct: 236 ADVFSLGLTILEVACNMELPHGGEGW-----------QQLRQGYLPPEFTAGLSSE-LR- 282
Query: 413 IVTIVRWCTQREGQARPSIKQVLR 436
+++ + + + R + + +L
Sbjct: 283 --SVLVMMLEPDPKLRATAEALLA 304
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 67/385 (17%), Positives = 140/385 (36%), Gaps = 50/385 (12%)
Query: 142 PPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI----------IGQGGFGTVYKAQFSD 191
+ + Q SP + + + ++ IG GG V++
Sbjct: 20 TAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEK 79
Query: 192 GSLIAVKRMDK--ISEQVEGDFCREIELLARLHH--RHLVALRGFCIEKRERFLMYEYMA 247
+ A+K ++ Q + EI L +L ++ L + I + +++ E
Sbjct: 80 KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-G 138
Query: 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV 307
N L L + R ++ A+ +H + H D+K +N L+ + +
Sbjct: 139 NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML 193
Query: 308 AKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE-----------YVVTQELTEKSDV 356
KL DFG+A+ + + V G YM PE +++ KSDV
Sbjct: 194 -KLIDFGIANQMQPDTTSV--VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 250
Query: 357 YSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS--ESRLAELVDPRIKDSFDMEQLRTIV 414
+S G +L + + Q N + + E ++ + ++D
Sbjct: 251 WSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD----------- 299
Query: 415 TIVRWCTQREGQARPSIKQVLR--ILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKA 472
+++ C +R+ + R SI ++L + + P++ E+ +Y S
Sbjct: 300 -VLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSI 358
Query: 473 HRSDPTFYSGDGRYLASSSSTSRSY 497
++ T Y + +SS+S+++
Sbjct: 359 LKAAKTLYEHYSGGESHNSSSSKTF 383
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 50/217 (23%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSL--------IAVKRMDKISEQVEGDFCREIELLARLHH 223
F+ +GQG F ++K + + +K +DK F ++++L H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 224 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL- 282
+HLV G C+ E L+ E++ GSL +L + ++ ++++A +A A+ +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLE 130
Query: 283 --HFYCDPPLCHRDIKSSNILLD--------ENFVAKLADFGLAHASKDGSICFEPVNTD 332
H ++ + NILL KL+D G++ I E
Sbjct: 131 ENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER---- 180
Query: 333 IRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVT 368
I P PE + + L +D +S+G L EI +
Sbjct: 181 IPWVP----PECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 51/225 (22%)
Query: 175 IIGQGGFGTVYKAQFSDGS----LIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVA 228
++G+G FG+V +AQ +AVK + D I+ +F RE + H H+
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 229 LRGFCIEKRERFLMY------EYMANGSLKDHL--HSPGRTP--LSWQTRIQIAIDVANA 278
L G + R + + +M +G L L G P L QT ++ +D+A
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 279 LEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG 335
+EYL +F HRD+ + N +L E+ +ADFGL+ I
Sbjct: 150 MEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSR--------------KIYS 189
Query: 336 TPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
Y + E + T SDV+++GV + EI+T
Sbjct: 190 GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-38
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 38/218 (17%)
Query: 171 NFSTIIGQGGFGTVYKAQFSDGS----LIAVKRM-DKISEQVEGDFCREIELLARLHHRH 225
+F+ +IG+G FG VY D AVK + F E ++ H +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 226 LVALRGFCIEKRERFLM-YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL-- 282
+++L G C+ L+ YM +G L++ + + + + I + VA ++YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKYLAS 146
Query: 283 -HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-----------HASKDGSICFEPVN 330
F HRD+ + N +LDE F K+ADFGLA H + PV
Sbjct: 147 KKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL---PVK 197
Query: 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
+M E + TQ+ T KSDV+S+GV+L E++T
Sbjct: 198 --------WMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-38
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 28/205 (13%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRG 231
IG+G FG V + G+ +AVK + K + F E ++ +L H +LV L G
Sbjct: 25 LLQTIGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLG 81
Query: 232 FCIEKRERFLM-YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCD 287
+E++ + EYMA GSL D+L S GR+ L ++ ++DV A+EYL +F
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 138
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLA----HASKDGSICFEPVNTDIRGTPGYMDPE 343
HRD+ + N+L+ E+ VAK++DFGL G + P ++ T PE
Sbjct: 139 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---P----VKWTA----PE 184
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVT 368
+ ++ + KSDV+S+G++L EI +
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-38
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 50/224 (22%)
Query: 175 IIGQGGFGTVYKAQFSDGS----LIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVA 228
I+G+G FG+V + +AVK ++D S++ +F E + H +++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 229 LRGFCIEKRERFLMY-----EYMANGSLKDHL----HSPGRTPLSWQTRIQIAIDVANAL 279
L G CIE + + +M G L +L G + QT ++ +D+A +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 280 EYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 336
EYL +F HRD+ + N +L ++ +ADFGL+ I
Sbjct: 161 EYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSK--------------KIYSG 200
Query: 337 PGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
Y + E + + T KSDV+++GV + EI T
Sbjct: 201 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-38
Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 55/228 (24%)
Query: 176 IGQGGFGTVYKAQ------FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL 229
+G+G FG V+ A+ D L+AVK + + DF RE ELL L H H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHS--------------PGRTPLSWQTRIQIAIDV 275
G C + +++EYM +G L L + + L + IA +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 276 ANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 332
A+ + YL HF HRD+ + N L+ N + K+ DFG++ D
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSR--------------D 182
Query: 333 IRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
+ T Y M PE ++ ++ T +SDV+S+GV+L EI T
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-38
Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 50/227 (22%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGS------LIAVKRM-DKISEQVEGDFCREIELLARLHHR 224
S +GQG FG VY+ +A+K + + S + +F E ++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 225 HLVALRGFCIEKRERFLMYEYMANGSLKDHL--------HSPGRTPLSWQTRIQIAIDVA 276
H+V L G + + ++ E M G LK +L ++P P S IQ+A ++A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 277 NALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDI 333
+ + YL F HRD+ + N ++ E+F K+ DFG+ DI
Sbjct: 149 DGMAYLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMTR--------------DI 188
Query: 334 RGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
T Y M PE + T SDV+S+GVVL EI T
Sbjct: 189 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-38
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGS----LIAVKRM-DKISEQVEGDFCREIELLARLHHRHL 226
+IG+G FG VY ++ D + A+K + Q F RE L+ L+H ++
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 227 VALRGFCIEKRERFLM-YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL--- 282
+AL G + + YM +G L + SP R + + I + VA +EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQVARGMEYLAEQ 143
Query: 283 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD----IRGTPG 338
F HRD+ + N +LDE+F K+ADFGLA D + ++ T
Sbjct: 144 KF------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA- 196
Query: 339 YMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
E + T T KSDV+S+GV+L E++T
Sbjct: 197 ---LESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 69/315 (21%), Positives = 118/315 (37%), Gaps = 41/315 (13%)
Query: 71 LVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRKSRGLEDPE 130
+ + P H L+P + + I + + + S L
Sbjct: 1 MSPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQG 60
Query: 131 NLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFS 190
P ++ Q +F+ +IG+G FG VY
Sbjct: 61 ANTVHIDLSALNPELVQAVQH---------VVIGPSSLIVHFNEVIGRGHFGCVYHGTLL 111
Query: 191 DGS----LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM-YE 244
D AVK + F E ++ H ++++L G C+ L+
Sbjct: 112 DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171
Query: 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPLCHRDIKSSNIL 301
YM +G L++ + + + + I + VA +++L F HRD+ + N +
Sbjct: 172 YMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFLASKKF------VHRDLAARNCM 224
Query: 302 LDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 353
LDE F K+ADFGLA + + + PV +M E + TQ+ T K
Sbjct: 225 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK--------WMALESLQTQKFTTK 276
Query: 354 SDVYSYGVVLLEIVT 368
SDV+S+GV+L E++T
Sbjct: 277 SDVWSFGVLLWELMT 291
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 28/205 (13%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRG 231
IG+G FG V + G+ +AVK + K + F E ++ +L H +LV L G
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLG 253
Query: 232 FCIEKRERFLM-YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCD 287
+E++ + EYMA GSL D+L S GR+ L ++ ++DV A+EYL +F
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 310
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLA----HASKDGSICFEPVNTDIRGTPGYMDPE 343
HRD+ + N+L+ E+ VAK++DFGL G + P ++ T PE
Sbjct: 311 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---P----VKWTA----PE 356
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVT 368
+ ++ + KSDV+S+G++L EI +
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYS 381
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 60/238 (25%), Positives = 92/238 (38%), Gaps = 64/238 (26%)
Query: 175 IIGQGGFGTVYKAQFSDG------SLIAVKRM-DKISEQVEGDFCREIELLARLHHRHLV 227
+G+G FG V KA + +AVK + + S D E +L +++H H++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 228 ALRGFCIEKRERFLMYEYMANGSLKDHL----------------------HSPGRTPLSW 265
L G C + L+ EY GSL+ L P L+
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 266 QTRIQIAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322
I A ++ ++YL HRD+ + NIL+ E K++DFGL+
Sbjct: 150 GDLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSR----- 198
Query: 323 SICFEPVNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
D+ Y M E + T +SDV+S+GV+L EIVT
Sbjct: 199 ---------DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 30/205 (14%)
Query: 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
IG G FG V+ + + +A+K + + E DF E E++ +L H LV L G C+
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPLC 291
E+ L+ E+M +G L D+L + R + +T + + +DV + YL
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACV------I 126
Query: 292 HRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYMDPE 343
HRD+ + N L+ EN V K++DFG+ +S P ++ PE
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF---P----VKWAS----PE 175
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVT 368
+ KSDV+S+GV++ E+ +
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 30/206 (14%)
Query: 175 IIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC 233
+G G +G VY+ + SL +AVK + + + +VE +F +E ++ + H +LV L G C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 234 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPL 290
+ +++ E+M G+L D+L R +S + +A +++A+EYL +F
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF------ 132
Query: 291 CHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYMDP 342
HRD+ + N L+ EN + K+ADFGL+ A P+ + P
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIK--------WTAP 181
Query: 343 EYVVTQELTEKSDVYSYGVVLLEIVT 368
E + + + KSDV+++GV+L EI T
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 58/278 (20%), Positives = 110/278 (39%), Gaps = 38/278 (13%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDK--ISEQVEGDFCREIELLARL--HHRHLVALRG 231
IG GG V++ + A+K ++ Q + EI L +L H ++ L
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
+ I + +++ E N L L + R ++ A+ +H +
Sbjct: 96 YEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIH---QHGIV 149
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE-------- 343
H D+K +N L+ + + KL DFG+A+ + + V GT YM PE
Sbjct: 150 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSV--VKDSQVGTVNYMPPEAIKDMSSS 206
Query: 344 ---YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES--AQVCMASESRLAELVD 398
+++ KSDV+S G +L + + Q N + A + E ++ +
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 266
Query: 399 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
++D +++ C +R+ + R SI ++L
Sbjct: 267 KDLQD------------VLKCCLKRDPKQRISIPELLA 292
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 16/201 (7%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRG 231
+GQG FG V+ ++ + +A+K + + E F +E +++ +L H LV L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 246
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDP 288
E+ +++ EYM+ GSL D L L + +A +A+ + Y+ ++
Sbjct: 247 VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---- 301
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVT 347
HRD++++NIL+ EN V K+ADFGLA +D + I+ T PE +
Sbjct: 302 --VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALY 355
Query: 348 QELTEKSDVYSYGVVLLEIVT 368
T KSDV+S+G++L E+ T
Sbjct: 356 GRFTIKSDVWSFGILLTELTT 376
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFCREIELLARLHHRHLVALR 230
+G G +G VY+ + SL +AVK + + + +VE +F +E ++ + H +LV L
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 282
Query: 231 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
G C + +++ E+M G+L D+L R +S + +A +++A+EYL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339
Query: 291 CHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYMDP 342
HR++ + N L+ EN + K+ADFGL+ A P+ + P
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIK--------WTAP 388
Query: 343 EYVVTQELTEKSDVYSYGVVLLEIVT 368
E + + + KSDV+++GV+L EI T
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 30/205 (14%)
Query: 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
+G G FG V ++ +AVK + + S + +F +E + + +L H LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPLC 291
++ +++ EY++NG L ++L S G+ L +++ DV + +L F
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLESHQF------I 126
Query: 292 HRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYMDPE 343
HRD+ + N L+D + K++DFG+ +S P ++ + PE
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF---P----VKWSA----PE 175
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVT 368
+ + KSDV+++G+++ E+ +
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 30/205 (14%)
Query: 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
+G G FG V+ ++ + +AVK K F E L+ +L H+ LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVK-SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPLC 291
+ +++ EYM NGSL D L +P L+ + +A +A + ++ ++
Sbjct: 79 -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY------I 131
Query: 292 HRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYMDPE 343
HRD++++NIL+ + K+ADFGLA A + P I+ T PE
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF---P----IKWTA----PE 180
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVT 368
+ T KSDV+S+G++L EIVT
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 30/205 (14%)
Query: 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
+G G FG V ++ +A+K + + S + +F E +++ L H LV L G C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPLC 291
++R F++ EYMANG L ++L R Q +++ DV A+EYL F
Sbjct: 90 KQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQF------L 142
Query: 292 HRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYMDPE 343
HRD+ + N L+++ V K++DFGL+ +S P +R +P PE
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF---P----VRWSP----PE 191
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVT 368
++ + + KSD++++GV++ EI +
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-37
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 30/208 (14%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRG 231
+G G FG V+ A ++ + +AVK K F E ++ L H LV L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVK-TMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDP 288
++ + E+MA GSL D L S + I + +A + ++ ++
Sbjct: 251 VVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---- 305
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYM 340
HRD++++NIL+ + V K+ADFGLA A + I+ T
Sbjct: 306 --IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-------IKWTA--- 353
Query: 341 DPEYVVTQELTEKSDVYSYGVVLLEIVT 368
PE + T KSDV+S+G++L+EIVT
Sbjct: 354 -PEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-37
Identities = 68/282 (24%), Positives = 117/282 (41%), Gaps = 30/282 (10%)
Query: 175 IIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL 229
+G+G FG+V ++ + G ++AVK++ +E+ DF REIE+L L H ++V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 230 RGFCIEKRERFLMY--EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HF 284
+G C R L EY+ GSL+D+L + + +Q + +EYL +
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD----IRGTPGYM 340
HRD+ + NIL++ K+ DFGL F+ V I
Sbjct: 136 ------IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK-VKEPGESPIFWYA--- 185
Query: 341 DPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 400
PE + + + SDV+S+GVVL E+ T + + +
Sbjct: 186 -PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 401 IKDSFDMEQLRT----IVTIVRWCTQREGQARPSIKQVLRIL 438
+K++ + + I I+ C RPS + + +
Sbjct: 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 65/298 (21%), Positives = 117/298 (39%), Gaps = 68/298 (22%)
Query: 118 LIRRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATD------- 170
+ R+ + + S P + +PM S E +
Sbjct: 24 IPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTA-DTPMLAGVSEYELPEDPKWEFPRDK 82
Query: 171 -NFSTIIGQGGFGTVYKA--------QFSDGSLIAVKRM-DKISEQVEGDFCREIELLAR 220
+G+G FG V A + + +AVK + D +E+ D E+E++
Sbjct: 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM 142
Query: 221 L-HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHL--------------HSPGRTPLSW 265
+ H++++ L G C + +++ EY + G+L+++L + +++
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 266 QTRIQIAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322
+ + +A +EYL HRD+ + N+L+ EN V K+ADFGLA
Sbjct: 203 KDLVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLAR----- 251
Query: 323 SICFEPVNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
DI Y M PE + + T +SDV+S+GV++ EI T
Sbjct: 252 ---------DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 73/226 (32%), Positives = 105/226 (46%), Gaps = 44/226 (19%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGS------LIAVKRMDKISEQVEGDFCREIELLARLHHRH 225
+G+G FG V+ A+ + L+AVK + + SE DF RE ELL L H+H
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHL--HSP-----------GRTPLSWQTRIQIA 272
+V G C E R +++EYM +G L L H P PL + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 273 IDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA-------SKDG 322
VA + YL HF HRD+ + N L+ + V K+ DFG++ G
Sbjct: 165 SQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 218
Query: 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
P IR +M PE ++ ++ T +SDV+S+GVVL EI T
Sbjct: 219 RTML-P----IR----WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-36
Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 16/201 (7%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRG 231
+GQG FG V+ ++ + +A+K + + E F +E +++ +L H LV L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 329
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDP 288
E+ +++ EYM+ GSL D L L + +A +A+ + Y+ ++
Sbjct: 330 VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---- 384
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVT 347
HRD++++NIL+ EN V K+ADFGLA +D + I+ T PE +
Sbjct: 385 --VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALY 438
Query: 348 QELTEKSDVYSYGVVLLEIVT 368
T KSDV+S+G++L E+ T
Sbjct: 439 GRFTIKSDVWSFGILLTELTT 459
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 59/232 (25%)
Query: 176 IGQGGFGTVYKA--------QFSDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HHRH 225
+G+G FG V A + + +AVK + D +E+ D E+E++ + H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHL--------------HSPGRTPLSWQTRIQI 271
++ L G C + +++ EY + G+L+++L + ++++ +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 272 AIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328
+A +EYL HRD+ + N+L+ EN V K+ADFGLA
Sbjct: 163 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLAR----------- 205
Query: 329 VNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
DI Y M PE + + T +SDV+S+GV++ EI T
Sbjct: 206 ---DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 67/283 (23%), Positives = 117/283 (41%), Gaps = 32/283 (11%)
Query: 175 IIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL 229
+G+G FG+V ++ + G ++AVK++ +E+ DF REIE+L L H ++V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 230 RGFCIEKRERFLM--YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HF 284
+G C R L EY+ GSL+D+L + +Q + +EYL +
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTKRY 166
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG-----Y 339
HRD+ + NIL++ K+ DFGL ++ PG +
Sbjct: 167 ------IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV------KEPGESPIFW 214
Query: 340 MDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 399
PE + + + SDV+S+GVVL E+ T + + +
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274
Query: 400 RIKDSFDMEQLRT----IVTIVRWCTQREGQARPSIKQVLRIL 438
+K++ + + I I+ C RPS + + +
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 76/225 (33%), Positives = 108/225 (48%), Gaps = 45/225 (20%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSL---IAVKRM-DKISEQVEGDFCREIELLARL-HHRHL 226
F +IG+G FG V KA+ L A+KRM + S+ DF E+E+L +L HH ++
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 227 VALRGFCIEKRERFLMYEYMANGSLKDHLHS--------------PGRTPLSWQTRIQIA 272
+ L G C + +L EY +G+L D L + LS Q + A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 273 IDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA------HASKDGS 323
DVA ++YL F HRD+ + NIL+ EN+VAK+ADFGL+ G
Sbjct: 149 ADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 202
Query: 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
+ PV +M E + T SDV+SYGV+L EIV+
Sbjct: 203 L---PVR--------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 54/203 (26%), Positives = 81/203 (39%), Gaps = 21/203 (10%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
+G+G FG V++ + G AVK++ +E E+ A L +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVR-----LEVFRVEELVACAGLSSPRIVPLYGAVR 120
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPPLC 291
E + E + GSL + G P + LEYLH +
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPED-----RALYYLGQALEGLEYLH---TRRIL 172
Query: 292 HRDIKSSNILLDEN-FVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
H D+K+ N+LL + A L DFG A DG I GT +M PE VV +
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGK 231
Query: 350 -LTEKSDVYSYGVVLLEIVTARR 371
K D++S ++L ++
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCH 254
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 72/289 (24%)
Query: 132 LDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATD--------NFSTIIGQGGFGT 183
++ ++ P L + P+PM+Q+ K + IG+G FG
Sbjct: 3 MESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGR 62
Query: 184 VYKAQ------FSDGSLIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK 236
V++A+ + +++AVK + ++ S ++ DF RE L+A + ++V L G C
Sbjct: 63 VFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122
Query: 237 RERFLMYEYMANGSLKDHLHS----------------------PGRTPLSWQTRIQIAID 274
+ L++EYMA G L + L S PG PLS ++ IA
Sbjct: 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182
Query: 275 VANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331
VA + YL F HRD+ + N L+ EN V K+ADFGL+
Sbjct: 183 VAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSR-------------- 222
Query: 332 DIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
+I Y M PE + T +SDV++YGVVL EI +
Sbjct: 223 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-36
Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 175 IIGQGGFGTVYKAQF-----SDGSLIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 228
+G+G FG V ++ + G +AVK + + D +EIE+L L+H ++V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 229 LRGFCIEKRERFLM--YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 286
+G C E + E++ +GSLK++L ++ + +++ A+ + ++YL
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLG--- 143
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD----IRGTPGYMDP 342
HRD+ + N+L++ K+ DFGL A + + V D + P
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT-VKDDRDSPVFWYA----P 198
Query: 343 EYVVTQELTEKSDVYSYGVVLLEIVT 368
E ++ + SDV+S+GV L E++T
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 70/292 (23%), Positives = 119/292 (40%), Gaps = 36/292 (12%)
Query: 175 IIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL 229
+G+G FG+V ++ + G+L+AVK++ + DF REI++L LH +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 230 RGFCIEKRERFLMY--EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HF 284
RG + L EY+ +G L+D L L + + + +EYL
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSRRC 148
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG-----Y 339
HRD+ + NIL++ K+ADFGLA + PG +
Sbjct: 149 ------VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV------REPGQSPIFW 196
Query: 340 MDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 399
PE + + +SDV+S+GVVL E+ T C L+ L++
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE- 255
Query: 400 RIKDSFDMEQLRT----IVTIVRWCTQREGQARPS---IKQVLRILYESSDP 444
+++ + + +++ C Q RPS + L +L+ S
Sbjct: 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-36
Identities = 52/233 (22%), Positives = 94/233 (40%), Gaps = 56/233 (24%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGS------LIAVKRM-DKISEQVEGDFCREIELLARLHHR 224
F +G+ FG VYK + +A+K + DK + +F E L ARL H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 225 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHS--------------PGRTPLSWQTRIQ 270
++V L G + + +++ Y ++G L + L ++ L +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 271 IAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327
+ +A +EYL H H+D+ + N+L+ + K++D GL
Sbjct: 133 LVAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFR---------- 176
Query: 328 PVNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
++ Y M PE ++ + + SD++SYGVVL E+ +
Sbjct: 177 ----EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-36
Identities = 54/212 (25%), Positives = 85/212 (40%), Gaps = 27/212 (12%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGF 232
I+GQG V++ + G L A+K + IS + RE E+L +L+H+++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 233 CIEKRERFLMY---EYMANGSLKDHLHSPGRT-PLSWQTRIQIAIDVANALEYLHFYCDP 288
E+ E+ GSL L P L + + DV + +L +
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131
Query: 289 PLCHRDIKSSNILL----DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
+ HR+IK NI+ D V KL DFG A +D + GT Y+ P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-----VSLYGTEEYLHPDM 186
Query: 345 V--------VTQELTEKSDVYSYGVVLLEIVT 368
++ D++S GV T
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-36
Identities = 56/232 (24%), Positives = 89/232 (38%), Gaps = 55/232 (23%)
Query: 172 FSTIIGQGGFGTVYKA------QFSDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HH 223
F +G G FG V +A + +AVK + + E+++++ L H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 224 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHS------------PGRTPLSWQTRIQI 271
++V L G C ++ EY G L + L + S + +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 272 AIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328
+ VA + +L + HRD+ + N+LL VAK+ DFGLA
Sbjct: 170 SSQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLAR----------- 212
Query: 329 VNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
DI Y M PE + T +SDV+SYG++L EI +
Sbjct: 213 ---DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-36
Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 175 IIGQGGFGTVYKAQFSDGSL-----IAVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 228
++G G FGTVYK + +A+K + + S + + E ++A + + H+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFY 285
L G C+ L+ + M G L D++ + Q + + +A + YL
Sbjct: 82 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRL- 138
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD--IRGTPGYMDPE 343
HRD+ + N+L+ K+ DFGLA + I+ +M E
Sbjct: 139 -----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALE 189
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVT 368
++ + T +SDV+SYGV + E++T
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 175 IIGQGGFGTVYKAQF-----SDGSLIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 228
+G+G FG V + G ++AVK + Q + +EI++L L+H H++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 229 LRGFCIEKRERFLM--YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---H 283
+G C + L EY+ GSL+D+L R + + A + + YL H
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD----IRGTPGY 339
+ HRD+ + N+LLD + + K+ DFGLA A +G + V D + +
Sbjct: 155 Y------IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VREDGDSPVF----W 203
Query: 340 MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
PE + + SDV+S+GV L E++T
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 66/220 (30%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGS------LIAVKRM-DKISEQVEGDFCREIELLARLHHR 224
+G G FG VY+ Q S +AVK + + SEQ E DF E ++++ +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 225 HLVALRGFCIEKRERFLMYEYMANGSLKDHL-----HSPGRTPLSWQTRIQIAIDVANAL 279
++V G ++ RF++ E MA G LK L + L+ + +A D+A
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 280 EYL---HFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVNTDI 333
+YL HF HRDI + N LL VAK+ DFG+A S
Sbjct: 154 QYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-------R 200
Query: 334 RGTPGY-----MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
+G M PE + T K+D +S+GV+L EI +
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 64/249 (25%), Positives = 109/249 (43%), Gaps = 34/249 (13%)
Query: 135 TSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGS- 193
T+ + P+ KF E + +IG G FG VYK S
Sbjct: 16 TTENLYFQGAM----GSDPNQAVLKF-TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG 70
Query: 194 ----LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248
+A+K + +E+ DF E ++ + H +++ L G + + ++ EYM N
Sbjct: 71 KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMEN 130
Query: 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDEN 305
G+L L S + + +A ++YL ++ HRD+ + NIL++ N
Sbjct: 131 GALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLANMNY------VHRDLAARNILVNSN 183
Query: 306 FVAKLADFGLAHASKDGSICFEPVNTD------IRGTPGYMDPEYVVTQELTEKSDVYSY 359
V K++DFGL+ +D E T IR T PE + ++ T SDV+S+
Sbjct: 184 LVCKVSDFGLSRVLEDDP---EATYTTSGGKIPIRWTA----PEAISYRKFTSASDVWSF 236
Query: 360 GVVLLEIVT 368
G+V+ E++T
Sbjct: 237 GIVMWEVMT 245
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 60/235 (25%), Positives = 96/235 (40%), Gaps = 58/235 (24%)
Query: 172 FSTIIGQGGFGTVYKAQ------FSDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HH 223
+G+G FG V +A + +AVK + + + E+++L + HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 224 RHLVALRGFCIEKRE-RFLMYEYMANGSLKDHLHS--------------PGRTPLSWQTR 268
++V L G C + ++ E+ G+L +L S + L+ +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 269 IQIAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325
I + VA +E+L HRD+ + NILL E V K+ DFGLA
Sbjct: 151 ICYSFQVAKGMEFLASRKC------IHRDLAARNILLSEKNVVKICDFGLAR-------- 196
Query: 326 FEPVNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
DI P Y M PE + + T +SDV+S+GV+L EI +
Sbjct: 197 ------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 59/241 (24%), Positives = 102/241 (42%), Gaps = 23/241 (9%)
Query: 140 FPPPRSLRKFQEGPSPMFQKFSY-KETKKATDNFSTIIGQGGFGTVYKAQFSDGS----L 194
P P+ + P S+ +E + + + IIG G G V +
Sbjct: 20 LPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVP 79
Query: 195 IAVKRM-DKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKD 253
+A+K + +E+ DF E ++ + H +++ L G R ++ EYM NGSL
Sbjct: 80 VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 254 HLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKL 310
L + + + + V + YL + HRD+ + N+L+D N V K+
Sbjct: 140 FLRTHDGQ-FTIMQLVGMLRGVGAGMRYLSDLGY------VHRDLAARNVLVDSNLVCKV 192
Query: 311 ADFGLAHASKDGSICFEPVNTD---IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 367
+DFGL+ +D IR T PE + + + SDV+S+GVV+ E++
Sbjct: 193 SDFGLSRVLEDDPDAAYTTTGGKIPIRWTA----PEAIAFRTFSSASDVWSFGVVMWEVL 248
Query: 368 T 368
Sbjct: 249 A 249
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 59/232 (25%)
Query: 176 IGQGGFGTVYKA--------QFSDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HHRH 225
+G+G FG V A + + + +AVK + +E+ D E+E++ + H++
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHS--------------PGRTPLSWQTRIQI 271
++ L G C + +++ EY + G+L+++L + LS + +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 272 AIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328
A VA +EYL HRD+ + N+L+ E+ V K+ADFGLA
Sbjct: 197 AYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLAR----------- 239
Query: 329 VNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
DI Y M PE + + T +SDV+S+GV+L EI T
Sbjct: 240 ---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 55/236 (23%), Positives = 86/236 (36%), Gaps = 59/236 (25%)
Query: 172 FSTIIGQGGFGTVYKAQ------FSDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HH 223
F +G G FG V +A +AVK + E+++L+ L +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 224 RHLVALRGFCIEKRERFLMYEYMANGSLKDHL----------------HSPGRTPLSWQT 267
++V L G C ++ EY G L + L L +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 268 RIQIAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324
+ + VA + +L + HRD+ + NILL + K+ DFGLA
Sbjct: 147 LLSFSYQVAKGMAFLASKNC------IHRDLAARNILLTHGRITKICDFGLAR------- 193
Query: 325 CFEPVNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
DI+ Y M PE + T +SDV+SYG+ L E+ +
Sbjct: 194 -------DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 6e-35
Identities = 74/297 (24%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 176 IGQGGFGTVYKAQFSDGSL---IAVKRMDKISEQVEGD------FCREIELLARLHHRHL 226
+G GG TVY A+ D L +A+K + F RE+ ++L H+++
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIF---IPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 227 VALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 286
V++ E +L+ EY+ +L +++ S G PLS T I + + +++ H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH--- 128
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD-IRGTPGYMDPEYV 345
D + HRDIK NIL+D N K+ DFG+A A + S+ T+ + GT Y PE
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL----TQTNHVLGTVQYFSPEQA 184
Query: 346 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA----QVCMASESRLAELVDPRI 401
+ E +D+YS G+VL E++ +G+ V A Q + + + V I
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPF-NGETAVSIAIKHIQDSVPNVTT---DVRKDI 240
Query: 402 KDSFDMEQLRTIVTIVRWCTQREGQARP-SIKQVLRILYESSDPMHSGFVQAVEDEE 457
S ++ T+++ R +I+++ L + D+
Sbjct: 241 PQSLS--------NVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELDKM 289
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-35
Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 14/203 (6%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC 233
++G+G +G VY + IA+K + + + EI L L H+++V G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 234 IEKRERFLMYEYMANGSLKDHL-HSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 292
E + E + GSL L G + QT + L+YLH D + H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145
Query: 293 RDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 350
RDIK N+L++ + V K++DFG + + P GT YM PE ++ +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGIN----PCTETFTGTLQYMAPE-IIDKGPR 200
Query: 351 --TEKSDVYSYGVVLLEIVTARR 371
+ +D++S G ++E+ T +
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKP 223
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 29/232 (12%)
Query: 151 EGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGS----LIAVKRM-DKISE 205
E P+ +F+ KE + ++G G FG V + S +A+K + +E
Sbjct: 29 EDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 206 QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW 265
+ DF E ++ + H +++ L G + + ++ EYM NGSL L +
Sbjct: 88 KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTV 146
Query: 266 QTRIQIAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322
+ + +A+ ++YL + HRD+ + NIL++ N V K++DFGL +D
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200
Query: 323 SICFEPVNTD------IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
E T IR T PE + ++ T SDV+SYG+VL E+++
Sbjct: 201 P---EAAYTTRGGKIPIRWTS----PEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 36/217 (16%)
Query: 175 IIGQGGFGTVYKAQFSDGS------LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLV 227
+G G FG VY+ Q S +AVK + + SEQ E DF E ++++ +H+++V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 228 ALRGFCIEKRERFLMYEYMANGSLKDHL-----HSPGRTPLSWQTRIQIAIDVANALEYL 282
G ++ RF++ E MA G LK L + L+ + +A D+A +YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 283 ---HFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 336
HF HRDI + N LL VAK+ DFG+A +G
Sbjct: 198 EENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-------RKGG 244
Query: 337 PGY-----MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
M PE + T K+D +S+GV+L EI +
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 28/208 (13%)
Query: 176 IGQGGFGTVYKAQFSDGSL---IAVKRMDKISEQVEGD------FCREIELLARLHHRHL 226
+G+GG G VY+A+ D +A+K M SE + D RE RL H+
Sbjct: 42 VGRGGMGDVYEAE--DTVRERIVALKLM---SETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 227 VALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 286
V + F + ++ + L L G PL+ + I + +AL+ H
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAH--- 151
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT---DIRGTPGYMDPE 343
HRD+K NIL+ + A L DFG+A A+ D + T + GT YM PE
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL------TQLGNTVGTLYYMAPE 205
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVTARR 371
T ++D+Y+ VL E +T
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSP 233
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 55/212 (25%), Positives = 84/212 (39%), Gaps = 27/212 (12%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGD-FCREIELLARLHHRHLVALRGF 232
I+GQG V++ + G L A+K + IS D RE E+L +L+H+++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 233 CIEKRERFLMY---EYMANGSLKDHLHSPGRT-PLSWQTRIQIAIDVANALEYLHFYCDP 288
E+ E+ GSL L P L + + DV + +L +
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131
Query: 289 PLCHRDIKSSNILL----DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
+ HR+IK NI+ D V KL DFG A +D GT Y+ P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-----GTEEYLHPDM 186
Query: 345 V--------VTQELTEKSDVYSYGVVLLEIVT 368
++ D++S GV T
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 60/241 (24%), Positives = 93/241 (38%), Gaps = 64/241 (26%)
Query: 172 FSTIIGQGGFGTVYKAQ------FSDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HH 223
F ++G G FG V A +AVK + +K E++++ +L H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 224 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHS---------------------PGRTP 262
++V L G C +L++EY G L ++L S
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 263 LSWQTRIQIAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 319
L+++ + A VA +E+L HRD+ + N+L+ V K+ DFGLA
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSC------VHRDLAARNVLVTHGKVVKICDFGLAR-- 220
Query: 320 KDGSICFEPVNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIV 367
DI Y M PE + T KSDV+SYG++L EI
Sbjct: 221 ------------DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
Query: 368 T 368
+
Sbjct: 269 S 269
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 57/258 (22%), Positives = 101/258 (39%), Gaps = 43/258 (16%)
Query: 142 PPRSLRKFQEGPSPMFQKFSYKETKKAT-DNFSTI--IGQGGFGTVYKAQFSDGSLIAVK 198
P S++ S + Y + K +++ I + QG F + + D A+K
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALK 60
Query: 199 RMDK-----------------ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241
+ +K + DF E++++ + + + + G E ++
Sbjct: 61 KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYI 120
Query: 242 MYEYMANGSLKDHLHSPGRTPLSWQTRI------QIAIDVANALEYLHFYCDPPLCHRDI 295
+YEYM N S+ ++ I I V N+ Y+H + +CHRD+
Sbjct: 121 IYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDV 178
Query: 296 KSSNILLDENFVAKLADFGLAHASKDG---SICFEPVNTDIRGTPGYMDPEYVVTQELT- 351
K SNIL+D+N KL+DFG + D GT +M PE+ +
Sbjct: 179 KPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR---------GTYEFMPPEFFSNESSYN 229
Query: 352 -EKSDVYSYGVVLLEIVT 368
K D++S G+ L +
Sbjct: 230 GAKVDIWSLGICLYVMFY 247
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-34
Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 29/210 (13%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSL----IAVKRM-DKISEQVEGDFCREIELLARLHHRHL 226
+ I+G+G FG VY+ +++ +AVK + + F E ++ L H H+
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 227 VALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---H 283
V L G E+ +++ E G L +L + L T + ++ + A+ YL +
Sbjct: 76 VKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLESIN 133
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG----- 338
HRDI NIL+ KL DFGL+ +D + +
Sbjct: 134 C------VHRDIAVRNILVASPECVKLGDFGLSRYIED--------EDYYKASVTRLPIK 179
Query: 339 YMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
+M PE + + T SDV+ + V + EI++
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 75/335 (22%), Positives = 126/335 (37%), Gaps = 55/335 (16%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMD-KISEQVEGDFCREIELLARLHHRHLVALRG-F 232
+G G G V+K G ++A K + +I + RE+++L + ++V G F
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 292
+ M E+M GSL L GR P ++ +I V L YL + H
Sbjct: 101 YSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKV--SIAVIKGLTYLR--EKHKIMH 155
Query: 293 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 352
RD+K SNIL++ KL DFG++ S+ N+ + GT YM PE + +
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVS-GQLIDSMA----NSFV-GTRSYMSPERLQGTHYSV 209
Query: 353 KSDVYSYGVVLLEIVTAR----------RAVQDGKNLVESAQVCMASESRLAELVDPRIK 402
+SD++S G+ L+E+ R + G + A ++
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269
Query: 403 DSFDM----EQLRTIVT-----------------IVRWCTQREGQARPSIKQVLR----I 437
DS E L IV V C + R +KQ++
Sbjct: 270 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329
Query: 438 LYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKA 472
++ + +G++ + +P T A
Sbjct: 330 RSDAEEVDFAGWLCSTIGLN------QPSTPTHAA 358
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 61/315 (19%), Positives = 109/315 (34%), Gaps = 66/315 (20%)
Query: 152 GPSPMFQKFS--YKETKKATDNFSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDK--ISEQ 206
G M +++ + E +K IG G FG+V+K DG + A+KR K
Sbjct: 1 GAMGMKSRYTTEFHELEK--------IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV 52
Query: 207 VEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMY-EYMANGSLKDHLHSPGRT--P 262
E + RE+ A L H H+V + + L+ EY GSL D + R
Sbjct: 53 DEQNALREVYAHAVLGQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSY 111
Query: 263 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN----------------- 305
+ + V L Y+H L H DIK SNI +
Sbjct: 112 FKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168
Query: 306 --FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL--TEKSDVYSYGV 361
+ K+ D G + G ++ E V+ + K+D+++ +
Sbjct: 169 NKVMFKIGDLGHVTRISSPQVE--------EGDSRFLANE-VLQENYTHLPKADIFALAL 219
Query: 362 VLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCT 421
++ A ++G + + PRI ++ +++
Sbjct: 220 TVVCAAGAEPLPRNGDQW-----------HEIRQGRLPRIPQVLS-QEFT---ELLKVMI 264
Query: 422 QREGQARPSIKQVLR 436
+ + RPS +++
Sbjct: 265 HPDPERRPSAMALVK 279
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 175 IIGQGGFGTVYKAQFSDGS----LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVAL 229
IG+G FG V++ + +A+K + S+ V F +E + + H H+V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYC 286
G E +++ E G L+ L + L + I A ++ AL YL F
Sbjct: 82 IGVITENP-VWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKRF-- 137
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG-----YMD 341
HRDI + N+L+ N KL DFGL+ +D + + + G +M
Sbjct: 138 ----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--------YKASKGKLPIKWMA 185
Query: 342 PEYVVTQELTEKSDVYSYGVVLLEIVT 368
PE + + T SDV+ +GV + EI+
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILM 212
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 175 IIGQGGFGTVYKAQFSDGSL---IAVK--RMDKISEQVEGDFCREIELLARLHHRHLVAL 229
+G G FGTV K + + +AVK + + ++ + E ++ +L + ++V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYC 286
G C E L+ E G L +L I++ V+ ++YL +F
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVSMGMKYLEESNF-- 138
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD---IRGTPGYMDPE 343
HRD+ + N+LL AK++DFGL+ A + ++ ++ PE
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PE 190
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVT 368
+ + + KSDV+S+GV++ E +
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 30/201 (14%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 231
+G+G F VY+A+ G +A+K +DK + E+++ +L H ++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 232 FCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRI---QIAIDVANALEYLHFYCD 287
E +L+ E NG + +L + + + R QI + YLH +
Sbjct: 79 -YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLYLHSHG- 132
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGS----ICFEPVNTDIRGTPGYMDP 342
+ HRD+ SN+LL N K+ADFGLA +C GTP Y+ P
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---------GTPNYISP 181
Query: 343 EYVVTQELTEKSDVYSYGVVL 363
E +SDV+S G +
Sbjct: 182 EIATRSAHGLESDVWSLGCMF 202
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 175 IIGQGGFGTVYKAQFSDGS-----LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 228
++G G FGTVYK + +A+K + + S + + E ++A + + H+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFY 285
L G C+ L+ + M G L D++ + Q + + +A + YL
Sbjct: 82 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRL- 138
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD--IRGTPGYMDPE 343
HRD+ + N+L+ K+ DFGLA + I+ +M E
Sbjct: 139 -----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALE 189
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVT 368
++ + T +SDV+SYGV + E++T
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-33
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 231
+G+G FG VY A+ ++A+K + K VE RE+E+ + L H +++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
+ + +L+ EY G++ L + +T I ++ANAL Y H +
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFD-EQRTATYIT-ELANALSYCHSKR---VI 131
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDG---SICFEPVNTDIRGTPGYMDPEYVVTQ 348
HRDIK N+LL K+ADFG + + +C GT Y+ PE + +
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---------GTLDYLPPEMIEGR 182
Query: 349 ELTEKSDVYSYGVVLLEIVT 368
EK D++S GV+ E +
Sbjct: 183 MHDEKVDLWSLGVLCYEFLV 202
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-33
Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 20/219 (9%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVAL--- 229
+G GGFG V + G +A+K+ + +S + +C EI+++ +L+H ++V+
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 230 ---RGFCIEKRERFLMYEYMANGSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFY 285
L EY G L+ +L+ L + D+++AL YLH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH-- 138
Query: 286 CDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 342
+ + HRD+K NI+L + + K+ D G A G +C T+ GT Y+ P
Sbjct: 139 -ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC-----TEFVGTLQYLAP 192
Query: 343 EYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 381
E + ++ T D +S+G + E +T R V+
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-33
Identities = 47/207 (22%), Positives = 90/207 (43%), Gaps = 30/207 (14%)
Query: 176 IGQGGFGTVYKAQFSDGS---LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVALRG 231
+G G FG+V + + +A+K + + + RE +++ +L + ++V L G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDP 288
C + L+ E G L L + ++ V+ ++YL +F
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNF---- 131
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE-------PVNTDIRGTPGYMD 341
HRD+ + N+LL AK++DFGL+ A + P ++
Sbjct: 132 --VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP----LKWYA---- 181
Query: 342 PEYVVTQELTEKSDVYSYGVVLLEIVT 368
PE + ++ + +SDV+SYGV + E ++
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 61/275 (22%), Positives = 107/275 (38%), Gaps = 35/275 (12%)
Query: 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGF 232
++G G GT+ D +AVKR+ + RE++LL H +++ F
Sbjct: 31 VLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD----REVQLLRESDEHPNVIRY--F 84
Query: 233 CIEKRERFLMY---EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
C EK +F Y E A +L++++ L + + + L +LH
Sbjct: 85 CTEKDRQFQ-YIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLH---SLN 138
Query: 290 LCHRDIKSSNILLDE-----NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
+ HRD+K NIL+ A ++DFGL G F + GT G++ PE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGWIAPEM 197
Query: 345 V---VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401
+ + T D++S G V +++ ++ + A + + P
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS---LDCLHPEK 254
Query: 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
+ +L + + Q RPS K VL+
Sbjct: 255 HEDVIAREL------IEKMIAMDPQKRPSAKHVLK 283
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 20/199 (10%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
+G G FG VYKA+ G+L A K ++ SE+ D+ EIE+LA H ++V L G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPPLC 291
+ ++M E+ G++ + L T QI + + AL +LH +
Sbjct: 87 HDGKLWIMIEFCPGGAVDA-IMLELDRGL---TEPQIQVVCRQMLEALNFLH---SKRII 139
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 351
HRD+K+ N+L+ +LADFG++ + + ++ I GTP +M PE V+ + +
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKT---LQKRDSFI-GTPYWMAPEVVMCETMK 195
Query: 352 E-----KSDVYSYGVVLLE 365
+ K+D++S G+ L+E
Sbjct: 196 DTPYDYKADIWSLGITLIE 214
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 37/215 (17%)
Query: 172 FSTIIGQGGFGTVYKAQFSDGSL-----IAVKRM-DKISEQVEGDFCREIELLARLHHRH 225
++G G FGTV+K + + +K + DK Q + + L H H
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL--- 282
+V L G C L+ +Y+ GSL DH+ R L Q + + +A + YL
Sbjct: 77 IVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 283 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA---------HASKDGSICFEPVNTDI 333
HR++ + N+LL ++ADFG+A + P+
Sbjct: 135 GM------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT---PIK--- 182
Query: 334 RGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
+M E + + T +SDV+SYGV + E++T
Sbjct: 183 -----WMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 71/312 (22%), Positives = 119/312 (38%), Gaps = 60/312 (19%)
Query: 161 SYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLAR 220
+++++ K I+G G GTV G +AVKRM EI+LL
Sbjct: 8 NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTE 64
Query: 221 L-HHRHLVALRGFCIEKRERFLMYEYMA----NGSLKDHLHSPGRTPLSWQTR-----IQ 270
H +++ +C E +RFL Y+A N +L+D + S + + + + I
Sbjct: 65 SDDHPNVIRY--YCSETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 271 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-------------ENFVAKLADFGLAH 317
+ +A+ + +LH + HRD+K NIL+ EN ++DFGL
Sbjct: 120 LLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 318 ASKDGSICFEPVNTDIRGTPGYMDPE-------YVVTQELTEKSDVYSYGVVLLEIVTAR 370
G F + GT G+ PE + LT D++S G V I++
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 371 RAVQDGKNLVESAQVCMA--SESRLAELVDPRI----KDSFDMEQLRTIVTIVRWCTQRE 424
+ K E + + S + L D + D ++ +
Sbjct: 237 KHPFGDKYSRE-SNIIRGIFSLDEMKCLHDRSLIAEATD------------LISQMIDHD 283
Query: 425 GQARPSIKQVLR 436
RP+ +VLR
Sbjct: 284 PLKRPTAMKVLR 295
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 57/217 (26%), Positives = 86/217 (39%), Gaps = 45/217 (20%)
Query: 175 IIGQGGFGTVYKAQF--SDGSLI--AVK--RMDKISEQ-VEGDFCREIELLARLHHRHLV 227
+G G FG V + ++ G + AVK + D +S+ DF RE+ + L HR+L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 228 ALRGFCIEKRERFLMY---EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL-- 282
L G + M E GSL D L T + A+ VA + YL
Sbjct: 85 RLYGVVLTPP----MKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES 139
Query: 283 -HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA----------HASKDGSICFEPVNT 331
F HRD+ + N+LL + K+ DFGL + + P
Sbjct: 140 KRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV---P--- 187
Query: 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
PE + T+ + SD + +GV L E+ T
Sbjct: 188 -FAWCA----PESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-32
Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 231
+G+G FG VY A+ + ++A+K + K E VE REIE+ + L H +++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
+ +++ +LM E+ G L L GR ++ + ++A+AL Y H +
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFD-EQRSATFME-ELADALHYCHERK---VI 136
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDG---SICFEPVNTDIRGTPGYMDPEYVVTQ 348
HRDIK N+L+ K+ADFG + + ++C GT Y+ PE + +
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---------GTLDYLPPEMIEGK 187
Query: 349 ELTEKSDVYSYGVVLLEIVT 368
EK D++ GV+ E +
Sbjct: 188 THDEKVDLWCAGVLCYEFLV 207
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-32
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 175 IIGQGGFGTVYKAQFSDGS----LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVAL 229
IG+G FG V++ + +A+K + S+ V F +E + + H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYC 286
G E +++ E G L+ L + L + I A ++ AL YL F
Sbjct: 457 IGVITENP-VWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESKRF-- 512
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG-----YMD 341
HRDI + N+L+ N KL DFGL+ +D + + + G +M
Sbjct: 513 ----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--------YKASKGKLPIKWMA 560
Query: 342 PEYVVTQELTEKSDVYSYGVVLLEIVT 368
PE + + T SDV+ +GV + EI+
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILM 587
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 176 IGQG--GFGTVYKAQF-SDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALR 230
IG+G TV A++ G + V+R++ S ++ E+ + +H ++V R
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 231 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCD 287
I E +++ +MA GS KD + + ++ + IA V AL+Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN---ELAIAYILQGVLKALDYIH---H 146
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPGYMDP 342
HR +K+S+IL+ + L+ H + + P ++ P
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP--KYSVKVLPWLSP 204
Query: 343 EYVVTQEL---TEKSDVYSYGVVLLEIVT 368
E V+ Q L KSD+YS G+ E+
Sbjct: 205 E-VLQQNLQGYDAKSDIYSVGITACELAN 232
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 176 IGQGGFGTVYKAQFSDGSL---IAVKRMDKISEQVEGD------FCREIELLARLHHRHL 226
+G GG V+ A+ D +AVK + + D F RE + A L+H +
Sbjct: 20 LGFGGMSEVHLAR--DLRDHRDVAVKVLR---ADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 227 VALRGFCIEKRERFLMY----EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 282
VA+ + + EY+ +L+D +H+ G P++ + I++ D AL +
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFS 132
Query: 283 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 342
H + HRD+K +NI++ K+ DFG+A A D + GT Y+ P
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-VIGTAQYLSP 188
Query: 343 EYVVTQELTEKSDVYSYGVVLLEIVTARR 371
E + +SDVYS G VL E++T
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 22/230 (9%)
Query: 145 SLRKFQEGPSPMFQKFSYKETKKATD---NFSTI--IGQGGFGTVYKAQ-FSDGSLIAVK 198
SL Q P Q E F + +G+G +G+VYKA G ++A+K
Sbjct: 1 SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60
Query: 199 RMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSP 258
++ + ++ + +EI ++ + H+V G + + +++ EY GS+ D +
Sbjct: 61 QVP-VESDLQ-EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR 118
Query: 259 GRTPLSWQTRIQIAI---DVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL 315
+ L T +IA LEYLH HRDIK+ NILL+ AKLADFG+
Sbjct: 119 NK-TL---TEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGV 171
Query: 316 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 365
A ++ NT I GTP +M PE + +D++S G+ +E
Sbjct: 172 A-GQLTDTMA--KRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
IGQG GTVY A + G +A+++M+ + + EI ++ + ++V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPPLC 291
E +++ EY+A GSL D + T + QIA + ALE+LH +
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE---TCM---DEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 292 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV--NTDIRGTPGYMDPEYVVTQE 349
HRDIKS NILL + KL DFG I E +T + GTP +M PE V +
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFC-----AQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192
Query: 350 LTEKSDVYSYGVVLLEIV 367
K D++S G++ +E++
Sbjct: 193 YGPKVDIWSLGIMAIEMI 210
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 4e-31
Identities = 41/251 (16%), Positives = 78/251 (31%), Gaps = 29/251 (11%)
Query: 141 PPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQFSD------G 192
P S E + E + + +G+G F VY+A D
Sbjct: 36 KPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNK 95
Query: 193 SLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK 252
+K + + +E L + + + L+ E + G+L
Sbjct: 96 QKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLL 155
Query: 253 DHLHSPGRT---PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL------- 302
+ ++ T + I A+ + +E +H D + H DIK N +L
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQ 212
Query: 303 ----DENFVAKLADFGLAHASKDGSICFEPVN-TDIRGTPGYMDPEYVVTQELTEKSDVY 357
D + L D G S D + + T T G+ E + + + D +
Sbjct: 213 DDEDDLSAGLALIDLGQ---SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269
Query: 358 SYGVVLLEIVT 368
+ ++
Sbjct: 270 GVAATVYCMLF 280
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 27/201 (13%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
IG+G G V A+ G +AVK MD +Q E+ ++ H ++V + +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPPLC 291
E +++ E++ G+L D + L QIA V AL YLH +
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQ---VRL---NEEQIATVCEAVLQALAYLH---AQGVI 163
Query: 292 HRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPGYMDPEYVV 346
HRDIKS +ILL + KL+DFG K + + GTP +M PE +
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--------KSLV-GTPYWMAPEVIS 214
Query: 347 TQELTEKSDVYSYGVVLLEIV 367
+ D++S G++++E+V
Sbjct: 215 RSLYATEVDIWSLGIMVIEMV 235
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 232
IG G V A +A+KR++ K ++ + +EI+ +++ HH ++V+
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCHHPNIVSYYTS 81
Query: 233 CIEKRERFLMYEYMANGSLKD---HLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYC 286
+ K E +L+ + ++ GS+ D H+ + G IA +V LEYLH
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--- 138
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYV 345
HRD+K+ NILL E+ ++ADFG+ A + G I V GTP +M PE V
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE-V 197
Query: 346 VTQELT--EKSDVYSYGVVLLEIVT 368
+ Q K+D++S+G+ +E+ T
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELAT 222
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-30
Identities = 50/205 (24%), Positives = 80/205 (39%), Gaps = 27/205 (13%)
Query: 176 IGQGGFGTVYKA--QFSDGSLIAVKRMDKISEQVEGD-FCREIELLARLHHRHLVALRGF 232
I GG G +Y A + +G + +K + + E + LA + H +V + F
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 233 CIEKRER-----FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 287
+++ EY+ SLK L I +++ AL YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLH---S 200
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMDPEYVV 346
L + D+K NI+L E + KL D G + G + GTPG+ PE +V
Sbjct: 201 IGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFGYLY---------GTPGFQAPE-IV 249
Query: 347 TQELTEKSDVYSYGVVLLEIVTARR 371
T +D+Y+ G L +
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLP 274
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-30
Identities = 45/203 (22%), Positives = 90/203 (44%), Gaps = 22/203 (10%)
Query: 176 IGQGGFGTVYKAQFSDGS---LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVALRG 231
+G G FG+V + + +A+K + + + RE +++ +L + ++V L G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDP 288
C + L+ E G L L + ++ V+ ++YL +F
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNF---- 457
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD---IRGTPGYMDPEYV 345
HR++ + N+LL AK++DFGL+ A + + ++ PE +
Sbjct: 458 --VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECI 511
Query: 346 VTQELTEKSDVYSYGVVLLEIVT 368
++ + +SDV+SYGV + E ++
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 27/228 (11%)
Query: 152 GPSPMFQKFSYKET---KKATDNFST------IIGQGGFGTVYKAQF-SDGSLIAVKRMD 201
GP M + +T FS ++G+G FG V + G AVK +
Sbjct: 1 GPGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 60
Query: 202 K---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSP 258
K + + RE++LL +L H +++ L F +K +L+ E G L D + S
Sbjct: 61 KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR 120
Query: 259 GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGL 315
R S +I V + + Y+H + HRD+K N+LL ++ ++ DFGL
Sbjct: 121 KR--FSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGL 175
Query: 316 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 363
+ + D GT Y+ PE V+ EK DV+S GV+L
Sbjct: 176 STHFEASKKM-----KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVA----- 228
+G G +G VYK + G L A+K MD ++ E + +EI +L + HHR++
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKKYSHHRNIATYYGAF 90
Query: 229 LRGFCIEKRER--FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLH 283
++ ++ +M E+ GS+ D + + L IA ++ L +LH
Sbjct: 91 IKKNPPGMDDQLWLVM-EFCGAGSVTDLIKNTKGNTL---KEEWIAYICREILRGLSHLH 146
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 343
+ HRDIK N+LL EN KL DFG++ A D ++ NT I GTP +M PE
Sbjct: 147 ---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS-AQLDRTVG--RRNTFI-GTPYWMAPE 199
Query: 344 YVVTQELTE-----KSDVYSYGVVLLEI 366
+ E + KSD++S G+ +E+
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEM 227
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 20/199 (10%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 232
IG+G FG V+K ++A+K +D + +++E D +EI +L++ ++ G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYGS 88
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPP 289
++ + +++ EY+ GS D L PL QIA ++ L+YLH
Sbjct: 89 YLKDTKLWIIMEYLGGGSALDLLEP---GPL---DETQIATILREILKGLDYLH---SEK 139
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
HRDIK++N+LL E+ KLADFG+A + NT + GTP +M PE +
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVA-GQLTDTQI--KRNTFV-GTPFWMAPEVIKQSA 195
Query: 350 LTEKSDVYSYGVVLLEIVT 368
K+D++S G+ +E+
Sbjct: 196 YDSKADIWSLGITAIELAR 214
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-30
Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 172 FSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVA 228
+G G +G V + A+K + K +S E+ +L L H +++
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
L F +KR +L+ E G L D + + + I V + + YLH +
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHN-- 156
Query: 289 PLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 345
+ HRD+K N+LL +++ + K+ DFGL+ ++ + GT Y+ PE V
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM-----KERLGTAYYIAPE-V 209
Query: 346 VTQELTEKSDVYSYGVVL 363
+ ++ EK DV+S GV+L
Sbjct: 210 LRKKYDEKCDVWSIGVIL 227
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-30
Identities = 52/202 (25%), Positives = 84/202 (41%), Gaps = 33/202 (16%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 231
+G+GGF ++ + A K + K + EI + L H+H+V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 232 FCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLS-WQTR---IQIAIDVANALEYLHFYC 286
E + F++ E SL + L+ + R QI +YLH
Sbjct: 83 -FFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIV----LGCQYLHRNR 135
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGS----ICFEPVNTDIRGTPGYMD 341
+ HRD+K N+ L+E+ K+ DFGLA DG +C GTP Y+
Sbjct: 136 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---------GTPNYIA 183
Query: 342 PEYVVTQELTEKSDVYSYGVVL 363
PE + + + + DV+S G ++
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIM 205
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 70/322 (21%), Positives = 121/322 (37%), Gaps = 67/322 (20%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMD-KISEQVEGDFCREIELLARLH-HRHLVALRGF 232
+G G G V+K +F G +IAVK+M +++ +++++ + H ++V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 292
I + F+ E M + K G P ++ + + AL YL + H
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKM--TVAIVKALYYLK--EKHGVIH 148
Query: 293 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 352
RD+K SNILLDE KL DFG++ + G YM PE + + T+
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGIS-GRLVDDK---AKDRSA-GCAAYMAPERIDPPDPTK 203
Query: 353 -----KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407
++DV+S G+ L+E LA P D
Sbjct: 204 PDYDIRADVWSLGISLVE---------------------------LATGQFPYKNCKTDF 236
Query: 408 EQLRTIVT------------------IVRWCTQREGQARPSIKQVLR----ILYESSDPM 445
E L ++ V+ C ++ + RP ++L YE+ +
Sbjct: 237 EVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296
Query: 446 HSGFVQAVEDEEYEETDGRPRT 467
+ + + V + E P +
Sbjct: 297 VASWFKDVMA-KTESPRSGPSS 317
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 65/294 (22%), Positives = 124/294 (42%), Gaps = 37/294 (12%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMD-KISEQVEGDFCREIE-LLARLHHRHLVALRGF 232
+G+G +G V K + G ++AVKR+ ++ Q + +++ + + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 233 CIEKRERFLMYEYMANGSL----KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
+ + ++ E M + SL K + P +I A+ + ALE+LH
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKI--AVSIVKALEHLH--SKL 129
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 348
+ HRD+K SN+L++ K+ DFG++ + + D G YM PE +
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDDV---AKDIDA-GCKPYMAPE-RINP 183
Query: 349 ELTE-----KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403
EL + KSD++S G+ ++E+ R + Q+ E +L +
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ--QLKQVVEEPSPQLPADKFSA 241
Query: 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR----ILYESSDPMHSGFVQAV 453
F V C ++ + RP+ ++++ L+ES + FV+ +
Sbjct: 242 EF--------VDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVASFVKLI 287
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 55/251 (21%), Positives = 93/251 (37%), Gaps = 39/251 (15%)
Query: 129 PENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFST--IIGQGGFGTVYK 186
P + K + P + ++ + +G+GGF ++
Sbjct: 4 PADPGKAGVPGVAAPGAPAAAPPAKEIP----EVLVDPRSRRRYVRGRFLGKGGFAKCFE 59
Query: 187 AQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRER-FL 241
+ A K + K + EI + L H+H+V G E + F+
Sbjct: 60 ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFV 118
Query: 242 MYEYMANGSLKDHLHSPGRTPLS-WQTR---IQIAIDVANALEYLHFYCDPPLCHRDIKS 297
+ E SL + L+ + R QI +YLH + HRD+K
Sbjct: 119 VLELCRRRSLLELHKRRKA--LTEPEARYYLRQIV----LGCQYLHRNR---VIHRDLKL 169
Query: 298 SNILLDENFVAKLADFGLA-HASKDGS----ICFEPVNTDIRGTPGYMDPEYVVTQELTE 352
N+ L+E+ K+ DFGLA DG +C GTP Y+ PE + + +
Sbjct: 170 GNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---------GTPNYIAPEVLSKKGHSF 220
Query: 353 KSDVYSYGVVL 363
+ DV+S G ++
Sbjct: 221 EVDVWSIGCIM 231
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 32/359 (8%), Positives = 66/359 (18%), Gaps = 73/359 (20%)
Query: 120 RRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQG 179
R+ E ++ + +P + K + G
Sbjct: 25 CREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQG---ERKLK--------LVEPLRVG 73
Query: 180 GFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFC-- 233
V+ A+K S ARL R
Sbjct: 74 DRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRL 133
Query: 234 ------------------------IEKRERFLMYEYMANGSLKD-----HLHSPGRTPLS 264
L+ + L+ R
Sbjct: 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEG 192
Query: 265 WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324
+ + L L H N+ + + L D
Sbjct: 193 ILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP 249
Query: 325 CFEPVNTDIRGTPGYMDPEYVVTQE---LTEKSDVYSYGVVLLEIVTAR----RAVQDGK 377
P P + T + + G+ + + K
Sbjct: 250 AS--------SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 378 NLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
+ + + LA + D + T++ + + R + +
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPDF--------VKTLIGRFLNFDRRRRLLPLEAME 352
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 15/193 (7%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC 233
++G G F V+ Q G L A+K + K + EI +L ++ H ++V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 234 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 293
+L+ + ++ G L D + G + + + V +A++YLH + + HR
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLH---ENGIVHR 130
Query: 294 DIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 350
D+K N+L +EN + DFGL+ ++G + + GTPGY+ PE + +
Sbjct: 131 DLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM------STACGTPGYVAPEVLAQKPY 184
Query: 351 TEKSDVYSYGVVL 363
++ D +S GV+
Sbjct: 185 SKAVDCWSIGVIT 197
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 19/221 (8%)
Query: 150 QEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISE 205
S + ++ T N ++G+G FG V K + AVK ++K ++
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 206 QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW 265
RE+ELL +L H +++ L + +++ E G L D + R S
Sbjct: 64 DTS-TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSE 120
Query: 266 QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDG 322
+I V + + Y+H + + HRD+K NILL +++ K+ DFGL+ +
Sbjct: 121 HDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 363
+ D GT Y+ PE V+ EK DV+S GV+L
Sbjct: 178 TKM-----KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-29
Identities = 56/249 (22%), Positives = 96/249 (38%), Gaps = 34/249 (13%)
Query: 134 KTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDN--FSTIIGQGGFGTVYKAQF-S 190
+ P + K+ K ++ +G G +G V + +
Sbjct: 4 HHHHSSGRENLYFQGIAINPGM----YVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKN 59
Query: 191 DGSLIAVKRMDK-------------ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR 237
S A+K + K E+ + EI LL L H +++ L +K+
Sbjct: 60 GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK 119
Query: 238 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 297
+L+ E+ G L + + + + I + + + YLH + + HRDIK
Sbjct: 120 YFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKHN---IVHRDIKP 174
Query: 298 SNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 354
NILL + K+ DFGL+ D GT Y+ PE V+ ++ EK
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKL-----RDRLGTAYYIAPE-VLKKKYNEKC 228
Query: 355 DVYSYGVVL 363
DV+S GV++
Sbjct: 229 DVWSCGVIM 237
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-29
Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 18/201 (8%)
Query: 171 NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLV 227
F +G G FG V+ + S G +K ++K +E EIE+L L H +++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME-QIEAEIEVLKSLDHPNII 83
Query: 228 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTR--IQIAIDVANALEYLHFY 285
+ + +++ E G L + + S + ++ + NAL Y H
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH-- 141
Query: 286 CDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 342
+ H+D+K NIL + K+ DFGLA K GT YM P
Sbjct: 142 -SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA-----GTALYMAP 195
Query: 343 EYVVTQELTEKSDVYSYGVVL 363
E V +++T K D++S GVV+
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVM 215
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 27/206 (13%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK---------ISEQVEGDFCREIELLARL-HH 223
I+G+G V + AVK +D +++ +E+++L ++ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 224 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 283
+++ L+ FL+++ M G L D+L LS + +I + + LH
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALH 141
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 343
+ HRD+K NILLD++ KL DFG + G E GTP Y+ PE
Sbjct: 142 KLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC-----GTPSYLAPE 193
Query: 344 ------YVVTQELTEKSDVYSYGVVL 363
++ D++S GV++
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 61/248 (24%), Positives = 101/248 (40%), Gaps = 28/248 (11%)
Query: 134 KTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFST--IIGQGGFGTVYKAQF-S 190
L P + + + P + + K+ + +IG+G V + +
Sbjct: 58 AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117
Query: 191 DGSLIAVKRMDK--------ISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFL 241
G AVK M+ E+V RE +L ++ H H++ L FL
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177
Query: 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 301
+++ M G L D+L LS + I + A+ +LH + HRD+K NIL
Sbjct: 178 VFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENIL 232
Query: 302 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE------YVVTQELTEKSD 355
LD+N +L+DFG + + G E GTPGY+ PE ++ D
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEKLRELC-----GTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 356 VYSYGVVL 363
+++ GV+L
Sbjct: 288 LWACGVIL 295
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 19/218 (8%)
Query: 153 PSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQVE 208
S + ++ T N ++G+G FG V K + AVK ++K ++
Sbjct: 7 HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66
Query: 209 GDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTR 268
RE+ELL +L H +++ L + +++ E G L D + R S
Sbjct: 67 -TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDA 123
Query: 269 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSIC 325
+I V + + Y+H + HRD+K NILL +++ K+ DFGL+ + +
Sbjct: 124 ARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 363
D GT Y+ PE V+ EK DV+S GV+L
Sbjct: 181 -----KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 66/251 (26%), Positives = 110/251 (43%), Gaps = 32/251 (12%)
Query: 129 PENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYK 186
P + P + + P + +K+ FS + IG G FG VY
Sbjct: 15 PTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKD--DPEKLFSDLREIGHGSFGAVYF 72
Query: 187 AQ-FSDGSLIAVKRMDKISEQVEGDF---CREIELLARLHHRHLVALRGFCIEKRERFLM 242
A+ + ++A+K+M +Q + +E+ L +L H + + RG + + +L+
Sbjct: 73 ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132
Query: 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPPLCHRDIKSSN 299
EY GS D L + PL ++IA L YLH + HRD+K+ N
Sbjct: 133 MEYCL-GSASDLLEVHKK-PL---QEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGN 184
Query: 300 ILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE---KSD 355
ILL E + KL DFG + + N+ + GTP +M PE ++ + + K D
Sbjct: 185 ILLSEPGLVKLGDFGSASIMAPA--------NSFV-GTPYWMAPEVILAMDEGQYDGKVD 235
Query: 356 VYSYGVVLLEI 366
V+S G+ +E+
Sbjct: 236 VWSLGITCIEL 246
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 45/308 (14%), Positives = 87/308 (28%), Gaps = 74/308 (24%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGD----------------------- 210
++GQ +A G V
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 211 -----FCREIELLARLHHRHLVALRGFC--IEKRERFLMYEYMA--NGSLKDHLHSPGRT 261
F +L+ + ++ +R + RF +Y M + + L S T
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 262 --PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 319
L R+Q+ + V L LH Y L H ++ +I+LD+ L F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 320 KDGSICFEPVNTDIRGTPGYMDPEYVVTQEL-----------TEKSDVYSYGVVLLEIVT 368
+DG+ + G+ PE + T D ++ G+V+ I
Sbjct: 255 RDGA------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 369 ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQAR 428
A + + ++ S + + V + ++ + + R
Sbjct: 309 ADLPI-TKDAALGGSEWIFRSCKNIPQPV----RA------------LLEGFLRYPKEDR 351
Query: 429 PSIKQVLR 436
Q +
Sbjct: 352 LLPLQAME 359
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 18/202 (8%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGF 232
++G+G V AVK ++K + RE+E+L + HR+++ L F
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 292
E+ +L++E M GS+ H+H + + DVA+AL++LH + + H
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLH---NKGIAH 134
Query: 293 RDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIR---GTPGYMDPEYVV 346
RD+K NIL ++ K+ DF L K C ++ G+ YM PE V
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 347 TQELTEKS-----DVYSYGVVL 363
D++S GV+L
Sbjct: 195 AFSEEASIYDKRCDLWSLGVIL 216
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-28
Identities = 51/197 (25%), Positives = 82/197 (41%), Gaps = 15/197 (7%)
Query: 171 NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL 229
IG+G +G V A A K++ K + F +EIE++ L H +++ L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
+ + +L+ E G L + + +I DV +A+ Y H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKL---N 126
Query: 290 LCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 346
+ HRD+K N L + KL DFGLA K G + GTP Y+ P+ V+
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-----RTKVGTPYYVSPQ-VL 180
Query: 347 TQELTEKSDVYSYGVVL 363
+ D +S GV++
Sbjct: 181 EGLYGPECDEWSAGVMM 197
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 72/315 (22%), Positives = 128/315 (40%), Gaps = 36/315 (11%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMD-KISEQVEGDFCREIELLARL-HHRHLVALRGF 232
IG+G +G+V K G ++AVKR+ + E+ + +++++ R ++V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 233 CIEKRERFLMYEYMANGSLKD----HLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
+ + ++ E M+ K + P +I + AL +L +
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKI--TLATVKALNHLKE--NL 145
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 348
+ HRDIK SNILLD + KL DFG++ SI T G YM PE +
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGIS-GQLVDSI----AKTRDAGCRPYMAPE-RIDP 199
Query: 349 ELTE-----KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403
+ +SDV+S G+ L E+ T R ++ + Q+ + +L + ++
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QLTQVVKGDPPQLSNSEERE 257
Query: 404 -SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR----ILYESSDPMHSGFVQAVEDEEY 458
S V C ++ RP K++L+ ++YE + +V + D +
Sbjct: 258 FSPSFINF------VNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILD-QM 310
Query: 459 EETDGRPRTSQRKAH 473
T P H
Sbjct: 311 PATPSSPMYVDHHHH 325
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 49/249 (19%), Positives = 98/249 (39%), Gaps = 19/249 (7%)
Query: 124 RGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI------IG 177
RG + + P+ + + +++K+ + + + +G
Sbjct: 2 RGSHHHHHHGSKVRGKYDGPKI-NDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELG 60
Query: 178 QGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK 236
G FG V++ + + G + K ++ + EI ++ +LHH L+ L +K
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120
Query: 237 RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIK 296
E L+ E+++ G L D + + +S I L+++H + + H DIK
Sbjct: 121 YEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMH---EHSIVHLDIK 176
Query: 297 SSNILL--DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 354
NI+ + K+ DFGLA I T + PE V + + +
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNPDEIV-----KVTTATAEFAAPEIVDREPVGFYT 231
Query: 355 DVYSYGVVL 363
D+++ GV+
Sbjct: 232 DMWAIGVLG 240
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 54/245 (22%), Positives = 89/245 (36%), Gaps = 22/245 (8%)
Query: 129 PENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFST------IIGQGGFG 182
+D + + S P Y D S +G+G
Sbjct: 8 SSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATS 67
Query: 183 TVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241
VY+ + A+K + K + EI +L RL H +++ L+ E L
Sbjct: 68 IVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125
Query: 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 301
+ E + G L D + G S + + A+ YLH + HRD+K N+L
Sbjct: 126 VLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLL 180
Query: 302 L---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYS 358
+ K+ADFGL+ + + GTPGY PE + + D++S
Sbjct: 181 YATPAPDAPLKIADFGLSKIVEHQVLMKTVC-----GTPGYCAPEILRGCAYGPEVDMWS 235
Query: 359 YGVVL 363
G++
Sbjct: 236 VGIIT 240
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 52/230 (22%), Positives = 93/230 (40%), Gaps = 34/230 (14%)
Query: 156 MFQKFSYKETKKATDNFST------IIGQGGFGTVYKA-QFSDGSLIAVKRMDK------ 202
+F + + +G G G V A + +A++ + K
Sbjct: 117 VFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG 176
Query: 203 --ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGR 260
+ EIE+L +L+H ++ ++ F + + +++ E M G L D + R
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR 235
Query: 261 TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAH 317
L T + A++YLH + + HRD+K N+LL +E+ + K+ DFG +
Sbjct: 236 --LKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290
Query: 318 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL----TEKSDVYSYGVVL 363
+ S+ GTP Y+ PE V+ D +S GV+L
Sbjct: 291 ILGETSLMRTLC-----GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 165 TKKATDNFST--IIGQGGFGTVYKA-QFSDGSLIAVKRMDK--ISEQVEGDFCREIELLA 219
+ K +DN+ +G+G F V + + G A K ++ +S + RE +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 220 RLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 279
+L H ++V L E+ +L+++ + G L + + + S + ++
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESI 118
Query: 280 EYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 336
Y H + HR++K N+LL + KLADFGLA D GT
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-----GT 170
Query: 337 PGYMDPEYVVTQELTEKSDVYSYGVVL 363
PGY+ PE + ++ D+++ GV+L
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 57/236 (24%), Positives = 90/236 (38%), Gaps = 51/236 (21%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMDK-----ISEQVEGDFCREIELLARLHHRHLVAL 229
IGQG +G V A + ++ A+K M+K I+ + E+ L+ +LHH ++ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ------------------- 270
+++ L+ E G L D L+
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 271 -------------------IAIDVANALEYLHFYCDPPLCHRDIKSSNILL--DENFVAK 309
I + +AL YLH + +CHRDIK N L +++F K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 310 LADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV--VTQELTEKSDVYSYGVVL 363
L DFGL+ + T GTP ++ PE + + K D +S GV+L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 54/252 (21%), Positives = 95/252 (37%), Gaps = 25/252 (9%)
Query: 121 RKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGG 180
P + P PPP+ +F +K + + K S ++G G
Sbjct: 18 APPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKV---TSQVLGLGI 74
Query: 181 FGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFC----I 234
G V + A+K + RE+EL R H+V +
Sbjct: 75 NGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVYENLYA 129
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 294
++ ++ E + G L + G + + +I + A++YLH + HRD
Sbjct: 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRD 186
Query: 295 IKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 351
+K N+L N + KL DFG A + + P TP Y+ PE + ++
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-----YTPYYVAPEVLGPEKYD 241
Query: 352 EKSDVYSYGVVL 363
+ D++S GV++
Sbjct: 242 KSCDMWSLGVIM 253
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 60/257 (23%), Positives = 103/257 (40%), Gaps = 25/257 (9%)
Query: 120 RRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFS------ 173
+ E N D T P R+ + P+P F ++ +
Sbjct: 34 SGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPP-APFDHRIVTAKQGAVNSFYTVS 92
Query: 174 --TIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALR 230
I+G G FG V+K + + G +A K + + + + EI ++ +L H +L+ L
Sbjct: 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLY 152
Query: 231 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
K + L+ EY+ G L D + L+ I + + ++H +
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYN-LTELDTILFMKQICEGIRHMH---QMYI 208
Query: 291 CHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 347
H D+K NIL D + K+ DFGLA K GTP ++ PE VV
Sbjct: 209 LHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKL-----KVNFGTPEFLAPE-VVN 261
Query: 348 QE-LTEKSDVYSYGVVL 363
+ ++ +D++S GV+
Sbjct: 262 YDFVSFPTDMWSVGVIA 278
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 52/250 (20%), Positives = 95/250 (38%), Gaps = 16/250 (6%)
Query: 120 RRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFST--IIG 177
R++ RG + E K + + + + D++ +G
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELG 166
Query: 178 QGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK 236
G FG V++ + G+ A K + E + +EI+ ++ L H LV L +
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226
Query: 237 RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIK 296
E ++YE+M+ G L + + +S ++ V L ++H + H D+K
Sbjct: 227 NEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLK 282
Query: 297 SSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 353
NI+ N + KL DFGL GT + PE + +
Sbjct: 283 PENIMFTTKRSNEL-KLIDFGLTAHLDPKQSV-----KVTTGTAEFAAPEVAEGKPVGYY 336
Query: 354 SDVYSYGVVL 363
+D++S GV+
Sbjct: 337 TDMWSVGVLS 346
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 53/229 (23%), Positives = 94/229 (41%), Gaps = 18/229 (7%)
Query: 143 PRSLRKFQEGPSPMFQKFSYKETKKATDNFST--IIGQGGFGTVYKA-QFSDGSLIAVKR 199
P +F + K +DN+ +G+G F V + + G A K
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 200 MDK--ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHS 257
++ +S + RE + +L H ++V L E+ +L+++ + G L + + +
Sbjct: 62 INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA 121
Query: 258 PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFG 314
R S + ++ Y H + HR++K N+LL + KLADFG
Sbjct: 122 --REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFG 176
Query: 315 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 363
LA D GTPGY+ PE + ++ D+++ GV+L
Sbjct: 177 LAIEVNDSEAWHGFA-----GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 49/200 (24%), Positives = 77/200 (38%), Gaps = 18/200 (9%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVKRMDK-----ISEQVEGDFCREIELLARLHHRHLVA 228
+IG+G F V + G AVK +D D RE + L H H+V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYC 286
L ++++E+M L + + + + AL Y H
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH--- 147
Query: 287 DPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 343
D + HRD+K +LL + + KL FG+A + + GTP +M PE
Sbjct: 148 DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA----GGRVGTPHFMAPE 203
Query: 344 YVVTQELTEKSDVYSYGVVL 363
V + + DV+ GV+L
Sbjct: 204 VVKREPYGKPVDVWGCGVIL 223
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 4e-26
Identities = 45/246 (18%), Positives = 87/246 (35%), Gaps = 26/246 (10%)
Query: 200 MDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHS-P 258
S +I + ++ V K ++ + +LKD ++
Sbjct: 97 WPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156
Query: 259 GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-- 316
+ I I +A A+E+LH L HRD+K SNI + V K+ DFGL
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 317 ------HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTAR 370
+ + +T GT YM PE + + K D++S G++L E++ +
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF 273
Query: 371 RAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS 430
+ + + ++ + + F ++ +V+ RP
Sbjct: 274 STQMERVRI-------------ITDVRNLKFPLLFT-QKYPQEHMMVQDMLSPSPTERPE 319
Query: 431 IKQVLR 436
++
Sbjct: 320 ATDIIE 325
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 54/199 (27%), Positives = 86/199 (43%), Gaps = 21/199 (10%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEG------DFCREIELLARLHHRHLVA 228
+G G F V K Q G A K + K + RE+ +L + H +++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
L K + L+ E ++ G L D L L+ Q + + + YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLH---SK 127
Query: 289 PLCHRDIKSSNILL----DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
+ H D+K NI+L N KL DFG+AH + G+ +I GTP ++ PE
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-----KNIFGTPEFVAPEI 182
Query: 345 VVTQELTEKSDVYSYGVVL 363
V + L ++D++S GV+
Sbjct: 183 VNYEPLGLEADMWSIGVIT 201
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 45/196 (22%), Positives = 78/196 (39%), Gaps = 17/196 (8%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMDK--ISEQVEGDFCREIELLARL-HHRHLVALRG 231
+G+G F V + S G A K + K + + EI +L ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
E L+ EY A G + +S I++ + + YLH +
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IV 153
Query: 292 HRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 348
H D+K NILL K+ DFG++ +I GTP Y+ PE ++
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL-----REIMGTPEYLAPE-ILNY 207
Query: 349 E-LTEKSDVYSYGVVL 363
+ +T +D+++ G++
Sbjct: 208 DPITTATDMWNIGIIA 223
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 28/209 (13%)
Query: 171 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK--------ISEQVEGDFCREIELLARL 221
S +G G G V A + +A+K + K + EIE+L +L
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 222 HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 281
+H ++ ++ F + + +++ E M G L D + R L T + A++Y
Sbjct: 73 NHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQY 129
Query: 282 LHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 338
LH + HRD+K N+LL +E+ + K+ DFG + + S+ GTP
Sbjct: 130 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-----GTPT 181
Query: 339 YMDPEYVVTQEL----TEKSDVYSYGVVL 363
Y+ PE V+ D +S GV+L
Sbjct: 182 YLAPE-VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 21/200 (10%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEG------DFCREIELLARLHHRHLV 227
+G G F V K + S G A K + K + + RE+ +L ++ H +++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 228 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 287
L + + L+ E ++ G L D L LS + + + + YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLH---T 133
Query: 288 PPLCHRDIKSSNILL----DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 343
+ H D+K NI+L KL DFGLAH +DG +I GTP ++ PE
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-----KNIFGTPEFVAPE 188
Query: 344 YVVTQELTEKSDVYSYGVVL 363
V + L ++D++S GV+
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 21/199 (10%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEG------DFCREIELLARLHHRHLVA 228
+G G F V K + S G A K + K + + RE+ +L ++ H +++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
L + + L+ E ++ G L D L LS + + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLH---TK 134
Query: 289 PLCHRDIKSSNILL----DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
+ H D+K NI+L KL DFGLAH +DG +I GTP ++ PE
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-----KNIFGTPEFVAPEI 189
Query: 345 VVTQELTEKSDVYSYGVVL 363
V + L ++D++S GV+
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 49/222 (22%), Positives = 86/222 (38%), Gaps = 21/222 (9%)
Query: 150 QEGPSPMFQKFSYKETKKATD--NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQ 206
Q + ++ + + TD IG G + + + AVK +DK
Sbjct: 2 QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61
Query: 207 VEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW 265
EIE+L R H +++ L+ + + +++ E M G L D + + S
Sbjct: 62 PT----EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR--QKFFSE 115
Query: 266 QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLAHASKD 321
+ + + +EYLH + HRD+K SNIL ++ DFG A +
Sbjct: 116 REASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 363
+ T ++ PE + Q D++S GV+L
Sbjct: 173 ENGLL----MTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 63/250 (25%), Positives = 113/250 (45%), Gaps = 24/250 (9%)
Query: 130 ENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKAT-DNFS--TIIGQGGFGTVYK 186
+ S+ PF F F ++ + E + T + F ++G+GGFG V
Sbjct: 148 LTHEYLSVAPFADYLDSIYFNR-----FLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCA 202
Query: 187 AQFSD-GSLIAVKRMDK----ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRER-F 240
Q G + A K+++K + E ++L +++ R +V+L + E ++
Sbjct: 203 CQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKQILEKVNSRFVVSLA-YAYETKDALC 260
Query: 241 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 300
L+ M G LK H++ G+ + A ++ LE LH + +RD+K NI
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENI 317
Query: 301 LLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYG 360
LLD++ +++D GLA +G + + GT GYM PE V + T D ++ G
Sbjct: 318 LLDDHGHIRISDLGLAVHVPEG----QTIKG-RVGTVGYMAPEVVKNERYTFSPDWWALG 372
Query: 361 VVLLEIVTAR 370
+L E++ +
Sbjct: 373 CLLYEMIAGQ 382
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 40/192 (20%), Positives = 83/192 (43%), Gaps = 15/192 (7%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
+G+G FG V++ + S K + +EI +L HR+++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHESFE 71
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 294
E +++E+++ + + +++ L+ + + V AL++LH + + H D
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSH---NIGHFD 127
Query: 295 IKSSNILL--DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE-LT 351
I+ NI+ + K+ +FG A K G + P Y PE V + ++
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-----RLLFTAPEYYAPE-VHQHDVVS 181
Query: 352 EKSDVYSYGVVL 363
+D++S G ++
Sbjct: 182 TATDMWSLGTLV 193
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRGF 232
IG+G F V A+ G +A+K +DK ++ RE+ ++ L+H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 292
++ +L+ EY + G + D+L + GR + + + +A++Y H + H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKR---IVH 137
Query: 293 RDIKSSNILLDENFVAKLADFGLAHASKDGSI----CFEPVNTDIRGTPGYMDPEYVVTQ 348
RD+K+ N+LLD + K+ADFG ++ G C G P Y PE +
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---------GAPPYAAPE-LFQG 187
Query: 349 ELTE--KSDVYSYGVVLLEIVT 368
+ + + DV+S GV+L +V+
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVS 209
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 44/307 (14%), Positives = 80/307 (26%), Gaps = 73/307 (23%)
Query: 175 IIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIELLARL--------- 221
++GQ +A G V E+ L L
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 222 --HHRHLVALRGFCIEKR----------------ERFLMYEYMA--NGSLKDHLHSPGRT 261
H R + ++ RF +Y M + + L S T
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 262 --PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 319
L R+Q+ + V L LH Y L H ++ +I+LD+ L F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 320 KDGSICFEPVNTDIRGTPGYMDPEYV----------VTQELTEKSDVYSYGVVLLEIVTA 369
++ G+ PE +T D ++ G+ + I A
Sbjct: 262 GASAVS--------PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 370 RRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARP 429
+ ++ S + + V ++ + + R
Sbjct: 314 DLPN-TDDAALGGSEWIFRSCKNIPQPVRA----------------LLEGFLRYPKEDRL 356
Query: 430 SIKQVLR 436
Q +
Sbjct: 357 LPLQAME 363
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 50/215 (23%), Positives = 83/215 (38%), Gaps = 24/215 (11%)
Query: 154 SPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFC 212
SP +Q + K +G+G F K AVK + K ++E +
Sbjct: 4 SPFYQHYDLDLKDK-------PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQ 53
Query: 213 REIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI 271
+EI L H ++V L ++ FL+ E + G L + + S I
Sbjct: 54 KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYI 111
Query: 272 AIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEP 328
+ +A+ ++H + HRD+K N+L ++N K+ DFG A +
Sbjct: 112 MRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL-- 166
Query: 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 363
T Y PE + E D++S GV+L
Sbjct: 167 --KTPCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 51/224 (22%), Positives = 94/224 (41%), Gaps = 28/224 (12%)
Query: 154 SPMFQKFSYKETKKA--TDNF---STIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQV 207
S + F E KK TD++ ++G G G V + G A+K +
Sbjct: 10 SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--- 66
Query: 208 EGDFCREIELLARL-HHRHLVALRGFC----IEKRERFLMYEYMANGSLKDHLHSPGRTP 262
+E++ + H+V + KR ++ E M G L + G
Sbjct: 67 --KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA 124
Query: 263 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHAS 319
+ + +I D+ A+++LH + + HRD+K N+L +++ V KL DFG A +
Sbjct: 125 FTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181
Query: 320 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 363
++ TP Y+ PE + ++ + D++S GV++
Sbjct: 182 TQNAL------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 36/204 (17%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDK-----ISEQVEGDFCREIELLARLHHRHLVAL 229
+G+G +G V A +AVK +D E ++ +EI + L+H ++V
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK----KEICINKMLNHENVVKF 70
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCD 287
G E ++L EY + G L D + P R Q+ + YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLHGIG- 125
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI-------CFEPVNTDIRGTPGYM 340
+ HRDIK N+LLDE K++DFGLA + + C GT Y+
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---------GTLPYV 174
Query: 341 DPEYVVTQELT-EKSDVYSYGVVL 363
PE + +E E DV+S G+VL
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL 198
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 59/246 (23%), Positives = 93/246 (37%), Gaps = 45/246 (18%)
Query: 136 SLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQ-FSDGSL 194
+L+ P L QK+S +G G FG V+ A
Sbjct: 2 ALEEPPKAVELEGLAACEGEYSQKYSTMSP----------LGSGAFGFVWTAVDKEKNKE 51
Query: 195 IAVKRMDK--------ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246
+ VK + K I + G EI +L+R+ H +++ + + L+ E
Sbjct: 52 VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKH 111
Query: 247 ANGS-LKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD 303
+G L + R + I Q+ +A+ YL + HRDIK NI++
Sbjct: 112 GSGLDLFAFIDRHPRLDEPLASYIFRQLV----SAVGYLRLKD---IIHRDIKDENIVIA 164
Query: 304 ENFVAKLADFGLAHASKDGSI----CFEPVNTDIRGTPGYMDPEYVVTQELTE--KSDVY 357
E+F KL DFG A + G + C GT Y PE V+ + +++
Sbjct: 165 EDFTIKLIDFGSAAYLERGKLFYTFC---------GTIEYCAPE-VLMGNPYRGPELEMW 214
Query: 358 SYGVVL 363
S GV L
Sbjct: 215 SLGVTL 220
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 21/199 (10%)
Query: 176 IGQGGFGTVYKA-QFSDGSLIAVKRMDK------ISEQVEGDFCREIELLARLHHRHLVA 228
+G G F V K + S G A K + K D RE+ +L + H +++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
L K + L+ E +A G L D L L+ + + + N + YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQ-- 134
Query: 289 PLCHRDIKSSNILL----DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
+ H D+K NI+L K+ DFGLAH G+ +I GTP ++ PE
Sbjct: 135 -IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-----KNIFGTPEFVAPEI 188
Query: 345 VVTQELTEKSDVYSYGVVL 363
V + L ++D++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVIT 207
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 29/200 (14%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 231
+G G FG V + G +AVK +++ S V G REI+ L H H++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPP 289
+ F++ EY++ G L D++ GR R+ QI +A++Y H +
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL----SAVDYCHRHM--- 131
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI----CFEPVNTDIRGTPGYMDPEYV 345
+ HRD+K N+LLD + AK+ADFGL++ DG C G+P Y PE V
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---------GSPNYAAPE-V 181
Query: 346 VTQELTE--KSDVYSYGVVL 363
++ L + D++S GV+L
Sbjct: 182 ISGRLYAGPEVDIWSCGVIL 201
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 46/195 (23%), Positives = 82/195 (42%), Gaps = 15/195 (7%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRG 231
+G+G F V + G A ++ +S + RE + L H ++V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
E+ +L+++ + G L + + + R S + A+ + H +
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMG---VV 132
Query: 292 HRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 348
HR++K N+LL + KLADFGLA + + GTPGY+ PE +
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW----FGFAGTPGYLSPEVLRKD 188
Query: 349 ELTEKSDVYSYGVVL 363
+ D+++ GV+L
Sbjct: 189 PYGKPVDLWACGVIL 203
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 36/204 (17%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDK-----ISEQVEGDFCREIELLARLHHRHLVAL 229
+G+G +G V A +AVK +D E ++ +EI + L+H ++V
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK----KEICINKMLNHENVVKF 70
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCD 287
G E ++L EY + G L D + P R Q+ + YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLHGIG- 125
Query: 288 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI-------CFEPVNTDIRGTPGYM 340
+ HRDIK N+LLDE K++DFGLA + + C GT Y+
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---------GTLPYV 174
Query: 341 DPEYVVTQELT-EKSDVYSYGVVL 363
PE + +E E DV+S G+VL
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL 198
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 55/202 (27%), Positives = 87/202 (43%), Gaps = 35/202 (17%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 231
IG G FG + L+AVK +++ I E V+ REI L H ++V +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ----REIINHRSLRHPNIVRFKE 83
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPP 289
+ ++ EY + G L + + + GR Q+ + + Y H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL----SGVSYCHSMQ--- 136
Query: 290 LCHRDIKSSNILLDENFVA--KLADFGLAHASKDGSI----CFEPVNTDIRGTPGYMDPE 343
+CHRD+K N LLD + K+ DFG + +S S GTP Y+ PE
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---------GTPAYIAPE 187
Query: 344 YVVTQELTE--KSDVYSYGVVL 363
V+ ++ + +DV+S GV L
Sbjct: 188 -VLLRQEYDGKIADVWSCGVTL 208
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 62/244 (25%), Positives = 113/244 (46%), Gaps = 25/244 (10%)
Query: 138 KPFPPPRSLRKFQEGPSPMFQKFSYKETKKAT-DNFS--TIIGQGGFGTVYKAQFSD-GS 193
PF F F ++ + E + D F ++G+GGFG V+ Q G
Sbjct: 157 APFQEFLDSLYFLR-----FLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGK 211
Query: 194 LIAVKRMDK--ISEQVEGDFCR-EIELLARLHHRHLVALRGFCIEKRER-FLMYEYMANG 249
L A K+++K + ++ E ++LA++H R +V+L + E + L+ M G
Sbjct: 212 LYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGG 270
Query: 250 SLKDHLHSPGRTPLSW---QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF 306
++ H+++ + + A + + LE+LH + +RD+K N+LLD++
Sbjct: 271 DIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGLEHLH---QRNIIYRDLKPENVLLDDDG 326
Query: 307 VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEI 366
+++D GLA + GTPG+M PE ++ +E D ++ GV L E+
Sbjct: 327 NVRISDLGLA---VELKAGQTKTKG-YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEM 382
Query: 367 VTAR 370
+ AR
Sbjct: 383 IAAR 386
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 58/240 (24%), Positives = 87/240 (36%), Gaps = 31/240 (12%)
Query: 141 PPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQ-FSDGSLIAV 197
PR + KE + + +G GGFG+VY SD +A+
Sbjct: 14 LVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 73
Query: 198 KRMDK--ISEQVEGDFC----REIELLARLHHR--HLVALRGFCIEKRERFLMYEYMAN- 248
K ++K IS+ E E+ LL ++ ++ L + L+ E
Sbjct: 74 KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 133
Query: 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV- 307
L D + G L + V A+ + H + HRDIK NIL+D N
Sbjct: 134 QDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGE 188
Query: 308 AKLADFGLAHASKDGSI---CFEPVNTDIRGTPGYMDPEYVVTQELT-EKSDVYSYGVVL 363
KL DFG KD GT Y PE++ + V+S G++L
Sbjct: 189 LKLIDFGSGALLKDTVYTDFD---------GTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 38/204 (18%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK-------ISEQVEGDFCREIELLARLHHRHLV 227
+G+G FG V A + +A+K + + + +VE REI L L H H++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE----REISYLKLLRHPHII 72
Query: 228 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFY 285
L + ++ EY A G L D++ R R QI A+EY H +
Sbjct: 73 KLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQII----CAIEYCHRH 127
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI----CFEPVNTDIRGTPGYMD 341
+ HRD+K N+LLD+N K+ADFGL++ DG+ C G+P Y
Sbjct: 128 K---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---------GSPNYAA 175
Query: 342 PEYVVTQELTE--KSDVYSYGVVL 363
PE V+ +L + DV+S G+VL
Sbjct: 176 PE-VINGKLYAGPEVDVWSCGIVL 198
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDK--------ISEQVEGDFCREIELLARLHHRHL 226
+G+G +G V + S+ AVK + K V+ +EI+LL RL H+++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK----KEIQLLRRLRHKNV 68
Query: 227 VALRG--FCIEKRERFLMYEYMANGS--LKDHLHSPGRTPLSWQTR---IQIAIDVANAL 279
+ L + EK++ +++ EY G + D + R P+ Q Q+ ID L
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPV-CQAHGYFCQL-ID---GL 122
Query: 280 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA---HASKDGSICFEPVNTDIRGT 336
EYLH + H+DIK N+LL K++ G+A H C T +G+
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC----RT-SQGS 174
Query: 337 PGYMDPEYVVTQELTE--KSDVYSYGVVLLEIVT 368
P + PE + K D++S GV L I T
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 29/200 (14%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 231
+G G FG V + G +AVK +++ S V G REI+ L H H++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 232 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPP 289
+ F++ EY++ G L D++ GR R+ QI + ++Y H +
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL----SGVDYCHRHM--- 136
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI----CFEPVNTDIRGTPGYMDPEYV 345
+ HRD+K N+LLD + AK+ADFGL++ DG C G+P Y PE V
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---------GSPNYAAPE-V 186
Query: 346 VTQELTE--KSDVYSYGVVL 363
++ L + D++S GV+L
Sbjct: 187 ISGRLYAGPEVDIWSSGVIL 206
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 70/244 (28%), Positives = 115/244 (47%), Gaps = 24/244 (9%)
Query: 132 LDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATD-NFSTIIGQGGFGTVYKAQF- 189
+D T+ +P P SL+ Q P P K+ D F I+G+G F TV A+
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQP--------RKKRPEDFKFGKILGEGSFSTVVLAREL 52
Query: 190 SDGSLIAVKRMDK---ISE-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245
+ A+K ++K I E +V RE ++++RL H V L + + + Y
Sbjct: 53 ATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 111
Query: 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 305
NG L ++ G + TR A ++ +ALEYLH + HRD+K NILL+E+
Sbjct: 112 AKNGELLKYIRKIGSFDET-CTRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNED 166
Query: 306 FVAKLADFGLAHASKDGSICFEPVNTD-IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLL 364
++ DFG A K S + + GT Y+ PE + + + SD+++ G ++
Sbjct: 167 MHIQITDFGTA---KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIY 223
Query: 365 EIVT 368
++V
Sbjct: 224 QLVA 227
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 58/233 (24%), Positives = 95/233 (40%), Gaps = 68/233 (29%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK------------------------------IS 204
IG+G +G V A +D + A+K + K
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 205 EQVEGDFCREIELLARLHHRHLVALRGFCIE------KRERFLMYEYMANGSLKDHLHSP 258
EQV +EI +L +L H ++V L +E + ++++E + G + + P
Sbjct: 81 EQVY----QEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVME---VP 129
Query: 259 GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318
PLS D+ +EYLH+ + HRDIK SN+L+ E+ K+ADFG+++
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 319 SKDG-----SICFEPVNTDIRGTPGYMDPEYVVTQELT---EKSDVYSYGVVL 363
K + GTP +M PE + + DV++ GV L
Sbjct: 187 FKGSDALLSNTV---------GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 11/173 (6%)
Query: 150 QEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQFSDGSLIAVK--RMDKISE 205
++ Y + + + + +G+G +G VYKA+ S G ++A+K R+D E
Sbjct: 3 HHHHHSSGRENLY--FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE 60
Query: 206 QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW 265
+ REI LL LHH ++V+L +R L++E+M LK L +T L
Sbjct: 61 GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDEN-KTGLQD 118
Query: 266 QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318
+ + + H + HRD+K N+L++ + KLADFGLA A
Sbjct: 119 SQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARA 168
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 49/205 (23%), Positives = 79/205 (38%), Gaps = 31/205 (15%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK------ISEQVEGDFCREIELLARLH----HR 224
+G+GGFGTV+ +D +A+K + + E+ LL ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 225 HLVALRGFCIEKRERFLMYEYMANGS-LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 283
++ L + + L+ E L D++ G L V A+++ H
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCH 156
Query: 284 FYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSI---CFEPVNTDIRGTPGY 339
+ HRDIK NIL+D AKL DFG D GT Y
Sbjct: 157 SRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---------GTRVY 204
Query: 340 MDPEYVVTQELT-EKSDVYSYGVVL 363
PE++ + + V+S G++L
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILL 229
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 12/153 (7%)
Query: 170 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC---REIELLARLHH 223
+ + I IG+G +G V+K + D G ++A+K+ SE REI +L +L H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61
Query: 224 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 283
+LV L KR L++EY + ++ L R + I A+ + H
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH 119
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 316
+ HRD+K NIL+ ++ V KL DFG A
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFA 149
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 46/169 (27%), Positives = 85/169 (50%), Gaps = 12/169 (7%)
Query: 154 SPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGD 210
S + ++ + + + +G+G +G V K + D G ++A+K+ S+ +
Sbjct: 9 SSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMV 67
Query: 211 FC---REIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQT 267
REI+LL +L H +LV L C +K+ +L++E++ + ++ D L L +Q
Sbjct: 68 KKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPN-GLDYQV 125
Query: 268 RIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 316
+ + N + + H + + HRDIK NIL+ ++ V KL DFG A
Sbjct: 126 VQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 13/161 (8%)
Query: 164 ETKKATDNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVK--RMDKISEQVEGDFC---REI 215
+ K + + +G+G F TVYKA+ + ++A+K ++ SE +G REI
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 216 ELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDV 275
+LL L H +++ L K L++++M L+ + L+ +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNS-LVLTPSHIKAYMLMT 121
Query: 276 ANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 316
LEYLH + + HRD+K +N+LLDEN V KLADFGLA
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 5e-22
Identities = 62/258 (24%), Positives = 107/258 (41%), Gaps = 35/258 (13%)
Query: 127 EDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFS--TIIGQGGFGTV 184
E +NL + F +F + K ++FS IIG+GGFG V
Sbjct: 152 EICQNLRGDVFQKFIESDKFTRFCQ------WKNVELNIHLTMNDFSVHRIIGRGGFGEV 205
Query: 185 YKAQFSD-GSLIAVKRMDKIS----EQVEGDFC-REI-ELLARLHHRHLVALRGFCIEKR 237
Y + +D G + A+K +DK + R + L++ +V + +
Sbjct: 206 YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTP 264
Query: 238 ER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIK 296
++ + + M G L HL G + R A ++ LE++H + + +RD+K
Sbjct: 265 DKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAA-EIILGLEHMH---NRFVVYRDLK 319
Query: 297 SSNILLDENFVAKLADFGLAHASKDG---SICFEPVNTDIRGTPGYMDPEYVVTQELTEK 353
+NILLDE+ +++D GLA + GT GYM PE + +
Sbjct: 320 PANILLDEHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVLQKGVAYDS 370
Query: 354 S-DVYSYGVVLLEIVTAR 370
S D +S G +L +++
Sbjct: 371 SADWFSLGCMLFKLLRGH 388
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 6e-22
Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 9/152 (5%)
Query: 170 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHR 224
+NF + IG+G +G VYKA+ G ++A+K R+D +E V REI LL L+H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 225 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
++V L + + +L++E++ + LK + + T + + L + H
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLA 316
+ + HRD+K N+L++ KLADFGLA
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 6e-22
Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 9/153 (5%)
Query: 170 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRH 225
+ + + IG+G +G VYKAQ + G A+K R++K E + REI +L L H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
+V L K+ L++E++ + LK L L T + + N + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318
+ HRD+K N+L++ K+ADFGLA A
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARA 149
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 170 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKI----SEQVEGDFCREIELLARLH 222
D+F + IG+G FG V Q +D + A+K M+K +V F +E++++ L
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF-KELQIMQGLE 73
Query: 223 HRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 281
H LV L + + E F++ + + G L+ HL ++ I ++ AL+Y
Sbjct: 74 HPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-TVKLFIC-ELVMALDY 130
Query: 282 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG----SICFEPVNTDIRGTP 337
L + HRD+K NILLDE+ + DF +A ++ GT
Sbjct: 131 LQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---------GTK 178
Query: 338 GYMDPEYVVTQELTEKS---DVYSYGVVLLEIVTARR 371
YM PE +++ S D +S GV E++ RR
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 5e-21
Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 170 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHR 224
+ + IG+G +GTV+KA+ ++A+K R+D E V REI LL L H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 225 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
++V L ++ L++E+ + LK + S L + + L + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318
+ HRD+K N+L++ N KLA+FGLA A
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARA 150
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 170 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHR 224
+ + IGQG FG V+KA+ G +A+K M+ E REI++L L H
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 225 HLVALRGFCIEKRER--------FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVA 276
++V L C K +L++++ + L L + + ++ +
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLL 134
Query: 277 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 316
N L Y+H + HRD+K++N+L+ + V KLADFGLA
Sbjct: 135 NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 8e-21
Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 18/250 (7%)
Query: 127 EDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTV 184
+ L K + G M + + + + F + +G+G FG V
Sbjct: 105 TVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKV 164
Query: 185 YKAQFSD-GSLIAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVALRGFCIEKRER 239
+ G A+K + K ++V E +L H L AL+ + + +R
Sbjct: 165 ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-ENRVLQNSRHPFLTALK-YSFQTHDR 222
Query: 240 -FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSS 298
+ EY G L HL + R A ++ +AL+YLH + + +RD+K
Sbjct: 223 LCFVMEYANGGELFFHLSRERVFSED-RARFYGA-EIVSALDYLHSEKN--VVYRDLKLE 278
Query: 299 NILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYS 358
N++LD++ K+ DFGL K+G + T GTP Y+ PE + + D +
Sbjct: 279 NLMLDKDGHIKITDFGL---CKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWG 334
Query: 359 YGVVLLEIVT 368
GVV+ E++
Sbjct: 335 LGVVMYEMMC 344
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 46/200 (23%), Positives = 78/200 (39%), Gaps = 29/200 (14%)
Query: 127 EDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTV 184
++ + P + + D + I +G+G +G V
Sbjct: 4 HHHHHMGTLEAQTQGPGSMSVSAAPSATSI-------------DRYRRITKLGEGTYGEV 50
Query: 185 YKAQ-FSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241
YKA +A+K R++ E V G RE+ LL L HR+++ L+ L
Sbjct: 51 YKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110
Query: 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 301
++EY N LK ++ +S + + N + + H HRD+K N+L
Sbjct: 111 IFEYAEN-DLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLL 164
Query: 302 LDENFVA-----KLADFGLA 316
L + + K+ DFGLA
Sbjct: 165 LSVSDASETPVLKIGDFGLA 184
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 15/156 (9%)
Query: 170 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDKIS-EQVEGDFC---REIELLARLH 222
+ + + +G+G + TVYK + +L+A+K +I E EG C RE+ LL L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALK---EIRLEHEEGAPCTAIREVSLLKDLK 58
Query: 223 HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 282
H ++V L ++ L++EY+ + LK +L G ++ + L Y
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYC 116
Query: 283 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318
H + HRD+K N+L++E KLADFGLA A
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLARA 149
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 53/271 (19%), Positives = 104/271 (38%), Gaps = 67/271 (24%)
Query: 129 PENLDKTSLKPFPPPRSLRK--FQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYK 186
L+ L P P + K +G + ++ +Y K IG G FG V++
Sbjct: 7 NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKV--------IGNGSFGVVFQ 58
Query: 187 AQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRER------F 240
A+ + +A+K++ ++ + RE++++ + H ++V L+ F ++
Sbjct: 59 AKLVESDEVAIKKV-LQDKRFKN---RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114
Query: 241 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAID--------VANALEYLHFYCDPPLCH 292
L+ EY+ ++ + + + + + +L Y+H +CH
Sbjct: 115 LVLEYV-PETVYRASRH------YAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICH 164
Query: 293 RDIKSSNILLDEN-FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT---- 347
RDIK N+LLD V KL DFG A ++ Y+ +
Sbjct: 165 RDIKPQNLLLDPPSGVLKLIDFGSAKI-------LIAGEPNV---------SYICSRYYR 208
Query: 348 --------QELTEKSDVYSYGVVLLEIVTAR 370
T D++S G V+ E++ +
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 63/242 (26%), Positives = 99/242 (40%), Gaps = 30/242 (12%)
Query: 144 RSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRM 200
+ + F + P+ + KE + D+F + IG+G F V + G + A+K M
Sbjct: 37 KYVADFLQWAEPIVVRL--KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM 94
Query: 201 DK--ISEQVEGDFCR-EIELLARLHHRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLH 256
+K + ++ E R E ++L R + L F + +L+ EY G L L
Sbjct: 95 NKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS 153
Query: 257 SPGRT-PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL 315
G P R +A ++ A++ +H HRDIK NILLD +LADFG
Sbjct: 154 KFGERIPAEM-ARFYLA-EIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS 208
Query: 316 A-HASKDGSI-CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVY-------SYGVVLLEI 366
DG++ V GTP Y+ PE + + Y + GV E+
Sbjct: 209 CLKLRADGTVRSLVAV-----GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263
Query: 367 VT 368
Sbjct: 264 FY 265
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 41/161 (25%), Positives = 69/161 (42%), Gaps = 16/161 (9%)
Query: 168 ATDNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKIS-EQVEGDFC---REIELLAR 220
++ F + +G G + TVYK + G +A+K ++ + EG REI L+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK---EVKLDSEEGTPSTAIREISLMKE 59
Query: 221 LHHRHLVALRGFCIEKRERFLMYEYMAN---GSLKDHLHSPGRTPLSWQTRIQIAIDVAN 277
L H ++V L + + L++E+M N + L +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 278 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318
L + H + HRD+K N+L+++ KL DFGLA A
Sbjct: 120 GLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA 157
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-20
Identities = 35/263 (13%), Positives = 75/263 (28%), Gaps = 56/263 (21%)
Query: 176 IGQGGFGTVYKAQFSDGSL---IAVKRMD---KISEQVEGDFCREIELLARLHHRHLVAL 229
G ++A D +L +A+ +D + + V + L+R+ + +
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
+ ++ E++ GSL++ T S I+ +A A + H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
+ S + + + LA P M
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAY------------------------PATMPDA------ 179
Query: 350 LTEKSDVYSYGVVLLEIVTARR--AVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407
+ D+ G L ++ R ++ + A+ A + +D I
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS- 237
Query: 408 EQLRTIVTIVRWCTQREGQARPS 430
+ Q +G R +
Sbjct: 238 -------AVAARSVQGDGGIRSA 253
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 72/259 (27%), Positives = 111/259 (42%), Gaps = 40/259 (15%)
Query: 125 GLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATD-NFSTIIGQGGFGT 183
G+ P+ + + P PPP ++ GPS K +D +F +IG+G FG
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSS-------NPHAKPSDFHFLKVIGKGSFGK 53
Query: 184 VYKAQF-SDGSLIAVKRMDKIS----EQVEGDFCREIE---LLARLHHRHLVALRGFCIE 235
V A+ ++ AVK + K + ++ + E LL + H LV L F +
Sbjct: 54 VLLARHKAEEVFYAVKVLQKKAILKKKEEK---HIMSERNVLLKNVKHPFLVGLH-FSFQ 109
Query: 236 KRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 294
++ + + +Y+ G L HL + R A ++A+AL YLH + +RD
Sbjct: 110 TADKLYFVLDYINGGELFYHLQRERCFLEP-RARFYAA-EIASALGYLH---SLNIVYRD 164
Query: 295 IKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
+K NILLD L DFGL H S + C GTP Y+ PE + Q
Sbjct: 165 LKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC---------GTPEYLAPEVLHKQP 215
Query: 350 LTEKSDVYSYGVVLLEIVT 368
D + G VL E++
Sbjct: 216 YDRTVDWWCLGAVLYEMLY 234
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-20
Identities = 51/170 (30%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 166 KKATDNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFC------REIE 216
AT + + IG G +GTVYKA+ G +A+K + ++ G RE+
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVA 63
Query: 217 LLARLH---HRHLVALRGFCIEKRER-----FLMYEYMANGSLKDHLHSPGRTPLSWQTR 268
LL RL H ++V L C R L++E++ L+ +L L +T
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122
Query: 269 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318
+ L++LH C + HRD+K NIL+ KLADFGLA
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 45/184 (24%), Positives = 80/184 (43%), Gaps = 28/184 (15%)
Query: 155 PM---FQKFSYKETKKATDNFSTI---IGQGGFGTVYKAQFSD---GSLIAVKRMDKISE 205
M F+ E ++ D F +G+G +G VYKA+ D A+K+++
Sbjct: 2 KMDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--T 59
Query: 206 QVEGDFCREIELLARLHHRHLVALRGFCIEKRER--FLMYEYMANGSLKDHLHSPGRTPL 263
+ CREI LL L H ++++L+ + +R +L+++Y + L + +
Sbjct: 60 GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKA 118
Query: 264 SWQTRIQIAIDVA-------NALEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLAD 312
+ + V + + YLH + HRD+K +NIL+ E K+AD
Sbjct: 119 NKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD 175
Query: 313 FGLA 316
G A
Sbjct: 176 MGFA 179
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 62/244 (25%), Positives = 105/244 (43%), Gaps = 26/244 (10%)
Query: 136 SLKPFPPPRSLRKFQEGPSPMF-QKFSYKETKKAT-DNFSTI--IGQGGFGTVYKAQFSD 191
+ K S+++F F +K+ A D F I +G G FG V + +
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 192 GSLI-AVKRMDKIS----EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246
A+K +DK +Q+E E +L ++ LV L + +++ EY+
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF 306
A G + HL GR R A + EYLH D L +RD+K N+L+D+
Sbjct: 124 AGGEMFSHLRRIGRFSEP-HARFYAA-QIVLTFEYLH-SLD--LIYRDLKPENLLIDQQG 178
Query: 307 VAKLADFGLAHASKDG--SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLL 364
++ DFG A K ++C GTP + PE ++++ + D ++ GV++
Sbjct: 179 YIQVTDFGFAKRVKGRTWTLC---------GTPEALAPEIILSKGYNKAVDWWALGVLIY 229
Query: 365 EIVT 368
E+
Sbjct: 230 EMAA 233
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 70/243 (28%)
Query: 158 QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC-REI 215
Q+ SY +TK IG G FG VY+A+ D G L+A+K++ + F RE+
Sbjct: 52 QEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNREL 98
Query: 216 ELLARLHHRHLVALRGFCIEKRERF------LMYEYMA---NGSLKDHLHSPGRTPLS-- 264
+++ +L H ++V LR F E+ L+ +Y+ + + + P+
Sbjct: 99 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 158
Query: 265 ----WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHAS 319
+Q +L Y+H + +CHRDIK N+LLD + V KL DFG A
Sbjct: 159 KLYMYQL--------FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 320 KDGSICFEPVNTDIRGTPGYMDPEYVVT------------QELTEKSDVYSYGVVLLEIV 367
G EP N Y+ + + T DV+S G VL E++
Sbjct: 208 VRG----EP-NV-----------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251
Query: 368 TAR 370
+
Sbjct: 252 LGQ 254
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 166 KKATDNFSTI--IGQGGFGTVYKAQ--FSDGSLIAVK--RMDKISEQVEGDFCREIELLA 219
+A + + IG+G +G V+KA+ + G +A+K R+ E + RE+ +L
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 220 RLH---HRHLVALRGFCIEKRER-----FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI 271
L H ++V L C R L++E++ + L +L + +T +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDM 125
Query: 272 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318
+ L++LH + + HRD+K NIL+ + KLADFGLA
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 169
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 33/212 (15%)
Query: 171 NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK----ISEQVEGDFCREIELLARLHHRH 225
++ ++G+G FG V + + G A+K + K ++V E +L H
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHPF 66
Query: 226 LVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
L AL+ + + +R + EY G L HL + R A ++ +ALEYLH
Sbjct: 67 LTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGA-EIVSALEYLH- 122
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG--------SICFEPVNTDIRGT 336
+ +RDIK N++LD++ K+ DFGL K+G + C GT
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGL---CKEGISDGATMKTFC---------GT 168
Query: 337 PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
P Y+ PE + + D + GVV+ E++
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 19/224 (8%)
Query: 153 PSPMFQKFSYKETKKATD-NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK----ISEQ 206
P ++ S + K D ++G+G FG V+ A+F A+K + K + +
Sbjct: 1 PELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD 60
Query: 207 VEGDFC-REIELLARLHHRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLS 264
VE + + L H L + + +E F + EY+ G L H+ S + LS
Sbjct: 61 VECTMVEKRV-LSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS 118
Query: 265 WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324
+ A ++ L++LH + +RD+K NILLD++ K+ADFG+ K+ +
Sbjct: 119 -RATFYAA-EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGM---CKEN-M 169
Query: 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
+ GTP Y+ PE ++ Q+ D +S+GV+L E++
Sbjct: 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 3e-18
Identities = 58/256 (22%), Positives = 105/256 (41%), Gaps = 21/256 (8%)
Query: 123 SRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKAT-DNFSTI--IGQG 179
G E E L + + + ++ + + + + + +F+ + +G+G
Sbjct: 293 PEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKG 352
Query: 180 GFGTVYKAQFSD-GSLIAVKRMDK----ISEQVEGDFC-REIELLARLHHRHLVALRGFC 233
FG V ++ L AVK + K + VE + + L L L C
Sbjct: 353 SFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGKPPFLTQLH-SC 410
Query: 234 IEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 292
+ +R + + EY+ G L H+ GR A ++A L +L + +
Sbjct: 411 FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-HAVFYAA-EIAIGLFFLQ---SKGIIY 465
Query: 293 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 352
RD+K N++LD K+ADFG+ K+ I GTP Y+ PE + Q +
Sbjct: 466 RDLKLDNVMLDSEGHIKIADFGM---CKEN-IWDGVTTKTFCGTPDYIAPEIIAYQPYGK 521
Query: 353 KSDVYSYGVVLLEIVT 368
D +++GV+L E++
Sbjct: 522 SVDWWAFGVLLYEMLA 537
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 45/230 (19%), Positives = 79/230 (34%), Gaps = 52/230 (22%)
Query: 143 PRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMD 201
P Q + + YK T + ++G G G V + A+K +
Sbjct: 2 PHVKSGLQIKKNAIIDD--YKVTSQ-------VLGLGINGKVLQIFNKRTQEKFALKMLQ 52
Query: 202 KISEQVEGDFCREIELLARL-HHRHLVALRGFC----IEKRERFLMYEYMANGSLKDHLH 256
RE+EL R H+V + ++ ++ E + G L +
Sbjct: 53 DCP-----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ 107
Query: 257 SPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADF 313
G + + +I + A++YLH + HRD+K N+L N + KL DF
Sbjct: 108 DRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF 164
Query: 314 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 363
G A E ++ + D++S GV++
Sbjct: 165 GFA-------------------------KE-TTGEKYDKSCDMWSLGVIM 188
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 50/276 (18%), Positives = 89/276 (32%), Gaps = 90/276 (32%)
Query: 172 FSTIIGQGGFGTVYKA------QFSDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HH 223
+G+G FG V +A + + +AVK + + + E+++L + HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 224 RHLVALRGFCIEKRERFLM-YEYMANGSLKDHLHSPGRTPLSWQTRIQIA---------- 272
++V L G C + ++ E+ G+L +L S + ++T+
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 273 ---------------------------IDVANALEYLHFYCDPPLCHRD----------- 294
+ E L
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 295 ---IKSSNIL----------LDENFVAKLADFGLA---------HASKDGSICFEPVNTD 332
+ S + L E V K+ DFGLA D + P+
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLK-- 260
Query: 333 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
+M PE + + T +SDV+S+GV+L EI +
Sbjct: 261 ------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 8e-18
Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 28/240 (11%)
Query: 144 RSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRM 200
+++ ++ E P K K+ + ++F + IG+G FG V + + + A+K +
Sbjct: 50 KNILEYLEWAKPFTSKV--KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKIL 107
Query: 201 DK--ISEQVEGDFCR-EIELLARLHHRHLVALRG-FCIEKRERFLMYEYMANGSLKDHLH 256
+K + ++ E R E ++L + + L F + +M +Y G L L
Sbjct: 108 NKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM-DYYVGGDLLTLLS 166
Query: 257 -SPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL 315
R P R +A ++ A++ +H HRDIK NIL+D N +LADFG
Sbjct: 167 KFEDRLPEEM-ARFYLA-EMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 221
Query: 316 A-HASKDGSI-CFEPVNTDIRGTPGYMDPEYVVTQELTEKS-----DVYSYGVVLLEIVT 368
+DG++ V GTP Y+ PE + E + D +S GV + E++
Sbjct: 222 CLKLMEDGTVQSSVAV-----GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 171 NFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDK----ISEQVEGDFC-REIELLARLHHR 224
NF ++G+G FG V ++ L AVK + K + VE + + L
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGKPP 81
Query: 225 HLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 283
L L C + +R + + EY+ G L H+ GR A ++A L +L
Sbjct: 82 FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-HAVFYAA-EIAIGLFFLQ 138
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 343
+ +RD+K N++LD K+ADFG+ K+ I GTP Y+ PE
Sbjct: 139 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGM---CKEN-IWDGVTTKTFCGTPDYIAPE 191
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVT 368
+ Q + D +++GV+L E++
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLA 216
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 171 NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK----ISEQVEGDFCREIE---LLARLH 222
+ +IG+G + V + + A+K + K E ++ + E +
Sbjct: 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDID---WVQTEKHVFEQASN 68
Query: 223 HRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 281
H LV L C + R F + EY+ G L H+ + P R A +++ AL Y
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSA-EISLALNY 125
Query: 282 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMD 341
LH + + +RD+K N+LLD KL D+G+ K+G + + GTP Y+
Sbjct: 126 LH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM---CKEG-LRPGDTTSTFCGTPNYIA 178
Query: 342 PEYVVTQELTEKSDVYSYGVVLLEIVT 368
PE + ++ D ++ GV++ E++
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMA 205
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 25/231 (10%)
Query: 150 QEGPSPMFQKFSYKETKKAT-DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDK--- 202
+E M + S K + +F + IG+G + V + + A++ + K
Sbjct: 31 EEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV 90
Query: 203 -ISEQVEGDFCREIE---LLARLHHRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHS 257
E ++ + E +H LV L C + R F + EY+ G L H+
Sbjct: 91 NDDEDID---WVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQR 146
Query: 258 PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH 317
+ P R A +++ AL YLH + + +RD+K N+LLD KL D+G+
Sbjct: 147 QRKLPEE-HARFYSA-EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM-- 199
Query: 318 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
K+G + + GTP Y+ PE + ++ D ++ GV++ E++
Sbjct: 200 -CKEG-LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 68/230 (29%), Positives = 103/230 (44%), Gaps = 24/230 (10%)
Query: 152 GPSPMFQ---KFSYKETKKAT-DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDK-- 202
GP + + + DNF I +G+G FG V A+ G L AVK + K
Sbjct: 1 GPKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV 60
Query: 203 --ISEQVEGDFC-REIELLARLHHRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSP 258
+ VE + I L +H L L C + +R F + E++ G L H+
Sbjct: 61 ILQDDDVECTMTEKRI-LSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKS 118
Query: 259 GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318
R + + R A ++ +AL +LH D + +RD+K N+LLD KLADFG+
Sbjct: 119 RRFDEA-RARFYAA-EIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGM--- 170
Query: 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
K+G IC GTP Y+ PE + D ++ GV+L E++
Sbjct: 171 CKEG-ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 65/250 (26%), Positives = 112/250 (44%), Gaps = 26/250 (10%)
Query: 130 ENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKA 187
+LD +L+ +++ F K ++ + +++ + IG+G FG V
Sbjct: 34 YDLDFPALRK---NKNIDNFLSRYKDTINKI--RDLRMKAEDYEVVKVIGRGAFGEVQLV 88
Query: 188 QF-SDGSLIAVKRMDK--ISEQVEGDFCR-EIELLARLHHRHLVALRG-FCIEKRERFLM 242
+ S + A+K + K + ++ + F E +++A + +V L F ++ +M
Sbjct: 89 RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148
Query: 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL 302
EYM G L + + S P W R A +V AL+ +H HRD+K N+LL
Sbjct: 149 -EYMPGGDLVNLM-SNYDVPEKW-ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLL 201
Query: 303 DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK----SDVYS 358
D++ KLADFG K +T + GTP Y+ PE + +Q D +S
Sbjct: 202 DKSGHLKLADFGT--CMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWS 258
Query: 359 YGVVLLEIVT 368
GV L E++
Sbjct: 259 VGVFLYEMLV 268
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 34/223 (15%)
Query: 163 KETKKAT-DNFSTI--IGQGGFGTVY----KAQFSDGSLIAVKRMDKIS----EQVEGDF 211
+ +KA F + +GQG FG V+ + L A+K + K + ++V
Sbjct: 16 EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM 75
Query: 212 CREIELLARLHHRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ 270
R+I L ++H +V L + + + +L+ +++ G L L +
Sbjct: 76 ERDI--LVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-DVKFY 131
Query: 271 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSIC 325
+A ++A AL++LH + +RD+K NILLDE KL DFGL+ H K S C
Sbjct: 132 LA-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 187
Query: 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
GT YM PE V + T+ +D +S+GV++ E++T
Sbjct: 188 ---------GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 52/233 (22%), Positives = 97/233 (41%), Gaps = 43/233 (18%)
Query: 158 QKFSYKETKKATDNFSTI--IGQGGFGTVYKAQF----SDGSLIAVKRMDKIS-----EQ 206
+ K + F + +G+GG+G V++ + + G + A+K + K +
Sbjct: 5 TSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD 64
Query: 207 VEGDFCREIE--LLARLHHRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPL 263
+ E +L + H +V L + + + +L+ EY++ G L L G
Sbjct: 65 TA---HTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFME 120
Query: 264 SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG- 322
+A +++ AL +LH + +RD+K NI+L+ KL DFGL K+
Sbjct: 121 D-TACFYLA-EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGL---CKESI 172
Query: 323 -------SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
+ C GT YM PE ++ D +S G ++ +++T
Sbjct: 173 HDGTVTHTFC---------GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLT 216
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 55/257 (21%), Positives = 93/257 (36%), Gaps = 66/257 (25%)
Query: 152 GPSPMFQKF----SYKETKKATDNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKR----- 199
GP M + + ++K D F GQG FGTV + G +A+K+
Sbjct: 1 GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP 60
Query: 200 MDKISEQVEGDFCREIELLARLHHRHLVALR-GFCIEKRERF------LMYEYMANGSLK 252
+ E + ++ LA LHH ++V L+ F ++ EY+ +L
Sbjct: 61 RFRNRE------LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLH 113
Query: 253 DHL--HSPGRTPLSW---QTRI-QIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-EN 305
+ + + + Q+ ++ LH +CHRDIK N+L++ +
Sbjct: 114 RCCRNYYRRQVAPPPILIKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEAD 168
Query: 306 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT------------QELTEK 353
KL DFG A EP N Y+ + Q T
Sbjct: 169 GTLKLCDFGSAKKLSPS----EP-NV-----------AYICSRYYRAPELIFGNQHYTTA 212
Query: 354 SDVYSYGVVLLEIVTAR 370
D++S G + E++
Sbjct: 213 VDIWSVGCIFAEMMLGE 229
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 5e-17
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 170 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDKIS----EQVEGDFCREIELLARLH 222
+F + +G G FG V+ + +G A+K + K +QVE E +L+ +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND-ERLMLSIVT 64
Query: 223 HRHLVALRG-FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 281
H ++ + G F ++ +M +Y+ G L L R P + A +V ALEY
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIM-DYIEGGELFSLLRKSQRFPNP-VAKFYAA-EVCLALEY 121
Query: 282 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG--SICFEPVNTDIRGTPGY 339
LH + +RD+K NILLD+N K+ DFG A D ++C GTP Y
Sbjct: 122 LH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC---------GTPDY 169
Query: 340 MDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
+ PE V T+ + D +S+G+++ E++
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 65/345 (18%), Positives = 128/345 (37%), Gaps = 63/345 (18%)
Query: 120 RRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IG 177
++ + + + ++ RK P + D + IG
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62
Query: 178 QGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVALRG- 231
G +G V +A + ++A+K++ ++ E + C REI +L RL+H H+V +
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI--DCKRILREIAILNRLNHDHVVKVLDI 120
Query: 232 FCIEKRERF----LMYEYMANGSLKDHLHSPGRTPLSWQTRIQ-IAIDVANALEYLHFYC 286
+ E+F ++ E + K +P L+ + I+ + ++ ++Y+H
Sbjct: 121 VIPKDVEKFDELYVVLEIA-DSDFKKLFRTP--VYLT-ELHIKTLLYNLLVGVKYVH--- 173
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPGYMD 341
+ HRD+K +N L++++ K+ DFGLA + + + P D+
Sbjct: 174 SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233
Query: 342 P-------EYVVTQ-----EL-------TEKSDVYSYGVVLLEIVTARRAVQD------- 375
+VVT+ EL TE DV+S G + E++ +
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293
Query: 376 ---GKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIV 417
G + C D + + +QL I I+
Sbjct: 294 LFPGSS-------CFPLSPDQKAGNDFKFHTRGNRDQLNVIFNIL 331
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 55/235 (23%), Positives = 81/235 (34%), Gaps = 52/235 (22%)
Query: 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGD-------FC----REIELLARLHH 223
I G +G V S+G +A+KR+ C REI LL HH
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 224 RHLVALRG-FCIEKRERF----LMYEYMANGSLKDHLHSPGRTPLSWQTRIQ-IAIDVAN 277
+++ LR F + L+ E M L +H R +S IQ +
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHD-QRIVIS-PQHIQYFMYHILL 145
Query: 278 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 337
L LH + + HRD+ NILL +N + DF LA
Sbjct: 146 GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLARED---------------TAD 187
Query: 338 GYMDPEYVVT------------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV 380
YV + T+ D++S G V+ E+ R+A+ G
Sbjct: 188 ANK-THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN-RKALFRGSTFY 240
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 62/265 (23%), Positives = 98/265 (36%), Gaps = 41/265 (15%)
Query: 127 EDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTV 184
E + + + K +NF + +G G +G V
Sbjct: 11 EGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKV 70
Query: 185 Y---KAQFSD-GSLIAVKRMDKIS-----EQVEGDFCREIE---LLARLHHRHLVALRGF 232
+ K D G L A+K + K + + E E L LV L +
Sbjct: 71 FLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE---HTRTERQVLEHIRQSPFLVTLH-Y 126
Query: 233 CIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 291
+ + L+ +Y+ G L HL R + +I + ++ ALE+LH +
Sbjct: 127 AFQTETKLHLILDYINGGELFTHLSQRERFTEH-EVQIYVG-EIVLALEHLH---KLGII 181
Query: 292 HRDIKSSNILLDENFVAKLADFGLA------HASKDGSICFEPVNTDIRGTPGYMDPEYV 345
+RDIK NILLD N L DFGL+ + C GT YM P+ V
Sbjct: 182 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC---------GTIEYMAPDIV 232
Query: 346 VTQEL--TEKSDVYSYGVVLLEIVT 368
+ + D +S GV++ E++T
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLT 257
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 51/225 (22%), Positives = 99/225 (44%), Gaps = 41/225 (18%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVAL 229
+IG+G +G VY A + +A+K+++++ E + C REI +L RL +++ L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI--DCKRILREITILNRLKSDYIIRL 90
Query: 230 RG-FCIEKRERF----LMYEYMANGSLKDHLHSPGRTPLSWQTRIQ-IAIDVANALEYLH 283
+ +F ++ E + LK +P L+ + I+ I ++ ++H
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTP--IFLT-EEHIKTILYNLLLGENFIH 146
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRG 335
+ + HRD+K +N LL+++ K+ DFGLA + E +
Sbjct: 147 ---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 336 TPGYMDPEYVVTQ-----EL-------TEKSDVYSYGVVLLEIVT 368
+ +VVT+ EL T+ D++S G + E++
Sbjct: 204 LKKQL-TSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 42/230 (18%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVAL 229
++G+G +G V A G ++A+K+++ + + F REI++L H +++ +
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL---FALRTLREIKILKHFKHENIITI 74
Query: 230 RG-FCIEKRERF----LMYEYMANGSLKDHLHSPGRT-PLSWQTRIQ-IAIDVANALEYL 282
+ E F ++ E M D LH T LS IQ A++ L
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQ----TD-LHRVISTQMLS-DDHIQYFIYQTLRAVKVL 128
Query: 283 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 342
H + HRD+K SN+L++ N K+ DFGLA + N++ G M
Sbjct: 129 H---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES----AADNSEPTGQQSGM-V 180
Query: 343 EYVVTQ-----EL-------TEKSDVYSYGVVLLEIVTARRAVQDGKNLV 380
E+V T+ E+ + DV+S G +L E+ RR + G++
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYR 229
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 9e-15
Identities = 45/218 (20%), Positives = 92/218 (42%), Gaps = 29/218 (13%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVAL 229
IG G G V A + +A+K++ + + RE+ L+ ++H++++ L
Sbjct: 32 PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT--HAKRAYRELVLMKCVNHKNIIGL 89
Query: 230 R------GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ-IAIDVANALEYL 282
E ++ +++ E M + L + L R+ + + +++L
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDA----N-LCQVIQMELD-HERMSYLLYQMLCGIKHL 143
Query: 283 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 342
H + HRD+K SNI++ + K+ DFGLA + + T T Y P
Sbjct: 144 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAP 195
Query: 343 EYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV 380
E ++ E D++S G ++ E++ + G + +
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIK-GGVLFPGTDHI 232
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 45/206 (21%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVALR 230
IG G G V A + +A+K++ + + RE+ L+ ++H+++++L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT--HAKRAYRELVLMKCVNHKNIISLL 127
Query: 231 ------GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
E ++ +L+ E M +L + L + + + +++LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDA-----NLCQVIQMELDHERMSYLLYQMLCGIKHLH- 181
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
+ HRD+K SNI++ + K+ DFGLA + + T T Y PE
Sbjct: 182 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEV 234
Query: 345 VVTQELTEKSDVYSYGVVLLEIVTAR 370
++ E D++S G ++ E+V +
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 51/229 (22%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVALR 230
+G G +G+V A G +A+K++ + + F RE+ LL + H +++ L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI--FAKRAYRELLLLKHMQHENVIGLL 89
Query: 231 ------GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ-IAIDVANALEYLH 283
+ +L+ +M D L S + +IQ + + L+Y+H
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQ----TD-LQKIMGLKFS-EEKIQYLVYQMLKGLKYIH 143
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 343
+ HRD+K N+ ++E+ K+ DFGLA R M
Sbjct: 144 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLA-----------------RHADAEM-TG 182
Query: 344 YVVTQ-----EL-------TEKSDVYSYGVVLLEIVTARRAVQDGKNLV 380
YVVT+ E+ + D++S G ++ E++T + + GK+ +
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYL 230
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 49/229 (21%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVALR 230
IG+G +G V A + +A+K++ Q +C REI++L R H +++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT---YCQRTLREIKILLRFRHENIIGIN 91
Query: 231 G-FCIEKRERF----LMYEYMANGSLKDHLHSPGRT-PLSWQTRIQ-IAIDVANALEYLH 283
E+ ++ + M D L+ +T LS I + L+Y+H
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLME----TD-LYKLLKTQHLS-NDHICYFLYQILRGLKYIH 145
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 343
+ HRD+K SN+LL+ K+ DFGLA + G++ E
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-----------DHTGFL-TE 190
Query: 344 YVVTQ-----EL-------TEKSDVYSYGVVLLEIVTARRAVQDGKNLV 380
YV T+ E+ T+ D++S G +L E+++ R + GK+ +
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFPGKHYL 238
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 38/192 (19%), Positives = 72/192 (37%), Gaps = 33/192 (17%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVE---GDFCREIELLARLHHRHLVA--- 228
+ G +Y+A S + + + K S +++ G E R V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 229 ----LRGFCI---------EKRERFLMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAID 274
I + + RFL+ + G SL+ L + LS ++ +Q+A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 275 VANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGS--ICF-EP 328
+ +ALE+LH H ++ + NI + D++ V LA +G A + + E
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQV-TLAGYGFAFRYCPSGKHVAYVEG 223
Query: 329 VNTDIRGTPGYM 340
+ G ++
Sbjct: 224 SRSPHEGDLEFI 235
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 45/247 (18%), Positives = 80/247 (32%), Gaps = 72/247 (29%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC-REIELLARLHHRHLVALRGF 232
+G G FG V + + G A+K K+ + + RE++++ L H +++ L +
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALK---KVLQDPR--YKNRELDIMKVLDHVNIIKLVDY 68
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA--IDVANALEY----LHFYC 286
+ + K + G + + + +EY LH
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 287 D---------PPL---------------------CHRDIKSSNILLD-ENFVAKLADFGL 315
P CHRDIK N+L++ ++ KL DFG
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGS 188
Query: 316 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVT------------QELTEKSDVYSYGVVL 363
A EP + Y+ + E T D++S G V
Sbjct: 189 AKKLIPS----EP-SV-----------AYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 364 LEIVTAR 370
E++ +
Sbjct: 233 GELILGK 239
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 42/233 (18%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLH-HRHLVA 228
+G+G +G V+K+ G ++AVK++ + REI +L L H ++V
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST--DAQRTFREIMILTELSGHENIVN 73
Query: 229 LRGFCI--EKRERFLMYEYMANGSLKDHLHSPGRT-PLSWQTRIQ-IAIDVANALEYLHF 284
L R+ +L+++YM D LH+ R L Q + + ++YLH
Sbjct: 74 LLNVLRADNDRDVYLVFDYME----TD-LHAVIRANILE-PVHKQYVVYQLIKVIKYLH- 126
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLA-------HASKDGSICFEPVNTDIRGTP 337
L HRD+K SNILL+ K+ADFGL+ + + + +
Sbjct: 127 --SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 338 GYMDPEYVVT------------QELTEKSDVYSYGVVLLEIVTARRAVQDGKN 378
+ +YV T + T+ D++S G +L EI+ + + G +
Sbjct: 185 PIL-TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC-GKPIFPGSS 235
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 51/229 (22%), Positives = 92/229 (40%), Gaps = 53/229 (23%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVALR 230
+G G +G V A G+ +A+K++ + + F RE+ LL + H +++ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL--FAKRAYRELRLLKHMRHENVIGLL 90
Query: 231 GFCI--EKRERF----LMYEYMANGSLKDHLHSPGRT-PLSWQTRIQIAIDVANALEYLH 283
E + F L+ +M D L + L + + L Y+H
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFMG----TD-LGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 343
+ HRD+K N+ ++E+ K+ DFGLA R M
Sbjct: 146 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLA-----------------RQADSEM-TG 184
Query: 344 YVVTQ-----EL-------TEKSDVYSYGVVLLEIVTARRAVQDGKNLV 380
YVVT+ E+ T+ D++S G ++ E++T + + G + +
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTLFKGSDHL 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 2e-12
Identities = 43/270 (15%), Positives = 78/270 (28%), Gaps = 74/270 (27%)
Query: 150 QEGPSPM---FQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVK-------- 198
Q+GP P + +K IG+G FG V++ +D + +A+K
Sbjct: 7 QKGPVPFSHCLPTEKLQRCEK--------IGEGVFGEVFQTI-ADHTPVAIKIIAIEGPD 57
Query: 199 RMDKISEQVEGDFCREIELLARLH---------HRHLVALRGFCI--------------- 234
++ ++ + EI + L + L
Sbjct: 58 LVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDH 117
Query: 235 ---------------EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 279
+ + F++ E+ G L S T I + +L
Sbjct: 118 YNSTKGSANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASL 174
Query: 280 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR----- 334
HRD+ N+LL + + KL +S S + D
Sbjct: 175 AVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232
Query: 335 --GTPGYMD---PEYVVTQELTEKSDVYSY 359
G + D E + T + + D+Y
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 29/190 (15%)
Query: 162 YKETKKATDNFSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLAR 220
Y+ +K IG G FG +Y + G +A+K ++ E ++
Sbjct: 11 YRLGRK--------IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKM 60
Query: 221 LHH-RHLVALRGFCIEKRERFLMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAIDVANA 278
+ + +R E ++ E + G SL+D + R S +T + +A + +
Sbjct: 61 MQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRK-FSLKTVLLLADQMISR 117
Query: 279 LEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLAHASKDGS----ICFEPVN 330
+EY+H HRD+K N L+ N V + DFGLA +D I + N
Sbjct: 118 IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVY-IIDFGLAKKYRDARTHQHIPYRE-N 172
Query: 331 TDIRGTPGYM 340
++ GT Y
Sbjct: 173 KNLTGTARYA 182
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 55/228 (24%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVALR 230
+G G +G+V A + G +AVK++ + + + RE+ LL + H +++ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 94
Query: 231 GFCI--EKRERF----LMYEYMANGSLKDHLHSPGRT-PLSWQTRIQ-IAIDVANALEYL 282
E F L+ M D L++ + L+ +Q + + L+Y+
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLMG----AD-LNNIVKCQKLT-DDHVQFLIYQILRGLKYI 148
Query: 283 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 342
H + HRD+K SN+ ++E+ K+ DFGLA R T M
Sbjct: 149 H---SADIIHRDLKPSNLAVNEDCELKILDFGLA-----------------RHTADEM-T 187
Query: 343 EYVVTQ-----EL-------TEKSDVYSYGVVLLEIVTARRAVQDGKN 378
YV T+ E+ + D++S G ++ E++T R + G +
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 234
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 42/194 (21%), Positives = 75/194 (38%), Gaps = 37/194 (19%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKR--MDKISEQVEGDFCREIELLARLHHRHLVA----- 228
IGQGGFG +Y A + + + K+ G E++ R +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 229 ----------LRGFCIEKRE----RFLMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAI 273
G + + RF++ + G L+ + + S +T +Q+++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKR-FSRKTVLQLSL 159
Query: 274 DVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGS----ICF 326
+ + LEY+H + H DIK+SN+LL + + V L D+GLA+
Sbjct: 160 RILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQV-YLVDYGLAYRYCPEGVHKAYAA 215
Query: 327 EPVNTDIRGTPGYM 340
+P GT +
Sbjct: 216 DP-KRCHDGTIEFT 228
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 44/193 (22%), Positives = 72/193 (37%), Gaps = 38/193 (19%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVA------ 228
IG GGFG +Y A + A + K+ Q G E++ R+ + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 229 ---------LRGF----CIEKRERFLMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAID 274
G + RF++ E + G L+ G T +Q+ I
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGT--FKKSTVLQLGIR 159
Query: 275 VANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGS----ICFE 327
+ + LEY+H H DIK++N+LL + + V LAD+GL++
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQV-YLADYGLSYRYCPNGNHKQYQEN 215
Query: 328 PVNTDIRGTPGYM 340
P GT +
Sbjct: 216 P-RKGHNGTIEFT 227
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 43/192 (22%), Positives = 75/192 (39%), Gaps = 31/192 (16%)
Query: 162 YKETKKATDNFSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLAR 220
YK ++ IG+G FG +++ + +A+K + S+ E
Sbjct: 12 YKVGRR--------IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKL 61
Query: 221 LHH-RHLVALRGFCIEKRERFLMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAIDVANA 278
L + + F E L+ + + G SL+D L GR S +T A +
Sbjct: 62 LAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRK-FSVKTVAMAAKQMLAR 118
Query: 279 LEYLHFYCDPPLCHRDIKSSNILL------DENFVAKLADFGLAHASKDGS----ICFEP 328
++ +H L +RDIK N L+ + N + + DFG+ +D I +
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIY-VVDFGMVKFYRDPVTKQHIPYRE 174
Query: 329 VNTDIRGTPGYM 340
++ GT YM
Sbjct: 175 -KKNLSGTARYM 185
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 53/241 (21%), Positives = 96/241 (39%), Gaps = 60/241 (24%)
Query: 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVAL 229
+G GG G V+ A +D +A+K KI REI+++ RL H ++V +
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQS-VKHALREIKIIRRLDHDNIVKV 73
Query: 230 R----------GFCIEKRERF----LMYEYMANGSLKDHLHSPGRT-PLSWQTRIQ-IAI 273
+ ++ EYM D L + PL + +
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TD-LANVLEQGPLL-EEHARLFMY 127
Query: 274 DVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPVNTD 332
+ L+Y+H + HRD+K +N+ ++ E+ V K+ DFGLA
Sbjct: 128 QLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY--------- 175
Query: 333 IRGTPGYMDPEYVVTQ-----EL-------TEKSDVYSYGVVLLEIVTARRAVQDGKNLV 380
G++ E +VT+ L T+ D+++ G + E++T + + G + +
Sbjct: 176 --SHKGHL-SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT-GKTLFAGAHEL 231
Query: 381 E 381
E
Sbjct: 232 E 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 47/189 (24%), Positives = 79/189 (41%), Gaps = 27/189 (14%)
Query: 162 YKETKKATDNFSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLAR 220
++ +K IG G FG +Y +A+K + ++ E ++
Sbjct: 9 FRLGRK--------IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRI 58
Query: 221 LH-HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 279
L + +R F +E L+ + + SL+D + R LS +T + +A + N +
Sbjct: 59 LQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRK-LSLKTVLMLADQMINRV 116
Query: 280 EYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLAHASKDGS----ICFEPVNT 331
E++H HRDIK N L+ N V + DFGLA +D S I + N
Sbjct: 117 EFVHSKS---FLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKKYRDTSTHQHIPYRE-NK 171
Query: 332 DIRGTPGYM 340
++ GT Y
Sbjct: 172 NLTGTARYA 180
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 44/192 (22%), Positives = 73/192 (38%), Gaps = 31/192 (16%)
Query: 162 YKETKKATDNFSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLAR 220
++ KK IG G FG + + +A+K S E +
Sbjct: 11 FRVGKK--------IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQ 60
Query: 221 LHH-RHLVALRGFCIEKRERFLMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAIDVANA 278
L + + F + ++ E + G SL+D RT S +T + IAI + +
Sbjct: 61 LGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRT-FSLKTVLMIAIQLISR 117
Query: 279 LEYLHFYCDPPLCHRDIKSSNILL------DENFVAKLADFGLAHASKDGS----ICFEP 328
+EY+H L +RD+K N L+ + + + DF LA D I +
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAKEYIDPETKKHIPYRE 173
Query: 329 VNTDIRGTPGYM 340
+ + GT YM
Sbjct: 174 -HKSLTGTARYM 184
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 45/224 (20%), Positives = 86/224 (38%), Gaps = 52/224 (23%)
Query: 176 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFC 233
+G+G + V++A + VK + + ++ REI++L L +++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITL--AD 98
Query: 234 I----EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHFYCDP 288
I R L++E++ N K L+ I+ + ++ AL+Y H
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLT-DYDIRFYMYEILKALDYCH---SM 149
Query: 289 PLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPVNTDIRGT-PGYMDPEYVV 346
+ HRD+K N+++D E+ +L D+GLA PG V
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLA-----------------EFYHPGQEYNVRVA 192
Query: 347 T------------QELTEKSDVYSYGVVLLEIVTARRAVQDGKN 378
+ Q D++S G +L ++ + G +
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 46/221 (20%), Positives = 88/221 (39%), Gaps = 43/221 (19%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVK---RMDKISEQVEGDFCREIELLARL----HHRHL 226
+G G F TV+ A+ + + +A+K +E E EI+LL R+ + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE----DEIKLLQRVNDADNTKED 81
Query: 227 VALRGFCIEKRERF-----------LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDV 275
++ + F +++E + +L + + QI+ +
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 276 ANALEYLHFYCDPPLCHRDIKSSNILLDE------NFVAKLADFGLAHASKDGSICF--E 327
L+Y+H C + H DIK N+L++ K+AD G A C+ E
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--------CWYDE 190
Query: 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
I+ T Y PE ++ +D++S ++ E++T
Sbjct: 191 HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 31/208 (14%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVKRM---DKISEQVEGDFCREIELLARLHHR------ 224
+IG+G FG V KA +A+K + + Q EI +L L +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNTM 159
Query: 225 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
+++ + + + +E ++ +L + + S + A + L+ LH
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH- 217
Query: 285 YCDPPLCHRDIKSSNILLDENFVA--KLADFGLAHASKDGSICFE--PVNTDIRGTPGYM 340
+ H D+K NILL + + K+ DF GS C+E V T I+ + Y
Sbjct: 218 --KNRIIHCDLKPENILLKQQGRSGIKVIDF--------GSSCYEHQRVYTYIQ-SRFYR 266
Query: 341 DPEYVVTQELTEKSDVYSYGVVLLEIVT 368
PE ++ D++S G +L E++T
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLT 294
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVK---RMDKISEQVEGDFCREIELLARLHHR------ 224
+IG+G FG V KA + +A+K Q + E+ LL ++
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMKY 116
Query: 225 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
++V L+ + + L++E ++ +L D L + +S + A + AL +L
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA- 174
Query: 285 YCDPPLCHRDIKSSNILL--DENFVAKLADFGLAHASKDGSICF--EPVNTDIRGTPGYM 340
+ + H D+K NILL + K+ DF GS C + + I+ + Y
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDF--------GSSCQLGQRIYQYIQ-SRFYR 225
Query: 341 DPEYVVTQELTEKSDVYSYGVVLLEIVT 368
PE ++ D++S G +L+E+ T
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 45/223 (20%), Positives = 79/223 (35%), Gaps = 39/223 (17%)
Query: 175 IIGQGGFGTVYKAQ-FSDGSLIAVK---RMDKISEQVEGDFCREIELLARLHHRHLVALR 230
+G G FG V Q + AVK + K + + E ++L ++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAK----IEADILKKIQNDD--INN 95
Query: 231 GFCIEKRERF-------LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 283
++ +F L++E + SL + + + I++ AL YL
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR----GTPGY 339
L H D+K NILLD+ + K + +T I+ G +
Sbjct: 155 ---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 340 MD---PEYVVTQ---------EL--TEKSDVYSYGVVLLEIVT 368
+ T+ L SD++S+G VL E+ T
Sbjct: 212 KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 8e-06
Identities = 48/362 (13%), Positives = 93/362 (25%), Gaps = 118/362 (32%)
Query: 31 LDNVSAIEIASCF-FQVRRL----------------NIPPVSEPSSSMLAPKASPSPLVA 73
L NV + + F + L + S L P S L+
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS-LLL 308
Query: 74 --VSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRR-KSRGLEDPE 130
+ L + +P L++I + + K +
Sbjct: 309 KYLDCRPQDLP-REVLTTNPRRLSIIAE-----------SIRDGLATWDNWKHVNCDKLT 356
Query: 131 NLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFS 190
+ ++SL P RK MF + S + F
Sbjct: 357 TIIESSLNVLEPA-EYRK-------MFDRLS-------------V-------------FP 382
Query: 191 DGSLIAVKRM-----DKISEQVEG--DFCREIELLAR--------LHHRHLVALRGFCIE 235
+ I + D I V + + L+ + + +L L+
Sbjct: 383 PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL-ELKVKLEN 441
Query: 236 KRE--RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY-------C 286
+ R ++ Y ++ S P D +Y + +
Sbjct: 442 EYALHRSIVDHY----NIPKTFDSDDLIPPYL--------D-----QYFYSHIGHHLKNI 484
Query: 287 DPPLCHRDIKSSNILLDENFV-AKLADFGLAHASKDGSICFEPVNTDIRGTPGYM---DP 342
+ P R + LD F+ K+ A + + ++ Y+ DP
Sbjct: 485 EHP--ERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSIL---NTLQQLKFYKPYICDNDP 539
Query: 343 EY 344
+Y
Sbjct: 540 KY 541
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 47/265 (17%), Positives = 79/265 (29%), Gaps = 87/265 (32%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVK---RMDKISEQVEGDFCREIELLARL-----HHRHL 226
+G G F TV+ + +A+K + +E EI LL + + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL----DEIRLLKSVRNSDPNDPN- 99
Query: 227 VALRGFCIEKRERF-----------LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDV 275
R ++ + F +++E + + L + L +I V
Sbjct: 100 ---REMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQV 155
Query: 276 ANALEYLHFYCDPPLCHRDIKSSNILL--------------------------------- 302
L+YLH C + H DIK NILL
Sbjct: 156 LQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 303 ----------------DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 346
E K+AD G A + DI+ T Y E ++
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH------KHFTEDIQ-TRQYRSLEVLI 266
Query: 347 TQELTEKSDVYSYGVVLLEIVTARR 371
+D++S + E+ T
Sbjct: 267 GSGYNTPADIWSTACMAFELATGDY 291
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 46/218 (21%), Positives = 78/218 (35%), Gaps = 33/218 (15%)
Query: 175 IIGQGGFGTVYKA--QFSDGSLIAVK---RMDKISEQVEGDFCREIELLARLHHR----- 224
+G+G FG V + S +A+K + K E EI +L ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR----LEINVLKKIKEKDKENK 81
Query: 225 -HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 283
V + + + +E + + + L P +A + +AL +LH
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 140
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD-----------GSICF--EPVN 330
+ L H D+K NIL + L + + K GS F E
Sbjct: 141 ---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHT 197
Query: 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 368
T + T Y PE ++ + DV+S G +L E
Sbjct: 198 TIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 518 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.13 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.98 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.73 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.73 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.54 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.44 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.43 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.21 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.12 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.97 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.96 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.82 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.49 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.46 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.4 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.36 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.32 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.26 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.21 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.1 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.03 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.43 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.13 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.29 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.33 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.72 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 92.28 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 91.66 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 91.63 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.82 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.08 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.96 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-58 Score=459.69 Aligned_cols=261 Identities=22% Similarity=0.360 Sum_probs=212.6
Q ss_pred HHHHHHhhhhhhhcceecceEEEEEEec------CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeee
Q 010088 163 KETKKATDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIE 235 (518)
Q Consensus 163 ~~l~~a~~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 235 (518)
.|+..++..|.+.||+|+||+||+|++. +++.||||+++... ....++|.+|+.+|++++|||||+++|+|.+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 3444456678889999999999999873 46799999997533 3445789999999999999999999999999
Q ss_pred cCceEEEEEecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEE
Q 010088 236 KRERFLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 301 (518)
Q Consensus 236 ~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NIL 301 (518)
.+..+||||||++|||.++|+... ...++|.++++|+.|||.||+||| +++||||||||+|||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVL 177 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceE
Confidence 999999999999999999996532 235999999999999999999999 889999999999999
Q ss_pred ecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchH
Q 010088 302 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLV 380 (518)
Q Consensus 302 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~ 380 (518)
|++++++||+|||+++....... ........||++|||||++.++.|+.++|||||||+||||+| |+.||.+... .
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-~ 254 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADY--YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-Q 254 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGC--BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-H
T ss_pred ECCCCCEEECCcccceeccCCCc--eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-H
Confidence 99999999999999986543221 123345679999999999999999999999999999999999 8889875433 3
Q ss_pred HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 381 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 381 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
+....... ... +.... +++..+.+++..||+.||++||||+||+++|+.
T Consensus 255 ~~~~~i~~-~~~------~~~p~----~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 255 DVVEMIRN-RQV------LPCPD----DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHHHHHHT-TCC------CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHc-CCC------CCCcc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 33332221 111 11122 233568899999999999999999999999964
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=452.82 Aligned_cols=254 Identities=33% Similarity=0.497 Sum_probs=204.8
Q ss_pred hhhhhcceecceEEEEEEec------CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
.+.+.||+|+||+||+|++. ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 45678999999999999874 478999999987777777889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEe
Q 010088 245 YMANGSLKDHLHSPG-------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA 311 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 311 (518)
||++|+|.++|+... ..+++|.++++|+.|||.||+||| +++||||||||+||||++++++||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEEEc
Confidence 999999999997642 246999999999999999999999 8899999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhc
Q 010088 312 DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASE 390 (518)
Q Consensus 312 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~ 390 (518)
|||+++....... ........||+.|||||++.+..++.++|||||||+||||+| |+.||...... +....... .
T Consensus 201 DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-~~~~~i~~-g 276 (329)
T 4aoj_A 201 DFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-EAIDCITQ-G 276 (329)
T ss_dssp CCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-HHHHHHHH-T
T ss_pred ccccceeccCCCc--ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-HHHHHHHc-C
Confidence 9999986644321 112345679999999999999999999999999999999999 89999754433 22222211 1
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 391 SRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 391 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+ +.....++ ..+.+|+.+||+.||++||||+||+++|+..
T Consensus 277 ~~------~~~p~~~~----~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 277 RE------LERPRACP----PEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp CC------CCCCTTCC----HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred CC------CCCccccc----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 11 11222333 5688999999999999999999999998653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=451.36 Aligned_cols=254 Identities=30% Similarity=0.489 Sum_probs=209.4
Q ss_pred hhhhhhcceecceEEEEEEec------CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
+.+.+.||+|+||+||+|++. +|..||||+++..+....++|.+|+++|++++|||||+++|+|.+++..+|||
T Consensus 15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 94 (299)
T 4asz_A 15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 94 (299)
T ss_dssp EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 446678999999999999864 47889999998777777788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEee
Q 010088 244 EYMANGSLKDHLHSPG-----------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLAD 312 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 312 (518)
|||++|+|.++|+..+ ...++|.++++|+.|||.||+||| +++||||||||+||||++++++||+|
T Consensus 95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEECC
Confidence 9999999999997532 346999999999999999999999 88999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhcc
Q 010088 313 FGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASES 391 (518)
Q Consensus 313 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~ 391 (518)
||+|+........ .......||+.|||||++.+..|+.++|||||||+||||+| |+.||..... .+........ .
T Consensus 172 FGla~~~~~~~~~--~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-~~~~~~i~~~-~ 247 (299)
T 4asz_A 172 FGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIECITQG-R 247 (299)
T ss_dssp CSCHHHHTGGGCE--EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHHHHT-C
T ss_pred cccceecCCCCce--eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcC-C
Confidence 9999865433211 12334569999999999999999999999999999999999 8999975433 2332222211 1
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 392 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 392 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
. +.....+ ...+.+++..||+.||++|||++||++.|+.
T Consensus 248 ~------~~~p~~~----~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 248 V------LQRPRTC----PQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp C------CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C------CCCCccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 1112223 3568899999999999999999999988864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-56 Score=442.79 Aligned_cols=256 Identities=28% Similarity=0.423 Sum_probs=201.7
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
..|.+.||+|+||+||+|++.+ .||||+++.. .....+.|.+|+++|++++|||||+++|+|.+ +..+||||||+
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~ 114 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE 114 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred eEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence 3466789999999999998753 5999998643 34456789999999999999999999999865 57899999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
||+|.++|+... ..++|.++++|+.|||.||+||| +++||||||||+||||++++++||+|||+|+....... .
T Consensus 115 gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~--~ 188 (307)
T 3omv_A 115 GSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG--S 188 (307)
T ss_dssp SCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred CCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc--c
Confidence 999999997643 35999999999999999999999 88999999999999999999999999999986543221 1
Q ss_pred cccccccCCCcccCcccccc---CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.......||+.|||||++.+ +.|+.++|||||||+||||+||+.||.+..+........ .... ..|.+. .
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~-~~~~-----~~p~~~-~ 261 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV-GRGY-----ASPDLS-K 261 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH-HTTC-----CCCCST-T
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH-hcCC-----CCCCcc-c
Confidence 12345679999999999864 468999999999999999999999997655443333222 1111 112111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
...+....+.+++..||+.||++||||.||+++|+..
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1123345688999999999999999999999988653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-55 Score=439.39 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=211.5
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
+.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+.+..|||||||+||+
T Consensus 78 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 157 (346)
T 4fih_A 78 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 157 (346)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEE
T ss_pred EeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 4467999999999999875 689999999976555556778999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|.+++.. ..+++..+..|+.||+.||+||| +++||||||||+||||+.++.+||+|||+|+...... ...
T Consensus 158 L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~----~~~ 227 (346)
T 4fih_A 158 LTDIVTH---TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----PRR 227 (346)
T ss_dssp HHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS----CCB
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC----Ccc
Confidence 9999975 24999999999999999999999 8999999999999999999999999999998765432 124
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 410 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 410 (518)
...+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.... +....+.... .+.+.. .....
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~~-------~~~~~~--~~~~s 297 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMKMIRDNL-------PPRLKN--LHKVS 297 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSS-------CCCCSC--GGGSC
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHcCC-------CCCCCc--cccCC
Confidence 5678999999999999999999999999999999999999999754433 3322222111 111111 11122
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 411 RTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 411 ~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
..+.+++.+||+.||++|||++|+++|.|....
T Consensus 298 ~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 298 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 468899999999999999999999999887644
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=446.28 Aligned_cols=253 Identities=24% Similarity=0.409 Sum_probs=206.5
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
+.+.+.||+|+||+||+|+.. +|+.||||+++.. .....+.|.+|+++|++|+|||||++++++.+.+..|||||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 345678999999999999875 6899999998643 3444578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
+||+|.++|...+...+++.+++.|+.||+.||+||| +++||||||||+||||+.++.+||+|||+|+......
T Consensus 106 ~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--- 179 (350)
T 4b9d_A 106 EGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--- 179 (350)
T ss_dssp TTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH---
T ss_pred CCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc---
Confidence 9999999997665666899999999999999999999 8999999999999999999999999999998764321
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
...+..+||+.|||||++.+..|+.++|||||||+||||+||+.||.... ..+....+.... . +.+...++
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-~~~~~~~i~~~~--~-----~~~~~~~s 250 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLKIISGS--F-----PPVSLHYS 250 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHTC--C-----CCCCTTSC
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-HHHHHHHHHcCC--C-----CCCCccCC
Confidence 12345679999999999999999999999999999999999999997543 333333332221 1 11222333
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..+.+++.+||+.||++|||++|+++|.|..
T Consensus 251 ----~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 281 (350)
T 4b9d_A 251 ----YDLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281 (350)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHhcCHHhh
Confidence 4588999999999999999999999987764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=426.31 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=203.7
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeee----cCceEEEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE----KRERFLMYE 244 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e 244 (518)
|.+.||+|+||+||+|++. ++..||||++... .....+.|.+|+++|++|+|||||+++++|.+ ++..+||||
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE 109 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence 5567999999999999875 5889999998643 34445679999999999999999999999875 345799999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecccCCCcEEecC-CCcEEEeeccccccCCC
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP--LCHRDIKSSNILLDE-NFVAKLADFGLAHASKD 321 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiHrDlk~~NILl~~-~~~~kl~DfGla~~~~~ 321 (518)
||++|+|.++|++. ..+++..+..|+.||+.||+||| +++ ||||||||+||||+. ++.+||+|||+|+....
T Consensus 110 y~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 110 LMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999764 35999999999999999999999 666 999999999999984 89999999999986433
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
. ......||+.|||||++. +.|+.++|||||||+||||+||+.||.+..+............. + +.+
T Consensus 185 ~------~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~----~~~ 251 (290)
T 3fpq_A 185 S------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--P----ASF 251 (290)
T ss_dssp T------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--C----GGG
T ss_pred C------ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--C----CCC
Confidence 2 234568999999999886 46999999999999999999999999766655554443322111 1 111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
....+ ..+.+++.+||+.||++|||++|+++|.|..
T Consensus 252 ~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~ 287 (290)
T 3fpq_A 252 DKVAI----PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287 (290)
T ss_dssp GGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CccCC----HHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 11222 3578999999999999999999999998764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=440.80 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=212.4
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||+|
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 334568999999999999875 6899999999766555667799999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.+++... .+++..+..|+.||+.||+||| +++||||||||+||||+.+|.+||+|||+|+...... .
T Consensus 233 G~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~----~ 302 (423)
T 4fie_A 233 GALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----P 302 (423)
T ss_dssp EEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC----C
T ss_pred CcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC----c
Confidence 9999999742 4999999999999999999999 8999999999999999999999999999998764432 1
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCC--CCCC
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK--DSFD 406 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~--~~~~ 406 (518)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.... +....+.... .+.+. ..++
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~~-------~~~~~~~~~~s 374 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMKMIRDNL-------PPRLKNLHKVS 374 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSC-------CCCCSCTTSSC
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHcCC-------CCCCcccccCC
Confidence 235678999999999999999999999999999999999999999755433 3222222111 11111 1223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
..+.+|+.+||+.||++|||+.|+++|.|....
T Consensus 375 ----~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 375 ----PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp ----HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ----HHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 458899999999999999999999999887644
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-54 Score=427.54 Aligned_cols=261 Identities=27% Similarity=0.383 Sum_probs=197.8
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC----ceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR----ERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~e~ 245 (518)
+.+.+.||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|+|.+.+ ..+|||||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 34567899999999999998 689999999864322 1223345666667899999999999998764 57999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCceecccCCCcEEecCCCcEEEeeccccccCC
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY-----CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~ 320 (518)
|++|+|.++|+.. .++|..+++|+.|++.||+|||.. +.++||||||||+||||++++++||+|||+|+...
T Consensus 83 ~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 83 HEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999999753 499999999999999999999932 23499999999999999999999999999998765
Q ss_pred CCCcccccccccccCCCcccCccccccC------CCCccccchhhHHHHHHHHhCCccccCCc-------------chHH
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQ------ELTEKSDVYSYGVVLLEIVTARRAVQDGK-------------NLVE 381 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwS~Gvll~el~tG~~p~~~~~-------------~~~~ 381 (518)
..............||++|||||++.+. .++.++|||||||+||||+||+.|+.... ...+
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 4432222233456799999999998754 46789999999999999999987653211 0111
Q ss_pred HHHHHHhhccccccccCCcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 382 SAQVCMASESRLAELVDPRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 382 ~~~~~~~~~~~l~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...... ..+..+|.+.... +.+....+.+++.+||+.||++||||.||++.|..
T Consensus 240 ~~~~~~-----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 240 EMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHHHH-----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHH-----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 111111 1122233333222 23566789999999999999999999999999865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-54 Score=436.20 Aligned_cols=260 Identities=26% Similarity=0.351 Sum_probs=209.5
Q ss_pred HHHHhhhhhhhcceecceEEEEEEecC------CcEEEEEEecccc-chhHHHHHHHHHHHHHcCC-CCeeeEeeeeeec
Q 010088 165 TKKATDNFSTIIGQGGFGTVYKAQFSD------GSLIAVKRMDKIS-EQVEGDFCREIELLARLHH-RHLVALRGFCIEK 236 (518)
Q Consensus 165 l~~a~~~f~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~ 236 (518)
+....+.+.+.||+|+||+||+|++.. ++.||||+++... ....+.|.+|+++|.+++| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 334455667899999999999998643 3689999997543 3445679999999999965 8999999999775
Q ss_pred -CceEEEEEecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEE
Q 010088 237 -RERFLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 301 (518)
Q Consensus 237 -~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NIL 301 (518)
+..++|||||++|+|.++|+... ...++|.+++.|+.|||.||+||| +++||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCcccee
Confidence 56899999999999999997422 245899999999999999999999 899999999999999
Q ss_pred ecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchH
Q 010088 302 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLV 380 (518)
Q Consensus 302 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~ 380 (518)
|++++++||+|||+|+........ .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.....
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~--~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eCCCCCEEECcchhhhhcccCCCc--eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999876443311 12345679999999999999999999999999999999998 899997544333
Q ss_pred HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 381 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 381 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...... ....+ +.....++ ..+.+++..||+.||++|||+.||+++|..
T Consensus 296 ~~~~~i-~~g~~------~~~p~~~~----~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 296 EFCRRL-KEGTR------MRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp HHHHHH-HHTCC------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHH-HcCCC------CCCCccCC----HHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 332222 22111 22222233 468899999999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-54 Score=426.03 Aligned_cols=248 Identities=24% Similarity=0.342 Sum_probs=207.7
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.++||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..|+||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 556789999999999999875 6899999999643 233456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
|+||+|.++|.+.+ .+++..+..++.||+.||+||| +++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 114 ~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~- 187 (311)
T 4aw0_A 114 AKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK- 187 (311)
T ss_dssp CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT-
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC-
Confidence 99999999997643 5999999999999999999999 89999999999999999999999999999987643321
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.......+||+.|||||++.+..|+.++||||+||+||||+||+.||... +..+....+...... +...+
T Consensus 188 -~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~~--------~p~~~ 257 (311)
T 4aw0_A 188 -QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEGLIFAKIIKLEYD--------FPEKF 257 (311)
T ss_dssp -CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCC--------CCTTC
T ss_pred -cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCC--------CCccc
Confidence 11345678999999999999999999999999999999999999999754 333444433333222 22233
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRI 437 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~ 437 (518)
+ ..+.+++.+||+.||++|||++|++.+
T Consensus 258 s----~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 258 F----PKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp C----HHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred C----HHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 3 457899999999999999999986443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=416.41 Aligned_cols=249 Identities=26% Similarity=0.385 Sum_probs=195.7
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.+.||+|+||+||+|+.. +|+.||||++++.. ......+.+|+++|++++|||||++++++.+.+..|+||||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 94 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY 94 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 456678999999999999875 68999999986432 23346799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
| +|+|.+++.+.+ .+++..+..++.||+.||+||| +++|+||||||+||||++++.+||+|||+|+......
T Consensus 95 ~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 166 (275)
T 3hyh_A 95 A-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-- 166 (275)
T ss_dssp C-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred C-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence 9 689999997643 5999999999999999999999 8999999999999999999999999999998655432
Q ss_pred cccccccccCCCcccCccccccCCC-CccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
......||+.|||||.+.+..+ +.++||||+||+||||+||+.||.+. +.....+........ +...
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-~~~~~~~~i~~~~~~--------~p~~ 234 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-SIPVLFKNISNGVYT--------LPKF 234 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCC--------CCTT
T ss_pred ---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHcCCCC--------CCCC
Confidence 2345679999999999998876 57999999999999999999999753 344444333322222 2222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.+ ..+.+++.+||+.||++|||++|+++|.|...
T Consensus 235 ~s----~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 235 LS----PGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp SC----HHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred CC----HHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 33 45789999999999999999999999988743
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=425.48 Aligned_cols=250 Identities=22% Similarity=0.235 Sum_probs=200.4
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
+.++||+|+||+||+|+.. +|+.||||+++.... +.+|+.+|++++|||||++++++.+++..|||||||+||+
T Consensus 62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 4467999999999999875 589999999975322 2479999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC-cEEEeeccccccCCCCCcccc-c
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-VAKLADFGLAHASKDGSICFE-P 328 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~~-~ 328 (518)
|.++|+..+ .+++..+..|+.||+.||+||| +++||||||||+||||+.++ .+||+|||+|+.......... .
T Consensus 137 L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 137 LGQLIKQMG--CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp HHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 999998643 5999999999999999999999 99999999999999999987 699999999987654322111 1
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
.....+||+.|||||++.+..|+.++|||||||+||||+||+.||....... ....+......+. .+...++
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~~~~-----~~~~~~s-- 283 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIASEPPPIR-----EIPPSCA-- 283 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHHSCCGGG-----GSCTTSC--
T ss_pred cCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHcCCCCch-----hcCccCC--
Confidence 2234579999999999999999999999999999999999999996533221 1111122111111 1222233
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..+.+++.+||+.||++|||+.|++++|...
T Consensus 284 --~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 284 --PLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp --HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 5588999999999999999999999988653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=422.35 Aligned_cols=250 Identities=25% Similarity=0.347 Sum_probs=201.2
Q ss_pred hhhhhhcceecceEEEEEEec----CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
+.+.+.||+|+||+||+|+.. .++.||||++++.. ......+.+|+++|++++|||||++++++.+.+..|+||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 456779999999999999762 46899999986432 233456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
|||+||+|.++|.+.+ .+++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+......
T Consensus 106 Ey~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp CCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999999998643 5999999999999999999999 8999999999999999999999999999998654332
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
.......||+.|||||.+.+..|+.++|||||||+||||+||+.||... +..+....+...... +..
T Consensus 181 ----~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-~~~~~~~~i~~~~~~--------~p~ 247 (304)
T 3ubd_A 181 ----KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-DRKETMTMILKAKLG--------MPQ 247 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCC--------CCT
T ss_pred ----ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-CHHHHHHHHHcCCCC--------CCC
Confidence 1234568999999999999999999999999999999999999999754 333433333322211 122
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhcC
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYES 441 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~~L~~~ 441 (518)
..+ ..+.+++.+||+.||++||| ++|+++|.|+.
T Consensus 248 ~~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~ 286 (304)
T 3ubd_A 248 FLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286 (304)
T ss_dssp TSC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGT
T ss_pred cCC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcccc
Confidence 233 45789999999999999998 58999988764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=407.92 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=190.7
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCc---------
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRE--------- 238 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--------- 238 (518)
+++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++|+|||||++++++.+.+.
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 445678999999999999875 68999999986433 3445679999999999999999999999876543
Q ss_pred ---eEEEEEecCCCCHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecc
Q 010088 239 ---RFLMYEYMANGSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG 314 (518)
Q Consensus 239 ---~~lV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfG 314 (518)
.|+|||||++|+|.+++..... ...++..++.|+.||+.||+||| +++|+||||||+||||+.++.+||+|||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEccCc
Confidence 6899999999999999986543 23567778999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCccc--------ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHH
Q 010088 315 LAHASKDGSICF--------EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC 386 (518)
Q Consensus 315 la~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~ 386 (518)
+|+......... ....+..+||+.|||||.+.+..|+.++|||||||+||||++ ||....+........
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~ 240 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence 998764432110 012234579999999999999999999999999999999996 664322211111111
Q ss_pred HhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 387 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 387 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
. ....+. ...+....+.+++.+||+.||++|||+.|+++|.+..
T Consensus 241 ~--~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~ 284 (299)
T 4g31_A 241 R--NLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284 (299)
T ss_dssp H--TTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGC
T ss_pred h--cCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence 1 111110 0112234567899999999999999999999987764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=408.38 Aligned_cols=265 Identities=23% Similarity=0.360 Sum_probs=204.3
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeee------cCceEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIE------KRERFL 241 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~~l 241 (518)
.+.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+..||
T Consensus 57 ~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~i 136 (398)
T 4b99_A 57 EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 136 (398)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEE
Confidence 45678999999999999875 69999999996532 3344678899999999999999999998764 357899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
|||||+ |+|.+++... ..+++..+..|+.||+.||+||| +++||||||||+|||++.++.+||+|||+|+....
T Consensus 137 vmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 137 VLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 999996 6899999864 35999999999999999999999 89999999999999999999999999999987644
Q ss_pred CCcccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
............+||+.|||||++.+. .++.++||||+||++|||++|+.||...... +....+..............
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCGGGTC-
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCChHHhhh
Confidence 332222334567899999999998775 5699999999999999999999999754433 33322222111111000000
Q ss_pred ------------C--CCCCCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 401 ------------I--KDSFDME-----QLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 401 ------------l--~~~~~~~-----~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+ ....+.+ ....+.+++.+||+.||++|||++|+++|.|...
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 0 0001111 1245789999999999999999999999998864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=396.14 Aligned_cols=262 Identities=22% Similarity=0.299 Sum_probs=200.3
Q ss_pred hhhhhhcceecceEEEEEEec----CCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.+.+.||+|+||+||+|+.+ .++.||||++..... ...+.+|+++|..+ +||||+++++++.+.+..|+|||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 445678999999999999753 467899999865432 35688999999999 69999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC-CcEEEeeccccccCCCCC
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGS 323 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DfGla~~~~~~~ 323 (518)
||++|+|.++++ .+++.++..++.|++.||+||| +.+|+||||||+||||+.+ +.+||+|||+|+......
T Consensus 101 ~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 101 YLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp CCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred CCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 999999999995 3899999999999999999999 8999999999999999876 899999999998654332
Q ss_pred ccc------------------------ccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcc
Q 010088 324 ICF------------------------EPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKN 378 (518)
Q Consensus 324 ~~~------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~ 378 (518)
... ....+..+||+.|||||++.+. .++.++||||+||++|||+||+.||..+.+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 110 0112345799999999999775 589999999999999999999999976655
Q ss_pred hHHHHHHHHhhccc------------------------cc---------cccCCcCCCC---------CCHHHHHHHHHH
Q 010088 379 LVESAQVCMASESR------------------------LA---------ELVDPRIKDS---------FDMEQLRTIVTI 416 (518)
Q Consensus 379 ~~~~~~~~~~~~~~------------------------l~---------~~~d~~l~~~---------~~~~~~~~l~~l 416 (518)
..+....+....+. .. +...|.+... ..........++
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 43332221110000 00 0000000000 000112457899
Q ss_pred HHHccccCCCCCCCHHHHHHHhhcC
Q 010088 417 VRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 417 i~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+.+||+.||++|||++|+++|.|+.
T Consensus 333 l~~lL~~dP~~R~ta~eaL~Hp~f~ 357 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALLHPFFK 357 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHHCcCChhHCcCHHHHhcCcccC
Confidence 9999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=413.67 Aligned_cols=256 Identities=20% Similarity=0.282 Sum_probs=213.9
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||+||+|+.. +|+.||+|.+........+.+.+|+++|+.|+|||||++++++.+.+..|||||||+|
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 455678999999999999875 6899999999776666667899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC--CcEEEeeccccccCCCCCccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN--FVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~--~~~kl~DfGla~~~~~~~~~~ 326 (518)
|+|.++|.... ..+++.++..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+|+......
T Consensus 239 g~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--- 311 (573)
T 3uto_A 239 GELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--- 311 (573)
T ss_dssp CBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC---
Confidence 99999997543 35999999999999999999999 8999999999999999854 899999999998775543
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
......||+.|||||++.+..|+.++|||||||+||||++|+.||.+... .+....+......+.. .....++
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-~~~~~~i~~~~~~~~~----~~~~~~s 384 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRNVKSCDWNMDD----SAFSGIS 384 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHTTCCCCCS----GGGTTSC
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHHHHHhCCCCCCc----ccccCCC
Confidence 23456799999999999999999999999999999999999999975443 3333333322222211 1112223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
..+.+|+.+||+.||.+||++.|+++|.|....
T Consensus 385 ----~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 385 ----EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp ----HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 457899999999999999999999999987643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=380.03 Aligned_cols=281 Identities=42% Similarity=0.747 Sum_probs=234.1
Q ss_pred ccccCHHHHHHHhhhhh--hhcceecceEEEEEEecCCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeee
Q 010088 157 FQKFSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFC 233 (518)
Q Consensus 157 ~~~~~~~~l~~a~~~f~--~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 233 (518)
...|++.++..++.+|. ++||+|+||+||+|+..+|+.||||++.... ......|.+|++++++++||||++++++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 35688899988887774 6899999999999998889999999987543 22334789999999999999999999999
Q ss_pred eecCceEEEEEecCCCCHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEe
Q 010088 234 IEKRERFLMYEYMANGSLKDHLHSPG--RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA 311 (518)
Q Consensus 234 ~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 311 (518)
.+.+..++||||+++|+|.+++.... ...++|..+..|+.|++.||+|||..+..+|+||||||+|||+++++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998643 3459999999999999999999994333399999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCcccc-------CCcchHHHHH
Q 010088 312 DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQ-------DGKNLVESAQ 384 (518)
Q Consensus 312 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~-------~~~~~~~~~~ 384 (518)
|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||. .......+..
T Consensus 177 Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 177 DFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp CCSSCEECCSSSS---CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred cCccccccCcccc---cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 9999986543321 12344569999999999999999999999999999999999999995 1122233332
Q ss_pred HHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 385 VCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 385 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
. ......+..+.+..+...+..+....+.+++..||+.||.+|||+.||+++|+..
T Consensus 254 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 254 G-LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp T-TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred H-HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 2 2233455667777777788889999999999999999999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=408.96 Aligned_cols=247 Identities=26% Similarity=0.362 Sum_probs=201.0
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHH---HHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCRE---IELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.++||+|+||+||+|+.. +|+.||||++++.. ......+.+| +.+++.++|||||++++++.+.+..|||||
T Consensus 193 i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmE 272 (689)
T 3v5w_A 193 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272 (689)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEe
Confidence 3468999999999999876 68999999986421 1222233444 566667789999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
||+||+|.++|...+ .+++..+..++.||+.||+||| +.+||||||||+||||+.+|.+||+|||+|+......
T Consensus 273 y~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~- 346 (689)
T 3v5w_A 273 LMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 346 (689)
T ss_dssp CCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence 999999999998643 4999999999999999999999 9999999999999999999999999999998765432
Q ss_pred ccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCC--cchHHHHHHHHhhccccccccCCcC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDG--KNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~--~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
....+||+.|||||++.. ..|+.++|||||||+||||++|+.||... .+............. .+
T Consensus 347 -----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~--------~~ 413 (689)
T 3v5w_A 347 -----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--------EL 413 (689)
T ss_dssp -----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC--------CC
T ss_pred -----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC--------CC
Confidence 345689999999999964 57999999999999999999999999643 233333333222221 12
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhcC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYES 441 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~~L~~~ 441 (518)
...++ ..+.+++..||+.||.+|++ ++||++|.|+.
T Consensus 414 p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~ 454 (689)
T 3v5w_A 414 PDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454 (689)
T ss_dssp CTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGT
T ss_pred CccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcccc
Confidence 22333 45789999999999999998 79999998875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=374.17 Aligned_cols=263 Identities=43% Similarity=0.692 Sum_probs=224.7
Q ss_pred hhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHH
Q 010088 173 STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK 252 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 252 (518)
.+.||+|+||+||+|++.+|..||||++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 46899999999999998889999999987766666778999999999999999999999999999999999999999999
Q ss_pred HHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 253 DHLHSPG--RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 253 ~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
+++.... ...++|..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 124 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 198 (321)
T 2qkw_B 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ--THLS 198 (321)
T ss_dssp GGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC--CCCB
T ss_pred HHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccccccccc--cccc
Confidence 9997643 235999999999999999999999 88999999999999999999999999999986433221 1123
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCc-----chHHHHHHHHhhccccccccCCcCCCCC
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK-----NLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~-----~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ....+... ......+...+++.+....
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 277 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE-SHNNGQLEQIVDPNLADKI 277 (321)
T ss_dssp CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHH-HHTTTCCCSSSSSSCTTCS
T ss_pred cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhh-ccccccHHHhcChhhcccc
Confidence 34568999999999999999999999999999999999999986422 22333222 2233456677788887778
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..+....+.+++.+||+.||++||++.|++++|+..
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 888999999999999999999999999999999754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=367.27 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=210.8
Q ss_pred hhhhcceecceEEEEEEe-cCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 172 FSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
+.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 24 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (297)
T 3fxz_A 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (297)
T ss_dssp CCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred eeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCC
Confidence 456899999999999986 4689999999876555556779999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........ ..
T Consensus 104 L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~ 173 (297)
T 3fxz_A 104 LTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS----KR 173 (297)
T ss_dssp HHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC----CB
T ss_pred HHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc----cc
Confidence 99999753 4899999999999999999999 88999999999999999999999999999986544321 23
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 410 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 410 (518)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||.................. .... +....
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---~~~~-------~~~~~ 243 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP---ELQN-------PEKLS 243 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC---CCSC-------GGGSC
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCCC-------ccccC
Confidence 4567999999999999999999999999999999999999999765544333222211111 1101 11223
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCC
Q 010088 411 RTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 444 (518)
Q Consensus 411 ~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~ 444 (518)
..+.+++.+||+.||++|||++|++++.+.....
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 244 AIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 5688999999999999999999999998876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=367.63 Aligned_cols=269 Identities=23% Similarity=0.328 Sum_probs=220.5
Q ss_pred ccCHHHHHHHhhh------------hhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCC
Q 010088 159 KFSYKETKKATDN------------FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRH 225 (518)
Q Consensus 159 ~~~~~~l~~a~~~------------f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n 225 (518)
.|++++++.++.. +.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 5788888888754 2357999999999999886 69999999997666666678999999999999999
Q ss_pred eeeEeeeeeecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC
Q 010088 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 305 (518)
Q Consensus 226 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 305 (518)
|+++++++...+..++||||+++|+|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.+
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence 99999999999999999999999999999975 34999999999999999999999 8899999999999999999
Q ss_pred CcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHH
Q 010088 306 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 385 (518)
Q Consensus 306 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~ 385 (518)
+.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~-~~~ 252 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP----KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MKR 252 (321)
T ss_dssp CCEEECCCTTCEECCSSSC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHH
T ss_pred CcEEEeeeeeeeecccCcc----ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 9999999999986544321 23456799999999999999999999999999999999999999975543322 222
Q ss_pred HHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCCc
Q 010088 386 CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHS 447 (518)
Q Consensus 386 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~ 447 (518)
.... ..+.+.. .......+.+++.+||+.||++||++.|++++.+......+.
T Consensus 253 ~~~~-------~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 305 (321)
T 2c30_A 253 LRDS-------PPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE 305 (321)
T ss_dssp HHHS-------SCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGG
T ss_pred HhcC-------CCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCcc
Confidence 1111 1111111 111224588999999999999999999999998876544433
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=358.50 Aligned_cols=277 Identities=39% Similarity=0.681 Sum_probs=228.3
Q ss_pred ccccCHHHHHHHhhhhh--------hhcceecceEEEEEEecCCcEEEEEEeccc----cchhHHHHHHHHHHHHHcCCC
Q 010088 157 FQKFSYKETKKATDNFS--------TIIGQGGFGTVYKAQFSDGSLIAVKRMDKI----SEQVEGDFCREIELLARLHHR 224 (518)
Q Consensus 157 ~~~~~~~~l~~a~~~f~--------~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~ 224 (518)
...|++.++.+++.+|. +.||+|+||+||+|.. +++.||||++... .....+.|.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 45799999999999987 4599999999999987 6889999998642 234456799999999999999
Q ss_pred CeeeEeeeeeecCceEEEEEecCCCCHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec
Q 010088 225 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD 303 (518)
Q Consensus 225 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~ 303 (518)
||+++++++.+.+..++||||+++|+|.+++.... ..+++|..++.++.|++.||+||| +.+|+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence 99999999999999999999999999999997532 346999999999999999999999 88999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcc---hH
Q 010088 304 ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN---LV 380 (518)
Q Consensus 304 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~---~~ 380 (518)
+++.+||+|||+++........ .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||..... ..
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQT--VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSC--EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred CCCcEEEeeccccccccccccc--ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 9999999999999865432211 12334579999999998764 589999999999999999999999964322 22
Q ss_pred HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 381 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 381 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+..........+.+.+++.+. .........+.+++..||+.||.+||++++++++|.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 3333333333444555555543 34567778899999999999999999999999999753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=369.42 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=207.9
Q ss_pred hhhhhcceecceEEEEEEe-cCCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.||+|+||+||+|+. .+|+.||||++... .......+.+|+++|+.++||||+++++++...+..++||||++
T Consensus 18 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 97 (328)
T 3fe3_A 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS 97 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCC
Confidence 3456899999999999987 47899999998643 33445678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.....+.
T Consensus 98 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---- 168 (328)
T 3fe3_A 98 GGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---- 168 (328)
T ss_dssp TCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC----
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC----
Confidence 999999997643 4999999999999999999999 8899999999999999999999999999998655433
Q ss_pred cccccccCCCcccCccccccCCCC-ccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELT-EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
......||+.|+|||.+.+..+. .++|||||||++|||++|+.||... +..+...........+ ....+
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~--------p~~~s 238 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-NLKELRERVLRGKYRI--------PFYMS 238 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCCC--------CTTSC
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCC--------CCCCC
Confidence 23456799999999999888775 7999999999999999999999644 3333333333222111 11222
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
..+.+++..||+.||.+|||++|+++|.|...
T Consensus 239 ----~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 239 ----TDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp ----HHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred ----HHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 45789999999999999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=362.02 Aligned_cols=254 Identities=31% Similarity=0.506 Sum_probs=198.9
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.+.||+|+||+||+|+. +|..||||++.... ......|.+|+++|++++||||+++++++.+.+..++||||++
T Consensus 39 y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 3p86_A 39 LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS 117 (309)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred ceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCC
Confidence 34557899999999999987 68899999986533 3445679999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 248 NGSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPP--LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 248 ~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
+|+|.+++..... ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 118 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 194 (309)
T 3p86_A 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL 194 (309)
T ss_dssp TCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred CCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc
Confidence 9999999986432 24899999999999999999999 888 99999999999999999999999999975443221
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||............ .... ....+...
T Consensus 195 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~-~~~~------~~~~~~~~ 263 (309)
T 3p86_A 195 ----SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV-GFKC------KRLEIPRN 263 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH-HHSC------CCCCCCTT
T ss_pred ----ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcC------CCCCCCcc
Confidence 224457999999999999999999999999999999999999999754432222111 1111 01112222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
++ ..+.+++..||+.||.+||++.++++.|....
T Consensus 264 ~~----~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 264 LN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp SC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 33 45889999999999999999999999886543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=364.93 Aligned_cols=257 Identities=26% Similarity=0.433 Sum_probs=205.3
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
.+.++||+|+||+||+|+.. +|..||+|++........+.|.+|++++.+++||||+++++++.+.+..++||||+++|
T Consensus 13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 92 (310)
T 3s95_A 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG 92 (310)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCC
Confidence 34578999999999999875 58999999987766777788999999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc--
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE-- 327 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~-- 327 (518)
+|.+++.... ..++|..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus 93 ~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 93 TLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp BHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 9999997643 35999999999999999999999 88999999999999999999999999999986543321100
Q ss_pred --------cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCC
Q 010088 328 --------PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 399 (518)
Q Consensus 328 --------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~ 399 (518)
.......||+.|+|||.+.+..++.++||||||+++|||++|..|+......... .........+.
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~------~~~~~~~~~~~ 242 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------FGLNVRGFLDR 242 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT------SSBCHHHHHHH
T ss_pred ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH------Hhhhhhccccc
Confidence 0112457999999999999999999999999999999999999888642111000 00000000111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 400 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.....++ ..+.+++..||+.||++||++.++++.|...
T Consensus 243 ~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 243 YCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp TCCTTCC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111122 3588999999999999999999999988654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=372.06 Aligned_cols=254 Identities=25% Similarity=0.406 Sum_probs=205.4
Q ss_pred hhhhhhcceecceEEEEEEec--------CCcEEEEEEeccc-cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCce
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS--------DGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRER 239 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 239 (518)
+.+.+.||+|+||+||+|++. ++..||||+++.. .......+.+|+++|+++ +||||++++++|.+.+..
T Consensus 83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 162 (370)
T 2psq_A 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162 (370)
T ss_dssp EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSC
T ss_pred CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCE
Confidence 345678999999999999862 3567999999754 334456799999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC
Q 010088 240 FLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 305 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 305 (518)
++||||+++|+|.+++.... ...+++..++.++.||+.||+||| +.+|+||||||+||||+.+
T Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTEN 239 (370)
T ss_dssp EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTT
T ss_pred EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEECCC
Confidence 99999999999999997533 235899999999999999999999 8899999999999999999
Q ss_pred CcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHH
Q 010088 306 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQ 384 (518)
Q Consensus 306 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~ 384 (518)
+.+||+|||+++........ .......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||..... .+...
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-~~~~~ 316 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELFK 316 (370)
T ss_dssp CCEEECCCSSCEETTCCCTT--CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGHHH
T ss_pred CCEEEccccCCcccCcccce--ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHH
Confidence 99999999999865443211 12334567889999999999999999999999999999999 8888864332 22222
Q ss_pred HHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 385 VCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 385 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
..... . .+..... ....+.+++..||+.||++||++.|++++|..
T Consensus 317 ~~~~~-~------~~~~~~~----~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 317 LLKEG-H------RMDKPAN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp HHHTT-C------CCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhcC-C------CCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11111 0 1111222 23568899999999999999999999999865
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=365.50 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=208.5
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccch------hHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQ------VEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
+.+.+.||+|+||+||+|+.. +|..||+|.++..... ..+.+.+|+.+|.+++||||+++++++.+.+..++|
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence 345678999999999999876 5899999998653321 346799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC----cEEEeecccccc
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF----VAKLADFGLAHA 318 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DfGla~~ 318 (518)
|||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||+++++ .+||+|||+++.
T Consensus 94 ~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 94 LELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999764 35999999999999999999999 88999999999999998877 799999999987
Q ss_pred CCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccC
Q 010088 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD 398 (518)
Q Consensus 319 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d 398 (518)
...+. ......||+.|+|||.+.+..++.++|||||||++|||++|..||..... .+....+......+.
T Consensus 169 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~~~~---- 238 (361)
T 2yab_A 169 IEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QETLANITAVSYDFD---- 238 (361)
T ss_dssp CCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHTTCCCCC----
T ss_pred cCCCC-----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCC----
Confidence 65432 23456799999999999999999999999999999999999999975433 233222222111111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 399 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 399 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+...... ...+.+++..||+.||.+|||+.|+++|.|...
T Consensus 239 ~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 239 EEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred chhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 1111112 245889999999999999999999999988753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=365.75 Aligned_cols=256 Identities=23% Similarity=0.380 Sum_probs=204.9
Q ss_pred hhhhhhhcceecceEEEEEEec----CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
.+.+.++||+|+||+||+|++. .+..||||.++.. .....+.|.+|+.+|++++||||+++++++.+.+..++||
T Consensus 50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 129 (325)
T 3kul_A 50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129 (325)
T ss_dssp GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEE
T ss_pred HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEe
Confidence 3455678999999999999884 3556999999754 3445578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+++|+|.++++... ..+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 130 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 130 EYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp ECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999999997643 35999999999999999999999 8899999999999999999999999999998764432
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
.. ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....... .. .....
T Consensus 206 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~~~~~~-~~------~~~~~ 276 (325)
T 3kul_A 206 DA-AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-VISSVEE-GY------RLPAP 276 (325)
T ss_dssp -C-CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-HHHHHHT-TC------CCCCC
T ss_pred cc-eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-HHHHHHc-CC------CCCCC
Confidence 11 112233456889999999999999999999999999999999 999996544322 2221111 11 11111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.. ....+.+++..||+.||.+||++.++++.|...
T Consensus 277 ~~----~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 277 MG----CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 22 235688999999999999999999999998653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=363.69 Aligned_cols=250 Identities=22% Similarity=0.338 Sum_probs=207.8
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.++||+|+||+||+|+.. +|+.||+|++++. .......+.+|+.+|.+++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~ 86 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence 345578999999999999876 6899999998643 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-- 159 (337)
T 1o6l_A 87 ANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-- 159 (337)
T ss_dssp CTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC--
Confidence 9999999999753 35899999999999999999999 8899999999999999999999999999998543222
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .............. +....
T Consensus 160 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~--------~p~~~ 228 (337)
T 1o6l_A 160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIR--------FPRTL 228 (337)
T ss_dssp --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC--------CCTTS
T ss_pred --CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC-HHHHHHHHHcCCCC--------CCCCC
Confidence 12345679999999999999999999999999999999999999997543 23333332222211 12222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
+ ..+.+++..||+.||++|| +++|+++|.++.
T Consensus 229 s----~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~ 265 (337)
T 1o6l_A 229 S----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp C----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred C----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence 3 4588999999999999999 999999998875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=351.40 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=208.8
Q ss_pred hhhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.+.||+|+||+||+|++.++..||||++..... ...++.+|++++.+++||||+++++++.+.+..++||||+++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN 87 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred heeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence 3445678999999999999998888999999875433 346799999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|.+++...+ ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 88 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--- 160 (268)
T 3sxs_A 88 GCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV--- 160 (268)
T ss_dssp CBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE---
T ss_pred CcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh---
Confidence 99999997542 35899999999999999999999 889999999999999999999999999999866544321
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.......... ...... ....+ ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~~~----~~~~~---~~~-- 230 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL-KVSQGH----RLYRP---HLA-- 230 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTC----CCCCC---TTS--
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH-HHHcCC----CCCCC---CcC--
Confidence 2234456788999999999899999999999999999999 998986544332222 111111 01111 112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
...+.+++..||+.||++|||+.+++++|....+
T Consensus 231 --~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 231 --SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp --CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred --hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 2458899999999999999999999999977654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=357.21 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=208.8
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEeccccc------hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE------QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 241 (518)
.+.+.+.||+|+||+||+|+.. +|..||+|.+..... ...+.+.+|+.+|.+++||||+++++++.+....++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3556678999999999999876 589999999864322 135679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC----cEEEeeccccc
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF----VAKLADFGLAH 317 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DfGla~ 317 (518)
||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 92 ILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999764 35999999999999999999999 88999999999999999887 89999999998
Q ss_pred cCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccccc
Q 010088 318 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 397 (518)
Q Consensus 318 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 397 (518)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +..............
T Consensus 167 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~-- 238 (326)
T 2y0a_A 167 KIDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANVSAVNYEFED-- 238 (326)
T ss_dssp ECCTTS-----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHTCCCCCH--
T ss_pred ECCCCC-----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHHhcCCCcCc--
Confidence 764432 224457999999999999899999999999999999999999999754332 222222111111110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
...... ...+.+++..||+.||++|||+.|+++|.+....
T Consensus 239 --~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 239 --EYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp --HHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred --cccccC----CHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 001111 2458899999999999999999999999887543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=348.92 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=207.2
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.+.||+|+||+||+|++.++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 90 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred ceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCC
Confidence 345678999999999999998899999999875432 3467999999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 91 ~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~ 163 (269)
T 4hcu_A 91 CLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TS 163 (269)
T ss_dssp BHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH---HS
T ss_pred cHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccccc---cc
Confidence 9999997643 35899999999999999999999 88999999999999999999999999999986543321 12
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .+........ ..+......
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-~~~~~~~~~~-------~~~~~~~~~--- 232 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG-------FRLYKPRLA--- 232 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTT-------CCCCCCTTS---
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-HHHHHHHhcC-------ccCCCCCcC---
Confidence 334557888999999999999999999999999999999 8888865433 2222222111 011111122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
...+.+++..||+.||++||++++++++|.+.
T Consensus 233 -~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 233 -STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 24588999999999999999999999999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=358.50 Aligned_cols=254 Identities=18% Similarity=0.262 Sum_probs=208.4
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||+||+|+.. +|..||+|.+... ......+.+|+.+|..++||||+++++++.+.+..++||||+++
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 85 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence 345678999999999999876 5889999988643 33456789999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC--CCcEEEeeccccccCCCCCccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE--NFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~ 326 (518)
|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+++....+.
T Consensus 86 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--- 158 (321)
T 1tki_A 86 LDIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--- 158 (321)
T ss_dssp CBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---
Confidence 99999997643 35999999999999999999999 889999999999999987 7899999999998765443
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
......||+.|+|||.+.+..++.++|||||||++|||++|..||...... +.............. ......
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~----~~~~~~- 230 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYTFDE----EAFKEI- 230 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCCCH----HHHTTS-
T ss_pred --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHcCCCCCCh----hhhccC-
Confidence 223456899999999999888999999999999999999999999754432 333222222211111 001112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
...+.+++.+||+.||.+|||+.|+++|.|...
T Consensus 231 ---s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 231 ---SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ---CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ---CHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 246889999999999999999999999988654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=352.93 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=202.9
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||+||+|+.. ++..||+|.+... .....+.|.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 93 (294)
T 4eqm_A 14 KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI 93 (294)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCC
Confidence 45578999999999999875 6899999988532 2344567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++|+|.+++...+ ++++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 94 ~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 166 (294)
T 4eqm_A 94 EGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-- 166 (294)
T ss_dssp CSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc--
Confidence 9999999997643 5999999999999999999999 88999999999999999999999999999986544321
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
.......||+.|+|||.+.+..++.++||||||+++|||+||+.||..................... .......
T Consensus 167 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~- 240 (294)
T 4eqm_A 167 -TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVT----TDVRKDI- 240 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHH----HHSCTTS-
T ss_pred -cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcc----hhcccCC-
Confidence 1233456999999999999999999999999999999999999999765443322222111111111 1111222
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcCCC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARP-SIKQVLRILYESSD 443 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RP-s~~evl~~L~~~~~ 443 (518)
...+.+++.+||+.||.+|| +++++.+.|.....
T Consensus 241 ---~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 241 ---PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp ---CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred ---CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 35688999999999999998 88888888876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=354.95 Aligned_cols=265 Identities=23% Similarity=0.310 Sum_probs=210.7
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC--ceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKR--ERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~e~ 245 (518)
+.+.++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 345678999999999999886 48999999987533 334567889999999999999999999988765 77999999
Q ss_pred cCCCCHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe----cCCCcEEEeeccccccCC
Q 010088 246 MANGSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLAHASK 320 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DfGla~~~~ 320 (518)
+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 999999999986432 34999999999999999999999 8899999999999999 788899999999998765
Q ss_pred CCCcccccccccccCCCcccCccccc--------cCCCCccccchhhHHHHHHHHhCCccccCCc---chHHHHHHHHhh
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVV--------TQELTEKSDVYSYGVVLLEIVTARRAVQDGK---NLVESAQVCMAS 389 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~---~~~~~~~~~~~~ 389 (518)
... ......||+.|+|||.+. +..++.++|||||||++|||++|+.||.... ...+........
T Consensus 168 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 168 DDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp TTC-----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred CCC-----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 433 223456999999999886 5788999999999999999999999996322 222333322222
Q ss_pred cc--cccccc-----------CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 390 ES--RLAELV-----------DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 390 ~~--~l~~~~-----------d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.. .+..+. +..............+.+++..||+.||++||+++|+++++.+..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11 000000 011122445677788999999999999999999999999987643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=372.02 Aligned_cols=256 Identities=25% Similarity=0.444 Sum_probs=195.1
Q ss_pred hhhhhhhcceecceEEEEEEec----CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
.+.+.++||+|+||+||+|++. ++..||||.++.. .....+.|.+|+.+|++++||||++++++|.+.+..++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 3445678999999999999875 4678999998753 3445568999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+++|+|.++++..+ ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 126 e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 126 EYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp ECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred eCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999999998643 35999999999999999999999 8899999999999999999999999999998654432
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
.. ........++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +...... .....
T Consensus 202 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-~~~~~i~-~~~~~--------- 269 (373)
T 2qol_A 202 EA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-DVIKAVD-EGYRL--------- 269 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-HHHHHHH-TTEEC---------
T ss_pred cc-ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH-cCCCC---------
Confidence 11 011222345788999999999999999999999999999998 99998654332 2222211 11110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..+......+.+++..||+.||.+||++.+|++.|...
T Consensus 270 -~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 270 -PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp -CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 11112335688999999999999999999999988654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=360.03 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=200.1
Q ss_pred hhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCc----eEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE----RFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~~lV~e~~ 246 (518)
.+.++||+|+||+||+|++. ++.||||++.... .....+.+|+.+|.+++||||+++++++.+... .++||||+
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~ 104 (322)
T 3soc_A 27 QLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104 (322)
T ss_dssp EEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred hhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecC
Confidence 35578999999999999875 8999999986533 333456779999999999999999999988553 69999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC----------CceecccCCCcEEecCCCcEEEeecccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP----------PLCHRDIKSSNILLDENFVAKLADFGLA 316 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~----------~iiHrDlk~~NILl~~~~~~kl~DfGla 316 (518)
++|+|.++++.. .++|..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 105 EKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp TTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 999999999753 4999999999999999999999 77 9999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccCCCcccCcccccc-----CCCCccccchhhHHHHHHHHhCCccccCCcc-------------
Q 010088 317 HASKDGSICFEPVNTDIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKN------------- 378 (518)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~------------- 378 (518)
+........ .......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||....+
T Consensus 179 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 179 LKFEAGKSA--GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp EEECTTSCC--CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccCc--cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 765443211 12334579999999999876 3566789999999999999999999864221
Q ss_pred --hHHHHHHHHhhccccccccCCcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 379 --LVESAQVCMASESRLAELVDPRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 379 --~~~~~~~~~~~~~~l~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...+.... . .....+.+...+ .......+.+++.+||+.||++|||+.||++.|..
T Consensus 257 ~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 257 PSLEDMQEVV-V-----HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp CCHHHHHHHH-T-----TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Cchhhhhhhh-h-----cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11111111 0 111112222111 12455679999999999999999999999999865
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=358.97 Aligned_cols=255 Identities=24% Similarity=0.334 Sum_probs=203.4
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 10 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 89 (323)
T 3tki_A 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 89 (323)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCC
Confidence 34568999999999999876 68999999986432 23345688999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 90 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~ 162 (323)
T 3tki_A 90 GELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--ER 162 (323)
T ss_dssp EEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE--EC
T ss_pred CcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc--cc
Confidence 99999998643 4999999999999999999999 89999999999999999999999999999976533221 11
Q ss_pred ccccccCCCcccCccccccCCC-CccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.................... .+ ..
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----~~--~~---- 232 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL----NP--WK---- 232 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS----TT--GG----
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC----Cc--cc----
Confidence 2345679999999999987775 7789999999999999999999975443222222111111100 00 01
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.....+.+++.+||+.||++|||+.|++++.|...
T Consensus 233 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 12245789999999999999999999999987753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=386.06 Aligned_cols=259 Identities=23% Similarity=0.389 Sum_probs=212.3
Q ss_pred HHHhhhhhhhcceecceEEEEEEecC-CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 166 KKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 166 ~~a~~~f~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
....+.+.+.||+|+||+||+|++.. +..||||.++.... ..++|.+|+.+|++++||||++++++|.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34445667899999999999999874 88999999875432 35789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++|+|.+++.......+++..++.|+.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++.......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 999999999998665567999999999999999999999 88999999999999999999999999999987644321
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
. ......++..|+|||.+....++.++|||||||+||||+| |+.||...... +..... .... ......
T Consensus 374 ~---~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-~~~~~~-~~~~------~~~~~~ 442 (495)
T 1opk_A 374 T---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELL-EKDY------RMERPE 442 (495)
T ss_dssp E---CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHH-HTTC------CCCCCT
T ss_pred e---ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHH-HcCC------CCCCCC
Confidence 1 2234456789999999999999999999999999999999 88888643322 222111 1111 111112
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
.....+.+++.+||+.||++||++.+|++.|.....
T Consensus 443 ----~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 443 ----GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ----CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 223568899999999999999999999999987654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=381.95 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=208.8
Q ss_pred hhhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.+.||+|+||+||+|++.++..||||.++... ...+.|.+|+.+|++++||||+++++++. .+..++||||+++
T Consensus 189 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~ 266 (454)
T 1qcf_A 189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAK 266 (454)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCC
Confidence 345567899999999999999888999999997543 34578999999999999999999999986 6678999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.++++......+++..++.++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++....... .
T Consensus 267 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~---~ 340 (454)
T 1qcf_A 267 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---T 340 (454)
T ss_dssp CBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH---H
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce---e
Confidence 99999998654446899999999999999999999 88999999999999999999999999999987643221 1
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......+|..|+|||.+....++.++|||||||+||||+| |+.||..... .+...... ...++ .....
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-~~~~~~i~-~~~~~------~~~~~--- 409 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVIRALE-RGYRM------PRPEN--- 409 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHH-HTCCC------CCCTT---
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH-cCCCC------CCCCC---
Confidence 2233456889999999999999999999999999999999 9999865433 22222211 11111 11122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
....+.+++..||+.||++|||+++|++.|.....
T Consensus 410 -~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 410 -CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 23568899999999999999999999999977544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=360.46 Aligned_cols=254 Identities=21% Similarity=0.336 Sum_probs=207.7
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
.+.+.+.||+|+||+||+|... +|..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~ 109 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 4556678999999999999875 5899999998643 334456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC---CcEEEeeccccccCCCC
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN---FVAKLADFGLAHASKDG 322 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DfGla~~~~~~ 322 (518)
+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.+ +.+||+|||++......
T Consensus 110 ~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 110 VTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999999764 35899999999999999999999 8899999999999999864 45999999999876543
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ............... + ..
T Consensus 185 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~~---~-~~ 254 (362)
T 2bdw_A 185 E-----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAYDYPS---P-EW 254 (362)
T ss_dssp C-----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCCCT---T-GG
T ss_pred c-----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCCCCCc---c-cc
Confidence 2 224567999999999999999999999999999999999999999755432 222222222111110 0 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
... ...+.+++..||+.||++||++.+++++.|..
T Consensus 255 ~~~----~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 289 (362)
T 2bdw_A 255 DTV----TPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289 (362)
T ss_dssp GGS----CHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred cCC----CHHHHHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence 112 24588999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=353.89 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=200.5
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHH--cCCCCeeeEeeeeeec----CceEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLAR--LHHRHLVALRGFCIEK----RERFLMY 243 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~lV~ 243 (518)
+.+.+.||+|+||+||+|++ +|+.||||++... ....+.+|.+++.. ++||||+++++++... ...++||
T Consensus 10 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 34567899999999999988 6899999998643 34567778888877 7899999999997653 4579999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCceecccCCCcEEecCCCcEEEeecccccc
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY-----CDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~ 318 (518)
||+++|+|.++++. ..+++..+++++.|++.||+|||.. ++.+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 162 (301)
T 3q4u_A 86 HYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162 (301)
T ss_dssp CCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred hhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence 99999999999964 3599999999999999999999932 257999999999999999999999999999976
Q ss_pred CCCCCcccccccccccCCCcccCccccccC------CCCccccchhhHHHHHHHHhC----------CccccCCc---ch
Q 010088 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ------ELTEKSDVYSYGVVLLEIVTA----------RRAVQDGK---NL 379 (518)
Q Consensus 319 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwS~Gvll~el~tG----------~~p~~~~~---~~ 379 (518)
................||+.|+|||.+.+. .++.++||||||+++|||+|| +.||.... ..
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~ 242 (301)
T 3q4u_A 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242 (301)
T ss_dssp EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence 544332222223445799999999999876 456799999999999999999 77775321 11
Q ss_pred HHHHHHHHhhccccccccCCcCCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 380 VESAQVCMASESRLAELVDPRIKD-SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 380 ~~~~~~~~~~~~~l~~~~d~~l~~-~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
............. .+.+.. ..+......+.+++..||+.||++|||+.+|++.|..
T Consensus 243 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 243 FEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp HHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred hhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 1222221111111 111111 1223566789999999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=360.84 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=194.0
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
.+.+.||+|+||+||+|+.. +++.||||+++... ..+.+.+|+++|.+++||||+++++++.+.+..++||||+++|
T Consensus 56 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 133 (349)
T 2w4o_A 56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG 133 (349)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCC
Confidence 34568999999999999986 47899999987543 3456889999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC---CCcEEEeeccccccCCCCCccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DfGla~~~~~~~~~~ 326 (518)
+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+++......
T Consensus 134 ~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--- 205 (349)
T 2w4o_A 134 ELFDRIVEKG--YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--- 205 (349)
T ss_dssp BHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc---
Confidence 9999997643 4899999999999999999999 889999999999999975 8899999999998654332
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+................... . ......
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~---~-~~~~~~- 278 (349)
T 2w4o_A 206 --LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI---S-PWWDEV- 278 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC---T-TTTTTS-
T ss_pred --ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC---C-chhhhC-
Confidence 223457999999999999999999999999999999999999999765544333333222221111 1 111122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 444 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~ 444 (518)
...+.+++.+||+.||++||++.|++++.|.....
T Consensus 279 ---~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 279 ---SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ---CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ---CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 24688999999999999999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=356.26 Aligned_cols=262 Identities=23% Similarity=0.290 Sum_probs=202.2
Q ss_pred hhhhcceecceEEEEEEecCCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.||+|+||+||+|+..+|+.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 25 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~- 103 (311)
T 3niz_A 25 KLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK- 103 (311)
T ss_dssp EEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-
T ss_pred hhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-
Confidence 456899999999999999889999999986432 33346789999999999999999999999999999999999984
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 104 ~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~----~ 175 (311)
T 3niz_A 104 DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR----S 175 (311)
T ss_dssp EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----
T ss_pred CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc----c
Confidence 8888887643 35999999999999999999999 88999999999999999999999999999986543321 2
Q ss_pred cccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc----ccccc------C
Q 010088 330 NTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR----LAELV------D 398 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~----l~~~~------d 398 (518)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||................... ..... +
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 344578999999999876 568999999999999999999999996543332222211110000 00000 0
Q ss_pred CcC--CCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 399 PRI--KDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 399 ~~l--~~~~~~-----~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
... ...... .....+.+++..||+.||++|||++|+++|.|+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 000 000000 11246789999999999999999999999988753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=373.53 Aligned_cols=253 Identities=25% Similarity=0.428 Sum_probs=204.6
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.+.||+|+||+||+|++. +|+.||||.++.. .......|.+|+++|++++||||++++++|.+.+..++||||++
T Consensus 116 ~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 195 (377)
T 3cbl_A 116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 195 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCC
Confidence 345678999999999999986 6899999998753 23344678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+|+|.++++..+ ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 196 ~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~-- 269 (377)
T 3cbl_A 196 GGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA-- 269 (377)
T ss_dssp TCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE--
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee--
Confidence 999999997532 34899999999999999999999 889999999999999999999999999999865433211
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
.......++..|+|||.+.+..++.++|||||||++|||+| |..||...... +.... ...... ......+
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-~~~~~-~~~~~~------~~~~~~~- 340 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-QTREF-VEKGGR------LPCPELC- 340 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-HHHHH-HHTTCC------CCCCTTC-
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH-HHcCCC------CCCCCCC-
Confidence 11122335778999999999999999999999999999999 88888654332 22111 111111 1111222
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...+.+++..||+.||++|||++++++.|..
T Consensus 341 ---~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 341 ---PDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 3568899999999999999999999999865
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=364.29 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=202.5
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
.++||+|+||+||+|+.. +|..||+|+++.......+.|.+|+++|.+++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 357999999999999875 6899999999876656667899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe--cCCCcEEEeeccccccCCCCCcccccc
Q 010088 252 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL--DENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 252 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl--~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||+ ++++.+||+|||+++...... .
T Consensus 174 ~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-----~ 244 (373)
T 2x4f_A 174 FDRIIDES-YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-----K 244 (373)
T ss_dssp HHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-----B
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-----c
Confidence 99886532 35899999999999999999999 8899999999999999 567899999999998765432 1
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ...........+. ......++
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~----~~~~~~~~--- 316 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNNILACRWDLE----DEEFQDIS--- 316 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCCSC----SGGGTTSC---
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCCCC----hhhhccCC---
Confidence 234569999999999998999999999999999999999999997554332 2222222211111 11111222
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 410 LRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..+.+++..||+.||.+||++.|++++.|..
T Consensus 317 -~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~ 347 (373)
T 2x4f_A 317 -EEAKEFISKLLIKEKSWRISASEALKHPWLS 347 (373)
T ss_dssp -HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred -HHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence 4688999999999999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=366.28 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=203.8
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.+.++||+|+||+||+|+.. +|+.||||++++. .......+.+|..+|..+ +||||+++++++.+.+..++|||
T Consensus 25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E 104 (353)
T 3txo_A 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME 104 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence 445678999999999999876 5899999998643 233445688999999998 69999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++......
T Consensus 105 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~- 178 (353)
T 3txo_A 105 FVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG- 178 (353)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccCC-
Confidence 999999999997643 4999999999999999999999 8899999999999999999999999999998543322
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+....+......+ ...
T Consensus 179 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~~~~i~~~~~~~--------p~~ 246 (353)
T 3txo_A 179 ---VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAILNDEVVY--------PTW 246 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCC--------CTT
T ss_pred ---ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCC--------CCC
Confidence 12345679999999999999999999999999999999999999997543 333333333222111 112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHhhcC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSI------KQVLRILYES 441 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~------~evl~~L~~~ 441 (518)
.+ ..+.+++..||+.||++||++ +++++|.++.
T Consensus 247 ~~----~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~ 285 (353)
T 3txo_A 247 LH----EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285 (353)
T ss_dssp SC----HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred CC----HHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence 22 457899999999999999998 8999998775
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=356.16 Aligned_cols=264 Identities=27% Similarity=0.414 Sum_probs=201.3
Q ss_pred hhhhhhcceecceEEEEEEe-----cCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 242 (518)
+.+.+.||+|+||+||+|++ .+|+.||||++........+.|.+|+++|.+++||||++++++|... ...++|
T Consensus 12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 91 (295)
T 3ugc_A 12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 91 (295)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEE
T ss_pred hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEE
Confidence 44567899999999999985 25889999999876666677899999999999999999999998654 568999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 92 MEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp EECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred EEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 99999999999997643 34999999999999999999999 889999999999999999999999999999876443
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc-------cccc
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES-------RLAE 395 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~-------~l~~ 395 (518)
... ........++..|+|||.+.+..++.++||||||+++|||+||..|+..... ...... .... .+.+
T Consensus 168 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 168 KEF-FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFMRMI-GNDKQGQMIVFHLIE 243 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH--HHHHHH-CTTCCTHHHHHHHHH
T ss_pred cce-eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH--HHHhhh-cCccccchhHHHHHH
Confidence 211 1122344577889999999999999999999999999999999988753211 110000 0000 0000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 396 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 396 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+........+......+.+++..||+.||++|||++|+++.|...
T Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0000001111122335689999999999999999999999998654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=351.56 Aligned_cols=263 Identities=24% Similarity=0.284 Sum_probs=205.7
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.||+|+||+||+|+.. +|+.||||++... .......+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (292)
T 3o0g_A 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence 34568999999999999875 5899999998643 23345678999999999999999999999999999999999998
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+ +|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 156 (292)
T 3o0g_A 85 Q-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--- 156 (292)
T ss_dssp E-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS---
T ss_pred C-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc---
Confidence 6 566555432 235999999999999999999999 88999999999999999999999999999986543321
Q ss_pred cccccccCCCcccCccccccCC-CCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccc--------ccC
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQE-LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE--------LVD 398 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~--------~~d 398 (518)
......||+.|+|||.+.+.. ++.++|||||||++|||++|+.|+..+.+..+.............. ..+
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 234457899999999997765 8999999999999999999999977666555444433221111000 000
Q ss_pred C---------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 399 P---------RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 399 ~---------~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
. .............+.+++..||+.||++|||++|+++|.|...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 0 0000011122356889999999999999999999999988753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=358.32 Aligned_cols=252 Identities=23% Similarity=0.293 Sum_probs=199.0
Q ss_pred HHHHhhhhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceE
Q 010088 165 TKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERF 240 (518)
Q Consensus 165 l~~a~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 240 (518)
+....+...++||+|+||+||+|+.. +|+.||||++... .......+..|+..+.++ +|+||++++++|.+.+..+
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 33445556678999999999999886 6899999988643 233344566777777666 8999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCC
Q 010088 241 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~ 320 (518)
+||||+ +++|.+++...+ ..++|..+..|+.|++.||+||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 134 lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 999999 679999987543 35999999999999999999999 8899999999999999999999999999988654
Q ss_pred CCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
... ......||++|+|||++.+ .++.++|||||||++|||++|..++......... .. .. ..+.
T Consensus 209 ~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-----~~-~~----~~~~ 272 (311)
T 3p1a_A 209 TAG-----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-----RQ-GY----LPPE 272 (311)
T ss_dssp -----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH-----TT-TC----CCHH
T ss_pred cCC-----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-----hc-cC----CCcc
Confidence 432 2344569999999998875 7999999999999999999998777543221111 10 00 1111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+.... ...+.+++.+||+.||++|||++|++++.|..
T Consensus 273 ~~~~~----~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 309 (311)
T 3p1a_A 273 FTAGL----SSELRSVLVMMLEPDPKLRATAEALLALPVLR 309 (311)
T ss_dssp HHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred cccCC----CHHHHHHHHHHcCCChhhCcCHHHHHhCcccc
Confidence 11122 25688999999999999999999999988764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=363.32 Aligned_cols=256 Identities=21% Similarity=0.306 Sum_probs=210.6
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||+||+|... +|..||+|.+..........+.+|+++|.+++||||+++++++.+.+..++||||+++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g 132 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence 445678999999999999875 6899999998766555566899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC--CCcEEEeeccccccCCCCCccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE--NFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~ 326 (518)
|+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+++......
T Consensus 133 g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~--- 205 (387)
T 1kob_A 133 GELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--- 205 (387)
T ss_dssp CBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---
T ss_pred CcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc---
Confidence 99999997643 35999999999999999999999 889999999999999974 5789999999998765432
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +........... .++......+
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~----~~~~~~~~~s 278 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWE----FDEDAFSSVS 278 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCC----CCSSTTTTSC
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC----CCccccccCC
Confidence 123446999999999999999999999999999999999999999765433 222222211111 1111122223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
..+.+++..||+.||++||++.|++++.|....
T Consensus 279 ----~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 279 ----PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp ----HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ----HHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 458899999999999999999999999887644
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=348.27 Aligned_cols=252 Identities=27% Similarity=0.434 Sum_probs=204.1
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.+.||+|+||+||+|++.++..||||++..... ..+++.+|++++.+++|+||+++++++.+.+..++||||+++|
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (283)
T 3gen_A 26 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 104 (283)
T ss_dssp EEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTC
T ss_pred HHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCC
Confidence 445678999999999999998888999999975433 3467999999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 105 ~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~ 177 (283)
T 3gen_A 105 CLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TS 177 (283)
T ss_dssp BHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH---HS
T ss_pred cHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccccc---cc
Confidence 9999997632 34999999999999999999999 88999999999999999999999999999986543321 12
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
.....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... ......... .........+
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-~~~~~~~~~-------~~~~~~~~~~-- 247 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-ETAEHIAQG-------LRLYRPHLAS-- 247 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHHTT-------CCCCCCTTCC--
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-HHHHHHhcc-------cCCCCCCcCC--
Confidence 234457889999999999999999999999999999998 99998754432 222221111 1111111222
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..+.+++..||+.||.+||++++++++|...
T Consensus 248 --~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 248 --EKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp --HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 4688999999999999999999999999653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=364.39 Aligned_cols=255 Identities=26% Similarity=0.363 Sum_probs=204.1
Q ss_pred hhhhhhcceecceEEEEEEe------cCCcEEEEEEecccc-chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCc-eE
Q 010088 170 DNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRE-RF 240 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~-~~ 240 (518)
+.+.+.||+|+||+||+|++ .+++.||||+++... ....+.+.+|++++.++ +||||++++++|.+.+. .+
T Consensus 24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~ 103 (359)
T 3vhe_A 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 103 (359)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence 44567899999999999974 246799999997533 34456799999999999 79999999999988654 89
Q ss_pred EEEEecCCCCHHHHhcCCCC------------------------------------------------------------
Q 010088 241 LMYEYMANGSLKDHLHSPGR------------------------------------------------------------ 260 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 260 (518)
+||||+++|+|.++++....
T Consensus 104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3vhe_A 104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183 (359)
T ss_dssp EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence 99999999999999976432
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccccccCC
Q 010088 261 ----TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 336 (518)
Q Consensus 261 ----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt 336 (518)
..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++........ .......||
T Consensus 184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~t 258 (359)
T 3vhe_A 184 DLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGDARLP 258 (359)
T ss_dssp CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC--EEC--CEEC
T ss_pred chhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc--hhccccCCC
Confidence 12899999999999999999999 889999999999999999999999999999865433211 123445689
Q ss_pred CcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHH
Q 010088 337 PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVT 415 (518)
Q Consensus 337 ~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~ 415 (518)
+.|+|||.+.+..++.++||||||+++|||+| |+.||................ . ........+ ..+.+
T Consensus 259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~------~~~~~~~~~----~~l~~ 327 (359)
T 3vhe_A 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-T------RMRAPDYTT----PEMYQ 327 (359)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT-C------CCCCCTTCC----HHHHH
T ss_pred ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC-C------CCCCCCCCC----HHHHH
Confidence 99999999999999999999999999999998 999997544333322222111 1 111122222 45889
Q ss_pred HHHHccccCCCCCCCHHHHHHHhhc
Q 010088 416 IVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 416 li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
++..||+.||++||++.|++++|..
T Consensus 328 li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 328 TMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHHHHHH
Confidence 9999999999999999999999965
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=366.28 Aligned_cols=251 Identities=20% Similarity=0.320 Sum_probs=203.5
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.+.++||+|+||+||+|+.. +++.||+|++++.. ......+.+|..+|.++ +||||+++++++.+.+..++|||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E 133 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 133 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence 345678999999999999876 57899999987532 23345688999999988 89999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++|+|..++...+ .+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++......
T Consensus 134 ~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~- 207 (396)
T 4dc2_A 134 YVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 207 (396)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC-
Confidence 999999999997643 4999999999999999999999 8899999999999999999999999999998532221
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCc--------chHHHHHHHHhhccccccc
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK--------NLVESAQVCMASESRLAEL 396 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~--------~~~~~~~~~~~~~~~l~~~ 396 (518)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......+......
T Consensus 208 ---~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------ 278 (396)
T 4dc2_A 208 ---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------ 278 (396)
T ss_dssp ---CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC------
T ss_pred ---CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc------
Confidence 12355679999999999999999999999999999999999999995321 1111222222111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHhhcC
Q 010088 397 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSI------KQVLRILYES 441 (518)
Q Consensus 397 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~------~evl~~L~~~ 441 (518)
..+...++ ..+.+++..||+.||.+||++ .|+++|.++.
T Consensus 279 --~~~p~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~ 323 (396)
T 4dc2_A 279 --IRIPRSLS----VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323 (396)
T ss_dssp --CCCCTTSC----HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred --cCCCCcCC----HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence 11222233 457899999999999999984 7999998775
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=361.90 Aligned_cols=255 Identities=22% Similarity=0.353 Sum_probs=200.5
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCC--CCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHH--RHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.+.||+|+||+||++...++..||||++... .......+.+|+.+|.+++| +||+++++++.+.+..++|||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 89 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 89 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence 3456789999999999999888999999998643 33445779999999999976 999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+.+|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++ ++.+||+|||+++........
T Consensus 90 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 90 CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 5688999999864 35999999999999999999999 88999999999999997 578999999999866443211
Q ss_pred cccccccccCCCcccCcccccc-----------CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccc
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVT-----------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 394 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~ 394 (518)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....+..........
T Consensus 164 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~------ 235 (343)
T 3dbq_A 164 --VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID------ 235 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC------
T ss_pred --ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc------
Confidence 12345679999999999865 67899999999999999999999999764443332222221
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 395 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 395 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
+.....++......+.+++..||+.||.+|||+.|+++|.|....
T Consensus 236 ----~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 236 ----PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp ----TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ----CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 111111111112458899999999999999999999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=374.77 Aligned_cols=246 Identities=28% Similarity=0.457 Sum_probs=201.5
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC-ceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR-ERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||+||+|.+. |+.||||.++... ..+.|.+|+.+|++++||||++++++|.+.+ ..++||||+++
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~ 271 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred eEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence 344578999999999999984 7899999997543 4567999999999999999999999988765 78999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.+++...+...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 272 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~------ 342 (450)
T 1k9a_A 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------ 342 (450)
T ss_dssp CBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc------
Confidence 99999998765556899999999999999999999 889999999999999999999999999999854322
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
.....++..|+|||.+.+..++.++||||||++||||+| |+.||...... +...... ... .......
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~~~i~-~~~------~~~~p~~--- 410 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVE-KGY------KMDAPDG--- 410 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-THHHHHH-TTC------CCCCCTT---
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH-cCC------CCCCCCc---
Confidence 122357889999999999999999999999999999999 99998643322 1111111 111 1111222
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
....+.+++..||+.||.+||++.++++.|..
T Consensus 411 -~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 411 -CPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 23568899999999999999999999998864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=356.00 Aligned_cols=247 Identities=24% Similarity=0.373 Sum_probs=207.3
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 345578999999999999876 68999999986432 23346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 88 IEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp CCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 99999999997643 4899999999999999999999 999999999999999999999999999999865432
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+...... +...+
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~--------~p~~~ 226 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKILNAELR--------FPPFF 226 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHCCCC--------CCTTS
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC--------CCCCC
Confidence 23457999999999999999999999999999999999999999755433 333322222211 11222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
+ ..+.+++.+||+.||++|| +++++++|.+..
T Consensus 227 ~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~ 263 (318)
T 1fot_A 227 N----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 263 (318)
T ss_dssp C----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred C----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcccc
Confidence 3 4588999999999999999 999999998875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=359.71 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=206.4
Q ss_pred HhhhhhhhcceecceEEEEEEec-CCcEEEEEEecccc-----chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEE
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-----EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 241 (518)
..+.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34566789999999999999875 68999999985321 1235679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc---EEEeecccc
Q 010088 242 MYEYMANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV---AKLADFGLA 316 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DfGla 316 (518)
||||+++|+|.+++... ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999887542 2335899999999999999999999 889999999999999986654 999999999
Q ss_pred ccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccc
Q 010088 317 HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL 396 (518)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~ 396 (518)
+....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .............
T Consensus 181 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~~~~~~--- 251 (351)
T 3c0i_A 181 IQLGESGL----VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYKM--- 251 (351)
T ss_dssp EECCTTSC----BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHHTCCCC---
T ss_pred eEecCCCe----eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHcCCCCC---
Confidence 87654321 23445799999999999999999999999999999999999999975321 2222222111111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 397 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 397 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
++...... ...+.+++.+||+.||++||++.|+++|.|..
T Consensus 252 -~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 291 (351)
T 3c0i_A 252 -NPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALNHPWLK 291 (351)
T ss_dssp -CHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred -CccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence 11111112 24688999999999999999999999988764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=365.37 Aligned_cols=266 Identities=21% Similarity=0.276 Sum_probs=206.0
Q ss_pred hhhhhhccee--cceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQG--GFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.+.++||+| +||+||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 106 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 106 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence 3456789999 99999999986 68999999986432 3445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++|+|.+++.......+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||++........
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 107 FMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp CCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred ccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 999999999998655556999999999999999999999 88999999999999999999999999999865422211
Q ss_pred c---cccccccccCCCcccCcccccc--CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCC
Q 010088 325 C---FEPVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 399 (518)
Q Consensus 325 ~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~ 399 (518)
. .........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+............. .+..+.+.
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~ 260 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG---TVPCLLDT 260 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC---CCCccccc
Confidence 1 0112233478999999999987 67999999999999999999999999754332222111100 00000000
Q ss_pred cC------------------------------------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 400 RI------------------------------------KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 400 ~l------------------------------------~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.. ...........+.+++.+||+.||++|||+.|+++|.|..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 00 0001112235689999999999999999999999988764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=367.12 Aligned_cols=255 Identities=20% Similarity=0.287 Sum_probs=206.6
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
.+.+.+.||+|+||+||+|... +|..+|+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL 91 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence 3455678999999999999864 68999999986432 34456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec---CCCcEEEeeccccccCCCC
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DfGla~~~~~~ 322 (518)
+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+|||++ +++.+||+|||+++.....
T Consensus 92 ~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 92 VTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999999997643 5999999999999999999999 88999999999999998 5688999999999866543
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|..||.+.... +...........+. .+. .
T Consensus 167 ~~----~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~~---~~~-~ 237 (444)
T 3soa_A 167 QQ----AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-RLYQQIKAGAYDFP---SPE-W 237 (444)
T ss_dssp CC----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTCCCCC---TTT-T
T ss_pred Cc----eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhCCCCCC---ccc-c
Confidence 21 234567999999999999999999999999999999999999999754432 32222222221111 111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
...+ ..+.+++..||+.||++|||+.|+++|.|..
T Consensus 238 ~~~s----~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~ 272 (444)
T 3soa_A 238 DTVT----PEAKDLINKMLTINPSKRITAAEALKHPWIS 272 (444)
T ss_dssp TTSC----HHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred ccCC----HHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 1222 4588999999999999999999999998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=342.62 Aligned_cols=248 Identities=21% Similarity=0.376 Sum_probs=203.6
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~ 245 (518)
+.+.+.||+|+||+||+|++ +|..||||++... .....+.|.+|+.++++++||||+++++++.+. +..++||||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred hHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 34557899999999999998 4899999998743 334456799999999999999999999999887 788999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP--LCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
+++|+|.+++.......+++..++.++.|++.||+||| +.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-- 165 (271)
T 3kmu_A 91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-- 165 (271)
T ss_dssp CTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred cCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence 99999999998766667999999999999999999999 778 99999999999999999999999998764322
Q ss_pred cccccccccccCCCcccCccccccCCCCc---cccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTE---KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.||............ .... ..+.
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~------~~~~ 231 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV-ALEG------LRPT 231 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH-HHSC------CCCC
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH-HhcC------CCCC
Confidence 2346899999999998765544 799999999999999999999755433222221 1111 1122
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+....+ ..+.+++..||+.||++|||++++++.|...
T Consensus 232 ~~~~~~----~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 232 IPPGIS----PHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 222333 4588999999999999999999999998764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=349.50 Aligned_cols=262 Identities=25% Similarity=0.309 Sum_probs=201.7
Q ss_pred hhhhhcceecceEEEEEEecCCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.||+|+||+||+|+..+|+.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (288)
T 1ob3_A 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred hhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC
Confidence 3456899999999999998889999999986432 23346788999999999999999999999999999999999985
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 -~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 155 (288)
T 1ob3_A 85 -DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR---- 155 (288)
T ss_dssp -EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred -CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc----
Confidence 9999987643 35899999999999999999999 88999999999999999999999999999976543211
Q ss_pred ccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc----cccc-----ccC
Q 010088 329 VNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----RLAE-----LVD 398 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~----~l~~-----~~d 398 (518)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.................. .... ..+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 1234568999999999876 45899999999999999999999999755443332222111000 0000 011
Q ss_pred CcCCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 399 PRIKD-------SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 399 ~~l~~-------~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+.... .+.......+.+++.+||+.||++|||++|+++|.|..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 285 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 11100 00011235678999999999999999999999988764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=376.88 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=202.4
Q ss_pred hhhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.+.||+|+||+||+|.+.++..||||.++... ...++|.+|+++|++++||||+++++++.+ +..++||||+++
T Consensus 185 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~ 262 (452)
T 1fmk_A 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 262 (452)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcC
Confidence 344567899999999999999888899999987543 234679999999999999999999999876 778999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.+++.......+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++....... .
T Consensus 263 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---~ 336 (452)
T 1fmk_A 263 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---T 336 (452)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce---e
Confidence 99999997543446999999999999999999999 88999999999999999999999999999986544321 1
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......++..|+|||.+.+..++.++||||||++||||+| |+.||...... +...... ...+ .....
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~~~i~-~~~~------~~~~~---- 404 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVE-RGYR------MPCPP---- 404 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHH-TTCC------CCCCT----
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH-cCCC------CCCCC----
Confidence 2233457889999999999999999999999999999999 88888654332 2222211 1111 11112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
.....+.+++..||+.||++|||++++++.|.....
T Consensus 405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 223568899999999999999999999999976543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=364.47 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=207.6
Q ss_pred hhhhhhhcceecceEEEEEEec--------CCcEEEEEEeccc-cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCc
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS--------DGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRE 238 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 238 (518)
.+.+.+.||+|+||+||+|+.. .+..||||+++.. .......+.+|+++++++ +||||++++++|.+.+.
T Consensus 70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 149 (382)
T 3tt0_A 70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 149 (382)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCc
Confidence 4455678999999999999862 2468999998754 334457799999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC
Q 010088 239 RFLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE 304 (518)
Q Consensus 239 ~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~ 304 (518)
.++||||+++|+|.+++.... ...+++..++.|+.|++.||+||| +.+|+||||||+||||+.
T Consensus 150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTE 226 (382)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECT
T ss_pred eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEcC
Confidence 999999999999999997543 235999999999999999999999 889999999999999999
Q ss_pred CCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHH
Q 010088 305 NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESA 383 (518)
Q Consensus 305 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~ 383 (518)
++.+||+|||+++........ .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+..
T Consensus 227 ~~~~kL~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-~~~~~ 303 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELF 303 (382)
T ss_dssp TCCEEECSCSCCCCSSCCCTT--CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHH
T ss_pred CCcEEEcccCccccccccccc--ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHH
Confidence 999999999999866543211 12344567889999999999999999999999999999999 888886433 33332
Q ss_pred HHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 384 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 384 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
....... .+.....++ ..+.+++..||+.||++||+++||+++|...
T Consensus 304 ~~~~~~~-------~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 304 KLLKEGH-------RMDKPSNCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp HHHHTTC-------CCCCCSSCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCC-------CCCCCccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2221111 111122222 4688999999999999999999999998654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=357.86 Aligned_cols=250 Identities=21% Similarity=0.333 Sum_probs=197.6
Q ss_pred hhhhhhcceecceEEEEEEe----cCCcEEEEEEecccc----chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 241 (518)
+.+.++||+|+||+||+++. .+|+.||+|+++... ......+.+|+.+|++++||||+++++++...+..++
T Consensus 19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 98 (327)
T 3a62_A 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL 98 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence 44567899999999999987 478999999987532 2334568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 99 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 99 ILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 999999999999997533 4899999999999999999999 88999999999999999999999999999975432
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ............ +
T Consensus 174 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~--------~ 240 (327)
T 3a62_A 174 DG----TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-KTIDKILKCKLN--------L 240 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTCCC--------C
T ss_pred CC----ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCCC--------C
Confidence 22 1234457999999999999999999999999999999999999999754432 222222222111 1
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
....+ ..+.+++.+||+.||++|| ++.|+++|.+..
T Consensus 241 p~~~~----~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~ 281 (327)
T 3a62_A 241 PPYLT----QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281 (327)
T ss_dssp CTTSC----HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGS
T ss_pred CCCCC----HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCccc
Confidence 12222 4588999999999999999 889999998875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=364.66 Aligned_cols=256 Identities=28% Similarity=0.400 Sum_probs=204.6
Q ss_pred hhhhhhhcceecceEEEEEEec------CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 241 (518)
.+.+.+.||+|+||+||+|++. ++..||||++... .......+.+|+.++++++||||+++++++.+....++
T Consensus 72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 151 (367)
T 3l9p_A 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151 (367)
T ss_dssp GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEE
Confidence 3456678999999999999853 4678999998643 34455679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC---cEEEeec
Q 010088 242 MYEYMANGSLKDHLHSPG-----RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF---VAKLADF 313 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~Df 313 (518)
||||+++|+|.+++.... ...+++..++.++.||+.||+||| +.+|+||||||+||||+.++ .+||+||
T Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence 999999999999997532 245999999999999999999999 88999999999999999544 5999999
Q ss_pred cccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccc
Q 010088 314 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESR 392 (518)
Q Consensus 314 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~ 392 (518)
|+++....... ........||+.|+|||.+.+..++.++|||||||++|||+| |..||..... .+......... .
T Consensus 229 G~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-~~~~~~i~~~~-~ 304 (367)
T 3l9p_A 229 GMARDIYRAGY--YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGG-R 304 (367)
T ss_dssp HHHHHHHHHSS--CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTC-C
T ss_pred ccccccccccc--cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCC-C
Confidence 99974322111 012234568999999999999999999999999999999998 8888865433 22222221111 0
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 393 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 393 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
....... ...+.+++..||+.||.+||++.+|+++|+..
T Consensus 305 ------~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 305 ------MDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp ------CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCccC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111222 24588999999999999999999999999764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=351.71 Aligned_cols=251 Identities=23% Similarity=0.376 Sum_probs=204.2
Q ss_pred hhhhhhcceecceEEEEEEecC-C-------cEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSD-G-------SLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 241 (518)
+.+.+.||+|+||+||+|+... + ..||+|.+........+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL 89 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence 4456789999999999997653 3 4799999977666667889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc--------EEEeec
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV--------AKLADF 313 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~--------~kl~Df 313 (518)
||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+||
T Consensus 90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 90 VQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp EEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred EEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 999999999999997643 34899999999999999999999 889999999999999998887 999999
Q ss_pred cccccCCCCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc
Q 010088 314 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR 392 (518)
Q Consensus 314 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 392 (518)
|++...... ....||+.|+|||.+.+ ..++.++||||||+++|||++|+.++.............. ....
T Consensus 166 g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~-~~~~ 236 (289)
T 4fvq_A 166 GISITVLPK--------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-DRHQ 236 (289)
T ss_dssp CSCTTTSCH--------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCC
T ss_pred cccccccCc--------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh-ccCC
Confidence 998754322 23457899999999987 7799999999999999999997766655444433332221 1111
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 010088 393 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM 445 (518)
Q Consensus 393 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~ 445 (518)
+.. .. ...+.+++..||+.||++|||+.+++++|.....+.
T Consensus 237 ~~~--------~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 237 LPA--------PK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp CCC--------CS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred CCC--------CC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 111 11 124778999999999999999999999998876544
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=356.81 Aligned_cols=257 Identities=30% Similarity=0.469 Sum_probs=206.7
Q ss_pred hhhhhhcceecceEEEEEEec------CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
+.+.+.||+|+||+||+|+.. ++..||||.++.. .......|.+|+.++.+++||||++++++|.+.+..++|
T Consensus 49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 128 (343)
T 1luf_A 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 128 (343)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence 344578999999999999875 3488999998754 334456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcE
Q 010088 243 YEYMANGSLKDHLHSPG----------------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 300 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NI 300 (518)
|||+++|+|.+++.... ...+++.+++.++.||+.||+||| +.+|+||||||+||
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NI 205 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNC 205 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceE
Confidence 99999999999997532 156999999999999999999999 88999999999999
Q ss_pred EecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcch
Q 010088 301 LLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNL 379 (518)
Q Consensus 301 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~ 379 (518)
|++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~- 282 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH- 282 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-
T ss_pred EECCCCeEEEeecCCCcccccCcc--ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh-
Confidence 999999999999999975433221 112234568899999999999999999999999999999999 9889865432
Q ss_pred HHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 380 VESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 380 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
.+........ .. +.....+ ...+.+++..||+.||++||++.+++++|....+
T Consensus 283 ~~~~~~~~~~--~~-----~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 283 EEVIYYVRDG--NI-----LACPENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp HHHHHHHHTT--CC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHHHHhCC--Cc-----CCCCCCC----CHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 2222221111 11 1112222 2468899999999999999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=348.39 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=197.0
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccc--------------------------hhHHHHHHHHHHHHHcC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE--------------------------QVEGDFCREIELLARLH 222 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~ 222 (518)
+.+.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++|++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 345678999999999999875 688999999864321 12356899999999999
Q ss_pred CCCeeeEeeeeee--cCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcE
Q 010088 223 HRHLVALRGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 300 (518)
Q Consensus 223 H~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NI 300 (518)
||||+++++++.+ .+..++||||+++|+|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNL 168 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGE
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHE
Confidence 9999999999987 5678999999999999887643 35999999999999999999999 88999999999999
Q ss_pred EecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCC---CCccccchhhHHHHHHHHhCCccccCCc
Q 010088 301 LLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE---LTEKSDVYSYGVVLLEIVTARRAVQDGK 377 (518)
Q Consensus 301 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwS~Gvll~el~tG~~p~~~~~ 377 (518)
|++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDA----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSC----EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EECCCCCEEEecCCCccccccccc----cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999986654321 224457999999999997655 4788999999999999999999997543
Q ss_pred chHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 378 NLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 378 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
. .............. + .....+ ..+.+++.+||+.||++||++.|+++|.|.
T Consensus 245 ~-~~~~~~~~~~~~~~-----~-~~~~~~----~~l~~li~~~l~~dp~~R~s~~e~l~hp~~ 296 (298)
T 2zv2_A 245 I-MCLHSKIKSQALEF-----P-DQPDIA----EDLKDLITRMLDKNPESRIVVPEIKLHPWV 296 (298)
T ss_dssp H-HHHHHHHHHCCCCC-----C-SSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred H-HHHHHHHhcccCCC-----C-CccccC----HHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence 3 22222221111111 1 111222 458899999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=358.03 Aligned_cols=260 Identities=25% Similarity=0.365 Sum_probs=206.3
Q ss_pred HhhhhhhhcceecceEEEEEEe------cCCcEEEEEEeccc-cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCce
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRER 239 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 239 (518)
..+.+.+.||+|+||+||+|+. .++..||||.+... .....+.+.+|+.+|.++ +||||+++++++...+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 3445567899999999999986 24568999998743 233456799999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCC
Q 010088 240 FLMYEYMANGSLKDHLHSPGR---------------------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSS 298 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~ 298 (518)
++||||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChh
Confidence 999999999999999976432 24899999999999999999999 889999999999
Q ss_pred cEEecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCc
Q 010088 299 NILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGK 377 (518)
Q Consensus 299 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~ 377 (518)
|||++.++.+||+|||++......... .......||+.|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hEEEcCCCcEEeCCCccCcccccCccc--eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999865433211 12334567889999999999999999999999999999998 999997544
Q ss_pred chHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 378 NLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 378 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
.......... .. ..+...... ...+.+++..||+.||.+||++.+++++|.....
T Consensus 280 ~~~~~~~~~~-~~------~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 280 VDANFYKLIQ-NG------FKMDQPFYA----TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CSHHHHHHHH-TT------CCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cHHHHHHHHh-cC------CCCCCCCCC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 3322222211 11 111111222 3568899999999999999999999999977544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=361.70 Aligned_cols=250 Identities=23% Similarity=0.359 Sum_probs=206.4
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.+.++||+|+||+||+|+.. +|+.||||+++... ......+..|..+|..+ +||||+++++++.+.+..++|||
T Consensus 19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E 98 (345)
T 1xjd_A 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 98 (345)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 345678999999999999986 58999999986532 23345688899999987 89999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 172 (345)
T 1xjd_A 99 YLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 172 (345)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-
Confidence 999999999997533 4899999999999999999999 8899999999999999999999999999998643322
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+....+.... +.+...
T Consensus 173 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~--------~~~p~~ 240 (345)
T 1xjd_A 173 ---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIRMDN--------PFYPRW 240 (345)
T ss_dssp ---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCC--------CCCCTT
T ss_pred ---CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHhCC--------CCCCcc
Confidence 123456799999999999999999999999999999999999999975433 33333322221 112222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHHhhcC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIK-QVLRILYES 441 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~-evl~~L~~~ 441 (518)
.+ ..+.+++.+||+.||++||++. ++++|.++.
T Consensus 241 ~s----~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~ 274 (345)
T 1xjd_A 241 LE----KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274 (345)
T ss_dssp SC----HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred cC----HHHHHHHHHHhcCCHhHcCCChHHHHcCcccc
Confidence 22 4588999999999999999998 888887764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=348.19 Aligned_cols=266 Identities=24% Similarity=0.278 Sum_probs=204.2
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEecccc-----chhHHHHHHHHHHHHHcC---CCCeeeEeeeeeecC--
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-----EQVEGDFCREIELLARLH---HRHLVALRGFCIEKR-- 237 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~-- 237 (518)
.+.+.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+.++++++ ||||++++++|....
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~ 89 (308)
T 3g33_A 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD 89 (308)
T ss_dssp CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence 3455678999999999999864 68999999986322 122346778888887775 999999999998765
Q ss_pred ---ceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecc
Q 010088 238 ---ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG 314 (518)
Q Consensus 238 ---~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfG 314 (518)
..++||||+. |+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 90 REIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp SEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 4799999997 69999998766666999999999999999999999 8899999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc--
Q 010088 315 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR-- 392 (518)
Q Consensus 315 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~-- 392 (518)
+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...................
T Consensus 166 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 166 LARIYSYQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp CTTTSTTCC-----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccCCCc-----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 998654332 2345678999999999999999999999999999999999999997654433332221111100
Q ss_pred --ccccc---CCcCC--CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 393 --LAELV---DPRIK--DSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 393 --l~~~~---d~~l~--~~~~-----~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
+.... ...+. .... .+....+.+++..||+.||++|||+.|+++|.|....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 00000 00000 0000 0122568899999999999999999999999877543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=355.81 Aligned_cols=255 Identities=24% Similarity=0.334 Sum_probs=199.2
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCc---------
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE--------- 238 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--------- 238 (518)
+.+.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+++|++++||||++++++|.+...
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~ 87 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE 87 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence 344578999999999999986 7899999998643 33455789999999999999999999999866542
Q ss_pred ------------------------------------------------eEEEEEecCCCCHHHHhcCCCC-CCCCHHHHH
Q 010088 239 ------------------------------------------------RFLMYEYMANGSLKDHLHSPGR-TPLSWQTRI 269 (518)
Q Consensus 239 ------------------------------------------------~~lV~e~~~~gsL~~~l~~~~~-~~l~~~~~~ 269 (518)
.++||||+++|+|.+++..... ...++..++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 167 (332)
T 3qd2_B 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL 167 (332)
T ss_dssp --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHH
T ss_pred hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHH
Confidence 7999999999999999986442 346777899
Q ss_pred HHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc--------ccccccccCCCcccC
Q 010088 270 QIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF--------EPVNTDIRGTPGYMD 341 (518)
Q Consensus 270 ~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~--------~~~~~~~~gt~~y~a 341 (518)
.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......... ........||+.|+|
T Consensus 168 ~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 168 HIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 99999999999999 8899999999999999999999999999998765432110 012244579999999
Q ss_pred ccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHcc
Q 010088 342 PEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCT 421 (518)
Q Consensus 342 PE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl 421 (518)
||.+.+..++.++||||||+++|||++|..|+.... ....... ....+ .........+.+++..||
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~---~~~~~~~--~~~~~---------~~~~~~~~~~~~li~~~l 310 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---RIITDVR--NLKFP---------LLFTQKYPQEHMMVQDML 310 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH---HHHHHHH--TTCCC---------HHHHHHCHHHHHHHHHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH---HHHHHhh--ccCCC---------cccccCChhHHHHHHHHc
Confidence 999999999999999999999999999876653211 1111100 00000 011233356789999999
Q ss_pred ccCCCCCCCHHHHHHHhhcC
Q 010088 422 QREGQARPSIKQVLRILYES 441 (518)
Q Consensus 422 ~~dp~~RPs~~evl~~L~~~ 441 (518)
+.||++||++.|++++.+..
T Consensus 311 ~~~p~~Rps~~~~l~~~~f~ 330 (332)
T 3qd2_B 311 SPSPTERPEATDIIENAIFE 330 (332)
T ss_dssp CSSGGGSCCHHHHHHSTTCC
T ss_pred cCCCCcCCCHHHHhhchhhh
Confidence 99999999999999987753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=352.93 Aligned_cols=266 Identities=20% Similarity=0.272 Sum_probs=209.4
Q ss_pred cCHHHHHHHhhhhh-hhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcC-CCCeeeEeeeee
Q 010088 160 FSYKETKKATDNFS-TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLH-HRHLVALRGFCI 234 (518)
Q Consensus 160 ~~~~~l~~a~~~f~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~ 234 (518)
|...+.....+.+. +.||+|+||+||+|+.. +|+.||||++.... ......+.+|+.++.++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33334444444444 68999999999999876 58999999986532 334567999999999994 699999999999
Q ss_pred ecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC---CCcEEEe
Q 010088 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLA 311 (518)
Q Consensus 235 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~ 311 (518)
+.+..++||||+++|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEe
Confidence 9999999999999999999997665567999999999999999999999 889999999999999997 7899999
Q ss_pred eccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc
Q 010088 312 DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 391 (518)
Q Consensus 312 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (518)
|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||............ .....
T Consensus 177 Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-~~~~~ 250 (327)
T 3lm5_A 177 DFGMSRKIGHAC-----ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI-SQVNV 250 (327)
T ss_dssp CGGGCEEC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHTCC
T ss_pred eCccccccCCcc-----ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH-Hhccc
Confidence 999998664432 123457999999999999999999999999999999999999999755433222221 11111
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 392 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 392 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
... ...... ....+.+++..||+.||.+||++++++++.|...
T Consensus 251 ~~~----~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~ 293 (327)
T 3lm5_A 251 DYS----EETFSS----VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293 (327)
T ss_dssp CCC----TTTTTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred ccC----chhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence 111 111112 2355889999999999999999999999988754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=366.49 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=205.4
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.++||+|+||+||+|+.. +|+.||+|++++.. ......+.+|+.++..++||||+++++++.+.+..++||||++
T Consensus 73 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 152 (410)
T 3v8s_A 73 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 152 (410)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 3468999999999999886 58899999986421 2223458899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+|+|.++++.. .+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++........
T Consensus 153 gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~-- 224 (410)
T 3v8s_A 153 GGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-- 224 (410)
T ss_dssp TEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE--
T ss_pred CCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc--
Confidence 99999999753 4899999999999999999999 889999999999999999999999999999866543321
Q ss_pred cccccccCCCcccCccccccCC----CCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQE----LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......+......+. -|. ..
T Consensus 225 -~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~~~~---~p~-~~ 298 (410)
T 3v8s_A 225 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMNHKNSLT---FPD-DN 298 (410)
T ss_dssp -ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHTHHHHCC---CCT-TC
T ss_pred -cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-hhHHHHHHhcccccc---CCC-cc
Confidence 234567999999999997665 88999999999999999999999975433 333333222111110 011 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHhhcCC
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQA--RPSIKQVLRILYESS 442 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~--RPs~~evl~~L~~~~ 442 (518)
.++ ..+.+++..||+.+|.+ ||+++||++|.|+..
T Consensus 299 ~~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 299 DIS----KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp CCC----HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred ccc----HHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 222 45889999999999988 999999999998864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=357.57 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=195.6
Q ss_pred hhhhhhcceecceEEEEEEec-CCc----EEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGS----LIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
+.+.++||+|+||+||+|++. +|. .||+|.+... .......|.+|+.++++++||||++++++|.+. ..++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~ 95 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 95 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEE
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEE
Confidence 345578999999999999864 344 3688877542 334557899999999999999999999999875 478999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+.+|+|.+++.... ..+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 96 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 96 QLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp ECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 9999999999997643 35999999999999999999999 8899999999999999999999999999998654432
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
.. .......+|..|+|||.+.+..++.++|||||||++|||+| |+.||...... ....... .... .
T Consensus 172 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~-~~~~------~--- 238 (327)
T 3poz_A 172 KE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILE-KGER------L--- 238 (327)
T ss_dssp C---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHH-TTCC------C---
T ss_pred cc--ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-HHHHHHH-cCCC------C---
Confidence 21 12234457889999999999999999999999999999999 99998643322 1111111 1111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..+......+.+++.+||+.||.+||++.+++++|...
T Consensus 239 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 239 -PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred -CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11112235688999999999999999999999998654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=367.41 Aligned_cols=255 Identities=21% Similarity=0.303 Sum_probs=205.7
Q ss_pred hhhcceecceEEEEEEecC-CcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 173 STIIGQGGFGTVYKAQFSD-GSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.++||+|+||+||+|++.+ |+.||+|++++.. ......+.+|+.++..++||||++++++|.+.+..++||||+++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 4789999999999999864 7899999986422 22234488999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||||+.++.+||+|||+++....... .
T Consensus 159 g~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~---~ 231 (437)
T 4aw2_A 159 GDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT---V 231 (437)
T ss_dssp CBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC---E
T ss_pred CcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC---c
Confidence 99999998642 35999999999999999999999 89999999999999999999999999999976544331 1
Q ss_pred ccccccCCCcccCccccc-----cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 329 VNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
......||+.|+|||++. ...++.++|||||||++|||++|+.||...... +....+...... ..-|....
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~---~~~p~~~~ 307 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHKER---FQFPTQVT 307 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHHH---CCCCSSCC
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-HHHHhhhhcccc---ccCCcccc
Confidence 234467999999999987 567899999999999999999999999754433 333332221111 11111112
Q ss_pred CCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHhhcCC
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQA--RPSIKQVLRILYESS 442 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~--RPs~~evl~~L~~~~ 442 (518)
..+ ..+.+++.+||..+|++ ||+++|+++|.|+..
T Consensus 308 ~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 308 DVS----ENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp CSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred cCC----HHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 233 45788999999888888 999999999998753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=351.70 Aligned_cols=259 Identities=23% Similarity=0.310 Sum_probs=194.7
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.||+|+||+||+|... +|+.||||+++... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~- 86 (317)
T 2pmi_A 8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD- 86 (317)
T ss_dssp -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-
T ss_pred eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-
Confidence 34568999999999999875 58999999986433 2334678899999999999999999999999999999999998
Q ss_pred CCHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 249 GSLKDHLHSP----GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 249 gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 163 (317)
T 2pmi_A 87 NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163 (317)
T ss_dssp CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence 5999988642 1245899999999999999999999 88999999999999999999999999999986543221
Q ss_pred ccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc----ccc-----
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----RLA----- 394 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~----~l~----- 394 (518)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.................. ...
T Consensus 164 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 164 ----TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp ----CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred ----cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 2234578999999999876 46899999999999999999999999755443222221111000 000
Q ss_pred ----------------cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 395 ----------------ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 395 ----------------~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+...+...... ...+.+++.+||+.||++|||++|++++.|..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 298 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPL----DGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCC----CHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred hhcccccccccchhHHHhhcccccccC----CHHHHHHHHHHCCCCcccCCCHHHHhCChhhh
Confidence 00011111112 24688999999999999999999999988764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=362.48 Aligned_cols=248 Identities=21% Similarity=0.326 Sum_probs=192.4
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeee----cCceEEEEEecC
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIE----KRERFLMYEYMA 247 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~lV~e~~~ 247 (518)
++||+|+||+||+|... +|+.||||+++.. ..+.+|++++.++ +||||+++++++.. ....++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 57999999999999876 5899999998632 4567899988555 89999999999875 567899999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC---CCcEEEeeccccccCCCCCc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DfGla~~~~~~~~ 324 (518)
+|+|.+++...+...+++..+..|+.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+++......
T Consensus 143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~- 218 (400)
T 1nxk_A 143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN- 218 (400)
T ss_dssp SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCC-
Confidence 999999998766567999999999999999999999 889999999999999997 7899999999998654322
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchH---HHHHHHHhhccccccccCCcC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV---ESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~---~~~~~~~~~~~~l~~~~d~~l 401 (518)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............+. .+.
T Consensus 219 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~---~~~- 290 (400)
T 1nxk_A 219 ----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP---NPE- 290 (400)
T ss_dssp ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC---TTT-
T ss_pred ----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC---Ccc-
Confidence 2245678999999999999999999999999999999999999996433211 01111111111111 010
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
...+ ...+.+++..||+.||++|||+.|+++|.|...
T Consensus 291 ~~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 291 WSEV----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp TTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cccC----CHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 1122 245889999999999999999999999988754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=356.82 Aligned_cols=250 Identities=21% Similarity=0.331 Sum_probs=204.0
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEe
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
.+.+.||+|+||+||+|+.. +|+.||+|+++.. .......+.+|+.++.++ +||||+++++++.+.+..++||||
T Consensus 12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~ 91 (345)
T 3a8x_A 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 91 (345)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence 45578999999999999886 5889999998753 233445688999999998 899999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-- 164 (345)
T 3a8x_A 92 VNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-- 164 (345)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC--
Confidence 99999999997533 4999999999999999999999 8899999999999999999999999999998543221
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCc--------chHHHHHHHHhhcccccccc
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK--------NLVESAQVCMASESRLAELV 397 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~--------~~~~~~~~~~~~~~~l~~~~ 397 (518)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ......+......
T Consensus 165 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------- 235 (345)
T 3a8x_A 165 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------- 235 (345)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-------
T ss_pred --CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-------
Confidence 12345679999999999999999999999999999999999999996321 1111112211111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHhhcC
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSI------KQVLRILYES 441 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~------~evl~~L~~~ 441 (518)
..+....+ ..+.+++..||+.||.+||++ .++++|.++.
T Consensus 236 -~~~p~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~ 280 (345)
T 3a8x_A 236 -IRIPRSLS----VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280 (345)
T ss_dssp -CCCCTTSC----HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred -CCCCCCCC----HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence 11222223 458899999999999999994 8999988774
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=343.02 Aligned_cols=247 Identities=31% Similarity=0.511 Sum_probs=192.2
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEecccc----chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.+.||+|+||+||+|.+ .|..||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF 87 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred eeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence 34557899999999999997 48999999986432 22346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC---ceecccCCCcEEecC--------CCcEEEeecc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP---LCHRDIKSSNILLDE--------NFVAKLADFG 314 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~---iiHrDlk~~NILl~~--------~~~~kl~DfG 314 (518)
+++++|.+++.. ..+++..+..++.|++.||+||| +.+ |+||||||+|||++. ++.+||+|||
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 88 ARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp CTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred CCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999964 35999999999999999999999 666 999999999999986 7789999999
Q ss_pred ccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccc
Q 010088 315 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 394 (518)
Q Consensus 315 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~ 394 (518)
+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.............. ..
T Consensus 162 ~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~---- 230 (271)
T 3dtc_A 162 LAREWHRTT------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM-NK---- 230 (271)
T ss_dssp C-------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT-SC----
T ss_pred ccccccccc------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc-CC----
Confidence 997654322 2345689999999999999999999999999999999999999976543322222111 11
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 395 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 395 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
......... ...+.+++.+||+.||++||++.|++++|..
T Consensus 231 --~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 --LALPIPSTC----PEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp --CCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred --CCCCCCccc----CHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 111112222 3568899999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=358.76 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=205.4
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.++||+|+||+||+++.. +|+.||+|.+... .......+.+|+++|.+++||||+++++++.+.+..++||||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 96 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL 96 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 345578999999999999876 5889999998642 223446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+.+|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++......
T Consensus 97 ~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-- 169 (384)
T 4fr4_A 97 LLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-- 169 (384)
T ss_dssp CTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC--
Confidence 99999999998643 5999999999999999999999 8899999999999999999999999999998764432
Q ss_pred cccccccccCCCcccCcccccc---CCCCccccchhhHHHHHHHHhCCccccCC--cchHHHHHHHHhhccccccccCCc
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDG--KNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~Gvll~el~tG~~p~~~~--~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||... .............. ..
T Consensus 170 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------~~ 238 (384)
T 4fr4_A 170 ---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--------VT 238 (384)
T ss_dssp ---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--------CC
T ss_pred ---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--------cC
Confidence 2355679999999999864 45899999999999999999999999642 22222222221111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHhhcC
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPS-IKQVLRILYES 441 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-~~evl~~L~~~ 441 (518)
....++ ..+.+++..||+.||.+||+ ++++++|.++.
T Consensus 239 ~p~~~s----~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~ 276 (384)
T 4fr4_A 239 YPSAWS----QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276 (384)
T ss_dssp CCTTSC----HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGT
T ss_pred CCCcCC----HHHHHHHHHHhcCCHhHhcccHHHHHcChhhh
Confidence 112222 46889999999999999998 89999887764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=348.14 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=208.6
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEeccccc------hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE------QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 241 (518)
.+.+.+.||+|+||+||+|+.. +|..||||.+..... ...+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3556789999999999999876 589999999864322 135679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC----cEEEeeccccc
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF----VAKLADFGLAH 317 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DfGla~ 317 (518)
||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||++.
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 93 ILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999864 35899999999999999999999 88999999999999999888 79999999998
Q ss_pred cCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccccc
Q 010088 318 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 397 (518)
Q Consensus 318 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 397 (518)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... +............
T Consensus 168 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~---- 237 (321)
T 2a2a_A 168 EIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANITSVSYDF---- 237 (321)
T ss_dssp ECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHTTCCCC----
T ss_pred ecCccc-----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhccccc----
Confidence 665432 224456999999999999999999999999999999999999999754332 2222222111111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
++...... ...+.+++..||+.||++||++.|+++|.+...
T Consensus 238 ~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 238 DEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp CHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred Chhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 11111112 245889999999999999999999999988753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=349.92 Aligned_cols=257 Identities=24% Similarity=0.371 Sum_probs=207.7
Q ss_pred hhhhhhhcceecceEEEEEEe------cCCcEEEEEEecccc-chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERF 240 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 240 (518)
.+.+.+.||+|+||+||+|++ .++..||||.+.... ....+.+.+|+.++.++ +||||+++++++.+.+..+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 103 (313)
T 1t46_A 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (313)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence 345567899999999999985 246899999987543 23457799999999999 9999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC
Q 010088 241 LMYEYMANGSLKDHLHSPGR----------------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE 304 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~ 304 (518)
+||||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTH 180 (313)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEET
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEcC
Confidence 99999999999999975432 25899999999999999999999 889999999999999999
Q ss_pred CCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHH
Q 010088 305 NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESA 383 (518)
Q Consensus 305 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~ 383 (518)
++.+||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||+| |+.||..........
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred CCCEEEccccccccccccccc--eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 999999999999866543311 12234557889999999999999999999999999999999 898886544332222
Q ss_pred HHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 384 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 384 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..... . ..+...... ...+.+++.+||+.||.+||++.|++++|...
T Consensus 259 ~~~~~-~------~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 259 KMIKE-G------FRMLSPEHA----PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp HHHHH-T------CCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcc-C------CCCCCcccC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 22111 1 111111222 25688999999999999999999999998653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=340.41 Aligned_cols=251 Identities=22% Similarity=0.268 Sum_probs=205.2
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||+||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (277)
T 3f3z_A 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90 (277)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCC
Confidence 445678999999999999876 4679999998765555567899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe---cCCCcEEEeeccccccCCCCCcc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||++.......
T Consensus 91 ~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-- 163 (277)
T 3f3z_A 91 GELFERVVHK--RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-- 163 (277)
T ss_dssp CBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--
Confidence 9999998753 34899999999999999999999 8899999999999999 788999999999998655433
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
......||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... ................ ...
T Consensus 164 ---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~----~~~- 233 (277)
T 3f3z_A 164 ---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIREGTFTFPEKD----WLN- 233 (277)
T ss_dssp ---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCCHHH----HTT-
T ss_pred ---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCCCchh----hhc-
Confidence 2244569999999998865 48999999999999999999999997544332 2222221111111100 001
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
....+.+++..||+.||++||++.+++++.+.
T Consensus 234 ---~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~ 265 (277)
T 3f3z_A 234 ---VSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265 (277)
T ss_dssp ---SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred ---CCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 12568899999999999999999999998765
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=357.87 Aligned_cols=246 Identities=22% Similarity=0.342 Sum_probs=206.7
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+++|.+++||||+++++++.+.+..++||||+
T Consensus 44 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 123 (350)
T 1rdq_E 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123 (350)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 34568999999999999876 68999999986432 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---- 194 (350)
T 1rdq_E 124 AGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp TTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC----
Confidence 9999999997643 4899999999999999999999 899999999999999999999999999999865432
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+....+...... +...++
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~~--------~p~~~~ 262 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIYEKIVSGKVR--------FPSHFS 262 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCC--------CCTTCC
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-HHHHHHHHcCCCC--------CCCCCC
Confidence 2345799999999999999999999999999999999999999975433 2333332222111 122233
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhcC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYES 441 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~~L~~~ 441 (518)
..+.+++..||+.||.+||+ ++++++|.++.
T Consensus 263 ----~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~ 298 (350)
T 1rdq_E 263 ----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp ----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred ----HHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence 45889999999999999998 99999998775
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=355.09 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=205.4
Q ss_pred hhhhhhcceecceEEEEEEe-cCCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+...+.||+|+||+||+|+. .+|+.||||++.... ......+.+|+++|++++||||+++++++.+.+..++||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 34456899999999999986 478999999986432 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+. |+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 136 CL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp CS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 97 6888888543 245999999999999999999999 889999999999999999999999999999765332
Q ss_pred cccccccccCCCcccCccccc---cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC-
Q 010088 326 FEPVNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI- 401 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l- 401 (518)
....||+.|+|||.+. ...++.++|||||||++|||++|+.||............ .... .+.+
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~-~~~~-------~~~~~ 274 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-AQNE-------SPALQ 274 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHSC-------CCCCC
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HhcC-------CCCCC
Confidence 3456999999999984 567899999999999999999999999765443332222 1111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCCc
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHS 447 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~ 447 (518)
...++ ..+.+++..||+.||++||++++++++.+........
T Consensus 275 ~~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~ 316 (348)
T 1u5q_A 275 SGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 316 (348)
T ss_dssp CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred CCCCC----HHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCcc
Confidence 11222 4588999999999999999999999999876654443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=354.09 Aligned_cols=261 Identities=24% Similarity=0.270 Sum_probs=200.8
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEeccc-----cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-----SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
.+.+.+.||+|+||+||+|+.. ++..||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 106 (345)
T 3hko_A 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV 106 (345)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence 4556789999999999999875 6889999998642 334557899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhh
Q 010088 243 YEYMANGSLKDHLHSPG--------------------------------------RTPLSWQTRIQIAIDVANALEYLHF 284 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~ 284 (518)
|||+++|+|.+++.... ...+++..+..++.|++.||+|||
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH- 185 (345)
T 3hko_A 107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH- 185 (345)
T ss_dssp EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH-
Confidence 99999999999995210 112356778899999999999999
Q ss_pred cCCCCceecccCCCcEEecCCC--cEEEeeccccccCCCCCcccccccccccCCCcccCcccccc--CCCCccccchhhH
Q 010088 285 YCDPPLCHRDIKSSNILLDENF--VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYG 360 (518)
Q Consensus 285 ~~~~~iiHrDlk~~NILl~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~G 360 (518)
+.+|+||||||+|||++.++ .+||+|||+++.................||+.|+|||.+.+ ..++.++||||||
T Consensus 186 --~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 186 --NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp --HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred --HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 88999999999999998776 89999999998543221111112345679999999999865 6789999999999
Q ss_pred HHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 361 VVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 361 vll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
+++|||++|+.||......... .........+. .+.. .. ....+.+++..||+.||.+||++.+++++.|.
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~---~~~~-~~----~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~ 334 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTI-SQVLNKKLCFE---NPNY-NV----LSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHH-HHHHHCCCCTT---SGGG-GG----SCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred HHHHHHHHCCCCCCCCChHHHH-HHHHhcccccC---Cccc-cc----CCHHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence 9999999999999755443222 22222211111 1110 11 12468899999999999999999999998876
Q ss_pred C
Q 010088 441 S 441 (518)
Q Consensus 441 ~ 441 (518)
.
T Consensus 335 ~ 335 (345)
T 3hko_A 335 S 335 (345)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=352.83 Aligned_cols=255 Identities=25% Similarity=0.372 Sum_probs=205.7
Q ss_pred hhhhhhcceecceEEEEEEe------cCCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
+.+.+.||+|+||+||+|.. .++..||||.+... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence 34557899999999999976 24588999998753 334457799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcE
Q 010088 243 YEYMANGSLKDHLHSPGR----------------------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 300 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NI 300 (518)
|||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+||
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp~NI 181 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNI 181 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccchheE
Confidence 999999999999975432 34899999999999999999999 88999999999999
Q ss_pred EecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcch
Q 010088 301 LLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNL 379 (518)
Q Consensus 301 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~ 379 (518)
|+++++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSY--VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCE--ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred EEcCCCCEEEccccccccccccccc--eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999866443221 12234457889999999999999999999999999999999 99998654322
Q ss_pred HHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 380 VESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 380 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
....... ... .+...... ...+.+++..||+.||++||++.+++++|...
T Consensus 260 -~~~~~~~-~~~------~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 260 -RLFNLLK-TGH------RMERPDNC----SEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp -GHHHHHH-TTC------CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHhh-cCC------cCCCCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111 110 11112222 35688999999999999999999999998653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=353.51 Aligned_cols=258 Identities=23% Similarity=0.314 Sum_probs=204.5
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcC-----CCCeeeEeeeeeecCceEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-----HRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~lV~ 243 (518)
+.+.++||+|+||+||+|+.. +|+.||||+++.. ......+..|++++.++. |+||+++++++...+..++||
T Consensus 37 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~ 115 (360)
T 3llt_A 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIF 115 (360)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEE
Confidence 445578999999999999874 6899999998643 334466788999999997 999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-------------------
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE------------------- 304 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~------------------- 304 (518)
||+ +++|.+++.......+++..+..++.||+.||+||| +.+|+||||||+|||+++
T Consensus 116 e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 116 EPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp CCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred cCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 999 999999998766566999999999999999999999 899999999999999975
Q ss_pred ------CCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcc
Q 010088 305 ------NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 378 (518)
Q Consensus 305 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~ 378 (518)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDY-------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSC-------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccCCCCEEEEeccCceecCCC-------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence 789999999999864432 2345789999999999999999999999999999999999999975443
Q ss_pred hHHHHHHHHhhccccc-------------cccC-CcC----CCCC-CHH---------------HHHHHHHHHHHccccC
Q 010088 379 LVESAQVCMASESRLA-------------ELVD-PRI----KDSF-DME---------------QLRTIVTIVRWCTQRE 424 (518)
Q Consensus 379 ~~~~~~~~~~~~~~l~-------------~~~d-~~l----~~~~-~~~---------------~~~~l~~li~~Cl~~d 424 (518)
........ .....++ ..++ ..+ .... ... ....+.+++..||+.|
T Consensus 265 ~~~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 265 MEHLAMME-SIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHH-HHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHH-HhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 32222211 1100000 0000 000 0000 000 0146789999999999
Q ss_pred CCCCCCHHHHHHHhhc
Q 010088 425 GQARPSIKQVLRILYE 440 (518)
Q Consensus 425 p~~RPs~~evl~~L~~ 440 (518)
|++|||++|+++|.|.
T Consensus 344 P~~Rpta~elL~hp~f 359 (360)
T 3llt_A 344 PTLRPSPAELLKHKFL 359 (360)
T ss_dssp GGGSCCHHHHTTSGGG
T ss_pred hhhCCCHHHHhcCccc
Confidence 9999999999998765
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=357.31 Aligned_cols=246 Identities=24% Similarity=0.369 Sum_probs=202.3
Q ss_pred hhhhhcceecceEEEEEEe-cCCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||+||+|+. .+|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 12 ~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 91 (336)
T 3h4j_B 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA 91 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC
Confidence 4557899999999999987 468999999986421 223357899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
+|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++.....+.
T Consensus 92 -~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--- 162 (336)
T 3h4j_B 92 -GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--- 162 (336)
T ss_dssp -CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---
T ss_pred -CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc---
Confidence 789999987543 4999999999999999999999 8899999999999999999999999999998765443
Q ss_pred ccccccccCCCcccCccccccCCC-CccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccC--CcCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD--PRIKD 403 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d--~~l~~ 403 (518)
......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.+.... .....+.. ..+..
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----------~~~~~i~~~~~~~p~ 229 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-----------NLFKKVNSCVYVMPD 229 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-----------TCBCCCCSSCCCCCT
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-----------HHHHHHHcCCCCCcc
Confidence 2344579999999999988776 78999999999999999999999753211 00011111 11112
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.. ...+.+++.+||+.||.+|||++|++++.|...
T Consensus 230 ~~----s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 230 FL----SPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred cC----CHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 22 345889999999999999999999999988754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=372.67 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=198.3
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.++||+|+||+||+|+.. +|+.||||++... .......+.+|+.+|++++||||++++++|.+.+..++||||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence 344578999999999999875 6899999998642 233445688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
+++|+|.+++... ..+++..+..++.||+.||+||| + .+|+||||||+||||+.++.+||+|||+++......
T Consensus 230 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 303 (446)
T 4ejn_A 230 ANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG- 303 (446)
T ss_dssp CSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-
Confidence 9999999999753 35999999999999999999999 6 899999999999999999999999999998643322
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.......||+.|+|||++.+..++.++|||||||+||||++|+.||..... ............. +...
T Consensus 304 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~~--------~p~~ 371 (446)
T 4ejn_A 304 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEIR--------FPRT 371 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCC--------CCTT
T ss_pred ---cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-HHHHHHHHhCCCC--------CCcc
Confidence 123456799999999999999999999999999999999999999975443 2333322222211 1122
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcCC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS 442 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~~ 442 (518)
.+ ..+.+++..||+.||.+|| +++|+++|.++..
T Consensus 372 ~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 372 LG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp SC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 22 4588999999999999999 9999999988753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=361.92 Aligned_cols=255 Identities=22% Similarity=0.344 Sum_probs=201.6
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccc--cchhHHHHHHHHHHHHHcC--CCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLH--HRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.+.||+|+||+||+|...+|..||||++... .......+.+|+.+|.+++ |+||+++++++...+..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 4456789999999999999888999999998643 3445578999999999996 5999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+.+++|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++ ++.+||+|||+++........
T Consensus 137 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 137 CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 56889999998643 5899999999999999999999 89999999999999995 579999999999866443211
Q ss_pred cccccccccCCCcccCcccccc-----------CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccc
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVT-----------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 394 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~ 394 (518)
.......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....+.............
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~--- 285 (390)
T 2zmd_A 211 --VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH--- 285 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS---
T ss_pred --ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc---
Confidence 12345679999999999865 46899999999999999999999999765443333222221111
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 395 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 395 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
........ ...+.+++..||+.||.+||++.|++++.|....
T Consensus 286 ---~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 286 ---EIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp ---CCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ---cCCCCccc----hHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 01111111 2468899999999999999999999999887544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=367.72 Aligned_cols=258 Identities=19% Similarity=0.261 Sum_probs=197.8
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec------CceEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERFL 241 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 241 (518)
.+.+.||+|+||+||+|... +|+.||||++... .......+.+|+.+|+.++||||+++++++... ...++
T Consensus 65 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 144 (464)
T 3ttj_A 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144 (464)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred EEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEE
Confidence 34568999999999999865 5899999998653 334456789999999999999999999998655 35699
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||+++ +|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+||||+.++.+||+|||+++....
T Consensus 145 v~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 145 VMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred EEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 9999976 57777753 3899999999999999999999 88999999999999999999999999999986544
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccc-----
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL----- 396 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~----- 396 (518)
.. ..+...||+.|+|||++.+..++.++|||||||+||||++|+.||........+............+.
T Consensus 217 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 217 SF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp CC-----CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred Cc-----ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 32 23456799999999999999999999999999999999999999976554433333221111110000
Q ss_pred ---------------------cCCcCCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 397 ---------------------VDPRIKDSF---DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 397 ---------------------~d~~l~~~~---~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+...+.... .......+.+++.+||+.||++|||++|+++|.|..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~ 360 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence 000000000 011246789999999999999999999999998875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=346.49 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=199.9
Q ss_pred hhhhhcceecceEEEEEEecC----CcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeee-cCceEEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIE-KRERFLMYE 244 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e 244 (518)
.+.++||+|+||+||+|++.+ +..+|+|.+.... ......+.+|+.++++++||||++++++|.+ .+..++|||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 107 (298)
T 3f66_A 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 107 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence 345789999999999998643 2368999987533 3445679999999999999999999998654 457899999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 108 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 108 YMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp CCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred CCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 999999999997643 45899999999999999999999 88999999999999999999999999999986654332
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
..........+|+.|+|||.+.+..++.++||||||+++|||++|+.|+....+..+.......... ......
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 256 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-------LLQPEY 256 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC-------CCCCTT
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC-------CCCCcc
Confidence 2222334556788999999999999999999999999999999965554433333222222221111 111112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+ ..+.+++..||+.||++||+++++++.|...
T Consensus 257 ~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 257 CP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp CC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22 4688999999999999999999999998654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=345.77 Aligned_cols=254 Identities=26% Similarity=0.417 Sum_probs=203.6
Q ss_pred hhhcceecceEEEEEEecC----CcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCce-EEEEEec
Q 010088 173 STIIGQGGFGTVYKAQFSD----GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRER-FLMYEYM 246 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV~e~~ 246 (518)
.++||+|+||+||+|++.+ +..||+|.+.... ....+.|.+|+.++++++||||+++++++.+.+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 4689999999999998643 2379999987543 34457899999999999999999999999877655 9999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
.+|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.........
T Consensus 106 ~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 106 CHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred cCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 9999999998643 45899999999999999999999 8899999999999999999999999999998654433222
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
........+|+.|+|||.+.+..++.++||||||+++|||++|+.|+....+............ ........
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~- 253 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-------RLPQPEYC- 253 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-------CCCCCTTC-
T ss_pred cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-------CCCCCccc-
Confidence 2233455688999999999999999999999999999999997777654444333322221111 01111122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
...+.+++..||+.||.+|||++++++.|...
T Consensus 254 ---~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 254 ---PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---hHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 24688999999999999999999999998654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=339.45 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=206.3
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.+.||+|+||+||+|...++..||+|.+..... ..+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG 88 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence 345678999999999999998889999999975433 3467999999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 89 ~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~---~~ 161 (267)
T 3t9t_A 89 CLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TS 161 (267)
T ss_dssp BHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH---HS
T ss_pred cHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccc---cc
Confidence 9999997543 35899999999999999999999 88999999999999999999999999999986543221 12
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+......... ........
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~i~~~~-------~~~~~~~~--- 230 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGF-------RLYKPRLA--- 230 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTC-------CCCCCTTS---
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-HHHHHHHhcCC-------cCCCCccC---
Confidence 234457889999999998999999999999999999999 8888865432 22222221110 11111112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
...+.+++.+||+.||++||++.+++++|.+.
T Consensus 231 -~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 231 -STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 24688999999999999999999999998653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=357.66 Aligned_cols=250 Identities=23% Similarity=0.322 Sum_probs=206.4
Q ss_pred hhhhhhcceecceEEEEEEecC-CcEEEEEEeccc---cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.+.++||+|+||+||+|+... |+.||||+++.. .......+.+|..+|..+ +||||+++++++.+.+..++|||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E 101 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 101 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence 4456789999999999998864 789999998653 223446688999999988 79999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++......
T Consensus 102 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 175 (353)
T 2i0e_A 102 YVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 175 (353)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-
Confidence 999999999997543 4999999999999999999999 8899999999999999999999999999998543222
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+....+...... +...
T Consensus 176 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~~~~i~~~~~~--------~p~~ 243 (353)
T 2i0e_A 176 ---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIMEHNVA--------YPKS 243 (353)
T ss_dssp ---CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC--------CCTT
T ss_pred ---cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC-HHHHHHHHHhCCCC--------CCCC
Confidence 12345679999999999999999999999999999999999999997543 33333333322211 1222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhcC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYES 441 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~~L~~~ 441 (518)
.+ ..+.+++..||+.||.+||+ ++++++|.++.
T Consensus 244 ~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~ 281 (353)
T 2i0e_A 244 MS----KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281 (353)
T ss_dssp SC----HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGT
T ss_pred CC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcccc
Confidence 22 45889999999999999994 69999988764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=358.43 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=194.7
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||+||+++.. +|+.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 100 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence 345678999999999999886 68999999986533 2335688999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc--EEEeeccccccCCCCCccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV--AKLADFGLAHASKDGSICF 326 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~--~kl~DfGla~~~~~~~~~~ 326 (518)
|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+++......
T Consensus 101 ~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--- 172 (361)
T 3uc3_A 101 GELYERICNAG--RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 172 (361)
T ss_dssp CBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC---
Confidence 99999997533 4999999999999999999999 899999999999999987765 9999999997433221
Q ss_pred ccccccccCCCcccCccccccCCCCcc-ccchhhHHHHHHHHhCCccccCCcc---hHHHHHHHHhhccccccccCCcCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEK-SDVYSYGVVLLEIVTARRAVQDGKN---LVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDVwS~Gvll~el~tG~~p~~~~~~---~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
......||+.|+|||.+.+..++.+ +|||||||++|||++|+.||..... .....+........++. .
T Consensus 173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~ 244 (361)
T 3uc3_A 173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD------D 244 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT------T
T ss_pred --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC------c
Confidence 2244569999999999988887766 8999999999999999999975332 22222222221111110 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
...+ ..+.+++.+||+.||++|||+.|+++|.|..
T Consensus 245 ~~~s----~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 279 (361)
T 3uc3_A 245 IRIS----PECCHLISRIFVADPATRISIPEIKTHSWFL 279 (361)
T ss_dssp SCCC----HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred CCCC----HHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence 1122 4588999999999999999999999998874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=349.87 Aligned_cols=254 Identities=24% Similarity=0.402 Sum_probs=208.8
Q ss_pred HhhhhhhhcceecceEEEEEEecC-CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
..+.+.+.||+|+||+||+|.+.+ +..||+|.+.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 91 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence 344556789999999999998864 8899999987533 34577999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 166 (288)
T 3kfa_A 92 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-- 166 (288)
T ss_dssp TTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS--
T ss_pred CCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc--
Confidence 9999999998766667999999999999999999999 88999999999999999999999999999986654331
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... ........ . ........+
T Consensus 167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-~~~~~~~~-~------~~~~~~~~~ 237 (288)
T 3kfa_A 167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEK-D------YRMERPEGC 237 (288)
T ss_dssp -EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHT-T------CCCCCCTTC
T ss_pred -ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHhc-c------CCCCCCCCC
Confidence 12334557889999999999999999999999999999999 88888643322 22111111 1 111111222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...+.+++..||+.||.+||++.++++.|..
T Consensus 238 ----~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 238 ----PEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 3568899999999999999999999998865
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=381.39 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=206.2
Q ss_pred hhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
.+.+.||+|+||+||+|++.++..||||+++... ...++|.+|+++|++++|+||++++++|.+ +..++||||+++|+
T Consensus 270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gs 347 (535)
T 2h8h_A 270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 347 (535)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred hhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence 3456799999999999999888899999997543 234679999999999999999999999876 67899999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|.++|+......+++..++.|+.||+.||+||| +.+|+||||||+||||++++.+||+|||+++....... ...
T Consensus 348 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~ 421 (535)
T 2h8h_A 348 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TAR 421 (535)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH---HTT
T ss_pred HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce---ecc
Confidence 999997543345999999999999999999999 88999999999999999999999999999986543221 122
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
....++..|+|||.+....++.++|||||||+||||+| |+.||..... .+...... ...+ ...... .
T Consensus 422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-~~~~~~i~-~~~~------~~~~~~----~ 489 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVE-RGYR------MPCPPE----C 489 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-HHHHHHHH-TTCC------CCCCTT----C
T ss_pred cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH-cCCC------CCCCCC----C
Confidence 33457889999999999999999999999999999999 8888865433 22222211 1111 111122 2
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 410 LRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
...+.++|..||+.||++||++++|++.|.....
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 3568899999999999999999999999977544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=345.22 Aligned_cols=248 Identities=26% Similarity=0.482 Sum_probs=194.3
Q ss_pred hhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
.+.+.||+|+||+||+|++ .++.||||++... ...+.|.+|+++|++++||||+++++++. +..++||||+++|+
T Consensus 11 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 11 EVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGS 85 (307)
T ss_dssp EEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCB
T ss_pred eeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCC
Confidence 4457899999999999988 4789999998643 34567999999999999999999999887 45899999999999
Q ss_pred HHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc-EEEeeccccccCCCCCccccc
Q 010088 251 LKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV-AKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 251 L~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~-~kl~DfGla~~~~~~~~~~~~ 328 (518)
|.+++..... ..+++..++.++.|++.||+|||..+..+|+||||||+|||++.++. +||+|||++......
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~------ 159 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------ 159 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc------
Confidence 9999986543 24789999999999999999999432289999999999999998876 799999999754332
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcch-HHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL-VESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~-~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ........ .. ..+......+
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~------~~~~~~~~~~- 230 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NG------TRPPLIKNLP- 230 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-TT------CCCCCBTTCC-
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-cC------CCCCcccccC-
Confidence 23346899999999999999999999999999999999999999743322 11111111 11 1112222233
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..+.+++.+||+.||++||++++++++|...
T Consensus 231 ---~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 231 ---KPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 4588999999999999999999999998654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=366.03 Aligned_cols=257 Identities=22% Similarity=0.345 Sum_probs=194.4
Q ss_pred HHhhhhhhhcceecceEEEEEEec-CCcEEEEEEecccc--------chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC
Q 010088 167 KATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--------EQVEGDFCREIELLARLHHRHLVALRGFCIEKR 237 (518)
Q Consensus 167 ~a~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 237 (518)
...+.+.+.||+|+||+||+|... +++.||||++.... ......+.+|+++|++++||||+++++++. .+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 344556678999999999999875 57999999986421 112235889999999999999999999975 45
Q ss_pred ceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC---CcEEEeecc
Q 010088 238 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN---FVAKLADFG 314 (518)
Q Consensus 238 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DfG 314 (518)
..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.+ +.+||+|||
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 689999999999999998764 35999999999999999999999 8899999999999999754 459999999
Q ss_pred ccccCCCCCcccccccccccCCCcccCcccccc---CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc
Q 010088 315 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 391 (518)
Q Consensus 315 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (518)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..................
T Consensus 288 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 288 HSKILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362 (419)
T ss_dssp TTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred cceecCCCc-----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence 998765432 2345679999999999853 67888999999999999999999999754332222111111111
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 392 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 392 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.. .+...... ...+.+++.+||+.||++||+++|+++|.|...
T Consensus 363 ~~----~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 363 NF----IPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp CC----CHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CC----Cchhhccc----CHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 00 01111111 256889999999999999999999999998754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=362.81 Aligned_cols=255 Identities=26% Similarity=0.447 Sum_probs=190.7
Q ss_pred hhhhhcceecceEEEEEEec--CC--cEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeee-cCceEEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS--DG--SLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIE-KRERFLMYE 244 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~--~g--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e 244 (518)
.+.++||+|+||+||+|++. ++ ..||||.++.. .....+.|.+|+.++++++||||++++++|.+ .+..++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 45578999999999999864 22 46899988653 33456789999999999999999999998765 457899999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++|+|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 172 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 172 YMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp CCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999997643 35899999999999999999999 88999999999999999999999999999986543322
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
..........+|+.|+|||.+.+..++.++||||||+++|||+| |..||...... +......... . .....
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-~~~~~~~~~~-~------~~~p~ 319 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGR-R------LLQPE 319 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-CHHHHHHTTC-C------CCCCT
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-HHHHHHHcCC-C------CCCCC
Confidence 11112344567889999999999999999999999999999999 55566433221 1111111111 1 11111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+ ...+.+++..||+.||++||++.+++++|...
T Consensus 320 ~~----~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 320 YC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22 24688999999999999999999999998654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.92 Aligned_cols=250 Identities=20% Similarity=0.265 Sum_probs=184.5
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
+.||+|+||+||+|+.. +|+.||||++... ....+.+|+.++.++. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 57999999999999885 5899999998642 3457889999999997 99999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC---cEEEeeccccccCCCCCccccc
Q 010088 252 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF---VAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 252 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DfGla~~~~~~~~~~~~ 328 (518)
.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++.......
T Consensus 94 ~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---- 164 (325)
T 3kn6_A 94 FERIKKK--KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ---- 164 (325)
T ss_dssp HHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC----
Confidence 9999864 35999999999999999999999 88999999999999997765 899999999986544321
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcc------hHHHHHHHHhhccccccccCCcCC
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN------LVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~------~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+........... ..
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~--------~~ 236 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS--------FE 236 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--------CC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--------CC
Confidence 22345689999999999999999999999999999999999999964321 12222221111100 00
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
..........+.+++..||+.||.+||+++|++++.|....
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 00001123568899999999999999999999999887643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=341.50 Aligned_cols=248 Identities=27% Similarity=0.482 Sum_probs=197.9
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccch-------hHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQ-------VEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 241 (518)
+.+.+.||+|+||+||+|++. +++.||||++...... ..+.+.+|++++++++||||+++++++.+.. ++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l 98 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM 98 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence 345678999999999999875 6899999998543221 1167899999999999999999999986544 79
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecccCCCcEEecCCCc-----EEEeecc
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP--LCHRDIKSSNILLDENFV-----AKLADFG 314 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiHrDlk~~NILl~~~~~-----~kl~DfG 314 (518)
||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+ |+||||||+|||++.++. +||+|||
T Consensus 99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred EEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 999999999999987643 46999999999999999999999 888 999999999999988776 9999999
Q ss_pred ccccCCCCCcccccccccccCCCcccCcccc--ccCCCCccccchhhHHHHHHHHhCCccccCCcchHH-HHHHHHhhcc
Q 010088 315 LAHASKDGSICFEPVNTDIRGTPGYMDPEYV--VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE-SAQVCMASES 391 (518)
Q Consensus 315 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~-~~~~~~~~~~ 391 (518)
+++..... .....||+.|+|||.+ ....++.++||||||+++|||++|+.||........ ...... ..
T Consensus 175 ~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~- 245 (287)
T 4f0f_A 175 LSQQSVHS-------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR-EE- 245 (287)
T ss_dssp TCBCCSSC-------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH-HS-
T ss_pred cccccccc-------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh-cc-
Confidence 99754332 2446799999999998 345678999999999999999999999975432221 111111 11
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 392 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 392 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...+.+.... ...+.+++..||+.||.+||+++++++.|.+
T Consensus 246 ----~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 246 ----GLRPTIPEDC----PPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp ----CCCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ----CCCCCCCccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1112222222 3568899999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=363.25 Aligned_cols=255 Identities=21% Similarity=0.276 Sum_probs=204.1
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.++||+|+||+||+++.. +|+.||||++++.. ......+.+|..+|.+++|+||+++++++.+.+..|+||||++
T Consensus 65 ~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~ 144 (412)
T 2vd5_A 65 ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYV 144 (412)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence 3468999999999999885 68999999986422 2233458899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+|+|.+++...+ ..+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++........
T Consensus 145 gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~-- 218 (412)
T 2vd5_A 145 GGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-- 218 (412)
T ss_dssp SCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE--
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc--
Confidence 999999997533 35999999999999999999999 889999999999999999999999999999866443211
Q ss_pred cccccccCCCcccCccccc-------cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 328 PVNTDIRGTPGYMDPEYVV-------TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
......||+.|+|||++. ...++.++|||||||++|||++|+.||...... +....+...... ...|.
T Consensus 219 -~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~---~~~p~ 293 (412)
T 2vd5_A 219 -RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-ETYGKIVHYKEH---LSLPL 293 (412)
T ss_dssp -ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHHH---CCCC-
T ss_pred -ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccC---cCCCc
Confidence 123457999999999987 357899999999999999999999999754433 322222221111 11121
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHHhhcCC
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQAR---PSIKQVLRILYESS 442 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~R---Ps~~evl~~L~~~~ 442 (518)
....++ ..+.+++.+||. +|.+| |+++|+++|.++..
T Consensus 294 ~~~~~s----~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 294 VDEGVP----EEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp ---CCC----HHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred cccCCC----HHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 122233 458899999999 99998 69999999988753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=340.59 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=204.7
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.+.||+|+||+||+|...++..||||.+.... ...+.+.+|++++++++||||+++++++. .+..++||||++++
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 92 (279)
T 1qpc_A 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENG 92 (279)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTC
T ss_pred hhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCC
Confidence 44567899999999999999888899999987543 23567999999999999999999999986 45689999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.......+++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||++......... .
T Consensus 93 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~ 166 (279)
T 1qpc_A 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT---A 166 (279)
T ss_dssp BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE---C
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc---c
Confidence 9999997643336999999999999999999999 889999999999999999999999999999876543321 2
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +........ .........
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~-------~~~~~~~~~--- 235 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERG-------YRMVRPDNC--- 235 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTT-------CCCCCCTTC---
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-HHHHHHhcc-------cCCCCcccc---
Confidence 234457889999999998899999999999999999999 88888654332 222221111 111111222
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...+.+++..||+.||++||++.++++.|..
T Consensus 236 -~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 236 -PEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -cHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 2568899999999999999999999998865
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=360.23 Aligned_cols=263 Identities=19% Similarity=0.236 Sum_probs=200.5
Q ss_pred hhhhhhcceecceEEEEEEecC------CcEEEEEEeccccchh-----------HHHHHHHHHHHHHcCCCCeeeEeee
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSD------GSLIAVKRMDKISEQV-----------EGDFCREIELLARLHHRHLVALRGF 232 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~g~ 232 (518)
+.+.+.||+|+||+||+|.+.+ ++.||||++....... ...+..|+..+..++|+||++++++
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 116 (364)
T 3op5_A 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116 (364)
T ss_dssp EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence 4456789999999999998864 4789999986543211 1224456666777789999999999
Q ss_pred eeec----CceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec--CCC
Q 010088 233 CIEK----RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD--ENF 306 (518)
Q Consensus 233 ~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~--~~~ 306 (518)
+... ...++||||+ +++|.+++... ...+++..++.|+.||+.||+||| +.+|+||||||+||||+ .++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSCTT
T ss_pred eeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCCCC
Confidence 9875 4589999999 99999999764 245999999999999999999999 88999999999999999 889
Q ss_pred cEEEeeccccccCCCCCccc---ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHH
Q 010088 307 VAKLADFGLAHASKDGSICF---EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA 383 (518)
Q Consensus 307 ~~kl~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~ 383 (518)
.+||+|||+++......... ........||+.|+|||.+.+..++.++|||||||++|||+||+.||..........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 99999999997654322110 111234569999999999999999999999999999999999999997432222222
Q ss_pred HH-HHhhccccccccCCcCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 384 QV-CMASESRLAELVDPRIK-DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 384 ~~-~~~~~~~l~~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.. .......+.+++++.+. ..+ ...+.+++..||+.||.+||++.+|++.|...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANA----PGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHhhhhHHHHHHHhcccccC----HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 11 11112233444443332 122 24688999999999999999999999988654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=375.19 Aligned_cols=250 Identities=25% Similarity=0.365 Sum_probs=208.8
Q ss_pred hhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 173 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.++||+|+||.||+|+.. +|+.||||++... .......+.+|+++|.+++||||+++++++.+.+..++||||+++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 268 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence 468999999999999885 6899999998643 223346688999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.+++...+...+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++....+.
T Consensus 269 g~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~----- 340 (576)
T 2acx_A 269 GDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----- 340 (576)
T ss_dssp CBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-----
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccCc-----
Confidence 99999998766666999999999999999999999 8899999999999999999999999999998765433
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcc---hHHHHHHHHhhccccccccCCcCCCCC
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN---LVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~---~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............ ..+...+
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~--------~~~p~~~ 412 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP--------EEYSERF 412 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC--------CCCCTTS
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc--------ccCCccC
Confidence 22345799999999999999999999999999999999999999975432 222222222111 1112222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcCC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS 442 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~~ 442 (518)
+ ..+.+++..||+.||.+|| +++|+++|.++..
T Consensus 413 s----~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 413 S----PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp C----HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred C----HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 3 4588999999999999999 8999999988753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=351.89 Aligned_cols=253 Identities=24% Similarity=0.373 Sum_probs=197.4
Q ss_pred hhhhhcceecceEEEEEEec-CCcE----EEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSL----IAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
.+.++||+|+||+||+|++. +|.. ||+|.+.... ......+.+|+.++.+++||||++++++|. .+..++|||
T Consensus 16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 94 (325)
T 3kex_A 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ 94 (325)
T ss_dssp EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence 34568999999999999875 3443 7888775432 333456789999999999999999999986 567899999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+.+|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 95 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 95 YLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp CCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred eCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 999999999997642 35899999999999999999999 88999999999999999999999999999987654332
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
. .......||..|+|||.+.+..++.++||||||+++|||+| |+.||...... +........ ... ..+ .
T Consensus 171 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~-~~~---~~~---~ 240 (325)
T 3kex_A 171 Q--LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-EVPDLLEKG-ERL---AQP---Q 240 (325)
T ss_dssp C--CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-HHHHHHHTT-CBC---CCC---T
T ss_pred c--ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-HHHHHHHcC-CCC---CCC---C
Confidence 1 12344568889999999999999999999999999999999 99999754322 222211111 110 001 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
. ....+.+++..||+.||.+||++.+++++|....
T Consensus 241 ~----~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 241 I----CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp T----BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred c----CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 1124678999999999999999999999997643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=346.43 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=197.1
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
++||+|+||+||+|+.. +|+.||||++..........+.+|+++|.++ +||||+++++++.+.+..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 47999999999999864 6899999999766555567899999999995 799999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc---EEEeeccccccCCCCCcc---
Q 010088 252 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV---AKLADFGLAHASKDGSIC--- 325 (518)
Q Consensus 252 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DfGla~~~~~~~~~--- 325 (518)
.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||++.........
T Consensus 99 ~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 173 (316)
T 2ac3_A 99 LSHIHKR--RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173 (316)
T ss_dssp HHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------
T ss_pred HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccc
Confidence 9999764 35899999999999999999999 889999999999999998776 999999998765322110
Q ss_pred cccccccccCCCcccCcccccc-----CCCCccccchhhHHHHHHHHhCCccccCCcch--------------HHHHHHH
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--------------VESAQVC 386 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~--------------~~~~~~~ 386 (518)
.........||+.|+|||.+.. ..++.++|||||||++|||++|+.||...... .......
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 253 (316)
T 2ac3_A 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253 (316)
T ss_dssp --------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHH
T ss_pred cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHH
Confidence 0111233469999999999875 56889999999999999999999999643211 1111111
Q ss_pred HhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 387 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 387 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
......++.. .... ....+.+++.+||+.||++||++.|+++|.|...
T Consensus 254 ~~~~~~~~~~----~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 254 QEGKYEFPDK----DWAH----ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHCCCCCCHH----HHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred hccCcccCch----hccc----CCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 1111110000 0011 1246889999999999999999999999988753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=340.12 Aligned_cols=253 Identities=21% Similarity=0.341 Sum_probs=205.5
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.||+|+||+||+|... +|..||+|++... .......+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 88 (284)
T 3kk8_A 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 88 (284)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCC
Confidence 34568999999999999875 5899999998643 33445678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc---EEEeeccccccCCCCCc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV---AKLADFGLAHASKDGSI 324 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DfGla~~~~~~~~ 324 (518)
+|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||++.......
T Consensus 89 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~- 162 (284)
T 3kk8_A 89 GGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 162 (284)
T ss_dssp SCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-
Confidence 99999988754 35899999999999999999999 889999999999999986655 9999999997655432
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ............ .+. ...
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~---~~~-~~~ 233 (284)
T 3kk8_A 163 ----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-YAQIKAGAYDYP---SPE-WDT 233 (284)
T ss_dssp ----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCCC---TTT-TTT
T ss_pred ----cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH-HHHHHhccccCC---chh-hcc
Confidence 22446799999999999999999999999999999999999999976543322 222211111111 111 112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.+ ..+.+++..||+.||++||++.|++++.+...
T Consensus 234 ~~----~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 234 VT----PEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp SC----HHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred cC----HHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 22 45889999999999999999999999887643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=346.69 Aligned_cols=263 Identities=23% Similarity=0.305 Sum_probs=201.1
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (311)
T 4agu_A 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD 85 (311)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCC
Confidence 34568999999999999886 58999999885433 2335678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 157 (311)
T 4agu_A 86 HTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--- 157 (311)
T ss_dssp EEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc---
Confidence 99999998764 34999999999999999999999 88999999999999999999999999999986543321
Q ss_pred cccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhc-------------ccc
Q 010088 328 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE-------------SRL 393 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~-------------~~l 393 (518)
......||..|+|||.+.+ ..++.++||||||+++|||++|+.||................. ...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 2234568999999999876 6789999999999999999999999976544332222111100 000
Q ss_pred ccccCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 394 AELVDPRIKDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 394 ~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.....+....... ......+.+++..||+.||++|||++|+++|.|...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 290 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence 0000000000000 012345889999999999999999999999988754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=344.69 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=192.1
Q ss_pred hhhhhhhcceecceEEEEEEecC----CcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
.+.+.+.||+|+||+||+|.+.. +..||+|.+... .....+.|.+|+.++++++||||+++++++. .+..++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 94 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 94 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence 34456789999999999998743 457999998653 3344567999999999999999999999984 56789999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 95 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 95 ELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp ECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 9999999999997543 35999999999999999999999 8899999999999999999999999999998664432
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
.. ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......... ...... . ...+.
T Consensus 171 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~-~~i~~~-~------~~~~~ 239 (281)
T 1mp8_A 171 YY---KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-GRIENG-E------RLPMP 239 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTT-C------CCCCC
T ss_pred cc---ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH-HHHHcC-C------CCCCC
Confidence 11 1233457789999999999999999999999999999997 88898654332211 111111 0 01112
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
... ...+.+++..||+.||++||++.+++++|..
T Consensus 240 ~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 240 PNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 222 3568899999999999999999999999865
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=341.68 Aligned_cols=258 Identities=18% Similarity=0.213 Sum_probs=203.9
Q ss_pred hhhhhhcceecceEEEEEEe-cCCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.+.||+|+||+||+|+. .+|+.||||.+.... ....+.+|+.++.++ +|+|++++++++.+....++||||+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 88 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 88 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence 34557899999999999986 478999999886432 234688999999999 7999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc-----EEEeeccccccCCCC
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV-----AKLADFGLAHASKDG 322 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~kl~DfGla~~~~~~ 322 (518)
+++|.+++...+ ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+++.....
T Consensus 89 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 89 GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 999999997543 35999999999999999999999 999999999999999987766 999999999866543
Q ss_pred Ccccc---cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcc--hHHHHHHHHhhcccccccc
Q 010088 323 SICFE---PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN--LVESAQVCMASESRLAELV 397 (518)
Q Consensus 323 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~--~~~~~~~~~~~~~~l~~~~ 397 (518)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ............... .
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~ 241 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST---P 241 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS---C
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc---c
Confidence 21100 123456799999999999999999999999999999999999999975321 112111111110000 0
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+.+...++ ..+.+++..||+.||++||++++|++.|...
T Consensus 242 ~~~~~~~~~----~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 242 LRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHhhCc----HHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 011111222 5688999999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=350.38 Aligned_cols=256 Identities=19% Similarity=0.229 Sum_probs=203.1
Q ss_pred hhhhhcceecceEEEEEEe-cCCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.||+|+||+||+|+. .+|+.||||.+..... ...+.+|+++++++ +|+||+++++++...+..++||||+ +
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (330)
T 2izr_A 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G 88 (330)
T ss_dssp EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence 3457899999999999986 4789999999864332 34688999999999 9999999999999999999999999 9
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc-----EEEeeccccccCCCCC
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV-----AKLADFGLAHASKDGS 323 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~kl~DfGla~~~~~~~ 323 (518)
++|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+++......
T Consensus 89 ~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 89 PSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 9999999754 246999999999999999999999 889999999999999998887 9999999998654332
Q ss_pred cccc---cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCC--cchHHHHHHHHhhccccccccC
Q 010088 324 ICFE---PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDG--KNLVESAQVCMASESRLAELVD 398 (518)
Q Consensus 324 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~--~~~~~~~~~~~~~~~~l~~~~d 398 (518)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||... ....+............. .
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~---~ 241 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP---I 241 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC---H
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC---H
Confidence 1100 0124567999999999999999999999999999999999999999753 223232222211110000 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 399 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 399 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..+... . ..+.+++..||+.||.+||++++|++.|...
T Consensus 242 ~~~~~~----~-p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 242 EVLCEN----F-PEMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHTTT----C-HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHhcc----C-hHHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 001111 1 2689999999999999999999999988654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=355.33 Aligned_cols=269 Identities=26% Similarity=0.373 Sum_probs=207.3
Q ss_pred hhhhhhcceecceEEEEEEe-----cCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeee--ecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI--EKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV 242 (518)
+.+.+.||+|+||+||+|++ .++..||||++........+.+.+|++++++++|+||+++++++. +....++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 104 (327)
T 3lxl_A 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV 104 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEE
Confidence 34567899999999999984 368899999998766666778999999999999999999999887 44568999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+++|+|.+++.... ..+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 105 MEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 99999999999997532 24999999999999999999999 889999999999999999999999999999876443
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhc---cccccccCC
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE---SRLAELVDP 399 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~---~~l~~~~d~ 399 (518)
... ........||..|+|||.+.+..++.++||||||+++|||++|+.|+................. ..+.+.+..
T Consensus 181 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 181 KDY-YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp CSE-EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred Ccc-ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 321 1123445688899999999999999999999999999999999999864221100000000000 000011111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 400 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
......+......+.+++..||+.||++||++.+++++|.....
T Consensus 260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11111122233568999999999999999999999999976543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=345.78 Aligned_cols=262 Identities=25% Similarity=0.372 Sum_probs=198.5
Q ss_pred HHHHhhhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHc--CCCCeeeEeeeeeec----Cc
Q 010088 165 TKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL--HHRHLVALRGFCIEK----RE 238 (518)
Q Consensus 165 l~~a~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~----~~ 238 (518)
.....+.+.+.||+|+||+||+|++. |+.||||++.... ...+.+|.+++..+ +||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 33445666789999999999999885 8999999985432 34455666666655 899999999999887 67
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC--------CceecccCCCcEEecCCCcEEE
Q 010088 239 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP--------PLCHRDIKSSNILLDENFVAKL 310 (518)
Q Consensus 239 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~--------~iiHrDlk~~NILl~~~~~~kl 310 (518)
.++||||+++|+|.++++.. .+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred eEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 89999999999999999753 4999999999999999999999 66 9999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccccCCCcccCccccccCCCCcc------ccchhhHHHHHHHHhC----------Ccccc
Q 010088 311 ADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK------SDVYSYGVVLLEIVTA----------RRAVQ 374 (518)
Q Consensus 311 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------sDVwS~Gvll~el~tG----------~~p~~ 374 (518)
+|||+++.................||+.|+|||.+.+.....+ +|||||||++|||+|| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999997654433221112234579999999999987766665 9999999999999999 56664
Q ss_pred CCc---chHHHHHHHHhhccccccccCCcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 375 DGK---NLVESAQVCMASESRLAELVDPRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 375 ~~~---~~~~~~~~~~~~~~~l~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
... ............ ....+.+.... ..+....+.+++.+||+.||++||++.+|+++|...
T Consensus 264 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCI-----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TTSCSSCCHHHHHHHHTT-----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhcCCCCchhhhHHHHhh-----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 321 111111111111 11112221111 125677899999999999999999999999999653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=367.85 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=206.6
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+.+|+.++||||+++++++...+..++||||+
T Consensus 19 ~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 98 (476)
T 2y94_A 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV 98 (476)
T ss_dssp EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45568999999999999886 68999999986432 223467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....+.
T Consensus 99 ~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--- 170 (476)
T 2y94_A 99 SGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--- 170 (476)
T ss_dssp SSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC---
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc---
Confidence 9999999997643 5999999999999999999999 9999999999999999999999999999998765433
Q ss_pred ccccccccCCCcccCccccccCCC-CccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.+... ............. .....
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~--------~p~~~ 239 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-PTLFKKICDGIFY--------TPQYL 239 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-HHHHHHHHTTCCC--------CCTTC
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-HHHHHHHhcCCcC--------CCccC
Confidence 2244579999999999988765 6899999999999999999999975433 2333222221111 11122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+ ..+.+++..||+.||.+|||++|+++|.|...
T Consensus 240 s----~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 240 N----PSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp C----HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred C----HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 2 45889999999999999999999999887643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=350.62 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=195.5
Q ss_pred hhhhhhcceecceEEEEEEe-cCCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCce----EE
Q 010088 170 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRER----FL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~----~l 241 (518)
+.+.+.||+|+||+||+|+. .+|+.||||++... .......|.+|++++.+++||||+++++++...... ++
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l 93 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 93 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence 34567899999999999987 46899999998653 233346789999999999999999999998876543 99
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||+++|+|.++++..+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 94 v~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 94 VMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 999999999999997543 5999999999999999999999 88999999999999999999999999999986544
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||............ ...........
T Consensus 169 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~---- 242 (311)
T 3ork_A 169 SGNSV-TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-VREDPIPPSAR---- 242 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHCCCCCHHHH----
T ss_pred ccccc-ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hcCCCCCcccc----
Confidence 32111 1223456899999999999999999999999999999999999999755433222222 21111111110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.... ...+.+++.+||+.||.+||+..+++.+.+.
T Consensus 243 ~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 243 HEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp STTC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred cCCC----CHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 1112 2458899999999999999998888876544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=345.53 Aligned_cols=257 Identities=27% Similarity=0.445 Sum_probs=194.3
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.+.||+|+||+||+|++. ..||||.++.. .....+.|.+|+++|++++|+||+++++++ .....++||||++
T Consensus 26 y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~ 102 (289)
T 3og7_A 26 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCE 102 (289)
T ss_dssp CEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCC
T ss_pred eeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecC
Confidence 445678999999999999864 35999998643 334457799999999999999999999975 4567899999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 176 (289)
T 3og7_A 103 GSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG--S 176 (289)
T ss_dssp EEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred CCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccc--c
Confidence 999999997543 45999999999999999999999 88999999999999999999999999999975443211 1
Q ss_pred cccccccCCCcccCccccc---cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.......||+.|+|||.+. +..++.++||||||+++|||++|+.||................. . .+.+. .
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~----~~~~~-~ 249 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS--L----SPDLS-K 249 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS--C----CCCTT-S
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc--c----Ccchh-h
Confidence 1233456999999999986 56788999999999999999999999976555443333222111 1 11111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
........+.+++..||+.||.+||++.++++.|.+..
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11122356899999999999999999999999997754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=341.28 Aligned_cols=254 Identities=26% Similarity=0.345 Sum_probs=199.5
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.+.||+|+||+||+++.. +|..+|+|.+.... ....+.+.+|+++|++++||||+++++++.+.+..++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 102 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence 3455679999999999999875 58899999986533 334577999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe---cCCCcEEEeeccccccCCC
Q 010088 247 ANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKD 321 (518)
Q Consensus 247 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DfGla~~~~~ 321 (518)
++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||++.....
T Consensus 103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999998542 1346999999999999999999999 8899999999999999 4568899999999976544
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
.. ......||+.|+|||.+. ..++.++||||||+++|||++|+.||.... ..+.............. .
T Consensus 180 ~~-----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~-----~ 247 (285)
T 3is5_A 180 DE-----HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-LEEVQQKATYKEPNYAV-----E 247 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCCCC------
T ss_pred cc-----cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC-HHHHHhhhccCCccccc-----c
Confidence 32 234456899999999875 578999999999999999999999997543 22222221111111100 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
....+ ..+.+++..||+.||++||++.|++++.|..
T Consensus 248 ~~~~~----~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~ 283 (285)
T 3is5_A 248 CRPLT----PQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283 (285)
T ss_dssp -CCCC----HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred cCcCC----HHHHHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence 11122 4578999999999999999999999987753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=338.03 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=202.6
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeee----cCceEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE----KRERFLMY 243 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 243 (518)
.+.+.||+|+||+||+|... ++..||+|.+... .......+.+|+.++++++||||+++++++.. ....++||
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 108 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence 34568999999999999875 5789999988643 34455679999999999999999999999875 34589999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecccCCCcEEec-CCCcEEEeeccccccCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP--LCHRDIKSSNILLD-ENFVAKLADFGLAHASK 320 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiHrDlk~~NILl~-~~~~~kl~DfGla~~~~ 320 (518)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+ |+||||||+|||++ +++.+||+|||++....
T Consensus 109 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999999999753 34899999999999999999999 777 99999999999998 78999999999997544
Q ss_pred CCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
... .....||+.|+|||.+. +.++.++||||||+++|||++|+.||.................. . ..
T Consensus 184 ~~~------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~----~~ 250 (290)
T 1t4h_A 184 ASF------AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--P----AS 250 (290)
T ss_dssp TTS------BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--C----GG
T ss_pred ccc------cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--c----cc
Confidence 332 23456999999999876 56999999999999999999999999866555444433222111 1 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.....+ ..+.+++..||+.||.+||++.++++|.|...
T Consensus 251 ~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 251 FDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred cCCCCC----HHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 111112 45889999999999999999999999988753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=347.25 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=205.9
Q ss_pred hhhhhhhcceecceEEEEEEec--------CCcEEEEEEeccc-cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCc
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS--------DGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRE 238 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 238 (518)
.+.+.+.||+|+||+||+|++. ++..||||+++.. .......+.+|++++.++ +||||+++++++.+.+.
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 115 (334)
T 2pvf_A 36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 115 (334)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCc
Confidence 3455678999999999999863 4678999998754 334456799999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC
Q 010088 239 RFLMYEYMANGSLKDHLHSPGR--------------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE 304 (518)
Q Consensus 239 ~~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~ 304 (518)
.++||||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.
T Consensus 116 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEEcC
Confidence 9999999999999999986432 34899999999999999999999 889999999999999999
Q ss_pred CCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHH
Q 010088 305 NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESA 383 (518)
Q Consensus 305 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~ 383 (518)
++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+..
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~~~~ 269 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELF 269 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSE--ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHH
T ss_pred CCCEEEccccccccccccccc--cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC-HHHHH
Confidence 999999999999866543211 12234457889999999998899999999999999999999 888886433 22322
Q ss_pred HHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 384 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 384 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
....... .+...... ...+.+++.+||+.||.+||++.+++++|...
T Consensus 270 ~~~~~~~-------~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 270 KLLKEGH-------RMDKPANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHHHTC-------CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcCC-------CCCCCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2221111 11112222 24688999999999999999999999998653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=351.56 Aligned_cols=273 Identities=24% Similarity=0.306 Sum_probs=208.5
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--------Cc
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK--------RE 238 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~~ 238 (518)
+.+.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+++|.+++||||+++++++... +.
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (351)
T 3mi9_A 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 98 (351)
T ss_dssp EEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CE
T ss_pred eeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCce
Confidence 345678999999999999884 68999999885432 23345788999999999999999999999873 46
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccccc
Q 010088 239 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318 (518)
Q Consensus 239 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~ 318 (518)
.++||||+++ +|.+.+.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 99 IYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp EEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 8999999975 8888776543 35999999999999999999999 88999999999999999999999999999986
Q ss_pred CCCCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccccc
Q 010088 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 397 (518)
Q Consensus 319 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 397 (518)
................||+.|+|||.+.+ ..++.++|||||||++|||++|+.||................. ......
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~ 252 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG-SITPEV 252 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCTTT
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCChhh
Confidence 54332221223345678999999998876 5689999999999999999999999976543332222211111 111100
Q ss_pred CCcC-------------CCCCC-HHH------HHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCCcc
Q 010088 398 DPRI-------------KDSFD-MEQ------LRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSG 448 (518)
Q Consensus 398 d~~l-------------~~~~~-~~~------~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~ 448 (518)
.+.. ..... .+. ...+.+++.+||+.||++|||++|+++|.|....+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 323 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence 0000 00000 111 245889999999999999999999999999987766544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=341.30 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=201.1
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||+||+|+.. ++..||||++.... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (279)
T 3fdn_A 12 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 91 (279)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecC
Confidence 34568999999999999876 57799999985422 223467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~--- 163 (279)
T 3fdn_A 92 PLGTVYRELQKL--SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--- 163 (279)
T ss_dssp TTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCccc---
Confidence 999999999754 34899999999999999999999 8999999999999999999999999999986543322
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... +.......... ......+
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~--------~~~~~~~ 231 (279)
T 3fdn_A 164 ---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-ETYKRISRVEF--------TFPDFVT 231 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCC--------CCCTTSC
T ss_pred ---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-HHHHHHHhCCC--------CCCCcCC
Confidence 23457899999999999999999999999999999999999999754332 22222221111 1112222
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..+.+++..||+.||.+||+++|+++|.|..
T Consensus 232 ----~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~ 262 (279)
T 3fdn_A 232 ----EGARDLISRLLKHNPSQRPMLREVLEHPWIT 262 (279)
T ss_dssp ----HHHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred ----HHHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence 4578999999999999999999999998763
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=341.49 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=204.3
Q ss_pred HHHHhhhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeee--------
Q 010088 165 TKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE-------- 235 (518)
Q Consensus 165 l~~a~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------- 235 (518)
.....+...+.||+|+||.||+|+.. +|+.||+|++.... ..+.+|++++.+++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 33444556678999999999999886 78999999987543 356789999999999999999998864
Q ss_pred --------cCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc
Q 010088 236 --------KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV 307 (518)
Q Consensus 236 --------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 307 (518)
....++||||+++|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||+++++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCC
Confidence 345799999999999999997654456999999999999999999999 889999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHH
Q 010088 308 AKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCM 387 (518)
Q Consensus 308 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~ 387 (518)
+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+..... ....
T Consensus 161 ~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~-- 230 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG-----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---FFTD-- 230 (284)
T ss_dssp EEECCCTTCEESSCCS-----CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH---HHHH--
T ss_pred EEECcchhheeccccc-----cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH---HHHH--
Confidence 9999999998765432 22345699999999999999999999999999999999999988753211 1111
Q ss_pred hhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 388 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 388 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+.+..+...++ ..+.+++..||+.||.+||++.|++++|+...
T Consensus 231 --------~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 231 --------LRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp --------HHTTCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred --------hhcccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 11111222233 35789999999999999999999999997654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=342.08 Aligned_cols=254 Identities=21% Similarity=0.379 Sum_probs=205.3
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.+.||+|+||+||+++.. +|+.||+|.+..........+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence 4556678999999999999875 689999999976554455678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe---cCCCcEEEeeccccccCCCCCc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DfGla~~~~~~~~ 324 (518)
+|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||++ ++++.+||+|||++.......
T Consensus 90 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~- 163 (304)
T 2jam_A 90 GGELFDRILERG--VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI- 163 (304)
T ss_dssp SCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT-
T ss_pred CccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc-
Confidence 999999987533 4899999999999999999999 8899999999999999 788999999999987544321
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ............. .......
T Consensus 164 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~----~~~~~~~ 233 (304)
T 2jam_A 164 -----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-KLFEKIKEGYYEF----ESPFWDD 233 (304)
T ss_dssp -----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHCCCCC----CTTTTTT
T ss_pred -----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCCCC----Ccccccc
Confidence 23346899999999999999999999999999999999999999754432 2222222111111 1111122
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
. ...+.+++..||+.||++||++.|++++.+...
T Consensus 234 ~----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 234 I----SESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp S----CHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred C----CHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 2 256889999999999999999999999887654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=348.49 Aligned_cols=255 Identities=23% Similarity=0.378 Sum_probs=190.9
Q ss_pred hhhhhhcceecceEEEEEEecCC----cEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCce----
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDG----SLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRER---- 239 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 239 (518)
+.+.+.||+|+||+||+|++... ..||||.++.. .....+.|.+|++++++++||||+++++++...+..
T Consensus 25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (323)
T 3qup_A 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP 104 (323)
T ss_dssp CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence 44567899999999999987543 27999998643 344567899999999999999999999999887655
Q ss_pred --EEEEEecCCCCHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeec
Q 010088 240 --FLMYEYMANGSLKDHLHSP----GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADF 313 (518)
Q Consensus 240 --~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~Df 313 (518)
++||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+||
T Consensus 105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEEeec
Confidence 9999999999999998632 1235999999999999999999999 889999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccc
Q 010088 314 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESR 392 (518)
Q Consensus 314 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~ 392 (518)
|+++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......... ....... .
T Consensus 182 g~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-~~~~~~~-~ 257 (323)
T 3qup_A 182 GLSRKIYSGDYY--RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY-NYLIGGN-R 257 (323)
T ss_dssp CC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTTC-C
T ss_pred cccccccccccc--cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH-HHHhcCC-C
Confidence 999865443311 12234457889999999999999999999999999999999 88888654433222 2111111 0
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 393 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 393 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
...... ....+.+++..||+.||++||++.++++.|.+.
T Consensus 258 ------~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 258 ------LKQPPE----CMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp ------CCCCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCc----cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111112 235688999999999999999999999988664
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=340.39 Aligned_cols=249 Identities=21% Similarity=0.357 Sum_probs=202.8
Q ss_pred hcceecceEEEEEEec---CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 175 IIGQGGFGTVYKAQFS---DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
.||+|+||+||+|.+. ++..||||.++.. .....+.+.+|++++.+++||||+++++++ +.+..++||||+++++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~ 95 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 95 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence 7999999999999863 5788999999754 334567799999999999999999999999 5667999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......... ...
T Consensus 96 L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~-~~~ 170 (287)
T 1u59_A 96 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TAR 170 (287)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE-CCC
T ss_pred HHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCccee-ecc
Confidence 99999754 345999999999999999999999 8899999999999999999999999999998764433211 122
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... +....... .. .+......
T Consensus 171 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~i~~-~~------~~~~~~~~---- 238 (287)
T 1u59_A 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQ-GK------RMECPPEC---- 238 (287)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHHHHHT-TC------CCCCCTTC----
T ss_pred ccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHhc-CC------cCCCCCCc----
Confidence 33457899999999998899999999999999999999 99999754432 22222111 10 11122222
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 410 LRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
...+.+++..||+.||++||++.+++++|+..
T Consensus 239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 239 PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 35688999999999999999999999999653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=351.90 Aligned_cols=244 Identities=22% Similarity=0.315 Sum_probs=202.6
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc--------chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--------EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERF 240 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 240 (518)
+.+.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+.+|++++||||+++++++.+.+..+
T Consensus 26 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 105 (335)
T 3dls_A 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ 105 (335)
T ss_dssp EEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEE
Confidence 444578999999999999864 68999999986532 123346788999999999999999999999999999
Q ss_pred EEEEecCCC-CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccC
Q 010088 241 LMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 319 (518)
Q Consensus 241 lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~ 319 (518)
+||||+.+| +|.+++.... .+++..+..|+.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 106 lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 106 LVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 999999777 9999998643 4999999999999999999999 889999999999999999999999999999876
Q ss_pred CCCCcccccccccccCCCcccCccccccCCC-CccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccC
Q 010088 320 KDGSICFEPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD 398 (518)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d 398 (518)
.... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ......
T Consensus 181 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------~~~~~~ 242 (335)
T 3dls_A 181 ERGK-----LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------VEAAIH 242 (335)
T ss_dssp CTTC-----CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------TTTCCC
T ss_pred CCCC-----ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------HhhccC
Confidence 5443 2234569999999999988776 78999999999999999999999642211 011111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 399 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 399 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+ ....+ ..+.+++..||+.||++||++.+++++.|...
T Consensus 243 ~--~~~~~----~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 243 P--PYLVS----KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp C--SSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred C--CcccC----HHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 0 11122 45889999999999999999999999988754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=338.94 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=202.8
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEeccccc------hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE------QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 241 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 241 (518)
.+.+.+.||+|+||+||+|+.. +|+.||+|.++.... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 4556678999999999999886 689999998864321 135679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC----cEEEeeccccc
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF----VAKLADFGLAH 317 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DfGla~ 317 (518)
||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||++.
T Consensus 86 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 86 ILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999999753 35999999999999999999999 88999999999999998877 89999999998
Q ss_pred cCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccccc
Q 010088 318 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 397 (518)
Q Consensus 318 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 397 (518)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... +............
T Consensus 161 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~---- 230 (283)
T 3bhy_A 161 KIEAGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-ETLTNISAVNYDF---- 230 (283)
T ss_dssp ECC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTTCCCC----
T ss_pred eccCCC-----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-HHHHHhHhcccCC----
Confidence 654432 123456899999999999999999999999999999999999999754432 2222211111111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
++...... ...+.+++.+||+.||++||++.+++++.+.
T Consensus 231 ~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 269 (283)
T 3bhy_A 231 DEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269 (283)
T ss_dssp CHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred cchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence 11111111 2458899999999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=349.52 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=201.9
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEec
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.+.||+|+||+||+|+.. +|+.||||.++.... .+.+|++++.++ +||||+++++++.+.+..++||||+
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 98 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence 3455678999999999999876 588999999875432 245788999888 7999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC----CcEEEeeccccccCCCC
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN----FVAKLADFGLAHASKDG 322 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~----~~~kl~DfGla~~~~~~ 322 (518)
++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+|||+.++ +.+||+|||+++.....
T Consensus 99 ~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 99 KGGELLDKILRQK--FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 9999999997643 5999999999999999999999 8899999999999998543 35999999999865443
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCC--cchHHHHHHHHhhccccccccCCc
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDG--KNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~--~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||... ....+....+......+ ...
T Consensus 174 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~----~~~ 245 (342)
T 2qr7_A 174 NG----LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL----SGG 245 (342)
T ss_dssp TC----CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC----CST
T ss_pred CC----ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc----Ccc
Confidence 21 234457899999999998888999999999999999999999999743 22333333222211111 111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..... ...+.+++..||+.||++||++.++++|.|..
T Consensus 246 ~~~~~----s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~ 282 (342)
T 2qr7_A 246 YWNSV----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282 (342)
T ss_dssp TTTTS----CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred ccccC----CHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence 11122 24688999999999999999999999998763
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=348.89 Aligned_cols=264 Identities=23% Similarity=0.385 Sum_probs=201.3
Q ss_pred hhhhhhcceecceEEEEEEe-----cCCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 241 (518)
+...+.||+|+||+||+|++ .+|+.||||++... .......+.+|++++.+++||||+++++++.+. ...++
T Consensus 23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 34557899999999999984 36889999998743 334457799999999999999999999999876 66899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 103 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 999999999999996432 35999999999999999999999 88999999999999999999999999999987654
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhc-----cccccc
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE-----SRLAEL 396 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~-----~~l~~~ 396 (518)
.... ........||..|+|||.+.+..++.++||||||+++|||+||+.|+...... ......... ..+...
T Consensus 179 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 179 DKEY-YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL--FLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp TCCE-EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--HHHHHCSCCGGGHHHHHHHH
T ss_pred CCcc-eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH--HhhccCCcccccCHHHHHHH
Confidence 4321 11234456888999999999999999999999999999999999886432110 000000000 000000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 397 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 397 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
+........+......+.+++..||+.||.+|||+.++++.|..
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 00000111112223568899999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=341.15 Aligned_cols=259 Identities=25% Similarity=0.421 Sum_probs=211.8
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
...+.||+|+||+||+|+.. +|+.||||.+.... ....+.+.+|+.++.+++||||+++++++.+....++||||+++
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 104 (303)
T 3a7i_A 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 104 (303)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred HHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCC
Confidence 34568999999999999875 68999999986433 34457899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 105 ~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 174 (303)
T 3a7i_A 105 GSALDLLEP---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---- 174 (303)
T ss_dssp EEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC----
T ss_pred CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc----
Confidence 999999974 35999999999999999999999 88999999999999999999999999999976544321
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..... ...+.+...++
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~-------~~~~~~~~~~~-- 244 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL-FLIPK-------NNPPTLEGNYS-- 244 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHH-------SCCCCCCSSCC--
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH-HHhhc-------CCCCCCccccC--
Confidence 224457899999999999999999999999999999999999999754432221 11111 11122233333
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCCcchhh
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQ 451 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~~ 451 (518)
..+.+++..||+.||.+||++.+++++.+.........+..
T Consensus 245 --~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~ 285 (303)
T 3a7i_A 245 --KPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLT 285 (303)
T ss_dssp --HHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCGGGGH
T ss_pred --HHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCccHHHH
Confidence 45889999999999999999999999987765444444443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=346.53 Aligned_cols=266 Identities=24% Similarity=0.312 Sum_probs=204.4
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccc-----hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-----QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
+.+.+.||+|+||+||+|+.. +|+.||||++..... .....+.+|++++.+++||||+++++++.+.+..++||
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 91 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEE
Confidence 445578999999999999875 589999999864221 12356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+++ +|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 92 e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 92 DFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp ECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 99986 8999887643 35899999999999999999999 8899999999999999999999999999998664332
Q ss_pred cccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc----cccc--
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR----LAEL-- 396 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~----l~~~-- 396 (518)
. ......||+.|+|||.+.+. .++.++|||||||++|||++|..||................... ..+.
T Consensus 167 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 167 R----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp C----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred c----cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 1 23456789999999998654 58999999999999999999999887655443333222111110 0000
Q ss_pred ----cCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCC
Q 010088 397 ----VDPRIKDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 444 (518)
Q Consensus 397 ----~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~ 444 (518)
+........+ ......+.+++..||+.||++|||+.|++++.+....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 0000000011 11225689999999999999999999999999886543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=377.51 Aligned_cols=248 Identities=21% Similarity=0.362 Sum_probs=197.5
Q ss_pred hcceecceEEEEEEec---CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 175 IIGQGGFGTVYKAQFS---DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
.||+|+||+||+|.+. ++..||||+++... ....++|.+|+++|++++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999874 45689999997543 3456789999999999999999999999976 67999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|.+++... ...+++..+..|+.||+.||+||| +.+|+||||||+||||++++.+||+|||+++......... ...
T Consensus 422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~ 496 (613)
T 2ozo_A 422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TAR 496 (613)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee-eec
Confidence 99999754 345999999999999999999999 8899999999999999999999999999998764332111 112
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
....+|+.|+|||++.+..++.++|||||||+||||+| |+.||...... +....+. ...+ ..... ..
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-~~~~~i~-~~~~------~~~p~----~~ 564 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIE-QGKR------MECPP----EC 564 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-HHHHHHH-TTCC------CCCCT----TC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHH-cCCC------CCCCC----cC
Confidence 23346789999999999999999999999999999998 99999754433 2222211 1111 11112 23
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 410 LRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...+.+++..||+.||++||++.+|++.|..
T Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 565 PPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 3568899999999999999999999998854
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=337.91 Aligned_cols=252 Identities=24% Similarity=0.338 Sum_probs=202.2
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCCHH
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK 252 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 252 (518)
.+||+|+||+||+|+.. ++..||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 37999999999999874 68899999997666566678999999999999999999999999999999999999999999
Q ss_pred HHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-CCcEEEeeccccccCCCCCccccccc
Q 010088 253 DHLHSP-GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 253 ~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
+++... ....+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++........ ..
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~----~~ 180 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP----CT 180 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---------
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC----cc
Confidence 999754 2345789999999999999999999 889999999999999987 89999999999986543221 22
Q ss_pred ccccCCCcccCccccccCC--CCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 331 TDIRGTPGYMDPEYVVTQE--LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~--~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
....||+.|+|||.+.+.. ++.++||||||+++|||++|+.||............... ....+.+....+
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~-- 252 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM------FKVHPEIPESMS-- 252 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH------HCCCCCCCTTSC--
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc------ccccccccccCC--
Confidence 3456899999999987653 889999999999999999999999643322211111100 011122233333
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
..+.+++..||+.||++||++.+++++.+...
T Consensus 253 --~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 253 --AEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp --HHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred --HHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence 46889999999999999999999999887754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=347.62 Aligned_cols=263 Identities=26% Similarity=0.405 Sum_probs=202.8
Q ss_pred hhhhhcceecceEEEEEEec-----CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec--CceEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-----DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLM 242 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 242 (518)
.+.+.||+|+||+||++.+. +|+.||||++.... ......+.+|+++|++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 34568999999999998753 57899999997543 34456799999999999999999999999874 578999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+++|+|.+++... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 114 ~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp ECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 9999999999999753 3999999999999999999999 889999999999999999999999999999876544
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHH---HhhccccccccCC
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC---MASESRLAELVDP 399 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~---~~~~~~l~~~~d~ 399 (518)
... ........+|..|+|||.+.+..++.++||||||+++|||+||+.||............. ......+.+.+..
T Consensus 188 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 188 HEY-YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp CSE-EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred ccc-cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 321 112344568889999999999999999999999999999999999986422110000000 0000001111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 400 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
......+......+.+++.+||+.||++||++.|+++.|..
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11111122233568999999999999999999999998865
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=337.67 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=183.7
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||+||+|+.. +|+.||||.+.... ......+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 14 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (278)
T 3cok_A 14 KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMC 93 (278)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecC
Confidence 34568999999999999874 78999999986432 223467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 94 ~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 167 (278)
T 3cok_A 94 HNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-- 167 (278)
T ss_dssp TTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred CCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--
Confidence 9999999998643 45999999999999999999999 88999999999999999999999999999986543221
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .... ..+.......+
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~--------~~~~~~~~~~~ 236 (278)
T 3cok_A 168 --KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-NKVV--------LADYEMPSFLS 236 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CC--------SSCCCCCTTSC
T ss_pred --cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-HHHh--------hcccCCccccC
Confidence 123456899999999999989999999999999999999999999654322111 0000 00111122222
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
..+.+++.+||+.||++||++++++++.+...
T Consensus 237 ----~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 237 ----IEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp ----HHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred ----HHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 46889999999999999999999999887653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=341.47 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=206.7
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
...+.||+|+||+||+|+.. +++.||+|.+... .....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 97 (294)
T 2rku_A 18 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 97 (294)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecC
Confidence 34568999999999999886 4789999988643 2344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 170 (294)
T 2rku_A 98 RRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-- 170 (294)
T ss_dssp TTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc--
Confidence 999999998753 35999999999999999999999 88999999999999999999999999999986543221
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... +.......... .+....+
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~--------~~~~~~~ 239 (294)
T 2rku_A 171 --RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-ETYLRIKKNEY--------SIPKHIN 239 (294)
T ss_dssp --CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTTCC--------CCCTTSC
T ss_pred --ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhhccC--------CCccccC
Confidence 223456899999999999989999999999999999999999999754432 22222211111 1112222
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
..+.+++.+||+.||++||++++++++.+....
T Consensus 240 ----~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 240 ----PVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ----HHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 458899999999999999999999998877544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=349.55 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=196.9
Q ss_pred hhhhcceecceEEEEEEecC-----CcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 172 FSTIIGQGGFGTVYKAQFSD-----GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.++||+|+||+||+|++.. +..||||.++.. .......|.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 127 (333)
T 1mqb_A 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 127 (333)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeC
Confidence 44689999999999998753 236999998753 334456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 128 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 128 MENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp CTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred CCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 99999999997542 35999999999999999999999 889999999999999999999999999999865433211
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
........+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... +...... .... .....
T Consensus 204 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-~~~~~~~-~~~~------~~~~~- 273 (333)
T 1mqb_A 204 -TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAIN-DGFR------LPTPM- 273 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHH-TTCC------CCCCT-
T ss_pred -ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHH-CCCc------CCCcc-
Confidence 111223456889999999999999999999999999999999 99999654332 2222211 1111 11111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.....+.+++..||+.||++||++.+++++|...
T Consensus 274 ---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 274 ---DCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp ---TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2235688999999999999999999999998653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=353.81 Aligned_cols=263 Identities=23% Similarity=0.286 Sum_probs=195.6
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
+.+.+.||+|+||+||+|+.. +|+.||||+++... ......+.+|+++|++++||||+++++++.+.+..++||||+
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 115 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA 115 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecC
Confidence 344578999999999999865 68999999986433 233456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe-----cCCCcEEEeeccccccCCC
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL-----DENFVAKLADFGLAHASKD 321 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl-----~~~~~~kl~DfGla~~~~~ 321 (518)
+ |+|.+++.... .+++..+..|+.|++.||+||| +.+|+||||||+|||+ ++++.+||+|||+++....
T Consensus 116 ~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 116 E-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp S-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred C-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 8 59999997643 4999999999999999999999 8899999999999999 4556699999999976543
Q ss_pred CCcccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc----cccc
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR----LAEL 396 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~----l~~~ 396 (518)
... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||................... ....
T Consensus 190 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 190 PIR----QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp --------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccc----ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 221 22445689999999999874 58999999999999999999999997655443333322111100 0000
Q ss_pred c--------CCcCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 397 V--------DPRIKDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 397 ~--------d~~l~~~~~~-----~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
. .+........ .....+.+++..||+.||++|||++|+++|.|+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 324 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence 0 0000000000 01256889999999999999999999999988754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=346.89 Aligned_cols=258 Identities=27% Similarity=0.417 Sum_probs=206.7
Q ss_pred hhhhhhcceecceEEEEEEec------CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
+.+.+.||+|+||+||+|++. ++..||||.+.... ......|.+|+.++++++|+||+++++++.+.+..++|
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 106 (322)
T 1p4o_A 27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 106 (322)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEE
Confidence 445678999999999999764 36789999987533 34456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecc
Q 010088 243 YEYMANGSLKDHLHSPG--------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG 314 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfG 314 (518)
|||+++|+|.+++.... ...+++..+++++.|++.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEEECcCc
Confidence 99999999999986421 245799999999999999999999 8899999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhcccc
Q 010088 315 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRL 393 (518)
Q Consensus 315 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l 393 (518)
+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ........... ..
T Consensus 184 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~~~~--~~ 258 (322)
T 1p4o_A 184 MTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLRFVMEG--GL 258 (322)
T ss_dssp CCCGGGGGGCE--EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-HHHHHHHHHTT--CC
T ss_pred ccccccccccc--ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-HHHHHHHHHcC--Cc
Confidence 99765332211 12233457889999999999999999999999999999999 788876433 22222222111 11
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCC
Q 010088 394 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 444 (518)
Q Consensus 394 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~ 444 (518)
+...... ...+.+++..||+.||.+||++.+++++|.....+
T Consensus 259 -----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 259 -----LDKPDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp -----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -----CCCCCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 1111222 35688999999999999999999999999876553
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=351.19 Aligned_cols=263 Identities=25% Similarity=0.415 Sum_probs=203.8
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.++||+|+||+||+|+.. +|+.||||++.... ......+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 107 (331)
T 4aaa_A 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD 107 (331)
T ss_dssp EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCC
Confidence 34568999999999999886 48999999885432 3334568899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 108 ~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 179 (331)
T 4aaa_A 108 HTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--- 179 (331)
T ss_dssp EEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred cchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc---
Confidence 999999876533 4999999999999999999999 88999999999999999999999999999976543221
Q ss_pred cccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHh-------------hcccc
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMA-------------SESRL 393 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~-------------~~~~l 393 (518)
......||+.|+|||.+.+. .++.++||||||+++|||++|+.||............... .....
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 22345689999999998775 7899999999999999999999999765544333322211 11111
Q ss_pred ccccCCcCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 394 AELVDPRIKDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 394 ~~~~d~~l~~~~~~-----~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.....+.+...... .....+.+++..||+.||++||++.|++++.|...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 11112222211111 12356899999999999999999999999987753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=341.40 Aligned_cols=256 Identities=19% Similarity=0.301 Sum_probs=201.6
Q ss_pred hhhhhhcceecceEEEEEEe-cCCcEEEEEEeccccchhHHHHHHHHHHHHHcC-CCCeeeEeeeeee--cCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIE--KRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~e~ 245 (518)
+.+.+.||+|+||+||+|+. .+|+.||||+++... .+.+.+|+++|.+++ |+||+++++++.+ ....++||||
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred eEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 34557899999999999986 468999999986432 467899999999997 9999999999987 5678999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC-cEEEeeccccccCCCCCc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-VAKLADFGLAHASKDGSI 324 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DfGla~~~~~~~~ 324 (518)
+++++|.+++.. +++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++......
T Consensus 115 ~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~- 185 (330)
T 3nsz_A 115 VNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 185 (330)
T ss_dssp CCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred cCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence 999999999863 889999999999999999999 88999999999999999766 89999999998654432
Q ss_pred ccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc--ccccc-----
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES--RLAEL----- 396 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~--~l~~~----- 396 (518)
......||..|+|||.+.+ ..++.++|||||||++|||++|+.||..+....+.......... .+.+.
T Consensus 186 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 186 ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp ----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred ----ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 2244578999999999877 67999999999999999999999999655443332221111000 00000
Q ss_pred --cCC----------------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 397 --VDP----------------RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 397 --~d~----------------~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.++ .............+.+++..||+.||++|||++|+++|.|+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~ 324 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence 000 000000111235689999999999999999999999998875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=345.41 Aligned_cols=257 Identities=26% Similarity=0.356 Sum_probs=205.3
Q ss_pred hhhhhhhcceecceEEEEEEe------cCCcEEEEEEecccc-chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecC-ce
Q 010088 169 TDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKR-ER 239 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-~~ 239 (518)
.+.+.+.||+|+||+||+|++ .+++.||||.+.... ......+.+|+.++.++ +||||+++++++...+ ..
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 107 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 107 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence 344567899999999999975 246899999987543 33456799999999999 7999999999988765 48
Q ss_pred EEEEEecCCCCHHHHhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC
Q 010088 240 FLMYEYMANGSLKDHLHSPGR--------------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 305 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 305 (518)
++||||+++|+|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.+
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEK 184 (316)
T ss_dssp EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCC
Confidence 999999999999999986442 22889999999999999999999 8899999999999999999
Q ss_pred CcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHH
Q 010088 306 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQ 384 (518)
Q Consensus 306 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~ 384 (518)
+.+||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||+| |+.||...........
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 262 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCEEECCCccccccccCccc--eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence 99999999999865433211 12234567899999999999999999999999999999998 9999865443333322
Q ss_pred HHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 385 VCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 385 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
...... ........+ ..+.+++..||+.||.+||++.+++++|...
T Consensus 263 ~~~~~~-------~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 263 RLKEGT-------RMRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp HHHHTC-------CCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccCc-------cCCCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 221111 111122222 4588999999999999999999999999653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=349.91 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=203.6
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccc--------hhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCce
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE--------QVEGDFCREIELLARL-HHRHLVALRGFCIEKRER 239 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 239 (518)
+.+.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.++.++ +||||+++++++......
T Consensus 96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 175 (365)
T 2y7j_A 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEE
T ss_pred cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEE
Confidence 334478999999999999986 699999998864321 2245688999999999 799999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccC
Q 010088 240 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 319 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~ 319 (518)
++||||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||++...
T Consensus 176 ~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 176 FLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 9999999999999999753 35999999999999999999999 889999999999999999999999999999866
Q ss_pred CCCCcccccccccccCCCcccCcccccc------CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccc
Q 010088 320 KDGSICFEPVNTDIRGTPGYMDPEYVVT------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 393 (518)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l 393 (518)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ............
T Consensus 251 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~ 324 (365)
T 2y7j_A 251 EPGE-----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-MLRMIMEGQYQF 324 (365)
T ss_dssp CTTC-----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCC
T ss_pred CCCc-----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCC
Confidence 5432 2244679999999999863 358899999999999999999999997544332 222221111110
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 394 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 394 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.. +. .... ...+.+++..||+.||++||++.+++++.|..
T Consensus 325 ~~---~~-~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 325 SS---PE-WDDR----SSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp CH---HH-HSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CC---cc-cccC----CHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 00 00 0111 24588999999999999999999999998763
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=354.23 Aligned_cols=266 Identities=24% Similarity=0.351 Sum_probs=193.9
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecC--ceEEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLH-HRHLVALRGFCIEKR--ERFLM 242 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~lV 242 (518)
.+.+.+.||+|+||+||+|... +|+.||||++... .......+.+|+.+|.++. ||||+++++++...+ ..++|
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 89 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence 3445678999999999999875 6899999998643 3344567889999999997 999999999997554 68999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||++ |+|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 90 FDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred ecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 99997 699999975 35899999999999999999999 889999999999999999999999999999865321
Q ss_pred Cc-----------------ccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHH
Q 010088 323 SI-----------------CFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQ 384 (518)
Q Consensus 323 ~~-----------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~ 384 (518)
.. ......+...||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 10 00112344679999999999876 6799999999999999999999999976544433332
Q ss_pred HHHhhcccccccc----------------------CCcCCCCCC------------HHHHHHHHHHHHHccccCCCCCCC
Q 010088 385 VCMASESRLAELV----------------------DPRIKDSFD------------MEQLRTIVTIVRWCTQREGQARPS 430 (518)
Q Consensus 385 ~~~~~~~~l~~~~----------------------d~~l~~~~~------------~~~~~~l~~li~~Cl~~dp~~RPs 430 (518)
..........+.+ .......++ ......+.+++.+||+.||++|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 2211100000000 000000000 011246889999999999999999
Q ss_pred HHHHHHHhhcC
Q 010088 431 IKQVLRILYES 441 (518)
Q Consensus 431 ~~evl~~L~~~ 441 (518)
++|+++|.|..
T Consensus 323 ~~e~l~Hp~~~ 333 (388)
T 3oz6_A 323 ANDALKHPFVS 333 (388)
T ss_dssp HHHHTTSTTTT
T ss_pred HHHHhCCHHHH
Confidence 99999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=354.68 Aligned_cols=266 Identities=23% Similarity=0.311 Sum_probs=210.0
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC--ceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKR--ERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~e~ 245 (518)
+.+.++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+.+ ..++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 345678999999999999886 48999999987533 334567889999999999999999999998765 67999999
Q ss_pred cCCCCHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe----cCCCcEEEeeccccccCC
Q 010088 246 MANGSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLAHASK 320 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DfGla~~~~ 320 (518)
+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 999999999986432 34999999999999999999999 8899999999999999 778889999999998765
Q ss_pred CCCcccccccccccCCCcccCcccccc--------CCCCccccchhhHHHHHHHHhCCccccCC---cchHHHHHHHHhh
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVT--------QELTEKSDVYSYGVVLLEIVTARRAVQDG---KNLVESAQVCMAS 389 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDVwS~Gvll~el~tG~~p~~~~---~~~~~~~~~~~~~ 389 (518)
... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||... ....+........
T Consensus 168 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 168 DDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CGG-----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred CCC-----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 432 2234579999999999865 56788999999999999999999999632 2222332222221
Q ss_pred cc--ccccc---c--------CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 390 ES--RLAEL---V--------DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 390 ~~--~l~~~---~--------d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
.. .+... . +..............+.+++..||+.||++||+++++++.+.....
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 11 00000 0 0111223456777889999999999999999999999998876544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=348.81 Aligned_cols=250 Identities=22% Similarity=0.353 Sum_probs=206.6
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
..+.||+|+||+||+++.. +++.||+|.+... .....+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 45 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 124 (335)
T 2owb_A 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 124 (335)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCC
Confidence 4568999999999999886 4789999998643 23445678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 125 ~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--- 196 (335)
T 2owb_A 125 RRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--- 196 (335)
T ss_dssp TCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC---
T ss_pred CCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc---
Confidence 99999998753 35999999999999999999999 88999999999999999999999999999986543221
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......||..|+|||.+.+..++.++||||||+++|||++|+.||...... +.......... .+....+
T Consensus 197 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~--------~~~~~~~- 265 (335)
T 2owb_A 197 -RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-ETYLRIKKNEY--------SIPKHIN- 265 (335)
T ss_dssp -CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCC--------CCCTTSC-
T ss_pred -cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHhcCCC--------CCCccCC-
Confidence 223456999999999999999999999999999999999999999754332 22222221111 1122222
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
..+.+++.+||+.||++||++.|++++.+....
T Consensus 266 ---~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 266 ---PVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ---HHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 457889999999999999999999998877544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.92 Aligned_cols=261 Identities=19% Similarity=0.237 Sum_probs=204.2
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHc------CCCCeeeEeeeeeecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL------HHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~~lV 242 (518)
+.+.++||+|+||+||+|... +++.||||+++.. ......+.+|+.++..+ +|+||+++++++...+..++|
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 177 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence 345678999999999999875 5899999998753 33446788899999888 467999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc--EEEeeccccccCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV--AKLADFGLAHASK 320 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~--~kl~DfGla~~~~ 320 (518)
|||+. ++|.+++.......+++..+..|+.||+.||+||| +.+|+||||||+||||+.++. +||+|||+++...
T Consensus 178 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp ECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 99996 69999998766566999999999999999999999 889999999999999999887 9999999997544
Q ss_pred CCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc---------
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES--------- 391 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~--------- 391 (518)
.. .....||+.|+|||++.+..++.++|||||||+||||+||+.||..................
T Consensus 254 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~ 326 (429)
T 3kvw_A 254 QR-------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326 (429)
T ss_dssp CC-------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred Cc-------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 32 23457899999999999999999999999999999999999999755433222221111000
Q ss_pred -ccccccCCc---------------------------C---CCCCCH------HHHHHHHHHHHHccccCCCCCCCHHHH
Q 010088 392 -RLAELVDPR---------------------------I---KDSFDM------EQLRTIVTIVRWCTQREGQARPSIKQV 434 (518)
Q Consensus 392 -~l~~~~d~~---------------------------l---~~~~~~------~~~~~l~~li~~Cl~~dp~~RPs~~ev 434 (518)
.....++.. . ...... .....+.+++.+||+.||++|||++|+
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~ 406 (429)
T 3kvw_A 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA 406 (429)
T ss_dssp TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence 000000000 0 000000 012458899999999999999999999
Q ss_pred HHHhhcCC
Q 010088 435 LRILYESS 442 (518)
Q Consensus 435 l~~L~~~~ 442 (518)
++|.|...
T Consensus 407 L~Hpw~~~ 414 (429)
T 3kvw_A 407 LRHPWLRR 414 (429)
T ss_dssp HTSTTTC-
T ss_pred hCChhhcc
Confidence 99988754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=334.87 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=205.3
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.+.||+|+||+||+|+.. +|+.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (276)
T 2yex_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (276)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecC
Confidence 445678999999999999876 68999999986432 3445678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........ .
T Consensus 89 ~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~ 161 (276)
T 2yex_A 89 GGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--E 161 (276)
T ss_dssp TEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE--E
T ss_pred CCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc--h
Confidence 99999999763 35899999999999999999999 88999999999999999999999999999976533221 1
Q ss_pred cccccccCCCcccCccccccCCC-CccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
.......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.................... . .....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~--~~~~~- 234 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL----N--PWKKI- 234 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS----T--TGGGS-
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc----C--chhhc-
Confidence 12345678999999999987765 7799999999999999999999975433222211111111000 0 00112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
...+.+++..||+.||++||++.|++++.+..
T Consensus 235 ---~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 266 (276)
T 2yex_A 235 ---DSAPLALLHKILVENPSARITIPDIKKDRWYN 266 (276)
T ss_dssp ---CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred ---CHHHHHHHHHHCCCCchhCCCHHHHhcCcccc
Confidence 24578999999999999999999999988764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=379.14 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=196.9
Q ss_pred hhcceecceEEEEEEec---CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 174 TIIGQGGFGTVYKAQFS---DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.||+|+||+||+|.+. .+..||||+++... ....++|.+|+++|.+++||||++++++|. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 37999999999999663 46789999997533 334578999999999999999999999986 4568999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.+++... ..+++..++.|+.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++......... .
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~ 527 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-K 527 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc-c
Confidence 9999999753 35999999999999999999999 8899999999999999999999999999998765433211 1
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... +....... .. .......
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-~~~~~i~~-~~------~~~~p~~--- 596 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEK-GE------RMGCPAG--- 596 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHT-TC------CCCCCTT---
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHc-CC------CCCCCCC---
Confidence 2234457889999999999999999999999999999998 99999754432 22222111 11 1111222
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
....+.+++..||+.||++||++.+|++.|..
T Consensus 597 -~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 597 -CPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp -CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 23568899999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=339.29 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=197.9
Q ss_pred hhhhhcceecceEEEEEEecC----CcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 171 NFSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
.+.+.||+|+||+||+|++.+ +..||||.+... .....+.|.+|+.++++++||||+++++++.+ +..++||||
T Consensus 15 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 93 (281)
T 3cc6_A 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMEL 93 (281)
T ss_dssp EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEec
Confidence 345789999999999998643 246999998754 33455779999999999999999999999765 567899999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.........
T Consensus 94 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 94 YPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp CTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred CCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence 99999999997532 35899999999999999999999 889999999999999999999999999999865443211
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.......... ... .... ......
T Consensus 170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~-~~~-~~~~------~~~~~~ 238 (281)
T 3cc6_A 170 ---KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG-VLE-KGDR------LPKPDL 238 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH-HHH-HTCC------CCCCTT
T ss_pred ---ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH-HHh-cCCC------CCCCCC
Confidence 2234457889999999998999999999999999999998 999996443322111 111 1111 111122
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.+ ..+.+++..||+.||++||++.+++++|..
T Consensus 239 ~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 239 CP----PVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp CC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----HHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 22 458899999999999999999999999865
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=367.86 Aligned_cols=249 Identities=25% Similarity=0.389 Sum_probs=205.9
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
++||+|+||+||+|+.. +|+.||+|++.... ......+.+|+++|.+++||||+++++++.+.+..++||||++||
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 57999999999999885 68999999986432 233467899999999999999999999999999999999999999
Q ss_pred CHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 250 SLKDHLHSPG--RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 250 sL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
+|.+++.... ...+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++.......
T Consensus 271 ~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~--- 344 (543)
T 3c4z_A 271 DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--- 344 (543)
T ss_dssp BHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---
T ss_pred CHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc---
Confidence 9999997643 346999999999999999999999 88999999999999999999999999999987654321
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCc---chHHHHHHHHhhccccccccCCcCCCC
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK---NLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~---~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......+....... .....
T Consensus 345 -~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--------~~p~~ 415 (543)
T 3c4z_A 345 -KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--------TYPDK 415 (543)
T ss_dssp -CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--------CCCTT
T ss_pred -ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--------CCCcc
Confidence 2234579999999999999999999999999999999999999997542 22233332222211 11122
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHhhcC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSI-----KQVLRILYES 441 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~-----~evl~~L~~~ 441 (518)
++ ..+.+++..||+.||++||++ +++++|.++.
T Consensus 416 ~s----~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~ 453 (543)
T 3c4z_A 416 FS----PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453 (543)
T ss_dssp SC----HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGT
T ss_pred cC----HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcccc
Confidence 22 458899999999999999964 8899888765
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=350.11 Aligned_cols=263 Identities=21% Similarity=0.228 Sum_probs=196.8
Q ss_pred hhhhhhcceecceEEEEEEec----CCcEEEEEEeccccch-----------hHHHHHHHHHHHHHcCCCCeeeEeeeee
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKISEQ-----------VEGDFCREIELLARLHHRHLVALRGFCI 234 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g~~~ 234 (518)
+.+.+.||+|+||+||+|+.. ++..+|||++...... ....+.+|+..+..++|+||+++++++.
T Consensus 39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~ 118 (345)
T 2v62_A 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL 118 (345)
T ss_dssp EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEE
T ss_pred EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccc
Confidence 445678999999999999885 5688999988653321 1234678889999999999999999998
Q ss_pred e----cCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC--cE
Q 010088 235 E----KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF--VA 308 (518)
Q Consensus 235 ~----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~--~~ 308 (518)
. ....++||||+ +++|.+++...+ .+++..++.++.||+.||+||| +.+|+||||||+|||++.++ .+
T Consensus 119 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 119 TEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTSE
T ss_pred cccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCcE
Confidence 8 67889999999 999999998644 6999999999999999999999 88999999999999999877 99
Q ss_pred EEeeccccccCCCCCcc---cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCC-cchHHHHH
Q 010088 309 KLADFGLAHASKDGSIC---FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDG-KNLVESAQ 384 (518)
Q Consensus 309 kl~DfGla~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~-~~~~~~~~ 384 (518)
||+|||+++........ .........||+.|+|||.+.+..++.++|||||||++|||++|+.||... .+......
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 99999999765432110 011224557999999999999999999999999999999999999999532 22211111
Q ss_pred HHHhhccccccccCCcCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 385 VCMASESRLAELVDPRIK-DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 385 ~~~~~~~~l~~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
........+......... ..+ ...+.+++..||+.||++||++++|++.|....
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSS----CCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHhhcccccHHHHhhcccccc----HHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111111111111111000 012 246899999999999999999999999997654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=340.32 Aligned_cols=256 Identities=21% Similarity=0.308 Sum_probs=197.0
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.+.||+|+||+||+|+.. +++.||||.+.... ....+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL 115 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence 345678999999999999875 68899999986432 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 116 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 189 (309)
T 2h34_A 116 INGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL- 189 (309)
T ss_dssp CCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc-
Confidence 9999999999753 35999999999999999999999 88999999999999999999999999999976544321
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .. ............. ....+
T Consensus 190 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~-~~~~~~~~~~~~~----~~~~~ 261 (309)
T 2h34_A 190 --TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VM-GAHINQAIPRPST----VRPGI 261 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HH-HHHHHSCCCCGGG----TSTTC
T ss_pred --ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HH-HHHhccCCCCccc----cCCCC
Confidence 1223456899999999999999999999999999999999999999754322 11 1111111111111 11122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcCCC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARP-SIKQVLRILYESSD 443 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RP-s~~evl~~L~~~~~ 443 (518)
+ ..+.+++.+||+.||++|| +++++++.|.....
T Consensus 262 ~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 262 P----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp C----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred C----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 2 4588999999999999999 99999999987654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=356.32 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=195.6
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHH-HHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIEL-LARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.+.++||+|+||+||+|+.. ++..||||++++.. ......+.+|..+ ++.++||||+++++++.+.+..|+|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 445679999999999999886 57899999986532 2234456777776 467899999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++......
T Consensus 120 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~- 193 (373)
T 2r5t_A 120 YINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN- 193 (373)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccCC-
Confidence 999999999997633 4899999999999999999999 8999999999999999999999999999998643221
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+....+...... +...
T Consensus 194 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~~~~i~~~~~~--------~~~~ 261 (373)
T 2r5t_A 194 ---STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNILNKPLQ--------LKPN 261 (373)
T ss_dssp ---CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-HHHHHHHHHHSCCC--------CCSS
T ss_pred ---CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhcccC--------CCCC
Confidence 12345679999999999999999999999999999999999999997543 33333333322111 1122
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH----HHHHHHhhcC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSI----KQVLRILYES 441 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~----~evl~~L~~~ 441 (518)
++ ..+.+++..||+.||.+||++ .++++|.++.
T Consensus 262 ~~----~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~ 298 (373)
T 2r5t_A 262 IT----NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298 (373)
T ss_dssp SC----HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGT
T ss_pred CC----HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcccc
Confidence 23 458899999999999999997 5777776653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=338.31 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=205.1
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.+.||+|+||+||+|+.. ++..||||.+.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 95 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence 345578999999999999876 57899999985422 22346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 168 (284)
T 2vgo_A 96 APRGELYKELQKHG--RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-- 168 (284)
T ss_dssp CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence 99999999997643 4899999999999999999999 8999999999999999999999999999987554321
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .......... ..+....
T Consensus 169 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~--------~~~~~~~ 235 (284)
T 2vgo_A 169 ----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-ETHRRIVNVD--------LKFPPFL 235 (284)
T ss_dssp ----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTTC--------CCCCTTS
T ss_pred ----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-HHHHHHhccc--------cCCCCcC
Confidence 23456899999999999999999999999999999999999999754432 2222222111 1122222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+ ..+.+++..||+.||.+||+++++++|.+..
T Consensus 236 ~----~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~ 267 (284)
T 2vgo_A 236 S----DGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267 (284)
T ss_dssp C----HHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred C----HHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence 2 4588999999999999999999999987653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=336.90 Aligned_cols=248 Identities=23% Similarity=0.332 Sum_probs=200.8
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 244 (518)
.+.+.+.||+|+||+||+|+.. +|+.||||++... ......++.+|+..+.++ +||||+++++++.+.+..++|||
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e 91 (289)
T 1x8b_A 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE 91 (289)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence 3445678999999999999886 6899999998743 334556789999999999 99999999999999999999999
Q ss_pred ecCCCCHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC------------------
Q 010088 245 YMANGSLKDHLHSPG--RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE------------------ 304 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~------------------ 304 (518)
|+++|+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-------------------
T ss_pred ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999997532 245899999999999999999999 889999999999999984
Q ss_pred -CCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHH
Q 010088 305 -NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES 382 (518)
Q Consensus 305 -~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~ 382 (518)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|..++.........
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~ 240 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSPQ--------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240 (289)
T ss_dssp -CCCEEECCCTTCEETTCSC--------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHH
T ss_pred CceEEEEcccccccccCCcc--------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHH
Confidence 4489999999998654322 23589999999999765 6678999999999999999998876544322111
Q ss_pred HHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 383 AQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 383 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
. ... .+.+...++ ..+.+++..||+.||++||++.|++++.+...
T Consensus 241 ----~--~~~-----~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 241 ----R--QGR-----LPRIPQVLS----QEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp ----H--TTC-----CCCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred ----H--cCC-----CCCCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 1 111 122222333 45889999999999999999999999987653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=348.34 Aligned_cols=262 Identities=22% Similarity=0.309 Sum_probs=196.0
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccc-hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+++|++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 83 (324)
T 3mtl_A 5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 83 (324)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-
Confidence 34568999999999999886 689999999864332 222345689999999999999999999999999999999997
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.+++...+ ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---- 155 (324)
T 3mtl_A 84 KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK---- 155 (324)
T ss_dssp EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc----
Confidence 59999987643 35999999999999999999999 88999999999999999999999999999976543221
Q ss_pred ccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc----cccccC-----
Q 010088 329 VNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR----LAELVD----- 398 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~----l~~~~d----- 398 (518)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||................... +.....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 2234568999999999876 578999999999999999999999997544332222221111110 000000
Q ss_pred ----CcCCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 399 ----PRIKDSF----DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 399 ----~~l~~~~----~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+...... .......+.+++..||+.||++|||++|+++|.|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 286 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence 0000000 001124578999999999999999999999998774
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=351.32 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=197.3
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC------ceE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR------ERF 240 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~ 240 (518)
+.+.+.||+|+||+||+|... +|+.||||++... .......+.+|+++|++++||||+++++++...+ ..+
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 344568999999999999874 6899999998542 3334567899999999999999999999987653 459
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCC
Q 010088 241 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~ 320 (518)
+||||+ +++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 107 lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp EEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 999999 8899999975 34899999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccc------
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL------ 393 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l------ 393 (518)
.. .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....................
T Consensus 180 ~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 180 SE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp SS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cc-------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 32 244578999999999877 6899999999999999999999999975544333222211111000
Q ss_pred -------------ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 394 -------------AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 394 -------------~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+......+. .........+.+++.+||+.||++|||++|+++|.+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence 000000000 001122356889999999999999999999999988754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=349.92 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=204.3
Q ss_pred hhhhhhhcceecceEEEEEEecC------CcEEEEEEecccc-chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFSD------GSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERF 240 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 240 (518)
.+.+.+.||+|+||+||+|.... +..||+|.+.... ......+.+|+.++.++ +||||+++++++.+.+..+
T Consensus 47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 126 (333)
T 2i1m_A 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126 (333)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceE
Confidence 34456789999999999998742 2479999987543 34456799999999999 8999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcE
Q 010088 241 LMYEYMANGSLKDHLHSPG------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVA 308 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 308 (518)
+||||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGGEE
T ss_pred EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCCeE
Confidence 9999999999999986421 235899999999999999999999 8899999999999999999999
Q ss_pred EEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHH
Q 010088 309 KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCM 387 (518)
Q Consensus 309 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~ 387 (518)
||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||+| |..||.............
T Consensus 204 kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~- 280 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV- 280 (333)
T ss_dssp EBCCCGGGCCGGGCTTS--EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH-
T ss_pred EECccccccccccccce--eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH-
Confidence 99999999865332211 12234557889999999999999999999999999999999 888886543322222211
Q ss_pred hhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 388 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 388 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.... ........ ...+.+++..||+.||.+||++.+++++|..
T Consensus 281 ~~~~------~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 281 KDGY------QMAQPAFA----PKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp HHTC------CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hcCC------CCCCCCCC----CHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 1111 11111112 2468899999999999999999999999865
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=353.90 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=202.7
Q ss_pred hhhhhhcceecceEEEEEEe----cCCcEEEEEEecccc----chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceE
Q 010088 170 DNFSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKIS----EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERF 240 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 240 (518)
+.+.++||+|+||+||+|+. .+|+.||||+++... ......+.+|+++|.++ +|+||+++++++...+..+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 44567899999999999987 368999999986432 23345678899999999 6999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCC
Q 010088 241 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~ 320 (518)
+||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++...
T Consensus 136 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999997543 5999999999999999999999 8899999999999999999999999999998653
Q ss_pred CCCcccccccccccCCCcccCcccccc--CCCCccccchhhHHHHHHHHhCCccccCCc---chHHHHHHHHhhcccccc
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGK---NLVESAQVCMASESRLAE 395 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvll~el~tG~~p~~~~~---~~~~~~~~~~~~~~~l~~ 395 (518)
.... .......||+.|+|||.+.+ ..++.++|||||||+||||++|+.||.... .............
T Consensus 211 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----- 282 (355)
T 1vzo_A 211 ADET---ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----- 282 (355)
T ss_dssp GGGG---GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-----
T ss_pred cCCC---CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC-----
Confidence 3221 12334579999999999985 357899999999999999999999996322 2223322222211
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 396 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 396 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
+.....++ ..+.+++.+||+.||.+|| +++|++++++..
T Consensus 283 ---~~~~~~~~----~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~ 326 (355)
T 1vzo_A 283 ---PPYPQEMS----ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326 (355)
T ss_dssp ---CCCCTTSC----HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred ---CCCCcccC----HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence 11222222 4588999999999999999 999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=342.54 Aligned_cols=269 Identities=28% Similarity=0.414 Sum_probs=209.4
Q ss_pred cCHHHHHHHhhhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHH--cCCCCeeeEeeeeeecC
Q 010088 160 FSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLAR--LHHRHLVALRGFCIEKR 237 (518)
Q Consensus 160 ~~~~~l~~a~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~ 237 (518)
+...+.....+.+.+.||+|+||+||+|++ +|+.||||.+... ....+.+|++++.. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 334455556677778999999999999998 5899999998643 34568899999988 78999999999998876
Q ss_pred ----ceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCceecccCCCcEEecCCCcE
Q 010088 238 ----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY-----CDPPLCHRDIKSSNILLDENFVA 308 (518)
Q Consensus 238 ----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiHrDlk~~NILl~~~~~~ 308 (518)
..++||||+++|+|.+++... .+++..++.++.|++.||+|||.. ++.+|+||||||+|||++.++.+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred CccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence 789999999999999999753 499999999999999999999932 14689999999999999999999
Q ss_pred EEeeccccccCCCCCcccccccccccCCCcccCccccccC------CCCccccchhhHHHHHHHHhC----------Ccc
Q 010088 309 KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ------ELTEKSDVYSYGVVLLEIVTA----------RRA 372 (518)
Q Consensus 309 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwS~Gvll~el~tG----------~~p 372 (518)
||+|||+++.................||+.|+|||.+.+. .++.++||||||+++|||+|| ..|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 9999999976544332211123455799999999998765 334789999999999999999 677
Q ss_pred ccCCc----chHHHHHHHHhhccccccccCCcCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 373 VQDGK----NLVESAQVCMASESRLAELVDPRIKDS-FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 373 ~~~~~----~~~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
|.... ....+..... .....+.+... ...+....+.+++.+||+.||++||++.+|+++|...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVC------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHT------TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCcCcccHHHHHHHHH------HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 75431 1222222111 11112222211 1236677899999999999999999999999999654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=345.10 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=201.7
Q ss_pred hhhhhhcceecceEEEEEEe-cCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeee----cCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE----KRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e 244 (518)
+.+.+.||+|+||+||+++. .+|+.||||++........+.+.+|++++++++||||+++++++.. ....++|||
T Consensus 31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 110 (317)
T 2buj_A 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110 (317)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEE
Confidence 44567899999999999987 4789999999876666667789999999999999999999999873 347899999
Q ss_pred ecCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 245 YMANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 245 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|+++|+|.+++... ....+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp CCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred eCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 99999999998742 2356999999999999999999999 889999999999999999999999999998754321
Q ss_pred Cccc-----ccccccccCCCcccCccccccCC---CCccccchhhHHHHHHHHhCCccccC----CcchHHHHHHHHhhc
Q 010088 323 SICF-----EPVNTDIRGTPGYMDPEYVVTQE---LTEKSDVYSYGVVLLEIVTARRAVQD----GKNLVESAQVCMASE 390 (518)
Q Consensus 323 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwS~Gvll~el~tG~~p~~~----~~~~~~~~~~~~~~~ 390 (518)
.... ........||+.|+|||.+.... ++.++||||||+++|||++|+.||.. ........ ...
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----~~~ 263 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV----QNQ 263 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH----HCC
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh----hcc
Confidence 1000 00112345799999999987543 78999999999999999999999852 11111111 000
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 010088 391 SRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM 445 (518)
Q Consensus 391 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~ 445 (518)
.. ......+ ...+.+++..||+.||.+||++.+++++|.....+.
T Consensus 264 ~~------~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 264 LS------IPQSPRH----SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp --------CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred CC------CCccccC----CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 00 0011122 256889999999999999999999999998765543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=353.61 Aligned_cols=259 Identities=18% Similarity=0.210 Sum_probs=201.4
Q ss_pred hhhhhhcceecceEEEEEEecC---------CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeee------------
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSD---------GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVA------------ 228 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~------------ 228 (518)
+.+.+.||+|+||+||+|+... +..||||.+... ..+.+|++++.+++||||++
T Consensus 44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 3456789999999999998763 789999998643 46889999999999999988
Q ss_pred ---Eeeeeee-cCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC
Q 010088 229 ---LRGFCIE-KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE 304 (518)
Q Consensus 229 ---l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~ 304 (518)
+++++.. .+..++||||+ +++|.+++.......+++..++.++.||+.||+||| +.+|+||||||+|||++.
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEET
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcC
Confidence 6677766 67889999999 999999998653456999999999999999999999 889999999999999999
Q ss_pred CC--cEEEeeccccccCCCCCcc---cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCc-c
Q 010088 305 NF--VAKLADFGLAHASKDGSIC---FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK-N 378 (518)
Q Consensus 305 ~~--~~kl~DfGla~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~-~ 378 (518)
++ .+||+|||+++........ .........||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 9999999999865432211 0112234579999999999999999999999999999999999999997543 2
Q ss_pred hHHHHHHHHhhccccccccCCcCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 379 LVESAQVCMASESRLAELVDPRIK-DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 379 ~~~~~~~~~~~~~~l~~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.................+.+.... ...+ ..+.+++..||+.||++||+++++++.|...
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPS----ETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp HHHHHHHHHHHHHSCCCEECTTSCEECCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccCChhhhhhhccccCCCc----HHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 222222111111111222221111 1122 5688999999999999999999999998664
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=349.70 Aligned_cols=263 Identities=22% Similarity=0.324 Sum_probs=209.1
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccch-----------------hHHHHHHHHHHHHHcCCCCeeeEeee
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-----------------VEGDFCREIELLARLHHRHLVALRGF 232 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~H~niv~l~g~ 232 (518)
+.+.+.||+|+||+||+|+. +|+.||||.+...... ....|.+|+.++.+++||||++++++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred eEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 34557899999999999998 8999999998642211 11789999999999999999999999
Q ss_pred eeecCceEEEEEecCCCCHHHH------hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCceecccCCCcEEecCC
Q 010088 233 CIEKRERFLMYEYMANGSLKDH------LHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDEN 305 (518)
Q Consensus 233 ~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiHrDlk~~NILl~~~ 305 (518)
+.+.+..++||||+++|+|.++ +.......+++..+..++.|++.||+||| + .+|+||||||+||+++.+
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEECTT
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEEcCC
Confidence 9999999999999999999999 66544567999999999999999999999 7 899999999999999999
Q ss_pred CcEEEeeccccccCCCCCcccccccccccCCCcccCccccccC-CCCc-cccchhhHHHHHHHHhCCccccCCcchHHHH
Q 010088 306 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTE-KSDVYSYGVVLLEIVTARRAVQDGKNLVESA 383 (518)
Q Consensus 306 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~ 383 (518)
+.+||+|||++...... ......||..|+|||.+.+. .++. ++||||||+++|||++|+.||.......+..
T Consensus 189 ~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp SCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred CcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99999999999865443 22445799999999999877 6666 9999999999999999999997655534444
Q ss_pred HHHHhhccccccccC----CcCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 384 QVCMASESRLAELVD----PRIK---DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 384 ~~~~~~~~~l~~~~d----~~l~---~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.........++.... +... ..........+.+++..||+.||.+||++.|++++.+...
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 333222111111000 0000 0000122356889999999999999999999999988754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=344.75 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=199.2
Q ss_pred HhhhhhhhcceecceEEEEEEec-CCcEEEEEEecccc--------chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCc
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--------EQVEGDFCREIELLARLHHRHLVALRGFCIEKRE 238 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 238 (518)
..+.+.+.||+|+||+||+|+.. +|+.||||.+.... ......+.+|+++|.+++||||+++++++... .
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~ 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-D 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-c
Confidence 44566789999999999999875 57899999986422 12234588999999999999999999998665 4
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc---EEEeeccc
Q 010088 239 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV---AKLADFGL 315 (518)
Q Consensus 239 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DfGl 315 (518)
.++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 89999999999999999764 35999999999999999999999 889999999999999987654 99999999
Q ss_pred cccCCCCCcccccccccccCCCcccCccccc---cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc
Q 010088 316 AHASKDGSICFEPVNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR 392 (518)
Q Consensus 316 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 392 (518)
++...... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||...................
T Consensus 164 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (322)
T 2ycf_A 164 SKILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238 (322)
T ss_dssp CEECCCCH-----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred ceeccccc-----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence 98664432 123456899999999874 5678999999999999999999999996543221111111111110
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 393 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 393 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
. .+...... ...+.+++..||+.||++||++.+++++.+...
T Consensus 239 ~----~~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 239 F----IPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp C----CHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred c----Cchhhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 0 01111112 246889999999999999999999999988754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=348.67 Aligned_cols=264 Identities=26% Similarity=0.409 Sum_probs=204.3
Q ss_pred hhhhhhcceecceEEEEEEe-----cCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC--ceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR--ERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 242 (518)
+.+.+.||+|+||+||+|++ .+|+.||||++........+.|.+|++++++++||||+++++++...+ ..++|
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence 44567899999999999984 368899999998766666778999999999999999999999987654 78999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 123 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp ECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred EECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 99999999999997643 35999999999999999999999 889999999999999999999999999999876543
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhc------cccccc
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE------SRLAEL 396 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~------~~l~~~ 396 (518)
.... .......++..|+|||.+.+..++.++||||||+++|||+||..|+..... .......... ..+.+.
T Consensus 199 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 199 KEYY-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSEE-ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccc-ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--HHHHhhccccchhhhHHHHHHH
Confidence 3211 122334578889999999988899999999999999999999988753211 1000000000 000011
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 397 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 397 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
+........+......+.+++..||+.||++||++.++++.|..
T Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11000011111223568899999999999999999999999865
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=333.57 Aligned_cols=249 Identities=25% Similarity=0.406 Sum_probs=196.7
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
.+.+.||+|+||+||+|+.. +|+.||||.+.... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (276)
T 2h6d_A 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93 (276)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEecc
Confidence 34568999999999999886 68999999986432 233467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--- 165 (276)
T 2h6d_A 94 SGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--- 165 (276)
T ss_dssp CSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred CCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc---
Confidence 9999999997543 4899999999999999999999 8899999999999999999999999999998765432
Q ss_pred ccccccccCCCcccCccccccCCC-CccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ............ .+....
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~--------~~~~~~ 234 (276)
T 2h6d_A 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-PTLFKKIRGGVF--------YIPEYL 234 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCC--------CCCTTS
T ss_pred --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhcCcc--------cCchhc
Confidence 1234568999999999987765 6899999999999999999999965432 222222211111 111222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+ ..+.+++.+||+.||++||++.+++++.+...
T Consensus 235 ~----~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 235 N----RSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred C----HHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 2 45889999999999999999999999887643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=343.32 Aligned_cols=262 Identities=25% Similarity=0.373 Sum_probs=203.3
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
.+.+.||+|+||+||+|+.. +|..||+|.+..........+.+|++++.+++||||+++++++...+..++||||++++
T Consensus 22 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (302)
T 2j7t_A 22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG 101 (302)
T ss_dssp EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTE
T ss_pred eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCC
Confidence 34568999999999999986 58999999987666666678999999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....... ..
T Consensus 102 ~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~ 173 (302)
T 2j7t_A 102 AVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL----QK 173 (302)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH----HC
T ss_pred cHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc----cc
Confidence 9999986532 34999999999999999999999 8899999999999999999999999999875321110 11
Q ss_pred cccccCCCcccCccccc-----cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 330 NTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.....||+.|+|||.+. ...++.++||||||+++|||++|+.|+........... ..... ...... ..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~--~~~~~~---~~- 246 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK-IAKSD--PPTLLT---PS- 246 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HHHSC--CCCCSS---GG-
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH-HhccC--CcccCC---cc-
Confidence 23356899999999983 56789999999999999999999999975443322221 11111 011111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCCcchh
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFV 450 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~ 450 (518)
.....+.+++..||+.||++||++.++++|.+...........
T Consensus 247 ---~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~ 289 (302)
T 2j7t_A 247 ---KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALR 289 (302)
T ss_dssp ---GSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCHHHH
T ss_pred ---ccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccchhHH
Confidence 1224688999999999999999999999998876554433333
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=341.20 Aligned_cols=246 Identities=28% Similarity=0.454 Sum_probs=194.0
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec-CceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK-RERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||+||+|+. .|+.||||.++... ..+.|.+|++++.+++||||+++++++.+. +..++||||+++
T Consensus 23 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 99 (278)
T 1byg_A 23 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 99 (278)
T ss_dssp EEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred ceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCC
Confidence 34567899999999999987 58899999987533 456799999999999999999999997654 478999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----- 171 (278)
T 1byg_A 100 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 171 (278)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc-----
Confidence 99999997644334899999999999999999999 8899999999999999999999999999987543321
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
....++..|+|||.+.+..++.++||||||+++|||+| |+.||...... +...... .. ..+......
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~-~~------~~~~~~~~~-- 239 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVE-KG------YKMDAPDGC-- 239 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-GHHHHHT-TT------CCCCCCTTC--
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHh-cC------CCCCCcccC--
Confidence 23357889999999999999999999999999999998 99988643321 2111111 10 111122222
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...+.+++..||+.||++||++.++++.|..
T Consensus 240 --~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 240 --PPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 3568899999999999999999999998865
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=360.16 Aligned_cols=266 Identities=21% Similarity=0.321 Sum_probs=185.3
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec-----CceEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK-----RERFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~l 241 (518)
+.+.++||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|.+++|+||+++++++... ...|+
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 134 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134 (458)
T ss_dssp EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence 345678999999999999875 6899999998653 334456799999999999999999999998543 56899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||+ +|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++....
T Consensus 135 v~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 135 VLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 99998 57999999764 35999999999999999999999 88999999999999999999999999999986542
Q ss_pred CCcc-----------------------cccccccccCCCcccCcccc-ccCCCCccccchhhHHHHHHHHh---------
Q 010088 322 GSIC-----------------------FEPVNTDIRGTPGYMDPEYV-VTQELTEKSDVYSYGVVLLEIVT--------- 368 (518)
Q Consensus 322 ~~~~-----------------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwS~Gvll~el~t--------- 368 (518)
.... .....+...||++|+|||++ ....++.++|||||||+||||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 2110 00123456789999999976 45679999999999999999999
Q ss_pred --CCccccCCcc-------------------hHHHHHHHHhhccc--------------------cccccCCcCCCCCCH
Q 010088 369 --ARRAVQDGKN-------------------LVESAQVCMASESR--------------------LAELVDPRIKDSFDM 407 (518)
Q Consensus 369 --G~~p~~~~~~-------------------~~~~~~~~~~~~~~--------------------l~~~~d~~l~~~~~~ 407 (518)
|+.+|..... .......+...-+. +.......+...+ .
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 367 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF-P 367 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS-T
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC-C
Confidence 4444432110 00111100000000 0000000000000 1
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.....+.+|+.+||+.||++|||++|+++|.|...
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~ 402 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence 11356889999999999999999999999998764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.30 Aligned_cols=251 Identities=23% Similarity=0.379 Sum_probs=199.5
Q ss_pred hhhh-hcceecceEEEEEEec---CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 171 NFST-IIGQGGFGTVYKAQFS---DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 171 ~f~~-~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
.+.+ .||+|+||+||+|.+. ++..||||.++... ....+.+.+|++++.+++||||+++++++ +.+..++|||
T Consensus 19 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 97 (291)
T 1xbb_A 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVME 97 (291)
T ss_dssp EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEE
Confidence 3445 8999999999999653 46889999986432 33356799999999999999999999999 6678899999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 98 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred eCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 99999999999864 34999999999999999999999 88999999999999999999999999999986644332
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
.. .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... +....... .. .+....
T Consensus 173 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~-~~------~~~~~~ 243 (291)
T 1xbb_A 173 YY-KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEK-GE------RMGCPA 243 (291)
T ss_dssp EE-EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHT-TC------CCCCCT
T ss_pred cc-cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHHc-CC------CCCCCC
Confidence 11 12233456789999999998889999999999999999999 99999754432 22222111 11 111222
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.. ...+.+++..||+.||.+||++.++++.|..
T Consensus 244 ~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 244 GC----PREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp TC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 22 3568899999999999999999999999865
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=353.49 Aligned_cols=266 Identities=20% Similarity=0.292 Sum_probs=186.4
Q ss_pred hhcceecceEEEEEEec---CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeee--cCceEEEEEecCC
Q 010088 174 TIIGQGGFGTVYKAQFS---DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE--KRERFLMYEYMAN 248 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~ 248 (518)
++||+|+||+||+|++. ++..||||++..... ...+.+|+.+|++++||||+++++++.. ....++||||+.
T Consensus 27 ~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~- 103 (405)
T 3rgf_A 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 103 (405)
T ss_dssp CCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred cEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence 47999999999999875 478999999875332 3468899999999999999999999964 568899999997
Q ss_pred CCHHHHhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe----cCCCcEEEeeccccc
Q 010088 249 GSLKDHLHSP-------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLAH 317 (518)
Q Consensus 249 gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DfGla~ 317 (518)
|+|.+++... ....+++..+..|+.||+.||+||| +.+|+||||||+|||| +.++.+||+|||+++
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 5888887521 1235999999999999999999999 8899999999999999 678999999999998
Q ss_pred cCCCCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcch--------HHHHHHHHh
Q 010088 318 ASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--------VESAQVCMA 388 (518)
Q Consensus 318 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~--------~~~~~~~~~ 388 (518)
........ ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... .+....+..
T Consensus 181 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 181 LFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred ecCCCCcc-cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 65432211 112344679999999999987 45899999999999999999999999643221 111111111
Q ss_pred hccc-----ccccc------------CCcCCCCCCHH---------HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 389 SESR-----LAELV------------DPRIKDSFDME---------QLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 389 ~~~~-----l~~~~------------d~~l~~~~~~~---------~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.-+. +..+. ........... ....+.+++..||+.||.+|||++|+++|.|+..
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~ 339 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTS
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhcc
Confidence 0000 00000 00000000000 0245789999999999999999999999999987
Q ss_pred CCCC
Q 010088 443 DPMH 446 (518)
Q Consensus 443 ~~~~ 446 (518)
.+..
T Consensus 340 ~~~~ 343 (405)
T 3rgf_A 340 DPLP 343 (405)
T ss_dssp SSCC
T ss_pred CCCC
Confidence 6543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=357.88 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=195.8
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC------ceEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR------ERFLMY 243 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV~ 243 (518)
...++||+|+||+||+|++. +|+.||||++..... .+.+|+++|++++|+||+++++++.... ..++||
T Consensus 57 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred EeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 34568999999999999986 589999999864322 2347999999999999999999986432 367999
Q ss_pred EecCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC-CcEEEeeccccccCC
Q 010088 244 EYMANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASK 320 (518)
Q Consensus 244 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DfGla~~~~ 320 (518)
||+++ +|.+.+.. .....+++..+..++.||+.||+||| +.+|+||||||+||||+.+ +.+||+|||+++...
T Consensus 133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99985 67666542 12346999999999999999999999 8999999999999999954 678999999998654
Q ss_pred CCCcccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhc---------
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE--------- 390 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~--------- 390 (518)
.+. ......||+.|+|||++.+. .++.++|||||||+||||++|+.||.................
T Consensus 209 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 209 RGE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp TTC-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred cCC-----CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 432 22345789999999998764 799999999999999999999999976554333332221110
Q ss_pred --cccccccCCcCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 391 --SRLAELVDPRIKDS-----FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 391 --~~l~~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
....+...+.+... +.......+.+++.+||+.||.+||++.|+++|.|+.
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~ 341 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence 01111111111110 1111235689999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=339.00 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=193.7
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.+.||+|+||+||+|... +|..||||++... .......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 113 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence 445678999999999999874 6899999998642 334456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 246 MANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 246 ~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
+++|+|.+++.. .....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 999999999864 12345899999999999999999999 8899999999999999999999999999987654322
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCc-chHHHHHHHHhhccccccccCCcCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK-NLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~-~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ............ .... ...
T Consensus 191 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~----~~~ 260 (310)
T 2wqm_A 191 T----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPP----LPS 260 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT--CSCC----CCT
T ss_pred c----cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc--cCCC----Ccc
Confidence 1 1234568999999999999999999999999999999999999996433 222222221111 1111 111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
..++ ..+.+++..||+.||.+||++.+|++.|..
T Consensus 261 ~~~~----~~l~~li~~~l~~dp~~Rps~~~il~~l~~ 294 (310)
T 2wqm_A 261 DHYS----EELRQLVNMCINPDPEKRPDVTYVYDVAKR 294 (310)
T ss_dssp TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 2222 468899999999999999999999999865
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=346.41 Aligned_cols=252 Identities=33% Similarity=0.474 Sum_probs=199.8
Q ss_pred hhhhhhcceecceEEEEEEec-CCcE--EEEEEeccc-cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSL--IAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.+.+.||+|+||+||+|+.. +|.. +|+|.+... .......+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 106 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 106 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence 345678999999999999875 4554 499988643 334456799999999999 89999999999999999999999
Q ss_pred ecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEE
Q 010088 245 YMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKL 310 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 310 (518)
|+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeEEE
Confidence 999999999997643 246999999999999999999999 899999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhh
Q 010088 311 ADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMAS 389 (518)
Q Consensus 311 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~ 389 (518)
+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||..... .+...... .
T Consensus 184 ~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-~~~~~~~~-~ 256 (327)
T 1fvr_A 184 ADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLP-Q 256 (327)
T ss_dssp CCTTCEESSCEEC-----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHGG-G
T ss_pred cccCcCccccccc-----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-HHHHHHhh-c
Confidence 9999987432211 1233457889999999998899999999999999999998 9999965432 22222111 1
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 390 ESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 390 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
. ......... ...+.+++.+||+.||.+||++.+++++|...
T Consensus 257 ~------~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 257 G------YRLEKPLNC----DDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp T------CCCCCCTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C------CCCCCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 111111222 25688999999999999999999999998654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=341.63 Aligned_cols=256 Identities=25% Similarity=0.437 Sum_probs=199.7
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeee------cCceEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIE------KRERFLM 242 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~------~~~~~lV 242 (518)
.+.+.||+|+||+||+|+.. +|+.||||++.... .....+.+|+.++.++ +||||+++++++.. .+..++|
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv 105 (326)
T 2x7f_A 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 105 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEE
T ss_pred EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEE
Confidence 34578999999999999874 68999999986433 3346789999999999 79999999999987 4578999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+++|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 106 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp EECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred EEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 99999999999998654456999999999999999999999 889999999999999999999999999998765432
Q ss_pred CcccccccccccCCCcccCccccc-----cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccccc
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 397 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 397 (518)
.. ......||+.|+|||.+. +..++.++||||||+++|||++|+.||.+........... . .......
T Consensus 183 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~--~~~~~~~ 255 (326)
T 2x7f_A 183 VG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-R--NPAPRLK 255 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-H--SCCCCCS
T ss_pred cc----ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh-c--CccccCC
Confidence 11 123456899999999986 5678999999999999999999999997554332222111 1 1111111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM 445 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~ 445 (518)
...++ ..+.+++..||+.||.+||++.+++++.+....+.
T Consensus 256 ----~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 256 ----SKKWS----KKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp ----CSCSC----HHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred ----ccccC----HHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 11222 46889999999999999999999999988765543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=338.49 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=201.7
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeee--cCceEEEEEe
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE--KRERFLMYEY 245 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~ 245 (518)
.+.+.||+|+||+||+|+.. +|+.||+|.+... .....+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 88 (279)
T 2w5a_A 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88 (279)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeC
Confidence 34568999999999999876 6899999998643 33445679999999999999999999998854 5688999999
Q ss_pred cCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----ceecccCCCcEEecCCCcEEEeecccccc
Q 010088 246 MANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPP-----LCHRDIKSSNILLDENFVAKLADFGLAHA 318 (518)
Q Consensus 246 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----iiHrDlk~~NILl~~~~~~kl~DfGla~~ 318 (518)
+++|+|.+++... ....+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp CTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred CCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 9999999999742 2345999999999999999999999 666 99999999999999999999999999986
Q ss_pred CCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccC
Q 010088 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD 398 (518)
Q Consensus 319 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d 398 (518)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .......... ..
T Consensus 166 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~i~~~--~~----- 233 (279)
T 2w5a_A 166 LNHDTS----FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-KELAGKIREG--KF----- 233 (279)
T ss_dssp C---CH----HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHT--CC-----
T ss_pred eccccc----cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-HHHHHHHhhc--cc-----
Confidence 544321 12334689999999999998999999999999999999999999975432 2222221111 11
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 399 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 399 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+.+...++ ..+.+++.+||+.||.+||++.|++++++...
T Consensus 234 ~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 234 RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ccCCcccC----HHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 11222222 56889999999999999999999999987653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=338.32 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=193.1
Q ss_pred hhhhhhhcceecceEEEEEEec----CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC-----
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR----- 237 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 237 (518)
.+.+.+.||+|+||+||+|.+. .+..||||.+... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 114 (313)
T 3brb_A 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP 114 (313)
T ss_dssp GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence 3445678999999999999764 2458999998643 3344567999999999999999999999998765
Q ss_pred ceEEEEEecCCCCHHHHhcC----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeec
Q 010088 238 ERFLMYEYMANGSLKDHLHS----PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADF 313 (518)
Q Consensus 238 ~~~lV~e~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~Df 313 (518)
..++||||+++|+|.+++.. .....+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEeec
Confidence 34999999999999999842 23456999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccc
Q 010088 314 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESR 392 (518)
Q Consensus 314 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~ 392 (518)
|+++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... .........
T Consensus 192 g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~~~~~~-- 266 (313)
T 3brb_A 192 GLSKKIYSGDYY--RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-MYDYLLHGH-- 266 (313)
T ss_dssp SCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHHHHTTC--
T ss_pred Ccceeccccccc--CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHHcCC--
Confidence 999865443211 12234457889999999999999999999999999999999 778886543322 221111110
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 393 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 393 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+...... ...+.+++..||+.||.+||++.+++++|...
T Consensus 267 -----~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 267 -----RLKQPEDC----LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp -----CCCCBTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCccc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111222 25688999999999999999999999998653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=351.94 Aligned_cols=261 Identities=20% Similarity=0.226 Sum_probs=202.8
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcC--------CCCeeeEeeeee----e
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH--------HRHLVALRGFCI----E 235 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~----~ 235 (518)
.+.+.++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+++|.+++ |+||+++++++. .
T Consensus 38 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~ 116 (397)
T 1wak_A 38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116 (397)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred eEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence 3456678999999999999865 5889999998743 344567899999999996 788999999987 4
Q ss_pred cCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CceecccCCCcEEecCCC--------
Q 010088 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP-PLCHRDIKSSNILLDENF-------- 306 (518)
Q Consensus 236 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~iiHrDlk~~NILl~~~~-------- 306 (518)
....++||||+ +++|.+++.......+++..+..|+.||+.||+||| +. +|+||||||+||||+.++
T Consensus 117 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 117 GTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 56789999999 567777765544456999999999999999999999 77 999999999999999775
Q ss_pred -----------------------------------------cEEEeeccccccCCCCCcccccccccccCCCcccCcccc
Q 010088 307 -----------------------------------------VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 345 (518)
Q Consensus 307 -----------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 345 (518)
.+||+|||+++..... .....||+.|+|||.+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSCCSCGGGCCHHHH
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccCCCCCcccCChhh
Confidence 8999999999865432 2345789999999999
Q ss_pred ccCCCCccccchhhHHHHHHHHhCCccccCCcc-----hHHHHHHHHhhcccc-----------ccccCCc-----C---
Q 010088 346 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN-----LVESAQVCMASESRL-----------AELVDPR-----I--- 401 (518)
Q Consensus 346 ~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~-----~~~~~~~~~~~~~~l-----------~~~~d~~-----l--- 401 (518)
.+..++.++|||||||+||||+||+.||..... ............... .+.+... +
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 999999999999999999999999999964321 111111111100000 0000000 0
Q ss_pred -----------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 402 -----------KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 402 -----------~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
....+.+....+.+++.+||+.||++|||+.|+++|.|..
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0123456677899999999999999999999999998763
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=344.80 Aligned_cols=256 Identities=24% Similarity=0.425 Sum_probs=191.9
Q ss_pred hhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHH--HHHcCCCCeeeEeeeeee-----cCceEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEL--LARLHHRHLVALRGFCIE-----KRERFLMY 243 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~-----~~~~~lV~ 243 (518)
.+.+.||+|+||+||+|+. +|+.||||++.... ...+..|.++ +..++|+||+++++++.. ....++||
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred heeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 3456899999999999987 68999999986432 2344445444 445899999999986543 23568999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC---------CceecccCCCcEEecCCCcEEEeecc
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP---------PLCHRDIKSSNILLDENFVAKLADFG 314 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~---------~iiHrDlk~~NILl~~~~~~kl~DfG 314 (518)
||+++|+|.+++... ..++..+.+++.|++.||+||| +. +|+||||||+|||++.++.+||+|||
T Consensus 92 e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 92 EYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp CCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred ecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 999999999999753 3689999999999999999999 77 99999999999999999999999999
Q ss_pred ccccCCCCCccc----ccccccccCCCcccCcccccc-------CCCCccccchhhHHHHHHHHhCCccccCCcch----
Q 010088 315 LAHASKDGSICF----EPVNTDIRGTPGYMDPEYVVT-------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNL---- 379 (518)
Q Consensus 315 la~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~---- 379 (518)
+++......... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+..+...
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 998654322110 112234569999999999876 45678999999999999999998887543221
Q ss_pred ------------HHHHHHHHhhccccccccCCcCCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 380 ------------VESAQVCMASESRLAELVDPRIKDSF--DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 380 ------------~~~~~~~~~~~~~l~~~~d~~l~~~~--~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
............ ..+.+.... .......+.+++.+||+.||++|||++|+++.|...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREK-----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSC-----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhhcccCCCchHHHHHhhhcccc-----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 011111111111 111222111 224566799999999999999999999999998664
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=348.45 Aligned_cols=258 Identities=19% Similarity=0.288 Sum_probs=194.6
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC------ceEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR------ERFL 241 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l 241 (518)
.+.+.||+|+||+||+|... +|+.||||++... .......+.+|+.+++.++||||+++++++...+ ..++
T Consensus 28 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~l 107 (371)
T 2xrw_A 28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 107 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred eEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEE
Confidence 34568999999999999875 6899999998642 3344567899999999999999999999987654 6799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||++ |+|.+++.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 108 v~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 108 VMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred EEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 999997 488888863 3899999999999999999999 88999999999999999999999999999986543
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccccc----
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV---- 397 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~---- 397 (518)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........+............+..
T Consensus 180 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 180 SF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cc-----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 22 224457999999999999999999999999999999999999999765544333322111000000000
Q ss_pred ---------CCc-------------CCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 398 ---------DPR-------------IKDS---FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 398 ---------d~~-------------l~~~---~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+. .... ........+.+++.+||+.||++|||++|+++|.|..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 000 0000 0112356789999999999999999999999998764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=360.32 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=200.6
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
.+.+.+.||+|+||+||+|+.. ++..||||++.... ......+.+|+.+|++++||||++++++|.+....++||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 117 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 3556678999999999999886 68899999986532 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC---CCcEEEeeccccccCCCC
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKDG 322 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DfGla~~~~~~ 322 (518)
+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 118 ~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 118 YKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999999988753 34999999999999999999999 889999999999999976 456999999999876543
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
. ......||+.|+|||++. ..++.++|||||||++|||++|..||..... .+...........+. .+. .
T Consensus 193 ~-----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~---~~~-~ 261 (494)
T 3lij_A 193 K-----KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-QEILRKVEKGKYTFD---SPE-W 261 (494)
T ss_dssp B-----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCCCC---SGG-G
T ss_pred c-----cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCC---chh-c
Confidence 2 234567999999999875 5799999999999999999999999975443 233332222211111 111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...+ ..+.+++..||+.||.+|||+.|+++|.|.
T Consensus 262 ~~~s----~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 295 (494)
T 3lij_A 262 KNVS----EGAKDLIKQMLQFDSQRRISAQQALEHPWI 295 (494)
T ss_dssp TTSC----HHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred ccCC----HHHHHHHHHHCCCChhhCccHHHHhcCccc
Confidence 1222 458899999999999999999999998765
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=343.75 Aligned_cols=257 Identities=27% Similarity=0.402 Sum_probs=201.3
Q ss_pred HhhhhhhhcceecceEEEEEEe------cCCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceE
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERF 240 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 240 (518)
..+.+.+.||+|+||+||+|++ .++..||||.+... ......++.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 3455667899999999999984 24678999998643 3445567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC---CCcEEEee
Q 010088 241 LMYEYMANGSLKDHLHSPGR-----TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLAD 312 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~D 312 (518)
+||||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+|||++. +..+||+|
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEECc
Confidence 99999999999999975432 35899999999999999999999 889999999999999984 45699999
Q ss_pred ccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhcc
Q 010088 313 FGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASES 391 (518)
Q Consensus 313 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~ 391 (518)
||+++........ .......||+.|+|||.+.+..++.++||||||+++|||+| |+.||..... .+........ .
T Consensus 187 fg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~~~~-~ 262 (327)
T 2yfx_A 187 FGMARDIYRASYY--RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSG-G 262 (327)
T ss_dssp CHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTT-C
T ss_pred ccccccccccccc--ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-HHHHHHHhcC-C
Confidence 9999754332211 12234567899999999999999999999999999999998 8888865432 2222221111 1
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 392 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 392 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+.....++ ..+.+++..||+.||.+||++.+++++|+..
T Consensus 263 ------~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 263 ------RMDPPKNCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp ------CCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111122222 4688999999999999999999999999764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=358.82 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=204.7
Q ss_pred HhhhhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
..+.+.++||+|+||+||+|+.. +|+.||||++... .......+.+|+++|++++||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 34566789999999999999875 6899999998642 23345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec---CCCcEEEeeccccccCCC
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKD 321 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DfGla~~~~~ 321 (518)
|+.+|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++ .++.+||+|||+++....
T Consensus 102 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 102 LYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999998754 35999999999999999999999 88999999999999995 466899999999986544
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
.. ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||...... +............. .+.
T Consensus 177 ~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~---~~~- 245 (486)
T 3mwu_A 177 NT-----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVETGKYAFD---LPQ- 245 (486)
T ss_dssp C---------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCSC---SGG-
T ss_pred CC-----ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCC---Ccc-
Confidence 32 2244579999999999865 5999999999999999999999999754432 33222222111110 010
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.... ...+.+++..||+.||.+|||+.++++|.|...
T Consensus 246 ~~~~----s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 246 WRTI----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp GGGS----CHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred cCCC----CHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 0112 245889999999999999999999999987643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=341.88 Aligned_cols=259 Identities=19% Similarity=0.289 Sum_probs=205.0
Q ss_pred hhhhhhcceecceEEEEEEe--cCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCC------eeeEeeeeeecCceEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQF--SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRH------LVALRGFCIEKRERFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~~~l 241 (518)
+.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|++++..++|+| ++++++++...+..++
T Consensus 16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l 94 (339)
T 1z57_A 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI 94 (339)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence 44567899999999999986 36889999998753 234567889999999997654 9999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-----------------
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE----------------- 304 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~----------------- 304 (518)
||||+ +++|.+++...+..++++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 95 v~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 95 VFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99999 899999998766567999999999999999999999 889999999999999987
Q ss_pred --CCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHH
Q 010088 305 --NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES 382 (518)
Q Consensus 305 --~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~ 382 (518)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEH-------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp ESCCCEEECCCSSCEETTSC-------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred ccCCCceEeeCcccccCccc-------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 678999999999864332 23457899999999999999999999999999999999999999754432221
Q ss_pred HHHHHhhccccccc-------------------------------cCCcC-CCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 010088 383 AQVCMASESRLAEL-------------------------------VDPRI-KDSFDMEQLRTIVTIVRWCTQREGQARPS 430 (518)
Q Consensus 383 ~~~~~~~~~~l~~~-------------------------------~d~~l-~~~~~~~~~~~l~~li~~Cl~~dp~~RPs 430 (518)
... ......++.. ..+.. ...........+.+++..||+.||++|||
T Consensus 244 ~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 244 AMM-ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHH-HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHH-HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 111 1100000000 00000 00112244577999999999999999999
Q ss_pred HHHHHHHhhcC
Q 010088 431 IKQVLRILYES 441 (518)
Q Consensus 431 ~~evl~~L~~~ 441 (518)
+.|++++.+..
T Consensus 323 ~~ell~hp~f~ 333 (339)
T 1z57_A 323 LREALKHPFFD 333 (339)
T ss_dssp HHHHTTSGGGG
T ss_pred HHHHhcCHHHH
Confidence 99999987663
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=339.39 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=204.7
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||+||+|... +|+.||||.+.... ....+.+|+.++.+++||||+++++++...+..++||||+++
T Consensus 31 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (314)
T 3com_A 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGA 108 (314)
T ss_dssp EEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCC
Confidence 445678999999999999886 58999999986533 346789999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.+++... ...+++..+..++.+++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 109 ~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---- 180 (314)
T 3com_A 109 GSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA---- 180 (314)
T ss_dssp EEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS----
T ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc----
Confidence 9999998632 235999999999999999999999 88999999999999999999999999999976544321
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||............. .. .......+ . .
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~--~~~~~~~~---~----~ 250 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP-TN--PPPTFRKP---E----L 250 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HS--CCCCCSSG---G----G
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh-cC--CCcccCCc---c----c
Confidence 2234568999999999999999999999999999999999999997654332222111 11 00111011 1 1
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM 445 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~ 445 (518)
....+.+++..||+.||.+||++.+++++.+......
T Consensus 251 ~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 251 WSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp SCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 1246889999999999999999999999988765543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=360.75 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=206.1
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
.+.+.++||+|+||+||+|+.. +|+.||||++.... ......+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 4556678999999999999886 68999999985432 3445679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe---cCCCcEEEeeccccccCCC
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKD 321 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DfGla~~~~~ 321 (518)
|+.+|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++....
T Consensus 107 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 107 VYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 999999999997643 5999999999999999999999 8899999999999999 5678999999999986654
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
.. ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||...... +............. .+.
T Consensus 182 ~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~---~~~- 250 (484)
T 3nyv_A 182 SK-----KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKGKYTFE---LPQ- 250 (484)
T ss_dssp CC-----SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCCC---SGG-
T ss_pred cc-----ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCCCCC---Ccc-
Confidence 32 2234569999999998865 7999999999999999999999999754432 22222222111110 010
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
... ....+.+++..||+.||++|||+.|+++|.|..
T Consensus 251 ~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~ 286 (484)
T 3nyv_A 251 WKK----VSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 286 (484)
T ss_dssp GGG----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred ccc----CCHHHHHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence 011 224688999999999999999999999988764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=346.27 Aligned_cols=253 Identities=23% Similarity=0.372 Sum_probs=194.1
Q ss_pred hhhhhcceecceEEEEEEec-CCc----EEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGS----LIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
.+.++||+|+||+||+|++. ++. .||+|.+... .......+.+|+.++++++||||++++++|... ..++|+|
T Consensus 18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~v~~ 96 (327)
T 3lzb_A 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ 96 (327)
T ss_dssp EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEEEEC
T ss_pred eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceEEEE
Confidence 44578999999999999864 344 3577777532 344567899999999999999999999999875 4889999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+.+|+|.+++.... ..+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 97 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 97 LMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp CCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred ecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 999999999997643 35999999999999999999999 88999999999999999999999999999986543321
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... +....... ... .....
T Consensus 173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~~~~-~~~------~~~~~ 242 (327)
T 3lzb_A 173 E--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEK-GER------LPQPP 242 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHT-TCC------CCCCT
T ss_pred c--ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHc-CCC------CCCCc
Confidence 1 12234457889999999999999999999999999999999 99998654322 22211111 110 11111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
. ....+.+++..||+.||.+||++.|+++.|....
T Consensus 243 ~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 243 I----CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp T----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2 2245889999999999999999999999987643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=353.07 Aligned_cols=260 Identities=24% Similarity=0.326 Sum_probs=201.9
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.+.||+|+||+||+|+.. +|..||+|++... .......+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 114 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 114 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred ceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCC
Confidence 344568999999999999886 6899999998754 34445779999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP-PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
+|+|.+++...+ .+++..+..++.+++.||+||| +. +|+||||||+|||++.++.+||+|||++......
T Consensus 115 ~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 185 (360)
T 3eqc_A 115 GGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 185 (360)
T ss_dssp TCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----
Confidence 999999997643 4899999999999999999999 64 8999999999999999999999999998643221
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHh-hcc--------------
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMA-SES-------------- 391 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~-~~~-------------- 391 (518)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....... ...
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE-LELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH-HHHHHC-------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccCCCCCCCcccCCC
Confidence 2234579999999999999999999999999999999999999996533211 1100000 000
Q ss_pred -------------c----cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 392 -------------R----LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 392 -------------~----l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
. +..+................+.+++..||+.||++|||++|+++|.|..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 329 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 0 0000000000000011224688999999999999999999999988763
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=353.24 Aligned_cols=258 Identities=19% Similarity=0.291 Sum_probs=196.4
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec------------
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK------------ 236 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------------ 236 (518)
+.+.+.||+|+||+||+|+.. +|+.||||++...... ..+|+++|+.++|+||+++++++...
T Consensus 9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 345678999999999999874 6899999988643322 34799999999999999999998543
Q ss_pred --------------------------CceEEEEEecCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 010088 237 --------------------------RERFLMYEYMANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288 (518)
Q Consensus 237 --------------------------~~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 288 (518)
...++||||++ |+|.+.+.. .....+++..+..++.|++.||+||| +.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~ 160 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SL 160 (383)
T ss_dssp -------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TT
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 23789999998 588777753 22346999999999999999999999 99
Q ss_pred CceecccCCCcEEec-CCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHH
Q 010088 289 PLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEI 366 (518)
Q Consensus 289 ~iiHrDlk~~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el 366 (518)
+|+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||.+.+. .++.++|||||||++|||
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-----PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-----CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-----CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 999999999999998 68999999999998654432 22445689999999998764 589999999999999999
Q ss_pred HhCCccccCCcchHHHHHHHHhhcc-----------ccccccCCcCCCC-----CCHHHHHHHHHHHHHccccCCCCCCC
Q 010088 367 VTARRAVQDGKNLVESAQVCMASES-----------RLAELVDPRIKDS-----FDMEQLRTIVTIVRWCTQREGQARPS 430 (518)
Q Consensus 367 ~tG~~p~~~~~~~~~~~~~~~~~~~-----------~l~~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dp~~RPs 430 (518)
++|+.||.................. ...+..-+.+... ++......+.+++..||+.||++|||
T Consensus 236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315 (383)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 9999999765544333332211110 0011111111100 11112356889999999999999999
Q ss_pred HHHHHHHhhc
Q 010088 431 IKQVLRILYE 440 (518)
Q Consensus 431 ~~evl~~L~~ 440 (518)
+.|+++|.++
T Consensus 316 ~~e~l~hp~f 325 (383)
T 3eb0_A 316 PYEAMAHPFF 325 (383)
T ss_dssp HHHHHTSGGG
T ss_pred HHHHhcCHHH
Confidence 9999998765
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=339.84 Aligned_cols=262 Identities=23% Similarity=0.327 Sum_probs=202.6
Q ss_pred hhhhhcceecceEEEEEEe--cCCcEEEEEEecccc--chhHHHHHHHHHHHHHc---CCCCeeeEeeeee-----ecCc
Q 010088 171 NFSTIIGQGGFGTVYKAQF--SDGSLIAVKRMDKIS--EQVEGDFCREIELLARL---HHRHLVALRGFCI-----EKRE 238 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~--~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~-----~~~~ 238 (518)
.+.+.||+|+||+||+|+. .+|+.||||++.... ......+.+|+.+++.+ +||||++++++|. ....
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 93 (326)
T 1blx_A 14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred eeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCce
Confidence 3457899999999999987 368899999886422 22234577888887777 8999999999987 4567
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccccc
Q 010088 239 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318 (518)
Q Consensus 239 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~ 318 (518)
.++||||+. |+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 94 LTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp EEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 899999998 69999998765556999999999999999999999 88999999999999999999999999999976
Q ss_pred CCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhc----cccc
Q 010088 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE----SRLA 394 (518)
Q Consensus 319 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~----~~l~ 394 (518)
..... ......||..|+|||.+.+..++.++||||||+++|||++|+.||................. ..+.
T Consensus 170 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 170 YSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp CCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred ccCCC-----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 54321 23456789999999999999999999999999999999999999976554433322211100 0000
Q ss_pred cccC-Cc--C-------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 395 ELVD-PR--I-------KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 395 ~~~d-~~--l-------~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.... +. . ...+.......+.+++.+||+.||++||++.++++|.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 301 (326)
T 1blx_A 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301 (326)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccc
Confidence 0000 00 0 0001112235688999999999999999999999988764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=333.03 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=203.9
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---------chhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCce
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---------EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRER 239 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 239 (518)
...+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|++++.++. ||||+++++++...+..
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 99 (298)
T 1phk_A 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 99 (298)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeE
Confidence 34568999999999999885 58999999986432 123456889999999995 99999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccC
Q 010088 240 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 319 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~ 319 (518)
++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 100 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 100 FLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 9999999999999999753 35999999999999999999999 889999999999999999999999999999865
Q ss_pred CCCCcccccccccccCCCcccCccccc------cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccc
Q 010088 320 KDGSICFEPVNTDIRGTPGYMDPEYVV------TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 393 (518)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l 393 (518)
.... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||...... .............
T Consensus 175 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~ 248 (298)
T 1phk_A 175 DPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LMLRMIMSGNYQF 248 (298)
T ss_dssp CTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCC
T ss_pred CCCc-----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-HHHHHHhcCCccc
Confidence 4432 223456899999999885 456889999999999999999999999754432 2222222211111
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 394 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 394 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
. .+. .......+.+++.+||+.||++||++.|++++.+..
T Consensus 249 ~---~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (298)
T 1phk_A 249 G---SPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288 (298)
T ss_dssp C---TTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred C---ccc-----ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhh
Confidence 0 010 012235688999999999999999999999988764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=347.42 Aligned_cols=272 Identities=22% Similarity=0.299 Sum_probs=198.8
Q ss_pred HHHHHHHhhhh--hhhcceecceEEEEEEecCCcEEEEEEeccccc-----------hhHHHHHHHHHHHHHcCCCCeee
Q 010088 162 YKETKKATDNF--STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISE-----------QVEGDFCREIELLARLHHRHLVA 228 (518)
Q Consensus 162 ~~~l~~a~~~f--~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~niv~ 228 (518)
..++.....+| .+.||+|+||+||+|...+|..||||++..... ...+.+.+|++++.+++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 34444444444 478999999999999988899999998853221 12367999999999999999999
Q ss_pred Eeeeeeec-----CceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec
Q 010088 229 LRGFCIEK-----RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD 303 (518)
Q Consensus 229 l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~ 303 (518)
+++++... ...++||||+. |+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLA 168 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEc
Confidence 99998543 35799999998 68888887543 46999999999999999999999 88999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHH
Q 010088 304 ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES 382 (518)
Q Consensus 304 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~ 382 (518)
.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.........
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADA-----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp TTCCEEECCTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred CCCCEEEEecCccccccccc-----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999997543322 2344578999999999876 67999999999999999999999999755433222
Q ss_pred HHHHHhhc-cc-----------cccccCCcCCC---C----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 383 AQVCMASE-SR-----------LAELVDPRIKD---S----FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 383 ~~~~~~~~-~~-----------l~~~~d~~l~~---~----~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
........ .. ..+.....+.. . ........+.+++..||+.||++|||+.|+++|.+...-
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 22111000 00 00000000000 0 001112568899999999999999999999999887654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=346.65 Aligned_cols=253 Identities=26% Similarity=0.353 Sum_probs=183.7
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcC-CCCeeeEeeeeee--------cCce
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIE--------KRER 239 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--------~~~~ 239 (518)
+.+.++||+|+||+||+|+.. +|+.||||++..........+.+|+.++.++. ||||+++++++.. ....
T Consensus 30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 109 (337)
T 3ll6_A 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109 (337)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence 445678999999999999875 68999999987666666678999999999996 9999999999843 3357
Q ss_pred EEEEEecCCCCHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecccCCCcEEecCCCcEEEeecccc
Q 010088 240 FLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLHFYCDPP--LCHRDIKSSNILLDENFVAKLADFGLA 316 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiHrDlk~~NILl~~~~~~kl~DfGla 316 (518)
++||||+. |+|.+++.. .....+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+|||++
T Consensus 110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 110 LLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred EEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 99999996 799998864 12345999999999999999999999 778 999999999999999999999999999
Q ss_pred ccCCCCCccc--------ccccccccCCCcccCcccc---ccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHH
Q 010088 317 HASKDGSICF--------EPVNTDIRGTPGYMDPEYV---VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 385 (518)
Q Consensus 317 ~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~ 385 (518)
+......... ........||+.|+|||.+ .+..++.++||||||+++|||++|+.||.+...... ..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~- 263 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-VN- 263 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-hc-
Confidence 8664432110 0011234589999999998 567789999999999999999999999965332211 00
Q ss_pred HHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 386 CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 386 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
. .......... ...+.+++..||+.||.+||++.|++++|+..
T Consensus 264 ---~------~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 264 ---G------KYSIPPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp -----------CCCCTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ---C------cccCCccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0000011111 13477899999999999999999999999764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=344.07 Aligned_cols=263 Identities=19% Similarity=0.247 Sum_probs=204.7
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcC-CC-----CeeeEeeeeeecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-HR-----HLVALRGFCIEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~~~~lV 242 (518)
+.+.++||+|+||+||+|+.. +|+.||||+++.. .....++.+|+.++..++ |+ +|+++++++...+..++|
T Consensus 56 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 134 (382)
T 2vx3_A 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLV 134 (382)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEE
T ss_pred EEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEE
Confidence 344578999999999999875 5789999998743 334567888999999885 55 499999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec--CCCcEEEeeccccccCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD--ENFVAKLADFGLAHASK 320 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~--~~~~~kl~DfGla~~~~ 320 (518)
|||+. |+|.+++.......+++..+..++.|++.||+|||.. +.+|+||||||+||||+ .++.+||+|||+++...
T Consensus 135 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~ 212 (382)
T 2vx3_A 135 FEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212 (382)
T ss_dssp EECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence 99996 5999999876555699999999999999999999942 47899999999999995 47889999999998654
Q ss_pred CCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccc----
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL---- 396 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~---- 396 (518)
.. .....||+.|+|||.+.+..++.++|||||||++|||+||+.||.......................
T Consensus 213 ~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (382)
T 2vx3_A 213 QR-------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA 285 (382)
T ss_dssp CC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred cc-------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 32 2345789999999999999999999999999999999999999976544332222211100000000
Q ss_pred ------c----CCc------------C-------------------------CCCCCHHHHHHHHHHHHHccccCCCCCC
Q 010088 397 ------V----DPR------------I-------------------------KDSFDMEQLRTIVTIVRWCTQREGQARP 429 (518)
Q Consensus 397 ------~----d~~------------l-------------------------~~~~~~~~~~~l~~li~~Cl~~dp~~RP 429 (518)
+ +.. . .......+...+.+++.+||+.||++||
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp 365 (382)
T 2vx3_A 286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI 365 (382)
T ss_dssp TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC
T ss_pred HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC
Confidence 0 000 0 0011223445789999999999999999
Q ss_pred CHHHHHHHhhcCC
Q 010088 430 SIKQVLRILYESS 442 (518)
Q Consensus 430 s~~evl~~L~~~~ 442 (518)
|++|+++|.|...
T Consensus 366 ta~e~L~hp~f~~ 378 (382)
T 2vx3_A 366 QPYYALQHSFFKK 378 (382)
T ss_dssp CHHHHTTSGGGCC
T ss_pred CHHHHhcCccccc
Confidence 9999999988753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=341.37 Aligned_cols=265 Identities=24% Similarity=0.391 Sum_probs=187.0
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.||+|+||+||+|... +|..||||++.... .....++.+|+.++.+++||||+++++++...+..++||||+++
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 97 (303)
T 2vwi_A 18 ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97 (303)
T ss_dssp EEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTT
T ss_pred hhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccC
Confidence 35578999999999999864 68999999886432 33456788999999999999999999999999999999999999
Q ss_pred CCHHHHhcC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 249 GSLKDHLHS------PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 249 gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|+|.+++.. .....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 174 (303)
T 2vwi_A 98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174 (303)
T ss_dssp CBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred CchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence 999999863 12345899999999999999999999 889999999999999999999999999998765432
Q ss_pred Ccc-cccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccc-cccCC
Q 010088 323 SIC-FEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA-ELVDP 399 (518)
Q Consensus 323 ~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~-~~~d~ 399 (518)
... .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...................+. ...++
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (303)
T 2vwi_A 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDK 254 (303)
T ss_dssp -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----
T ss_pred CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccc
Confidence 211 1112234569999999999876 57899999999999999999999999765443322222111111111 11112
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 400 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.....++ ..+.+++..||+.||.+||++.+++++.+...
T Consensus 255 ~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 255 EMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred hhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 2222233 45889999999999999999999999887643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=352.54 Aligned_cols=261 Identities=22% Similarity=0.341 Sum_probs=196.5
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCc------eEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE------RFLMY 243 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~lV~ 243 (518)
+.+.++||+|+||+||+|+..++..||+|++...... ..+|+++|+.++||||+++++++..... .++||
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 3456789999999999999987777999987543222 2379999999999999999999976543 78999
Q ss_pred EecCCCCHHHHhc-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec-CCCcEEEeeccccccCCC
Q 010088 244 EYMANGSLKDHLH-SPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKD 321 (518)
Q Consensus 244 e~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DfGla~~~~~ 321 (518)
||++++.+....+ ......+++..+..++.|++.||+||| +.+|+||||||+||||+ .++.+||+|||+++....
T Consensus 118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 9998754443332 111345999999999999999999999 88999999999999999 799999999999987644
Q ss_pred CCcccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc---------
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES--------- 391 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~--------- 391 (518)
+. ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..................
T Consensus 195 ~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 195 GE-----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp TC-----CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred CC-----CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 32 22445789999999998764 5899999999999999999999999765443333222111000
Q ss_pred --ccccccCCcCCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 392 --RLAELVDPRIKD-----SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 392 --~l~~~~d~~l~~-----~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
...+..-+..+. .+.......+.+++.+||+.||++|||+.|+++|.|+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence 000000011110 011112356899999999999999999999999988754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=333.01 Aligned_cols=257 Identities=19% Similarity=0.288 Sum_probs=197.7
Q ss_pred hhhhhcceecceEEEEEEe-cCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeee-eecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC-IEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~e~~~~ 248 (518)
.+.+.||+|+||+||+|+. .+|+.||||++..... ...+.+|+.++.+++|+|++..++++ .+.+..++||||+ +
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 3uzp_A 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-C
Confidence 3457899999999999987 4789999998864332 34688999999999988877666665 5566789999999 9
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe---cCCCcEEEeeccccccCCCCCcc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+ ++++.+||+|||+++........
T Consensus 89 ~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 89 PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 99999997432 35999999999999999999999 8899999999999999 48899999999999866543211
Q ss_pred cc---cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcc--hHHHHHHHHhhccccccccCCc
Q 010088 326 FE---PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN--LVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 326 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~--~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ............ +.. ..+.
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~-~~~~ 241 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK--MST-PIEV 241 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH--HHS-CHHH
T ss_pred cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc--cCC-chHH
Confidence 00 112456799999999999999999999999999999999999999964221 101111110000 000 0001
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+...++ ..+.+++..||+.||++||++.++++.|...
T Consensus 242 ~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 242 LCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred HHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 111222 4588999999999999999999999988654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=358.65 Aligned_cols=252 Identities=21% Similarity=0.289 Sum_probs=201.2
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccc-------------hhHHHHHHHHHHHHHcCCCCeeeEeeeeee
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-------------QVEGDFCREIELLARLHHRHLVALRGFCIE 235 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 235 (518)
+.+.++||+|+||+||+|+.. ++..||||++..... ...+.+.+|+.+|++++||||+++++++.+
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 117 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 345578999999999999876 578999999864321 334678999999999999999999999999
Q ss_pred cCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC---cEEEee
Q 010088 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF---VAKLAD 312 (518)
Q Consensus 236 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~D 312 (518)
....++||||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|
T Consensus 118 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 118 KKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999998753 34999999999999999999999 88999999999999998775 699999
Q ss_pred ccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc
Q 010088 313 FGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR 392 (518)
Q Consensus 313 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 392 (518)
||+++...... ......||+.|+|||.+. +.++.++|||||||++|||++|..||..... .+...........
T Consensus 193 fg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 193 FGLSSFFSKDY-----KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-QDIIKKVEKGKYY 265 (504)
T ss_dssp CTTCEECCTTS-----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCC
T ss_pred CCCCEEcCCCC-----ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCC
Confidence 99998765432 234557999999999876 5699999999999999999999999975433 2332222221111
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 393 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 393 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.. ....... ...+.+++..||+.||.+|||++|+++|.|..
T Consensus 266 ~~----~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 306 (504)
T 3q5i_A 266 FD----FNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306 (504)
T ss_dssp CC----HHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred CC----ccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhcCHhhh
Confidence 10 0000112 24688999999999999999999999998764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=375.70 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=207.9
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+++.++||+|+||+||+|+.. +|+.||||++++. .......+..|..+|..+ +|+||+++++++.+.+..|||||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E 422 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence 445578999999999999876 5789999998742 233446788999999988 79999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++|+|.++++..+ .+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++......
T Consensus 423 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~- 496 (674)
T 3pfq_A 423 YVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 496 (674)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-
T ss_pred CcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC-
Confidence 999999999998643 4999999999999999999999 8899999999999999999999999999998543222
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.......||+.|+|||++.+..++.++|||||||+||||++|+.||.... ..+..+.+...... +...
T Consensus 497 ---~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~--------~p~~ 564 (674)
T 3pfq_A 497 ---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIMEHNVA--------YPKS 564 (674)
T ss_dssp ---CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHSSCCC--------CCTT
T ss_pred ---cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC-HHHHHHHHHhCCCC--------CCcc
Confidence 12345679999999999999999999999999999999999999997543 33444433332211 1122
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHhhcC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSI-----KQVLRILYES 441 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~-----~evl~~L~~~ 441 (518)
++ ..+.+++..||+.||++||++ +||++|.++.
T Consensus 565 ~s----~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~ 602 (674)
T 3pfq_A 565 MS----KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602 (674)
T ss_dssp SC----HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred CC----HHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcccc
Confidence 23 458899999999999999997 8999988775
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=351.53 Aligned_cols=267 Identities=20% Similarity=0.304 Sum_probs=196.0
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec-----CceEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK-----RERFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~l 241 (518)
+.+.++||+|+||+||+|+.. +|+.||||++... .......+.+|+++|++++|+||+++++++... ...|+
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence 345678999999999999875 5789999999753 334456799999999999999999999999876 57899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||+. |+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++....
T Consensus 108 v~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 108 VLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 999996 5999999864 35999999999999999999999 88999999999999999999999999999986543
Q ss_pred CCcc------------------cccccccccCCCcccCcccc-ccCCCCccccchhhHHHHHHHHhCCccc---------
Q 010088 322 GSIC------------------FEPVNTDIRGTPGYMDPEYV-VTQELTEKSDVYSYGVVLLEIVTARRAV--------- 373 (518)
Q Consensus 322 ~~~~------------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwS~Gvll~el~tG~~p~--------- 373 (518)
.... .....+...||++|+|||.+ ....++.++|||||||++|||++|..|+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 2210 00123566799999999986 5567999999999999999999854433
Q ss_pred -cCCcch-----------------HHHHHHHHhhccc-cc------------cccC-CcCCCCCC-----HHHHHHHHHH
Q 010088 374 -QDGKNL-----------------VESAQVCMASESR-LA------------ELVD-PRIKDSFD-----MEQLRTIVTI 416 (518)
Q Consensus 374 -~~~~~~-----------------~~~~~~~~~~~~~-l~------------~~~d-~~l~~~~~-----~~~~~~l~~l 416 (518)
..+.+. ......++..-+. .. ..+. .......+ ......+.++
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 222210 1111111100000 00 0000 00000000 0122568899
Q ss_pred HHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 417 VRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 417 i~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+.+||+.||++|||++|+++|.|...
T Consensus 342 l~~mL~~dP~~R~ta~e~L~Hp~f~~ 367 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDHPYLKD 367 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred HHHHhcCCcccCCCHHHHhcChhhhh
Confidence 99999999999999999999988764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=355.62 Aligned_cols=240 Identities=17% Similarity=0.177 Sum_probs=187.6
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecc---ccchhHHHHHHHH---HHHHHcCCCCeeeEe-------eeeeecC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDK---ISEQVEGDFCREI---ELLARLHHRHLVALR-------GFCIEKR 237 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~~~~~~ 237 (518)
+.+.||+|+||+||+|+.. +|+.||||++.. ......+.|.+|+ ++|++++||||++++ +++.+.+
T Consensus 77 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 156 (377)
T 3byv_A 77 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156 (377)
T ss_dssp EEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred EcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence 4568999999999999864 689999999863 2334557899999 555566899999998 5555443
Q ss_pred -----------------ceEEEEEecCCCCHHHHhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceeccc
Q 010088 238 -----------------ERFLMYEYMANGSLKDHLHSPGR-----TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 295 (518)
Q Consensus 238 -----------------~~~lV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl 295 (518)
..++||||+ +|+|.+++...+. ..++|..++.|+.||+.||+||| +.+|+||||
T Consensus 157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDi 232 (377)
T 3byv_A 157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYL 232 (377)
T ss_dssp SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCC
T ss_pred CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence 278999999 6899999975321 23456888999999999999999 889999999
Q ss_pred CCCcEEecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccC-----------CCCccccchhhHHHHH
Q 010088 296 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-----------ELTEKSDVYSYGVVLL 364 (518)
Q Consensus 296 k~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDVwS~Gvll~ 364 (518)
||+||||+.++.+||+|||+++.... ......| +.|+|||.+.+. .++.++|||||||+||
T Consensus 233 kp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 233 RPVDIVLDQRGGVFLTGFEHLVRDGA-------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTC-------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCEEEEechhheecCC-------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 99999999999999999999985332 2234567 999999999887 8999999999999999
Q ss_pred HHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 365 EIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 365 el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
||++|+.||...... .....+... ...++ ..+.+++..||+.||++||++.|++++.+.
T Consensus 305 elltg~~Pf~~~~~~-----------~~~~~~~~~--~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 305 WIWCADLPITKDAAL-----------GGSEWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp HHHHSSCCC-----------------CCSGGGGSS--CCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred HHHHCCCCCcccccc-----------cchhhhhhh--ccCCC----HHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence 999999999643211 011111110 12223 458899999999999999999999998765
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=335.82 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=187.4
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc-c-hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-E-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
+.+.+.||+|+||+||+|+.. +|+.||||++.... . .....+.++...++.++||||+++++++.+.+..++||||+
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM 88 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECC
T ss_pred hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehh
Confidence 345578999999999999874 68999999986532 2 22233445555677889999999999999999999999999
Q ss_pred CCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 247 ANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDP-PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 247 ~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
+ |+|.+++.. .....+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 164 (290)
T 3fme_A 89 D-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164 (290)
T ss_dssp S-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred c-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence 7 588887753 12346999999999999999999999 76 99999999999999999999999999997654432
Q ss_pred cccccccccccCCCcccCcccc----ccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYV----VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 399 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~ 399 (518)
......||+.|+|||.+ .+..++.++||||||+++|||++|+.||.................. ...
T Consensus 165 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~--- 234 (290)
T 3fme_A 165 -----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS--PQL--- 234 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--CCC---
T ss_pred -----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--CCc---
Confidence 22334699999999996 5667899999999999999999999999754433332222221110 111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 400 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
....+ ...+.+++..||+.||++|||+.|+++|.+..
T Consensus 235 -~~~~~----~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~ 271 (290)
T 3fme_A 235 -PADKF----SAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271 (290)
T ss_dssp -CTTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred -ccccC----CHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence 01122 24588999999999999999999999988764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=335.20 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=200.7
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc----chhHHHHHHHHHHHHHcCCCCeeeEeeeee--ecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVALRGFCI--EKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV 242 (518)
+.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++|+||+++++++. +.+..++|
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 345678999999999999875 58899999986432 234567999999999999999999999984 45688999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||++++ |.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 87 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred ehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999876 777776555567999999999999999999999 889999999999999999999999999999865432
Q ss_pred CcccccccccccCCCcccCccccccCC--CCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQE--LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
.. ........||+.|+|||.+.+.. ++.++||||||+++|||++|+.||.... ............ ..
T Consensus 163 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~i~~~~--------~~ 231 (305)
T 2wtk_C 163 AA--DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGS--------YA 231 (305)
T ss_dssp CS--SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHCC--------CC
T ss_pred cc--ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-HHHHHHHHhcCC--------CC
Confidence 21 11223456899999999987644 4779999999999999999999997543 323322222111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+...++ ..+.+++.+||+.||.+||++.|++++.+...
T Consensus 232 ~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 232 IPGDCG----PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp CCSSSC----HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred CCCccC----HHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 222222 45889999999999999999999999887643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=345.85 Aligned_cols=258 Identities=22% Similarity=0.334 Sum_probs=184.8
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec------CceEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERFL 241 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 241 (518)
.+.+.||+|+||+||+|... +|+.||||++... .......+.+|+++|+.++||||+++++++... ...++
T Consensus 32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l 111 (367)
T 2fst_X 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111 (367)
T ss_dssp EEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence 34568999999999999864 6899999998643 234456788999999999999999999998754 56799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
|+||+ +++|.+++.. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 112 v~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 112 VTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp EEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred Eeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 99999 7899999875 35999999999999999999999 88999999999999999999999999999986443
Q ss_pred CCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCC-
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP- 399 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~- 399 (518)
. .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.....................+....
T Consensus 185 ~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 185 E-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred c-------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 2 234579999999999877 6899999999999999999999999975544332222211111000000000
Q ss_pred ----------cC--CCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 400 ----------RI--KDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 400 ----------~l--~~~~~~-----~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.+ ...... .....+.+++.+||+.||++|||+.|+++|.+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 00 000111 11245889999999999999999999999988764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=334.29 Aligned_cols=257 Identities=27% Similarity=0.397 Sum_probs=195.8
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeee-------------
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE------------- 235 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------------- 235 (518)
+.+.+.||+|+||+||+|+.. +|+.||||++... ......+.+|+.++++++||||+++++++.+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK 86 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------C
T ss_pred chhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccccc
Confidence 445678999999999999875 6899999998643 3445679999999999999999999998865
Q ss_pred cCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccc
Q 010088 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL 315 (518)
Q Consensus 236 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGl 315 (518)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 87 KSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred CCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 356799999999999999997533 35788999999999999999999 88999999999999999999999999999
Q ss_pred cccCCCCCcc----------cccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHH
Q 010088 316 AHASKDGSIC----------FEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQ 384 (518)
Q Consensus 316 a~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~ 384 (518)
++........ .........||+.|+|||.+.+. .++.++||||||+++|||++ |+....+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 9865432100 00122345689999999998764 78999999999999999998 4443322222222
Q ss_pred HHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 385 VCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 385 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
...... ..+...++......+.+++..||+.||.+||++.+++++.|...
T Consensus 240 ~~~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 240 KLRSVS--------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHSTT--------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred hccccc--------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 221111 11122223333456889999999999999999999999988754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=339.07 Aligned_cols=255 Identities=22% Similarity=0.349 Sum_probs=198.9
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccc--cchhHHHHHHHHHHHHHcC--CCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLH--HRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.+.||+|+||+||++...+|+.||||.+... .......+.+|++++.+++ |+||+++++++.+.+..++|||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 108 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence 4456789999999999999888999999998643 3445578999999999997 5999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+.+++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++ +.+||+|||+++........
T Consensus 109 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 109 CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence 5688999999764 35899999999999999999999 889999999999999965 89999999999865433211
Q ss_pred cccccccccCCCcccCcccccc-----------CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccc
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVT-----------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 394 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~ 394 (518)
.......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..................
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--- 257 (313)
T 3cek_A 183 --VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH--- 257 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS---
T ss_pred --ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc---
Confidence 12234568999999999865 47888999999999999999999999765443332222221110
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 395 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 395 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
........ ...+.+++..||+.||.+||++.|++++.+....
T Consensus 258 ---~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 258 ---EIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp ---CCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred ---ccCCcccc----hHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 11111112 2468899999999999999999999999877544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=342.24 Aligned_cols=265 Identities=21% Similarity=0.303 Sum_probs=202.4
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec-----CceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEK-----RERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV 242 (518)
+.+.+.||+|+||+||+|+.. ++..||||++.... ......+.+|+++|.+++||||+++++++... ...++|
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence 345578999999999999875 68899999987433 33446789999999999999999999998765 368999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+. |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 109 ~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 109 QDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 99997 5999999753 4999999999999999999999 889999999999999999999999999999865432
Q ss_pred CcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccccc----
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV---- 397 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~---- 397 (518)
... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.....................+..
T Consensus 182 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 182 HDH-TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GCB-CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCc-cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 211 112244579999999998754 45899999999999999999999999755433322222111000000000
Q ss_pred ---------CCcCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 398 ---------DPRIKDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 398 ---------d~~l~~~~~~-----~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
........+. .....+.+++.+||+.||++|||+.|+++|.|...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence 0000001111 11246889999999999999999999999988754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=333.27 Aligned_cols=258 Identities=19% Similarity=0.280 Sum_probs=197.5
Q ss_pred hhhhhhcceecceEEEEEEe-cCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeee-eecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC-IEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~e~~~ 247 (518)
+.+.+.||+|+||+||+|+. .+|+.||||.+..... ...+.+|++++..++|+|++..++++ .+.+..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 4hgt_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence 44567899999999999986 4689999998654322 24588999999999988877776666 5567789999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe---cCCCcEEEeeccccccCCCCCc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DfGla~~~~~~~~ 324 (518)
+++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 88 ~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 88 GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 999999997432 35999999999999999999999 8899999999999999 7899999999999986654321
Q ss_pred cc---ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcch--HHHHHHHHhhccccccccCC
Q 010088 325 CF---EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--VESAQVCMASESRLAELVDP 399 (518)
Q Consensus 325 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~--~~~~~~~~~~~~~l~~~~d~ 399 (518)
.. ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ........... +... .+
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~-~~ 240 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK--MSTP-IE 240 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH--HHSC-HH
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc--ccch-hh
Confidence 10 01223567999999999999999999999999999999999999999643211 01111100000 0000 00
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 400 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.+...++ ..+.+++..||+.||++||++.++++.|...
T Consensus 241 ~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 241 VLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 0111222 4688999999999999999999999988654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=344.79 Aligned_cols=246 Identities=16% Similarity=0.183 Sum_probs=196.8
Q ss_pred hhhhhhcceecceEEEEEE------ecCCcEEEEEEeccccchhHHHHHHHHHHHHHcC---CCCeeeEeeeeeecCceE
Q 010088 170 DNFSTIIGQGGFGTVYKAQ------FSDGSLIAVKRMDKISEQVEGDFCREIELLARLH---HRHLVALRGFCIEKRERF 240 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~ 240 (518)
+.+.++||+|+||+||+|. ..+++.||||+++... ..++.+|++++.+++ |+||+++++++...+..+
T Consensus 67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~ 143 (365)
T 3e7e_A 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV 143 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence 3445789999999999994 3468899999986533 456888899998887 999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-----------CC
Q 010088 241 LMYEYMANGSLKDHLHSP---GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-----------NF 306 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-----------~~ 306 (518)
+||||+++|+|.++++.. ....++|..++.|+.||+.||+||| +.+|+||||||+||||+. ++
T Consensus 144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccccccC
Confidence 999999999999999631 2346999999999999999999999 899999999999999998 89
Q ss_pred cEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHH
Q 010088 307 VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC 386 (518)
Q Consensus 307 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~ 386 (518)
.+||+|||+++....... ........||++|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 221 ~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------- 291 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPK--GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG------- 291 (365)
T ss_dssp TEEECCCTTCEEGGGSCT--TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-------
T ss_pred CEEEeeCchhhhhhccCC--CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC-------
Confidence 999999999975432110 11335567999999999999999999999999999999999999998532210
Q ss_pred HhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHhhc
Q 010088 387 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQAR-PSIKQVLRILYE 440 (518)
Q Consensus 387 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~R-Ps~~evl~~L~~ 440 (518)
... ....++.... ...+.+++..|++.+|.+| |+++++.+.|..
T Consensus 292 ---~~~----~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 292 ---ECK----PEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp ---EEE----ECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred ---cee----echhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 001 1111221111 3457789999999999999 577777776654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=341.32 Aligned_cols=256 Identities=21% Similarity=0.327 Sum_probs=198.0
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCce------EE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRER------FL 241 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~------~l 241 (518)
.+.+.||+|+||+||+|... +|+.||||++... .......+.+|+.++++++||||+++++++...+.. ++
T Consensus 45 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 124 (371)
T 4exu_A 45 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 124 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred EEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEE
Confidence 34568999999999999875 6899999998653 334456789999999999999999999999877654 99
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||+. ++|.+++.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 125 v~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 125 VMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp EEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred EEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 999997 699988853 3999999999999999999999 88999999999999999999999999999975433
Q ss_pred CCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccC--
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD-- 398 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d-- 398 (518)
. .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.....................+...
T Consensus 197 ~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 197 E-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred C-------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 2 234568999999999877 789999999999999999999999997554333322221111100000000
Q ss_pred -------------CcCCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 399 -------------PRIKDSF---DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 399 -------------~~l~~~~---~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
......+ .......+.+++..||+.||++|||+.|+++|.|..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 328 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence 0000000 001135689999999999999999999999998875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=341.48 Aligned_cols=265 Identities=20% Similarity=0.269 Sum_probs=189.8
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCc-------eEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE-------RFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-------~~l 241 (518)
+.+.+.||+|+||+||+|+.. +|..||||++.... .....+.+|++.+..++||||+++++++...+. .++
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l 103 (360)
T 3e3p_A 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV 103 (360)
T ss_dssp EEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence 344578999999999999885 68999999885432 233567788999999999999999999976543 789
Q ss_pred EEEecCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-CCcEEEeecccccc
Q 010088 242 MYEYMANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHA 318 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DfGla~~ 318 (518)
||||+++ +|.+.+.. .....+++..+..++.|++.||+|||.+ +.+|+||||||+|||++. ++.+||+|||+++.
T Consensus 104 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~ 181 (360)
T 3e3p_A 104 VMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181 (360)
T ss_dssp EEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred Eeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence 9999986 55444331 1234589999999999999999999943 679999999999999997 89999999999986
Q ss_pred CCCCCcccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccc---
Q 010088 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA--- 394 (518)
Q Consensus 319 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~--- 394 (518)
..... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.....................
T Consensus 182 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 182 LSPSE-----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CCTTS-----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cCCCC-----CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 65433 22445689999999998654 4899999999999999999999999765443332222111000000
Q ss_pred cccCCc----------------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 395 ELVDPR----------------IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 395 ~~~d~~----------------l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
...++. ............+.+++..||+.||.+|||+.|+++|.|...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 000000 000111123467999999999999999999999999987653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=336.39 Aligned_cols=262 Identities=23% Similarity=0.308 Sum_probs=195.4
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeee--------------ec
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI--------------EK 236 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--------------~~ 236 (518)
..+.||+|+||+||+|... +|+.||||++........+.+.+|++++++++||||+++++++. +.
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 94 (320)
T 2i6l_A 15 DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94 (320)
T ss_dssp EEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSC
T ss_pred EEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccccc
Confidence 4568999999999999886 48999999987666666778999999999999999999999873 34
Q ss_pred CceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec-CCCcEEEeeccc
Q 010088 237 RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGL 315 (518)
Q Consensus 237 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DfGl 315 (518)
...++||||++ |+|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+|||++ +++.+||+|||+
T Consensus 95 ~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 95 NSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp SEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 67899999998 699999974 35899999999999999999999 88999999999999997 577999999999
Q ss_pred cccCCCCCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccc
Q 010088 316 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 394 (518)
Q Consensus 316 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~ 394 (518)
++........ ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ...........
T Consensus 168 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~ 245 (320)
T 2i6l_A 168 ARIMDPHYSH-KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM-QLILESIPVVH 245 (320)
T ss_dssp CBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHSCCCC
T ss_pred ccccCCCccc-ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCc
Confidence 9865432111 112234567999999998865 67899999999999999999999999765443222 22111110000
Q ss_pred -----cc-------cCCcCC-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 395 -----EL-------VDPRIK-DSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 395 -----~~-------~d~~l~-~~~~-----~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
++ +..... ...+ ......+.+++.+||+.||++||+++|+++|.+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 00 000000 0000 012356899999999999999999999999987754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.13 Aligned_cols=259 Identities=20% Similarity=0.281 Sum_probs=202.7
Q ss_pred hhhhhhcceecceEEEEEEec-CC-cEEEEEEeccccchhHHHHHHHHHHHHHcCCCC------eeeEeeeeeecCceEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DG-SLIAVKRMDKISEQVEGDFCREIELLARLHHRH------LVALRGFCIEKRERFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~~~l 241 (518)
+.+.+.||+|+||+||+|... ++ ..||||+++.. ......+.+|+.++.+++|+| ++.+.+++...+..++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~l 99 (355)
T 2eu9_A 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI 99 (355)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEE
T ss_pred EEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEE
Confidence 445678999999999999874 34 78999998743 334567889999999998766 9999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe-------------------
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL------------------- 302 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl------------------- 302 (518)
||||+ +++|.+++.......+++..+..++.||+.||+||| +.+|+||||||+|||+
T Consensus 100 v~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 100 AFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 99999 678888877655557999999999999999999999 8999999999999999
Q ss_pred cCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHH
Q 010088 303 DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES 382 (518)
Q Consensus 303 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~ 382 (518)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.........
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEH-------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp ESCCCEEECCCTTCEETTSC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cCCCcEEEeecCcccccccc-------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 56889999999999864332 23457999999999999999999999999999999999999999755433222
Q ss_pred HHHHHhhcccccc-c----------cCCcC---------------------CCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 010088 383 AQVCMASESRLAE-L----------VDPRI---------------------KDSFDMEQLRTIVTIVRWCTQREGQARPS 430 (518)
Q Consensus 383 ~~~~~~~~~~l~~-~----------~d~~l---------------------~~~~~~~~~~~l~~li~~Cl~~dp~~RPs 430 (518)
....... ...+. + ..... ...........+.+++..||+.||++|||
T Consensus 249 ~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 249 VMMEKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 2111100 00000 0 00000 00112233457899999999999999999
Q ss_pred HHHHHHHhhcC
Q 010088 431 IKQVLRILYES 441 (518)
Q Consensus 431 ~~evl~~L~~~ 441 (518)
+.|+++|.|..
T Consensus 328 ~~e~l~hp~f~ 338 (355)
T 2eu9_A 328 LAEALLHPFFA 338 (355)
T ss_dssp HHHHTTSGGGG
T ss_pred HHHHhcChhhc
Confidence 99999987664
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=352.59 Aligned_cols=254 Identities=9% Similarity=-0.001 Sum_probs=181.0
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHc--CCCCeeeEe-------eeeeec-
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL--HHRHLVALR-------GFCIEK- 236 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~H~niv~l~-------g~~~~~- 236 (518)
.+.+.||+|+||+||+|++. +|+.||||++.... ......+.+|+.++..| +||||++++ +++...
T Consensus 65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~ 144 (371)
T 3q60_A 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETT
T ss_pred eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCC
Confidence 35578999999999999875 68999999997643 23445678886655555 599988755 333322
Q ss_pred ----------------CceEEEEEecCCCCHHHHhcCCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCCceecc
Q 010088 237 ----------------RERFLMYEYMANGSLKDHLHSPGRTPLSWQTR------IQIAIDVANALEYLHFYCDPPLCHRD 294 (518)
Q Consensus 237 ----------------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~iiHrD 294 (518)
...++||||++ |+|.+++...+. .+.+..+ ..++.||+.||+||| +.+|+|||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHrD 219 (371)
T 3q60_A 145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGH 219 (371)
T ss_dssp SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEETT
T ss_pred CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccCc
Confidence 23799999999 899999975422 3466666 788899999999999 88999999
Q ss_pred cCCCcEEecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCcccccc--CCCCccccchhhHHHHHHHHhCCcc
Q 010088 295 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRA 372 (518)
Q Consensus 295 lk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvll~el~tG~~p 372 (518)
|||+||||+.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++|||||||+||||+||+.|
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR-------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE-------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC-------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999865432 124457799999999987 7899999999999999999999999
Q ss_pred ccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 373 VQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
|.......... + ........................+.+++.+||+.||++||++.++++|.|.
T Consensus 293 f~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 356 (371)
T 3q60_A 293 FGLVTPGIKGS---W-KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356 (371)
T ss_dssp TTBCCTTCTTC---C-CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred CCCcCcccccc---h-hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence 97542110000 0 0000000001111101011223568899999999999999999999988765
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=351.65 Aligned_cols=255 Identities=24% Similarity=0.288 Sum_probs=191.3
Q ss_pred hhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 173 STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
.++||+|+||+||.+...+|+.||||++... ..+.+.+|+.+|.++ +||||+++++++.+.+..++||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 3579999999998776668999999988642 235678999999987 89999999999999999999999995 699
Q ss_pred HHHhcCCCCCC-----CCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC-------------CcEEEeec
Q 010088 252 KDHLHSPGRTP-----LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-------------FVAKLADF 313 (518)
Q Consensus 252 ~~~l~~~~~~~-----l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-------------~~~kl~Df 313 (518)
.+++....... .++..++.++.||+.||+||| +.+|+||||||+||||+.+ +.+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 99998643211 234456789999999999999 8899999999999999754 48999999
Q ss_pred cccccCCCCCcccccccccccCCCcccCcccccc-------CCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHH
Q 010088 314 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-------QELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQV 385 (518)
Q Consensus 314 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~ 385 (518)
|+++.................||+.|+|||.+.+ ..++.++|||||||++|||+| |+.||.+...... .
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~ 249 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES---N 249 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH---H
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH---H
Confidence 9998765443221112334579999999999865 678999999999999999999 8889865432211 1
Q ss_pred HHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 386 CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 386 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.......+ +......+......+.+++.+||+.||.+||++.++++|.+...
T Consensus 250 i~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 250 IIRGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HhcCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 11111111 11122223456678999999999999999999999999988754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=334.46 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=194.4
Q ss_pred hhhhhhcceecceEEEEEEec--CCc--EEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS--DGS--LIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~--~g~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
+.+.+.||+|+||+||+|++. ++. .||||.++.. .....+.+.+|++++.+++||||+++++++.+.. .++|
T Consensus 20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 98 (291)
T 1u46_A 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV 98 (291)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence 445678999999999999864 233 6899988643 2345578999999999999999999999988754 8999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 99 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 99 TELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp EECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred EecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 99999999999997532 35899999999999999999999 889999999999999999999999999999876443
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
... ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+........... ...
T Consensus 175 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~~~~~------~~~ 246 (291)
T 1u46_A 175 DDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKIDKEGER------LPR 246 (291)
T ss_dssp CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTSCCC------CCC
T ss_pred ccc-hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-HHHHHHHHccCCC------CCC
Confidence 221 112234567889999999998889999999999999999999 9999865433 2222222211111 111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.... ...+.+++..||+.||.+||++.+++++|.+..
T Consensus 247 ~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 247 PEDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CcCc----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 1222 356889999999999999999999999997643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=356.14 Aligned_cols=257 Identities=21% Similarity=0.316 Sum_probs=199.5
Q ss_pred hhhhhcceecceEEEEEEe-cCCcEEEEEEeccccchhHHHHHHHHHHHHHcCC-CCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHH-RHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.++||+|+||+||+|+. .+|+.||||++..... ..++.+|++++..++| +++..+..++.+.+..++||||+ +
T Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g 86 (483)
T 3sv0_A 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (483)
T ss_dssp ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-C
Confidence 4557899999999999987 4689999998764332 2458899999999976 66667777777888899999999 9
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEe---cCCCcEEEeeccccccCCCCCcc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
++|.+++.... ..+++..++.|+.||+.||+||| +.+|+||||||+|||| +.++.+||+|||+++........
T Consensus 87 ~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 87 PSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 99999997432 35999999999999999999999 8899999999999999 68899999999999876543211
Q ss_pred c---ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcc--hHHHHHHHHhhccccccccCCc
Q 010088 326 F---EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN--LVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 326 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~--~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
. ........||+.|+|||.+.+..++.++|||||||+||||++|+.||..... ........... .+...+. .
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~--~~~~~~~-~ 239 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--KVATSIE-A 239 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH--HHHSCHH-H
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc--cccccHH-H
Confidence 0 0112356799999999999999999999999999999999999999975332 11111111110 0110000 0
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+...++ ..+.+++..||+.||++||++.+|++.|...
T Consensus 240 l~~~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 240 LCRGYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHTTSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HhcCCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111222 4689999999999999999999999887654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=326.43 Aligned_cols=257 Identities=24% Similarity=0.336 Sum_probs=204.6
Q ss_pred HHHHHhhhhhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceE
Q 010088 164 ETKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERF 240 (518)
Q Consensus 164 ~l~~a~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 240 (518)
......+.+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 334455666789999999999999886 68999999986432 334567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC---CcEEEeeccccc
Q 010088 241 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN---FVAKLADFGLAH 317 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DfGla~ 317 (518)
+||||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.+ +.+||+|||++.
T Consensus 98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999999886533 4899999999999999999999 8899999999999999754 479999999998
Q ss_pred cCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccccc
Q 010088 318 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 397 (518)
Q Consensus 318 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 397 (518)
...... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... +............
T Consensus 173 ~~~~~~-----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~---- 241 (287)
T 2wei_A 173 CFQQNT-----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVETGKYAF---- 241 (287)
T ss_dssp TBCCCS-----SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCC----
T ss_pred eecCCC-----ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCC----
Confidence 654432 1233458899999998865 5899999999999999999999999754332 2222222111110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
+......++ ..+.+++..||+.||++||++.|++++.+.
T Consensus 242 ~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~ell~hp~~ 280 (287)
T 2wei_A 242 DLPQWRTIS----DDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (287)
T ss_dssp CSGGGTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred CchhhhhcC----HHHHHHHHHHcccChhhCcCHHHHhcCHHH
Confidence 000011222 458899999999999999999999998764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.00 Aligned_cols=262 Identities=19% Similarity=0.242 Sum_probs=203.3
Q ss_pred hhhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcC-----------CCCeeeEeeeeeec
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-----------HRHLVALRGFCIEK 236 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~~ 236 (518)
.+.+.+.||+|+||+||+|+.. +|+.||||++... ......+.+|++++.+++ |+||+++++++...
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 3456678999999999999874 6899999998743 234567889999999986 89999999998865
Q ss_pred C----ceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CceecccCCCcEEec------CC
Q 010088 237 R----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP-PLCHRDIKSSNILLD------EN 305 (518)
Q Consensus 237 ~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~iiHrDlk~~NILl~------~~ 305 (518)
+ ..++||||+ +++|.+++.......+++..+..++.||+.||+||| +. +|+||||||+|||++ .+
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCc
Confidence 4 789999999 899999998755566999999999999999999999 77 999999999999994 44
Q ss_pred CcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcc-----hH
Q 010088 306 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN-----LV 380 (518)
Q Consensus 306 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~-----~~ 380 (518)
+.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||+||+.||..... ..
T Consensus 175 ~~~kl~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp EEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred ceEEEcccccccccCCC-------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 58999999999765432 2345789999999999999999999999999999999999999964321 01
Q ss_pred HHHHHHHhhcccccc-----------ccC----------Cc---------CCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 010088 381 ESAQVCMASESRLAE-----------LVD----------PR---------IKDSFDMEQLRTIVTIVRWCTQREGQARPS 430 (518)
Q Consensus 381 ~~~~~~~~~~~~l~~-----------~~d----------~~---------l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs 430 (518)
.........-..++. .++ .. -...++......+.+++..||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111111110000000 000 00 011244566788999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 010088 431 IKQVLRILYESS 442 (518)
Q Consensus 431 ~~evl~~L~~~~ 442 (518)
++|+++|.+...
T Consensus 328 ~~ell~hp~f~~ 339 (373)
T 1q8y_A 328 AGGLVNHPWLKD 339 (373)
T ss_dssp HHHHHTCGGGTT
T ss_pred HHHHhhChhhhc
Confidence 999999988754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=335.19 Aligned_cols=265 Identities=20% Similarity=0.299 Sum_probs=199.9
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec-----CceEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEK-----RERFLMY 243 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~ 243 (518)
.+.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++... ...++||
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 93 (353)
T 2b9h_A 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ 93 (353)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence 34568999999999999876 68999999986433 33456788999999999999999999988764 6789999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+. |+|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 94 e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 94 ELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp CCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred eccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 9997 699999875 35999999999999999999999 8899999999999999999999999999998654322
Q ss_pred cccc------cccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccc---
Q 010088 324 ICFE------PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL--- 393 (518)
Q Consensus 324 ~~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l--- 393 (518)
.... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....................
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence 1100 01233578999999998764 7789999999999999999999999975543322221111000000
Q ss_pred --ccccCC-------cCC--CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 394 --AELVDP-------RIK--DSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 394 --~~~~d~-------~l~--~~~~-----~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.....+ .+. .... ......+.+++.+||+.||++|||+.|+++|.+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 000000 000 0000 012256889999999999999999999999988754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=337.75 Aligned_cols=256 Identities=20% Similarity=0.314 Sum_probs=197.3
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCc------eEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE------RFL 241 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~l 241 (518)
...+.||+|+||+||+|+.. +|+.||||++... .......+.+|+.++++++||||+++++++...+. .++
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 106 (353)
T 3coi_A 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 106 (353)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEE
Confidence 34568999999999999875 6899999998653 33345678999999999999999999999987654 499
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||+. |+|.+++.. .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 107 v~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 107 VMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp EEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred Eecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 999997 688888753 4999999999999999999999 88999999999999999999999999999976432
Q ss_pred CCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc--------
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR-------- 392 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~-------- 392 (518)
. .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...................
T Consensus 179 ~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 179 E-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred C-------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence 2 234568999999999876 678999999999999999999999997554332222211110000
Q ss_pred -----------cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 393 -----------LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 393 -----------l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+.....+.+. .........+.+++.+||+.||++||++.++++|.+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0000000110 011123356899999999999999999999999988753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=337.38 Aligned_cols=247 Identities=20% Similarity=0.299 Sum_probs=173.1
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHH-HHHHHcCCCCeeeEeeeeee----cCceEEEEEecC
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREI-ELLARLHHRHLVALRGFCIE----KRERFLMYEYMA 247 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~~ 247 (518)
++||+|+||+||+|+.. +|+.||||++.... ...+|+ ..+..+.|+||+++++++.. ....++||||++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 46999999999999886 68999999986432 122333 34566799999999999876 445899999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC---CCcEEEeeccccccCCCCCc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DfGla~~~~~~~~ 324 (518)
+|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+++......
T Consensus 110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~- 185 (336)
T 3fhr_A 110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA- 185 (336)
T ss_dssp TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc-
Confidence 999999998776667999999999999999999999 889999999999999976 4569999999998654322
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHH---HHHHHhhccccccccCCcC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES---AQVCMASESRLAELVDPRI 401 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~---~~~~~~~~~~l~~~~d~~l 401 (518)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ......... .. ....
T Consensus 186 -----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~-~~~~ 256 (336)
T 3fhr_A 186 -----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY---GF-PNPE 256 (336)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------CC-CTTT
T ss_pred -----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc---cc-Cchh
Confidence 23456899999999998889999999999999999999999999643221110 000000000 00 0001
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
... ....+.+++..||+.||.+|||+.|++++.|...
T Consensus 257 ~~~----~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 257 WSE----VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp STT----CCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hcc----CCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 112 2356889999999999999999999999987653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=336.86 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=178.2
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHH-HHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIE-LLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.||+|+||+||+|... +|+.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||||+++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (327)
T 3aln_A 26 DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST 105 (327)
T ss_dssp C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred ehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC
Confidence 4568999999999999885 68999999987543 333455666766 66677999999999999999999999999985
Q ss_pred CCHHHHhcC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 249 GSLKDHLHS---PGRTPLSWQTRIQIAIDVANALEYLHFYCDP-PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 249 gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
+|.+++.. .....+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+|||+++......
T Consensus 106 -~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 180 (327)
T 3aln_A 106 -SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI- 180 (327)
T ss_dssp -EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred -ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc-
Confidence 88877752 22346999999999999999999999 77 99999999999999999999999999998654332
Q ss_pred ccccccccccCCCcccCcccc----ccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 325 CFEPVNTDIRGTPGYMDPEYV----VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
......||+.|+|||.+ .+..++.++||||||+++|||++|+.||.......+... .......+.
T Consensus 181 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------~~~~~~~~~ 249 (327)
T 3aln_A 181 ----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT-------QVVKGDPPQ 249 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C-------CCCCSCCCC
T ss_pred ----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH-------HHhcCCCCC
Confidence 12334699999999998 456789999999999999999999999975432211111 001111111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+...........+.+++..||+.||++||++.+++++.+..
T Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 290 (327)
T 3aln_A 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290 (327)
T ss_dssp CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence 11111112235688999999999999999999999987653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=363.26 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=200.3
Q ss_pred HhhhhhhhcceecceEEEEEEecC----CcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
..+.+.+.||+|+||+||+|.+.. +..||||.++.. .....+.|.+|+.++++++||||+++++++. .+..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence 344556789999999999998742 467999998653 3344577999999999999999999999985 4678999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 469 ~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 99999999999997543 35999999999999999999999 889999999999999999999999999999876443
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... +........ .. +.+
T Consensus 545 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-~~~~~i~~~-~~------~~~ 613 (656)
T 2j0j_A 545 TYY---KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENG-ER------LPM 613 (656)
T ss_dssp ------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHHT-CC------CCC
T ss_pred cce---eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcC-CC------CCC
Confidence 211 2233457889999999999999999999999999999997 88888654332 222221111 11 111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...+ ...+.+++..||+.||.+||++.++++.|..
T Consensus 614 ~~~~----~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 614 PPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Cccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2222 3568899999999999999999999999865
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=333.05 Aligned_cols=245 Identities=25% Similarity=0.390 Sum_probs=194.7
Q ss_pred HhhhhhhhcceecceEEEEEEec-CCcEEEEEEeccccc------hhHHHHHHHHHHHHHc----CCCCeeeEeeeeeec
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE------QVEGDFCREIELLARL----HHRHLVALRGFCIEK 236 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~g~~~~~ 236 (518)
..+.+.+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+.++.++ +|+||+++++++...
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 34556789999999999999874 688999999864322 1233467899999999 899999999999999
Q ss_pred CceEEEEEe-cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec-CCCcEEEeecc
Q 010088 237 RERFLMYEY-MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFG 314 (518)
Q Consensus 237 ~~~~lV~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DfG 314 (518)
+..++|||| +.+++|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred CeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 999999999 78999999997633 5999999999999999999999 88999999999999999 89999999999
Q ss_pred ccccCCCCCcccccccccccCCCcccCccccccCCCC-ccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccc
Q 010088 315 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT-EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 393 (518)
Q Consensus 315 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l 393 (518)
+++...... .....||..|+|||.+.+..+. .++||||||+++|||++|+.||...... ....
T Consensus 186 ~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~--- 249 (312)
T 2iwi_A 186 SGALLHDEP------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-------LEAE--- 249 (312)
T ss_dssp SCEECCSSC------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------HHTC---
T ss_pred hhhhcccCc------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH-------hhhc---
Confidence 998665432 2345699999999999877664 5899999999999999999999642211 1111
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 394 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 394 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
..+....+ ..+.+++.+||+.||++||+++|++++.+...
T Consensus 250 -----~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~ 289 (312)
T 2iwi_A 250 -----LHFPAHVS----PDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289 (312)
T ss_dssp -----CCCCTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred -----cCCcccCC----HHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence 11112222 45889999999999999999999999987654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=331.71 Aligned_cols=255 Identities=21% Similarity=0.323 Sum_probs=195.0
Q ss_pred hhhhhcceecceEEEEEEecCCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.||+|+||+||+|+..+ .+|+|.++.. .....+.|.+|+.++.+++|+||+++++++.+.+..++||||+++
T Consensus 36 ~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~ 113 (319)
T 2y4i_B 36 EIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG 113 (319)
T ss_dssp ECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCS
T ss_pred EEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccC
Confidence 355789999999999998753 4999988643 223345688999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc-cc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC-FE 327 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-~~ 327 (518)
++|.+++...+ ..+++..+..++.|++.||+||| +.+|+||||||+|||++ ++.+||+|||+++........ ..
T Consensus 114 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~ 188 (319)
T 2y4i_B 114 RTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE 188 (319)
T ss_dssp EEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----------C
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccc
Confidence 99999997643 35899999999999999999999 88999999999999998 679999999998754321110 01
Q ss_pred cccccccCCCcccCcccccc---------CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccC
Q 010088 328 PVNTDIRGTPGYMDPEYVVT---------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD 398 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d 398 (518)
.......||+.|+|||.+.. ..++.++||||||+++|||++|+.||...... ......... .......
T Consensus 189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~--~~~~~~~ 265 (319)
T 2y4i_B 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-AIIWQMGTG--MKPNLSQ 265 (319)
T ss_dssp CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-HHHHHHHTT--CCCCCCC
T ss_pred cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhccC--CCCCCCc
Confidence 12234468999999999864 45788999999999999999999999754432 222211111 1111111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 399 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 399 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
. ..+ ..+.+++..||+.||.+||++.++++.|.....
T Consensus 266 ~----~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 266 I----GMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp S----SCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred C----CCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1 112 348899999999999999999999999977644
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=328.29 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=180.5
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccc--hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE--QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
.+.+.||+|+||+||+|+.. +|+.||||++..... .....+.++..++..++||||+++++++.+.+..++||||+
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 106 (318)
T 2dyl_A 28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106 (318)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred cccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence 34568999999999999885 689999999865332 22233445556788889999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP-PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++.+..+.... ...+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+|||++.......
T Consensus 107 ~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--- 179 (318)
T 2dyl_A 107 GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--- 179 (318)
T ss_dssp SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc---
Confidence 55555555422 345899999999999999999999 64 99999999999999999999999999997654332
Q ss_pred ccccccccCCCcccCccccc-----cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 327 EPVNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
......||+.|+|||.+. ...++.++||||||+++|||++|+.||.......+........... .. + .
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~--~-~ 252 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP--LL--P-G 252 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC--CC--C-S
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC--CC--C-c
Confidence 223456899999999984 5578899999999999999999999997654443333332222110 00 0 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...++ ..+.+++..||+.||.+||++++++++.+.
T Consensus 253 ~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (318)
T 2dyl_A 253 HMGFS----GDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287 (318)
T ss_dssp SSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred cCCCC----HHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence 01122 458899999999999999999999998765
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=335.36 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=199.8
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccc------hhHHHHHHHHHHHHHcC--CCCeeeEeeeeeecCceE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE------QVEGDFCREIELLARLH--HRHLVALRGFCIEKRERF 240 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~ 240 (518)
+.+.+.||+|+||+||+|+.. +|+.||||.+..... .....+.+|+.++.+++ |+||+++++++...+..+
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~ 124 (320)
T 3a99_A 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 124 (320)
T ss_dssp EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence 445678999999999999864 689999999864321 12245778999999996 599999999999999999
Q ss_pred EEEEecCC-CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec-CCCcEEEeecccccc
Q 010088 241 LMYEYMAN-GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHA 318 (518)
Q Consensus 241 lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DfGla~~ 318 (518)
+||||+.+ ++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++ +++.+||+|||+++.
T Consensus 125 lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 125 LILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp EEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 99999986 8999999763 35899999999999999999999 88999999999999999 789999999999987
Q ss_pred CCCCCcccccccccccCCCcccCccccccCCC-CccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccccc
Q 010088 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 397 (518)
Q Consensus 319 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 397 (518)
..... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ....
T Consensus 200 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~~~~------- 259 (320)
T 3a99_A 200 LKDTV------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------IRGQ------- 259 (320)
T ss_dssp CCSSC------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------HHCC-------
T ss_pred ccccc------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-------hccc-------
Confidence 65432 234569999999999987766 67899999999999999999999643211 1110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
.......+ ..+.+++.+||+.||++||++++++++.+....
T Consensus 260 -~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 260 -VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp -CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -ccccccCC----HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 01112223 458899999999999999999999999877543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=338.19 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=188.3
Q ss_pred hhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
..++||+|+||+||.....+|+.||||++..... ..+.+|+++|+++ +||||+++++++.+.+..++||||+. |+
T Consensus 28 ~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~ 103 (432)
T 3p23_A 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT 103 (432)
T ss_dssp EEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred cCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence 4568999999996655556899999999864322 2356899999999 79999999999999999999999996 69
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-----CCcEEEeeccccccCCCCCcc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-----NFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~kl~DfGla~~~~~~~~~ 325 (518)
|.+++..... .+.+..+..++.||+.||+||| +.+|+||||||+||||+. ...+||+|||+++........
T Consensus 104 L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 104 LQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp HHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred HHHHHHhcCC-CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 9999986543 3555667899999999999999 889999999999999953 346889999999876543211
Q ss_pred cccccccccCCCcccCccccc---cCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
. .......||+.|+|||.+. ...++.++|||||||++|||+| |..||...... ...... ..... . ..
T Consensus 180 ~-~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--~~~~~~-~~~~~-~----~~ 250 (432)
T 3p23_A 180 F-SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--QANILL-GACSL-D----CL 250 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--HHHHHT-TCCCC-T----TS
T ss_pred e-eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--HHHHHh-ccCCc-c----cc
Confidence 1 1234567999999999997 4677889999999999999999 88888543221 111111 11010 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.........+.+++.+||+.||.+||++.++++|.++..
T Consensus 251 --~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 251 --HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp --CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred --CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 011233455789999999999999999999999987753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=355.47 Aligned_cols=261 Identities=22% Similarity=0.311 Sum_probs=202.1
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeee------cCceEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIE------KRERFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~~l 241 (518)
+.+.+.||+|+||+||+|... +|..||||++... .......|.+|++++.+++||||+++++++.. .+..++
T Consensus 16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~L 95 (676)
T 3qa8_A 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL 95 (676)
T ss_dssp -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEE
Confidence 445678999999999999874 6899999988653 34456779999999999999999999998765 667899
Q ss_pred EEEecCCCCHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCc---EEEeeccccc
Q 010088 242 MYEYMANGSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV---AKLADFGLAH 317 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DfGla~ 317 (518)
||||+++|+|.+++.... ...+++..+..|+.+++.||+||| +.+|+||||||+|||++.++. +||+|||++.
T Consensus 96 VmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 96 AMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp EEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 999999999999998643 235899999999999999999999 889999999999999997664 9999999998
Q ss_pred cCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc---ccc
Q 010088 318 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES---RLA 394 (518)
Q Consensus 318 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~---~l~ 394 (518)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........|......... ...
T Consensus 173 ~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 173 ELDQGE-----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp BTTSCC-----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred cccccc-----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 765443 224467999999999999999999999999999999999999999765443332211100000 000
Q ss_pred cccCC--------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 010088 395 ELVDP--------RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438 (518)
Q Consensus 395 ~~~d~--------~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L 438 (518)
+.... .............+.+++..||+.||++||++.+++++.
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp 299 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVG 299 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCT
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCH
Confidence 00000 011223344567899999999999999999998866544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=348.25 Aligned_cols=232 Identities=23% Similarity=0.335 Sum_probs=186.1
Q ss_pred hhhhhhcceecceEEEEEEec--CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCc-----eEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS--DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE-----RFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~l 241 (518)
+.+.+.||+|+||+||+|.+. +|+.||||++... .......|.+|+++|.+++||||+++++++...+. .|+
T Consensus 82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence 445678999999999999875 5899999988643 33445678999999999999999999999988766 799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||+++++|.+++.. .++|.+++.|+.||+.||+||| +.+|+||||||+|||++.+ .+||+|||+++....
T Consensus 162 v~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 162 VMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred EEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 9999999999988754 5999999999999999999999 8899999999999999986 899999999986543
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
. ....||++|+|||.+.+.. +.++|||||||+||||++|..|+..... ..+.
T Consensus 234 ~--------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~------------~~~~------- 285 (681)
T 2pzi_A 234 F--------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV------------DGLP------- 285 (681)
T ss_dssp C--------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC------------SSCC-------
T ss_pred C--------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc------------cccc-------
Confidence 2 3456999999999987654 8999999999999999999888753110 0000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI 437 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~ 437 (518)
...........+.+++.+||+.||++||+..+.+.+
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 321 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA 321 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHH
Confidence 000011223568899999999999999965554443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=312.19 Aligned_cols=226 Identities=20% Similarity=0.325 Sum_probs=179.0
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHH-HHcCCCCeeeEeeeeee----cCceEEEEEecC
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELL-ARLHHRHLVALRGFCIE----KRERFLMYEYMA 247 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~lV~e~~~ 247 (518)
++||+|+||+||+|... +|+.||||+++. ...+.+|+.++ +.++||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 57999999999999874 689999999864 24577899988 55589999999999887 677899999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC---CCcEEEeeccccccCCCCCc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DfGla~~~~~~~~ 324 (518)
+|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||++....
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---- 171 (299)
T 3m2w_A 99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---- 171 (299)
T ss_dssp SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence 999999998766567999999999999999999999 889999999999999998 7899999999986432
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
+..++.++|||||||++|||++|+.||......... ......+..... .
T Consensus 172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------~~~~~~~~~~~~--~ 220 (299)
T 3m2w_A 172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGMKTRIRMGQY--E 220 (299)
T ss_dssp ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------CCSCCSSCTTCC--S
T ss_pred ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------HHHHHHHhhccc--c
Confidence 134678899999999999999999999643221100 000000000000 1
Q ss_pred CCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 405 FDM----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 405 ~~~----~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
.+. .....+.+++..||+.||.+||++.|+++|.+...
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence 111 12356899999999999999999999999987643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=326.96 Aligned_cols=240 Identities=18% Similarity=0.173 Sum_probs=180.3
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCC-CCeeeEe----------------
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHH-RHLVALR---------------- 230 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~niv~l~---------------- 230 (518)
..++||+|+||+||+|++. +|+.||||++.... ....+.|.+|+.++..++| +|.....
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 3468999999999999864 68999999987322 2335679999999999987 3221111
Q ss_pred -----eeeee-----cCceEEEEEecCCCCHHHHhc-----CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceeccc
Q 010088 231 -----GFCIE-----KRERFLMYEYMANGSLKDHLH-----SPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 295 (518)
Q Consensus 231 -----g~~~~-----~~~~~lV~e~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl 295 (518)
.++.. ....+++|+++ +++|.+++. ......++|..++.|+.|++.||+||| +.+|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCc
Confidence 11111 12456777765 689999984 223445889999999999999999999 899999999
Q ss_pred CCCcEEecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCcccc----------ccCCCCccccchhhHHHHHH
Q 010088 296 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV----------VTQELTEKSDVYSYGVVLLE 365 (518)
Q Consensus 296 k~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDVwS~Gvll~e 365 (518)
||+||||+.++.+||+|||+++..... .....| +.|+|||.+ ....++.++|||||||++||
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 999999999999999999998764332 244567 999999999 55568899999999999999
Q ss_pred HHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 366 IVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 366 l~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
|+||+.||...... .....++.. ...++ ..+.+++..||+.||++||++.+++++.+.
T Consensus 310 lltg~~Pf~~~~~~-----------~~~~~~~~~--~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~ 367 (413)
T 3dzo_A 310 IWCADLPNTDDAAL-----------GGSEWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEY 367 (413)
T ss_dssp HHHSSCCCCTTGGG-----------SCSGGGGSS--CCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred HHHCCCCCCCcchh-----------hhHHHHHhh--cccCC----HHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 99999999653221 011111111 01222 568899999999999999999999887544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=306.21 Aligned_cols=225 Identities=14% Similarity=0.107 Sum_probs=177.2
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.+.||+|+||+||+|+.. +|+.||||.+.... ......|.+|+.++.+++||||+++++++.+.+..|+||||
T Consensus 33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 112 (286)
T 3uqc_A 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW 112 (286)
T ss_dssp EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence 345568999999999999886 48999999987532 33346799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
+++++|.+++... ....++.+|+.|++.||+||| +.+|+||||||+|||+++++.+||+++|
T Consensus 113 ~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 113 IRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp CCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred cCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 9999999999642 355678899999999999999 8899999999999999999999998544
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCC--C
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK--D 403 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~--~ 403 (518)
|++ .++.++|||||||++|||+||+.||.......... ........... .
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~ 226 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--------PAERDTAGQPIEPA 226 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--------ECCBCTTSCBCCHH
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--------HHHHHhccCCCChh
Confidence 333 26889999999999999999999997543210000 00000000000 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.........+.+++.+||+.||++| |+.|+++.|...
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 0001122568999999999999999 999999999664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=315.91 Aligned_cols=247 Identities=16% Similarity=0.151 Sum_probs=185.9
Q ss_pred HhhhhhhhcceecceEEEEEEecCCcEEEEEEecccc--------chhHHHHHHHHHHHHHcC---------CCCeeeEe
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS--------EQVEGDFCREIELLARLH---------HRHLVALR 230 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l~ 230 (518)
..+.+.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.+|++++ |+||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 3455667999999999999988 78999999986432 223467899999999986 77777776
Q ss_pred eeee-----------------e-------------cCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 010088 231 GFCI-----------------E-------------KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 280 (518)
Q Consensus 231 g~~~-----------------~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~ 280 (518)
+.+. + .+..++||||+++|++.+.+.+ ..+++..+..|+.||+.||+
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHH
Confidence 6542 2 6789999999999987777743 35899999999999999999
Q ss_pred HHhhcCCCCceecccCCCcEEecCCC--------------------cEEEeeccccccCCCCCcccccccccccCCCccc
Q 010088 281 YLHFYCDPPLCHRDIKSSNILLDENF--------------------VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 340 (518)
Q Consensus 281 yLH~~~~~~iiHrDlk~~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~ 340 (518)
|||. +.+|+||||||+||||+.++ .+||+|||+|+..... ...||+.|+
T Consensus 176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------~~~gt~~y~ 244 (336)
T 2vuw_A 176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---------IVVFCDVSM 244 (336)
T ss_dssp HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------EEECCCCTT
T ss_pred HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------cEEEeeccc
Confidence 9992 35899999999999999887 9999999999865432 236999999
Q ss_pred CccccccCCCCccccchhhHHH-HHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHH
Q 010088 341 DPEYVVTQELTEKSDVYSYGVV-LLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRW 419 (518)
Q Consensus 341 aPE~~~~~~~~~~sDVwS~Gvl-l~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~ 419 (518)
|||.+.+.. +.++||||||++ .+++++|..|+.+............. ... ................+.+++.+
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~s~~~~dli~~ 318 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK-QMT----FKTKCNTPAMKQIKRKIQEFHRT 318 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHH-TCC----CSSCCCSHHHHHHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhh-hhc----cCcccchhhhhhcCHHHHHHHHH
Confidence 999998766 889999998777 77889999888531100011111110 000 00111111123456789999999
Q ss_pred ccccCCCCCCCHHHHH-HHhhc
Q 010088 420 CTQREGQARPSIKQVL-RILYE 440 (518)
Q Consensus 420 Cl~~dp~~RPs~~evl-~~L~~ 440 (518)
||+.| |++|++ +|.|.
T Consensus 319 ~L~~d-----sa~e~l~~Hp~f 335 (336)
T 2vuw_A 319 MLNFS-----SATDLLCQHSLF 335 (336)
T ss_dssp GGGSS-----SHHHHHHHCGGG
T ss_pred HhccC-----CHHHHHhcCCCc
Confidence 99977 999999 88775
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=289.90 Aligned_cols=185 Identities=16% Similarity=0.085 Sum_probs=131.4
Q ss_pred hcceecceEEEEEEe-cCCcEEEEEEeccc----------cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEE
Q 010088 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKI----------SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 242 (518)
..+.|++|.+..++. --|+.+|||.+... .+...++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 467888887777643 35889999998542 123346799999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||++|++|.++|...+ +++.. +|+.||+.||+||| ++|||||||||+||||+++|.+||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999998754 46654 58899999999999 999999999999999999999999999999876543
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCcc
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRA 372 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p 372 (518)
.. ......||++|||||.+.+ .+..++|+||+|++++++.++..+
T Consensus 393 ~~----~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS----WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C----CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Cc----cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 21 2345679999999999865 467789999999999888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-28 Score=261.90 Aligned_cols=186 Identities=19% Similarity=0.203 Sum_probs=147.3
Q ss_pred hhhcceecceEEEEEEecCCcEEEEEEecccc--------chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 173 STIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS--------EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
.++||+|+||+||+|+. .+..+++|+..... ....+.|.+|+++|++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 35899999999999965 57888998764321 1123458999999999999999977777778888899999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+++|+|.+++.. +..++.|++.||+||| +.+|+||||||+|||+++ .+||+|||+++.......
T Consensus 420 ~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 420 YINGKLAKDVIED----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp CCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred CCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999975 4689999999999999 889999999999999998 999999999987654321
Q ss_pred cc---ccccccccCCCcccCcccccc--CCCCccccchhhHHHHHHHHhCCcccc
Q 010088 325 CF---EPVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQ 374 (518)
Q Consensus 325 ~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvll~el~tG~~p~~ 374 (518)
.. ........||+.|||||++.. ..|+..+|+|+..+-.++-+.++.+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 10 001235679999999999976 678888999999999998888776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.1e-25 Score=216.70 Aligned_cols=141 Identities=13% Similarity=0.079 Sum_probs=115.5
Q ss_pred hhhcceecceEEEEEEecCCcEEEEEEeccccc------------------hhHHHHHHHHHHHHHcCCCCeeeEeeeee
Q 010088 173 STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISE------------------QVEGDFCREIELLARLHHRHLVALRGFCI 234 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 234 (518)
.+.||+|+||.||+|+..+|+.||||.++.... .....+.+|+.+|++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 378999999999999987799999999863221 13456899999999999 5 66666553
Q ss_pred ecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecc
Q 010088 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG 314 (518)
Q Consensus 235 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfG 314 (518)
.+..++||||+++|+|.+ +.. .....++.|++.||+||| +.+|+||||||+|||++ ++.+||+|||
T Consensus 172 -~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 172 -WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp -EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred -ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 356799999999999998 532 234579999999999999 89999999999999999 9999999999
Q ss_pred ccccCCCCCcccccccccccCCCcccCcccccc
Q 010088 315 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 347 (518)
Q Consensus 315 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 347 (518)
+|+. +..|+|||++..
T Consensus 238 ~a~~-----------------~~~~~a~e~l~r 253 (282)
T 1zar_A 238 QSVE-----------------VGEEGWREILER 253 (282)
T ss_dssp TCEE-----------------TTSTTHHHHHHH
T ss_pred CCeE-----------------CCCCCHHHHHHH
Confidence 9862 345788998743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.5e-20 Score=180.22 Aligned_cols=135 Identities=21% Similarity=0.197 Sum_probs=105.3
Q ss_pred hhhhcceecceEEEEEEe-cCCcE--EEEEEeccccc------------------------hhHHHHHHHHHHHHHcCCC
Q 010088 172 FSTIIGQGGFGTVYKAQF-SDGSL--IAVKRMDKISE------------------------QVEGDFCREIELLARLHHR 224 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l~H~ 224 (518)
+.+.||+|+||.||+|.. .+|+. ||||+++.... .....+.+|+.+|.+++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 456899999999999988 68888 99998653211 1113688999999999887
Q ss_pred Ce--eeEeeeeeecCceEEEEEecCC-C----CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCC
Q 010088 225 HL--VALRGFCIEKRERFLMYEYMAN-G----SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 297 (518)
Q Consensus 225 ni--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~ 297 (518)
|+ ..++++ +..+|||||+.+ | +|.++... .++..+..++.|++.||.|||. ..+|+||||||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlkp 199 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLSE 199 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCST
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCH
Confidence 64 344432 367899999942 4 77776542 2355678999999999999994 46899999999
Q ss_pred CcEEecCCCcEEEeeccccccC
Q 010088 298 SNILLDENFVAKLADFGLAHAS 319 (518)
Q Consensus 298 ~NILl~~~~~~kl~DfGla~~~ 319 (518)
+|||+++ .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 9999999998754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=7.1e-18 Score=171.42 Aligned_cols=135 Identities=13% Similarity=0.119 Sum_probs=97.2
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccc--------------hhHHHH--------HHHHHHHHHcCCCCee
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISE--------------QVEGDF--------CREIELLARLHHRHLV 227 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------------~~~~~~--------~~E~~~l~~l~H~niv 227 (518)
+.+.+.||+|+||.||+|...+|+.||||+++.... .....+ .+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 344568999999999999998999999998752110 011122 2455666666443332
Q ss_pred --eEeeeeeecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC
Q 010088 228 --ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 305 (518)
Q Consensus 228 --~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 305 (518)
..+++ ...+|||||++|++|.++... .....++.|++.+|.||| ..+||||||||.||||+++
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEE
T ss_pred CCeeeec----cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCC
Confidence 22221 234799999999998765432 234578899999999999 8899999999999999887
Q ss_pred C----------cEEEeeccccccC
Q 010088 306 F----------VAKLADFGLAHAS 319 (518)
Q Consensus 306 ~----------~~kl~DfGla~~~ 319 (518)
+ .+.|+||+.+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 6 3899999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1.3e-12 Score=126.40 Aligned_cols=138 Identities=17% Similarity=0.108 Sum_probs=108.7
Q ss_pred hhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
+...++.|+.+.||++.. +|..+++|............+.+|+++|+.+. +.++.++++++...+..|+||||++|.+
T Consensus 18 ~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 96 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL 96 (263)
T ss_dssp EEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred eEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence 345678888899999975 46899999886432223346889999999995 6778899999988889999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC-------------------------------------------- 286 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------- 286 (518)
|.+.+.. ......++.+++.+|+.||...
T Consensus 97 l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 97 CSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp HHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred hhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 9887421 1234578899999999999610
Q ss_pred ------------CCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 287 ------------DPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 287 ------------~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
...++|+|+++.||+++++..+.|+||+.+.
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999877667899999763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.28 E-value=9.6e-12 Score=119.68 Aligned_cols=128 Identities=17% Similarity=0.129 Sum_probs=98.0
Q ss_pred ceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCC--eeeEeeeeeecCceEEEEEecCCCCHHHH
Q 010088 177 GQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRH--LVALRGFCIEKRERFLMYEYMANGSLKDH 254 (518)
Q Consensus 177 G~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 254 (518)
+.|..+.||++...+|..+++|..... ....+.+|+.+++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355569999998777888999987543 2346789999999996545 456888888777899999999998884
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------------------
Q 010088 255 LHSPGRTPLSWQTRIQIAIDVANALEYLHFYC------------------------------------------------ 286 (518)
Q Consensus 255 l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------------ 286 (518)
... .+ ...++.+++..|+.||...
T Consensus 104 ~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 221 12 2367788888899998431
Q ss_pred -------CCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 287 -------DPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 287 -------~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
...++|+|++|.||++++++.++|+|||.+.
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887777899999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.1e-10 Score=118.25 Aligned_cols=139 Identities=15% Similarity=0.211 Sum_probs=105.1
Q ss_pred hcceecceEEEEEEecCCcEEEEEEec--ccc-chhHHHHHHHHHHHHHcC--CCCeeeEeeeeeec---CceEEEEEec
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMD--KIS-EQVEGDFCREIELLARLH--HRHLVALRGFCIEK---RERFLMYEYM 246 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~e~~ 246 (518)
.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.|. +.++.++++++.+. +..++||||+
T Consensus 45 ~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v 123 (359)
T 3dxp_A 45 QFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV 123 (359)
T ss_dssp ECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred EcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence 5889999999999875 4678888765 221 122346889999999997 45678899988776 3589999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC---------------------------------------- 286 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 286 (518)
+|..+.+.. ...++..++..++.++++.|+.||...
T Consensus 124 ~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 124 SGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp CCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred CCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 998775321 123778888999999999999999621
Q ss_pred ---------------CCCceecccCCCcEEecCCCc--EEEeecccccc
Q 010088 287 ---------------DPPLCHRDIKSSNILLDENFV--AKLADFGLAHA 318 (518)
Q Consensus 287 ---------------~~~iiHrDlk~~NILl~~~~~--~kl~DfGla~~ 318 (518)
...++|+|+++.|||+++++. +.|.||+.+..
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.98 E-value=6.5e-10 Score=110.00 Aligned_cols=187 Identities=22% Similarity=0.222 Sum_probs=121.4
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcC-CCC--eeeEeeeeeecC---ceEEEEEecCC
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRH--LVALRGFCIEKR---ERFLMYEYMAN 248 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~e~~~~ 248 (518)
.++.|....||+.. ..+++|..... .....+.+|+++|..+. +.. +.++++++...+ ..|+||++++|
T Consensus 27 ~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp EEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred ecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 58899999999863 46888875432 33467889999999984 332 345555543333 34899999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC------------------------------------------ 286 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------ 286 (518)
.+|.+... ..++..++..++.+++..|+.||...
T Consensus 101 ~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 101 VPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp EECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred eECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 88875432 13677788888999999999998511
Q ss_pred -------------CCCceecccCCCcEEecC--CCcEEEeeccccccCCCCCcccccccccc--cC---------CCccc
Q 010088 287 -------------DPPLCHRDIKSSNILLDE--NFVAKLADFGLAHASKDGSICFEPVNTDI--RG---------TPGYM 340 (518)
Q Consensus 287 -------------~~~iiHrDlk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~~~~~--~g---------t~~y~ 340 (518)
...++|+|+++.||++++ +..+.|+||+.+...... .......... .+ ..++.
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 135799999999999998 566889999988643211 1000000000 00 00111
Q ss_pred C-ccccccCCCCccccchhhHHHHHHHHhCCcccc
Q 010088 341 D-PEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQ 374 (518)
Q Consensus 341 a-PE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~ 374 (518)
. |+.... ...-.+.|++|.++|++.+|..++.
T Consensus 256 ~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 256 DIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1 121110 1122588999999999999987763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=4.2e-07 Score=87.78 Aligned_cols=133 Identities=20% Similarity=0.208 Sum_probs=97.6
Q ss_pred cceecce-EEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEEecCCCCHH
Q 010088 176 IGQGGFG-TVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMANGSLK 252 (518)
Q Consensus 176 lG~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 252 (518)
+..|..| .||+.... ++..+++|+-.. ....++.+|...|+.+. +--+.++++++.+.+..++|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445554 69987765 456788897543 23456889999999885 334678889999989999999999998887
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------------
Q 010088 253 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC---------------------------------------------- 286 (518)
Q Consensus 253 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------------- 286 (518)
+.... .......++.+++..|+-||...
T Consensus 109 ~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 109 QVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred ccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 76532 12234456677777777777421
Q ss_pred ---------CCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 287 ---------DPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 287 ---------~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
...++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137899999999999988777899999764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=6.3e-07 Score=88.60 Aligned_cols=134 Identities=18% Similarity=0.201 Sum_probs=95.3
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCC---CeeeEeeeee-ecCceEEEEEecCCCC
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHR---HLVALRGFCI-EKRERFLMYEYMANGS 250 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~e~~~~gs 250 (518)
.++.|....||+. |..+++|.... ......+.+|+++|..|.+. .+.+++.++. ..+..++||||++|.+
T Consensus 26 ~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 26 SLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred ecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 4788888899987 56788887532 23346789999999999753 3556677664 3456789999999988
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhc---------------------------------------------
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY--------------------------------------------- 285 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------- 285 (518)
|.+..-. .++...+..++.+++..|+.||..
T Consensus 100 l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 100 LGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp CHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred Cchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 8764221 145555666666666666666632
Q ss_pred ------------CCCCceecccCCCcEEecC---CCc-EEEeecccccc
Q 010088 286 ------------CDPPLCHRDIKSSNILLDE---NFV-AKLADFGLAHA 318 (518)
Q Consensus 286 ------------~~~~iiHrDlk~~NILl~~---~~~-~kl~DfGla~~ 318 (518)
....++|+|+++.||++++ ++. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1335699999999999987 455 58999997653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=4.2e-07 Score=91.61 Aligned_cols=78 Identities=6% Similarity=-0.028 Sum_probs=55.0
Q ss_pred hc-ceecceEEEEEEec-------CCcEEEEEEecccc---chhHHHHHHHHHHHHHcC-C--CCeeeEeeeeeec---C
Q 010088 175 II-GQGGFGTVYKAQFS-------DGSLIAVKRMDKIS---EQVEGDFCREIELLARLH-H--RHLVALRGFCIEK---R 237 (518)
Q Consensus 175 ~l-G~G~~g~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~---~ 237 (518)
.| +.|....+|+.... ++..+++|...... ......+.+|+.+|..|. + -.+.++++++.+. +
T Consensus 27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g 106 (357)
T 3ats_A 27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG 106 (357)
T ss_dssp EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence 46 78888999998764 26778888764322 101245788999998884 3 3567788887665 3
Q ss_pred ceEEEEEecCCCCHH
Q 010088 238 ERFLMYEYMANGSLK 252 (518)
Q Consensus 238 ~~~lV~e~~~~gsL~ 252 (518)
..++||||++|.++.
T Consensus 107 ~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 107 TPFFLMDYVEGVVPP 121 (357)
T ss_dssp SCEEEEECCCCBCCC
T ss_pred CceEEEEecCCCChh
Confidence 568999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=4.8e-06 Score=85.25 Aligned_cols=73 Identities=14% Similarity=0.085 Sum_probs=49.0
Q ss_pred hcceecceEEEEEEec-CCcEEEEEEeccccc-------hhHHHHHHHHHHHHHcCC--CC-eeeEeeeeeecCceEEEE
Q 010088 175 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-------QVEGDFCREIELLARLHH--RH-LVALRGFCIEKRERFLMY 243 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~n-iv~l~g~~~~~~~~~lV~ 243 (518)
.||.|.++.||++... ++..++||....... .....+..|.++|..+.. +. +.+++.+ +.+..++||
T Consensus 37 ~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvm 114 (397)
T 2olc_A 37 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM 114 (397)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred ECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEE
Confidence 5899999999999764 468899997642211 123457789999998842 33 3455544 345678999
Q ss_pred EecCCC
Q 010088 244 EYMANG 249 (518)
Q Consensus 244 e~~~~g 249 (518)
||+++.
T Consensus 115 E~l~g~ 120 (397)
T 2olc_A 115 EDLSHL 120 (397)
T ss_dssp CCCTTS
T ss_pred EeCCCc
Confidence 999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.12 E-value=1.2e-05 Score=79.99 Aligned_cols=138 Identities=19% Similarity=0.264 Sum_probs=79.8
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcC--CCCeeeEee------eeeecCceEEEEEec
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH--HRHLVALRG------FCIEKRERFLMYEYM 246 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g------~~~~~~~~~lV~e~~ 246 (518)
.|+.|..+.||+....+| .+++|+.... ...+..|+.++..|. .-.+.+++. +....+..+++|+|+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 356677899999987554 5889988652 133445566665553 113334443 123456789999999
Q ss_pred CCCCHH--------------HHhcC----CC-C-------CCCCHHHHH-------------------------------
Q 010088 247 ANGSLK--------------DHLHS----PG-R-------TPLSWQTRI------------------------------- 269 (518)
Q Consensus 247 ~~gsL~--------------~~l~~----~~-~-------~~l~~~~~~------------------------------- 269 (518)
+|.++. ..+|. .. . ..-.|....
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 11221 10 0 012343211
Q ss_pred HHHHHHHHHHHHHhh----------cCCCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 270 QIAIDVANALEYLHF----------YCDPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 270 ~i~~~ia~gL~yLH~----------~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
.+...+..++++|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123345666652 125789999999999999888899999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.97 E-value=4e-05 Score=75.72 Aligned_cols=135 Identities=16% Similarity=0.206 Sum_probs=91.2
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcC---CCCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH---HRHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
.|+.|....+|+... ++..+++|+.... ....|..|+..|+.|. ...+.++++++...+..++||||+++..+
T Consensus 43 ~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 43 KLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 488999999999876 5678888976532 2456889999999884 36688899988888889999999998765
Q ss_pred H--------H---HhcCCCC-C-------------------CCCHHHHH---HHHHH----------------HHHH-HH
Q 010088 252 K--------D---HLHSPGR-T-------------------PLSWQTRI---QIAID----------------VANA-LE 280 (518)
Q Consensus 252 ~--------~---~l~~~~~-~-------------------~l~~~~~~---~i~~~----------------ia~g-L~ 280 (518)
. . .||.... . .-+|.... ++..+ +..- ..
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 2 1 2332211 0 12465322 11111 1111 12
Q ss_pred HHhh-cCCCCceecccCCCcEEecCCCcEEEeecc
Q 010088 281 YLHF-YCDPPLCHRDIKSSNILLDENFVAKLADFG 314 (518)
Q Consensus 281 yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DfG 314 (518)
.|.. ...+.++|+|+.+.||+++.++ +.|.||.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3321 2257899999999999999887 8899984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.96 E-value=3.3e-05 Score=75.29 Aligned_cols=73 Identities=21% Similarity=0.284 Sum_probs=54.7
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCC---CCeeeEeeeeeecCceEEEEEecCCCCH
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHH---RHLVALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
.+|.|..+.||+.++.||+.|.||+...........|..|+..|+.|.- --+.+++++. ..++||||++++..
T Consensus 22 ~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 22 ERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERPP 97 (288)
T ss_dssp EEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCCC
T ss_pred ecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccCC
Confidence 5899999999999999999999998654444444568899999999842 2344555542 34789999987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.82 E-value=7e-05 Score=77.19 Aligned_cols=79 Identities=10% Similarity=0.038 Sum_probs=46.8
Q ss_pred CCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccC---CCCccccchhhHHHH
Q 010088 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ---ELTEKSDVYSYGVVL 363 (518)
Q Consensus 287 ~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwS~Gvll 363 (518)
...++|+|+++.|||+++++ ++|.||+.+......- +....-..-...|++|+..... .-....++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~---Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF---DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH---HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH---HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 67899999999999999876 9999999876422110 0000000001345565544311 111234555777778
Q ss_pred HHHHhC
Q 010088 364 LEIVTA 369 (518)
Q Consensus 364 ~el~tG 369 (518)
|+.+++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00039 Score=68.48 Aligned_cols=140 Identities=13% Similarity=0.123 Sum_probs=79.9
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCC--eeeEeee------eeecCceEEEEEec
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRH--LVALRGF------CIEKRERFLMYEYM 246 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~e~~ 246 (518)
.|+.|....+|+....+| .+++|..... .....+..|+.++..|...+ +.+++.. ....+..+++|+|+
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 366788899999987655 6788887642 12245667888887774222 2333321 12235678999999
Q ss_pred CCCCHHH--------------HhcC----CCCC---C---CCHHHHHH------------HHHHHHHHHHHHhhc----C
Q 010088 247 ANGSLKD--------------HLHS----PGRT---P---LSWQTRIQ------------IAIDVANALEYLHFY----C 286 (518)
Q Consensus 247 ~~gsL~~--------------~l~~----~~~~---~---l~~~~~~~------------i~~~ia~gL~yLH~~----~ 286 (518)
+|..+.. .+|. .... . ..|..... +...+...+++++.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 9865311 1221 0100 0 12432111 011244455555532 1
Q ss_pred CCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 287 ~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
...++|+|+++.|||++++..+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 4579999999999999987666899999764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00066 Score=67.33 Aligned_cols=138 Identities=13% Similarity=0.111 Sum_probs=72.5
Q ss_pred cceecceE-EEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCC--CCeeeEeeeeeecCceEEEEEecCCCCHH
Q 010088 176 IGQGGFGT-VYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHH--RHLVALRGFCIEKRERFLMYEYMANGSLK 252 (518)
Q Consensus 176 lG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 252 (518)
|+.|.... +|+....+|..+++|...... ..++..|+.++..+.. -.+.+++.++.+.+ +++||++.+.++.
T Consensus 26 l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~ 100 (333)
T 3csv_A 26 LAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFT 100 (333)
T ss_dssp --------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHH
T ss_pred CCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchH
Confidence 54454444 667765446777777543321 1234567777777742 23556666643332 7899999776665
Q ss_pred HHhc---------------------CCCC---CCCCHHHHH-------HH-------------HHHHHHHHHHHh---hc
Q 010088 253 DHLH---------------------SPGR---TPLSWQTRI-------QI-------------AIDVANALEYLH---FY 285 (518)
Q Consensus 253 ~~l~---------------------~~~~---~~l~~~~~~-------~i-------------~~~ia~gL~yLH---~~ 285 (518)
+++. .... ..++..... .+ ...+...++.+. ..
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 4332 1110 011111100 00 001112222221 11
Q ss_pred CCCCceecccCCCcEEecCC----CcEEEeecccccc
Q 010088 286 CDPPLCHRDIKSSNILLDEN----FVAKLADFGLAHA 318 (518)
Q Consensus 286 ~~~~iiHrDlk~~NILl~~~----~~~kl~DfGla~~ 318 (518)
....++|||+.+.||+++.+ +.+.|.||+.+..
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 25679999999999999875 6899999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00045 Score=67.54 Aligned_cols=69 Identities=10% Similarity=0.023 Sum_probs=43.2
Q ss_pred hcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCe-eeEeeeeeecCceEEEEEec-CCCCH
Q 010088 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL-VALRGFCIEKRERFLMYEYM-ANGSL 251 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~-~~gsL 251 (518)
.|+.|....+|+. ..+++|+....... ..+..+|+.++..+...++ .++++++ .+.-++|+||+ ++.+|
T Consensus 25 ~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 25 ERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred EcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 5788999999998 45788876542211 1223568888887753333 3555543 34457899999 65444
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00036 Score=72.06 Aligned_cols=71 Identities=20% Similarity=0.252 Sum_probs=48.5
Q ss_pred hcceecceEEEEEEecC--------CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCe-eeEeeeeeecCceEEEEEe
Q 010088 175 IIGQGGFGTVYKAQFSD--------GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL-VALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~ 245 (518)
.|+.|....||+....+ +..+++|+.... .....+.+|..++..|...++ .++++.+.+ .+|+||
T Consensus 80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 47788889999998753 478888877431 112456689999998853344 566665532 389999
Q ss_pred cCCCCH
Q 010088 246 MANGSL 251 (518)
Q Consensus 246 ~~~gsL 251 (518)
++|.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0024 Score=62.95 Aligned_cols=138 Identities=14% Similarity=0.116 Sum_probs=80.6
Q ss_pred cceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCC--CeeeEeee-----eeecCceEEEEEecCC
Q 010088 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHR--HLVALRGF-----CIEKRERFLMYEYMAN 248 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~lV~e~~~~ 248 (518)
|+ |....||+....+|+.+++|...... .....+..|..++..|... .+.+++.. ....+..+++|+|++|
T Consensus 34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 55 77889999887778789999875321 1234667788888887422 24444443 1223456889999987
Q ss_pred CCHH-----H------H---hcC----CC---CCCCCHHHH----HHH---------------HHHHHHHHHHHhhc---
Q 010088 249 GSLK-----D------H---LHS----PG---RTPLSWQTR----IQI---------------AIDVANALEYLHFY--- 285 (518)
Q Consensus 249 gsL~-----~------~---l~~----~~---~~~l~~~~~----~~i---------------~~~ia~gL~yLH~~--- 285 (518)
..+. . . +|. .. ....++... ..+ ...+...++.+...
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 5432 1 1 111 10 111233211 011 11111223333211
Q ss_pred -CCCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 286 -CDPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 286 -~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 245689999999999999 4 89999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00094 Score=69.45 Aligned_cols=72 Identities=15% Similarity=0.109 Sum_probs=46.9
Q ss_pred hcceecceEEEEEEecC-CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCe-eeEeeeeeecCceEEEEEecCCCCH
Q 010088 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL-VALRGFCIEKRERFLMYEYMANGSL 251 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL 251 (518)
.|+.|-...+|+....+ +..+++|+....... .-+..+|..++..|...++ .++++++. + .+||||++|.+|
T Consensus 115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 57788889999998765 478888876432211 1122589999999975555 46676652 2 359999987544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00093 Score=67.71 Aligned_cols=138 Identities=20% Similarity=0.227 Sum_probs=82.5
Q ss_pred hcceecceEEEEEEec--------CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCC-eeeEeeeeeecCceEEEEEe
Q 010088 175 IIGQGGFGTVYKAQFS--------DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRH-LVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~ 245 (518)
.|..|-...+|+.... ++..+++|+.... ......+.+|..+++.|.-.+ ..++++++.+ .+||||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 4566777889998764 2478888875332 123456678999998885222 3566666543 399999
Q ss_pred cCCCCHHH-----------------HhcCCC---CCCCC--HHHHHHHHHHHHH-------------------HHHHHhh
Q 010088 246 MANGSLKD-----------------HLHSPG---RTPLS--WQTRIQIAIDVAN-------------------ALEYLHF 284 (518)
Q Consensus 246 ~~~gsL~~-----------------~l~~~~---~~~l~--~~~~~~i~~~ia~-------------------gL~yLH~ 284 (518)
++|.+|.. .||... ..... |.++.++..++.. .+..|..
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 99865531 122211 11122 4555555544322 2333321
Q ss_pred -----cCCCCceecccCCCcEEecCC----CcEEEeeccccc
Q 010088 285 -----YCDPPLCHRDIKSSNILLDEN----FVAKLADFGLAH 317 (518)
Q Consensus 285 -----~~~~~iiHrDlk~~NILl~~~----~~~kl~DfGla~ 317 (518)
.....++|+|+.+.||+++++ +.+.|+||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 123578999999999999876 789999999774
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.00071 Score=68.18 Aligned_cols=72 Identities=11% Similarity=0.113 Sum_probs=43.6
Q ss_pred hcceecceEEEEEEecC---------CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCe-eeEeeeeeecCceEEEEE
Q 010088 175 IIGQGGFGTVYKAQFSD---------GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL-VALRGFCIEKRERFLMYE 244 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e 244 (518)
.|+.|....+|+....+ +..+++|+....... ..+...|..++..+...++ .++++.. .-++|||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~e 114 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIEE 114 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEEE
Confidence 46778888999998754 267888876542221 1234678888888853343 3566543 2378999
Q ss_pred ecCCCCH
Q 010088 245 YMANGSL 251 (518)
Q Consensus 245 ~~~~gsL 251 (518)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0026 Score=63.34 Aligned_cols=68 Identities=12% Similarity=0.102 Sum_probs=44.1
Q ss_pred ceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcC---CCCeeeEeee------eeecCceEEEEEecC
Q 010088 177 GQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH---HRHLVALRGF------CIEKRERFLMYEYMA 247 (518)
Q Consensus 177 G~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~------~~~~~~~~lV~e~~~ 247 (518)
|.|....||+....+| .+++|+...... ..|+.++..|. -+++.+.+.. ....+..++||+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444689999987777 899997754331 35666666663 1224555432 233467799999999
Q ss_pred CCCH
Q 010088 248 NGSL 251 (518)
Q Consensus 248 ~gsL 251 (518)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.13 E-value=0.016 Score=53.40 Aligned_cols=104 Identities=14% Similarity=0.113 Sum_probs=66.6
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
-||.+.|...+ .++++++++.++.|.+..|.-+-. ...-..+=+-+..|+|..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 37999997654 579999999999999999877621 11111223446899999999988764 1110
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccc
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV 373 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~ 373 (518)
.....+.+||... ...+.+.=|||+|+++|.-+--..+-
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 1123456788653 34567889999999999988654443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.29 E-value=0.048 Score=55.85 Aligned_cols=137 Identities=14% Similarity=0.175 Sum_probs=83.3
Q ss_pred hcceecceEEEEEEecC--------CcEEEEEEeccccchhHHHHHHHHHHHHHcCCCC-eeeEeeeeeecCceEEEEEe
Q 010088 175 IIGQGGFGTVYKAQFSD--------GSLIAVKRMDKISEQVEGDFCREIELLARLHHRH-LVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~ 245 (518)
.|..|-...+|+....+ +..+++++....... .-+..+|..+++.+.-.+ ..++++.+ .-++||||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEEE
Confidence 46677888999998753 578888876432221 223457888888885323 34555433 23789999
Q ss_pred cCCCCHHH--------------H---hcC--------C---CCCCCCHHHHHHHHHHH-------------------HHH
Q 010088 246 MANGSLKD--------------H---LHS--------P---GRTPLSWQTRIQIAIDV-------------------ANA 278 (518)
Q Consensus 246 ~~~gsL~~--------------~---l~~--------~---~~~~l~~~~~~~i~~~i-------------------a~g 278 (518)
++|.+|.. . ||. . ...+.-|.++.++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 99866421 0 111 0 12222355544444332 222
Q ss_pred HHHHhh---------------------cCCCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 279 LEYLHF---------------------YCDPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 279 L~yLH~---------------------~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
+.+|.. .....++|+|+.+.||+ ++++.+.|+||..|.
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 333321 11346899999999999 788899999999875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.33 E-value=0.22 Score=50.49 Aligned_cols=30 Identities=37% Similarity=0.560 Sum_probs=25.1
Q ss_pred CceecccCCCcEEe------cCCCcEEEeecccccc
Q 010088 289 PLCHRDIKSSNILL------DENFVAKLADFGLAHA 318 (518)
Q Consensus 289 ~iiHrDlk~~NILl------~~~~~~kl~DfGla~~ 318 (518)
.++|+|+.+.|||+ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999998753
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.72 E-value=0.17 Score=33.63 Aligned_cols=26 Identities=23% Similarity=0.376 Sum_probs=9.7
Q ss_pred ehhhHHHHHHHHHHHHHHHHHHHHHHc
Q 010088 96 LIPGIGIAVTAVAVILLMVLIILIRRK 122 (518)
Q Consensus 96 ~~~~i~~~~~~~~~~~~~~~~~~~r~~ 122 (518)
++.++..+++++++++++ +++++|||
T Consensus 13 IA~gVVgGv~~~~ii~~~-~~~~~RRr 38 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALG-IGLFMRRR 38 (44)
T ss_dssp STHHHHHHHHHHHHHHHH-HHHHHHTT
T ss_pred EEeehhHHHHHHHHHHHH-HHHHhhhh
Confidence 333333333333333333 33344433
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.28 E-value=0.15 Score=33.90 Aligned_cols=7 Identities=43% Similarity=0.857 Sum_probs=2.8
Q ss_pred HHHHHHc
Q 010088 116 IILIRRK 122 (518)
Q Consensus 116 ~~~~r~~ 122 (518)
++++|||
T Consensus 31 ~~~~RRR 37 (44)
T 2l2t_A 31 AVYVRRK 37 (44)
T ss_dssp HHHHHTT
T ss_pred HHHhhhh
Confidence 3444433
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=91.66 E-value=0.16 Score=32.70 Aligned_cols=26 Identities=23% Similarity=0.215 Sum_probs=11.0
Q ss_pred eehhhHHHHHHHHHHHHHHHHHHHHH
Q 010088 95 TLIPGIGIAVTAVAVILLMVLIILIR 120 (518)
Q Consensus 95 ~~~~~i~~~~~~~~~~~~~~~~~~~r 120 (518)
..+++|++.+++.+++++.+.++++|
T Consensus 11 GaIAGiVvG~v~gv~li~~l~~~~~r 36 (38)
T 2k1k_A 11 GEIVAVIFGLLLGAALLLGILVFRSR 36 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred CceeeeehHHHHHHHHHHHHHHHHee
Confidence 44555555544333333333333333
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=91.63 E-value=0.23 Score=32.89 Aligned_cols=16 Identities=44% Similarity=0.646 Sum_probs=7.0
Q ss_pred HHHHHHHHHHHHHHcc
Q 010088 108 AVILLMVLIILIRRKS 123 (518)
Q Consensus 108 ~~~~~~~~~~~~r~~~ 123 (518)
++++++++.+|+|||+
T Consensus 24 ~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 24 VVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHhheehhh
Confidence 3333444444445443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.82 E-value=1.4 Score=40.33 Aligned_cols=116 Identities=10% Similarity=0.184 Sum_probs=76.8
Q ss_pred CCCCeeeEeeeeeecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEE
Q 010088 222 HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 301 (518)
Q Consensus 222 ~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NIL 301 (518)
.||+++.. .+-.+.+...+.|+.-+++-=...++ .++...+++++.+|+...++++ .=+|--|.|+|++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEE
Confidence 68888866 45555566666565443222122233 2778899999999988876665 3378889999999
Q ss_pred ecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCcccc
Q 010088 302 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQ 374 (518)
Q Consensus 302 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~ 374 (518)
++.++.+++.=.|+-.. ++|. ..+...=.-.+=+++..+++++..|.
T Consensus 112 f~~~~~p~i~~RGik~~---------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNV---------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp ECTTSCEEESCCEETTT---------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EcCCCCEEEEEccCccC---------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999987775322 1222 11222223356778889999988774
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.08 E-value=1.9 Score=39.47 Aligned_cols=82 Identities=10% Similarity=0.085 Sum_probs=59.8
Q ss_pred CCCCeeeEeeeeeecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCceecccCCCcE
Q 010088 222 HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE-YLHFYCDPPLCHRDIKSSNI 300 (518)
Q Consensus 222 ~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~iiHrDlk~~NI 300 (518)
.||++ -..+-.+.+...+.|+.-+++.=...++. ++...+++++.+|+.... +++ .-+|--|.|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence 57888 33344566777777776544433444443 778899999998887666 554 457888999999
Q ss_pred EecCCCcEEEeeccc
Q 010088 301 LLDENFVAKLADFGL 315 (518)
Q Consensus 301 Ll~~~~~~kl~DfGl 315 (518)
++|.++.++|.-.|+
T Consensus 116 ~f~~~~~p~i~hRGi 130 (219)
T 4ano_A 116 MFNRALEPFFLHVGV 130 (219)
T ss_dssp EECTTCCEEESCCEE
T ss_pred EEeCCCcEEEEEcCC
Confidence 999999999987775
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.96 E-value=0.1 Score=54.07 Aligned_cols=60 Identities=12% Similarity=0.147 Sum_probs=17.6
Q ss_pred hhhcceecceEEEEEEecC-CcEEEE------EEecc--ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeee
Q 010088 173 STIIGQGGFGTVYKAQFSD-GSLIAV------KRMDK--ISEQVEGDFCREIELLARLHHRHLVALRGFCIE 235 (518)
Q Consensus 173 ~~~lG~G~~g~Vy~~~~~~-g~~vav------K~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 235 (518)
.+.|| ||.||+|.+.. ...||| |..+. .+......|.+|..++..++|+|+++.+++...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 34666 99999998864 367888 76543 223334568899999999999999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 518 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-69 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-67 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-67 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-63 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-63 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-45 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-39 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-23 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 7e-71
Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 17/266 (6%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 235
IG G FGTVYK ++ + + + + Q F E+ +L + H +++ G+
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 295
+ ++ ++ SL HLH T I IA A ++YLH + HRD+
Sbjct: 76 PQ-LAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDL 130
Query: 296 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE---LTE 352
KS+NI L E+ K+ DFGLA S + G+ +M PE + Q+ +
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWS--GSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 353 KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT 412
+SDVY++G+VL E++T + N + + +L R M++L
Sbjct: 189 QSDVYAFGIVLYELMTGQLPY-SNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL-- 245
Query: 413 IVTIVRWCTQREGQARPSIKQVLRIL 438
+ C +++ RP Q+L +
Sbjct: 246 ----MAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 7e-69
Identities = 70/263 (26%), Positives = 120/263 (45%), Gaps = 19/263 (7%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 235
+G G FG V+ ++ + +AVK + + S + F E L+ +L H+ LV L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 295
+ +++ EYM NGSL D L +P L+ + +A +A + ++ + HRD+
Sbjct: 80 E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 296 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 355
+++NIL+ + K+ADFGLA +D + + PE + T KSD
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYT---AREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 356 VYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVT 415
V+S+G++L EIVT R G E Q L D+ E +
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQ-------NLERGYRMVRPDNCPEE----LYQ 241
Query: 416 IVRWCTQREGQARPSIKQVLRIL 438
++R C + + RP+ + +L
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 5e-67
Identities = 66/269 (24%), Positives = 122/269 (45%), Gaps = 21/269 (7%)
Query: 171 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALR 230
F IG G FG V+ + + +A+K + + E DF E E++ +L H LV L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 231 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
G C+E+ L++E+M +G L D+L + R + +T + + +DV + + + +
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEG---MAYLEEACV 122
Query: 291 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 350
HRD+ + N L+ EN V K++DFG+ D +T + + PE
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS---STGTKFPVKWASPEVFSFSRY 179
Query: 351 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQ-VCMASESRLAELVDPRIKDSFDMEQ 409
+ KSDV+S+GV++ E+ + + + ++ E + + L +
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ------ 233
Query: 410 LRTIVTIVRWCTQREGQARPSIKQVLRIL 438
I+ C + + RP+ ++LR L
Sbjct: 234 ------IMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 6e-67
Identities = 72/265 (27%), Positives = 122/265 (46%), Gaps = 25/265 (9%)
Query: 175 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
IG+G FG V + G+ +AVK + + F E ++ +L H +LV L G +
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 235 EKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 293
E++ +++ EYMA GSL D+L S GR+ L ++ ++DV A+EYL HR
Sbjct: 71 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 127
Query: 294 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 353
D+ + N+L+ E+ VAK++DFGL + + PE + ++ + K
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTK 180
Query: 354 SDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTI 413
SDV+S+G++L EI + R L + R+ + D +
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-------RVEKGYKMDAPDGCPPA----V 229
Query: 414 VTIVRWCTQREGQARPSIKQVLRIL 438
+++ C + RPS Q+ L
Sbjct: 230 YEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (543), Expect = 6e-66
Identities = 60/296 (20%), Positives = 122/296 (41%), Gaps = 32/296 (10%)
Query: 160 FSYKETKKATDNFST-----------IIGQGGFGTVYKAQF----SDGSLIAVKRMDK-I 203
F++++ +A F+ +IG G FG V +A+K +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 204 SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPL 263
+E+ DF E ++ + H +++ L G + ++ E+M NGSL D
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125
Query: 264 SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323
+ + + +A ++YL HRD+ + NIL++ N V K++DFGL+ +D +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 324 ICFEPVNT-DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES 382
+ + + PE + ++ T SDV+SYG+V+ E+++ +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD- 241
Query: 383 AQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
+ ++ + M+ + ++ C Q++ RP Q++ L
Sbjct: 242 ----------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 1e-65
Identities = 67/270 (24%), Positives = 122/270 (45%), Gaps = 19/270 (7%)
Query: 171 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALR 230
F +G G FG V ++ +A+K + + E +F E +++ L H LV L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 231 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
G C ++R F++ EYMANG L ++L R Q +++ DV A+EYL
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 291 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 350
HRD+ + N L+++ V K++DFGL+ D + + + PE ++ +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT---SSVGSKFPVRWSPPEVLMYSKF 178
Query: 351 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 410
+ KSD++++GV++ EI + + + S AE + ++
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFT-----------NSETAEHIAQGLRLYRPHLAS 227
Query: 411 RTIVTIVRWCTQREGQARPSIKQVLRILYE 440
+ TI+ C + RP+ K +L + +
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (535), Expect = 8e-65
Identities = 71/287 (24%), Positives = 134/287 (46%), Gaps = 22/287 (7%)
Query: 153 PSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDF 211
SP + K+ E ++ +G G +G VY+ + +AVK + + + +VE +F
Sbjct: 5 SSPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EF 60
Query: 212 CREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI 271
+E ++ + H +LV L G C + +++ E+M G+L D+L R +S + +
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120
Query: 272 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331
A +++A+EYL HRD+ + N L+ EN + K+ADFGL+ + +
Sbjct: 121 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT---AHA 174
Query: 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 391
+ + PE + + + KSDV+++GV+L EI T + G +L S
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------S 223
Query: 392 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
++ EL++ + + ++R C Q RPS ++ +
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 1e-64
Identities = 69/272 (25%), Positives = 126/272 (46%), Gaps = 22/272 (8%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 235
+GQG FG V+ ++ + +A+K + + E F +E +++ +L H LV L
Sbjct: 25 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV-S 82
Query: 236 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 295
+ +++ EYM+ GSL D L L + +A +A+ + Y+ HRD+
Sbjct: 83 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 139
Query: 296 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 355
+++NIL+ EN V K+ADFGLA +D + + PE + T KSD
Sbjct: 140 RAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 196
Query: 356 VYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVT 415
V+S+G++L E+ T R G E + + V+ + E ++
Sbjct: 197 VWSFGILLTELTTKGRVPYPGMVNRE-----------VLDQVERGYRMPCPPECPESLHD 245
Query: 416 IVRWCTQREGQARPSIKQVLRIL---YESSDP 444
++ C ++E + RP+ + + L + S++P
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-63
Identities = 71/287 (24%), Positives = 126/287 (43%), Gaps = 29/287 (10%)
Query: 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 235
IG+G FG V++ ++ G +AVK E+ EI L H +++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 236 KR----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC----- 286
+ +L+ +Y +GSL D+L+ R ++ + I++A+ A+ L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 346
P + HRD+KS NIL+ +N +AD GLA + + GT YM PE +
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 347 TQ------ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL---- 396
E +++D+Y+ G+V EI ++ + S+ + E+
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 397 ----VDPRIKDSFD-MEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
+ P I + + E LR + I+R C G AR + ++ + L
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 2e-63
Identities = 68/275 (24%), Positives = 121/275 (44%), Gaps = 23/275 (8%)
Query: 171 NFSTIIGQGGFGTVYKAQFSDGS----LIAVKRMDKISEQVE-GDFCREIELLARLHHRH 225
+F+ +IG+G FG VY D AVK +++I++ E F E ++ H +
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 226 LVALRGFCIE-KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
+++L G C+ + ++ YM +G L++ + + P + + I + VA + F
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGM---KF 145
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
HRD+ + N +LDE F K+ADFGLA D T + +M E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 345 VVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA-ELVDPRIKD 403
+ TQ+ T KSDV+S+GV+L E++T N + + L E + +
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265
Query: 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
++ C + + RPS +++ +
Sbjct: 266 ------------VMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 4e-63
Identities = 70/304 (23%), Positives = 111/304 (36%), Gaps = 45/304 (14%)
Query: 168 ATDNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDK-ISEQVEGDFCREIELLARLHH 223
D+F I +G G G V+K G ++A K + I + RE+++L +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 224 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 283
++V G E + E+M GSL L GR + Q +++I V L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR 121
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 343
+ HRD+K SNIL++ KL DFG++ D + GT YM PE
Sbjct: 122 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTRSYMSPE 173
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN--------------LVESAQVCMAS 389
+ + +SD++S G+ L+E+ R + E+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 390 ESRLAELVDPRIKDSFDMEQLRTIVT-----------------IVRWCTQREGQARPSIK 432
L+ E L IV V C + R +K
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 433 QVLR 436
Q++
Sbjct: 294 QLMV 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 7e-63
Identities = 62/278 (22%), Positives = 111/278 (39%), Gaps = 27/278 (9%)
Query: 170 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHR 224
+++ + IG G +G K + SDG ++ K +D ++E + E+ LL L H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 225 HLVALRGFCIEKRER--FLMYEYMANGSLKDHLHSPG--RTPLSWQTRIQIAIDVANALE 280
++V I++ +++ EY G L + R L + +++ + AL+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 281 YLH--FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 338
H + HRD+K +N+ LD KL DFGLA + GTP
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT----SFAKAFVGTPY 179
Query: 339 YMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD 398
YM PE + EKSD++S G +L E+ + ++ R+
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 239
Query: 399 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
+ + I+ + RPS++++L
Sbjct: 240 DELNE------------IITRMLNLKDYHRPSVEEILE 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 6e-62
Identities = 65/273 (23%), Positives = 113/273 (41%), Gaps = 30/273 (10%)
Query: 170 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHH 223
++F +G+G FG VY A+ ++A+K + K VE RE+E+ + L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 224 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 283
+++ L G+ + +L+ EY G++ L Q ++ANAL Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH 123
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 343
+ HRDIK N+LL K+ADFG + + + GT Y+ PE
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------TLCGTLDYLPPE 174
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403
+ + EK D++S GV+ E + + + E+ + E + V +D
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGARD 233
Query: 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
++ + RP +++VL
Sbjct: 234 ------------LISRLLKHNPSQRPMLREVLE 254
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-60
Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 28/273 (10%)
Query: 172 FSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVA 228
F IG+G F TVYK ++ +A + +++ F E E+L L H ++V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 229 LRGFCIE----KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
K+ L+ E M +G+LK +L + + + L++LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLH- 129
Query: 285 YCDPPLCHRDIKSSNILL-DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 343
PP+ HRD+K NI + K+ D GLA + + GTP +M PE
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS------FAKAVIGTPEFMAPE 183
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403
+ ++ E DVY++G+ +LE+ T+ + +N + + R+ V P D
Sbjct: 184 -MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR-------RVTSGVKPASFD 235
Query: 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
+ +++ I+ C ++ R SIK +L
Sbjct: 236 KVAIPEVK---EIIEGCIRQNKDERYSIKDLLN 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (504), Expect = 4e-60
Identities = 82/301 (27%), Positives = 129/301 (42%), Gaps = 49/301 (16%)
Query: 170 DNFSTI--IGQGGFGTVYKAQ------FSDGSLIAVKRMDK-ISEQVEGDFCREIELLAR 220
+N + IG+G FG V++A+ + +++AVK + + S ++ DF RE L+A
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 221 LHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHS----------------------P 258
+ ++V L G C + L++EYMA G L + L S P
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 259 GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318
G PLS ++ IA VA + YL + HRD+ + N L+ EN V K+ADFGL+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 378
+ + + +M PE + T +SDV++YGVVL EI + G
Sbjct: 190 IYSAD--YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 379 LVESAQ-VCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI 437
E V + E + + ++R C + RPS + RI
Sbjct: 248 HEEVIYYVRDGNILACPENCPLELYN------------LMRLCWSKLPADRPSFCSIHRI 295
Query: 438 L 438
L
Sbjct: 296 L 296
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 6e-60
Identities = 57/268 (21%), Positives = 108/268 (40%), Gaps = 23/268 (8%)
Query: 176 IGQGGFGTVYKAQFSD---GSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALR 230
+G G FGTV K + +AVK + ++ + E ++ +L + ++V +
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 231 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 290
G C E L+ E G L +L + + I++ V+ ++YL
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SNF 128
Query: 291 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 350
HRD+ + N+LL AK++DFGL+ A + T + + PE + +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 351 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 410
+ KSDV+S+GV++ E + + G E + +++ +
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----------VTAMLEKGERMGCPAGCP 236
Query: 411 RTIVTIVRWCTQREGQARPSIKQVLRIL 438
R + ++ C + + RP V L
Sbjct: 237 REMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (502), Expect = 1e-59
Identities = 69/291 (23%), Positives = 117/291 (40%), Gaps = 35/291 (12%)
Query: 155 PMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVE 208
P + +K+ FS + IG G FG VY A+ + ++A+K+M S +
Sbjct: 2 PDVAELFFKD--DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 209 GDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTR 268
D +E+ L +L H + + RG + + +L+ EY + + PL
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEI 117
Query: 269 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328
+ L YLH + HRD+K+ NILL E + KL DFG A
Sbjct: 118 AAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------ 168
Query: 329 VNTDIRGTPGYMDPEYVVTQ---ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 385
GTP +M PE ++ + K DV+S G+ +E+ + + + + +
Sbjct: 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
Query: 386 CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
+ P ++ E R V C Q+ Q RP+ + +L+
Sbjct: 227 A--------QNESPALQSGHWSEYFR---NFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-59
Identities = 56/283 (19%), Positives = 115/283 (40%), Gaps = 24/283 (8%)
Query: 163 KETKKATDNFSTI---IGQGGFGTVYKAQF---SDGSLIAVKRMDKISEQVE-GDFCREI 215
K+ DN +G G FG+V + + +A+K + + +E+ + + RE
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 216 ELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDV 275
+++ +L + ++V L G C + L+ E G L L R + ++ V
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQV 118
Query: 276 ANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG 335
+ ++YL HRD+ + N+LL AK++DFGL+ A + + +
Sbjct: 119 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKW 174
Query: 336 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE 395
+ PE + ++ + +SDV+SYGV + E ++ + E +
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----------VMA 223
Query: 396 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
++ + E + ++ C + + RP V + +
Sbjct: 224 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-59
Identities = 64/270 (23%), Positives = 119/270 (44%), Gaps = 22/270 (8%)
Query: 175 IIGQGGFGTVYKAQFSDGS-----LIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVA 228
+IG G FG VYK S +A+K + +E+ DF E ++ + H +++
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
L G + + ++ EYM NG+L L S + + +A ++YL +
Sbjct: 74 LEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA---NM 129
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 348
HRD+ + NIL++ N V K++DFGL+ +D + + + PE + +
Sbjct: 130 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY-TTSGGKIPIRWTAPEAISYR 188
Query: 349 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408
+ T SDV+S+G+V+ E++T + E + + ++ + M+
Sbjct: 189 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----------VMKAINDGFRLPTPMD 237
Query: 409 QLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
I ++ C Q+E RP ++ IL
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 3e-59
Identities = 86/287 (29%), Positives = 128/287 (44%), Gaps = 38/287 (13%)
Query: 171 NFSTIIGQGGFGTVYKAQFSDGSL---IAVKRMDKI-SEQVEGDFCREIELLARL-HHRH 225
F +IG+G FG V KA+ L A+KRM + S+ DF E+E+L +L HH +
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLH--------------SPGRTPLSWQTRIQI 271
++ L G C + +L EY +G+L D L + + LS Q +
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 272 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331
A DVA ++YL HRD+ + NIL+ EN+VAK+ADFGL+ + T
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-----KKT 184
Query: 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 391
R +M E + T SDV+SYGV+L EIV+ G E
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------- 234
Query: 392 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
L E + + + + ++R C + + RPS Q+L L
Sbjct: 235 -LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 6e-59
Identities = 74/288 (25%), Positives = 123/288 (42%), Gaps = 33/288 (11%)
Query: 162 YKETKK---ATDNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREI 215
Y+ + D + I +G G FG VYKAQ L A K +D SE+ D+ EI
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 216 ELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDV 275
++LA H ++V L + +++ E+ A G++ + R PL+ +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQT 119
Query: 276 ANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG 335
+AL YLH D + HRD+K+ NIL + KLADFG++ + G
Sbjct: 120 LDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT----IQRRDSFIG 172
Query: 336 TPGYMDPEYVVTQEL-----TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE 390
TP +M PE V+ + K+DV+S G+ L+E+ + + ++ +
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP 232
Query: 391 SRLA--ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
LA KD ++ C ++ AR + Q+L+
Sbjct: 233 PTLAQPSRWSSNFKD------------FLKKCLEKNVDARWTTSQLLQ 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-58
Identities = 65/291 (22%), Positives = 116/291 (39%), Gaps = 39/291 (13%)
Query: 172 FSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKISEQVE-GDFCREIELLARL-HH 223
F +G G FG V +A +AVK + + E E+++L+ L +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 224 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLH----------------SPGRTPLSWQT 267
++V L G C ++ EY G L + L L +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 268 RIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327
+ + VA + +L HRD+ + NILL + K+ DFGLA K+ S
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS--NY 201
Query: 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCM 387
V + R +M PE + T +SDV+SYG+ L E+ + + G +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-------- 253
Query: 388 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
+S+ +++ + + I++ C + RP+ KQ+++++
Sbjct: 254 --DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 5e-58
Identities = 69/293 (23%), Positives = 115/293 (39%), Gaps = 44/293 (15%)
Query: 175 IIGQGGFGTVYKA------QFSDGSLIAVKRMDKISEQVE-GDFCREIELLARL-HHRHL 226
++G G FG V A + +AVK + + ++ E E++++ +L H ++
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 227 VALRGFCIEKRERFLMYEYMANGSLKDHLHSPGR---------------------TPLSW 265
V L G C +L++EY G L ++L S L++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 266 QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325
+ + A VA +E+L HRD+ + N+L+ V K+ DFGLA S
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN- 219
Query: 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 385
V + R +M PE + T KSDV+SYG++L EI + G +
Sbjct: 220 -YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA---- 274
Query: 386 CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
+L+ K I I++ C + + RPS + L
Sbjct: 275 ------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 7e-58
Identities = 60/274 (21%), Positives = 109/274 (39%), Gaps = 26/274 (9%)
Query: 170 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDK-ISEQVEGDFCREIELLARLHHRH 225
+++ + +G+G +G V A +AVK +D + + +EI + L+H +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
+V G E ++L EY + G L D + + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 345
+ HRDIK N+LLDE K++DFGLA + + E + + GT Y+ PE +
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--ERLLNKMCGTLPYVAPELL 177
Query: 346 VTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL--VDPRIK 402
+E E DV+S G+VL ++ + + ++ L +D
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
++ AR +I + +
Sbjct: 238 A------------LLHKILVENPSARITIPDIKK 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 6e-56
Identities = 63/283 (22%), Positives = 108/283 (38%), Gaps = 29/283 (10%)
Query: 170 DNFSTI--IGQGGFGTVYKAQF----SDGSLIAVKRMDK---ISEQVEGDFCREIELLAR 220
+ + +G G FG V + ++ +AVK + + DF RE+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 221 LHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 280
L HR+L+ L G + + + E GSL D L + T + A+ VA +
Sbjct: 68 LDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMG 125
Query: 281 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 340
YL HRD+ + N+LL + K+ DFGL A + + + +
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV-MQEHRKVPFAWC 181
Query: 341 DPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA--ELVD 398
PE + T+ + SD + +GV L E+ T + G N + RL E
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 399 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441
I + ++ C + + RP+ + L E+
Sbjct: 242 QDIYN------------VMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 1e-55
Identities = 65/264 (24%), Positives = 112/264 (42%), Gaps = 25/264 (9%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
IGQG GTVY A + G +A+++M+ + + EI ++ + ++V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 294
E +++ EY+A GSL D + T + + + ALE+LH + HRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRD 141
Query: 295 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 354
IKS NILL + KL DFG + + + GTP +M PE V + K
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQIT----PEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 355 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA--ELVDPRIKDSFDMEQLRT 412
D++S G++ +E++ + L + L E + +D
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD--------- 248
Query: 413 IVTIVRWCTQREGQARPSIKQVLR 436
+ C + + R S K++L+
Sbjct: 249 ---FLNRCLDMDVEKRGSAKELLQ 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-55
Identities = 66/319 (20%), Positives = 124/319 (38%), Gaps = 43/319 (13%)
Query: 167 KATD-NFSTIIGQGGFGTVYKAQFSD-----GSLIAVKRMDKI-SEQVEGDFCREIELLA 219
K T+ ++G G FGTVYK + +A+K + + S + + E ++A
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 220 RLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 279
+ + H+ L G C+ + + + M G L D++ Q + + +A +
Sbjct: 67 SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGM 124
Query: 280 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGY 339
YL L HRD+ + N+L+ K+ DFGLA E + +
Sbjct: 125 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKW 179
Query: 340 MDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 399
M E ++ + T +SDV+SYGV + E++T DG S ++ +++
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----------ASEISSILEK 228
Query: 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE------------------S 441
+ + I+ C + +RP ++++ +
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288
Query: 442 SDPMHSGFVQAVEDEEYEE 460
P S F +A+ DEE +
Sbjct: 289 PSPTDSNFYRALMDEEDMD 307
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 8e-55
Identities = 64/285 (22%), Positives = 113/285 (39%), Gaps = 26/285 (9%)
Query: 166 KKATDNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLA 219
KK ++F +G+G F TV A+ + A+K ++K I E RE ++++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 220 RLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 279
RL H V L + + + Y NG L ++ G ++ +AL
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSAL 121
Query: 280 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGY 339
EYLH + HRD+K NILL+E+ ++ DFG A S + GT Y
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANSFVGTAQY 176
Query: 340 MDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 399
+ PE + + + SD+++ G ++ ++V + N Q + E E P
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFPEKFFP 235
Query: 400 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 444
+ +D +V + R +++ + P
Sbjct: 236 KARD------------LVEKLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-53
Identities = 60/270 (22%), Positives = 103/270 (38%), Gaps = 26/270 (9%)
Query: 175 IIGQGGFGTVYKAQFSD----GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVAL 229
IG+G FG V++ + +A+K S+ V F +E + + H H+V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 230 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 289
G E +++ E G L+ L L + I A ++ AL YL
Sbjct: 74 IGVITENP-VWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLE---SKR 128
Query: 290 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 349
HRDI + N+L+ N KL DFGL+ +D + + + +M PE + +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST---YYKASKGKLPIKWMAPESINFRR 185
Query: 350 LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE-SAQVCMASESRLAELVDPRIKDSFDME 408
T SDV+ +GV + EI+ G + ++ + P +
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS----- 240
Query: 409 QLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
++ C + RP ++ L
Sbjct: 241 -------LMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 7e-53
Identities = 71/288 (24%), Positives = 123/288 (42%), Gaps = 31/288 (10%)
Query: 172 FSTIIGQGGFGTVYKA------QFSDGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHR 224
S +GQG FG VY+ + + +A+K +++ S + +F E ++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 225 HLVALRGFCIEKRERFLMYEYMANGSLKDHLH--------SPGRTPLSWQTRIQIAIDVA 276
H+V L G + + ++ E M G LK +L +P P S IQ+A ++A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 277 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 336
+ + YL HRD+ + N ++ E+F K+ DFG+ + +
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--YYRKGGKGLLP 198
Query: 337 PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL 396
+M PE + T SDV+S+GVVL EI T G + + + M E L +
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--EGGLLDK 256
Query: 397 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 444
D F+ ++R C Q + RPS +++ + E +P
Sbjct: 257 PDNCPDMLFE---------LMRMCWQYNPKMRPSFLEIISSIKEEMEP 295
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (456), Expect = 2e-52
Identities = 54/265 (20%), Positives = 102/265 (38%), Gaps = 21/265 (7%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC 233
+G G FG V++ + G+ A K + E + +EI+ ++ L H LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 234 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 293
+ E ++YE+M+ G L + + +S ++ V L ++H + H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHL 148
Query: 294 DIKSSNILL--DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 351
D+K NI+ + KL DFGL GT + PE + +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK-----VTTGTAEFAAPEVAEGKPVG 203
Query: 352 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR 411
+D++S GV+ +++ G+N E+ + + + + + I +
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMDDSAFSGISEDG------ 256
Query: 412 TIVTIVRWCTQREGQARPSIKQVLR 436
+R + R +I Q L
Sbjct: 257 --KDFIRKLLLADPNTRMTIHQALE 279
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (452), Expect = 2e-52
Identities = 60/279 (21%), Positives = 117/279 (41%), Gaps = 20/279 (7%)
Query: 162 YKETKKATDNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDKIS-EQVEGDFCREIEL 217
+K+ + D + +G G F V A+ L+A+K + K + E EG EI +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 218 LARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN 277
L ++ H ++VAL +L+ + ++ G L D + G + + ++ V +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLD 118
Query: 278 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 337
A++YLH + LDE+ ++DFGL+ GS+ + GTP
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL-----STACGTP 173
Query: 338 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 397
GY+ PE + + ++ D +S GV+ ++ +N + + + +E
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY-DENDAKLFEQILKAEYEFDSPY 232
Query: 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
I DS +R +++ + R + +Q L+
Sbjct: 233 WDDISDSA--------KDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (452), Expect = 5e-52
Identities = 53/264 (20%), Positives = 105/264 (39%), Gaps = 21/264 (7%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
+G G FG V++ + G + K ++ + EI ++ +LHH L+ L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 294
+K E L+ E+++ G L D + + +S I L+++H + + H D
Sbjct: 97 DKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152
Query: 295 IKSSNILLD--ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 352
IK NI+ + + K+ DFGLA I T + PE V + +
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-----ATAEFAAPEIVDREPVGF 207
Query: 353 KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT 412
+D+++ GV+ +++ G++ +E+ Q + E +
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFA-GEDDLETLQNVKRCDWEFDEDAFSSVSPEA------- 259
Query: 413 IVTIVRWCTQREGQARPSIKQVLR 436
++ Q+E + R ++ L
Sbjct: 260 -KDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 4e-51
Identities = 71/288 (24%), Positives = 126/288 (43%), Gaps = 40/288 (13%)
Query: 175 IIGQGGFGTVYKAQF--------SDGSLIAVKRMDK-ISEQVEGDFCREIELLARL-HHR 224
+G+G FG V A+ + + +AVK + +E+ D E+E++ + H+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 225 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP--------------LSWQTRIQ 270
+++ L G C + +++ EY + G+L+++L + LS + +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 271 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330
A VA +EYL HRD+ + N+L+ E+ V K+ADFGLA
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK--KT 194
Query: 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE 390
T+ R +M PE + + T +SDV+S+GV+L EI T + G + E
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------- 245
Query: 391 SRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
L +L+ + + ++R C RP+ KQ++ L
Sbjct: 246 --LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 170 bits (432), Expect = 6e-50
Identities = 55/286 (19%), Positives = 111/286 (38%), Gaps = 38/286 (13%)
Query: 170 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDK---------ISEQVEGDFCREIEL 217
+N+ +G+G V + AVK +D +++ +E+++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 218 LARLH-HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVA 276
L ++ H +++ L+ FL+++ M G L D+L LS + +I +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALL 120
Query: 277 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 336
+ LH + HRD+K NILLD++ KL DFG + G ++ GT
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-----REVCGT 172
Query: 337 PGYMDPEYVVTQEL------TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE 390
P Y+ PE + ++ D++S GV++ ++ + + ++ M+
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-WHRKQMLMLRMIMSGN 231
Query: 391 SRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
+ D+ +V + Q R + ++ L
Sbjct: 232 YQFGSPEWDDYSDTV--------KDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 9e-50
Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 38/287 (13%)
Query: 175 IIGQGGFGTVYKA------QFSDGSLIAVKRMDKISEQVEG-DFCREIELLAR-LHHRHL 226
+G+G FG V +A + + +AVK + + + E E+++L HH ++
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 227 VALRGFCIEKRER-FLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQI 271
V L G C + ++ E+ G+L +L S + L+ + I
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 272 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 331
+ VA +E+L HRD+ + NILL E V K+ DFGLA
Sbjct: 140 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR--KG 194
Query: 332 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 391
D R +M PE + + T +SDV+S+GV+L EI + + G + E
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------R 248
Query: 392 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
RL E R D E + + C E RP+ +++ L
Sbjct: 249 RLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 291
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 2e-49
Identities = 47/264 (17%), Positives = 101/264 (38%), Gaps = 22/264 (8%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
+G+G FG V++ S K + +EI +L HR+++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHESFE 71
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 294
E +++E+++ + + +++ L+ + + V AL++LH + H D
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127
Query: 295 IKSSNILLD--ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 352
I+ NI+ + K+ +FG A K G + P Y PE ++
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-----RLLFTAPEYYAPEVHQHDVVST 182
Query: 353 KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT 412
+D++S G ++ +++ + + + M +E E I
Sbjct: 183 ATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIEA------- 234
Query: 413 IVTIVRWCTQREGQARPSIKQVLR 436
+ V +E ++R + + L+
Sbjct: 235 -MDFVDRLLVKERKSRMTASEALQ 257
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (421), Expect = 2e-48
Identities = 63/270 (23%), Positives = 108/270 (40%), Gaps = 23/270 (8%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALR 230
I+G GG V+ A+ +AVK + F RE + A L+H +VA+
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 231 GFCIEKRER----FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 286
+ +++ EY+ +L+D +H+ G P++ + I++ D AL +
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFS---H 128
Query: 287 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 346
+ HRD+K +NI++ K+ DFG+A A D + GT Y+ PE
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-VIGTAQYLSPEQAR 187
Query: 347 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406
+ +SDVYS G VL E++T G + V A + + + D
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDPIPPSARHEGLSADLD 246
Query: 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
+V + + R +R
Sbjct: 247 --------AVVLKALAKNPENRYQTAAEMR 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-48
Identities = 62/274 (22%), Positives = 112/274 (40%), Gaps = 29/274 (10%)
Query: 170 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGD---FCREIELLAR-LH 222
++F +G+G FG V+ A+F A+K + K ++ D E +L+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 223 HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 282
H L + K F + EY+ G L H+ S + A ++ L++L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL 119
Query: 283 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 342
+ +RD+K NILLD++ K+ADFG+ + G + GTP Y+ P
Sbjct: 120 ---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----DAKTNTFCGTPDYIAP 172
Query: 343 EYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402
E ++ Q+ D +S+GV+L E++ + G++ E ++ K
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLEKEAK 231
Query: 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
D ++ RE + R ++ +R
Sbjct: 232 D------------LLVKLFVREPEKRLGVRGDIR 253
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (414), Expect = 8e-47
Identities = 59/278 (21%), Positives = 113/278 (40%), Gaps = 36/278 (12%)
Query: 170 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHH 223
+F + +G G FG V+ + +G A+K + K + + E +L+ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 224 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 283
++ + G + ++ F++ +Y+ G L L R P + L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALE 118
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 343
+ + +RD+K NILLD+N K+ DFG A D V + GTP Y+ PE
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-------VTYTLCGTPDYIAPE 171
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403
V T+ + D +S+G+++ E++ N +++ + + +E R + +KD
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNAELRFPPFFNEDVKD 230
Query: 404 SFDMEQLRTIVTIVRWC-----TQREGQARPSIKQVLR 436
++ +QR G + + V
Sbjct: 231 ------------LLSRLITRDLSQRLGNLQNGTEDVKN 256
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-45
Identities = 56/271 (20%), Positives = 107/271 (39%), Gaps = 27/271 (9%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGF 232
++G G G V + A+K + + RE+EL R H+V +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73
Query: 233 C----IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
++ ++ E + G L + G + + +I + A++YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 289 PLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 345
+ HRD+K N+L N + KL DFG A + + P TP Y+ PE +
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-----TPYYVAPEVL 185
Query: 346 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405
++ + D++S GV++ ++ L S M + R+ + P + S
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIRMGQYEFPNPEWSE 243
Query: 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
E+++ ++R + E R +I + +
Sbjct: 244 VSEEVK---MLIRNLLKTEPTQRMTITEFMN 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (399), Expect = 6e-45
Identities = 52/270 (19%), Positives = 101/270 (37%), Gaps = 18/270 (6%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
IG G FG +Y + G +A+K ++ + E ++ + + +C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWCG 72
Query: 235 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 294
+ + +M + SL+D + R S +T + +A + + +EY+H HRD
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128
Query: 295 IKSSNIL---LDENFVAKLADFGLAHASKDGS---ICFEPVNTDIRGTPGYMDPEYVVTQ 348
+K N L + + + DFGLA +D N ++ GT Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 349 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408
E + + D+ S G VL+ Q K + + SE ++ + + E
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STPIEVLCKGYPSE 247
Query: 409 QLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
T + +C +P + ++
Sbjct: 248 ----FATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 7e-44
Identities = 66/302 (21%), Positives = 117/302 (38%), Gaps = 38/302 (12%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRGF 232
IGQG FG V+KA+ G +A+K++ E REI++L L H ++V L
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 233 CIEKRER--------FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
C K +L++++ + + + LS R+ + L L++
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-----LNGLYY 132
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
+ HRD+K++N+L+ + V KLADFGLA A T+ T Y PE
Sbjct: 133 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 345 VVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403
++ ++ D++ G ++ E+ T R + G + + V P + +
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 404 SFDMEQLRTI--------------------VTIVRWCTQREGQARPSIKQVLRILYESSD 443
E+L + + ++ + R L + SD
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311
Query: 444 PM 445
PM
Sbjct: 312 PM 313
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (396), Expect = 9e-44
Identities = 62/276 (22%), Positives = 110/276 (39%), Gaps = 35/276 (12%)
Query: 170 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDK---ISEQVEGDFCRE---IELLAR 220
++FS IG+GGFG VY + +D G + A+K +DK +Q E E + L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 221 LHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 280
+V + + + + M G L HL G A ++ LE
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAAEIILGLE 121
Query: 281 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 340
++H + + +RD+K +NILLDE+ +++D GLA GT GYM
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA------SVGTHGYM 172
Query: 341 DPEYVVTQE-LTEKSDVYSYGVVLLEIVTARRAVQ--DGKNLVESAQVCMASESRLAELV 397
PE + +D +S G +L +++ + K+ E ++ + L +
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQ 433
P ++ ++ QR+ R
Sbjct: 233 SPELRS------------LLEGLLQRDVNRRLGCLG 256
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-43
Identities = 58/297 (19%), Positives = 108/297 (36%), Gaps = 35/297 (11%)
Query: 167 KATDNFSTI--IGQGGFGTVYKAQF--SDGSLIAVKRMDK--ISEQVEGDFCREIELLAR 220
+A + + IG+G +G V+KA+ + G +A+KR+ E + RE+ +L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 221 L---HHRHLVALRGFCIEKRERFLMYEYM----ANGSLKDHLHSPGRTPLSWQTRIQIAI 273
L H ++V L C R + + L +L + +T +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 274 DVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDI 333
+ L++LH + HRD+K NIL+ + KLADFGLA T +
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-----TSV 175
Query: 334 RGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC------- 386
T Y PE ++ D++S G + E+ + + ++ + ++
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 387 -------MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
+A + + + F + ++ C R S L
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-43
Identities = 68/293 (23%), Positives = 115/293 (39%), Gaps = 33/293 (11%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK-----ISEQVEGDFCREIELLARLHHRHLVA 228
+G+G F TVYKA+ + ++A+K++ + + REI+LL L H +++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
L K L++++M L+ + LEYLH
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLH---QH 119
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 348
+ HRD+K +N+LLDEN V KLADFGLA + T T Y PE +
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP----NRAYTHQVVTRWYRAPELLFGA 175
Query: 349 EL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407
+ D+++ G +L E++ R G + ++ + E P + D
Sbjct: 176 RMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 408 EQLRTIVTI----------------VRWCTQREGQARPSIKQVLRILYESSDP 444
++ I ++ AR + Q L++ Y S+ P
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 152 bits (385), Expect = 5e-43
Identities = 45/273 (16%), Positives = 90/273 (32%), Gaps = 22/273 (8%)
Query: 176 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFC 233
IG+G FG +++ + +A+K + S+ + E L + + F
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 234 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 293
E L+ + + G + L S +T A + ++ +H + L +R
Sbjct: 71 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 125
Query: 294 DIKSSNILLDENFV-----AKLADFGLAHASKDGS---ICFEPVNTDIRGTPGYMDPEYV 345
DIK N L+ + DFG+ +D ++ GT YM
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 346 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405
+ +E + + D+ + G V + + Q K + E + + + F
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG-F 244
Query: 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 438
E + + A P + +
Sbjct: 245 PEE----FYKYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 8e-43
Identities = 59/273 (21%), Positives = 102/273 (37%), Gaps = 40/273 (14%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGD------FCREIELLARLHHRH-- 225
++G GGFG+VY SD +A+K ++K G+ E+ LL ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
++ L + L+ E + R L + V A+ +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHC--- 126
Query: 286 CDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
+ + HRDIK NIL+D N KL DFG KD V TD GT Y PE+
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD------TVYTDFDGTRVYSPPEW 180
Query: 345 VVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403
+ + V+S G++L ++V + + ++ + + V +
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-------GQVFFRQRVSSECQH 233
Query: 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
++RWC RP+ +++
Sbjct: 234 ------------LIRWCLALRPSDRPTFEEIQN 254
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 8e-43
Identities = 60/272 (22%), Positives = 103/272 (37%), Gaps = 30/272 (11%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGD------FCREIELLARLHHRHLVA 228
+G G F V K + S G A K + K + RE+ +L + H +++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 229 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
L K + L+ E +A G L D L T I L +++
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI-----LNGVYYLHSL 132
Query: 289 PLCHRDIKSSNILLDENFVA----KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
+ H D+K NI+L + V K+ DFGLAH G+ +I GTP ++ PE
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-----KNIFGTPEFVAPEI 187
Query: 345 VVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404
V + L ++D++S GV+ +++ G E+ A +
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
+R ++ + R +I+ L+
Sbjct: 247 A--------KDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 149 bits (376), Expect = 7e-42
Identities = 62/288 (21%), Positives = 116/288 (40%), Gaps = 30/288 (10%)
Query: 170 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRM--DKISEQVEGDFCREIELLARLHHRH 225
+ + + IG+G +G VYKAQ + G A+K++ +K E + REI +L L H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 226 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
+V L K+ L++E++ K G L T + + N + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH-- 117
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 345
D + HRD+K N+L++ K+ADFGLA A + T Y P+ +
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE----IVTLWYRAPDVL 172
Query: 346 V-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC----------------MA 388
+ +++ + D++S G + E+V + ++ +
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 389 SESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 436
+ +P +SF + + ++ + + R + KQ L
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-41
Identities = 59/278 (21%), Positives = 103/278 (37%), Gaps = 33/278 (11%)
Query: 170 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHH 223
++F + +G+G FG V + + G A+K + K I++ E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 224 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 283
L AL+ + EY G L HL + + ++ +AL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSAL---E 119
Query: 284 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 343
+ + +RDIK N++LD++ K+ DFGL I GTP Y+ PE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE----GISDGATMKTFCGTPEYLAPE 175
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403
+ + D + GVV+ E++ R ++ ++ + E R + P K
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFELILMEEIRFPRTLSPEAKS 234
Query: 404 SFDMEQLRTIVTIVRWC-----TQREGQARPSIKQVLR 436
++ QR G K+V+
Sbjct: 235 ------------LLAGLLKKDPKQRLGGGPSDAKEVME 260
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-41
Identities = 72/311 (23%), Positives = 117/311 (37%), Gaps = 45/311 (14%)
Query: 151 EGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEG 209
+GP Q+ SY +TK +IG G FG VY+A+ G L+A+K++ +
Sbjct: 12 QGPDRP-QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN- 61
Query: 210 DFCREIELLARLHHRHLVALRGFCIEKRER------FLMYEYMANGSLKDHLH-SPGRTP 262
RE++++ +L H ++V LR F E+ L+ +Y+ + H S +
Sbjct: 62 ---RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118
Query: 263 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKD 321
L + +L Y+H +CHRDIK N+LLD + V KL DFG A
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL-- 379
G EP + I + T DV+S G VL E++ + +
Sbjct: 176 G----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231
Query: 380 ---------VESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVT-----IVRWCTQREG 425
+ + E P+IK + R + +
Sbjct: 232 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 426 QARPSIKQVLR 436
AR + +
Sbjct: 292 TARLTPLEACA 302
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-41
Identities = 68/290 (23%), Positives = 118/290 (40%), Gaps = 32/290 (11%)
Query: 170 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHR 224
+NF + IG+G +G VYKA+ G ++A+K R+D +E V REI LL L+H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 225 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
++V L + + +L++E++ + LK + + T + + L +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-- 118
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE- 343
+ HRD+K N+L++ KLADFGLA A + T T Y PE
Sbjct: 119 -HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----THEVVTLWYRAPEI 173
Query: 344 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403
+ + + D++S G + E+VT R G + ++ + E+V P +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFP-GDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 404 SFDMEQL-----------------RTIVTIVRWCTQREGQARPSIKQVLR 436
D + +++ + R S K L
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 55/287 (19%), Positives = 105/287 (36%), Gaps = 32/287 (11%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGD-FCREIELLARLHHRHLVALRGF 232
IG+G +G V A + +A+K++ Q REI++L R H +++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 233 C----IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 288
IE+ + + ++ L L LS + L+Y+H
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLK---TQHLSNDHICYFLYQILRGLKYIH---SA 128
Query: 289 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 348
+ HRD+K SN+LL+ K+ DFGLA + + + T Y PE ++
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV-ATRWYRAPEIMLNS 187
Query: 349 EL-TEKSDVYSYGVVLLEIVTAR-----RAVQDGKNLVESAQVCMASESRLAELVDPRIK 402
+ T+ D++S G +L E+++ R + D N + + E +
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 403 DSFDMEQLRTI-------------VTIVRWCTQREGQARPSIKQVLR 436
+ + + ++ R ++Q L
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-40
Identities = 62/282 (21%), Positives = 110/282 (39%), Gaps = 30/282 (10%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRM--DKISEQVEGDFCREIELLARLHHRHLVALRGF 232
IG+G +GTV+KA+ ++A+KR+ D E V REI LL L H+++V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 233 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 292
++ L++E+ K G + L+ L F + H
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCHSRNVLH 124
Query: 293 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQELT 351
RD+K N+L++ N KLA+FGLA A C+ + T Y P+ + + +
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCY----SAEVVTLWYRPPDVLFGAKLYS 180
Query: 352 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR 411
D++S G + E+ A R + G ++ + + E P + D +
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 412 TIVT-----------------IVRWCTQREGQARPSIKQVLR 436
+++ + R S ++ L+
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 3e-39
Identities = 63/306 (20%), Positives = 119/306 (38%), Gaps = 38/306 (12%)
Query: 144 RSLRKF-QEGPSPMFQKFSYKETKKAT-DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVK 198
S+++F + +K+ A D F I +G G FG V + G+ A+K
Sbjct: 13 ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 199 RMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHL 255
+DK + + E +L ++ LV L + +++ EY+A G + HL
Sbjct: 73 ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 256 HSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL 315
GR S A + EYLH L +RD+K N+L+D+ ++ DFG
Sbjct: 133 RRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 316 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQD 375
A + + GTP + PE ++++ + D ++ GV++ E+
Sbjct: 188 AK-------RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFF 239
Query: 376 GKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWC-----TQREGQARPS 430
++ + ++ + R +KD ++R T+R G +
Sbjct: 240 ADQPIQIYEKIVSGKVRFPSHFSSDLKD------------LLRNLLQVDLTKRFGNLKNG 287
Query: 431 IKQVLR 436
+ +
Sbjct: 288 VNDIKN 293
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (339), Expect = 3e-36
Identities = 51/300 (17%), Positives = 113/300 (37%), Gaps = 49/300 (16%)
Query: 170 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRH 225
D++ + +G+G + V++A ++ + VK + + ++ REI++L L +
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 226 LVALRGFCIEKRER--FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 283
++ L + R L++E++ N K L+ ++ AL+Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH 146
Query: 284 FYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 342
+ HRD+K N+++D E+ +L D+GLA G V + + P
Sbjct: 147 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-----ASRYFKGP 198
Query: 343 EYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVE---------SAQVCMASESR 392
E +V ++ D++S G +L ++ + G + + + +
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258
Query: 393 LAELVDPRIKDSFDMEQLRTIVTI----------------VRWCTQREGQARPSIKQVLR 436
+DPR D + + + + Q+R + ++ +
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 6e-36
Identities = 59/311 (18%), Positives = 116/311 (37%), Gaps = 48/311 (15%)
Query: 160 FSYKETKKATDNFS------TIIGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGD 210
F +E K +G G +G V A G+ +A+K++ + SE
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 211 FCREIELLARLHHRHLVALRGFCIEKR------ERFLMYEYMANGSLKDHLHSPGRTPLS 264
RE+ LL + H +++ L + +L+ +M G+ L L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMK--HEKLG 119
Query: 265 WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324
+ + L Y+H + HRD+K N+ ++E+ K+ DFGLA
Sbjct: 120 EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR------- 169
Query: 325 CFEPVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA 383
+ T T Y PE ++ T+ D++S G ++ E++T + + +L +
Sbjct: 170 QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229
Query: 384 QVCMASESRLAELVDPRIKD----------SFDMEQLRTIVT--------IVRWCTQREG 425
++ + + AE V D + + +I+T ++ +
Sbjct: 230 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 289
Query: 426 QARPSIKQVLR 436
+ R + + L
Sbjct: 290 EQRVTAGEALA 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 7e-34
Identities = 60/280 (21%), Positives = 104/280 (37%), Gaps = 36/280 (12%)
Query: 170 DNFSTI--IGQGGFGTVYKAQ----FSDGSLIAVKRMDKIS----EQVEGDFCREIELLA 219
+NF + +G G +G V+ + G L A+K + K + + E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 220 RL-HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 278
+ LV L + + L+ +Y+ G L HL R + I V
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEI 138
Query: 279 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 338
+ L + +RDIK NILLD N L DFGL+ D GT
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA---DETERAYDFCGTIE 195
Query: 339 YMDPEYVVTQE--LTEKSDVYSYGVVLLEIVTARR---AVQDGKNLVESAQVCMASESRL 393
YM P+ V + + D +S GV++ E++T + + E ++ + SE
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255
Query: 394 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQ 433
+ + KD +++ ++ + R
Sbjct: 256 PQEMSALAKD------------LIQRLLMKDPKKRLGCGP 283
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-31
Identities = 43/205 (20%), Positives = 86/205 (41%), Gaps = 22/205 (10%)
Query: 175 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRG 231
IG G G V A +A+K++ + ++ RE+ L+ ++H+++++L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 232 FCI------EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 285
E ++ +L+ E M + + + + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHSA 138
Query: 286 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 345
+ HRD+K SNI++ + K+ DFGLA + + T T Y PE +
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-----MMTPYVVTRYYRAPEVI 190
Query: 346 VTQELTEKSDVYSYGVVLLEIVTAR 370
+ E D++S G ++ E+V +
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-30
Identities = 53/312 (16%), Positives = 115/312 (36%), Gaps = 48/312 (15%)
Query: 159 KFSYKETKKA----TDNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEG-- 209
F +E K + + + +G G +G+V A G +AVK++ + + +
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 210 DFCREIELLARLHHRHLVALRGFCIEKR-----ERFLMYEYMANGSLKDHLHSPGRTPLS 264
RE+ LL + H +++ L R + ++ L + + L+
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLT 119
Query: 265 WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324
+ + L+Y+H + HRD+K SN+ ++E+ K+ DFGLA
Sbjct: 120 DDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------- 169
Query: 325 CFEPVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA 383
+ T T Y PE ++ + D++S G ++ E++T R + G + ++
Sbjct: 170 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQL 228
Query: 384 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTI-------------------VRWCTQRE 424
++ + + +I ++++ + + +
Sbjct: 229 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 288
Query: 425 GQARPSIKQVLR 436
R + Q L
Sbjct: 289 SDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (273), Expect = 6e-27
Identities = 36/211 (17%), Positives = 73/211 (34%), Gaps = 21/211 (9%)
Query: 176 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 234
+G G F TV+ A+ + + +A+K + + EI+LL R++
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 235 EKRERFLMYEYMANGSLK--------------DHLHSPGRTPLSWQTRIQIAIDVANALE 280
+ L + + + + QI+ + L+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 281 YLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGY 339
Y+H + H DIK N+L++ + L +A N+ T Y
Sbjct: 140 YMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--IQTREY 195
Query: 340 MDPEYVVTQELTEKSDVYSYGVVLLEIVTAR 370
PE ++ +D++S ++ E++T
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.1 bits (233), Expect = 7e-23
Identities = 31/201 (15%), Positives = 67/201 (33%), Gaps = 26/201 (12%)
Query: 175 IIGQGGFGTVYKAQFSDGSLIAVK----------RMDKISEQVEGDFCREIELLARLHHR 224
++G+G V+ VK ++ + + + F AR R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 225 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 284
L L+G + K +Y + N L + + + + + ++ + + +
Sbjct: 67 ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120
Query: 285 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 344
+ H D+ N+L+ E + + DF + E + D+R Y Y
Sbjct: 121 --HRGIVHGDLSQYNVLVSEEGI-WIIDFPQS-VEVGEEGWREILERDVRNIITYFSRTY 176
Query: 345 VVTQELTEKSDVYSYGVVLLE 365
+ D+ S +L+
Sbjct: 177 ------RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 518 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.52 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.15 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.72 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.17 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.66 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.01 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=420.44 Aligned_cols=251 Identities=28% Similarity=0.470 Sum_probs=200.5
Q ss_pred hhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
++.+.||+|+||+||+|++.++..||||+++... ...++|.+|++++++++|||||+++|+|.+.+..++||||+++|+
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 4567899999999999999889999999997543 335689999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|.+++.... ..++|..+++|+.|||.||+||| +++|+||||||+||||++++.+||+|||+++........ ..
T Consensus 87 L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~---~~ 159 (263)
T d1sm2a_ 87 LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT---SS 159 (263)
T ss_dssp HHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred HHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCce---ee
Confidence 999987643 45899999999999999999999 899999999999999999999999999999876543321 23
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 410 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 410 (518)
....||+.|+|||.+.+..++.++|||||||++|||+|++.|+....+..+......... + ...| ... .
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~---~~~p---~~~----~ 228 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-R---LYKP---RLA----S 228 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC-C---CCCC---TTS----C
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC-C---CCCc---ccc----C
Confidence 345789999999999999999999999999999999997666655555544444332211 1 1112 122 2
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 411 RTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 411 ~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
..+.+++..||+.||++||||+||+++|..
T Consensus 229 ~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 229 THVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 468899999999999999999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=422.69 Aligned_cols=252 Identities=27% Similarity=0.445 Sum_probs=210.2
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
+.+.+.||+|+||+||+|+++++..||||+++... ...+.|.+|+++|++++|||||+++|+|.+ +..++||||+++|
T Consensus 15 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g 92 (272)
T d1qpca_ 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENG 92 (272)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred eEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCC
Confidence 44567899999999999999888999999997543 334679999999999999999999998855 5679999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.......++|..+++|+.||+.||+||| +++|+||||||+||||++++.+||+|||+|+........ .
T Consensus 93 ~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~---~ 166 (272)
T d1qpca_ 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT---A 166 (272)
T ss_dssp BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE---C
T ss_pred cHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCccc---c
Confidence 9999987655556999999999999999999999 889999999999999999999999999999877554321 3
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....||+.|||||++.++.++.++|||||||+||||+||+.|+.......+..+..... ..+.....++
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-------~~~~~p~~~~--- 236 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-------YRMVRPDNCP--- 236 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------CCCCCCTTCC---
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-------CCCCCcccCh---
Confidence 345679999999999999999999999999999999999877776555554444333221 1122222333
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 410 LRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
..+.+++.+||+.||++||||++|++.|.+
T Consensus 237 -~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 237 -EELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp -HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 458899999999999999999999998853
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-54 Score=426.32 Aligned_cols=267 Identities=24% Similarity=0.435 Sum_probs=203.5
Q ss_pred cccCHHHHHHHhhhhh-----------hhcceecceEEEEEEecC-C---cEEEEEEeccc-cchhHHHHHHHHHHHHHc
Q 010088 158 QKFSYKETKKATDNFS-----------TIIGQGGFGTVYKAQFSD-G---SLIAVKRMDKI-SEQVEGDFCREIELLARL 221 (518)
Q Consensus 158 ~~~~~~~l~~a~~~f~-----------~~lG~G~~g~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l 221 (518)
+.|+++++..++.+|. ++||+|+||+||+|++.. | ..||||.+... .....++|.+|+++|+++
T Consensus 5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 84 (299)
T d1jpaa_ 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84 (299)
T ss_dssp CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence 3466667777776663 579999999999998752 3 36899988643 445557899999999999
Q ss_pred CCCCeeeEeeeeeecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEE
Q 010088 222 HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 301 (518)
Q Consensus 222 ~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NIL 301 (518)
+|||||+++|+|.+.+..++|||||++|+|.+++.... ..++|.++++|+.||+.||+||| +++|+||||||+|||
T Consensus 85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNIL 160 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEE
Confidence 99999999999999999999999999999999987643 35999999999999999999999 899999999999999
Q ss_pred ecCCCcEEEeeccccccCCCCCcccc-cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcch
Q 010088 302 LDENFVAKLADFGLAHASKDGSICFE-PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNL 379 (518)
Q Consensus 302 l~~~~~~kl~DfGla~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~ 379 (518)
|+.++++||+|||+++.......... .......||+.|||||.+.++.++.++|||||||+||||+| |+.||.+...
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~- 239 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN- 239 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999987654322111 11223468999999999999999999999999999999998 8888875443
Q ss_pred HHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 380 VESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 380 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.+...... ...+ +.... +....+.+++.+||+.||++|||+.||++.|..
T Consensus 240 ~~~~~~i~-~~~~------~~~~~----~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 240 QDVINAIE-QDYR------LPPPM----DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp HHHHHHHH-TTCC------CCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHH-cCCC------CCCCc----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 22222221 1111 11112 233568899999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.1e-54 Score=422.74 Aligned_cols=257 Identities=24% Similarity=0.406 Sum_probs=215.4
Q ss_pred HhhhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 168 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 168 a~~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
..+.+.+.||+|+||+||+|++. +|+.||||+++... ...++|.+|+++|++++|||||+++|+|.+.+..++|||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 34556788999999999999886 58899999987543 33567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
++|+|.+++.......++|..++.|+.||+.||+||| +++|+||||||+||||++++.+||+|||+|+........
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~- 171 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT- 171 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCce-
Confidence 9999999998666667999999999999999999999 889999999999999999999999999999876543321
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
......||+.|||||++.+..++.++|||||||++|||++|+.|+..+.+.......... . ..+.....++
T Consensus 172 --~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~-~------~~~~~~~~~~ 242 (287)
T d1opja_ 172 --AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-D------YRMERPEGCP 242 (287)
T ss_dssp --EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-T------CCCCCCTTCC
T ss_pred --eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc-C------CCCCCCccch
Confidence 234456899999999999999999999999999999999988888766665554433221 1 1122222333
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
..+.+++..||+.||++|||++||++.|....
T Consensus 243 ----~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 243 ----EKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 56889999999999999999999999886543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-53 Score=413.36 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=199.8
Q ss_pred hhhhhcceecceEEEEEEecCCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|+++|++++|||||+++|++.+ +..++|||||++
T Consensus 11 ~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~ 87 (276)
T d1uwha_ 11 TVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG 87 (276)
T ss_dssp CCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCE
T ss_pred EEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCC
Confidence 35578999999999999874 36999998643 34556789999999999999999999999865 568999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.++++..+ ..++|..+++|+.||+.||+||| +++||||||||+||||+.++.+||+|||+|+........ .
T Consensus 88 g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~--~ 161 (276)
T d1uwha_ 88 SSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS--H 161 (276)
T ss_dssp EEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc--c
Confidence 99999997643 35999999999999999999999 889999999999999999999999999999865443211 1
Q ss_pred ccccccCCCcccCcccccc---CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 329 VNTDIRGTPGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
......||+.|||||++.+ ..++.++|||||||+||||+||+.||.+............ .....+.. +.+...+
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~-~~~~~p~~--~~~~~~~ 238 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-RGYLSPDL--SKVRSNC 238 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH-HTSCCCCG--GGSCTTC
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh-cCCCCCcc--hhccccc
Confidence 2345679999999999864 3589999999999999999999999976554433332221 11111111 1122222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...+.+++.+||+.||++|||++||+++|+.
T Consensus 239 ----~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 239 ----PKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 3568899999999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-53 Score=416.15 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=210.7
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
.+.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+.+..|+|||||++|
T Consensus 23 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg 102 (293)
T d1yhwa1 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (293)
T ss_dssp CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred EEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCC
Confidence 34568999999999999874 68999999987655555678999999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++... .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+....... .
T Consensus 103 ~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~----~ 172 (293)
T d1yhwa1 103 SLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS----K 172 (293)
T ss_dssp BHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC----C
T ss_pred cHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc----c
Confidence 999988753 4999999999999999999999 89999999999999999999999999999987644321 2
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
.....||+.|||||.+.+..++.++|||||||++|||+||+.||.+............... ... .....+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~---~~~---~~~~~~---- 242 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT---PEL---QNPEKL---- 242 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS---CCC---SSGGGS----
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC---CCC---CCcccC----
Confidence 3456799999999999999999999999999999999999999976544333322221111 111 111122
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 410 LRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
...+.+++.+||+.||++|||++|+++|.|...
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 245889999999999999999999999988754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=413.12 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=208.6
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.+.||+|+||+||+|+.. +|+.||+|++.+. .......+.+|+++|++++||||+++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 455678999999999999885 6899999998642 233456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
|++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+|+......
T Consensus 88 ~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 88 APLGTVYRELQKLS--KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred cCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence 99999999997543 5999999999999999999999 8999999999999999999999999999998655432
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.....||+.|||||.+.+..++.++|||||||+||||++|+.||... +..+.......... .+....
T Consensus 161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~--------~~p~~~ 227 (263)
T d2j4za1 161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-TYQETYKRISRVEF--------TFPDFV 227 (263)
T ss_dssp ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTTCC--------CCCTTS
T ss_pred ----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCC--------CCCccC
Confidence 24467999999999999999999999999999999999999999644 33333333222221 122222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+ ..+.+++.+||+.||++|||++|+++|.|..
T Consensus 228 s----~~~~~li~~~L~~dp~~R~t~~eil~hp~~~ 259 (263)
T d2j4za1 228 T----EGARDLISRLLKHNPSQRPMLREVLEHPWIT 259 (263)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred C----HHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence 3 4588999999999999999999999987753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-53 Score=411.51 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=205.0
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+.+..|+|||||++
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 87 (271)
T d1nvra_ 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 87 (271)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCC
Confidence 45578999999999999875 68999999986433 23345689999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.++|... ..+++.++..++.||+.||+||| +.+|+||||||+||||++++.+||+|||+|+....... ..
T Consensus 88 g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~--~~ 160 (271)
T d1nvra_ 88 GELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--ER 160 (271)
T ss_dssp EEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE--EC
T ss_pred CcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc--cc
Confidence 9999999764 35999999999999999999999 88999999999999999999999999999987643321 12
Q ss_pred ccccccCCCcccCccccccCCC-CccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......||+.|||||++.+..+ +.++|||||||+||||+||+.||....+............... . .....+
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~----~--~~~~~s- 233 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL----N--PWKKID- 233 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS----T--TGGGSC-
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----C--ccccCC-
Confidence 3455789999999999988876 5789999999999999999999975443322222221111100 0 011122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..+.+++.+||+.||++|||++|+++|.|..
T Consensus 234 ---~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 264 (271)
T d1nvra_ 234 ---SAPLALLHKILVENPSARITIPDIKKDRWYN 264 (271)
T ss_dssp ---HHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred ---HHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence 4577899999999999999999999998774
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=408.39 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=202.6
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeee----cCceEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE----KRERFLMY 243 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 243 (518)
.|.+.||+|+||+||+|++. ++..||+|.+... .....+.|.+|+++|++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 35568999999999999875 5889999998643 34445679999999999999999999999875 34579999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecccCCCcEEec-CCCcEEEeeccccccCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP--LCHRDIKSSNILLD-ENFVAKLADFGLAHASK 320 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiHrDlk~~NILl~-~~~~~kl~DfGla~~~~ 320 (518)
||+++|+|.+++.+. ..+++..+..++.||+.||+||| +++ |+||||||+||||+ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999764 35999999999999999999999 766 99999999999997 58899999999998644
Q ss_pred CCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
.. ......||+.|||||.+.+ .++.++|||||||++|||++|+.||.+..+.....+....... .+.
T Consensus 167 ~~------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~------~~~ 233 (270)
T d1t4ha_ 167 AS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK------PAS 233 (270)
T ss_dssp TT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC------CGG
T ss_pred CC------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC------Ccc
Confidence 32 2345679999999998864 6999999999999999999999999766555544443322111 111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
+....+ ..+.+++.+||+.||++|||++|+++|.|.
T Consensus 234 ~~~~~~----~~~~~li~~~l~~dp~~R~s~~ell~Hp~f 269 (270)
T d1t4ha_ 234 FDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269 (270)
T ss_dssp GGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred cCccCC----HHHHHHHHHHccCCHhHCcCHHHHhCCccc
Confidence 111222 357899999999999999999999998775
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-53 Score=414.45 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=209.3
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
.+.+.||+|+||+||+|+.. +|..||||+++.......+.|.+|+++|++++|||||++++++.+.+..++|||||++|
T Consensus 15 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g 94 (288)
T d2jfla1 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCC
Confidence 34568999999999999875 68999999998766666778999999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.+++.+.+ .++++..+..++.||+.||+||| +.+|+||||||+||||+.++++||+|||+|+...... ..
T Consensus 95 ~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~----~~ 166 (288)
T d2jfla1 95 AVDAVMLELE-RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI----QR 166 (288)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----HH
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc----cc
Confidence 9999986532 35999999999999999999999 8899999999999999999999999999997543221 12
Q ss_pred cccccCCCcccCccccc-----cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 330 NTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
.....||+.|||||++. ...|+.++|||||||+||||+||+.||.+........... .... ..+..
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~-~~~~--~~~~~------ 237 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-KSEP--PTLAQ------ 237 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-HSCC--CCCSS------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH-cCCC--CCCCc------
Confidence 34567999999999984 4568999999999999999999999997654433322222 1111 11101
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
+......+.+++.+||+.||++|||++|+++|.|...+
T Consensus 238 -~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 238 -PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred -cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 11222568899999999999999999999999887644
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=404.20 Aligned_cols=250 Identities=28% Similarity=0.455 Sum_probs=208.7
Q ss_pred hhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
.|.+.||+|+||+||+|+++++..||||+++.... ..++|.+|+.++++++||||++++|+|.+++..++||||+++|+
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 46678999999999999998888999999976443 35689999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|.+++.... ..+++..+++++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++........ ..
T Consensus 86 l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~---~~ 158 (258)
T d1k2pa_ 86 LLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT---SS 158 (258)
T ss_dssp HHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC---CC
T ss_pred HHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCce---ee
Confidence 999986543 35899999999999999999999 889999999999999999999999999999866543321 23
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+....... ..+ ...| ...
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-~~~~~~~i~~-~~~---~~~p---~~~---- 226 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQ-GLR---LYRP---HLA---- 226 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-HHHHHHHHHT-TCC---CCCC---TTC----
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC-HHHHHHHHHh-CCC---CCCc---ccc----
Confidence 44678999999999999999999999999999999998 788886443 3333332221 111 1111 222
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 410 LRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...+.+++.+||+.||++|||+++++++|.+
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 2568899999999999999999999999854
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=412.41 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=200.4
Q ss_pred hhhhhcceecceEEEEEEecCC-----cEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFSDG-----SLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
.+.++||+|+||+||+|.+.++ ..||||+++.. ......+|.+|+++|++++|||||+++|+|.+.+..++|||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence 4567899999999999987642 37999998643 33445679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+.+|+|.+++.... ..++|.++++++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++.......
T Consensus 90 ~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 90 YMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp CCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred ecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 999999999886543 45999999999999999999999 89999999999999999999999999999987644321
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
. ........||+.|||||++.+..++.++|||||||+||||+||+.|+....+..+........ ..+....
T Consensus 166 ~-~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-------~~~~~~~- 236 (283)
T d1mqba_ 166 A-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-------FRLPTPM- 236 (283)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-------CCCCCCT-
T ss_pred c-ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-------CCCCCch-
Confidence 1 112344568999999999999999999999999999999999877776655554444332211 1111222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
+....+.+++.+||+.||++||+|.||++.|..
T Consensus 237 ---~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 237 ---DCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp ---TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 233568999999999999999999999998854
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=409.08 Aligned_cols=248 Identities=21% Similarity=0.347 Sum_probs=202.4
Q ss_pred hcceecceEEEEEEec---CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCCC
Q 010088 175 IIGQGGFGTVYKAQFS---DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS 250 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 250 (518)
.||+|+||+||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++|+|.+ +..++|||||++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999764 35689999997543 4455789999999999999999999999864 57899999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccccc
Q 010088 251 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 330 (518)
Q Consensus 251 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 330 (518)
|.+++.... ..+++..+.+|+.||+.||+||| +++|+||||||+||||+.++.+||+|||+++........ ....
T Consensus 95 L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~ 169 (285)
T d1u59a_ 95 LHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTAR 169 (285)
T ss_dssp HHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE-ECCC
T ss_pred HHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccccc-cccc
Confidence 999986543 45999999999999999999999 899999999999999999999999999999876544322 1223
Q ss_pred ccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 010088 331 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 409 (518)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 409 (518)
....||+.|||||.+.++.++.++|||||||++|||+| |+.||.+.... +....+. ...+ +.....++
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~~~~~i~-~~~~------~~~p~~~~--- 238 (285)
T d1u59a_ 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIE-QGKR------MECPPECP--- 238 (285)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHHHHH-TTCC------CCCCTTCC---
T ss_pred cccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHHH-cCCC------CCCCCcCC---
Confidence 44568999999999999999999999999999999998 89999754432 3222221 1111 12222333
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 410 LRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 410 ~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
..+.+++.+||+.||++||++.+|++.|..
T Consensus 239 -~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 239 -PELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp -HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 568899999999999999999999988753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=409.33 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=198.6
Q ss_pred hhcceecceEEEEEEecC---CcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 174 TIIGQGGFGTVYKAQFSD---GSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
++||+|+||+||+|.+.+ ++.||||+++.. .....++|.+|+++|++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 369999999999998753 468999998642 33445679999999999999999999999854 568999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|.++++.. ..++|..+++|+.||+.||+||| +++|+||||||+||||+.++.+||+|||+++........ ..
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YK 165 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-EE
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccc-cc
Confidence 9999999864 35999999999999999999999 889999999999999999999999999999876543321 12
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 407 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 407 (518)
......||+.|||||.+.+..++.++|||||||++|||+| |+.||.+... .+...... ...+ +.....++
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-~~~~~~i~-~~~~------~~~p~~~~- 236 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SEVTAMLE-KGER------MGCPAGCP- 236 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHH-TTCC------CCCCTTCC-
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-HHHHHHHH-cCCC------CCCCcccC-
Confidence 2344578999999999999999999999999999999998 8999975433 23222221 1111 11222233
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 408 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 408 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
..+.+++.+||+.||++|||+++|++.|..
T Consensus 237 ---~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 237 ---REMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp ---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 568899999999999999999999887743
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=410.89 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=205.6
Q ss_pred hhhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
.+.+.+.||+|+||+||+|+++++..||||+++... ...+.|.+|+.+|++++|+|||+++|+|.+ +..++||||+++
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 355677899999999999999888899999996543 345679999999999999999999999854 568999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
|+|..++.......++|.+++.|+.||+.||+||| +++|+||||||+||||++++++||+|||+++....... .
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~---~ 169 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---T 169 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCc---e
Confidence 99999997654456999999999999999999999 88999999999999999999999999999987654332 1
Q ss_pred ccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 329 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
......||+.|+|||++..+.++.++|||||||+||||+||+.|+.......+........ ..+......+
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-------~~~~~~~~~~-- 240 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-------YRMPCPPECP-- 240 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------CCCCCCTTSC--
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-------CCCCCCcccC--
Confidence 2344678999999999999999999999999999999999888877666655544433211 1112222333
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..+.+++.+||+.||++||+|++|++.|...
T Consensus 241 --~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 241 --ESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp --HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred --HHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 5688999999999999999999999988653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=409.32 Aligned_cols=254 Identities=25% Similarity=0.366 Sum_probs=193.8
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeee--cCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE--KRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e 244 (518)
+++.+.||+|+||+||+|+.. +|+.||||.+... .+...+.|.+|+++|++++|||||++++++.+ .+..|+|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 345678999999999999875 6899999998643 33445679999999999999999999999865 456899999
Q ss_pred ecCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCceecccCCCcEEecCCCcEEEeeccccccCC
Q 010088 245 YMANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYC--DPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 245 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~ 320 (518)
||++|+|.+++... ....+++..++.++.|++.||+|||+.. ..+|+||||||+||||+.++.+||+|||+|+...
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 99999999998642 2346999999999999999999999432 2459999999999999999999999999998765
Q ss_pred CCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCc
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
.... ......||+.|||||.+.+..++.++|||||||++|||+||+.||.... ..+......... . +.
T Consensus 166 ~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~-~~~~~~~i~~~~--~-----~~ 233 (269)
T d2java1 166 HDTS----FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREGK--F-----RR 233 (269)
T ss_dssp --------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHTC--C-----CC
T ss_pred cCCC----ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC-HHHHHHHHHcCC--C-----CC
Confidence 4321 2345679999999999999999999999999999999999999996533 333332222111 1 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
+...++ ..+.+++.+||+.||.+|||+.|+++|.|
T Consensus 234 ~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 234 IPYRYS----DELNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred CCcccC----HHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence 222333 45889999999999999999999998865
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-52 Score=415.97 Aligned_cols=255 Identities=26% Similarity=0.385 Sum_probs=204.1
Q ss_pred hhhhhhhcceecceEEEEEEecC------CcEEEEEEeccc-cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFSD------GSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERF 240 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 240 (518)
.+.+.++||+|+||+||+|++.. ...||||.+... .......|.+|+.+|.++ +|||||+++++|.+.+..+
T Consensus 38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (325)
T d1rjba_ 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117 (325)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence 45567899999999999998753 136999988643 334456799999999999 8999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCc
Q 010088 241 LMYEYMANGSLKDHLHSPGR---------------------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 299 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~N 299 (518)
+|||||++|+|.++|+.... ..++|..++.|+.||+.||+||| +++|+||||||+|
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~N 194 (325)
T d1rjba_ 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARN 194 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGG
T ss_pred EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchhc
Confidence 99999999999999976431 35899999999999999999999 8899999999999
Q ss_pred EEecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcc
Q 010088 300 ILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKN 378 (518)
Q Consensus 300 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~ 378 (518)
||++.++.+||+|||+|+........ .......||+.|||||.+.++.++.++|||||||+||||+| |+.||.+...
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cccccCCeEEEeeccccccccCCCce--eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999865443211 12334568999999999999999999999999999999998 8999865443
Q ss_pred hHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 379 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 379 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
....... .....+ +...... ...+.+|+.+||+.||++|||++||+++|.
T Consensus 273 ~~~~~~~-~~~~~~------~~~p~~~----~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DANFYKL-IQNGFK------MDQPFYA----TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHHHHHH-HHTTCC------CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHH-HhcCCC------CCCCCcC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3332222 211111 1122222 356889999999999999999999999984
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-51 Score=407.42 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=194.9
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+++.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+++|++++|||||++++++.+.+..|+|||||+
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 556789999999999999875 68999999986433 2334568899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec---CCCcEEEeeccccccCCCCCc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DfGla~~~~~~~~ 324 (518)
||+|.++|... ..+++..+..++.||+.||+||| +++|+||||||+|||+. +++.+||+|||+|+......
T Consensus 91 gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~- 164 (307)
T d1a06a_ 91 GGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS- 164 (307)
T ss_dssp SCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred CCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence 99999999864 35999999999999999999999 89999999999999994 57899999999998665433
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
......||+.|||||.+.+..++.++|||||||+||||++|+.||.+.... +............. ......
T Consensus 165 ----~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~~~~~~~----~~~~~~ 235 (307)
T d1a06a_ 165 ----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-KLFEQILKAEYEFD----SPYWDD 235 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHTTCCCCC----TTTTTT
T ss_pred ----eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCCCC----CccccC
Confidence 234567999999999999999999999999999999999999999755433 22222222221111 111122
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 443 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~ 443 (518)
.+ ..+.+++.+||+.||++|||++|+++|.|...+
T Consensus 236 ~s----~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 236 IS----DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp SC----HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred CC----HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 22 458899999999999999999999999887643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.8e-51 Score=411.06 Aligned_cols=255 Identities=20% Similarity=0.277 Sum_probs=212.7
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||++
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 107 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 445678999999999999875 6899999999876666667899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC--CCcEEEeeccccccCCCCCccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE--NFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~ 326 (518)
|+|.+++.... ..+++..+..|+.||+.||+||| +.+|+||||||+||||+. ++.+||+|||+++......
T Consensus 108 g~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--- 180 (350)
T d1koaa2 108 GELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--- 180 (350)
T ss_dssp CBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---
T ss_pred CCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc---
Confidence 99999996543 35999999999999999999999 899999999999999964 6899999999998765443
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
......||+.|||||++.+..++.++|||||||++|||+||+.||... +..+....+......+... .....+
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~----~~~~~s 253 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-NDDETLRNVKSCDWNMDDS----AFSGIS 253 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCSCCG----GGGGCC
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCcc----cccCCC
Confidence 234567999999999999999999999999999999999999999744 3334333333322222111 111122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
..+.+++.+||+.||++|||++|+++|.|...
T Consensus 254 ----~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~ 285 (350)
T d1koaa2 254 ----EDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285 (350)
T ss_dssp ----HHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 45889999999999999999999999987754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=406.86 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=207.2
Q ss_pred hhhhhhcceecceEEEEEEecCC----cEEEEEEecc-ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec-CceEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDG----SLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVALRGFCIEK-RERFLMY 243 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~ 243 (518)
.+|.++||+|+||+||+|++.++ ..||||+++. ......++|.+|+++|++++||||++++|+|.+. ...++||
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 35677899999999999987542 3689999975 3445567899999999999999999999998764 5789999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
|||++|+|.++++... ..+++..+++++.|++.||.||| +.+|+||||||+||||++++.+||+|||+++......
T Consensus 109 E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp ECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999999998643 35889999999999999999999 8999999999999999999999999999998765544
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 403 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~ 403 (518)
...........||+.|+|||.+.+..++.++||||||+++|||+||+.|+....+..+......... + +....
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~-~------~~~p~ 257 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-R------LLQPE 257 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC-C------CCCCT
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-C------CCCcc
Confidence 3322334456799999999999999999999999999999999999888876554444333322221 1 11112
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 404 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 404 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.. ...+.+++.+||+.||++||+|.||+++|...
T Consensus 258 ~~----~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 258 YC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cC----cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 22 24688999999999999999999999998654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=418.75 Aligned_cols=257 Identities=24% Similarity=0.345 Sum_probs=202.4
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
...+.||+|+||+||+|+.. +|+.||+|+++.. .......+.+|+.+|++++|||||+++++|.+.+..++|||||++
T Consensus 9 ~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~g 88 (322)
T d1s9ja_ 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 88 (322)
T ss_dssp EEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 34578999999999999875 6899999998653 344456799999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
|+|.+++.+.+ .+++..+..++.|++.||+||| + ++|+||||||+||||++++.+||+|||+|+.....
T Consensus 89 g~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----- 158 (322)
T d1s9ja_ 89 GSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----- 158 (322)
T ss_dssp EEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-----
T ss_pred CcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-----
Confidence 99999997643 4999999999999999999999 5 48999999999999999999999999999854321
Q ss_pred cccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccc-------------
Q 010088 328 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA------------- 394 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~------------- 394 (518)
......||+.|||||++.+..|+.++|||||||++|||++|+.||.....................
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 234568999999999999999999999999999999999999999654322111000000000000
Q ss_pred ---------------------cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 395 ---------------------ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 395 ---------------------~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
....+.+.. ......+.+++.+||+.||.+|||++|+++|.|..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~ 302 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCB---TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCcc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhC
Confidence 000000000 00124588999999999999999999999987653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-51 Score=406.30 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=206.1
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+...+.||+|+||+||+|+.. +|+.||||++.... ....+.|.+|+++|++++|||||++++++.+.+..|+||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 344568999999999999875 68899999986533 23446799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
|++|+|..++... .++++..+..++.||+.||+||| +++|+||||||+||||++++.+||+|||+|+.....
T Consensus 97 ~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 97 CLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp CSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred cCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 9999998776543 35999999999999999999999 899999999999999999999999999999865432
Q ss_pred cccccccccCCCcccCcccccc---CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+............ .. ..... .
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~-~~--~~~~~----~ 236 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NE--SPALQ----S 236 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SC--CCCCS----C
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-CC--CCCCC----C
Confidence 34579999999999864 4689999999999999999999999976544433332221 11 11111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM 445 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~ 445 (518)
..++ ..+.+++.+||+.||++|||++|+++|.|......
T Consensus 237 ~~~s----~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 237 GHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp TTSC----HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred CCCC----HHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCC
Confidence 1222 46889999999999999999999999887755433
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=405.47 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=204.0
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|++++||||+++++++.+++..|+||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 456679999999999999875 6899999998642 233446799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
|++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||||++++.+||+|||+|+........
T Consensus 90 ~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 90 AKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999999987643 5999999999999999999999 899999999999999999999999999999876433211
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.......||+.|||||++.+..++.++|||||||+||||+||+.||..... .+.......... .+...+
T Consensus 165 --~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~~~i~~~~~--------~~p~~~ 233 (288)
T d1uu3a_ 165 --ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-YLIFQKIIKLEY--------DFPEKF 233 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHTTCC--------CCCTTC
T ss_pred --cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-HHHHHHHHcCCC--------CCCccC
Confidence 123456799999999999999999999999999999999999999975433 333333322221 122233
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
+ ..+.+++.+||+.||++|||++|++++.+
T Consensus 234 s----~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 234 F----PKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp C----HHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred C----HHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 3 45789999999999999999999765543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=400.05 Aligned_cols=253 Identities=24% Similarity=0.332 Sum_probs=208.1
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEecccc------chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS------EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
+.+.+.||+|+||+||+|+.. +|+.||||++++.. ....+.|.+|+++|++++|||||++++++.+.+..++|
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 91 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 455678999999999999875 68999999986421 12356799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC----cEEEeecccccc
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF----VAKLADFGLAHA 318 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DfGla~~ 318 (518)
||||++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++.
T Consensus 92 ~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 92 LELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999999997643 5999999999999999999999 89999999999999998776 599999999987
Q ss_pred CCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccC
Q 010088 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD 398 (518)
Q Consensus 319 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d 398 (518)
...+. ......||+.|+|||.+.+..++.++|||||||+||||+||+.||..... .+.................
T Consensus 167 ~~~~~-----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~ 240 (293)
T d1jksa_ 167 IDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QETLANVSAVNYEFEDEYF 240 (293)
T ss_dssp CTTSC-----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHTTCCCCCHHHH
T ss_pred cCCCc-----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-HHHHHHHHhcCCCCCchhc
Confidence 65443 23456799999999999999999999999999999999999999975433 2332222222211111111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 399 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 399 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
... ...+.+++.+||+.||++|||++|+++|.|..
T Consensus 241 ----~~~----s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 275 (293)
T d1jksa_ 241 ----SNT----SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275 (293)
T ss_dssp ----TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTC
T ss_pred ----CCC----CHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 111 24578999999999999999999999998774
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.9e-50 Score=408.87 Aligned_cols=255 Identities=20% Similarity=0.299 Sum_probs=212.5
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+++.+.||+|+||+||+|+.. +|+.||||+++.........+.+|+++|++++|||||++++++.+++..|+|||||++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 445678999999999999874 6999999999766555567789999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec--CCCcEEEeeccccccCCCCCccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD--ENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~--~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
|+|.+++...+ ..+++.++..|+.||+.||+||| +.+|+||||||+||||+ .++.+||+|||+|+......
T Consensus 111 g~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--- 183 (352)
T d1koba_ 111 GELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--- 183 (352)
T ss_dssp CBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---
T ss_pred ChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC---
Confidence 99999886543 35999999999999999999999 89999999999999998 67899999999998765543
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
......||+.|||||++.+..++.++|||||||+||||+||+.||.+.... +...........+. .......+
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~~----~~~~~~~s 256 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWEFD----EDAFSSVS 256 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCCCC----SSTTTTSC
T ss_pred --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCC----cccccCCC
Confidence 234567999999999999999999999999999999999999999754433 33322222221111 11112223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
..+.+++.+||+.||.+|||+.|+++|.|...
T Consensus 257 ----~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 257 ----PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp ----HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 45889999999999999999999999987654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-50 Score=399.97 Aligned_cols=256 Identities=30% Similarity=0.467 Sum_probs=206.4
Q ss_pred hhhhhhcceecceEEEEEEec------CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
+++.+.||+|+||+||+|++. +++.||||+++... ....++|.+|+++|++++||||++++++|.+.+..++|
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 345678999999999999874 35789999987543 34456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcE
Q 010088 243 YEYMANGSLKDHLHSPG----------------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 300 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NI 300 (518)
|||+++|+|.++|+... ...++|..++.|+.|++.||+||| +.+||||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcccce
Confidence 99999999999996321 235899999999999999999999 89999999999999
Q ss_pred EecCCCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchH
Q 010088 301 LLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV 380 (518)
Q Consensus 301 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~ 380 (518)
||+.++.+||+|||+++........ ...+...||+.|+|||.+.+..++.++|||||||++|||++|..|+..+.+..
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~ 249 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCB--C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred EECCCCcEEEccchhheeccCCccc--cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence 9999999999999999865433211 12345678999999999999999999999999999999999976544444444
Q ss_pred HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 381 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 381 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+......... . +......+ ..+.+|+..||+.||++||||.||++.|+..
T Consensus 250 e~~~~v~~~~--~-----~~~p~~~~----~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 250 EVIYYVRDGN--I-----LACPENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HHHHHHHTTC--C-----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHHHHHcCC--C-----CCCCccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 4443322111 1 12222333 4688999999999999999999999999764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=396.34 Aligned_cols=245 Identities=29% Similarity=0.470 Sum_probs=194.8
Q ss_pred hhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec-CceEEEEEecCCC
Q 010088 171 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK-RERFLMYEYMANG 249 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~~~g 249 (518)
.|.+.||+|+||+||+|++ .|+.||||+++.. ...+.|.+|+++|++++||||++++|+|.+. +..++||||+++|
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred EEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 4567899999999999998 5789999999653 3346799999999999999999999998654 5689999999999
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
+|.++|.......++|..+++|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~------- 156 (262)
T d1byga_ 87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------- 156 (262)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC-------
Confidence 9999997654456999999999999999999999 889999999999999999999999999999864332
Q ss_pred cccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 010088 330 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 408 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 408 (518)
.....+|..|+|||++.+..++.++|||||||++|||+| |+.|+.. .+..+....... -..+.+....+
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~-------~~~~~~~~~~~-- 226 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEK-------GYKMDAPDGCP-- 226 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTT-------TCCCCCCTTCC--
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHc-------CCCCCCCccCC--
Confidence 234468999999999999999999999999999999999 5666543 333232222211 11222222233
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 409 QLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 409 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
..+.+++.+||+.||.+|||+.+++++|..
T Consensus 227 --~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 227 --PAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp --HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 568899999999999999999999999854
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=400.65 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=209.8
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+.+.++||+|+||+||+|+.. +|+.||||++++. .......+.+|+.+|++++||||+++++++.+.+..|+||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 345678999999999999874 6899999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
|++|+|.+++...+ .+++..+..++.||+.||+||| +++|+||||||+||||+.+|.+||+|||+|+......
T Consensus 87 ~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-- 159 (337)
T d1o6la_ 87 ANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-- 159 (337)
T ss_dssp CTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred cCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC--
Confidence 99999999998643 4899999999999999999999 8999999999999999999999999999998654322
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.......||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+........... +...+
T Consensus 160 --~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-~~~~~~~i~~~~~~--------~p~~~ 228 (337)
T d1o6la_ 160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIR--------FPRTL 228 (337)
T ss_dssp --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC--------CCTTS
T ss_pred --cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-HHHHHHHHhcCCCC--------CCccC
Confidence 12345679999999999999999999999999999999999999997543 33443333332222 22233
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhcC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYES 441 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~~L~~~ 441 (518)
+ ..+.+++..||+.||.+||+ ++|+++|.|+.
T Consensus 229 s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~ 265 (337)
T d1o6la_ 229 S----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp C----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred C----HHHHHHHHhhccCCchhhcccccccHHHHHcCcccc
Confidence 3 45788999999999999994 89999998874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-49 Score=397.74 Aligned_cols=247 Identities=24% Similarity=0.375 Sum_probs=208.0
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
+++.+.||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+.+|++++|||||++++++.+.+..|+||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 345678999999999999875 6899999998642 233456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 325 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 325 (518)
|+||+|..++.... .+++..+..++.||+.||+||| +++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 86 ~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 86 IEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp CCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred cCCccccccccccc--cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 99999999997643 4889999999999999999999 999999999999999999999999999999876543
Q ss_pred cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 010088 326 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 405 (518)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~ 405 (518)
.....||+.|||||.+.+..++.++|||||||+||||+||+.||..... .+...........+ ....
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~i~~~~~~~--------p~~~ 224 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYEKILNAELRF--------PPFF 224 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHCCCCC--------CTTS
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-HHHHHHHHcCCCCC--------CCCC
Confidence 2456799999999999999999999999999999999999999975433 33333333222211 1222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 406 DMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 406 ~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
+ ..+.+++.+||+.||.+|+ +++++++|.|..
T Consensus 225 s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~ 261 (316)
T d1fota_ 225 N----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261 (316)
T ss_dssp C----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred C----HHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccc
Confidence 3 4578999999999999996 999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.7e-49 Score=385.26 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=206.1
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---------chhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCce
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---------EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRER 239 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 239 (518)
++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+|++++ ||||+++++++.+++..
T Consensus 6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 85 (277)
T d1phka_ 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 85 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcce
Confidence 45678999999999999874 68999999986432 112346889999999997 99999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccC
Q 010088 240 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 319 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~ 319 (518)
|+|||||++|+|.++|+..+ ++++..+..++.||+.||+||| +++|+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 86 FLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999997643 5999999999999999999999 889999999999999999999999999999876
Q ss_pred CCCCcccccccccccCCCcccCcccccc------CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccc
Q 010088 320 KDGSICFEPVNTDIRGTPGYMDPEYVVT------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 393 (518)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l 393 (518)
..+. ......||+.|+|||.+.+ ..++.++||||+||+||||+||+.||....... ..+........+
T Consensus 161 ~~~~-----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~~~~ 234 (277)
T d1phka_ 161 DPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNYQF 234 (277)
T ss_dssp CTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCC
T ss_pred cCCC-----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHHHhCCCCC
Confidence 5543 2345679999999999863 357889999999999999999999997654332 233223222111
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 394 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 394 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.. + ....++ ..+.+++.+||+.||++|||++||++|.|..
T Consensus 235 ~~---~-~~~~~s----~~~~~li~~~L~~~p~~R~s~~eil~h~~~~ 274 (277)
T d1phka_ 235 GS---P-EWDDYS----DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274 (277)
T ss_dssp CT---T-TGGGSC----HHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred CC---c-ccccCC----HHHHHHHHHHccCChhHCcCHHHHHcCHHHH
Confidence 11 1 111222 5688999999999999999999999987763
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=396.74 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=196.6
Q ss_pred hhhhhhcceecceEEEEEEec-CCc----EEEEEEecc-ccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGS----LIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
+.+.++||+|+||+||+|++. +|+ .||||+++. ......++|.+|+++|++++|||||+++|+|.+ +..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeEEE
Confidence 345678999999999999875 343 689998864 334556789999999999999999999999986 4678889
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+.+|+|.+++... ...++|..+++|+.||+.||+||| +++|+||||||+||||+.++.+||+|||+++......
T Consensus 90 e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 90 QLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp ECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 999999999988754 346999999999999999999999 8899999999999999999999999999998765433
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
.. .......||+.|||||.+.++.++.++|||||||+||||+| |+.||... +..+....... ..+ +...
T Consensus 166 ~~--~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~-~~~~~~~~i~~-~~~------~~~p 235 (317)
T d1xkka_ 166 KE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEK-GER------LPQP 235 (317)
T ss_dssp C----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CGGGHHHHHHH-TCC------CCCC
T ss_pred cc--ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHc-CCC------CCCC
Confidence 21 12334568999999999999999999999999999999999 66676533 22222222211 111 1111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
.. ....+.+++.+||+.||++|||+.||+++|..
T Consensus 236 ~~----~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 236 PI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp TT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cc----cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 22 23568899999999999999999999999854
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=396.91 Aligned_cols=251 Identities=33% Similarity=0.479 Sum_probs=201.5
Q ss_pred hhhhhcceecceEEEEEEecC-Cc--EEEEEEeccc-cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceEEEEEe
Q 010088 171 NFSTIIGQGGFGTVYKAQFSD-GS--LIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~ 245 (518)
++.++||+|+||+||+|++.+ |. .||||+++.. .....+.|.+|+++|+++ +|||||+++|+|.+++..++||||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence 456789999999999998864 43 5788887543 344567899999999999 799999999999999999999999
Q ss_pred cCCCCHHHHhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEe
Q 010088 246 MANGSLKDHLHSP--------------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA 311 (518)
Q Consensus 246 ~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 311 (518)
+++|+|.++|+.. ....++|..+.+++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCceEEc
Confidence 9999999999753 2356999999999999999999999 8899999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc
Q 010088 312 DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 391 (518)
Q Consensus 312 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (518)
|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|..|+..+.+..+....... .
T Consensus 170 DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~-~- 242 (309)
T d1fvra_ 170 DFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-G- 242 (309)
T ss_dssp CTTCEESSCEEC-----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-T-
T ss_pred cccccccccccc-----cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh-c-
Confidence 999997654322 223456899999999999999999999999999999999987655445554444333221 1
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 392 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 392 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
..+...... ...+.+++.+||+.||++||||+||+++|..
T Consensus 243 -----~~~~~~~~~----~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 243 -----YRLEKPLNC----DDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp -----CCCCCCTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCCCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 112222222 3568899999999999999999999999854
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-50 Score=392.01 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=193.1
Q ss_pred hhhhhhhcceecceEEEEEEecC----CcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
.+++.+.||+|+||+||+|++.. +..||||.++.. .....+.|.+|+++|++++|||||+++|+|. .+..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence 34566789999999999998743 357899988653 3444567999999999999999999999985 46789999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
||+++|+|.+++.... ..+++..++.++.||+.||+||| +++|+||||||+||++++++.+||+|||+|+......
T Consensus 87 E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp ECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999999876533 35999999999999999999999 8999999999999999999999999999998654432
Q ss_pred cccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcCC
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 402 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 402 (518)
. .......||+.|+|||.+.+..++.++|||||||++|||+| |..|+...... +........ .. +.+.
T Consensus 163 ~---~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-~~~~~i~~~-~~------~~~~ 231 (273)
T d1mp8a_ 163 Y---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENG-ER------LPMP 231 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTT-CC------CCCC
T ss_pred c---eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-HHHHHHHcC-CC------CCCC
Confidence 1 12345568999999999999999999999999999999998 77787654332 222222111 11 1122
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
..++ ..+.+++..||+.||++|||+.||+++|..
T Consensus 232 ~~~~----~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 232 PNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 2333 568899999999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=392.45 Aligned_cols=261 Identities=27% Similarity=0.383 Sum_probs=196.9
Q ss_pred hhhhhhcceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC----ceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR----ERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~e~ 245 (518)
+.+.+.||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++||||++++|+|.+.+ ..++||||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 34567899999999999997 689999999864322 1222334555556789999999999998765 57999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCceecccCCCcEEecCCCcEEEeeccccccCC
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY-----CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~ 320 (518)
|++|+|.++|++. .++|..+++++.|+|.||+|||.. .+++|+||||||+||||++++.+||+|||+++...
T Consensus 83 ~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 83 HEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred ccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 9999999999853 499999999999999999999942 24799999999999999999999999999998765
Q ss_pred CCCcccccccccccCCCcccCccccccC------CCCccccchhhHHHHHHHHhCCccccCCc-------------chHH
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQ------ELTEKSDVYSYGVVLLEIVTARRAVQDGK-------------NLVE 381 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwS~Gvll~el~tG~~p~~~~~-------------~~~~ 381 (518)
..............||+.|||||++.+. .++.++|||||||+||||+||..|+.... ....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence 4432222234457799999999998654 26778999999999999999987763211 0111
Q ss_pred HHHHHHhhccccccccCCcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 382 SAQVCMASESRLAELVDPRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 382 ~~~~~~~~~~~l~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...... ..+..+|.+.... +.+....+.+++.+||+.||++|||+.||+++|.+
T Consensus 240 ~~~~~~-----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 240 EMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHHHH-----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHH-----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 111111 1112223332222 23456779999999999999999999999999865
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=393.10 Aligned_cols=256 Identities=26% Similarity=0.363 Sum_probs=195.8
Q ss_pred hhhhhhhcceecceEEEEEEec------CCcEEEEEEeccc-cchhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecC-ce
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKR-ER 239 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-~~ 239 (518)
.+.+.+.||+|+||+||+|++. +++.||||+++.. .....+.+.+|+.++.++ +|+||+.+++++.+.+ ..
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 93 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 93 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence 3556789999999999999864 2468999998743 334456788999998888 6899999999987654 68
Q ss_pred EEEEEecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC
Q 010088 240 FLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 305 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 305 (518)
++|||||++|+|.++|+... ...++|..++.++.||+.||+||| +++|+||||||+||||+++
T Consensus 94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECCC
Confidence 99999999999999996432 235899999999999999999999 8999999999999999999
Q ss_pred CcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCc-cccCCcchHHHHH
Q 010088 306 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARR-AVQDGKNLVESAQ 384 (518)
Q Consensus 306 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~-p~~~~~~~~~~~~ 384 (518)
+.+||+|||+|+........ .......||+.|||||.+.+..++.++|||||||++|||+||.. ||...........
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GCEEECC------CCSCTTS--CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CcEEEccCcchhhccccccc--cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999865433211 12345679999999999999999999999999999999999865 5544333322222
Q ss_pred HHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 385 VCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 385 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
. +.... .+......+ ..+.+++.+||+.||++|||++|++++|..
T Consensus 249 ~-~~~~~------~~~~~~~~~----~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 249 R-LKEGT------RMRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp H-HHHTC------CCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H-HhcCC------CCCCCccCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2 22211 122222233 458899999999999999999999999965
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-49 Score=389.94 Aligned_cols=263 Identities=24% Similarity=0.307 Sum_probs=202.2
Q ss_pred hhcceecceEEEEEEec-CCcEEEEEEeccccc-----hhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecC
Q 010088 174 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-----QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
++||+|+||+||+|+.. +|+.||||+++.... .....+.+|+++|++++|||||++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 47999999999999875 689999999864322 223568999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 327 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 327 (518)
++++..++.. ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 84 ~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--- 155 (299)
T d1ua2a_ 84 TDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--- 155 (299)
T ss_dssp EEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC---
T ss_pred chHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc---
Confidence 8887777654 335889999999999999999999 89999999999999999999999999999986654321
Q ss_pred cccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc----ccccccCC---
Q 010088 328 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----RLAELVDP--- 399 (518)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~----~l~~~~d~--- 399 (518)
......||+.|+|||.+.. ..++.++|||||||++|||+||+.||....+............. ...+....
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 2344579999999999865 46799999999999999999999998755443332222111000 00000000
Q ss_pred -cC--CCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 010088 400 -RI--KDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM 445 (518)
Q Consensus 400 -~l--~~~~~~-----~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~ 445 (518)
.. ....+. .....+.+++.+||+.||++|||++|+++|.|....+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 00 000111 11256889999999999999999999999998876554
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=393.47 Aligned_cols=259 Identities=26% Similarity=0.408 Sum_probs=210.8
Q ss_pred hhhhhhcceecceEEEEEEec------CCcEEEEEEeccc-cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
..+.+.||+|+||+||+|.+. +++.||||+++.. .......|.+|++++++++||||++++|+|...+..++|
T Consensus 22 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 101 (308)
T d1p4oa_ 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 101 (308)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEE
Confidence 345678999999999999863 3578999999753 344456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecc
Q 010088 243 YEYMANGSLKDHLHSP--------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG 314 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfG 314 (518)
|||+++|+|.+++... ....++|..+.+++.|+|.||+||| +++|+||||||+||||++++++||+|||
T Consensus 102 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~DFG 178 (308)
T d1p4oa_ 102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG 178 (308)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEeecc
Confidence 9999999999998632 2245799999999999999999999 8899999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccc
Q 010088 315 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 394 (518)
Q Consensus 315 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~ 394 (518)
+++........ .......||+.|+|||.+.+..++.++||||||+++|||+||+.++..+.+..+........ ..
T Consensus 179 la~~~~~~~~~--~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~-~~-- 253 (308)
T d1p4oa_ 179 MTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-GL-- 253 (308)
T ss_dssp CCCGGGGGGCE--EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-CC--
T ss_pred cceeccCCcce--eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC-CC--
Confidence 99865443221 12344568999999999999999999999999999999999975544455555544433221 11
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCC
Q 010088 395 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 444 (518)
Q Consensus 395 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~ 444 (518)
+.....++ ..+.+++.+||+.||++||||++|+++|....++
T Consensus 254 ----~~~p~~~~----~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 254 ----LDKPDNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp ----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ----CCCcccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 11222233 5699999999999999999999999999876554
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-50 Score=391.97 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=195.6
Q ss_pred hhhhhhcceecceEEEEEEecC--C--cEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSD--G--SLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 242 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~--g--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 242 (518)
+.+.+.||+|+||+||+|++.. + ..||||+++.. .....++|.+|+++|++++||||++++|+|.+ +..++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 3456789999999999998642 2 37899988642 33445789999999999999999999999965 567899
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+++|+|.+++.... ..+++..+++++.||+.||+||| +++|+||||||+||||+.++++||+|||+++.....
T Consensus 89 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 99999999999887543 35999999999999999999999 889999999999999999999999999999976544
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
... ........|+..|+|||.+.+..++.++|||||||++|||+| |+.||... +..+..........+ +..
T Consensus 165 ~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-~~~~~~~~i~~~~~~------~~~ 236 (273)
T d1u46a_ 165 DDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEGER------LPR 236 (273)
T ss_dssp CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTSCCC------CCC
T ss_pred CCc-ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-CHHHHHHHHHhCCCC------CCC
Confidence 321 112344568899999999999999999999999999999998 88888643 333333332222211 111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
....+ ..+.+++.+||+.||++|||+.||++.|.++
T Consensus 237 ~~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 237 PEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22223 4688999999999999999999999998763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=389.09 Aligned_cols=253 Identities=18% Similarity=0.261 Sum_probs=207.8
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
+.+.+.||+|+||+||+|... +|+.||||.++... .....+.+|+++|++++|||||++++++.+.+..|+|||||+|
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 345678999999999999875 68899999997543 3345688999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC--CCcEEEeeccccccCCCCCccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE--NFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~ 326 (518)
|+|.+++...+ ..+++.++..|+.||+.||+||| +.+|+||||||+|||++. .+.+||+|||+++......
T Consensus 86 g~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--- 158 (321)
T d1tkia_ 86 LDIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--- 158 (321)
T ss_dssp CBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC---
Confidence 99999997643 35999999999999999999999 899999999999999985 4589999999998765443
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +....+......+.....+ ..+
T Consensus 159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~----~~s 231 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYTFDEEAFK----EIS 231 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCCCHHHHT----TSC
T ss_pred --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCChhhcc----CCC
Confidence 223456899999999999999999999999999999999999999754433 3333333222222211111 122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 407 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..+.+++..||+.||++|||++|+++|.|..
T Consensus 232 ----~~~~~li~~~L~~dp~~R~s~~eil~hp~~~ 262 (321)
T d1tkia_ 232 ----IEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp ----HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 4578999999999999999999999987764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-49 Score=394.59 Aligned_cols=248 Identities=21% Similarity=0.309 Sum_probs=198.5
Q ss_pred hhcceecceEEEEEEe-cCCcEEEEEEeccccchhHHHHHHHHHHHHHc-CCCCeeeEeeeeee----cCceEEEEEecC
Q 010088 174 TIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIE----KRERFLMYEYMA 247 (518)
Q Consensus 174 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~lV~e~~~ 247 (518)
++||+|+||+||+|+. .+|+.||||+++.. ..+.+|++++.++ +|||||++++++.+ ....|+|||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 4699999999999987 46899999998642 4577899997766 89999999999865 356899999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC---CCcEEEeeccccccCCCCCc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DfGla~~~~~~~~ 324 (518)
||+|.++|...+...+++.++..|+.||+.||+||| +.+|+||||||+|||+++ ++.+||+|||+|+......
T Consensus 93 gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~- 168 (335)
T d2ozaa1 93 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN- 168 (335)
T ss_dssp SEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC-
T ss_pred CCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeeccCCC-
Confidence 999999998766667999999999999999999999 899999999999999985 5679999999998765433
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCC--cCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP--RIK 402 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~--~l~ 402 (518)
......||+.|||||++.+..|+.++|||||||+||||+||+.||............. ..+... .+.
T Consensus 169 ----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~-------~~i~~~~~~~~ 237 (335)
T d2ozaa1 169 ----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-------TRIRMGQYEFP 237 (335)
T ss_dssp ----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCSCSSSCC
T ss_pred ----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH-------HHHhcCCCCCC
Confidence 2345679999999999999999999999999999999999999996433221111000 000000 011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 403 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 403 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..........+.+++.+||+.||++|||+.|+++|.|..
T Consensus 238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 276 (335)
T d2ozaa1 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276 (335)
T ss_dssp TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence 111112345689999999999999999999999987653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.8e-48 Score=380.90 Aligned_cols=255 Identities=24% Similarity=0.350 Sum_probs=198.0
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCc----eEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE----RFL 241 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~~l 241 (518)
+.+.+.||+|+||+||+|+.. +|+.||||+++.. .......|.+|+++|++++||||+++++++...+. .|+
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 345678999999999999874 6899999999643 23345679999999999999999999999887543 789
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCC
Q 010088 242 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 321 (518)
Q Consensus 242 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 321 (518)
||||++||+|.+++...+ .+++.+++.|+.||+.||+||| +.+|+||||||+||||+.++..+|+|||++.....
T Consensus 89 vmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 999999999999987643 5999999999999999999999 89999999999999999999999999999875543
Q ss_pred CCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
.... ........||+.|||||.+.+..++.++|||||||++|||+||+.||...... +.................
T Consensus 164 ~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~--- 238 (277)
T d1o6ya_ 164 SGNS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-SVAYQHVREDPIPPSARH--- 238 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHCCCCCGGGTS---
T ss_pred cccc-ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-HHHHHHHhcCCCCCchhc---
Confidence 3211 12334567999999999999999999999999999999999999999754433 333332322222221111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhh
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARP-SIKQVLRILY 439 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RP-s~~evl~~L~ 439 (518)
...+ ..+.+++.+||+.||++|| +++++++.|.
T Consensus 239 -~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 239 -EGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp -SSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -cCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 2222 4688999999999999999 8999887664
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=390.10 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=208.4
Q ss_pred hhhhhhhcceecceEEEEEEec------CCcEEEEEEecccc-chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCceE
Q 010088 169 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERF 240 (518)
Q Consensus 169 ~~~f~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 240 (518)
.+.|.++||+|+||.||+|++. +++.||||+++... ......|.+|+.+++++ +|||||+++|+|.+.+..+
T Consensus 24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~ 103 (311)
T d1t46a_ 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (311)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEE
Confidence 4556789999999999999862 45789999997543 34456799999999999 6999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC
Q 010088 241 LMYEYMANGSLKDHLHSPG----------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE 304 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~ 304 (518)
+|||||++|+|.++++... ...+++..+.+++.||+.||+||| +++|+||||||+|||++.
T Consensus 104 lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTH 180 (311)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEET
T ss_pred EEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccccc
Confidence 9999999999999997432 235899999999999999999999 899999999999999999
Q ss_pred CCcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHH
Q 010088 305 NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQ 384 (518)
Q Consensus 305 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~ 384 (518)
++.+||+|||+++........ .......||+.|+|||.+.++.++.++|||||||++|||+|++.|+....+..+...
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cCcccccccchheeccCCCcc--eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999876544321 233456789999999999999999999999999999999996666554443333322
Q ss_pred HHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 385 VCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 385 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
....... .+...... ...+.+|+.+||+.||++|||+.||++.|..
T Consensus 259 ~~i~~~~------~~~~~~~~----~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 259 KMIKEGF------RMLSPEHA----PAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHHHHTC------CCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcCC------CCCCcccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2222211 11112222 3568999999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-48 Score=395.93 Aligned_cols=246 Identities=22% Similarity=0.346 Sum_probs=206.9
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEec
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 246 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 246 (518)
++.+.||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 44 ~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~ 123 (350)
T d1rdqe_ 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123 (350)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccc
Confidence 34568999999999999875 6999999998642 2233467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccc
Q 010088 247 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 326 (518)
Q Consensus 247 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 326 (518)
.+|+|..++...+ .+++..+..++.||+.||+||| +.+||||||||+||||+.++.+||+|||+|+.....
T Consensus 124 ~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 124 AGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp TTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred cccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 9999999997643 5999999999999999999999 899999999999999999999999999999876432
Q ss_pred ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 010088 327 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 406 (518)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~ 406 (518)
.....||+.|||||++.+..++.++|||||||+||||+||+.||..... ............. ....++
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~i~~~~~~--------~p~~~s 262 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIYEKIVSGKVR--------FPSHFS 262 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCC--------CCTTCC
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-HHHHHHHhcCCCC--------CCccCC
Confidence 2346799999999999999999999999999999999999999975433 3333332222211 122233
Q ss_pred HHHHHHHHHHHHHccccCCCCC-----CCHHHHHHHhhcC
Q 010088 407 MEQLRTIVTIVRWCTQREGQAR-----PSIKQVLRILYES 441 (518)
Q Consensus 407 ~~~~~~l~~li~~Cl~~dp~~R-----Ps~~evl~~L~~~ 441 (518)
..+.+++.+||+.||.+| |+++++++|.|+.
T Consensus 263 ----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~ 298 (350)
T d1rdqe_ 263 ----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp ----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred ----HHHHHHHHHHhhhCHHhccccccccHHHHHcCcccc
Confidence 458899999999999999 4999999998875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=385.68 Aligned_cols=254 Identities=27% Similarity=0.401 Sum_probs=201.3
Q ss_pred hhhhhhcceecceEEEEEEecC--------CcEEEEEEecccc-chhHHHHHHHHHHHHHc-CCCCeeeEeeeeeecCce
Q 010088 170 DNFSTIIGQGGFGTVYKAQFSD--------GSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRER 239 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 239 (518)
+.+.+.||+|+||.||+|+... +..||||+++... .....++.+|+..+.++ +|||||+++++|.+++..
T Consensus 15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~ 94 (299)
T d1fgka_ 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 94 (299)
T ss_dssp EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeE
Confidence 4456789999999999997632 3479999987543 34457899999999999 799999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC
Q 010088 240 FLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 305 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 305 (518)
++||||+++|+|.++|.... ...+++.++++++.||+.||+||| +.+|+||||||+|||++.+
T Consensus 95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTED 171 (299)
T ss_dssp EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTT
T ss_pred EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeecCC
Confidence 99999999999999997543 245899999999999999999999 8999999999999999999
Q ss_pred CcEEEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHh-CCccccCCcchHHHHH
Q 010088 306 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQ 384 (518)
Q Consensus 306 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~t-G~~p~~~~~~~~~~~~ 384 (518)
+.+||+|||+++........ .......||+.|+|||.+.++.++.++|||||||++|||++ |..||.+ .+..+...
T Consensus 172 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~-~~~~~~~~ 248 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFK 248 (299)
T ss_dssp CCEEECSTTCCCCGGGCCTT--CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHH
T ss_pred CCeEeccchhhccccccccc--cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC-CCHHHHHH
Confidence 99999999999866543321 23345678999999999999999999999999999999998 5666653 33333322
Q ss_pred HHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 385 VCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 385 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
... ... .+.....++ ..+.+++.+||+.||++|||+.||++.|..
T Consensus 249 ~i~-~~~------~~~~p~~~~----~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 249 LLK-EGH------RMDKPSNCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp HHH-TTC------CCCCCSSCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH-cCC------CCCCCccch----HHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 221 111 122222233 468899999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-49 Score=391.77 Aligned_cols=250 Identities=23% Similarity=0.357 Sum_probs=205.6
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccc---cchhHHHHHHHHHHHH-HcCCCCeeeEeeeeeecCceEEEEE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLA-RLHHRHLVALRGFCIEKRERFLMYE 244 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV~e 244 (518)
+.+.++||+|+||+||+|+.. +|+.||||++++. .....+.+..|..++. .++|||||++++++.+++..|+|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 446689999999999999875 6899999999642 2233456777888776 5899999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
||++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 84 y~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~- 157 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 157 (320)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred ecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence 999999999997643 4899999999999999999999 8899999999999999999999999999998654332
Q ss_pred ccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcCCCC
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 404 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 404 (518)
...+...||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+......... +.+...
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-~~~~~~~i~~~~--------~~~p~~ 225 (320)
T d1xjda_ 158 ---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIRMDN--------PFYPRW 225 (320)
T ss_dssp ---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCC--------CCCCTT
T ss_pred ---ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHcCC--------CCCCcc
Confidence 12345679999999999999999999999999999999999999997543 333333222221 222222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHHhhcC
Q 010088 405 FDMEQLRTIVTIVRWCTQREGQARPSIK-QVLRILYES 441 (518)
Q Consensus 405 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~-evl~~L~~~ 441 (518)
.+ ..+.+++.+||+.||++||++. ++++|.+..
T Consensus 226 ~s----~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~ 259 (320)
T d1xjda_ 226 LE----KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259 (320)
T ss_dssp SC----HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred CC----HHHHHHHHHhcccCCCCCcCHHHHHHhCchhc
Confidence 33 4588999999999999999995 788887654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.7e-48 Score=392.61 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=199.7
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc---chhHHHHHHH---HHHHHHcCCCCeeeEeeeeeecCceEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCRE---IELLARLHHRHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 243 (518)
.+.++||+|+||+||+|+.. +|+.||||++.... ......+.+| +.+++.++|||||++++++.+.+..|+||
T Consensus 7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivm 86 (364)
T d1omwa3 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 86 (364)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEE
Confidence 45678999999999999875 68999999985321 1222334444 66666678999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
|||++|+|.++|... ..+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+|+......
T Consensus 87 E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 87 DLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp CCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 999999999999764 34899999999999999999999 8999999999999999999999999999998765432
Q ss_pred cccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcc--hHHHHHHHHhhccccccccCCc
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKN--LVESAQVCMASESRLAELVDPR 400 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~--~~~~~~~~~~~~~~l~~~~d~~ 400 (518)
.....||+.|||||++.. ..++.++|||||||+||||+||+.||..... .....+.... ..+.
T Consensus 162 ------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~--------~~~~ 227 (364)
T d1omwa3 162 ------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--------MAVE 227 (364)
T ss_dssp ------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS--------CCCC
T ss_pred ------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--------CCCC
Confidence 245679999999999875 5689999999999999999999999965332 2221111110 1112
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhcC
Q 010088 401 IKDSFDMEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYES 441 (518)
Q Consensus 401 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~~L~~~ 441 (518)
+...++ ..+.+++.+||+.||++||+ ++|+++|.|+.
T Consensus 228 ~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~ 269 (364)
T d1omwa3 228 LPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269 (364)
T ss_dssp CCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGT
T ss_pred CCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcccc
Confidence 222333 45889999999999999999 79999998875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=377.07 Aligned_cols=261 Identities=25% Similarity=0.337 Sum_probs=201.1
Q ss_pred hhhhcceecceEEEEEEe-cCCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 172 FSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
..+.||+|+||+||+|+. .+|+.||||+++... ......+.+|+++|++++|||||++++++.+++..|+||||+.+
T Consensus 6 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~ 85 (298)
T d1gz8a_ 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 85 (298)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC
Confidence 346899999999999987 468999999986432 23456799999999999999999999999999999999999975
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++.+++.......+++..+..++.|++.||+||| +.+||||||||+|||++.++.+||+|||+|+...... .
T Consensus 86 -~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~----~ 157 (298)
T d1gz8a_ 86 -DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV----R 157 (298)
T ss_dssp -EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS----B
T ss_pred -chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc----c
Confidence 5555554444456999999999999999999999 8999999999999999999999999999998654432 1
Q ss_pred ccccccCCCcccCccccccCC-CCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCC------cC
Q 010088 329 VNTDIRGTPGYMDPEYVVTQE-LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP------RI 401 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~------~l 401 (518)
......||+.|+|||.+.... ++.++|||||||++|||++|+.||................ ....+...+ ..
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL-GTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCCTTTSTTGGGSTTC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhc-CCCchhhcccccccccc
Confidence 234567999999999887655 5789999999999999999999997554433333322111 111111000 00
Q ss_pred CCC------CCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 402 KDS------FDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 402 ~~~------~~~-----~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
... .+. .....+.+++.+||+.||++|||++|+++|.|..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~ 287 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhc
Confidence 000 000 1125678999999999999999999999997764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.8e-47 Score=374.51 Aligned_cols=260 Identities=25% Similarity=0.306 Sum_probs=201.0
Q ss_pred hhhhcceecceEEEEEEecCCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCCC
Q 010088 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG 249 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 249 (518)
..+.||+|+||+||+|+..+|+.||||+++... ......|.+|+.+|++++||||+++++++...+..+++|||+.++
T Consensus 6 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~ 85 (286)
T d1ob3a_ 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD 85 (286)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEE
T ss_pred eccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhh
Confidence 456899999999999999999999999986532 333568999999999999999999999999999999999999887
Q ss_pred CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCcccccc
Q 010088 250 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 329 (518)
Q Consensus 250 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 329 (518)
.+..+.... ..+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||++........ .
T Consensus 86 ~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~----~ 156 (286)
T d1ob3a_ 86 LKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR----K 156 (286)
T ss_dssp HHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred hHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc----c
Confidence 777776553 35999999999999999999999 88999999999999999999999999999986544321 2
Q ss_pred cccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc----c---ccccc--CC
Q 010088 330 NTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----R---LAELV--DP 399 (518)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~----~---l~~~~--d~ 399 (518)
.....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+........+....... . ..+.. +.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 234468999999999875 45789999999999999999999999765443333322211100 0 00000 00
Q ss_pred cCC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 400 RIK-------DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 400 ~l~-------~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
... ..........+.+++.+||+.||++|||++|+++|.|.
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f 284 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 000 00011122568899999999999999999999998775
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=375.36 Aligned_cols=242 Identities=24% Similarity=0.365 Sum_probs=198.0
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccc------hhHHHHHHHHHHHHHcC--CCCeeeEeeeeeecCceE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE------QVEGDFCREIELLARLH--HRHLVALRGFCIEKRERF 240 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~ 240 (518)
+.+.++||+|+||+||+|+.. +|+.||||+++.... .....+.+|+.+|++++ |||||++++++.+.+..+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence 445678999999999999875 689999999864221 11234678999999996 899999999999999999
Q ss_pred EEEEecCC-CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-CCcEEEeecccccc
Q 010088 241 LMYEYMAN-GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHA 318 (518)
Q Consensus 241 lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DfGla~~ 318 (518)
+||||+.+ +++.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++. ++.+||+|||+|+.
T Consensus 86 lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccccee
Confidence 99999976 6888888653 35999999999999999999999 899999999999999985 57999999999986
Q ss_pred CCCCCcccccccccccCCCcccCccccccCCC-CccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccccc
Q 010088 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 397 (518)
Q Consensus 319 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 397 (518)
.... ..+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||...... ....
T Consensus 161 ~~~~------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i-------~~~~------- 220 (273)
T d1xwsa_ 161 LKDT------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------IRGQ------- 220 (273)
T ss_dssp CCSS------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------HHCC-------
T ss_pred cccc------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH-------hhcc-------
Confidence 5432 2345679999999999987765 56799999999999999999999643211 1111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..++..++ ..+.+++.+||+.||++|||++|+++|.|..
T Consensus 221 -~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~hp~~~ 259 (273)
T d1xwsa_ 221 -VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259 (273)
T ss_dssp -CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred -cCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence 11222333 4588999999999999999999999998764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=374.65 Aligned_cols=271 Identities=24% Similarity=0.295 Sum_probs=203.2
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeee--------cCce
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE--------KRER 239 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~~~~ 239 (518)
...+.||+|+||+||+|+.. +|+.||||++... .......+.+|+++|++++|+||+++++++.. .+..
T Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~ 92 (318)
T d3blha1 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 92 (318)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CE
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceE
Confidence 34568999999999999874 7999999998532 33445678999999999999999999998865 3467
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccC
Q 010088 240 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 319 (518)
Q Consensus 240 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~ 319 (518)
++||||+.++.+..+... ...++...+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 93 YLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp EEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 999999988777665544 335889999999999999999999 899999999999999999999999999999866
Q ss_pred CCCCcccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccC
Q 010088 320 KDGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD 398 (518)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d 398 (518)
...............||+.|+|||.+.+. .++.++|||||||++|||++|+.||....+........ ...........
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~ 246 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS-QLCGSITPEVW 246 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HHHCCCCTTTS
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH-HhcCCCChhhc
Confidence 54332222233446799999999998765 68999999999999999999999997554433322221 11111111100
Q ss_pred CcCC-------------CCCCH-HH------HHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCCc
Q 010088 399 PRIK-------------DSFDM-EQ------LRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHS 447 (518)
Q Consensus 399 ~~l~-------------~~~~~-~~------~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~ 447 (518)
.... ..... +. ...+.+++.+||+.||++|||++|+++|.|+..++.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence 0000 00001 11 23567899999999999999999999999998776643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=373.77 Aligned_cols=262 Identities=22% Similarity=0.279 Sum_probs=198.0
Q ss_pred hhhhhcceecceEEEEEEec-C-CcEEEEEEeccc--cchhHHHHHHHHHHHHHc---CCCCeeeEeeeeee-----cCc
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-D-GSLIAVKRMDKI--SEQVEGDFCREIELLARL---HHRHLVALRGFCIE-----KRE 238 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~-g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~~ 238 (518)
...+.||+|+||+||+|+.. + ++.||||+++.. .......+.+|+.+|+.| +||||++++++|.. ...
T Consensus 10 ~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~ 89 (305)
T d1blxa_ 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 89 (305)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCce
Confidence 34568999999999999873 4 677999998642 222334567888887776 79999999999864 246
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeecccccc
Q 010088 239 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 318 (518)
Q Consensus 239 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~ 318 (518)
.+++|||+.++++....... ...+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++.
T Consensus 90 ~~~~~e~~~~~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 90 LTLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEECCSCBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEEEEeccCCchhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 79999999987776554433 345899999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccC
Q 010088 319 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD 398 (518)
Q Consensus 319 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d 398 (518)
..... ......||+.|+|||.+.+..++.++||||+||++|||+||+.||.........................
T Consensus 166 ~~~~~-----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 166 YSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hcccc-----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 54322 3456679999999999999999999999999999999999999997654433332221111000000000
Q ss_pred ----------CcC----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 399 ----------PRI----KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 399 ----------~~l----~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
... ...+.......+.+++.+||+.||++|||++|+++|.|..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~ 297 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhc
Confidence 000 0001111224578899999999999999999999998764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-46 Score=374.86 Aligned_cols=258 Identities=25% Similarity=0.364 Sum_probs=193.9
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec------CceEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERFLMY 243 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~ 243 (518)
+..++||+|+||+||+|+.. +|+.||||++...... +.+|+++|++++|+||+++++++... ...++||
T Consensus 23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 34568999999999999985 6899999998654322 34799999999999999999998653 2468999
Q ss_pred EecCCCCHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC-cEEEeeccccccCCC
Q 010088 244 EYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-VAKLADFGLAHASKD 321 (518)
Q Consensus 244 e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DfGla~~~~~ 321 (518)
|||+++.+..+.+. .....+++..+..|+.||+.||+||| +++|+||||||+||||+.++ .+||+|||+++....
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 99987644443321 22446999999999999999999999 99999999999999999765 899999999987654
Q ss_pred CCcccccccccccCCCcccCcccccc-CCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcc---------
Q 010088 322 GSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES--------- 391 (518)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~--------- 391 (518)
.. ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..................
T Consensus 176 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 176 GE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp TS-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred Cc-----ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 43 2344679999999998765 57899999999999999999999999755443332222110000
Q ss_pred --ccccccCCcCC-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 010088 392 --RLAELVDPRIK-----DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 440 (518)
Q Consensus 392 --~l~~~~d~~l~-----~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~ 440 (518)
...+..-+... ..........+.+++.+||+.||++|||+.|+++|.|+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 306 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 00000000000 00111223458899999999999999999999998765
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=359.69 Aligned_cols=261 Identities=24% Similarity=0.273 Sum_probs=208.6
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecCceEEEEEecCC
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 248 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 248 (518)
..+.||+|+||+||+|+.. +|+.||||+++.. .......+.+|+.+|+.++||||+++++++.+....++|++|+.+
T Consensus 6 ~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~ 85 (292)
T d1unla_ 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred eeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccc
Confidence 4468999999999999875 6899999998643 334467899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCccccc
Q 010088 249 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 328 (518)
Q Consensus 249 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 328 (518)
++|..++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.++.......
T Consensus 86 ~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~---- 156 (292)
T d1unla_ 86 DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR---- 156 (292)
T ss_dssp EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS----
T ss_pred ccccccccccc--ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc----
Confidence 99998887643 5889999999999999999999 89999999999999999999999999999987654331
Q ss_pred ccccccCCCcccCccccccCC-CCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccccc--------ccCC
Q 010088 329 VNTDIRGTPGYMDPEYVVTQE-LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE--------LVDP 399 (518)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~--------~~d~ 399 (518)
......++..|+|||.+.... ++.++|||||||++|||++|+.||..+.+..+.............+ ..+.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 233445788999999887655 6899999999999999999999988777666554443221111100 0000
Q ss_pred ----cC-----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 400 ----RI-----KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 400 ----~l-----~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
.. ...........+.+++.+||+.||.+|||++|+++|.|..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~ 287 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGS
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhc
Confidence 00 0001112235688999999999999999999999998774
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=366.26 Aligned_cols=255 Identities=22% Similarity=0.342 Sum_probs=193.8
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC------ceEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR------ERFLM 242 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV 242 (518)
..+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+ ..++|
T Consensus 22 ~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 101 (346)
T d1cm8a_ 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 101 (346)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEE
Confidence 4468999999999999875 6999999999743 3344567899999999999999999999998654 56999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
|||+ +++|..+++. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+|++|||+|+.....
T Consensus 102 ~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~ 174 (346)
T d1cm8a_ 102 MPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174 (346)
T ss_dssp EECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred Eecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceeccCCc
Confidence 9999 5688887764 34999999999999999999999 899999999999999999999999999999865432
Q ss_pred CcccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccc---------
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR--------- 392 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~--------- 392 (518)
.+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||...................
T Consensus 175 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 175 -------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp -------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred -------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 2456799999999998764 57899999999999999999999997654433322221111000
Q ss_pred ----------cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 393 ----------LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 393 ----------l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
+.+.....+. .........+.+++.+||+.||++|||++|+++|.|..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~ 305 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred chhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhC
Confidence 0000000000 00011124578999999999999999999999998764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-44 Score=361.07 Aligned_cols=257 Identities=18% Similarity=0.290 Sum_probs=199.0
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcC-CCCeeeEeeeeeec--CceEEEEEe
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEK--RERFLMYEY 245 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e~ 245 (518)
+.+.++||+|+||+||+|+.. +|+.||||+++... .+.+.+|+++|.+++ ||||+++++++... ...++||||
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 445678999999999999874 68999999986533 457889999999995 99999999998754 568999999
Q ss_pred cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCC-CcEEEeeccccccCCCCCc
Q 010088 246 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 246 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DfGla~~~~~~~~ 324 (518)
|.+|+|..+.+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.+ +.+||+|||+|+......
T Consensus 114 ~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 114 VNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp CCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred cCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence 99999987643 4899999999999999999999 8999999999999999865 469999999998765443
Q ss_pred ccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhh--------------
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS-------------- 389 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~-------------- 389 (518)
......||+.|+|||.+.+. .++.++||||+||++|||++|+.||....+...........
T Consensus 185 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 185 ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp ----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred ----cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 23456789999999998765 47999999999999999999999997665433221111100
Q ss_pred ---ccccccccCCc--------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 390 ---ESRLAELVDPR--------IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 390 ---~~~l~~~~d~~--------l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
........... ............+.+++.+||+.||++|||++|+++|.|+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00000000000 000000112245789999999999999999999999988753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=366.61 Aligned_cols=263 Identities=21% Similarity=0.293 Sum_probs=196.6
Q ss_pred hhhhhcceecceEEEEEEec-CCcEEEEEEecccc-chhHHHHHHHHHHHHHcCCCCeeeEeeeeeecC----ceEEEEE
Q 010088 171 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKR----ERFLMYE 244 (518)
Q Consensus 171 ~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~e 244 (518)
...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++||||+++++++.... ..+++++
T Consensus 11 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~ 90 (345)
T d1pmea_ 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVT 90 (345)
T ss_dssp EEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred EEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEE
Confidence 34578999999999999864 79999999997543 344567899999999999999999999987653 3355566
Q ss_pred ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCCc
Q 010088 245 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 324 (518)
|+.+|+|.+++... .+++..+..++.|++.||+||| +++||||||||+||||+.++.+||+|||+++.......
T Consensus 91 ~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 91 HLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp ECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred eecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 77899999999743 4999999999999999999999 89999999999999999999999999999986543321
Q ss_pred ccccccccccCCCcccCccccc-cCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccc-------
Q 010088 325 CFEPVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL------- 396 (518)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~------- 396 (518)
. ........||+.|+|||.+. ...++.++||||+||++|||++|+.||...................-.+.
T Consensus 165 ~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 165 H-TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp B-CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred c-ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 1 11234567999999999985 45678999999999999999999999975443322222111000000000
Q ss_pred -------cCCcCCCCCCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 397 -------VDPRIKDSFDME-----QLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 397 -------~d~~l~~~~~~~-----~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
..+.. ...+.. ....+.+++.+||+.||++|||+.|+++|.+..
T Consensus 244 ~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~ 299 (345)
T d1pmea_ 244 KARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299 (345)
T ss_dssp HHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred hhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 00000 011111 114588999999999999999999999997654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-45 Score=363.44 Aligned_cols=252 Identities=23% Similarity=0.312 Sum_probs=201.1
Q ss_pred hhhhhhcceecceEEEEEEec----CCcEEEEEEeccc----cchhHHHHHHHHHHHHHcCC-CCeeeEeeeeeecCceE
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKI----SEQVEGDFCREIELLARLHH-RHLVALRGFCIEKRERF 240 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~ 240 (518)
+.+.+.||+|+||+||+|+.. +|+.||||.++.. .....+.+.+|+++|++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 456679999999999999752 4789999998642 22334668899999999976 89999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCC
Q 010088 241 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 320 (518)
Q Consensus 241 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~ 320 (518)
+||||+.+|+|.+++...+ .+....+..++.|++.||+||| +.+|+||||||+||||+.++.+||+|||+++...
T Consensus 106 ~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999999997644 3778899999999999999999 8999999999999999999999999999998654
Q ss_pred CCCcccccccccccCCCcccCccccccC--CCCccccchhhHHHHHHHHhCCccccCCcc--h-HHHHHHHHhhcccccc
Q 010088 321 DGSICFEPVNTDIRGTPGYMDPEYVVTQ--ELTEKSDVYSYGVVLLEIVTARRAVQDGKN--L-VESAQVCMASESRLAE 395 (518)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwS~Gvll~el~tG~~p~~~~~~--~-~~~~~~~~~~~~~l~~ 395 (518)
..... ......|++.|++||.+.+. .++.++|||||||+||||+||+.||..... . ...........
T Consensus 181 ~~~~~---~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~----- 252 (322)
T d1vzoa_ 181 ADETE---RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----- 252 (322)
T ss_dssp GGGGG---GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-----
T ss_pred ccccc---cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC-----
Confidence 43221 23456799999999999764 478899999999999999999999964422 1 12222111111
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhcC
Q 010088 396 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES 441 (518)
Q Consensus 396 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L~~~ 441 (518)
+.+.... ...+.+++.+||+.||++|| +++|+++|.|+.
T Consensus 253 ---~~~~~~~----s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~ 296 (322)
T d1vzoa_ 253 ---PPYPQEM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296 (322)
T ss_dssp ---CCCCTTS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred ---CCCcccC----CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhc
Confidence 1122222 35688999999999999999 589999988764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.6e-44 Score=352.30 Aligned_cols=258 Identities=20% Similarity=0.275 Sum_probs=191.1
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCeee-EeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVA-LRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.+.||+|+||+||+|++. +|+.||||.+..... ..++.+|++++++++|+|++. +.++..+.+..++||||+
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 446678999999999999874 689999998765332 345889999999998766554 455556777889999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEec---CCCcEEEeeccccccCCCCCc
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSI 324 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DfGla~~~~~~~~ 324 (518)
+|+|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||++ .+..+||+|||+|+.......
T Consensus 86 ~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 86 GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 557766665432 35999999999999999999999 89999999999999985 456799999999987654332
Q ss_pred cc---ccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccCCcC
Q 010088 325 CF---EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 401 (518)
Q Consensus 325 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 401 (518)
.. ........||+.|||||.+.+..++.++|||||||++|||+||+.||...................+. ...+.+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 240 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPIEVL 240 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCHHHH
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CChhHh
Confidence 11 11234567999999999999999999999999999999999999999754322111111000000000 000111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 010088 402 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 439 (518)
Q Consensus 402 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~ 439 (518)
...++ ..+.+++..||+.+|++||++.++.+.|.
T Consensus 241 ~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 274 (299)
T d1ckia_ 241 CKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274 (299)
T ss_dssp TTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred ccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 22223 45889999999999999999998876654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-43 Score=349.77 Aligned_cols=258 Identities=18% Similarity=0.213 Sum_probs=200.8
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcCC-CCeeeEeeeeeecCceEEEEEecC
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHH-RHLVALRGFCIEKRERFLMYEYMA 247 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~ 247 (518)
+.+.+.||+|+||+||+|+.. +|+.||||.+.... ....+.+|++.+..|.| +|++.+++++.+....++||||+
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 345678999999999999875 68999999875433 23457889999999975 89999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecC-----CCcEEEeeccccccCCCC
Q 010088 248 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-----NFVAKLADFGLAHASKDG 322 (518)
Q Consensus 248 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~kl~DfGla~~~~~~ 322 (518)
+|+|.++++..+ ..+++.++..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+|+.....
T Consensus 84 ~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 84 GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 689999987543 35999999999999999999999 999999999999999974 578999999999876433
Q ss_pred Ccc---cccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcc--hHHHHHHHHhhcccccccc
Q 010088 323 SIC---FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN--LVESAQVCMASESRLAELV 397 (518)
Q Consensus 323 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~--~~~~~~~~~~~~~~l~~~~ 397 (518)
... .........||+.|||||.+.+..++.++|||||||++|||+||+.||..... ............... .
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~---~ 236 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST---P 236 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS---C
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC---C
Confidence 211 01123456799999999999999999999999999999999999999964322 222111111110000 0
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 398 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 398 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
-+.+...++ +.+.+++..|++.+|++||+++.+.+.+.+.
T Consensus 237 ~~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 237 LRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hHHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 011112222 4588999999999999999999888776543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=360.20 Aligned_cols=257 Identities=19% Similarity=0.266 Sum_probs=190.4
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEeccc--cchhHHHHHHHHHHHHHcCCCCeeeEeeeeeec------CceEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERFLM 242 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV 242 (518)
..++||+|+||+||+|++. +|+.||||++... .......+.+|+.+|++++||||+++++++... ...|+|
T Consensus 21 i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv 100 (355)
T d2b1pa1 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 100 (355)
T ss_dssp EEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEE
Confidence 3468999999999999876 6999999999643 334445789999999999999999999998643 578999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCC
Q 010088 243 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 322 (518)
Q Consensus 243 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 322 (518)
||||.++ +.+.+.. .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+|++|||+++.....
T Consensus 101 ~Ey~~~~-l~~~~~~----~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 101 MELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EeccchH-HHHhhhc----CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhccccc
Confidence 9999765 4455542 3899999999999999999999 899999999999999999999999999998866543
Q ss_pred CcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhcccc---------
Q 010088 323 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL--------- 393 (518)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l--------- 393 (518)
. ......||+.|+|||.+.+..++.++||||+||+++||++|+.||....................
T Consensus 173 ~-----~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 173 F-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred c-----ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 3 23456799999999999999999999999999999999999999975543333222211111000
Q ss_pred -----------------ccccCCcCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 010088 394 -----------------AELVDPRIKDS---FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 441 (518)
Q Consensus 394 -----------------~~~~d~~l~~~---~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~ 441 (518)
........... ........+.+++.+||+.||++|||++|+++|.|..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~ 315 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence 00000000000 1123456789999999999999999999999998765
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=355.38 Aligned_cols=257 Identities=21% Similarity=0.310 Sum_probs=195.5
Q ss_pred hhhhcceecceEEEEEEec-CCcEEEEEEecccc--chhHHHHHHHHHHHHHcCCCCeeeEeeeeeec-----CceEEEE
Q 010088 172 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK-----RERFLMY 243 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~ 243 (518)
..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|+||+++++++... ...++++
T Consensus 22 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~ 101 (348)
T d2gfsa1 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101 (348)
T ss_dssp EEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEE
Confidence 4468999999999999864 79999999997532 33445789999999999999999999998643 3457778
Q ss_pred EecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeeccccccCCCCC
Q 010088 244 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 323 (518)
Q Consensus 244 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 323 (518)
+|+.+|+|.+++... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+|++|||++.....
T Consensus 102 ~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 102 THLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp EECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred EeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccCc--
Confidence 888999999999653 4999999999999999999999 89999999999999999999999999999875432
Q ss_pred cccccccccccCCCcccCccccccC-CCCccccchhhHHHHHHHHhCCccccCCcchHHHHHHHHhhccccccccC----
Q 010088 324 ICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD---- 398 (518)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~l~~~~d---- 398 (518)
......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.....................+...
T Consensus 174 -----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 174 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp -----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred -----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 23456789999999987665 46889999999999999999999997554333222221111100000000
Q ss_pred ----------CcCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 010088 399 ----------PRIKDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 442 (518)
Q Consensus 399 ----------~~l~~~~~~-----~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~ 442 (518)
+... .... .....+.+++.+||+.||++|||++|+++|.|...
T Consensus 249 ~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 249 ESARNYIQSLTQMP-KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHHHHHHTTSCCCC-CCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhhhhhhhhcccCC-CcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 0000 0010 11245789999999999999999999999988753
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-38 Score=320.85 Aligned_cols=262 Identities=19% Similarity=0.219 Sum_probs=192.5
Q ss_pred hhhhhhcceecceEEEEEEec-CCcEEEEEEeccccchhHHHHHHHHHHHHHcC-----------CCCeeeEeeeeeec-
Q 010088 170 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-----------HRHLVALRGFCIEK- 236 (518)
Q Consensus 170 ~~f~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~~- 236 (518)
+.+.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++|++++ |+||+++++++...
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 456679999999999999874 79999999997543 23457788999998885 57899999988654
Q ss_pred -CceEEEEEecCCCC-HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCC------cE
Q 010088 237 -RERFLMYEYMANGS-LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF------VA 308 (518)
Q Consensus 237 -~~~~lV~e~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~------~~ 308 (518)
...+++|+++..+. ............+++..+..++.||+.||+|||+ ..+|+||||||+||||+.++ .+
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccccee
Confidence 45667777665543 3333333444568999999999999999999993 37999999999999998654 49
Q ss_pred EEeeccccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHHHHHHhCCccccCCcch------HHH
Q 010088 309 KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL------VES 382 (518)
Q Consensus 309 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll~el~tG~~p~~~~~~~------~~~ 382 (518)
|++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||...... ...
T Consensus 172 kl~dfg~s~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 172 KIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eEeecccccccccc-------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 99999998754332 24567999999999999999999999999999999999999998632211 111
Q ss_pred HHHH--Hhh--------ccccccccC---------C----------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 010088 383 AQVC--MAS--------ESRLAELVD---------P----------RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQ 433 (518)
Q Consensus 383 ~~~~--~~~--------~~~l~~~~d---------~----------~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~e 433 (518)
.... +.. ........+ . .............+.+++.+||+.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 1110 000 000000000 0 0012234566778999999999999999999999
Q ss_pred HHHHhhcC
Q 010088 434 VLRILYES 441 (518)
Q Consensus 434 vl~~L~~~ 441 (518)
+|+|.|+.
T Consensus 325 ~L~Hp~f~ 332 (362)
T d1q8ya_ 325 LVNHPWLK 332 (362)
T ss_dssp HHTCGGGT
T ss_pred HhcCcccC
Confidence 99998875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=8.8e-25 Score=200.69 Aligned_cols=168 Identities=13% Similarity=0.122 Sum_probs=120.3
Q ss_pred hhhhcceecceEEEEEEecCCcEEEEEEecccc------------------chhHHHHHHHHHHHHHcCCCCeeeEeeee
Q 010088 172 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS------------------EQVEGDFCREIELLARLHHRHLVALRGFC 233 (518)
Q Consensus 172 f~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 233 (518)
+.++||+|+||+||+|+..+|+.||||.++... ......+.+|...+.++.|.|++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 456899999999999998899999999864210 01122355788999999999999887653
Q ss_pred eecCceEEEEEecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecccCCCcEEecCCCcEEEeec
Q 010088 234 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADF 313 (518)
Q Consensus 234 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~Df 313 (518)
..+++|||++++.+.+ ++.....+++.|++.+|+||| +.+|+||||||+|||++++ .++|+||
T Consensus 84 ----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred ----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence 3479999998865533 344556789999999999999 8899999999999999976 5899999
Q ss_pred cccccCCCCCcccccccccccCCCcccCccccccCCCCccccchhhHHHH
Q 010088 314 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 363 (518)
Q Consensus 314 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvll 363 (518)
|+|+......... ......... .+. ....|+.++|+||..--+
T Consensus 147 G~a~~~~~~~~~~-~l~rd~~~~-----~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWRE-ILERDVRNI-----ITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHHH-HHHHHHHHH-----HHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcHH-HHHHHHHHH-----HHH-HcCCCCCcccHHHHHHHH
Confidence 9997654332100 000000000 011 235678899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.52 E-value=3e-07 Score=86.04 Aligned_cols=130 Identities=17% Similarity=0.142 Sum_probs=93.4
Q ss_pred cceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcC-CCCeeeEeeeeeecCceEEEEEecCCCCHHHHhcCC
Q 010088 180 GFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSP 258 (518)
Q Consensus 180 ~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~ 258 (518)
+.+.||+... ++..++||+...........+.+|...+..+. +--+.+++.++...+..++||++++|.++.+.....
T Consensus 26 s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~ 104 (263)
T d1j7la_ 26 SPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE 104 (263)
T ss_dssp SSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC
T ss_pred CCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc
Confidence 3468999865 56677888876544444456788999988884 434667888888888899999999998887655321
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------------------
Q 010088 259 GRTPLSWQTRIQIAIDVANALEYLHFYC---------------------------------------------------- 286 (518)
Q Consensus 259 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------------------- 286 (518)
. ....++.+++..|+.||...
T Consensus 105 ----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (263)
T d1j7la_ 105 ----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE 177 (263)
T ss_dssp ----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred ----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence 1 22345566666777777321
Q ss_pred ----CCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 287 ----DPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 287 ----~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
...++|+|+.+.|||+++++..-|.||+.+.
T Consensus 178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1137899999999999987777799999764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.15 E-value=3.8e-06 Score=77.83 Aligned_cols=129 Identities=18% Similarity=0.151 Sum_probs=85.8
Q ss_pred cceecc-eEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCC--CCeeeEeeeeeecCceEEEEEecCCCCHH
Q 010088 176 IGQGGF-GTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHH--RHLVALRGFCIEKRERFLMYEYMANGSLK 252 (518)
Q Consensus 176 lG~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 252 (518)
+..|.. +.||+...+++..+++|...... ...+..|+..|+.+.. -.+.++++++.+.+..++||+|++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 344443 67999988788888889765332 2346788888888743 33567788888888899999999886653
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----------------------------------------------
Q 010088 253 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY----------------------------------------------- 285 (518)
Q Consensus 253 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------------- 285 (518)
+.. .. ..+++.+++..|+-||..
T Consensus 95 ~~~-------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 95 SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred ccc-------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 210 11 111222333333333321
Q ss_pred --------CCCCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 286 --------CDPPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 286 --------~~~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
....++|+|+.+.|||++++..+-|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 12248999999999999988777899998654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.72 E-value=6.5e-05 Score=74.30 Aligned_cols=75 Identities=13% Similarity=0.109 Sum_probs=48.2
Q ss_pred hcceecceEEEEEEecC-CcEEEEEEecc----cc---chhHHHHHHHHHHHHHcC-C--CCeeeEeeeeeecCceEEEE
Q 010088 175 IIGQGGFGTVYKAQFSD-GSLIAVKRMDK----IS---EQVEGDFCREIELLARLH-H--RHLVALRGFCIEKRERFLMY 243 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~----~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~lV~ 243 (518)
.||.|....||+....+ |+.++||.-.. .. .........|.+.|..+. + ..+.+++.+ +.+..++||
T Consensus 33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvm 110 (392)
T d2pula1 33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM 110 (392)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEE
Confidence 58999999999998754 67899996431 11 112234567888888773 3 345556554 455678999
Q ss_pred EecCCCCH
Q 010088 244 EYMANGSL 251 (518)
Q Consensus 244 e~~~~gsL 251 (518)
|++.+..+
T Consensus 111 E~L~~~~~ 118 (392)
T d2pula1 111 EDLSHLKI 118 (392)
T ss_dssp CCCTTSEE
T ss_pred eccCCccc
Confidence 99987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.17 E-value=0.00068 Score=64.83 Aligned_cols=133 Identities=14% Similarity=0.149 Sum_probs=77.0
Q ss_pred eEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCe--eeEee-----eeeecCceEEEEEecCCCCHH--
Q 010088 182 GTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL--VALRG-----FCIEKRERFLMYEYMANGSLK-- 252 (518)
Q Consensus 182 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g-----~~~~~~~~~lV~e~~~~gsL~-- 252 (518)
-.||+.+.++|..+++|..+.. ....+++..|...+..|...++ +..+. .....+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 5899999999999999987542 2234667889988888853322 11111 223345678899998764331
Q ss_pred ---HH---------hc----CC---CCCCCCHHH-------------------HHHHHHHHHHHHHHHhh----cCCCCc
Q 010088 253 ---DH---------LH----SP---GRTPLSWQT-------------------RIQIAIDVANALEYLHF----YCDPPL 290 (518)
Q Consensus 253 ---~~---------l~----~~---~~~~l~~~~-------------------~~~i~~~ia~gL~yLH~----~~~~~i 290 (518)
.+ +| .. .+..+++.. +..+...+...++.+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 10 11 00 011222211 11122222333333322 124578
Q ss_pred eecccCCCcEEecCCCcEEEeeccccc
Q 010088 291 CHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 291 iHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
||+|+.+.|||++++ ..+.||+-+.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ecCCCCcccEEEeCC--ceEEechhcc
Confidence 999999999999754 4589999765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.66 E-value=0.0019 Score=63.24 Aligned_cols=71 Identities=21% Similarity=0.267 Sum_probs=47.6
Q ss_pred hcceecceEEEEEEecCC--------cEEEEEEeccccchhHHHHHHHHHHHHHcCCCCe-eeEeeeeeecCceEEEEEe
Q 010088 175 IIGQGGFGTVYKAQFSDG--------SLIAVKRMDKISEQVEGDFCREIELLARLHHRHL-VALRGFCIEKRERFLMYEY 245 (518)
Q Consensus 175 ~lG~G~~g~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~ 245 (518)
.|+.|-.-.+|+....++ ..|.+++... .. ...+..+|..+++.+.-.++ .++++++.. .+|+||
T Consensus 49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 577788899999987543 4566655442 22 23456689999998853344 467777642 689999
Q ss_pred cCCCCH
Q 010088 246 MANGSL 251 (518)
Q Consensus 246 ~~~gsL 251 (518)
++|.+|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.01 E-value=0.0054 Score=57.75 Aligned_cols=139 Identities=12% Similarity=0.044 Sum_probs=72.1
Q ss_pred cceecceEEEEEEecCCcEEEEEEeccccchhHHHHHHHHHHHHHcCCCCe--eeEee------eeeecCceEEEEEecC
Q 010088 176 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL--VALRG------FCIEKRERFLMYEYMA 247 (518)
Q Consensus 176 lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g------~~~~~~~~~lV~e~~~ 247 (518)
|..|---+.|+.+.++| .+++|+.+... ..++...|++++..|...++ ...+- +.........++.++.
T Consensus 26 i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 26 IAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp ECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred CCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 45666688999987665 48889875432 22345567777777743222 11111 1122345566777776
Q ss_pred CCCHHH--------------Hhc---C-CC----CCCCCH-----------------HHHHHHHHHHHHHHHHHh-hcCC
Q 010088 248 NGSLKD--------------HLH---S-PG----RTPLSW-----------------QTRIQIAIDVANALEYLH-FYCD 287 (518)
Q Consensus 248 ~gsL~~--------------~l~---~-~~----~~~l~~-----------------~~~~~i~~~ia~gL~yLH-~~~~ 287 (518)
+..... .++ . .. .....+ ......+..+...+.-.+ ....
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 543310 011 0 00 000000 011122222222222222 1225
Q ss_pred CCceecccCCCcEEecCCCcEEEeeccccc
Q 010088 288 PPLCHRDIKSSNILLDENFVAKLADFGLAH 317 (518)
Q Consensus 288 ~~iiHrDlk~~NILl~~~~~~kl~DfGla~ 317 (518)
.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 689999999999999998877899999764
|